PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Qaseem, A; McLean, RM; Starkey, M; Forciea, MA				Qaseem, Amir; McLean, Robert M.; Starkey, Melissa; Forciea, Mary Ann		Clinical Guidelines Comm Amer Coll	Diagnosis of Acute Gout: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							DUAL-ENERGY CT; JOINT FLUID ANALYSIS; CLASSIFICATION CRITERIA; INCIDENT GOUT; URATE CRYSTAL; RISK; IDENTIFICATION; MEN; MANAGEMENT; ARTHRITIS	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the diagnosis of gout. Methods: This guideline is based on a systematic review of published studies on gout diagnosis, identified using several data-bases, from database inception to February 2016. Evaluated outcomes included the accuracy of the test results; intermediate outcomes (results of laboratory and radiographic tests, such as serum urate and synovial fluid crystal analysis and radiographic or ultrasonography changes); clinical decision making (additional testing and pharmacologic or dietary management); short-term clinical (patient-centered) outcomes, such as pain and joint swelling and tenderness; and adverse effects of the tests. This guideline grades the evidence and recommendations by using the ACP grading system, which is based on the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method. Target Audience and Patient Population: The target audience for this guideline includes all clinicians, and the target patient population includes adults with joint inflammation suspected to be gout. Recommendation: ACP recommends that clinicians use synovial fluid analysis when clinical judgment indicates that diagnostic testing is necessary in patients with possible acute gout. (Grade: weak recommendation, low-quality evidence)	[Qaseem, Amir; Starkey, Melissa] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [McLean, Robert M.] Yale Univ, Sch Med, 46 Prince St, New Haven, CT 06519 USA; [Forciea, Mary Ann] Univ Penn Hlth Syst, 3615 Chestnut St, Philadelphia, PA 19104 USA	American College of Physicians; Yale University; University of Pennsylvania	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Bongartz T, 2015, ANN RHEUM DIS, V74, P1072, DOI 10.1136/annrheumdis-2013-205095; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Glazebrook KN, 2011, RADIOLOGY, V261, P516, DOI 10.1148/radiol.11102485; GORDON C, 1989, ANN RHEUM DIS, V48, P737, DOI 10.1136/ard.48.9.737; Huppertz A, 2014, RHEUMATOL INT, V34, P763, DOI 10.1007/s00296-014-2979-1; Janssens HJEM, 2010, ANN RHEUM DIS, V69, P1255, DOI 10.1136/ard.2009.123687; Jatuworapruk K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002730; Kienhorst LBE, 2015, RHEUMATOLOGY, V54, P609, DOI 10.1093/rheumatology/keu378; Krishnan E, 2013, ARTHRITIS RHEUM-US, V65, P3271, DOI 10.1002/art.38171; Lai KL, 2011, J MED ULTRASOUND, V19, P7, DOI 10.1016/j.jmu.2011.01.003; Lamers-Karnebeek FBG, 2014, CLIN RHEUMATOL, V33, P555, DOI 10.1007/s10067-014-2505-6; Li C, 2013, AM J PHARM BENEFIST, V5, pe46; [刘颖 Liu Ying], 2015, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V40, P652; Loffler C, 2015, J RHEUMATOL, V42, P513, DOI 10.3899/jrheum.140634; Malik A, 2009, JCR-J CLIN RHEUMATOL, V15, P22, DOI 10.1097/RHU.0b013e3181945b79; Neogi T, 2015, ANN RHEUM DIS, V74, P1789, DOI 10.1136/annrheumdis-2015-208237; Newberry SJ, 2016, AHRQ PUBLICATION, V15; Newberry SJ, 2017, ANN INTERN MED, V166, P27, DOI 10.7326/M16-0462; Park JW, 2014, KOREAN J INTERN MED, V29, P361, DOI 10.3904/kjim.2014.29.3.361; Pascal Z, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0701-7; Perez-Ruiz F, 2011, JCR-J CLIN RHEUMATOL, V17, P349, DOI 10.1097/RHU.0b013e3182314d40; Pollet S, 2015, JOINT BONE SPINE, V82, P161, DOI 10.1016/j.jbspin.2014.11.005; Qaseem A, 2017, ANN INTERN MED, V166, P58, DOI 10.7326/M16-0570; Rettenbacher T, 2008, EUR RADIOL, V18, P621, DOI 10.1007/s00330-007-0802-z; Richette P, 2015, ANN RHEUM DIS, V74, P1684, DOI 10.1136/annrheumdis-2013-204976; Santaguida PL, 2012, METHODS GUIDE MED TE; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Taylor WJ, 2016, J RHEUMATOL, V43, P150, DOI 10.3899/jrheum.150684; Taylor WJ, 2016, ANN RHEUM DIS, V75, P178, DOI 10.1136/annrheumdis-2014-206364; Taylor WJ, 2015, ARTHRIT CARE RES, V67, P1304, DOI 10.1002/acr.22585; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	36	37	40	1	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					52	+		10.7326/M16-0569	http://dx.doi.org/10.7326/M16-0569			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	27802479				2022-12-28	WOS:000391467900008
J	Rahman, A; Hamdani, SU; Awan, NR; Bryant, RA; Dawson, KS; Khan, MF; Azeemi, MMUH; Akhtar, P; Nazir, H; Chiumento, A; Sijbrandij, M; Wang, DL; Farooq, S; van Ommeren, M				Rahman, Atif; Hamdani, Syed Usman; Awan, Naila Riaz; Bryant, Richard A.; Dawson, Katie S.; Khan, Muhammad Firaz; Azeemi, Mian Mukhtar-ul-Haq; Akhtar, Parveen; Nazir, Huma; Chiumento, Anna; Sijbrandij, Marit; Wang, Duolao; Farooq, Saeed; van Ommeren, Mark			Effect of a Multicomponent Behavioral Intervention in Adults Impaired by Psychological Distress in a Conflict-Affected Area of Pakistan A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLUS PM PLUS; MENTAL-HEALTH 5; HOSPITAL ANXIETY; DEPRESSION SCALE; MANAGEMENT; CHALLENGES; DISORDERS; COMMUNITY; EVENTS; URDU	IMPORTANCE The mental health consequences of conflict and violence are wide-ranging and pervasive. Scalable interventions to address a range of mental health problems are needed. OBJECTIVE To test the effectiveness of a multicomponent behavioral intervention delivered by lay health workers to adults with psychological distress in primary care settings. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial was conducted from November 1, 2014, through January 28, 2016, in 3 primary care centers in Peshawar, Pakistan, that included 346 adult primary care attendees with high levels of both psychological distress and functional impairment according to the 12-item General Health Questionnaire and the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). INTERVENTIONS Lay health workers administered 5 weekly 90-minute individual sessions that included empirically supported strategies of problem solving, behavioral activation, strengthening social support, and stress management. The control was enhanced usual care. MAIN OUTCOMES AND MEASURES Primary outcomes, anxiety and depression symptoms, were independently measured at 3 months with the Hospital Anxiety and Depression Scale (HADS). Secondary outcomes were posttraumatic stress symptoms (Posttraumatic Stress Disorder Checklist for DSM-5), functional impairment (WHODAS 2.0), progress on problems for which the person sought help (Psychological Outcome Profiles), and symptoms of depressive disorder (9-item Patient Health Questionnaire). RESULTS Among 346 patients (mean [SD] age, 33.0[11.8] years; 78.9% women), 172 were randomly assigned to the intervention and 174 to enhanced usual care; among them, 146 and 160 completed the study, respectively. At baseline, the intervention and control groups had similar mean (SD) HADS scores on symptoms of anxiety (14.16 [3.17] vs 13.64 [3.20]; adjusted mean difference [AMD], 0.52; 95% CI, -0.22 to 1.27) and depression (12.67 [3.27] vs 12.49 [3.34]; AMD, 0.17, 95% CI, -0.54 to0.89). After 3 months of treatment, the intervention group had significantly lower mean (SD) HADS scores than the control group for anxiety (7.25 [3.63] vs 10.03 [3.87]; AMD, -2.77; 95% CI, -3.56 to -1.98) and depression (6.30 [3.40] vs 9.27 [3.56]; AMD, -2.98; 95% CI, -3.74 to -2.22). At 3 months, there were also significant differences in scores of posttraumatic stress(AMD, -5.86; 95% CI, -8.53 to -3.19), functional impairment (AMD, -4.17; 95% CI, -5.84 to -2.51), problems for which the person sought help(AMD, -1.58; 95% CI, -2.40 to -0.77), and symptoms of depressive disorder(AMD, -3.41; 95% CI, -4.49 to -2.34). CONCLUSIONS AND RELEVANCE Among adults impaired by psychological distress in a conflict-affected area, lay health worker administration of a brief multicomponent intervention based on established behavioral strategies, compared with enhanced usual care, resulted in clinically significant reductions in anxiety and depressive symptoms at 3 months.	[Rahman, Atif; Chiumento, Anna] Univ Liverpool, Liverpool, Merseyside, England; [Hamdani, Syed Usman; Akhtar, Parveen; Nazir, Huma] Human Dev Res Fdn, Islamabad, Pakistan; [Awan, Naila Riaz; Khan, Muhammad Firaz; Azeemi, Mian Mukhtar-ul-Haq; Farooq, Saeed] Lady Reading Hosp, Peshawar, Pakistan; [Bryant, Richard A.; Dawson, Katie S.] Univ New South Wales, Sydney, NSW, Australia; [Sijbrandij, Marit] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Wang, Duolao] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Farooq, Saeed] Keele Univ, Res Inst Primary Care & Hlth Sci, Keele, Staffs, England; [van Ommeren, Mark] WHO, Geneva, Switzerland	University of Liverpool; University of New South Wales Sydney; Vrije Universiteit Amsterdam; Liverpool School of Tropical Medicine; Keele University; World Health Organization	Rahman, A (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, 1-5 Dover St,Block B,Waterhouse Bldg, Liverpool L69 3BX, Merseyside, England.	atif.rahman@liverpool.ac.uk	Chiumento, Anna/GYU-0450-2022; Bryant, Richard/AAA-6479-2019; Sijbrandij, Marit/N-6131-2018; Nazir, Huma/AAU-8995-2021; Farooq, Saeed/HGT-7232-2022	Bryant, Richard/0000-0002-9607-819X; Sijbrandij, Marit/0000-0001-5430-9810; Farooq, Saeed/0000-0003-2088-6876; Hamdani, Syed Usman/0000-0002-5120-3225; Akhtar, Parveen/0000-0001-6219-3600; Wang, Duolao/0000-0003-2788-2464	Enhanced Learning and Research for Humanitarian Assistance's Research for Health in Humanitarian Crises initiative - UK Department for International Development; Wellcome Trust	Enhanced Learning and Research for Humanitarian Assistance's Research for Health in Humanitarian Crises initiative - UK Department for International Development; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Enhanced Learning and Research for Humanitarian Assistance's Research for Health in Humanitarian Crises initiative funded by the UK Department for International Development and the Wellcome Trust.	Ahmer S, 2007, BMC PSYCHIATRY, V7, DOI 10.1186/1471-244X-7-59; Ashworth M., 2005, PRIM CARE MENTAL HLT, V3, P261, DOI DOI 10.1080/09638230701879144; Ashworth M., 2004, COUNSELLING PSYCHOTH, V4, P27, DOI [10.1080/14733140412331383913, DOI 10.1080/14733140412331383913]; Bass JK, 2013, NEW ENGL J MED, V368, P2182, DOI 10.1056/NEJMoa1211853; Bernal G, 2006, J COMMUNITY PSYCHOL, V34, P121, DOI 10.1002/jcop.20096; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bolton P, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001757; Chiumento A, 2016, DEV WORLD BIOETH, V16, P15, DOI 10.1111/dewb.12076; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Dawson KS, 2015, WORLD PSYCHIATRY, V14, P354, DOI 10.1002/wps.20255; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Goldberg D.P., 1988, USERS GUIDE GEN HLTH; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Husain Nusrat, 2006, J Pak Med Assoc, V56, P366; Kakuma R, 2011, LANCET, V378, P1654, DOI 10.1016/S0140-6736(11)61093-3; Karim S, 2004, INT REV PSYCHIATR, V16, P83, DOI 10.1080/09540260310001635131; Khalily MT., 2012, ONLINE J COUNSEL ED, V1, P1; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Minhas FM, 1996, J COLL PHYS SURGEONS, V6, P133; Mohanty TR, 2014, S ASIA INTELL REV, V12; MUMFORD DB, 1991, ACTA PSYCHIAT SCAND, V83, P81, DOI 10.1111/j.1600-0447.1991.tb07370.x; Murray LK, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-30; Natsuaki MN, 2015, LANCET PSYCHIAT, V2, P573, DOI 10.1016/S2215-0366(15)00158-3; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rahman A, 2016, WORLD PSYCHIATRY, V15, P182, DOI 10.1002/wps.20312; Raudenbush SW, 2001, ANNU REV PSYCHOL, V52, P501, DOI 10.1146/annurev.psych.52.1.501; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; Sijbrandij M, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0602-y; Steel Z, 2009, JAMA-J AM MED ASSOC, V302, P537, DOI 10.1001/jama.2009.1132; Tol WA, 2013, JAMA-J AM MED ASSOC, V310, P477, DOI 10.1001/jama.2013.166723; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; United Nations Office for the Coordination of Humanitarian Affairs, 2016, GLOB HUM OV; van Ginneken N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009149.pub2; Weathers FW, 2013, THEPTSDCHECKLISTFORD; WHO, 2010, MEASURING HLTH DISAB; World Health Organization, 2016, PROBLEM MANAGEMENT P; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	146	147	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2609	2617		10.1001/jama.2016.17165	http://dx.doi.org/10.1001/jama.2016.17165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EG5UN	27837602	Green Accepted			2022-12-28	WOS:000391110200015
J	Voelker, R				Voelker, Rebecca			HCV Drug Warning	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1957	1957		10.1001/jama.2016.16352	http://dx.doi.org/10.1001/jama.2016.16352			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838707				2022-12-28	WOS:000387673800007
J	Dolgin, E				Dolgin, Elie			The three things that could help prevent a meltdown in health-care systems worldwide.	NATURE			English	Editorial Material																			0	18	20	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					156	158		10.1038/539156a	http://dx.doi.org/10.1038/539156a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830826	Bronze			2022-12-28	WOS:000387318500011
J	O'Connor, DL; Gibbins, S; Kiss, A; Bando, N; Brennan-Donnan, J; Ng, E; Campbell, DM; Vaz, S; Fusch, C; Asztalos, E; Church, P; Kelly, E; Ly, L; Daneman, A; Unger, S				O'Connor, Deborah L.; Gibbins, Sharyn; Kiss, Alex; Bando, Nicole; Brennan-Donnan, Joan; Ng, Eugene; Campbell, Douglas M.; Vaz, Simone; Fusch, Christoph; Asztalos, Elizabeth; Church, Paige; Kelly, Edmond; Ly, Linh; Daneman, Alan; Unger, Sharon		GTA DoMINO Feeding Grp	Effect of Supplemental Donor Human Milk Compared With Preterm Formula on Neurodevelopment of Very Low-Birth-Weight Infants at 18 Months A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; COGNITIVE-DEVELOPMENT; BREAST-MILK; OUTCOMES; GROWTH; IMPACT; DIET	IMPORTANCE For many very low-birth-weight (VLBW) infants, there is insufficient mother's milk, and a supplement of pasteurized donor human milk or preterm formula is required. Awareness of the benefits of mother's milk has led to an increase in use of donor milk, despite limited data evaluating its efficacy. OBJECTIVE To determine if nutrient-enriched donor milk compared with formula, as a supplement to mother's milk, reduces neonatal morbidity, supports growth, and improves neurodevelopment in VLBW infants. DESIGN, SETTING, AND PARTICIPANTS In this pragmatic, double-blind, randomized trial, VLBW infants were recruited from 4 neonatal units in Ontario, Canada, within 96 hours of birth between October 2010 and December 2012. Follow-up was completed in July 2015. INTERVENTIONS Infants were fed either donor milk or formula for 90 days or to discharge when mother's milk was unavailable. MAIN OUTCOMES AND MEASURES The primary outcome was the cognitive composite score on the Bayley Scales of Infant and Toddler Development, Third Edition (Bayley-III) at 18 months' corrected age (standardized mean, 100 [SD, 15]; minimal clinically important difference, 5 points). Secondary outcomes included Bayley-III language and motor composite scores, growth, and a dichotomous mortality and morbidity index. RESULTS Of 840 eligible infants, 363 (43.2%) were randomized (181 to donor milk and 182 to preterm formula); of survivors, 299 (92%) had neurodevelopment assessed. Mean birth weight and gestational age of infants was 996 (SD, 272) g and 27.7 (2.6) weeks, respectively, and 195 (53.7%) were male. No statistically significant differences in mean Bayley-III cognitive composite score (adjusted scores, 92.9 in donor milk group vs 94.5 in formula group; fully adjusted mean difference, -2.0 [95% CI, -5.8 to 1.8]), language composite score (adjusted scores, 87.3 in donor milk group vs 90.3 in formula group; fully adjusted mean difference, -3.1 [95% CI, -7.5 to 1.3]), or motor composite score (adjusted scores, 91.8 in donor milk group vs 94.0 in formula group; fully adjusted mean difference, -3.7 [95% CI, -7.4 to 0.09]) were observed between groups. There was no statistically significant difference in infants positive for the mortality and morbidity index (43% in donor milk group, 40% in formula group) or changes in growth z scores. CONCLUSIONS AND RELEVANCE Among VLBW infants, use of supplemental donor milk compared with formula did not improve neurodevelopment at 18 months' corrected age. If donor milk is used in settings with high provision of mother's milk, this outcome should not be considered a treatment goal.	[O'Connor, Deborah L.; Bando, Nicole; Brennan-Donnan, Joan] Hosp Sick Children, Physiol & Expt Med Program, Toronto, ON, Canada; [O'Connor, Deborah L.; Brennan-Donnan, Joan] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada; [Gibbins, Sharyn] Trillium Hlth Partners, Mississauga, ON, Canada; [Kiss, Alex] Sunnybrook Res Inst, Evaluat & Clin Sci, Toronto, ON, Canada; [Kiss, Alex] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Brennan-Donnan, Joan] Hosp Sick Children, Dept Clin Dietet, Toronto, ON, Canada; [Ng, Eugene; Asztalos, Elizabeth; Church, Paige] Sunnybrook Hlth Sci Ctr, Dept Pediat, Toronto, ON, Canada; [Ng, Eugene; Campbell, Douglas M.; Asztalos, Elizabeth; Church, Paige; Kelly, Edmond; Ly, Linh; Unger, Sharon] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Campbell, Douglas M.] St Michaels Hosp, Toronto, ON, Canada; [Campbell, Douglas M.] Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Campbell, Douglas M.; Ly, Linh; Unger, Sharon] Hosp Sick Children, Dept Neonatol, Toronto, ON, Canada; [Vaz, Simone] William Osler Hlth Syst, Dept Pediat, Brampton, ON, Canada; [Fusch, Christoph] McMaster Childrens Hosp, Dept Pediat, Hamilton, ON, Canada; [Fusch, Christoph] McMaster Univ, Hamilton, ON, Canada; [Kelly, Edmond; Unger, Sharon] Mt Sinai Hosp, Dept Pediat, Toronto, ON, Canada; [Daneman, Alan] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada; [Daneman, Alan] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Trillium Health Partners; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	O'Connor, DL (corresponding author), Univ Toronto, Hosp Sick Children, Dept Nutr Sci, Room 327,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	deborah.oconnor@utoronto.ca	Unger, Sharon/P-5855-2015; Asztalos, Elizabeth/L-8834-2019; O'Connor, Deborah L/O-8221-2018	Asztalos, Elizabeth/0000-0002-9468-2860; O'Connor, Deborah L/0000-0001-6331-091X; Unger, Sharon/0000-0001-8091-5742; Ng, Eugene/0000-0003-4329-8401; Bando, Nicole/0000-0003-4257-4785	Canadian Institutes of Health Research (MOP) [102638]; Ontario Ministry of Health and Long-Term Care [06465]	Canadian Institutes of Health Research (MOP)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This work was funded by the Canadian Institutes of Health Research (MOP No. 102638) and the Ontario Ministry of Health and Long-Term Care (grant No. 06465).	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Asztalos EV, 2017, AM J PERINAT, V34, P364, DOI 10.1055/s-0036-1592080; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Bayley N., 2019, BAYLEY SCALES INFANT; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Bode MM, 2014, J DEV BEHAV PEDIATR, V35, P570, DOI 10.1097/DBP.0000000000000110; Chirico G, 2008, J NUTR, V138, p1801S, DOI 10.1093/jn/138.9.1801S; Colaizy TT, 2015, CURR OPIN PEDIATR, V27, P172, DOI 10.1097/MOP.0000000000000201; Corpeleijn WE, 2016, JAMA PEDIATR, V170, P654, DOI 10.1001/jamapediatrics.2016.0183; Ehrenkranz RA, 2006, PEDIATRICS, V117, P1253, DOI 10.1542/peds.2005-1368; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216; Institute of Medicine, 2005, DIET REF INT EN CARB; Isaacs EB, 2008, PEDIATR RES, V63, P308, DOI 10.1203/PDR.0b013e318163a271; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Linsell L, 2015, JAMA PEDIATR, V169, P1162, DOI 10.1001/jamapediatrics.2015.2175; LUCAS A, 1994, ARCH DIS CHILD-FETAL, V70, pF141, DOI 10.1136/fn.70.2.F141; Lucas A, 1998, BRIT MED J, V317, P1481, DOI 10.1136/bmj.317.7171.1481; Makrides M, 2009, JAMA-J AM MED ASSOC, V301, P175, DOI 10.1001/jama.2008.945; Mitha A, 2013, PEDIATRICS, V132, pE372, DOI 10.1542/peds.2012-3979; O'Connor DL, 2015, CURR OPIN CLIN NUTR, V18, P269, DOI 10.1097/MCO.0000000000000160; O'Connor DL, 2003, J PEDIATR GASTR NUTR, V37, P437, DOI 10.1097/00005176-200310000-00008; Patel AL, 2013, J PERINATOL, V33, P514, DOI 10.1038/jp.2013.2; PATZ A, 1987, ARCH OPHTHALMOL-CHIC, V105, P905, DOI 10.1001/archopht.1987.01060070041024; Quigley M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002971.pub3; Schanler RJ, 2005, PEDIATRICS, V116, P400, DOI 10.1542/peds.2004-1974; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Shah P, 2012, CANADIAN NEONATAL NE; Shah P, 2011, CANADIAN NEONATAL NE; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Sun H, 2015, J PERINATOL, V35, P867, DOI 10.1038/jp.2015.87; Unger S, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-123; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Vohr BR, 2007, PEDIATRICS, V120, pe953, DOI 10.1542/peds.2006-3227; Vohr BR, 2006, PEDIATRICS, V118, pE115, DOI 10.1542/peds.2005-2382; Wadhawan R, 2009, PEDIATRICS, V123, pE220, DOI 10.1542/peds.2008-1126	37	139	141	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1897	1905		10.1001/jama.2016.16144	http://dx.doi.org/10.1001/jama.2016.16144			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27825008				2022-12-28	WOS:000387116500018
J	Mayor, S				Mayor, Susan			Early diagnosis of ectopic pregnancy is essential to reduce deaths, says guideline	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Association of Early Pregnancy Units Royal College of Obstetricians and Gynaecologists], 2016, BJOG	1	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2016	355								i5954	10.1136/bmj.i5954	http://dx.doi.org/10.1136/bmj.i5954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CQ	27821545				2022-12-28	WOS:000388002700004
J	Cohen, J				Cohen, Jon			MICE MADE EASY	SCIENCE			English	Editorial Material																			0	6	6	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					538	542		10.1126/science.354.6312.538	http://dx.doi.org/10.1126/science.354.6312.538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811248				2022-12-28	WOS:000386869800016
J	Sinatra, R; Wang, D; Deville, P; Song, CM; Barabasi, AL				Sinatra, Roberta; Wang, Dashun; Deville, Pierre; Song, Chaoming; Barabasi, Albert-Laszlo			Quantifying the evolution of individual scientific impact	SCIENCE			English	Article							SCIENCE; CAREER; UNIVERSALITY; PERFORMANCE; CREATIVITY; LANDMARKS; METRICS; AUTHOR; TEAMS; MODEL		[Sinatra, Roberta; Deville, Pierre; Barabasi, Albert-Laszlo] Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA; [Sinatra, Roberta; Deville, Pierre; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [Sinatra, Roberta] Cent European Univ, Ctr Network Sci & Math Dept, Budapest, Hungary; [Wang, Dashun] Northwestern Univ, Kellogg Sch Management, Evanston, IL 60208 USA; [Wang, Dashun] Northwestern Univ, Northwestern Inst Complex Syst, Evanston, IL 60208 USA; [Deville, Pierre] Catholic Univ Louvain, Dept Appl Math, Louvain La Neuve, Belgium; [Song, Chaoming] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; [Barabasi, Albert-Laszlo] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Cent European Univ, Ctr Network Sci, Budapest, Hungary; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA	Northeastern University; Northeastern University; Central European University; Northwestern University; Northwestern University; Universite Catholique Louvain; University of Miami; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central European University; Harvard University; Dana-Farber Cancer Institute	Barabasi, AL (corresponding author), Northeastern Univ, Ctr Complex Network Res, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Northeastern Univ, Dept Phys, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA.; Barabasi, AL (corresponding author), Cent European Univ, Ctr Network Sci, Budapest, Hungary.; Barabasi, AL (corresponding author), Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA.	alb@neu.edu	Barabasi, Albert-Laszlo/S-6474-2017; Sinatra, Roberta/G-9836-2012	Sinatra, Roberta/0000-0002-7558-1028; Barabasi, Albert/0000-0002-4028-3522	Air Force Office of Scientific Research (AFOSR) [FA9550-15-1-0077, FA9550-15-1-0364]; Future and Emerging Technologies Project - European Commission [317 532 "Multiplex"]; AFOSR [FA9550-15-1-0162]; Young Investigator Award; National Foundation for Scientific Research; Research Department of the Communaute francaise de Belgique (Large Graph Concerted Research Action)	Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Future and Emerging Technologies Project - European Commission; AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Young Investigator Award; National Foundation for Scientific Research; Research Department of the Communaute francaise de Belgique (Large Graph Concerted Research Action)	The Physical Review data set can be requested from the APS at http://journals.aps. org/datasets. Data with the result of the disambiguation procedure, described in section S1.1, can be found as supplementary materials. An interactive visualization of the data sets, focusing on the random-impact rule, can be found at www.barabasilab.com/scienceofsuccess/. We thank J. A. Evans, S. Fortunato, S. Lehmann, B. Uzzi, B. Coutinho, S. Gil, E. Guney, J. Huang, J. Menche, F. Simini, M. Szell, and all other colleagues at the Center for Complex Network Research (CCNR) for the valuable discussions and comments. We thank H. Shen for the help with the credit share analysis. R.S. and A.-L. B. were supported by Air Force Office of Scientific Research (AFOSR) grants FA9550-15-1-0077 and FA9550-15-1-0364. A.-L. B. was also supported by the Future and Emerging Technologies Project 317 532 "Multiplex" financed by the European Commission. D.W. was supported by AFOSR grant FA9550-15-1-0162 and a Young Investigator Award. P.D. acknowledges support by the National Foundation for Scientific Research and the Research Department of the Communaute francaise de Belgique (Large Graph Concerted Research Action). R. S. developed the majority of this work during her stay at the CCNR, supported by the J. S. McDonnell Foundation. All authors designed and did the research. R. S. analyzed the empirical data, developed the models and controls, and performed the calculations. A.-L. B. was the lead writer of the manuscript.	Acuna DE, 2012, NATURE, V489, P201, DOI 10.1038/489201a; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; [Anonymous], 1958, STAT EXTREMES, DOI DOI 10.7312/GUMB92958; Azoulay P, 2012, NATURE, V484, P31, DOI 10.1038/484031a; Azoulay P, 2011, RAND J ECON, V42, P527, DOI 10.1111/j.1756-2171.2011.00140.x; Borner K, 2004, P NATL ACAD SCI USA, V101, P5266, DOI 10.1073/pnas.0307625100; Bornmann L, 2011, J INFORMETR, V5, P346, DOI 10.1016/j.joi.2011.01.006; Clauset A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400005; Coles S., 2001, INTRO STAT MODELING; De Solla Price D. J., 1963, LITTLE SCI BIG SCI, DOI 10.7312/pric91844; Deville P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04770; Evans JA, 2013, SCIENCE, V342, P44, DOI 10.1126/science.1245218; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Fuyuno I, 2006, NATURE, V441, P792, DOI 10.1038/441792b; Garlaschelli D, 2003, NATURE, V423, P165, DOI 10.1038/nature01604; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Jones BF, 2011, P NATL ACAD SCI USA, V108, P18910, DOI 10.1073/pnas.1102895108; Kaur J, 2013, J INFORMETR, V7, P924, DOI 10.1016/j.joi.2013.09.002; Lehmann S, 2008, SCIENTOMETRICS, V76, P369, DOI 10.1007/s11192-007-1868-8; Lehmann S, 2006, NATURE, V444, P1003, DOI 10.1038/4441003a; Malmgren RD, 2010, NATURE, V465, P622, DOI 10.1038/nature09040; Mane KK, 2004, P NATL ACAD SCI USA, V101, P5287, DOI 10.1073/pnas.0307626100; Moody J, 2003, AM SOCIOL REV, V68, P103, DOI 10.2307/3088904; Owens B, 2013, NATURE, V502, P288, DOI 10.1038/502288a; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Penner O, 2013, SCI REP-UK, V3, DOI 10.1038/srep03052; Petersen AM, 2012, P NATL ACAD SCI USA, V109, P5213, DOI 10.1073/pnas.1121429109; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; Radicchi F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056103; Redner S, 2005, PHYS TODAY, V58, P49, DOI 10.1063/1.1996475; Rybski D, 2009, P NATL ACAD SCI USA, V106, P12640, DOI 10.1073/pnas.0902667106; Shen HW, 2014, P NATL ACAD SCI USA, V111, P12325, DOI 10.1073/pnas.1401992111; SIMONTON DK, 1991, DEV PSYCHOL, V27, P119, DOI 10.1037/0012-1649.27.1.119; Simonton DK, 1997, PSYCHOL REV, V104, P66, DOI 10.1037/0033-295X.104.1.66; Sinatra R, 2015, NAT PHYS, V11, P791, DOI 10.1038/nphys3494; Stringer MJ, 2010, J AM SOC INF SCI TEC, V61, P1377, DOI 10.1002/asi.21335; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Vicsek T, 2001, NATURE, V411, P421, DOI 10.1038/35078161; Wang DS, 2013, SCIENCE, V342, P127, DOI 10.1126/science.1237825; Way S. F., 2016, P 25 INT C WORLD WID; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Zhang CT, 2009, EMBO REP, V10, P416, DOI 10.1038/embor.2009.74	45	286	295	34	270	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312							aaf5239	10.1126/science.aaf5239	http://dx.doi.org/10.1126/science.aaf5239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811240				2022-12-28	WOS:000386869800040
J	Sommer, C				Sommer, Claudia			Exploring pain pathophysiology in patients	SCIENCE			English	Review							SMALL-FIBER NEUROPATHY; HEAT-EVOKED-POTENTIALS; SYNDROME TYPE-I; FIBROMYALGIA SYNDROME; DOUBLE-BLIND; DIFFERENTIAL EXPRESSION; ELECTRICAL-STIMULATION; DIABETIC-NEUROPATHY; CYTOKINE EXPRESSION; HEALTHY CONTROLS	Although animal models of pain have brought invaluable information on basic processes underlying pain pathophysiology, translation to humans is a problem. This Review will summarize what information has been gained by the direct study of patients with chronic pain. The techniques discussed range from patient phenotyping using quantitative sensory testing to specialized nociceptor neurophysiology, imaging methods of peripheral nociceptors, analyses of body fluids, genetics and epigenetics, and the generation of sensory neurons from patients via inducible pluripotent stem cells.	[Sommer, Claudia] Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany	University of Wurzburg	Sommer, C (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-97080 Wurzburg, Germany.	sommer@uni-wuerzburg.de	Sommer, Claudia/A-9820-2010	Sommer, Claudia/0000-0002-7064-5002	Baxalta; Genzyme; Grifols; Kedrion; Novartis; Astellas; Pfizer	Baxalta; Genzyme(Sanofi-AventisGenzyme Corporation); Grifols; Kedrion; Novartis(Novartis); Astellas(Astellas Pharmaceuticals); Pfizer(Pfizer)	C.S. is a consultant for the following companies, which provide medication for neuropathic pain or neuropathies: Baxalta, Genzyme, Grifols, Air Liquide, CSL-Behring, and Astellas. The author has given educational talks on neuropathic pain or neuropathies at events sponsored by the following companies: Baxalta, Genzyme, Grifols, Kedrion, Novartis, Astellas, and Pfizer.	Andersson M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24818; Attal N, 2016, LANCET NEUROL, V15, P555, DOI 10.1016/S1474-4422(16)00017-X; Backonja MM, 2009, CLIN J PAIN, V25, P641, DOI 10.1097/AJP.0b013e3181a68c7e; Backryd E, 2015, J PAIN RES, V8, P321, DOI 10.2147/JPR.S82970; Bali KK, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-22; Bell JT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms3978; Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Bjersing JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078762; Cao LS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7653; Cerda-Olmedo G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121903; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chan ACY, 2016, MUSCLE NERVE, V53, P671, DOI 10.1002/mus.25082; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; de Tommaso M, 2014, J NEUROL, V261, P461, DOI 10.1007/s00415-013-7211-9; Demant DT, 2015, PAIN, V156, P2234, DOI 10.1097/j.pain.0000000000000266; Demant DT, 2014, PAIN, V155, P2263, DOI 10.1016/j.pain.2014.08.014; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Dib-Hajj SD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007017; Doppler K, 2015, PAIN, V156, P2319, DOI 10.1097/j.pain.0000000000000285; Dotson RM, 1997, J CLIN NEUROPHYSIOL, V14, P32, DOI 10.1097/00004691-199701000-00003; Estacion M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-92; Estacion M, 2009, ANN NEUROL, V66, P862, DOI 10.1002/ana.21895; Granovsky Y, 2016, PAIN, V157, P1156, DOI 10.1097/j.pain.0000000000000495; Grone E, 2014, PAIN, V155, P1784, DOI 10.1016/j.pain.2014.06.003; Harrer JU, 2014, PAIN, V155, P2199, DOI 10.1016/j.pain.2014.08.003; Herrmann DN, 2006, MUSCLE NERVE, V33, P42, DOI 10.1002/mus.20419; Holbech JV, 2016, PAIN, V157, P1305, DOI 10.1097/j.pain.0000000000000563; Jiang MS, 2016, BRIT J OPHTHALMOL, V100, P9, DOI 10.1136/bjophthalmol-2014-306038; Katsarava Z, 2006, HEADACHE, V46, P1511, DOI 10.1111/j.1526-4610.2006.00446.x; Kawagoe S, 2013, MOL GENET METAB, V109, P386, DOI 10.1016/j.ymgme.2013.06.003; KESSLER W, 1992, EXP BRAIN RES, V91, P467; Kleggetveit IP, 2012, PAIN, V153, P2040, DOI 10.1016/j.pain.2012.05.017; Kress M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00033; Lagerburg V, 2015, MUSCLE NERVE, V51, P743, DOI 10.1002/mus.24465; Lebonvallet N, 2014, EXP DERMATOL, V23, P73, DOI 10.1111/exd.12294; Lefaucheur JP, 2012, NEUROPHYSIOL CLIN, V42, P199, DOI 10.1016/j.neucli.2011.12.003; Lenz M, 2013, PAIN, V154, P2142, DOI 10.1016/j.pain.2013.06.039; Madsen CS, 2012, NEUROSCIENCE, V223, P92, DOI 10.1016/j.neuroscience.2012.07.049; Mainka T, 2016, EUR J PAIN, V20, P116, DOI 10.1002/ejp.703; Massart R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19615; Moloney RD, 2016, CNS NEUROSCI THER, V22, P102, DOI 10.1111/cns.12490; Nolano M, 2008, BRAIN, V131, P1903, DOI 10.1093/brain/awn102; Oaklander AL, 2013, PAIN, V154, P2310, DOI 10.1016/j.pain.2013.06.001; Oaklander AL, 2009, ANN NEUROL, V65, P629, DOI 10.1002/ana.21692; Oki G, 2012, PAIN, V153, P532, DOI 10.1016/j.pain.2011.11.008; Orstavik K, 2006, J NEUROSCI, V26, P11287, DOI 10.1523/JNEUROSCI.2659-06.2006; Oudejans L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23573; Potvin S, 2016, PAIN, V157, P1704, DOI 10.1097/j.pain.0000000000000573; Reimann F, 2010, P NATL ACAD SCI USA, V107, P5148, DOI 10.1073/pnas.0913181107; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Seidel MF, 2013, OSTEOARTHR CARTILAGE, V21, P1223, DOI 10.1016/j.joca.2013.06.004; Serra J, 2014, ANN NEUROL, V75, P196, DOI 10.1002/ana.24065; Tavakoli M, 2010, EXP NEUROL, V223, P245, DOI 10.1016/j.expneurol.2009.08.033; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Treede RD, 2003, NEUROPHYSIOL CLIN, V33, P303, DOI 10.1016/j.neucli.2003.10.009; Truini A, 2012, PAIN, V153, P2048, DOI 10.1016/j.pain.2012.05.024; Uceyler N, 2007, NEUROLOGY, V69, P42, DOI 10.1212/01.wnl.0000265062.92340.a5; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Uceyler N, 2007, PAIN, V132, P195, DOI 10.1016/j.pain.2007.07.031; Uceyler N, 2006, ARTHRITIS RHEUM-US, V54, P2656, DOI 10.1002/art.22026; Uceyler N, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0472-4; Uceyler N, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0185-0; Uceyler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105269; Vartiainen N, 2016, BRAIN, V139, P708, DOI 10.1093/brain/awv389; Viet CT, 2011, PAIN, V152, P2323, DOI 10.1016/j.pain.2011.06.025; Wang H, 2009, CLIN J PAIN, V25, P1, DOI 10.1097/AJP.0b013e31817e13a3; Wasner G, 2005, J NEUROL, V252, P677, DOI 10.1007/s00415-005-0717-z; Waxman SG, 2014, LANCET NEUROL, V13, P1152, DOI 10.1016/S1474-4422(14)70150-4; Wiech K, 2016, SCIENCE, V354, P584, DOI 10.1126/science.aaf8934; Yarnitsky D, 2012, PAIN, V153, P1193, DOI 10.1016/j.pain.2012.02.021	71	29	30	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					588	592		10.1126/science.aaf8935	http://dx.doi.org/10.1126/science.aaf8935			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811270				2022-12-28	WOS:000386869800039
J	Yokoyama, Y; Esat, TM				Yokoyama, Yusuke; Esat, Tezer M.			GEOLOGY Deep-sea corals feel the flow	SCIENCE			English	Editorial Material							LEVEL		[Yokoyama, Yusuke] Univ Tokyo, Sch Sci, Atmosphere & Ocean Res Inst, Chiba, Japan; [Yokoyama, Yusuke] Univ Tokyo, Sch Sci, Dept Earth & Planetary Sci, Chiba, Japan; [Esat, Tezer M.] Australian Natl Univ, Res Sch Phys & Engn, Res Sch Earth Sci, Canberra, ACT 0200, Australia	University of Tokyo; University of Tokyo; Australian National University	Yokoyama, Y (corresponding author), Univ Tokyo, Sch Sci, Atmosphere & Ocean Res Inst, Chiba, Japan.; Yokoyama, Y (corresponding author), Univ Tokyo, Sch Sci, Dept Earth & Planetary Sci, Chiba, Japan.	yokoyama@aori.u-tokyo.ac.jp; tezer.esat@anu.edu.au						BARD E, 1991, GEOCHIM COSMOCHIM AC, V55, P2385, DOI 10.1016/0016-7037(91)90115-L; Chen TY, 2016, SCIENCE, V354, P626, DOI 10.1126/science.aag1015; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; EDWARDS RL, 1987, EARTH PLANET SC LETT, V81, P175, DOI 10.1016/0012-821X(87)90154-3; Esat TM, 2006, GEOCHIM COSMOCHIM AC, V70, P4140, DOI 10.1016/j.gca.2006.06.013; Esat TM, 2010, GEOCHIM COSMOCHIM AC, V74, P7008, DOI 10.1016/j.gca.2010.09.007; Gallup CD, 2002, SCIENCE, V295, P310, DOI 10.1126/science.1065494; Henderson GM, 2006, CHEM GEOL, V226, P298, DOI 10.1016/j.chemgeo.2005.09.026; Marino G, 2015, NATURE, V522, P197, DOI 10.1038/nature14499; Stirling CH, 1998, EARTH PLANET SC LETT, V160, P745, DOI 10.1016/S0012-821X(98)00125-3; Thompson WG, 2005, SCIENCE, V308, P401, DOI 10.1126/science.1104035; Yokoyama Y, 2016, P NATL ACAD SCI USA, V113, P2354, DOI 10.1073/pnas.1516908113	12	3	4	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					550	551		10.1126/science.aak9817	http://dx.doi.org/10.1126/science.aak9817			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811254				2022-12-28	WOS:000386869800021
J	Johnson, DB; Balko, JM; Compton, ML; Chalkias, S; Gorham, J; Xu, YM; Hicks, M; Puzanov, I; Alexander, MR; Bloomer, TL; Becker, JR; Slosky, DA; Phillips, EJ; Pilkinton, MA; Craig-Owens, L; Kola, N; Plautz, G; Reshef, DS; Deutsch, JS; Deering, RP; Olenchock, BA; Lichtman, AH; Roden, DM; Seidman, CE; Koralnik, IJ; Seidman, JG; Hoffman, RD; Taube, JM; Diaz, LA; Anders, RA; Sosman, JA; Moslehi, JJ				Johnson, Douglas B. dbj; Balko, Justin M. jmb; Compton, Margaret L. mlc; Chalkias, Spyridon sc; Gorham, Joshua jc; Xu, Yaomin yx; Hicks, Mellissa mh; Puzanov, Igor ip; Alexander, Matthew R. mra; Bloomer, Tyler L. tlb; Becker, Jason R. jrb; Slosky, David A. das; Phillips, Elizabeth J. ejp; Pilkinton, Mark A. map; Craig-Owens, Laura lco; Kola, Nina nk; Plautz, Gregory gp; Reshef, Daniel S. dsr; Deutsch, Jonathan S. jsd; Deering, Raquel P. rpd; Olenchock, Benjamin A. bao; Lichtman, Andrew H. ahl; Roden, Dan M. dmr; Seidman, Christine E. ces; Koralnik, Igor J. ijk; Seidman, Jonathan G. jgs; Hoffman, Robert D. rdh; Taube, Janis M. jmt; Diaz, Luis A. Jr lad; Anders, Robert A. raa; Sosman, Jeffrey A. jas; Moslehi, Javid J. jjm			Fulminant Myocarditis with Combination Immune Checkpoint Blockade	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DILATED CARDIOMYOPATHY; UNTREATED MELANOMA; PD-1 BLOCKADE; IPILIMUMAB; NIVOLUMAB; PEMBROLIZUMAB; INFLAMMATION; AUTOPSY; HEART; RISK	Immune checkpoint inhibitors have improved clinical outcomes associated with numerous cancers, but high-grade, immune-related adverse events can occur, particularly with combination immunotherapy. We report the cases of two patients with melanoma in whom fatal myocarditis developed after treatment with ipilimumab and nivolumab. In both patients, there was development of myositis with rhabdomyolysis, early progressive and refractory cardiac electrical instability, and myocarditis with a robust presence of T-cell and macrophage infiltrates. Selective clonal T-cell populations infiltrating the myocardium were identical to those present in tumors and skeletal muscle. Pharmacovigilance studies show that myocarditis occurred in 0.27% of patients treated with a combination of ipilimumab and nivolumab, which suggests that our patients were having a rare, potentially fatal, T-cell-driven drug reaction. (Funded by Vanderbilt-Ingram Cancer Center Ambassadors and others.)	[Johnson, Douglas B. dbj; Balko, Justin M. jmb; Hicks, Mellissa mh; Puzanov, Igor ip; Alexander, Matthew R. mra; Bloomer, Tyler L. tlb; Becker, Jason R. jrb; Slosky, David A. das; Phillips, Elizabeth J. ejp; Pilkinton, Mark A. map; Roden, Dan M. dmr; Sosman, Jeffrey A. jas; Moslehi, Javid J. jjm] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Balko, Justin M. jmb; Moslehi, Javid J. jjm] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Compton, Margaret L. mlc; Craig-Owens, Laura lco; Hoffman, Robert D. rdh] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Xu, Yaomin yx] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Roden, Dan M. dmr] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Xu, Yaomin yx; Roden, Dan M. dmr] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN 37232 USA; [Slosky, David A. das; Moslehi, Javid J. jjm] Vanderbilt Univ, Med Ctr, Cardiooncol Program, 2220 Pierce Ave, Nashville, TN 37232 USA; [Balko, Justin M. jmb] Vanderbilt Univ, Med Ctr, Breast Canc Res Program, Nashville, TN 37232 USA; [Xu, Yaomin yx] Vanderbilt Univ, Med Ctr, Ctr Quantitat Sci, Nashville, TN 37232 USA; [Chalkias, Spyridon sc] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Chalkias, Spyridon sc; Koralnik, Igor J. ijk] Beth Israel Deaconess Med Ctr, Div Neuroimmunol, Boston, MA 02215 USA; [Olenchock, Benjamin A. bao; Seidman, Christine E. ces; Seidman, Jonathan G. jgs] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Lichtman, Andrew H. ahl] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Gorham, Joshua jc; Seidman, Christine E. ces; Seidman, Jonathan G. jgs] Harvard Med Sch, Dept Genet, Boston, MA USA; [Seidman, Christine E. ces] Howard Hughes Med Inst, Chevy Chase, MD USA; [Kola, Nina nk; Plautz, Gregory gp; Reshef, Daniel S. dsr; Deutsch, Jonathan S. jsd] Bristol Myers Squibb, New York, NY USA; [Deering, Raquel P. rpd] Neon Therapeut, Cambridge, MA USA; [Taube, Janis M. jmt; Anders, Robert A. raa] Johns Hopkins Univ, Dept Pathol, Baltimore, MD USA; [Taube, Janis M. jmt] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD 21218 USA; [Diaz, Luis A. Jr lad] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Bristol-Myers Squibb; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Moslehi, JJ (corresponding author), Vanderbilt Univ, Med Ctr, Cardiooncol Program, 2220 Pierce Ave, Nashville, TN 37232 USA.	javid.moslehi@vanderbilt.edu	Roden, Dan/ABD-5412-2021; PUZANOV, IGOR/AAP-2966-2020; Bloomer, Tyler/S-9788-2019	PUZANOV, IGOR/0000-0002-9803-3497; Diaz, Luis/0000-0002-7079-8914; Alexander, Matthew/0000-0003-4739-7204; Compton, Margaret/0000-0002-0568-2309	Bready Family Foundation; National Cancer Institute [6R00CA181491]; Vanderbilt-Ingram Cancer Center Ambassadors; Breast Cancer Specialized Program of Research Excellence [P50 CA098131]; National Comprehensive Cancer Network Young Investigator Award; National Institutes of Health [K08 HL119355, P50 GM115305, U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, U01-HL098162]; Howard Hughes Medical Institute; Gilead Life Sciences; NATIONAL CANCER INSTITUTE [K23CA204726, P50CA098131, R00CA181491] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL098123, R01HL121363, U01HL098162, U01HL098147, U01HL098188, U01HL098163, K08HL119355, U01HL098153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM115305] Funding Source: NIH RePORTER	Bready Family Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt-Ingram Cancer Center Ambassadors; Breast Cancer Specialized Program of Research Excellence; National Comprehensive Cancer Network Young Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Gilead Life Sciences(Gilead Sciences); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by funding from the Bready Family Foundation (to Drs. Johnson and Balko), the National Cancer Institute (grant 6R00CA181491, to Dr. Balko), the Vanderbilt-Ingram Cancer Center Ambassadors (to Drs. Balko and Moslehi), the Breast Cancer Specialized Program of Research Excellence (grant P50 CA098131, to Drs. Balko and Moslehi), the National Comprehensive Cancer Network Young Investigator Award (to Dr. Johnson), the National Institutes of Health (grant K08 HL119355, to Dr. Olenchock; grant P50 GM115305, to Drs. Phillips and Roden; and grants U01-HL098188, U01-HL098147, U01-HL098153, U01-HL098163, U01-HL098123, and U01-HL098162, to Dr. J. Seidman), the Howard Hughes Medical Institute (to Dr. C. Seidman), and Gilead Life Sciences (to Dr. Olenchock).	Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; DeWitt WS, 2015, J VIROL, V89, P4517, DOI 10.1128/JVI.03474-14; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; Eggermont AMM, 2015, LANCET ONCOL, V16, P522, DOI 10.1016/S1470-2045(15)70122-1; Grabie N, 2007, CIRCULATION, V116, P2062, DOI 10.1161/CIRCULATIONAHA.107.709360; GRIFFIN LD, 1995, CARDIOVASC PATHOL, V4, P3, DOI 10.1016/1054-8807(94)00025-M; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iwama S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008002; Koelzer VH, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0117-1; Laubli H, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0057-1; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishino M, 2015, NEW ENGL J MED, V373, P288, DOI 10.1056/NEJMc1505197; Okazaki T, 2003, NAT MED, V9, P1477, DOI 10.1038/nm955; Pham J, 2016, CLIN EXP ALLERGY, V46, P1194, DOI 10.1111/cea.12772; Pollack A, 2015, NAT REV CARDIOL, V12, P670, DOI 10.1038/nrcardio.2015.108; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Tarrio ML, 2012, J IMMUNOL, V188, P4876, DOI 10.4049/jimmunol.1200389; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Wolchok JD, 2015, CELL, V162, P937, DOI 10.1016/j.cell.2015.07.045	24	1131	1206	19	119	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1749	1755		10.1056/NEJMoa1609214	http://dx.doi.org/10.1056/NEJMoa1609214			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806233	Green Accepted, Bronze			2022-12-28	WOS:000387007300008
J	Lombardo, MP				Lombardo, Maria Paola			PARTICLE PHYSICS Axions exposed	NATURE			English	News Item								Physicists are hunting for a particle called the axion that could solve two major puzzles in fundamental physics. An ambitious study calculates the expected mass of this particle, which might reshape the experimental searches. SEE LETTER p.69	[Lombardo, Maria Paola] Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy	Istituto Nazionale di Fisica Nucleare (INFN)	Lombardo, MP (corresponding author), Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy.	lombardo@lnf.infn.it						Berkowitz E, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.034507; Bonati C, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2016)155; Borsanyi S, 2016, NATURE, V539, P69, DOI 10.1038/nature20115; Borsanyi S, 2016, PHYS LETT B, V752, P175, DOI 10.1016/j.physletb.2015.11.020; Graham PW, 2015, ANNU REV NUCL PART S, V65, P485, DOI 10.1146/annurev-nucl-102014-022120; Patrignani C, 2016, CHINESE PHYS C, V40, DOI 10.1088/1674-1137/40/10/100001; PECCEI RD, 1977, PHYS REV LETT, V38, P1440, DOI 10.1103/PhysRevLett.38.1440; Petreczky P., 2016, J PHYS LE B IN PRESS; Trunin A, 2016, J PHYS CONF SER, V668, DOI 10.1088/1742-6596/668/1/012123; WEINBERG S, 1978, PHYS REV LETT, V40, P223, DOI 10.1103/PhysRevLett.40.223; WILCZEK F, 1978, PHYS REV LETT, V40, P279, DOI 10.1103/PhysRevLett.40.279	11	0	0	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					40	41		10.1038/539040a	http://dx.doi.org/10.1038/539040a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808202				2022-12-28	WOS:000386670100024
J	Tripathi, A; Gottesman, S				Tripathi, Arti; Gottesman, Susan			CELL BIOLOGY Phosphate on, rubbish out	NATURE			English	News Item							ARGININE PHOSPHORYLATION; QUALITY-CONTROL; PROTEIN; DESTRUCTION; MCSB	A previously unknown way in which cells mark proteins for destruction has been found in bacteria - phosphorylation of the amino acid arginine targets proteins for degradation by protease enzymes. SEE ARTICLE p.48	[Tripathi, Arti; Gottesman, Susan] Natl Canc Inst, Mol Biol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gottesman, S (corresponding author), Natl Canc Inst, Mol Biol Lab, Bethesda, MD 20892 USA.	gottesms@helix.nih.gov	Tripathi, Arti/J-6047-2019	Tripathi, Arti/0000-0002-1515-7102	NATIONAL CANCER INSTITUTE [ZIABC011203] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Elsholz AKW, 2010, EMBO J, V29, P3621, DOI 10.1038/emboj.2010.228; Fuhrmann J, 2009, SCIENCE, V324, P1323, DOI 10.1126/science.1170088; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jastrab JB, 2015, ANNU REV MICROBIOL, V69, P109, DOI 10.1146/annurev-micro-091014-104201; Kirstein J, 2007, EMBO J, V26, P2061, DOI 10.1038/sj.emboj.7601655; Kruger E, 2001, EMBO J, V20, P852, DOI 10.1093/emboj/20.4.852; Neher SB, 2003, GENE DEV, V17, P1084, DOI 10.1101/gad.1078003; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Schmidt A, 2014, MOL CELL PROTEOMICS, V13, P537, DOI 10.1074/mcp.M113.032292; Trentini DB, 2016, NATURE, V539, P48, DOI 10.1038/nature20122; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wozniak DJ, 2012, MICROBIOL-SGM, V158, P2568, DOI 10.1099/mic.0.060749-0	13	6	6	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					38	39		10.1038/539038a	http://dx.doi.org/10.1038/539038a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808186				2022-12-28	WOS:000386670100022
J	Nath, V				Nath, Vijaya			THE NHS IF ... What if NHS leaders were more representative of patients and staff?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Nath, Vijaya] Leadership Fdn Higher Educ, London WC1X 8LZ, England		Nath, V (corresponding author), Leadership Fdn Higher Educ, London WC1X 8LZ, England.	Vijaya.Nath@lfhe.ac.uk						Hunt V., 2015, DIVERSITY MATTERS; Kline R., 2014, SNOWY WHITE PEAKS NH; Mandall NA, 2005, BRIT DENT J, V199, P659, DOI 10.1038/sj.bdj.4812930; Newman P., 2015, NHS WOMEN LEADERSHIP	4	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2016	355								i5828	10.1136/bmj.i5828	http://dx.doi.org/10.1136/bmj.i5828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CU	27806961				2022-12-28	WOS:000387317900011
J	Kecklund, G; Axelsson, J				Kecklund, Goran; Axelsson, John			Health consequences of shift work and insufficient sleep	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOSE-RESPONSE RELATIONSHIP; MOTOR-VEHICLE CRASHES; ALL-CAUSE MORTALITY; BREAST-CANCER RISK; INDIVIDUAL-DIFFERENCES; NEUROBEHAVIORAL FUNCTION; CIRCADIAN MISALIGNMENT; COGNITIVE PERFORMANCE; DEPENDENT CHANGES; PROSTATE-CANCER	This review summarises the literature on shift work and its relation to insufficient sleep, chronic diseases, and accidents. It is based on 38 meta-analyses and 24 systematic reviews, with additional narrative reviews and articles used for outlining possible mechanisms by which shift work may cause accidents and adverse health. Evidence shows that the effect of shift work on sleep mainly concerns acute sleep loss in connection with night shifts and early morning shifts. A link also exists between shift work and accidents, type 2 diabetes (relative risk range 1.09-1.40), weight gain, coronary heart disease (relative risk 1.23), stroke (relative risk 1.05), and cancer (relative risk range 1.01-1.32), although the original studies showed mixed results. The relations of shift work to cardiometabolic diseases and accidents mimic those with insufficient sleep. Laboratory studies indicate that cardiometabolic stress and cognitive impairments are increased by shift work, as well as by sleep loss. Given that the health and safety consequences of shift work and insufficient sleep are very similar, they are likely to share common mechanisms. However, additional research is needed to determine whether insufficient sleep is a causal pathway for the adverse health effects associated with shift work.	[Kecklund, Goran] Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden; [Kecklund, Goran] Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands; [Axelsson, John] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Stockholm University; Radboud University Nijmegen; Karolinska Institutet	Kecklund, G (corresponding author), Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden.; Kecklund, G (corresponding author), Radboud Univ Nijmegen, Behav Sci Inst, Nijmegen, Netherlands.	goran.kecklund@su.se	Axelsson, John/AAH-5998-2019	Axelsson, John/0000-0003-3932-7310	Strategic Research Programme in Diabetes at Karolinska Institutet, Stockholm, Sweden; AFA Insurance; Nordforsk (Nordic Program on Health and Welfare)	Strategic Research Programme in Diabetes at Karolinska Institutet, Stockholm, Sweden; AFA Insurance; Nordforsk (Nordic Program on Health and Welfare)	JA has been supported by funding from the Strategic Research Programme in Diabetes at Karolinska Institutet, Stockholm, Sweden, and by AFA Insurance. GK has been supported by funding from Nordforsk (the Nordic Program on Health and Welfare) for the project "WOW: Working hours, health, well-being and participation in working life."	Akerstedt T, 2003, OCCUP MED-OXFORD, V53, P89, DOI 10.1093/occmed/kqg046; AKERSTEDT T, 1991, SCAND J WORK ENV HEA, V17, P330, DOI 10.5271/sjweh.1694; Akerstedt T, 2007, PHYSIOL BEHAV, V92, P250, DOI 10.1016/j.physbeh.2007.05.044; Albrecht SC, 2016, SCAND J PUBLIC HEALT, V44, P320, DOI 10.1177/1403494815618854; Alterman T, 2013, AM J IND MED, V56, P647, DOI 10.1002/ajim.22108; American Academy of Sleep Medicine, 2014, INT CLASSIFICATION S; Anothaisintawee T, 2016, SLEEP MED REV, V30, P11, DOI 10.1016/j.smrv.2015.10.002; Arendt J, 2010, OCCUP MED-OXFORD, V60, P10, DOI 10.1093/occmed/kqp162; Axelsson J, 2005, J CLIN ENDOCR METAB, V90, P4530, DOI 10.1210/jc.2005-0520; Axelsson J, 2004, INT ARCH OCC ENV HEA, V77, P121, DOI 10.1007/s00420-003-0482-1; Axelsson J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082291; Baglioni C, 2011, J AFFECT DISORDERS, V135, P10, DOI 10.1016/j.jad.2011.01.011; Bambra C, 2008, J EPIDEMIOL COMMUN H, V62, P764, DOI 10.1136/jech.2007.067249; Bambra CL, 2008, AM J PREV MED, V34, P427, DOI 10.1016/j.amepre.2007.12.023; Barger LK, 2015, J CLIN SLEEP MED, V11, P233, DOI 10.5664/jcsm.4534; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; Blask DE, 2009, SLEEP MED REV, V13, P257, DOI 10.1016/j.smrv.2008.07.007; Boggild H, 2001, SCAND J WORK ENV HEA, V27, P97, DOI 10.5271/sjweh.595; Boudreau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070813; Buxton OM, 2000, AM J PHYSIOL-REG I, V278, pR373, DOI 10.1152/ajpregu.2000.278.2.R373; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Cedernaes J, 2016, SLEEP MED REV; Chatburn A, 2014, NEUROSCI BIOBEHAV R, V47, P646, DOI 10.1016/j.neubiorev.2014.10.018; Clark I, 2016, SLEEP MED REV; Cohen S, 2009, ARCH INTERN MED, V169, P62, DOI 10.1001/archinternmed.2008.505; Copinschi G, 2014, FRONT HORM RES, V42, P59, DOI 10.1159/000358858; de Cordova PB, 2016, WORK, V53, P825, DOI 10.3233/WOR-162250; Depner CM, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0507-z; Devore EE, 2013, AM J EPIDEMIOL, V178, P1296, DOI 10.1093/aje/kwt214; Dijk DJ, 2010, SLEEP MED REV, V14, P151, DOI 10.1016/j.smrv.2009.07.002; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; Drake CL, 2015, J SLEEP RES, V24, P254, DOI 10.1111/jsr.12264; Driscoll TR, 2007, SLEEP MED REV, V11, P179, DOI 10.1016/j.smrv.2006.11.001; Dumont M, 2012, CHRONOBIOL INT, V29, P203, DOI 10.3109/07420528.2011.647177; Durmer JS, 2005, SEMIN NEUROL, V25, P117, DOI 10.1055/s-0029-1237117; Eckel RH, 2015, CURR BIOL, V25, P3004, DOI 10.1016/j.cub.2015.10.011; Eurofound, 2017, 6 EUR WORK COND SURV; Faraut B, 2013, SLEEP MED REV, V17, P433, DOI 10.1016/j.smrv.2012.12.006; Fisher SP, 2014, SLEEP, V37, P1727, DOI 10.5665/sleep.4156; FOLKARD S, 1992, ERGONOMICS, V35, P1453, DOI 10.1080/00140139208967414; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Fossum IN, 2013, IND HEALTH, V51, P530; Frost P, 2009, SCAND J WORK ENV HEA, V35, P163, DOI 10.5271/sjweh.1319; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Gan Y, 2015, OCCUP ENVIRON MED, V72, P72, DOI 10.1136/oemed-2014-102150; Ge BH, 2015, INT J STROKE, V10, P177, DOI 10.1111/ijs.12398; Guo XF, 2013, SLEEP MED, V14, P324, DOI 10.1016/j.sleep.2012.12.001; Harma M, 2006, SCAND J WORK ENV HEA, V32, P502; Haupt CM, 2008, ATHEROSCLEROSIS, V201, P205, DOI 10.1016/j.atherosclerosis.2007.12.059; He CL, 2015, INT ARCH OCC ENV HEA, V88, P533, DOI 10.1007/s00420-014-0986-x; He JY, 2014, J NEUROSCI, V34, P14697, DOI 10.1523/JNEUROSCI.2111-14.2014; Hung CS, 2013, SLEEP, V36, P59, DOI 10.5665/sleep.2302; Ijaz S, 2013, SCAND J WORK ENV HEA, V39, P431, DOI 10.5271/sjweh.3371; Irwin MR, 2015, ANNU REV PSYCHOL, V66, P143, DOI 10.1146/annurev-psych-010213-115205; Jia YJ, 2013, CANCER EPIDEMIOL, V37, P197, DOI 10.1016/j.canep.2013.01.005; Kamdar BB, 2013, BREAST CANCER RES TR, V138, P291, DOI 10.1007/s10549-013-2433-1; Ker K, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008508; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Kivimaki M, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0630-8; Knutsson A, 2014, CHRONOBIOL INT, V31, P1146, DOI 10.3109/07420528.2014.957308; Kolstad HA, 2008, SCAND J WORK ENV HEA, V34, P5, DOI 10.5271/sjweh.1194; Kucharczyk Erica R, 2012, Sleep Med Rev, V16, P547, DOI 10.1016/j.smrv.2012.01.005; Landolt HP, 2008, CURR PHARM DESIGN, V14, P3396, DOI 10.2174/138161208786549344; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Lange T, 2006, ARCH INTERN MED, V166, P1695, DOI 10.1001/archinte.166.16.1695; Leng Y, 2015, NEUROLOGY, V84, P1072, DOI 10.1212/WNL.0000000000001371; Leproult R, 2014, DIABETES, V63, P1860, DOI 10.2337/db13-1546; Leproult R, 2010, ENDOCR DEV, V17, P11, DOI 10.1159/000262524; Li YP, 2014, CIRCULATION, V129, P737, DOI 10.1161/CIRCULATIONAHA.113.004500; Liira J, 2014, COCHRANE DB SYST REV, V8; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lin XT, 2015, SLEEP MED, V16, P1381, DOI 10.1016/j.sleep.2015.02.543; Linton SJ, 2015, SLEEP MED REV, V23, P10, DOI 10.1016/j.smrv.2014.10.010; Lo JC, 2016, SLEEP MED, V17, P87, DOI 10.1016/j.sleep.2015.08.021; Lowden A, 2010, SCAND J WORK ENV HEA, V36, P150, DOI 10.5271/sjweh.2898; Ma N, 2015, SLEEP, V38, P233, DOI 10.5665/sleep.4404; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Mansukhani MP, 2012, POSTGRAD MED, V124, P241, DOI 10.3810/pgm.2012.07.2583; Marquie JC, 2015, OCCUP ENVIRON MED, V72, P258, DOI 10.1136/oemed-2013-101993; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Neil-Sztramko SE, 2014, SCAND J WORK ENV HEA, V40, P543, DOI 10.5271/sjweh.3445; Niu SF, 2011, J NURS RES, V19, P68, DOI 10.1097/JNR.0b013e31820c1879; Palagini L, 2013, CURR PHARM DESIGN, V19, P2409, DOI 10.2174/1381612811319130009; Patel SR, 2008, OBESITY, V16, P643, DOI 10.1038/oby.2007.118; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Pilcher JJ, 2000, SLEEP, V23, P155; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; Prather AA, 2015, SLEEP, V38, P1353, DOI 10.5665/sleep.4968; Proper Karin I, 2016, Am J Prev Med, V50, pe147, DOI 10.1016/j.amepre.2015.11.013; Puttonen S, 2011, CHRONOBIOL INT, V28, P528, DOI 10.3109/07420528.2011.580869; Puttonen S, 2010, SCAND J WORK ENV HEA, V36, P96, DOI 10.5271/sjweh.2894; Puttonen S, 2009, ATHEROSCLEROSIS, V205, P608, DOI 10.1016/j.atherosclerosis.2009.01.016; Qin YY, 2014, INT J CANCER, V134, P1166, DOI 10.1002/ijc.28452; Rajaratnam SMW, 2011, JAMA-J AM MED ASSOC, V306, P2567, DOI 10.1001/jama.2011.1851; Ramanathan L, 2011, FREE RADICAL BIO MED, V51, P1842, DOI 10.1016/j.freeradbiomed.2011.08.016; Rao DP, 2015, ONCOTARGETS THER, V8, P2817, DOI 10.2147/OTT.S89769; Retey JV, 2006, J NEUROSCI, V26, P10472, DOI 10.1523/JNEUROSCI.1538-06.2006; Reutrakul S, 2014, ANN NY ACAD SCI, V1311, P151, DOI 10.1111/nyas.12355; Ribeiro DCO, 1998, J ENDOCRINOL, V158, P305, DOI 10.1677/joe.0.1580305; Ruggiero JS, 2014, BIOL RES NURS, V16, P134, DOI 10.1177/1099800413476571; Saksvik IB, 2011, SLEEP MED REV, V15, P221, DOI 10.1016/j.smrv.2010.07.002; Sallinen M, 2010, SCAND J WORK ENV HEA, V36, P121, DOI 10.5271/sjweh.2900; Sigurdardottir LG, 2012, CANCER EPIDEM BIOMAR, V21, P1002, DOI 10.1158/1055-9965.EPI-12-0116; Sofi F, 2014, EUR J PREV CARDIOL, V21, P57, DOI 10.1177/2047487312460020; Sookoian S, 2007, J INTERN MED, V261, P285, DOI 10.1111/j.1365-2796.2007.01766.x; Stevens RG, 2014, CA-CANCER J CLIN, V64, P207, DOI 10.3322/caac.21218; Stevens RG, 2011, OCCUP ENVIRON MED, V68, P154, DOI 10.1136/oem.2009.053512; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Stutts JC, 2003, ACCIDENT ANAL PREV, V35, P321, DOI 10.1016/S0001-4575(02)00007-6; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; TORSVALL L, 1988, SLEEP, V11, P35, DOI 10.1093/sleep/11.1.35; Tucker P, 2003, LANCET, V361, P680, DOI 10.1016/S0140-6736(03)12566-4; Uehli K, 2014, SLEEP MED REV, V18, P61, DOI 10.1016/j.smrv.2013.01.004; Upala S, 2015, DIABETES RES CLIN PR, V109, pE11, DOI 10.1016/j.diabres.2015.06.003; Van Dongen HPA, 2011, PROG BRAIN RES, V190, P145, DOI 10.1016/B978-0-444-53817-8.00009-8; van Drongelen A, 2011, SCAND J WORK ENV HEA, V37, P263, DOI 10.5271/sjweh.3143; VANCAUTER E, 1990, HORM RES, V34, P45, DOI 10.1159/000181794; Vandelanotte C, 2015, J PHYS ACT HEALTH, V12, P200, DOI 10.1123/jpah.2013-0098; Vedaa O, 2016, ERGONOMICS, V59, P1, DOI 10.1080/00140139.2015.1052020; Villafuerte G, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/234952; Viola AU, 2007, CURR BIOL, V17, P613, DOI 10.1016/j.cub.2007.01.073; Virtanen M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7772; Vyas MV, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4800; Waage S, 2014, SLEEP MED, V15, P1449, DOI 10.1016/j.sleep.2014.07.014; Wagstaff AS, 2011, SCAND J WORK ENV HEA, V37, P173, DOI 10.5271/sjweh.3146; Wang F, 2013, ANN ONCOL, V24, P2724, DOI 10.1093/annonc/mdt283; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Wang X, 2015, ONCOTARGET, V6, P25046, DOI 10.18632/oncotarget.4502; Wang Y, 2015, J CLIN SLEEP MED, V11, P1047, DOI 10.5664/jcsm.5024; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Wickens CD, 2015, HUM FACTORS, V57, P930, DOI 10.1177/0018720815571935; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004; Wright KP, 2013, SLEEP MED REV, V17, P41, DOI 10.1016/j.smrv.2012.02.002; Wu YL, 2014, SLEEP MED, V15, P1456, DOI 10.1016/j.sleep.2014.07.018; Yang XR, 2015, HEART LUNG CIRC, V24, P1180, DOI 10.1016/j.hlc.2015.08.005; Zhai L, 2015, DEPRESS ANXIETY, V32, P664, DOI 10.1002/da.22386; Zhou X, 2011, SLEEP, V34, P931, DOI 10.5665/SLEEP.1130	140	485	495	19	170	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2016	355								i5210	10.1136/bmj.i5210	http://dx.doi.org/10.1136/bmj.i5210			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CP	27803010				2022-12-28	WOS:000387317200001
J	Ksionzek, KB; Lechtenfeld, OJ; McCallister, SL; Schmitt-Kopplin, P; Geuer, JK; Geibert, W; Koch, BP				Ksionzek, Kerstin B.; Lechtenfeld, Oliver J.; McCallister, S. Leigh; Schmitt-Kopplin, Philippe; Geuer, Jana K.; Geibert, Walter; Koch, Boris P.			Dissolved organic sulfur in the ocean: Biogeochemistry of a petagram inventory	SCIENCE			English	Article							REDUCED SULFUR; MATTER; CARBON; DIMETHYLSULFONIOPROPIONATE; PHYTOPLANKTON; DEGRADATION; ATLANTIC; SEAWATER; SULFIDE; DMSP	Although sulfur is an essential element for marine primary production and critical for climate processes, little is known about the oceanic pool of nonvolatile dissolved organic sulfur (DOS). We present a basin-scale distribution of solid-phase extractable DOS in the East Atlantic Ocean and the Atlantic sector of the Southern Ocean. Although molar DOS versus dissolved organic nitrogen (DON) ratios of 0.11 +/- 0.024 in Atlantic surface water resembled phytoplankton stoichiometry (sulfur/nitrogen similar to 0.08), increasing dissolved organic carbon (DOC) versus DOS ratios and decreasing methionine-S yield demonstrated selective DOS removal and active involvement in marine biogeochemical cycles. Based on stoichiometric estimates, the minimum global inventory of marine DOS is 6.7 petagrams of sulfur, exceeding all other marine organic sulfur reservoirs by an order of magnitude.	[Ksionzek, Kerstin B.; Lechtenfeld, Oliver J.; Geuer, Jana K.; Geibert, Walter; Koch, Boris P.] Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany; [Ksionzek, Kerstin B.; Koch, Boris P.] MARUM Ctr Marine Environm Sci, Leobener Str, D-28359 Bremen, Germany; [McCallister, S. Leigh] Virginia Commonwealth Univ, Dept Biol, Ctr Environm Studies, 1000 West Cary St, Richmond, VA 23284 USA; [Schmitt-Kopplin, Philippe] Helmholtz Zentrum Munchen HMGU, German Res Ctr Environm Hlth, Inst Ecol Chem, Analyt BioGeoChem BGC, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Chair Analyt Food Chem, Alte Akad 10, D-85354 Freising Weihenstephan, Germany; [Koch, Boris P.] Univ Appl Sci, Karlstadt 8, D-27568 Bremerhaven, Germany; [Lechtenfeld, Oliver J.] UFZ Helmholtz Ctr Environm Res, Dept Analyt Chem, Permoserstr 15, D-04318 Leipzig, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; Virginia Commonwealth University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Ksionzek, KB; Koch, BP (corresponding author), Alfred Wegener Inst, Helmholtz Ctr Polar & Marine Res, Handelshafen 12, D-27570 Bremerhaven, Germany.; Ksionzek, KB; Koch, BP (corresponding author), MARUM Ctr Marine Environm Sci, Leobener Str, D-28359 Bremen, Germany.; Koch, BP (corresponding author), Univ Appl Sci, Karlstadt 8, D-27568 Bremerhaven, Germany.	kerstin.ksionzek@awi.de; boris.koch@awi.de	Geibert, Walter/ABA-9785-2020; Koch, Boris P/B-2784-2009; Geuer, Jana/AAZ-2217-2020; Schmitt-Kopplin, Philippe/H-6271-2011; Lechtenfeld, Oliver J./A-6480-2013	Geibert, Walter/0000-0001-8646-2334; Koch, Boris P/0000-0002-8453-731X; Geuer, Jana/0000-0002-9663-5072; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lechtenfeld, Oliver J./0000-0001-5313-6014	DFG-Research Centre/Cluster of Excellence "The Ocean in the Earth System"; Deutsche Forschungsgemeinschaft (DFG) [KO 2164/8-1+2]	DFG-Research Centre/Cluster of Excellence "The Ocean in the Earth System"; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the DFG-Research Centre/Cluster of Excellence "The Ocean in the Earth System" and a Ph.D. grant by the Deutsche Forschungsgemeinschaft (DFG) in the framework of the priority program "Antarctic Research with comparative investigations in Arctic ice areas" (grant KO 2164/8-1+2). We are grateful to research vessel Polarstern captain, crew, and chief scientists G. Kattner (ANTXXV-1) and O. Bobel (ANTXXV-2); I. Stimac is acknowledged for technical support with ICP-MS analysis and K.-U. Ludwichowski for support with methionine analysis; we thank C. Marandino for DMS and DMSP data; S. Frickenhaus is acknowledged for support with statistical analysis, and B. Kanavati, M. Harir, and J. Uhl for support with FT-ICR-MS analyses. G. Kattner and R. Alheit are acknowledged for helpful discussions and proofreading. The data presented in this paper are available at the PANGEA data library (doi: 10.1594/PANGAEA.858568). B.P.K. designed the research. O.J.L and B.P.K. collected and processed the samples. K.B.K. and W.G. performed ICP-MS analysis and data evaluation. J.G. carried out methionine analyses, S.L.M. performed 14C analysis, and P.S.-K. performed FT-ICR-MS analysis. The paper was written by K.B.K. and B.P.K, with input from all coauthors.	ANDREAE MO, 1990, MAR CHEM, V30, P1, DOI 10.1016/0304-4203(90)90059-L; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Cutter GA, 2004, LIMNOL OCEANOGR, V49, P555, DOI 10.4319/lo.2004.49.2.0555; Davis J, 2007, LIMNOL OCEANOGR, V52, P2434, DOI 10.4319/lo.2007.52.6.2434; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Durham BP, 2015, P NATL ACAD SCI USA, V112, P453, DOI 10.1073/pnas.1413137112; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flerus R, 2012, BIOGEOSCIENCES, V9, P1935, DOI 10.5194/bg-9-1935-2012; Gali M, 2015, REMOTE SENS ENVIRON, V171, P171, DOI 10.1016/j.rse.2015.10.012; GIOVANELLI J, 1978, J BIOL CHEM, V253, P5665; Gonsior M, 2011, MAR CHEM, V123, P99, DOI 10.1016/j.marchem.2010.10.004; Hansell DA, 2013, ANNU REV MAR SCI, V5, P421, DOI 10.1146/annurev-marine-120710-100757; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Ho TY, 2003, J PHYCOL, V39, P1145, DOI 10.1111/j.0022-3646.2003.03-090.x; Hopkinson CS, 2002, DEEP-SEA RES PT II, V49, P4461, DOI 10.1016/S0967-0645(02)00125-X; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Kiene RP, 2006, LIMNOL OCEANOGR-METH, V4, P80, DOI 10.4319/lom.2006.4.80; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Lana A, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003850; Lechtenfeld OJ, 2014, GEOCHIM COSMOCHIM AC, V126, P321, DOI 10.1016/j.gca.2013.11.009; Moran MA, 2016, P NATL ACAD SCI USA, V113, P3143, DOI 10.1073/pnas.1514645113; Redfield A.C., 1963, SEA IDEA OBSERV, V2; Schmitt-Kopplin P, 2012, BIOGEOSCIENCES, V9, P1571, DOI 10.5194/bg-9-1571-2012; Sleighter RL, 2014, ENVIRON SCI TECH LET, V1, P345, DOI 10.1021/ez500229b; Smith DS, 2002, COMP BIOCHEM PHYS C, V133, P65, DOI 10.1016/S1532-0456(02)00108-4; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Zindler C, 2014, GEOPHYS RES LETT, V41, P3181, DOI 10.1002/2014GL059547	29	101	107	7	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					456	459		10.1126/science.aaf7796	http://dx.doi.org/10.1126/science.aaf7796			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789839	Green Published			2022-12-28	WOS:000387684400039
J	Shastin, D; Zaben, M; Leach, P				Shastin, Dmitri; Zaben, Malik; Leach, Paul			PRACTICE POINTER Life with a cerebrospinal fluid (CSF) shunt	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VENTRICULOPERITONEAL SHUNT		[Shastin, Dmitri; Zaben, Malik; Leach, Paul] Univ Wales Hosp, Dept Neurosurg, Cardiff CF14 4XW, S Glam, Wales; [Zaben, Malik] Cardiff Univ, Univ Wales Hosp, Inst Psychol Med & Clin Neurosci, Neurosci & Mental Hlth Res Inst,Sch Med, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Shastin, D (corresponding author), Univ Wales Hosp, Dept Neurosurg, Cardiff CF14 4XW, S Glam, Wales.	dmitri.shastin@gmail.com		Shastin, Dmitri/0000-0003-3937-3675; Zaben, Malik/0000-0002-7446-4532				Abode-Iyamah KO, 2016, J CLIN NEUROSCI, V25, P46, DOI 10.1016/j.jocn.2015.07.022; Amato-Watkins A, 2013, BRIT J NEUROSURG, V27, P9, DOI 10.3109/02688697.2012.716176; Anderson IA, 2012, BRIT J HOSP MED, V73, pC170, DOI 10.12968/hmed.2012.73.Sup11.C170; Blount JP, 2004, NEUROSURGERY, V54, P1190, DOI 10.1227/01.NEU.0000119236.08000.49; Driver and Vehicle Licensing Agency, 2016, NEUR DIS ASS FITN DR; Graber JJ, 2010, HEADACHE, V50, P146, DOI 10.1111/j.1526-4610.2009.01546.x; Home Office, NAT RECR STAND MED S; Jenkinson MD, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-4; Liakos AM, 2000, NEUROL RES, V22, P69; Medtronic, 2012, STRAT VALV MAGN FIEL; Royal Air Force, MED COND PRECL ENTR; Royal Navy, HER MAJ NAV SERV EL; Sahuquillo J, 2008, NEUROSURGERY, V62, P143, DOI 10.1227/01.NEU.0000311071.33615.E1; Schulz UG, 2006, BRIT J NEUROSURG, V20, P173, DOI 10.1080/02688690600777208; Shastin D, 2016, ACTA NEUROCHIR, V158, P1269, DOI 10.1007/s00701-016-2800-x	15	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2016	355								i5209	10.1136/bmj.i5209	http://dx.doi.org/10.1136/bmj.i5209			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LG	27797790	Green Accepted			2022-12-28	WOS:000386661400001
J	Kottakis, F; Nicolay, BN; Roumane, A; Karnik, R; Gu, HC; Nagle, JM; Boukhali, M; Hayward, MC; Li, YY; Chen, T; Liesa, M; Hammerman, PS; Wong, KK; Hayes, DN; Shirihai, OS; Dyson, NJ; Haas, W; Meissner, A; Bardeesy, N				Kottakis, Filippos; Nicolay, Brandon N.; Roumane, Ahlima; Karnik, Rahul; Gu, Hongcang; Nagle, Julia M.; Boukhali, Myriam; Hayward, Michele C.; Li, Yvonne Y.; Chen, Ting; Liesa, Marc; Hammerman, Peter S.; Wong, Kwok Kin; Hayes, D. Neil; Shirihai, Orian S.; Dyson, Nicholas J.; Haas, Wilhelm; Meissner, Alexander; Bardeesy, Nabeel			LKB1 loss links serine metabolism to DNA methylation and tumorigenesis	NATURE			English	Article							CANCER; PATHWAY; GROWTH; DIFFERENTIATION; BIOSYNTHESIS; PROGRESSION; MUTATIONS; SUPPORTS; GLYCINE; CELLS	Intermediary metabolism generates substrates for chromatin modification, enabling the potential coupling of metabolic and epigenetic states. Here we identify a network linking metabolic and epigenetic alterations that is central to oncogenic transformation downstream of the liver kinase B1 (LKB1, also known as STK11) tumour suppressor, an integrator of nutrient availability, metabolism and growth. By developing genetically engineered mouse models and primary pancreatic epithelial cells, and employing transcriptional, proteomics, and metabolic analyses, we find that oncogenic cooperation between LKB1 loss and KRAS activation is fuelled by pronounced mTOR-dependent induction of the serine-glycine-one-carbon pathway coupled to S-adenosylmethionine generation. At the same time, DNA methyltransferases are upregulated, leading to elevation in DNA methylation with particular enrichment at retrotransposon elements associated with their transcriptional silencing. Correspondingly, LKB1 deficiency sensitizes cells and tumours to inhibition of serine biosynthesis and DNA methylation. Thus, we define a hypermetabolic state that incites changes in the epigenetic landscape to support tumorigenic growth of LKB1-mutant cells, while resulting in potential therapeutic vulnerabilities.	[Kottakis, Filippos; Nicolay, Brandon N.; Roumane, Ahlima; Nagle, Julia M.; Boukhali, Myriam; Dyson, Nicholas J.; Haas, Wilhelm; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA; [Kottakis, Filippos; Roumane, Ahlima; Nagle, Julia M.; Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA; [Kottakis, Filippos; Nicolay, Brandon N.; Roumane, Ahlima; Nagle, Julia M.; Boukhali, Myriam; Dyson, Nicholas J.; Haas, Wilhelm; Bardeesy, Nabeel] Harvard Med Sch, Dept Med, Boston, MA 02114 USA; [Karnik, Rahul; Gu, Hongcang; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Karnik, Rahul; Gu, Hongcang; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Karnik, Rahul; Gu, Hongcang; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hayward, Michele C.; Hayes, D. Neil] UNC, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Li, Yvonne Y.; Chen, Ting; Hammerman, Peter S.; Wong, Kwok Kin] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Li, Yvonne Y.; Chen, Ting; Hammerman, Peter S.; Wong, Kwok Kin] Harvard Med Sch, Boston, MA 02115 USA; [Li, Yvonne Y.; Chen, Ting; Hammerman, Peter S.; Wong, Kwok Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Ting; Wong, Kwok Kin] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02215 USA; [Liesa, Marc; Shirihai, Orian S.] Boston Univ, Sch Med, Mitochondria ARC, Evans Ctr Interdisciplinary Res,Dept Med, Boston, MA 02118 USA; [Liesa, Marc; Shirihai, Orian S.] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Dept Med, Los Angeles, CA 90095 USA; [Hammerman, Peter S.] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Boston University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Bardeesy, N (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.; Bardeesy, N (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.; Bardeesy, N (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02114 USA.	bardeesy.nabeel@mgh.harvard.edu	Li, Yvonne/M-2459-2019; Liesa, Marc/K-8590-2019	Liesa, Marc/0000-0002-5909-8570; Karnik, Rahul/0000-0002-0400-635X; Chen, Ting/0000-0003-1725-7956; Gu, Hongcang/0000-0002-1439-7606	Granara-Skerry Trust; Linda J. Verville Foundation; Begg Family; NIH [P01 CA117969-07, R01 CA133557-05, P50CA1270003]; Hirshberg Foundation; NATIONAL CANCER INSTITUTE [P01CA117969, R01CA133557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099618] Funding Source: NIH RePORTER	Granara-Skerry Trust; Linda J. Verville Foundation; Begg Family; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hirshberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Kimmelman, K. Patra, L. J. Etchegaray, and R. Mostoslaysky for comments on the manuscript, and P. Foltopoulou, B. Martinez and Bardeesy laboratory members for advice. N.B. holds the Gallagher Endowed Chair in Gastrointestinal Cancer Research and received support from the Granara-Skerry Trust, the Linda J. Verville Foundation and the Begg Family, and grants from the NIH (P01 CA117969-07, R01 CA133557-05). F.K. is supported by a Hirshberg Foundation Career Development Award. F.K and N.B. were supported by NIH grant P50CA1270003 and are members of the Andrew Warshaw Institute.	Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Carey BW, 2015, NATURE, V518, P413, DOI 10.1038/nature13981; Chen Z, 2012, NATURE, V483, P613, DOI 10.1038/nature10937; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Elbarbary RA, 2016, SCIENCE, V351, DOI 10.1126/science.aac7247; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Giardiello FM, 2000, GASTROENTEROLOGY, V119, P1447, DOI 10.1053/gast.2000.20228; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Korsse SE, 2013, J MED GENET, V50, P59, DOI 10.1136/jmedgenet-2012-101277; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Liu WJ, 2012, CANCER CELL, V21, P751, DOI 10.1016/j.ccr.2012.03.048; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Maddocks ODK, 2016, MOL CELL, V61, P210, DOI 10.1016/j.molcel.2015.12.014; Mehrmohamadi M, 2014, CELL REP, V9, P1507, DOI 10.1016/j.celrep.2014.10.026; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shim EH, 2014, CANCER DISCOV, V4, P1290, DOI 10.1158/2159-8290.CD-13-0696; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Su GH, 1999, AM J PATHOL, V154, P1835, DOI 10.1016/S0002-9440(10)65440-5; Sun LC, 2015, CELL RES, V25, P429, DOI 10.1038/cr.2015.33; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Treppendahl MB, 2014, J CLIN INVEST, V124, P47, DOI 10.1172/JCI69737; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	39	174	181	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					390	395		10.1038/nature20132	http://dx.doi.org/10.1038/nature20132			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27799657	Green Accepted, Green Published			2022-12-28	WOS:000388161700046
J	Wiersma, DS				Wiersma, Diederik S.			Clear directions for random lasers	NATURE			English	Editorial Material							MODES; MEDIA	Random lasers use disordered structures to produce light, which is usually emitted in many directions. A random laser that can produce a collimated beam offers a wide range of applications, from imaging to security scanning.	[Wiersma, Diederik S.] Univ Florence, LENS, I-50019 Sesto Fiorentino, Italy; [Wiersma, Diederik S.] Natl Inst Metrol Res, Turin, Italy	University of Florence; Istituto Nazionale di Ricerca Metrologica (INRIM)	Wiersma, DS (corresponding author), Univ Florence, LENS, I-50019 Sesto Fiorentino, Italy.; Wiersma, DS (corresponding author), Natl Inst Metrol Res, Turin, Italy.	wiersma@lens.unifi.it	wiersma, diederik/ABG-6454-2021	wiersma, diederik/0000-0001-8150-7425				Cao H, 2001, PHYS REV LETT, V86, P4524, DOI 10.1103/PhysRevLett.86.4524; Fallert J, 2009, NAT PHOTONICS, V3, P279, DOI 10.1038/NPHOTON.2009.67; Hisch T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.023902; Leonetti M, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4792759; Liang HK, 2013, ADV MATER, V25, P6859, DOI 10.1002/adma.201303122; Schonhuber S, 2016, OPTICA, V3, P1035, DOI 10.1364/OPTICA.3.001035; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; Vynck K, 2012, NAT MATER, V11, P1017, DOI [10.1038/nmat3442, 10.1038/NMAT3442]; Wang J, 2011, NATURE, V471, P345, DOI 10.1038/nature09824; Wiersma DS, 2013, NAT PHOTONICS, V7, P188, DOI [10.1038/nphoton.2013.29, 10.1038/NPHOTON.2013.29]	10	10	10	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					360	361		10.1038/nature20477	http://dx.doi.org/10.1038/nature20477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27828942				2022-12-28	WOS:000388161700037
J	Chou, R; Dana, T; Blazina, I; Daeges, M; Jeanne, TL				Chou, Roger; Dana, Tracy; Blazina, Ian; Daeges, Monica; Jeanne, Thomas L.			Statins for Prevention of Cardiovascular Disease in Adults Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; AVERAGE CHOLESTEROL CONCENTRATIONS; CARDIAC OUTCOMES TRIAL; ARM ASCOT-LLA; DIABETES-MELLITUS; ATHEROSCLEROSIS PREVENTION; CAROTID ATHEROSCLEROSIS; HYPERTENSIVE PATIENTS; POSTMENOPAUSAL WOMEN	IMPORTANCE Cardiovascular disease (CVD), the leading cause of mortality and morbidity in the United States, may be potentially preventable with statin therapy. OBJECTIVE To systematically review benefits and harms of statins for prevention of CVD to inform the US Preventive Services Task Force. DATA SOURCES Ovid MEDLINE (from 1946), Cochrane Central Register of Controlled Trials (from 1991), and Cochrane Database of Systematic Reviews (from 2005) to June 2016. STUDY SELECTION Randomized clinical trials of statins vs placebo, fixed-dose vs titrated statins, and higher-vs lower-intensity statins in adults without prior cardiovascular events. DATA EXTRACTION AND SYNTHESIS One investigator abstracted data, a second checked data for accuracy, and 2 investigators independently assessed study quality using predefined criteria. Data were pooled using random-effects meta-analysis. MAIN OUTCOMES AND MEASURES All-cause mortality, CVD-related morbidity or mortality, and harms. RESULTS Nineteen trials (n = 71 344 participants [range, 95-17 802]; mean age, 51-66 years) compared statins vs placebo or no statin. Statin therapy was associated with decreased risk of all-cause mortality (risk ratio [RR], 0.86 [95% CI, 0.80 to 0.93]; I-2 = 0%; absolute risk difference [ARD], -0.40% [95% CI, -0.64% to -0.17%]), cardiovascular mortality (RR, 0.69 [95% CI, 0.54 to 0.88]; I-2 = 54%; ARD, -0.43%[95% CI, -0.75% to -0.11%]), stroke (RR, 0.71 [95% CI, 0.62 to 0.82]; I-2 = 0; ARD, -0.38%[95% CI, -0.53% to -0.23%]), myocardial infarction (RR, 0.64 [95% CI, 0.57 to 0.71]; I-2 = 0%; ARD, -0.81%[95% CI, -1.19 to -0.43%]), and composite cardiovascular outcomes (RR, 0.70 [95% CI, 0.63 to 0.78]; I-2 = 36%; ARD, -1.39% [95% CI, -1.79 to -0.99%]). Relative benefits appeared consistent in demographic and clinical subgroups, including populations without marked hyperlipidemia (total cholesterol level <200 mg/dL); absolute benefits were higher in subgroups at higher baseline risk. Statins were not associated with increased risk of serious adverse events (RR, 0.99 [95% CI, 0.94 to 1.04]), myalgias (RR, 0.96 [95% CI, 0.79 to 1.16]), or liver-related harms (RR, 1.10 [95% CI, 0.90 to 1.35]). In pooled analysis, statins were not associated with increased risk of diabetes (RR, 1.05 [95% CI, 0.91 to 1.20]), although statistical heterogeneity was present (I-2 = 52%), and 1 trial found high-intensity statins associated with increased risk (RR, 1.25 [95% CI, 1.05 to 1.49]). No trial directly compared titrated vs fixed-dose statins, and there were no clear differences based on statin intensity. CONCLUSIONS AND RELEVANCE In adults at increased CVD risk but without prior CVD events, statin therapy was associated with reduced risk of all-cause and cardiovascular mortality and CVD events, with greater absolute benefits in patients at greater baseline risk.	[Chou, Roger; Dana, Tracy; Blazina, Ian; Daeges, Monica] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Chou, Roger] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Jeanne, Thomas L.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA2902012000015I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract No. HHSA2902012000015I from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Albert MA, 2011, AM HEART J, V162, P106, DOI 10.1016/j.ahj.2011.03.032; Anderssen SA, 2005, ATHEROSCLEROSIS, V178, P387, DOI 10.1016/j.atherosclerosis.2004.08.033; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Beishuizen ED, 2004, DIABETES CARE, V27, P2887, DOI 10.2337/diacare.27.12.2887; Bone HG, 2007, J CLIN ENDOCR METAB, V92, P4671, DOI 10.1210/jc.2006-1909; Bonovas S, 2007, J CLIN ONCOL, V25, P3462, DOI 10.1200/JCO.2007.10.8936; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Chou R, 2015, AHRQ PUBLICATION; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Dale KM, 2006, JAMA-J AM MED ASSOC, V295, P74, DOI 10.1001/jama.295.1.74; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Dormuth CR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3244; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Finegold JA, 2014, EUR J PREV CARDIOL, V21, P464, DOI 10.1177/2047487314525531; Freeman DJ, 2001, CIRCULATION, V103, P357; FURBERG CD, 1994, CIRCULATION, V90, P1679, DOI 10.1161/01.CIR.90.4.1679; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2998, DOI 10.1001/jama.288.23.2998; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Goldfine AB, 2012, NEW ENGL J MED, V366, P19; Gotto AM, 2000, EUR HEART J, V21, P1627, DOI 10.1053/euhj.2000.2288; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Heljic B, 2009, BOSNIAN J BASIC MED, V9, P71, DOI 10.17305/bjbms.2009.2860; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jick SS, 2004, BRIT J CLIN PHARMACO, V58, P303, DOI 10.1111/j.1365-2125.2004.02142.x; Kashani A, 2006, CIRCULATION, V114, P2788, DOI 10.1161/CIRCULATIONAHA.106.624890; Kavousi M, 2014, JAMA-J AM MED ASSOC, V311, P1416, DOI 10.1001/jama.2014.2632; Knopp RH, 2006, DIABETES CARE, V29, P1478, DOI 10.2337/dc05-2415; Kostis JB, 2014, J CARDIOVASC PHARM T, V19, P191, DOI 10.1177/1074248413511690; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Lloyd-Jones DM, 2014, LANCET, V383, P600, DOI 10.1016/S0140-6736(13)62348-X; Macedo AF, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-51; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Mercuri M, 1996, AM J MED, V101, P627, DOI 10.1016/S0002-9343(96)00333-6; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Nakamura H, 2006, LANCET, V368, P1155, DOI 10.1016/S0140-6736(06)69472-5; National Institutes of Health, 2002, DET EV TREATM HIGH B; Newman CB, 2008, DIABETES VASC DIS RE, V5, P177, DOI 10.3132/dvdr.2008.029; Nissen SE, 2016, JAMA-J AM MED ASSOC, V315, P1580, DOI 10.1001/jama.2016.3608; Peeters G, 2015, ARTHRIT CARE RES, V67, P13, DOI 10.1002/acr.22389; Pham B, 2005, J CLIN EPIDEMIOL, V58, P769, DOI 10.1016/j.jclinepi.2004.08.021; Preiss D, 2011, CURR OPIN LIPIDOL, V22, P460, DOI 10.1097/MOL.0b013e32834b4994; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Richardson K, 2013, ANN INTERN MED, V159, P688, DOI 10.7326/0003-4819-159-10-201311190-00007; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; SALONEN R, 1995, CIRCULATION, V92, P1758, DOI 10.1161/01.CIR.92.7.1758; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Sever PS, 2004, DRUGS, V64, P43, DOI 10.2165/00003495-200464002-00005; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; SHEPHERD J, 1995, AM J CARDIOL, V76, pC113, DOI 10.1016/S0002-9149(99)80480-9; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stone NJ, 2013, EVIDENCE REPORT MANA; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Tonelli M, 2011, CAN MED ASSOC J, V183, pE1189, DOI 10.1503/cmaj.101280; US Preventive Services Task Force, 2016, REC STAT ST IN PRESS; US Preventive Services Task Force, 2008, AHRQ PUBLICATION, V08-05124-EF-3; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176	70	331	342	2	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					2008	2024		10.1001/jama.2015.15629	http://dx.doi.org/10.1001/jama.2015.15629			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838722	Bronze			2022-12-28	WOS:000387673800019
J	Thompson, PD				Thompson, Paul D.			What to Believe and Do About Statin-Associated Adverse Effects	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Thompson, Paul D.] Hartford Hosp, Hartford Healthcare Heart & Vasc Inst, 80 Seymour St, Hartford, CT 06102 USA	Hartford Hospital	Thompson, PD (corresponding author), Hartford Hosp, Hartford Healthcare Heart & Vasc Inst, 80 Seymour St, Hartford, CT 06102 USA.	paul.thompson@hhchealth.org						Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Ganga HV, 2014, AM HEART J, V168, P6, DOI 10.1016/j.ahj.2014.03.019; Hubal MJ, 2011, MUSCLE NERVE, V44, P393, DOI 10.1002/mus.22081; Nissen SE, 2016, JAMA-J AM MED ASSOC, V315, P1580, DOI 10.1001/jama.2016.3608; Parker BA, 2013, CIRCULATION, V127, P96, DOI 10.1161/CIRCULATIONAHA.112.136101; Taylor BA, 2015, ATHEROSCLEROSIS, V238, P329, DOI 10.1016/j.atherosclerosis.2014.12.016; Thompson PD, 2016, J AM COLL CARDIOL, V67, P2395, DOI 10.1016/j.jacc.2016.02.071; Voora D, 2009, J AM COLL CARDIOL, V54, P1609, DOI 10.1016/j.jacc.2009.04.053	8	20	21	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1969	1970		10.1001/jama.2016.16557	http://dx.doi.org/10.1001/jama.2016.16557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838726				2022-12-28	WOS:000387673800009
J	Gies, E				Gies, Erica			Can wind and solar fuel Africa's future?	NATURE			English	Article																		Anglada-Escude G, 2016, NATURE, V536, P437, DOI 10.1038/nature19106; Bousso R, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.063510; Dressing CD, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/45; Guillochon J, 2015, ASTROPHYS J LETT, V811, DOI 10.1088/2041-8205/811/2/L20; Hawking SW, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.231301; Ijjas A., 2014, PREPRINT; Loeb A, 2016, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2016/08/040; VILENKIN A, 1995, PHYS REV LETT, V74, P846, DOI 10.1103/PhysRevLett.74.846; WEINBERG S, 1987, PHYS REV LETT, V59, P2607, DOI 10.1103/PhysRevLett.59.2607	9	9	9	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					20	+		10.1038/539020a	http://dx.doi.org/10.1038/539020a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808213	Bronze			2022-12-28	WOS:000386670100008
J	Weiss, D; Weiss, MF				Weiss, Daniel; Weiss, Miriam F.			Lyme Disease	ANNALS OF INTERNAL MEDICINE			English	Letter									[Weiss, Daniel] Your Diabet Endocrine Nutr Grp, Mentor, OH 44060 USA; [Weiss, Miriam F.] Case Western Reserve Univ, Cleveland, OH 44106 USA	Case Western Reserve University	Weiss, D (corresponding author), Your Diabet Endocrine Nutr Grp, Mentor, OH 44060 USA.							Berndtson K, 2013, INT J GEN MED, V6, P291, DOI 10.2147/IJGM.S44114; Cameron DJ, 2014, EXPERT REV ANTI-INFE, V12, P1103, DOI 10.1586/14787210.2014.940900; Cook MJ, 2015, INT J GEN MED, V8, P1, DOI 10.2147/IJGM.S73791; Hu LT, 2016, ANN INTERN MED, V164, pITC65, DOI 10.7326/AITC201605030; Sapi E, 2013, INT J MED SCI, V10, P362, DOI 10.7150/ijms.5698	5	0	0	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					676	677		10.7326/L16-0410	http://dx.doi.org/10.7326/L16-0410			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802470				2022-12-28	WOS:000386908600020
J	Massonnet, F; Bellprat, O; Guemas, V; Doblas-Reyes, FJ				Massonnet, Francois; Bellprat, Omar; Guemas, Virginie; Doblas-Reyes, Francisco J.			Using climate models to estimate the quality of global observational data sets	SCIENCE			English	Article							PREDICTION	Observational estimates of the climate system are essential to monitoring and understanding ongoing climate change and to assessing the quality of climate models used to produce near- and long-term climate information. This study poses the dual and unconventional question: Can climate models be used to assess the quality of observational references? We show that this question not only rests on solid theoretical grounds but also offers insightful applications in practice. By comparing four observational products of sea surface temperature with a large multimodel climate forecast ensemble, we find compelling evidence that models systematically score better against the most recent, advanced, but also most independent product. These results call for generalized procedures of model-observation comparison and provide guidance for a more objective observational data set selection.	[Massonnet, Francois; Bellprat, Omar; Guemas, Virginie; Doblas-Reyes, Francisco J.] BSC CNS, Earth Sci Dept, Barcelona, Spain; [Massonnet, Francois] Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res TECLIM, ELI, Louvain La Neuve, Belgium; [Guemas, Virginie] CNRM, Toulouse, France; [Doblas-Reyes, Francisco J.] ICREA, Pg Lluis Companys 23, Barcelona 08010, Spain	Universitat Politecnica de Catalunya; Barcelona Supercomputer Center (BSC-CNS); Universite Catholique Louvain; ICREA	Massonnet, F (corresponding author), BSC CNS, Earth Sci Dept, Barcelona, Spain.; Massonnet, F (corresponding author), Catholic Univ Louvain, Georges Lemaitre Ctr Earth & Climate Res TECLIM, ELI, Louvain La Neuve, Belgium.	francois.massonnet@bsc.es	Massonnet, Francois/J-5315-2014; Guemas, Virginie/B-9090-2016	Massonnet, Francois/0000-0002-4697-5781; Guemas, Virginie/0000-0002-6340-3558	Belgian Fonds National de la Recherche Scientifique (FNRS); Ministerio de Economia y Competitividad (MINECO) Juan de la Cierva program; Spanish national project PICA-ICE [GA CGL2012-31987]; European Union [GA 308378]; EUCLEIA [GA 607085]; European Space Agency Living Planet Fellowship Programme under the project VERITAS; Climate Model User Group (CMUG) of the European Space Agency's Climate Change Initiative; ICREA Funding Source: Custom	Belgian Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Ministerio de Economia y Competitividad (MINECO) Juan de la Cierva program; Spanish national project PICA-ICE; European Union(European Commission); EUCLEIA; European Space Agency Living Planet Fellowship Programme under the project VERITAS; Climate Model User Group (CMUG) of the European Space Agency's Climate Change Initiative; ICREA(ICREA)	The research leading to these results has received funding from the Belgian Fonds National de la Recherche Scientifique (FNRS), the Ministerio de Economia y Competitividad (MINECO) Juan de la Cierva program, the Spanish national project PICA-ICE (GA CGL2012-31987), the European Union Seventh Framework Programme FP7 projects SPECS (GA 308378) and EUCLEIA (GA 607085), and the European Space Agency Living Planet Fellowship Programme under the project VERITAS, as well as the Climate Model User Group (CMUG) of the European Space Agency's Climate Change Initiative. We thank the National Oceanic and Atmospheric Administration, NSF, NASA, and U.S. Department of Energy for providing access to the North American Multi-Model Ensemble (NMME) database, and we acknowledge the help of the National Centers for Environmental Prediction, International Research Institute, and National Center for Atmospheric Research personnel in creating, updating, and maintaining the NMME archive. Acknowledgment is made for the use of the European Centre for Medium-Range Weather Forecasts computing and archive facilities in this research. We gratefully acknowledge the computer resources, technical expertise, and assistance provided by the Red Espanola de Supercomputacion (RES). All data used for the analyses conducted in this study are available at https://doi.org/10.1594/PANGAEA.864680. We acknowledge managers of the PANGAEA project for hosting this content.	Bellenger H, 2014, CLIM DYNAM, V42, P1999, DOI 10.1007/s00382-013-1783-z; Bellprat O, 2016, GEOPHYS RES LETT, V43, P2158, DOI 10.1002/2015GL067189; Collins M, 2012, NAT CLIM CHANGE, V2, P403, DOI 10.1038/NCLIMATE1414; Eyring V, 2016, GEOSCI MODEL DEV, V9, P1937, DOI 10.5194/gmd-9-1937-2016; Gleckler PJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008972; Hegerl GC, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/7/071001; Janssen PAEM, 2007, J ATMOS OCEAN TECH, V24, P1665, DOI 10.1175/JTECH2069.1; Kalnay E, 2002, ATMOSPHERIC MODELLIN, DOI [10.1017/CBO9780511802270, DOI 10.1017/CBO9780511802270]; Massonnet F, 2011, CRYOSPHERE, V5, P687, DOI 10.5194/tc-5-687-2011; Merchant CJ, 2014, GEOSCI DATA J, V1, P179, DOI 10.1002/gdj3.20; Palmer T., 2014, PREDICTABILITY WEATH; Reichler T, 2008, B AM METEOROL SOC, V89, P303, DOI 10.1175/BAMS-89-3-303; Sanderson BM, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052665; Scaife AA, 2014, GEOPHYS RES LETT, V41, P2514, DOI 10.1002/2014GL059637; Siegert S, 2016, J CLIMATE, V29, P995, DOI 10.1175/JCLI-D-15-0196.1; Steiger J. H, 1980, ANN M PSYCH SOC IOW; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Weigel AP, 2008, Q J ROY METEOR SOC, V134, P241, DOI 10.1002/qj.210; Wilks D., 2011, STAT METHODS ATMOSPH, P182; Xingfa G, 2015, IEEE GEOSCI REMOTE S, V3, P113, DOI DOI 10.1109/MGRS.2015.2467172	21	37	37	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					452	455		10.1126/science.aaf6369	http://dx.doi.org/10.1126/science.aaf6369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789838				2022-12-28	WOS:000387684400038
J	Rosenbaum, L				Rosenbaum, Lisa			Unlearning Our Helplessness - Coexisting Serious Mental and Medical Illness	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CANCER											Baggett T., 2014, SGIM FORUM, V37, P1; Howard LM, 2010, LANCET ONCOL, V11, P797, DOI 10.1016/S1470-2045(10)70085-1; Kisely S, 2013, JAMA PSYCHIAT, V70, P209, DOI 10.1001/jamapsychiatry.2013.278; Maier SF, 2016, PSYCHOL REV, V123, P349, DOI 10.1037/rev0000033; Saks Elyn R., 2002, REFUSING CARE FORCED; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	6	1	1	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2016	375	17					1690	1694		10.1056/NEJMms1610127	http://dx.doi.org/10.1056/NEJMms1610127			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2DX	27783917				2022-12-28	WOS:000387168900018
J	Hill, S; Kieny, MP				Hill, Suzanne; Kieny, Marie Paule			Towards access 2030	LANCET			English	Editorial Material									[Hill, Suzanne] WHO, Dept Essential Med & Hlth Prod, CH-1211 Geneva 27, Switzerland; [Kieny, Marie Paule] WHO, Hlth Syst & Innovat, CH-1211 Geneva 27, Switzerland	World Health Organization; World Health Organization	Hill, S (corresponding author), WHO, Dept Essential Med & Hlth Prod, CH-1211 Geneva 27, Switzerland.	hills@who.int	Kieny, Marie-Paule/N-3914-2017; Kieny, Marie-Paule/Q-1238-2019	Kieny, Marie-Paule/0000-0002-5943-6488; 	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Bauters T, 2016, J ONCOL PHARM PRACT, V22, P766, DOI 10.1177/1078155215610915; Cohen D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1445; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Taylor MM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159483; UN Secretary-General and Co-Chairs of the High-Level Panel, 2016, UN SECR GEN HIGH LEV; Vandenbroeck P, 2016, FUTURE SCENARIOS DRU; Wirtz VJ, 2016, LANCET; World Health Organization, 2015, WHO GUID COUNTR PHAR; World Health Organization, 2016, FULL LIST WHO MED PR	9	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					341	343		10.1016/S0140-6736(16)31904-3	http://dx.doi.org/10.1016/S0140-6736(16)31904-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27832875				2022-12-28	WOS:000392804700009
J	Sheyko, A; Finlay, CC; Jackson, A				Sheyko, Andrey; Finlay, Christopher C.; Jackson, Andrew			Magnetic reversals from planetary dynamo waves	NATURE			English	Article							CONVECTION-DRIVEN DYNAMOS; SIMULATIONS; DIPOLAR; TRANSITION; FREQUENCY; GEODYNAMO; BUOYANCY; MODELS; FLUX	A striking feature of many natural dynamos is their ability to undergo polarity reversals(1,2). The best documented example is Earth's magnetic field, which has reversed hundreds of times during its history(3,4). The origin of geomagnetic polarity reversals lies in a magnetohydrodynamic process that takes place in Earth's core, but the precise mechanism is debated(5). The majority of numerical geodynamo simulations that exhibit reversals operate in a regime in which the viscosity of the fluid remains important, and in which the dynamo mechanism primarily involves stretching and twisting of field lines by columnar convection(6). Here we present an example of another class of reversing-geodynamo model, which operates in a regime of comparatively low viscosity and high magnetic diffusivity. This class does not fit into the paradigm of reversal regimes that are dictated by the value of the local Rossby number (the ratio of advection to Coriolis force)(7,8). Instead, stretching of the magnetic field by a strong shear in the east-west flow near the imaginary cylinder just touching the inner core and parallel to the axis of rotation is crucial to the reversal mechanism in our models, which involves a process akin to kinematic dynamo waves(9,10). Because our results are relevant in a regime of low viscosity and high magnetic diffusivity, and with geophysically appropriate boundary conditions, this form of dynamo wave may also be involved in geomagnetic reversals.	[Sheyko, Andrey; Jackson, Andrew] Swiss Fed Inst Technol, Inst Geophys, CH-8092 Zurich, Switzerland; [Finlay, Christopher C.] Tech Univ Denmark, DTU Space, Div Geomagnetism, DK-2800 Lyngby, Denmark	Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Denmark	Sheyko, A (corresponding author), Swiss Fed Inst Technol, Inst Geophys, CH-8092 Zurich, Switzerland.	andrei.sheiko@erdw.ethz.ch	Finlay, Christopher C/B-5062-2014	Finlay, Christopher C/0000-0002-4592-2290	Centro Svizzero di Calcolo Scientifico (CSCS) [s577]; ERC [247303]; Danish Council for Independent Research (DFF) [4002-00366]	Centro Svizzero di Calcolo Scientifico (CSCS); ERC(European Research Council (ERC)European Commission); Danish Council for Independent Research (DFF)(Det Frie Forskningsrad (DFF))	We acknowledge the computational resources provided by the Centro Svizzero di Calcolo Scientifico (CSCS) under the project s577. We are grateful to J. M. Favre from CSCS for assistance with high-performance visualization. We thank A. Willis for developing the original dynamo code that was used for the calculations reported here, and P. Marti for subsequent optimizations for the CSCS Cray. This work was partially supported by ERC grant no. 247303 (MFECE) to A. J. and by the Danish Council for Independent Research (DFF) grant no. 4002-00366 to C.C.F.	Amit H, 2010, SPACE SCI REV, V155, P293, DOI 10.1007/s11214-010-9695-2; Aubert J, 2008, GEOPHYS J INT, V172, P945, DOI 10.1111/j.1365-246X.2007.03693.x; Busse FH, 2008, PHYS EARTH PLANET IN, V168, P237, DOI 10.1016/j.pepi.2008.06.007; Busse FH, 2006, GEOPHYS ASTRO FLUID, V100, P341, DOI 10.1080/03091920600784873; Christensen UR, 2006, GEOPHYS J INT, V166, P97, DOI 10.1111/j.1365-246X.2006.03009.x; Christensen UR, 2015, TREATISE GEOPHYS, V8, DOI DOI 10.1016/B978-0-444-53802-4.00145-7; Coe RS, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027903; Dietrich W, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/49001; Driscoll P, 2009, GEOPHYS J INT, V178, P1337, DOI [10.1111/j.1365-246x.2009.04234.x, 10.1111/j.1365-246X.2009.04234.x]; Dube C, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/1/69; Gastine T, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219799; Glatzmaier GA, 2002, ANNU REV EARTH PL SC, V30, P237, DOI 10.1146/annurev.earth.30.091201.140817; GUBBINS D, 1987, NATURE, V326, P167, DOI 10.1038/326167a0; Gubbins D, 2002, GEOPHYS ASTRO FLUID, V96, P481, DOI 10.1080/0309192021000037003; Jackson A, 2014, GEOPHYS J INT, V196, P712, DOI 10.1093/gji/ggt425; Jacobs JA, 1994, REVERSALS EARTHS MAG; Jones CA, 2014, ICARUS, V241, P148, DOI 10.1016/j.icarus.2014.06.020; Kida S, 1997, J PHYS SOC JPN, V66, P2194, DOI 10.1143/JPSJ.66.2194; Kutzner C, 2002, PHYS EARTH PLANET IN, V131, P29, DOI 10.1016/S0031-9201(02)00016-X; Merrill RT, 1999, REV GEOPHYS, V37, P201, DOI 10.1029/1998RG900004; Moffatt H.K., 1978, FIELD GENERATION ELE; Olson P, 2014, PHYS EARTH PLANET IN, V229, P122, DOI 10.1016/j.pepi.2014.01.009; Olson P, 2012, NAT GEOSCI, V5, P565, DOI [10.1038/NGEO1506, 10.1038/ngeo1506]; Olson P, 2006, EARTH PLANET SC LETT, V250, P561, DOI 10.1016/j.epsl.2006.08.008; Olson P, 2009, PHYS EARTH PLANET IN, V173, P121, DOI 10.1016/j.pepi.2008.11.010; Oruba L, 2014, GEOPHYS RES LETT, V41, P7115, DOI 10.1002/2014GL062069; Parker E.N., 1979, COSMICAL MAGNETIC FI; PARKER EN, 1955, ASTROPHYS J, V122, P293, DOI 10.1086/146087; Petrelis F, 2010, PHILOS T R SOC A, V368, P1595, DOI 10.1098/rsta.2009.0250; Petrelis F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.144503; Roberts PH, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/9/096801; ROBERTS PH, 1972, PHILOS TR R SOC S-A, V272, P663, DOI 10.1098/rsta.1972.0074; Rotvig J, 2009, PHYS EARTH PLANET IN, V176, P69, DOI 10.1016/j.pepi.2009.04.003; SAKURABA A, 2011, THE EARTH, P117, DOI DOI 10.1007/978-94-007-0323-0_8; Sakuraba A, 2009, NAT GEOSCI, V2, P802, DOI 10.1038/NGEO643; Sarson GR, 2000, PHILOS T R SOC A, V358, P921, DOI 10.1098/rsta.2000.0567; Schrinner M, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/121; Sheyko A, 2014, THESIS, P24; Sreenivasan B, 2014, GEOPHYS J INT, V199, P1698, DOI 10.1093/gji/ggu340; Takahashi F, 2007, EARTH PLANETS SPACE, V59, P665, DOI 10.1186/BF03352729; Wicht J, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2003GC000602; Wicht J, 2009, ADV GEOPHYS ENV MECH, P107, DOI 10.1007/978-3-540-76939-2_4; Willis AP, 2007, PHYS EARTH PLANET IN, V165, P83, DOI 10.1016/j.pepi.2007.08.002	43	18	19	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					551	+		10.1038/nature19842	http://dx.doi.org/10.1038/nature19842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27820946				2022-12-28	WOS:000388520600041
J	Friedrich, MJ				Friedrich, M. J.			Where Will Zika Spread?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1956	1956		10.1001/jama.2016.16151	http://dx.doi.org/10.1001/jama.2016.16151			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838728				2022-12-28	WOS:000387673800002
J	Clayton, JA; Tannenbaum, C				Clayton, Janine Austin; Tannenbaum, Cara			Reporting Sex, Gender, or Both in Clinical Research?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Clayton, Janine Austin] NIH, Off Res Womens Hlth, 6707 Democracy Blvd, Bethesda, MD 20817 USA; [Tannenbaum, Cara] Canadian Inst Hlth Res, Inst Gender & Hlth, Montreal, PQ, Canada	National Institutes of Health (NIH) - USA; Institute for Work & Health	Clayton, JA (corresponding author), NIH, Off Res Womens Hlth, 6707 Democracy Blvd, Bethesda, MD 20817 USA.	janine.clayton@nih.gov						Franconi F, 2014, EXPERT REV CLIN PHAR, V7, P469, DOI 10.1586/17512433.2014.922866; Heidari Shirin, 2016, Res Integr Peer Rev, V1, P2, DOI 10.1186/s41073-016-0007-6; Pelletier R, 2016, J AM COLL CARDIOL, V67, P127, DOI 10.1016/j.jacc.2015.10.067; Scheim AI, 2015, J SEX RES, V52, P1, DOI 10.1080/00224499.2014.893553; Schiebinger L, 2016, J AM COLL CARDIOL, V67, P136, DOI 10.1016/j.jacc.2015.11.029	5	237	237	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1863	1864		10.1001/jama.2016.16405	http://dx.doi.org/10.1001/jama.2016.16405			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27802482	Bronze			2022-12-28	WOS:000387116500008
J	Anderson, BP				Anderson, Brian P.			FLUID DYNAMICS Turbulence in a quantum gas	NATURE			English	News Item								The discovery of a cascade of sound waves across many wavelengths in an ultracold atomic gas advances our understanding of turbulence in fluids governed by quantum mechanics. SEE LETTER p.72	[Anderson, Brian P.] Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA	University of Arizona	Anderson, BP (corresponding author), Univ Arizona, Coll Opt Sci, Tucson, AZ 85721 USA.	brian.anderson@optics.arizona.edu	Anderson, Brian P/A-2286-2009	Anderson, Brian P/0000-0002-0442-7867				[Anonymous], 2001, QUANTIZED VORTEX DYN; Barenghi CF, 2014, P NATL ACAD SCI USA, V111, P4647, DOI 10.1073/pnas.1400033111; Navon N, 2016, NATURE, V539, P72, DOI 10.1038/nature20114; Pethick CJ, 2008, BOSE-EINSTEIN CONDENSATION IN DILUTE GASES, P1; Reeves MT, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.053621; White AC, 2014, P NATL ACAD SCI USA, V111, P4719, DOI 10.1073/pnas.1312737110; Zakharov V., 1992, KOLMOGOROV SPECTRA T	7	3	3	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					36	37		10.1038/539036a	http://dx.doi.org/10.1038/539036a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808204				2022-12-28	WOS:000386670100021
J	Haussmann, R; Donix, M				Haussmann, Robert; Donix, Markus			Disclosing Pleiotropic Effects During Genetic Risk Assessment for Alzheimer Disease	ANNALS OF INTERNAL MEDICINE			English	Letter							APOE GENOTYPE		[Haussmann, Robert; Donix, Markus] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital	Haussmann, R (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany.							Christensen KD, 2016, ANN INTERN MED, V164, P155, DOI 10.7326/M15-0187; Green RC, 2009, NEW ENGL J MED, V361, P245, DOI 10.1056/NEJMoa0809578; Lineweaver TT, 2014, AM J PSYCHIAT, V171, P201, DOI 10.1176/appi.ajp.2013.12121590; Tuminello Elizabeth R, 2011, Int J Alzheimers Dis, V2011, P726197, DOI 10.4061/2011/726197; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	5	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					673	673		10.7326/L16-0400	http://dx.doi.org/10.7326/L16-0400			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802468				2022-12-28	WOS:000386908600013
J	Plunkett, A				Plunkett, Adele			ASTROPHYSICS Birth of stellar siblings	NATURE			English	Editorial Material							STARS; MULTIPLICITY	Binary and multiple star systems result from the fragmentation of dense material in young molecular clouds. Observations reveal that this can occur on small scales, supporting a previous model of star formation. See Letter p.483	[Plunkett, Adele] European Southern Observ, Santiago 19001, Chile	European Southern Observatory	Plunkett, A (corresponding author), European Southern Observ, Santiago 19001, Chile.	aplunket@eso.org	Plunkett, Adele/ABC-2819-2020	Plunkett, Adele/0000-0002-9912-5705				Duchene G, 2013, ANNU REV ASTRON ASTR, V51, P269, DOI 10.1146/annurev-astro-081710-102602; Evans NJ, 2009, ASTROPHYS J SUPPL S, V181, P321, DOI 10.1088/0067-0049/181/2/321; MATHIEU RD, 1994, ANNU REV ASTRON ASTR, V32, P465, DOI 10.1146/annurev.aa.32.090194.002341; Pineda JE, 2015, NATURE, V518, P213, DOI 10.1038/nature14166; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Reipurth B., 2014, PROTOSTARS PLANETS, P267, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH012; Tobin JJ, 2016, NATURE, V538, P483, DOI 10.1038/nature20094; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861	8	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					466	467		10.1038/538466a	http://dx.doi.org/10.1038/538466a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786192				2022-12-28	WOS:000386654400045
J	Tyrakis, PA; Palazon, A; Macias, D; Lee, KL; Phan, AT; Velica, P; You, J; Chia, GS; Sim, J; Doedens, A; Abelanet, A; Evans, CE; Griffiths, JR; Poellinger, L; Goldrath, AW; Johnson, RS				Tyrakis, Petros A.; Palazon, Asis; Macias, David; Lee, Kian L.; Phan, Anthony T.; Velica, Pedro; You, Jia; Chia, Grace S.; Sim, Jingwei; Doedens, Andrew; Abelanet, Alice; Evans, Colin E.; Griffiths, John R.; Poellinger, Lorenz; Goldrath, Ananda W.; Johnson, Randall S.			S-2-hydroxyglutarate regulates CD8(+) T-lymphocyte fate	NATURE			English	Article							CELL-DIFFERENTIATION; ALPHA-KETOGLUTARATE; ONCOMETABOLITE 2-HYDROXYGLUTARATE; GENE-EXPRESSION; MUTANT IDH; MEMORY; EFFECTOR; CANCER; METABOLISM; ANTIGEN	R-2-hydroxyglutarate accumulates to millimolar levels in cancer cells with gain-of-function isocitrate dehydrogenase 1/2 mutations. These levels of R-2-hydroxyglutarate affect 2-oxoglutarate-dependent dioxygenases. Both metabolite enantiomers, R- and S-2-hydroxyglutarate, are detectible in healthy individuals, yet their physiological function remains elusive. Here we show that 2-hydroxyglutarate accumulates in mouse CD8(+) T cells in response to T-cell receptor triggering, and accumulates to millimolar levels in physiological oxygen conditions through a hypoxia-inducible factor 1-alpha (HIF-1 alpha)-dependent mechanism. S-2-hydroxyglutarate predominates over R-2-hydroxyglutarate in activated T cells, and we demonstrate alterations in markers of CD8(+) T-cell differentiation in response to this metabolite. Modulation of histone and DNA demethylation, as well as HIF-1 alpha stability, mediate these effects. S-2-hydroxyglutarate treatment greatly enhances the in vivo proliferation, persistence and anti-tumour capacity of adoptively transferred CD8(+) T cells. Thus, S-2-hydroxyglutarate acts as an immunometabolite that links environmental context, through a metabolic-epigenetic axis, to immune fate and function.	[Tyrakis, Petros A.; Palazon, Asis; Macias, David; Sim, Jingwei; Abelanet, Alice; Evans, Colin E.; Johnson, Randall S.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Tyrakis, Petros A.; Griffiths, John R.] Univ Cambridge, Cambridge Inst, Canc Res UK, Cambridge, England; [Lee, Kian L.; You, Jia; Chia, Grace S.; Poellinger, Lorenz] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore, Singapore; [Phan, Anthony T.; Doedens, Andrew; Goldrath, Ananda W.] Univ Calif San Diego, Mol Biol Sect, La Jolla, CA USA; [Velica, Pedro; Poellinger, Lorenz; Johnson, Randall S.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; National University of Singapore; University of California System; University of California San Diego; Karolinska Institutet	Johnson, RS (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England.; Johnson, RS (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden.	rsj33@cam.ac.uk	Macias, David/AAA-4114-2020; Palazon, Asis/ABI-1748-2020; Johnson, Randall/AAM-1189-2021; LEE, Kian Leong/E-3584-2013	Macias, David/0000-0002-8676-1964; Palazon, Asis/0000-0002-7172-7229; Johnson, Randall/0000-0002-4084-6639; LEE, Kian Leong/0000-0002-0443-2746; Velica, Pedro/0000-0002-0557-8544; Goldrath, Ananda/0000-0002-5900-508X; Evans, Colin/0000-0002-9251-357X; Sim, Jingwei/0000-0002-6009-5684; Tyrakis, Petros Andreas/0000-0003-3281-2153; Doedens, Andrew/0000-0003-2461-3496; Abelanet, Alice/0000-0001-5526-9515; Phan, Anthony/0000-0003-2935-6070	CRUK; MRC [1495954]; Wellcome Trust [WT092738MA]; Marie-Curie IEF; UCSD NIH Grant [5T32GM007240-36]; NIH [A1096852, A1072117]; Leukemia and Lymphoma Society; Pew Scholars Fund; Singapore National Research Foundation; Singapore Ministry of Education; NMRC [NMRC/CIRG/1389/2014]; Swedish Research Council; Swedish Cancer Foundation (Cancerfonden); Swedish Research Council (Vetenskapsradet); Cancer Research UK [11562] Funding Source: researchfish; Medical Research Council [1495954] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072117, R01AI096852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007240] Funding Source: NIH RePORTER	CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Marie-Curie IEF(European Commission); UCSD NIH Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pew Scholars Fund; Singapore National Research Foundation(National Research Foundation, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); NMRC(National Medical Research Council, Singapore); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation (Cancerfonden)(Swedish Cancer Society); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Cambridge Institute PK Bioanalytics Core facility for MS measurements: A. Cowburn, A. Wood, K. Lodge and E. Chilvers for human PBMCs; B. Jaggs for help with mouse work. P.A.T. was funded by CRUK, the MRC (1495954) and Wellcome Trust. J.R.G. was funded by CRUK. A.P. was funded by Marie-Curie IEF. A.T.P. was funded by UCSD NIH Grant (5T32GM007240-36). A.W.G. was funded by the NIH (A1096852, A1072117), Leukemia and Lymphoma Society, and Pew Scholars Fund, K.L.L., J.Y., G.S.C. and L.P. were funded by the Singapore National Research Foundation and Singapore Ministry of Education, the NMRC Clinician Scientist (NMRC/CIRG/1389/2014.) and the Swedish Research Council. R.S.J. and co-workers are funded by the Wellcome Trust (grant WT092738MA), the Swedish Cancer Foundation (Cancerfonden), and the Swedish Research Council (Vetenskapsradet). This work is dedicated to the memory of Lorenz Poellinger.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Arsenio J, 2014, NAT IMMUNOL, V15, P365, DOI 10.1038/ni.2842; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Crompton J. G., 2015, CELL MOL IMMUNOL; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009; Ghesquiere B, 2014, NATURE, V511, P167, DOI 10.1038/nature13312; GIBSON KM, 1993, PEDIATR RES, V34, P277, DOI 10.1203/00006450-199309000-00007; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Harland KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4547; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Ichiyama K, 2015, IMMUNITY, V42, P613, DOI 10.1016/j.immuni.2015.03.005; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kurtulus S, 2011, J IMMUNOL, V186, P5729, DOI 10.4049/jimmunol.1100102; Losman JA, 2013, GENE DEV, V27, P836, DOI 10.1101/gad.217406.113; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Patel KP, 2011, J MOL DIAGN, V13, P678, DOI 10.1016/j.jmoldx.2011.06.004; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rajagopalan KN, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0134-4; Rasmussen KD, 2016, GENE DEV, V30, P733, DOI 10.1101/gad.276568.115; Russ BE, 2014, IMMUNITY, V41, P853, DOI 10.1016/j.immuni.2014.11.001; Saha SK, 2014, NATURE, V513, P110, DOI 10.1038/nature13441; Song AH, 2005, J IMMUNOL, V175, P3534, DOI 10.4049/jimmunol.175.6.3534; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Zhang DJ, 2005, J IMMUNOL, V174, P6725, DOI 10.4049/jimmunol.174.11.6725; Zhang FQ, 2014, MOL THER, V22, P1698, DOI 10.1038/mt.2014.91	50	235	235	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					236	+		10.1038/nature20165	http://dx.doi.org/10.1038/nature20165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27798602	Green Accepted, Green Published			2022-12-28	WOS:000389548700050
J	Xia, Y; Lu, G; Liu, P; Dong, GB				Xia, Ying; Lu, Gang; Liu, Peng; Dong, Guangbin			Catalytic activation of carbon-carbon bonds in cyclopentanones	NATURE			English	Article							C-C BOND; ENANTIOSELECTIVE SYNTHESIS; (+)-EROGORGIAENE; MIGRATION; BREAKING	In the chemical industry, molecules of interest are based primarily on carbon skeletons. When synthesizing such molecules, the activation of carbon-carbon single bonds (C-C bonds) in simple substrates is strategically important: it offers a way of disconnecting such inert bonds, forming more active linkages (for example, between carbon and a transition metal) and eventually producing more versatile scaffolds(1-13). The challenge in achieving such activation is the kinetic inertness of C-C bonds and the relative weakness of newly formed carbon-metal bonds(6,14). The most common tactic starts with a three-or four-membered carbon-ring system(9-13), in which strain release provides a crucial thermodynamic driving force. However, broadly useful methods that are based on catalytic activation of unstrained C-C bonds have proven elusive, because the cleavage process is much less energetically favourable. Here we report a general approach to the catalytic activation of C-C bonds in simple cyclopentanones and some cyclohexanones. The key to our success is the combination of a rhodium pre-catalyst, an N-heterocyclic carbene ligand and an amino-pyridine co-catalyst. When an aryl group is present in the C3 position of cyclopentanone, the less strained C-C bond can be activated; this is followed by activation of a carbon-hydrogen bond in the aryl group, leading to efficient synthesis of functionalized alpha-tetralones-alpha common structural motif and versatile building block in organic synthesis. Furthermore, this method can substantially enhance the efficiency of the enantioselective synthesis of some natural products of terpenoids. Density functional theory calculations reveal a mechanism involving an intriguing rhodiumbridged bicyclic intermediate.	[Xia, Ying; Dong, Guangbin] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA; [Xia, Ying; Dong, Guangbin] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Lu, Gang; Liu, Peng] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA	University of Texas System; University of Texas Austin; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dong, GB (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.; Liu, P; Dong, GB (corresponding author), Univ Chicago, Dept Chem, Chicago, IL 60637 USA.; Liu, P (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	pengliu@pitt.edu; gbdong@uchicago.edu	Liu, Peng/A-9043-2008; Lu, Gang/M-5729-2017; Xia, Ying/T-6953-2019	Liu, Peng/0000-0002-8188-632X; Lu, Gang/0000-0002-7319-4315; Xia, Ying/0000-0002-4803-8599	Cancer Prevention Research Institute of Texas [R1118]; National Institute of General Medical Science [R01GM109054]; Welch Foundation [F1781]; Office of China Postdoctoral Council (OCPC) [38]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109054] Funding Source: NIH RePORTER	Cancer Prevention Research Institute of Texas; National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); Office of China Postdoctoral Council (OCPC); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by the Cancer Prevention Research Institute of Texas (grant R1118), the National Institute of General Medical Science (grant R01GM109054) and the Welch Foundation (grant F1781). G.D. is a Searle Scholar and Sloan fellow. Y.X. acknowledges the International Postdoctoral Exchange Fellowship Program 2015 from the Office of China Postdoctoral Council (OCPC, document 38, 2015). We thank Johnson Matthey for a donation of Rh salts, and Chiral Technologies for donation of chiral high-performance liquid-chromatography columns. We are grateful to Y. Xu for providing 1,4-dioxane, F. Mo for providing some 3-aryl cyclopentanones, and H. Lim for checking the experimental procedures. DFT calculations were performed using supercomputer resources at the Center for Simulation and Modeling at the University of Pittsburgh, and the Extreme Science and Engineering Discovery Environment supported by the National Science Foundation.	Albrecht M, 1999, J AM CHEM SOC, V121, P11898, DOI 10.1021/ja992494+; Chavan SP, 2012, TETRAHEDRON-ASYMMETR, V23, P1410, DOI 10.1016/j.tetasy.2012.09.008; Davies HML, 2005, ANGEW CHEM INT EDIT, V44, P1733, DOI 10.1002/anie.200462227; Dong G, 2014, TOP CURR CHEM, V346, P1, DOI 10.1007/978-3-642-55055-3; Elford TG, 2011, J AM CHEM SOC, V133, P16798, DOI 10.1021/ja207869f; GOZIN M, 1993, NATURE, V364, P699, DOI 10.1038/364699a0; HALPERN J, 1982, ACCOUNTS CHEM RES, V15, P238, DOI 10.1021/ar00080a002; Hayashi T, 2003, CHEM REV, V103, P2829, DOI 10.1021/cr020022z; JONES WD, 1993, NATURE, V364, P676, DOI 10.1038/364676a0; Jun CH, 2004, CHEM SOC REV, V33, P610, DOI 10.1039/b308864m; Jun CH, 2001, J AM CHEM SOC, V123, P751, DOI 10.1021/ja0033537; Lapointe D, 2010, CHEM LETT, V39, P1119, DOI 10.1246/cl.2010.1118; Li GZ, 2014, CHEM COMMUN, V50, P4328, DOI 10.1039/c4cc00816b; Mack DJ, 2013, ACS CATAL, V3, P272, DOI 10.1021/cs300771d; Masarwa A, 2014, NATURE, V505, P199, DOI 10.1038/nature12761; Matsuda T, 2007, J AM CHEM SOC, V129, P12086, DOI 10.1021/ja075141g; Matsuda T, 2015, CHEM COMMUN, V51, P7393, DOI 10.1039/c5cc01415h; Matsuda T, 2012, CHEM COMMUN, V48, P2988, DOI 10.1039/c2cc18098g; Mukai C, 2012, J AM CHEM SOC, V134, P19580, DOI 10.1021/ja309830p; Mukherjee P, 2012, ORG BIOMOL CHEM, V10, P3060, DOI 10.1039/c2ob07095b; MURAKAMI M, 1994, NATURE, V370, P540, DOI 10.1038/370540a0; Murakami M., 1999, TOP ORGANOMETAL CHEM, V3, P97, DOI DOI 10.1007/3-540-68525-1_5; Park YJ, 2008, ACCOUNTS CHEM RES, V41, P222, DOI 10.1021/ar700133y; Rybtchinski B, 1999, ANGEW CHEM INT EDIT, V38, P870, DOI 10.1002/(SICI)1521-3773(19990401)38:7<870::AID-ANIE870>3.0.CO;2-3; Satoh T, 2005, TOP ORGANOMETAL CHEM, V14, P1; Seiser T, 2011, ANGEW CHEM INT EDIT, V50, P7740, DOI 10.1002/anie.201101053; Seiser T, 2009, ANGEW CHEM INT EDIT, V48, P6320, DOI 10.1002/anie.200903189; Shigeno M, 2009, CHEM-EUR J, V15, P12929, DOI 10.1002/chem.200902593; Souillart L, 2015, CHEM REV, V115, P9410, DOI 10.1021/acs.chemrev.5b00138; Zeng R, 2015, J AM CHEM SOC, V137, P1408, DOI 10.1021/ja512306a	30	173	173	16	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					546	550		10.1038/nature19849	http://dx.doi.org/10.1038/nature19849			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27806379	Green Accepted			2022-12-28	WOS:000388520600040
J	Serruys, PW; Chevalier, B; Sotomi, Y; Cequier, A; Carrie, D; Piek, JJ; Van Boven, AJ; Dominici, M; Dudek, D; McClean, D; Helqvist, S; Haude, M; Reith, S; Almeida, MD; Campo, G; Iniguez, A; Sabate, M; Windecker, S; Onuma, Y				Serruys, Patrick W.; Chevalier, Bernard; Sotomi, Yohei; Cequier, Angel; Carrie, Didier; Piek, Jan J.; Van Boven, Ad J.; Dominici, Marcello; Dudek, Dariusz; McClean, Dougal; Helqvist, Steffen; Haude, Michael; Reith, Sebastian; Almeida, Manuel de Sousa; Campo, Gianluca; Iniguez, Andres; Sabate, Manel; Windecker, Stephan; Onuma, Yoshinobu			Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial	LANCET			English	Article							VASCULAR SCAFFOLD; VASODILATORY ACTION; IMPLANTATION; THROMBOSIS; DISEASE; PERFORMANCE; EXERCISE; OUTCOMES; COHORT	Background No medium-term data are available on the random comparison between everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents. The study aims to demonstrate two mechanistic properties of the bioresorbable scaffold: increase in luminal dimensions as a result of recovered vasomotion of the scaffolded vessel. Methods The ABSORB II trial is a prospective, randomised, active-controlled, single-blind, parallel two-group, multicentre clinical trial. We enrolled eligible patients aged 18-85 years with evidence of myocardial ischaemia and one or two de-novo native lesions in different epicardial vessels. We randomly assigned patients (2:1) to receive treatment with an everolimus-eluting bioresorbable scaffold (Absorb; Abbott Vascular, Santa Clara, CA, USA) or treatment with an everolimus-eluting metallic stent (Xience; Abbott Vascular, Santa Clara, CA, USA). Randomisation was stratified by diabetes status and number of planned target lesions. At 3 year follow-up, the primary endpoint was superiority of the Absorb bioresorbable scaffold versus the Xience metallic stent in angiographic vasomotor reactivity after administration of intracoronary nitrate. The co-primary endpoint is the non-inferiority of angiographic late luminal loss. For the endpoint of vasomotion, the comparison was tested using a two-sided t test. For the endpoint of late luminal loss, non-inferiority was tested using a one-sided asymptotic test, against a non-inferiority margin of 0.14 mm. The trial is registered at ClinicalTrials. gov, number NCT01425281. Findings Between Nov 28, 2011, and June 4, 2013, we enrolled 501 patients and randomly assigned them to the Absorb group (335 patients, 364 lesions) or the Xience group (166 patients, 182 lesions). The vasomotor reactivity at 3 years was not statistically different (Absorb group 0.047 mm [SD 0.109] vs Xience group 0.056 mm [0.117]; p(superiority) = 0.49), whereas the late luminal loss was larger in the Absorb group than in the Xience group (0.37 mm [0.45] vs 0.25 mm [0.25]; p(non-inferiority) = 0.78). This difference in luminal dimension was confirmed by intravascular ultrasound assessment of the minimum lumen area (4.32 mm(2) [SD 1.48] vs 5.38 mm(2) [1.51]; p < 0.0001). The secondary endpoints of patient-oriented composite endpoint, Seattle Angina Questionnaire score, and exercise testing were not statistically different in both groups. However, a device-oriented composite endpoint was significantly different between the Absorb group and the Xience group (10% vs 5%, hazard ratio 2.17 [95% CI 1.01-4.70]; log-rank test p=0.0425), mainly driven by target vessel myocardial infarction (6% vs 1%; p = 0.0108), including peri-procedural myocardial infarction (4% vs 1%; p = 0.16). Interpretation The trial did not meet its co-primary endpoints of superior vasomotor reactivity and non-inferior late luminal loss for the Absorb bioresorbable scaffold with respect to the metallic stent, which was found to have significantly lower late luminal loss than the Absorb scaffold. A higher rate of device-oriented composite endpoint due to target vessel myocardial infarction, including peri-procedural myocardial infarction, was observed in the Absorb group. The patient-oriented composite endpoint, anginal status, and exercise testing, were not statistically different between both devices at 3 years. Future studies should investigate the clinical impact of accurate intravascular imaging in sizing the device and in optimising the scaffold implantation. The benefit and need for prolonged dual antiplatelet therapy after bioresorbable scaffold implantation could also become a topic for future clinical research.	[Serruys, Patrick W.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Chevalier, Bernard] Inst Jacques Cartier, Massy, France; [Sotomi, Yohei; Piek, Jan J.] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Cequier, Angel] Bellvitge Univ Hosp, Barcelona, Spain; [Carrie, Didier] Hop Rangueil, Toulouse, France; [Van Boven, Ad J.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Dominici, Marcello] S Maria Univ Hosp, Terni, Italy; [Dudek, Dariusz] Jagiellonian Univ, Dept Intervent Cardiol, Krakow, Poland; [McClean, Dougal] Christchurch Hosp, Christchurch, New Zealand; [Helqvist, Steffen] Univ Copenhagen, Rigshosp, Copenhagen, Denmark; [Haude, Michael] Lukaskrankenhaus GmbH, Stadt Klinken Neuss, Med Clin 1, Neuss, Germany; [Reith, Sebastian] Univ Klinikum RWTH Aachen, Aachen, Germany; [Almeida, Manuel de Sousa] Hosp Santa Cruz, Carnaxide, Portugal; [Campo, Gianluca] Azienda Osped Univ S Anna, Cardiovasc Inst, Cona, FE, Italy; [Iniguez, Andres] Univ Hosp Vigo, Hosp Alvaro Cunqueiro, Dept Cardiol, Intervent Cardiol Unit, Vigo, Spain; [Sabate, Manel] Univ Barcelona, Inst dInvestigac Biomed August Pi Sunyer, Inst Invest Biomed August Pi & Sunyer, Thorax Inst,Univ Hosp Clin, Barcelona, Spain; [Windecker, Stephan] Inselspital Bern, Univ Klin Kardiol, Bern, Switzerland; [Onuma, Yoshinobu] Erasmus MC, ThoraxCtr, Rotterdam, Netherlands; [Onuma, Yoshinobu] Cardialysis, Rotterdam, Netherlands	Imperial College London; Jacques Cartier Private Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CHU de Toulouse; Medical Center Leeuwarden; Jagiellonian University; Christchurch Hospital New Zealand; Rigshospitalet; University of Copenhagen; RWTH Aachen University; RWTH Aachen University Hospital; Complexo Hospitalario Universitario de Vigo; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Bern; University Hospital of Bern; Erasmus University Rotterdam; Erasmus MC; Cardialysis	Serruys, PW (corresponding author), POB 2125, NL-3000 CC Rotterdam, Netherlands.	patrick.w.j.c.serruys@gmail.com	de Sousa Almeida, Manuel/ABC-5531-2020; Sabate, Manel/AAX-7245-2021; Onuma, Yoshinobu/AHB-6273-2022; Chevalier, Bernard/AAU-2855-2021	de Sousa Almeida, Manuel/0000-0003-2179-4738; Onuma, Yoshinobu/0000-0001-7702-0649; CARRIE, didier/0000-0003-2479-8144; Dominici, Marcello/0000-0002-9424-6583; Sabate Tenas, Manel/0000-0002-2316-3705; Campo, Gianluca/0000-0002-5150-188X; Piek, Jan/0000-0001-8666-7129	Abbott; AstraZeneca; Biotronik; Cardialysis; GLG Research; Medtronic; Sinomedical Sciences Technology; Societe Europa Digital Publishing; Stentys France; Svelte Medical Systems; Volcano; St Jude Medical; Qualimed; Abbott Vascular; Boston Scientific; Biosensor; Abbott Vascular International; Orbus Neich; Cardiac Dimensions; Lilly; Menarini; Edwards Lifesciences; Biosensors; Daiichi Sankyo; Sanofi	Abbott(Abbott Laboratories); AstraZeneca(AstraZeneca); Biotronik; Cardialysis; GLG Research; Medtronic(Medtronic); Sinomedical Sciences Technology; Societe Europa Digital Publishing; Stentys France; Svelte Medical Systems; Volcano; St Jude Medical(St. Jude Medical); Qualimed; Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Biosensor; Abbott Vascular International; Orbus Neich; Cardiac Dimensions; Lilly(Eli Lilly); Menarini(Menarini Group); Edwards Lifesciences; Biosensors; Daiichi Sankyo(Daiichi Sankyo Company Limited); Sanofi	PWS reports consultant fees from Abbott, AstraZeneca, Biotronik, Cardialysis, GLG Research, Medtronic, Sinomedical Sciences Technology, Societe Europa Digital Publishing, Stentys France, Svelte Medical Systems, Volcano, St Jude Medical, and Qualimed. BC is a consultant for Abbott Vascular. AC reports grants from Abbott Vascular. DC reports grant support from Biotronik, Abbott, Medtronic, Boston Scientific, AstraZeneca, and Biosensor, speaker's fees from Biotronik, Abbott, and Biosensor, and consultant fees from Biotronik, Boston scientific, and Abbott. JJP is a consultant for Abbott Vascular. MD reports grants and non-financial support from Abbott Vascular International. DD reports grants and personal fees from Abbott Vascular, Volcano, St Jude Medical, AstraZeneca, and Biotronik, and personal fees from Medtronic. DM is a member of the Advisory Board of Abbott Vascular. MH reports grant support from Biotronik, Orbus Neich, Abbott, Medtronic, and Cardiac Dimensions, speaker's fees from Biotronik, Orbus Neich, Abbott, Medtronic, Lilly, Volcano, and Cardiac Dimensions, and consultancy for Biotronik, Orbus Neich, and Abbott. GC reports personal fees from Menarini, Abbott Vascular, Boston Scientific, and AstraZeneca. MS reports personal fees from Abbott Vascular. SW reports grants from Abbott, Biotronik, Biosensors, Edwards Lifesciences, Medtronic, and St Jude Medical, personal fees from AstraZeneca, Daiichi Sankyo, and Sanofi, and grants and personal fees from Boston Scientific. YO is a member of the Advisory Board of Abbott Vascular. YS, AJVB, SH, SR, MdSA, and AI declare no competing interests.	Camm AJ., 2009, ESC TXB CARDIOVASCUL; Collet C, 2016, MINERVA CARDIOANGIOL; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Diletti R, 2012, AM HEART J, V164, P654, DOI 10.1016/j.ahj.2012.08.010; Gomez-Lara J, 2011, EUR HEART J, V32, P294, DOI 10.1093/eurheartj/ehq458; Hamilos MI, 2008, J AM COLL CARDIOL, V51, P2123, DOI 10.1016/j.jacc.2007.12.059; Ishibashi Y, 2015, JACC-CARDIOVASC INTE, V8, P1715, DOI 10.1016/j.jcin.2015.07.026; Ishibashi Y, 2015, JACC-CARDIOVASC INTE, V8, P1053, DOI 10.1016/j.jcin.2015.06.001; Karanasos A, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002369; Maier W, 2002, CIRCULATION, V105, P2373, DOI 10.1161/01.CIR.0000016360.97819.44; Onuma Y, 2016, EUROINTERVENTION, V12, P1090, DOI 10.4244/EIJY16M09_01; Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019; Raber L, 2015, J AM COLL CARDIOL, V66, P1901, DOI 10.1016/j.jacc.2015.08.853; Raber L, 2012, CIRCULATION, V125, P1110, DOI 10.1161/CIRCULATIONAHA.111.058560; Serruys PW, 2016, J AM COLL CARDIOL, V67, P766, DOI 10.1016/j.jacc.2015.11.060; Serruys PW, 2015, LANCET, V385, P43, DOI 10.1016/S0140-6736(14)61455-0; Serruys PW, 2014, EUROINTERVENTION, V9, P1271, DOI 10.4244/EIJV9I11A217; Shin DI, 2007, INT HEART J, V48, P553, DOI 10.1536/ihj.48.553; Sotomi Y, 2017, EUROINTERVENTION, V12, P1747, DOI 10.4244/EIJ-D-16-00471; Sotomi Y, 2016, JACC-CARDIOVASC INTE, V9, P1216, DOI 10.1016/j.jcin.2016.03.022; Sotomi Y, 2016, EUROINTERVENTION, V12, pE998, DOI 10.4244/EIJV12I8A163; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; SURYAPRANATA H, 1988, AM J CARDIOL, V61, P292, DOI 10.1016/0002-9149(88)90933-2; SURYAPRANATA H, 1992, AM J CARDIOL, V69, P1171, DOI 10.1016/0002-9149(92)90931-N; Suwannasom P, 2016, JACC-CARDIOVASC INTE, V9, P1231, DOI 10.1016/j.jcin.2016.03.027; Togni M, 2004, CIRCULATION, V110, P135, DOI 10.1161/01.CIR.0000134956.96543.4F; Waksman Ron, 2006, J Invasive Cardiol, V18, P70	27	394	408	1	93	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2479	2491		10.1016/S0140-6736(16)32050-5	http://dx.doi.org/10.1016/S0140-6736(16)32050-5			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC5IA	27806897				2022-12-28	WOS:000388166300026
J	Notz, D; Stroeve, J				Notz, Dirk; Stroeve, Julienne			Observed Arctic sea-ice loss directly follows anthropogenic CO2 emission	SCIENCE			English	Article							ENERGY-BALANCE; CLIMATE; BUDGET; FUTURE; CMIP5	Arctic sea ice is retreating rapidly, raising prospects of a future ice-free Arctic Ocean during summer. Because climate-model simulations of the sea-ice loss differ substantially, we used a robust linear relationship between monthly-mean September sea-ice area and cumulative carbon dioxide (CO2) emissions to infer the future evolution of Arctic summer sea ice directly from the observational record. The observed linear relationship implies a sustained loss of 3 +/- 0.3 square meters of September sea-ice area per metric ton of CO2 emission. On the basis of this sensitivity, Arctic sea ice will be lost throughout September for an additional 1000 gigatons of CO2 emissions. Most models show a lower sensitivity, which is possibly linked to an underestimation of the modeled increase in incoming longwave radiation and of the modeled transient climate response.	[Notz, Dirk] Max Planck Inst Meteorol, Hamburg, Germany; [Stroeve, Julienne] Natl Snow & Ice Data Ctr, Boulder, CO USA; [Stroeve, Julienne] UCL, London, England	Max Planck Society; University of London; University College London	Notz, D (corresponding author), Max Planck Inst Meteorol, Hamburg, Germany.	dirk.notz@mpimet.mpg.de	Notz, Dirk/P-4428-2017; Stroeve, Julienne/ABE-7227-2020	Notz, Dirk/0000-0003-0365-5654; Hegerl, Gabriele/0000-0002-4159-1295	Max Planck Research Fellowship; NASA [NNX12AB75G]; NSF [PLR 1304246]	Max Planck Research Fellowship(Max Planck Society); NASA(National Aeronautics & Space Administration (NASA)); NSF(National Science Foundation (NSF))	We are grateful to J. Marotzke for the suggestion to analyze the TCR and for helpful comments on the manuscript. We are also grateful to two anonymous reviewers, whose insightful comments were essential for framing the final version of our study. We further thank B. Soden, D. Olonscheck, and C. Li for helpful feedback. D.N. acknowledges funding through a Max Planck Research Fellowship. J.S. acknowledges funding from NASA grant NNX12AB75G and NSF grant PLR 1304246. All primary data used for this study are based on publicly available output from CMIP5 models and are also available upon request from publications@mpimet.mpg.de.	Cubasch U., 2001, PROJECTIONS FUTURE C, P525; Fasullo JT, 2012, SCIENCE, V338, P792, DOI 10.1126/science.1227465; Fetterer F., 2002, SEA ICE INDEX DIGITA; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Gillett NP, 2013, J CLIMATE, V26, P6844, DOI 10.1175/JCLI-D-12-00476.1; Gorodetskaya IV, 2008, J CLIMATE, V21, P866, DOI 10.1175/2007JCLI1614.1; Gregory JM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014575; Hadley Center for Climate Prediction and Research Met Office, 2006, HADISST 11 GLOB SEA; Herrington T, 2014, EARTH SYST DYNAM, V5, P409, DOI 10.5194/esd-5-409-2014; Jahn A, 2016, GEOPHYS RES LETT, V43, P9113, DOI 10.1002/2016GL070067; Johannessen OM, 2008, ATMOS OCEAN SCI LETT, V1, P51, DOI 10.1080/16742834.2008.11446766; Li C, 2013, J CLIMATE, V26, P5624, DOI 10.1175/JCLI-D-12-00492.1; Mahlstein I, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016709; MASSONNET F, 2012, CRYOSPHERE, V6, P1383, DOI [10.5194/tc-6-1383-2012, DOI 10.5194/tc-6-1383-2012]; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Meier WN, 2014, REV GEOPHYS, V52, P185, DOI 10.1002/2013RG000431; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; NORTH GR, 1975, J ATMOS SCI, V32, P2033, DOI 10.1175/1520-0469(1975)032<2033:TOEBCM>2.0.CO;2; Notz D, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0164; Notz D, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051094; Otto A, 2013, NAT GEOSCI, V6, P415, DOI 10.1038/ngeo1836; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Richardson M, 2016, NAT CLIM CHANGE, V6, P931, DOI [10.1038/NCLIMATE3066, 10.1038/nclimate3066]; Ridley JK, 2012, CRYOSPHERE, V6, P193, DOI 10.5194/tc-6-193-2012; Santer BD, 2014, NAT GEOSCI, V7, P185, DOI [10.1038/ngeo2098, 10.1038/NGEO2098]; Schmidt GA, 2014, NAT GEOSCI, V7, P158, DOI 10.1038/ngeo2105; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Stephens GL, 2012, NAT GEOSCI, V5, P691, DOI [10.1038/NGEO1580, 10.1038/ngeo1580]; Stroeve J, 2015, GLOBAL PLANET CHANGE, V135, P119, DOI 10.1016/j.gloplacha.2015.10.011; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Vihma T, 2014, SURV GEOPHYS, V35, P1175, DOI 10.1007/s10712-014-9284-0; Winton M, 2011, J CLIMATE, V24, P3924, DOI 10.1175/2011JCLI4146.1; Zickfeld K, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050205	34	261	267	13	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 11	2016	354	6313					747	750		10.1126/science.aag2345	http://dx.doi.org/10.1126/science.aag2345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4FS	27811286	Green Submitted			2022-12-28	WOS:000387326300037
J	Lyon, J				Lyon, Jeff			Precision Medicine Gets Boost	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1859	1859		10.1001/jama.2016.16235	http://dx.doi.org/10.1001/jama.2016.16235			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27824991				2022-12-28	WOS:000387116500004
J	Goncalves, JT; Schafer, ST; Gage, FH				Goncalves, J. Tiago; Schafer, Simon T.; Gage, Fred H.			Adult Neurogenesis in the Hippocampus: From Stem Cells to Behavior	CELL			English	Review							DENTATE GRANULE CELLS; NEURAL PROGENITOR CELLS; NEWLY GENERATED NEURONS; SPATIAL-PATTERN SEPARATION; NUCLEAR RECEPTOR TLX; IN-VIVO; NEWBORN NEURONS; CRITICAL PERIOD; SONIC HEDGEHOG; RNA-SEQ	The dentate gyrus of the mammalian hippocampus continuously generates new neurons during adulthood. These adult-born neurons become functionally active and are thought to contribute to learning and memory, especially during their maturation phase, when they have extraordinary plasticity. In this Review, we discuss the molecular machinery involved in the generation of new neurons from a pool of adult neural stem cells and their integration into functional hippocampal circuits. We also summarize the potential functions of these newborn neurons in the adult brain, their contribution to behavior, and their relevance to disease.	[Goncalves, J. Tiago; Schafer, Simon T.; Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Goncalves, J. Tiago] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA	Salk Institute; Yeshiva University; Albert Einstein College of Medicine	Gage, FH (corresponding author), Salk Inst Biol Studies, Lab Genet, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu		Schafer, Simon/0000-0002-2370-3652; Goncalves, J. Tiago/0000-0003-2303-1822	James S. McDonnell Foundation; G. Harold & Leila Y. Mathers Charitable Foundation; Annette Merle-Smith; JPB Foundation; NIH [MH092758, MH095741]; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED00]	James S. McDonnell Foundation; G. Harold & Leila Y. Mathers Charitable Foundation; Annette Merle-Smith; JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leona M. and Harry B. Helmsley Charitable Trust	We thank M.L. Gage, M.E. Janssen, and M. Pena for editorial comments. We also acknowledge support from The James S. McDonnell Foundation, G. Harold & Leila Y. Mathers Charitable Foundation, Annette Merle-Smith, JPB Foundation, NIH (Grants MH095741 and MH092758), and The Leona M. and Harry B. Helmsley Charitable Trust (Grant #2012-PG-MED00).	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barbosa JS, 2015, SCIENCE, V348, P789, DOI 10.1126/science.aaa2729; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Bergami M, 2015, NEURON, V85, P710, DOI 10.1016/j.neuron.2015.01.001; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Bond AM, 2014, STEM CELLS, V32, P2201, DOI 10.1002/stem.1688; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Calzolari F, 2015, NAT NEUROSCI, V18, P490, DOI 10.1038/nn.3963; Chambers RA, 2004, NEUROPSYCHOPHARMACOL, V29, P747, DOI 10.1038/sj.npp.1300358; Chancey JH, 2014, J NEUROSCI, V34, P2349, DOI 10.1523/JNEUROSCI.3620-13.2014; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Clemenson GD, 2015, HIPPOCAMPUS, V25, P385, DOI 10.1002/hipo.22380; Dahlhaus M, 2008, J NEUROSCI, V28, P10794, DOI 10.1523/JNEUROSCI.1348-08.2008; Danielson NB, 2016, NEURON, V90, P101, DOI 10.1016/j.neuron.2016.02.019; Deng W, 2013, ELIFE, V2, DOI 10.7554/eLife.00312; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Deshpande A, 2013, P NATL ACAD SCI USA, V110, pE1152, DOI 10.1073/pnas.1218991110; Dieni CV, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11313; Drew L.J., 2016, HIPPOCAMPUS; Du H., 2016, P NATL ACAD SCI US; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Ehm O, 2010, J NEUROSCI, V30, P13794, DOI 10.1523/JNEUROSCI.1567-10.2010; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Fortress AM, 2013, J NEUROSCI, V33, P12619, DOI 10.1523/JNEUROSCI.0659-13.2013; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gebara E, 2016, STEM CELLS, V34, P997, DOI 10.1002/stem.2266; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Guerrieri D, 2015, ONCOTARGET, V6, P18293, DOI 10.18632/oncotarget.4715; Guo JJU, 2011, NAT NEUROSCI, V14, P1345, DOI 10.1038/nn.2900; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Han JJ, 2016, NEURON, V91, P79, DOI 10.1016/j.neuron.2016.05.034; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hanchate NK, 2015, SCIENCE, V350, P1251, DOI 10.1126/science.aad2456; Hodge RD, 2012, J NEUROSCI, V32, P6275, DOI 10.1523/JNEUROSCI.0532-12.2012; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Ikrar T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00204; Imayoshi I, 2013, SCIENCE, V342, P1203, DOI 10.1126/science.1242366; Iwano T, 2012, DEVELOPMENT, V139, P3051, DOI 10.1242/dev.080002; Jang MH, 2013, CELL STEM CELL, V12, P215, DOI 10.1016/j.stem.2012.11.021; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kang WF, 2015, J NEUROSCI, V35, P10217, DOI 10.1523/JNEUROSCI.1469-15.2015; Kim HJ, 2015, J NEUROSCI, V35, P14872, DOI 10.1523/JNEUROSCI.4286-14.2015; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Ko HG, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-1; Kobilo T, 2014, LEARN MEMORY, V21, P119, DOI 10.1101/lm.033332.113; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Kvajo M, 2008, P NATL ACAD SCI USA, V105, P7076, DOI 10.1073/pnas.0802615105; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lacefield CO, 2012, HIPPOCAMPUS, V22, P106, DOI 10.1002/hipo.20860; Lai K, 2003, NAT NEUROSCI, V6, P21, DOI 10.1038/nn983; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Lavado A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000460; Lazic SE, 2004, NEUROREPORT, V15, P811, DOI 10.1097/00001756-200404090-00014; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Li Y, 2013, P NATL ACAD SCI USA, V110, P9106, DOI 10.1073/pnas.1306912110; Li Y, 2012, P NATL ACAD SCI USA, V109, P4290, DOI 10.1073/pnas.1120754109; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Niu WZ, 2011, J NEUROSCI, V31, P13816, DOI 10.1523/JNEUROSCI.1038-11.2011; Parent JM, 1997, J NEUROSCI, V17, P3727; Pernia-Andrade AJ, 2014, NEURON, V81, P140, DOI 10.1016/j.neuron.2013.09.046; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Pilz GA, 2016, J NEUROSCI, V36, P7407, DOI 10.1523/JNEUROSCI.3065-15.2016; Rangel LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4181; Restivo L, 2015, J NEUROSCI, V35, P10600, DOI 10.1523/JNEUROSCI.3238-14.2015; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Schafer ST, 2015, J NEUROSCI, V35, P4983, DOI 10.1523/JNEUROSCI.4130-14.2015; Seib DRM, 2013, CELL STEM CELL, V12, P204, DOI 10.1016/j.stem.2012.11.010; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shimozaki K, 2011, NEUROSCI RES, V71, pE124, DOI 10.1016/j.neures.2011.07.531; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Sierra A, 2015, CELL STEM CELL, V16, P488, DOI 10.1016/j.stem.2015.04.003; Singer BH, 2011, P NATL ACAD SCI USA, V108, P5437, DOI 10.1073/pnas.1015425108; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Stark SM, 2010, LEARN MEMORY, V17, P284, DOI 10.1101/lm.1768110; Stefanelli T, 2016, NEURON, V89, P1074, DOI 10.1016/j.neuron.2016.01.024; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Sultan S, 2015, NEURON, V88, DOI 10.1016/j.neuron.2015.10.037; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Tamura Y, 2016, J NEUROSCI, V36, P8123, DOI 10.1523/JNEUROSCI.0220-16.2016; Temprana SG, 2015, NEURON, V85, P116, DOI 10.1016/j.neuron.2014.11.023; Tong LM, 2014, J NEUROSCI, V34, P9506, DOI 10.1523/JNEUROSCI.0693-14.2014; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tronel S, 2012, HIPPOCAMPUS, V22, P292, DOI 10.1002/hipo.20895; Uda M, 2007, BRAIN RES, V1171, P9, DOI 10.1016/j.brainres.2007.06.099; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Vukovic J, 2012, J NEUROSCI, V32, P6435, DOI 10.1523/JNEUROSCI.5925-11.2012; Wang L, 2015, J NEUROSCI, V35, P8384, DOI 10.1523/JNEUROSCI.4682-14.2015; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Winner B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021287; Yousef H, 2015, STEM CELLS, V33, P1577, DOI 10.1002/stem.1943; Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	125	585	596	4	157	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					897	914		10.1016/j.cell.2016.10.021	http://dx.doi.org/10.1016/j.cell.2016.10.021			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814520	Bronze			2022-12-28	WOS:000389469000010
J	Bilimoria, KY; Barnard, C				Bilimoria, Karl Y.; Barnard, Cynthia			The New CMS Hospital Quality Star Ratings The Stars Are Not Aligned	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bilimoria, Karl Y.] Northwestern Univ, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Feinberg Sch Med, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA; [Bilimoria, Karl Y.] Northwestern Univ, Ctr Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA; [Barnard, Cynthia] Northwestern Med, Qual Div, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Bilimoria, KY (corresponding author), Northwestern Univ, Surg Outcomes & Qual Improvement Ctr, Dept Surg, Feinberg Sch Med, 633 N St Clair St,20th Floor, Chicago, IL 60611 USA.; Bilimoria, KY (corresponding author), Northwestern Univ, Ctr Healthcare Studies, Feinberg Sch Med, Chicago, IL 60611 USA.	k-bilimoria@northwestern.edu			AHRQ HHS [R01 HS024516] Funding Source: Medline; AHRQ R21HS021857 Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024516] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ R21HS021857; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Austin JM, 2015, HEALTH AFFAIR, V34, P423, DOI 10.1377/hlthaff.2014.0201; Berwick DM, 2016, JAMA-J AM MED ASSOC, V315, P1329, DOI 10.1001/jama.2016.1509; Bilimoria KY, 2013, JAMA-J AM MED ASSOC, V310, P1482, DOI 10.1001/jama.2013.280048; Centers for Medicare & Medicaid Services (CMS), 2016, OV HOSP QUAL STAR RA; Jha AK, 2016, JAMA-J AM MED ASSOC, V315, P2265, DOI 10.1001/jama.2016.5638; Rajaram R, 2015, JAMA-J AM MED ASSOC, V314, P375, DOI 10.1001/jama.2015.8609; Rajaram R, 2015, JAMA-J AM MED ASSOC, V313, P897, DOI 10.1001/jama.2015.52	7	29	29	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1761	1762		10.1001/jama.2016.13679	http://dx.doi.org/10.1001/jama.2016.13679			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802552				2022-12-28	WOS:000386569300010
J	Lyons, SK; Miller, JH; Amatangel, KL; Behrensmeyer, AK; Bercovici, A; Blois, JL; Davis, M; DiMichele, W; Du, A; Eronen, JT; Faith, JT; Graves, GR; Jud, N; Labandeira, C; Looy, CV; McGill, B; Patterson, D; Pineda-Munoz, S; Potts, R; Riddle, B; Terry, R; Toth, A; Ulrich, W; Villasenor, A; Wing, S; Anderson, H; Anderson, J; Gotelli, NJ				Lyons, S. Kathleen; Miller, Joshua H.; Amatangel, Kathryn L.; Behrensmeyer, Anna K.; Bercovici, Antoine; Blois, Jessica L.; Davis, Matt; DiMichele, William; Du, Andrew; Eronen, Jussi T.; Faith, J. Tyler; Graves, Gary R.; Jud, Nathan; Labandeira, Conrad; Looy, Cindy V.; McGill, Brian; Patterson, David; Pineda-Munoz, Silvia; Potts, Richard; Riddle, Brett; Terry, Rebecca; Toth, Aniko; Ulrich, Werner; Villasenor, Amelia; Wing, Scott; Anderson, Heidi; Anderson, John; Gotelli, Nicholas J.			How foreign is the past? Reply	NATURE			English	Letter							PLANT		[Lyons, S. Kathleen; Bercovici, Antoine; DiMichele, William; Pineda-Munoz, Silvia; Toth, Aniko; Wing, Scott] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Miller, Joshua H.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Amatangel, Kathryn L.] SUNY Coll Brockport, Dept Environm Sci & Biol, Brockport, NY 14420 USA; [Behrensmeyer, Anna K.; Blois, Jessica L.] Univ Calif Merced, Sch Nat Sci, 5200 North Lake Rd, Merced, CA 95343 USA; [Davis, Matt] Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06520 USA; [Du, Andrew; Patterson, David; Villasenor, Amelia] George Washington Univ, Dept Anthropol, Ctr Adv Study Hominid Paleobiol, Hominid Paleobiol Doctoral Program, Washington, DC 20052 USA; [Eronen, Jussi T.] Univ Helsinki, Dept Geosci & Geog, FIN-00014 Helsinki, Finland; [Faith, J. Tyler] Univ Queensland, Sch Social Sci, Brisbane, Qld 4072, Australia; [Graves, Gary R.] Smithsonian Inst, Natl Museum Nat Hist, Dept Vertebrate Zool, Washington, DC 20013 USA; [Graves, Gary R.] Univ Copenhagen, Ctr Macroecol Evolut & Climate, DK-2100 Copenhagen, Denmark; [Jud, Nathan] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Labandeira, Conrad] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Labandeira, Conrad] Capital Normal Univ, Key Lab Insect Evolut & Environm Changes, Beijing 100048, Peoples R China; [Looy, Cindy V.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Looy, Cindy V.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [McGill, Brian] Univ Maine, Sch Biol & Ecol & Sustainabil Solut Initiat, Orono, ME 04469 USA; [Potts, Richard] Smithsonian Inst, Natl Museum Nat Hist, Human Origins Program, Dept Anthropol, Washington, DC 20013 USA; [Riddle, Brett] Univ Nevada, Sch Life Sci, Las Vegas, NV 89154 USA; [Terry, Rebecca] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97731 USA; [Ulrich, Werner] Nicolaus Copernicus Univ, Chair Ecol & Biogeog, Lwowska 1, PL-87100 Torun, Poland; [Anderson, Heidi; Anderson, John] Univ Witwatersrand, Evolutionary Studies Inst, ZA-20150 Johannesburg, South Africa; [Gotelli, Nicholas J.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	Smithsonian Institution; Smithsonian National Museum of Natural History; University System of Ohio; University of Cincinnati; State University of New York (SUNY) System; University of California System; University of California Merced; Yale University; George Washington University; University of Helsinki; University of Queensland; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Copenhagen; State University System of Florida; University of Florida; University System of Maryland; University of Maryland College Park; Capital Normal University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Maine System; University of Maine Orono; Smithsonian Institution; Smithsonian National Museum of Natural History; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Oregon State University; Nicolaus Copernicus University; University of Witwatersrand; University of Vermont	Lyons, SK (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA.	lyonss2@si.edu	Terry, Rebecca/L-7019-2017; Jud, Nathan/AAI-2384-2020; Tóth, Anikó/AAT-6084-2021; Pineda-Munoz, Silvia/AAR-2292-2020; Villasenor, Amelia/AAR-5965-2021; Blois, Jessica/G-5893-2011; Eronen, Jussi/B-7978-2013	Terry, Rebecca/0000-0002-9803-6292; Jud, Nathan/0000-0001-6100-9779; Tóth, Anikó/0000-0002-3063-1917; Pineda-Munoz, Silvia/0000-0003-0597-4456; Blois, Jessica/0000-0003-4048-177X; Eronen, Jussi/0000-0002-0390-8044; Faith, J. Tyler/0000-0002-1101-7161; Lyons, S. Kathleen/0000-0001-5112-2508; Ulrich, Werner/0000-0002-8715-6619				DIMICHELE WA, 1987, REV PALAEOBOT PALYNO, V50, P151, DOI 10.1016/0034-6667(87)90044-3; Greb S. F., 2006, WETLANDS TIME, V399; Law BS, 1998, BIODIVERS CONSERV, V7, P323, DOI 10.1023/A:1008877611726; Lyons SK, 2016, NATURE, V529, P80, DOI 10.1038/nature16447; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Telford RJ, 2016, NATURE, V538, pE1, DOI 10.1038/nature20096; WING SL, 1995, PALAEOGEOGR PALAEOCL, V115, P117, DOI 10.1016/0031-0182(94)00109-L	7	0	0	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					E3	+		10.1038/nature20097	http://dx.doi.org/10.1038/nature20097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5IY	27786209				2022-12-28	WOS:000386654400002
J	Horton, R				Horton, Richard			Offline: How to hurt the NHS-a user's guide	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1968	1968		10.1016/S0140-6736(16)31901-8	http://dx.doi.org/10.1016/S0140-6736(16)31901-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ6EQ	27789007				2022-12-28	WOS:000385954800010
J	Rosenbaum, L				Rosenbaum, Lisa			Closing the Mortality Gap - Mental Illness and Medical Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISORDERS											Aggarwal A, 2013, AM J PREV MED, V44, P392, DOI 10.1016/j.amepre.2012.12.006; Appelbaum PS, 2007, NEW ENGL J MED, V357, P1834, DOI 10.1056/NEJMcp074045; APPELBAUM PS, 1983, JAMA-J AM MED ASSOC, V250, P1296, DOI 10.1001/jama.250.10.1296; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Druss BG, 2000, JAMA-J AM MED ASSOC, V283, P506, DOI 10.1001/jama.283.4.506; Graber MA, 2000, J GEN INTERN MED, V15, P204, DOI 10.1046/j.1525-1497.2000.04399.x; Li Y, 2011, HEALTH AFFAIR, V30, P1307, DOI 10.1377/hlthaff.2010.1084; Malzberg B, 1932, J AM STAT ASSOC, V27, P160, DOI 10.2307/2277862; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Schulman-Marcus J, 2016, AM J CARDIOL, V117, P1405, DOI 10.1016/j.amjcard.2016.02.006; Walker ER, 2015, JAMA PSYCHIAT, V72, P334, DOI 10.1001/jamapsychiatry.2014.2502; Xiong GL, 2008, PSYCHIAT SERV, V59, P929, DOI 10.1176/ps.2008.59.8.929	13	20	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1585	1589		10.1056/NEJMms1610125	http://dx.doi.org/10.1056/NEJMms1610125			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3HF	27797313				2022-12-28	WOS:000393102500014
J	Lane, R				Lane, Richard			Veronika Wirtz: global leader in improving access to medicines	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					357	357		10.1016/S0140-6736(16)32137-7	http://dx.doi.org/10.1016/S0140-6736(16)32137-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27836190				2022-12-28	WOS:000392804700018
J	Canter, RG; Penney, J; Tsai, LH				Canter, Rebecca G.; Penney, Jay; Tsai, Li-Huei			The road to restoring neural circuits for the treatment of Alzheimer's disease	NATURE			English	Review							MILD COGNITIVE IMPAIRMENT; AMYLOID PRECURSOR PROTEIN; DEEP BRAIN-STIMULATION; INDUCED NEURONAL DYSFUNCTION; LONG-TERM POTENTIATION; AGING HUMAN BRAIN; PHASE-I TRIAL; A-BETA; NUCLEUS BASALIS; NATIONAL INSTITUTE	Alzheimer's disease is a progressive loss of memory and cognition, for which there is no cure. Although genetic studies initially suggested a primary role for amyloid-beta in Alzheimer's disease, treatment strategies targeted at reducing amyloid-beta have failed to reverse cognitive symptoms. These clinical findings suggest that cognitive decline is the result of a complex pathophysiology and that targeting amyloid-beta alone may not be sufficient to treat Alzheimer's disease. Instead, a broad outlook on neural-circuit-damaging processes may yield insights into new therapeutic strategies for curing memory loss in the disease.	[Canter, Rebecca G.; Penney, Jay; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Tsai, Li-Huei] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.; Tsai, LH (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	lhtsai@mit.edu			US National Institutes of Health [R01 NS051874, R01 NS078839, RF1 AG042978, RF1 AG047661]; Barbara J. Weedon Fellowship; Norman B. Leventhal Fellowship; Human Frontier Science Program; JPB Foundation; Belfer Neurodegeneration Consortium; Glenn Foundation for Medical Research; Cure Alzheimer's Fund; Alana Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051874, R01NS078839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG042978, RF1AG047661] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barbara J. Weedon Fellowship; Norman B. Leventhal Fellowship; Human Frontier Science Program(Human Frontier Science Program); JPB Foundation; Belfer Neurodegeneration Consortium; Glenn Foundation for Medical Research; Cure Alzheimer's Fund; Alana Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the US National Institutes of Health for grants R01 NS051874, R01 NS078839, RF1 AG042978 and RF1 AG047661 in support of L.-H.T. We thank the Barbara J. Weedon Fellowship and Norman B. Leventhal Fellowship for supporting R.G.C. and the Human Frontier Science Program for supporting J.P. We also thank the JPB Foundation, the Belfer Neurodegeneration Consortium, the Glenn Foundation for Medical Research, the Cure Alzheimer's Fund and the Alana Foundation for support of L.-H.T. and for continued championship of ageing and neurodegenerative disease research. We thank C. Yao for contributions to the original figure artwork. Last, we express profound gratitude to A. Watson, H. Meharena, W. Raja and N. Dedic for insightful comments on the manuscript.	Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Anderson AJ, 2000, NEUROBIOL AGING, V21, P511, DOI 10.1016/S0197-4580(00)00126-3; Baglietto-Vargas D, 2015, J NEUROCHEM, V134, P915, DOI 10.1111/jnc.13195; Bakker A, 2015, NEUROIMAGE-CLIN, V7, P688, DOI 10.1016/j.nicl.2015.02.009; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2011, ACTA NEUROPATHOL, V121, P171, DOI 10.1007/s00401-010-0789-4; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bruen PD, 2008, BRAIN, V131, P2455, DOI 10.1093/brain/awn151; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Cacucci F, 2008, P NATL ACAD SCI USA, V105, P7863, DOI 10.1073/pnas.0802908105; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Ciupek SM, 2015, J NEUROSCI, V35, P8118, DOI 10.1523/JNEUROSCI.3130-14.2015; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Damoiseaux JS, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.024; Das U, 2013, NEURON, V79, P447, DOI 10.1016/j.neuron.2013.05.035; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Jager P. L., NATURE NEUROSCI, V17; De Jonghe C, 2001, HUM MOL GENET, V10, P1665, DOI 10.1093/hmg/10.16.1665; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; De Strooper B, 2014, CELL, V159, P721, DOI 10.1016/j.cell.2014.10.016; Diano S, 2006, NAT NEUROSCI, V9, P381, DOI 10.1038/nn1656; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dougherty JJ, 2003, J NEUROSCI, V23, P6740; Duggan SP, 2016, CELL SIGNAL, V28, P1, DOI 10.1016/j.cellsig.2015.10.006; Fabelo N, 2014, NEUROBIOL AGING, V35, P1801, DOI 10.1016/j.neurobiolaging.2014.02.005; Farlow MR, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0108-3; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Fleisher AS, 2008, ARCH NEUROL-CHICAGO, V65, P1031, DOI 10.1001/archneur.65.8.1031; Fletcher E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00106; Forsberg A, 2008, NEUROBIOL AGING, V29, P1456, DOI 10.1016/j.neurobiolaging.2007.03.029; Frost B, 2014, NAT NEUROSCI, V17, P357, DOI 10.1038/nn.3639; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hamelin L, 2016, BRAIN, V139, P1252, DOI 10.1093/brain/aww017; Hangya B, 2015, CELL, V162, P1155, DOI 10.1016/j.cell.2015.07.057; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hardy J, 1997, P NATL ACAD SCI USA, V94, P2095, DOI 10.1073/pnas.94.6.2095; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Jack CR, 2010, BRAIN, V133, P3336, DOI 10.1093/brain/awq277; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Jo DG, 2010, NEUROBIOL AGING, V31, P917, DOI 10.1016/j.neurobiolaging.2008.07.003; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kim D, 2008, NEURON, V60, P803, DOI 10.1016/j.neuron.2008.10.015; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; Kononenko NL, 2015, NEURON, V85, P484, DOI 10.1016/j.neuron.2014.12.016; Kuhn J, 2015, BRAIN STIMUL, V8, P838, DOI 10.1016/j.brs.2015.04.002; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Laxton AW, 2010, ANN NEUROL, V68, P521, DOI 10.1002/ana.22089; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Madabhushi R, 2015, CELL, V161, P1592, DOI 10.1016/j.cell.2015.05.032; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; May PC, 2015, J NEUROSCI, V35, P1199, DOI 10.1523/JNEUROSCI.4129-14.2015; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; Mesulam M, 2004, ANN NEUROL, V55, P815, DOI 10.1002/ana.20100; METHERATE R, 1992, J NEUROSCI, V12, P4701; Miller SE, 2015, DEV CELL, V33, P163, DOI 10.1016/j.devcel.2015.03.002; Moreau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5998; Mormino EC, 2014, JAMA NEUROL, V71, P1379, DOI 10.1001/jamaneurol.2014.2031; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nestor PJ, 2003, ANN NEUROL, V54, P343, DOI 10.1002/ana.10669; Nhan HS, 2015, ACTA NEUROPATHOL, V129, P1, DOI 10.1007/s00401-014-1347-2; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Orre M, 2014, NEUROBIOL AGING, V35, P2746, DOI 10.1016/j.neurobiolaging.2014.06.004; Ossenkoppele R, 2016, BRAIN, V139, P1551, DOI 10.1093/brain/aww027; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Pedersen JT, 2015, TRENDS MOL MED, V21, P394, DOI 10.1016/j.molmed.2015.03.003; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Rei D, 2015, P NATL ACAD SCI USA, V112, P7291, DOI 10.1073/pnas.1415845112; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Roy DS, 2016, NATURE, V531, P508, DOI 10.1038/nature17172; Sakae N, 2016, J NEUROSCI, V36, P3848, DOI 10.1523/JNEUROSCI.3757-15.2016; Sanchez PE, 2012, P NATL ACAD SCI USA, V109, pE2895, DOI 10.1073/pnas.1121081109; Sankar T, 2015, BRAIN STIMUL, V8, P645, DOI 10.1016/j.brs.2014.11.020; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; Scholl M, 2016, NEURON, V89, P971, DOI 10.1016/j.neuron.2016.01.028; Scholl M., 2016, NATURE, V539; Seo J, 2014, CELL, V157, P486, DOI 10.1016/j.cell.2014.01.065; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Siemers ER, 2016, ALZHEIMERS DEMENT, V12, P110, DOI [10.1016/j.jalz.2015.06.1893, 10.1016/j.dadm.2016.02.006]; Siskova Z, 2014, NEURON, V84, P1023, DOI 10.1016/j.neuron.2014.10.024; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sontag E, 1996, NEURON, V17, P1201, DOI 10.1016/S0896-6273(00)80250-0; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Suberbielle E, 2013, NAT NEUROSCI, V16, P613, DOI 10.1038/nn.3356; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Treusch S, 2011, SCIENCE, V334, P1241, DOI 10.1126/science.1213210; van der Kant R, 2015, DEV CELL, V32, P502, DOI 10.1016/j.devcel.2015.01.022; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Verghese PB, 2013, P NATL ACAD SCI USA, V110, pE1807, DOI 10.1073/pnas.1220484110; Verret L, 2012, CELL, V149, P708, DOI 10.1016/j.cell.2012.02.046; Villemagne VL, 2011, ANN NEUROL, V69, P181, DOI 10.1002/ana.22248; Vogelsberg-Ragaglia V, 2001, EXP NEUROL, V168, P402, DOI 10.1006/exnr.2001.7630; VOLICER L, 1995, DEMENTIA, V6, P258, DOI 10.1159/000106956; Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Xia D, 2015, NEURON, V85, P967, DOI 10.1016/j.neuron.2015.02.010; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Ye L, 2015, BRAIN PATHOL, V25, P743, DOI 10.1111/bpa.12252; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zhu CW, 2013, ALZHEIMERS DEMENT, V9, P733, DOI 10.1016/j.jalz.2012.09.015	151	295	304	20	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					187	196		10.1038/nature20412	http://dx.doi.org/10.1038/nature20412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830780				2022-12-28	WOS:000387318500029
J	Capogrosso, M; Milekovic, T; Borton, D; Wagner, F; Moraud, EM; Mignardot, JB; Buse, N; Gandar, J; Barraud, Q; Xing, D; Rey, E; Duis, S; Yang, JZ; Ko, WKD; Li, Q; Detemple, P; Denison, T; Micera, S; Bezard, E; Bloch, J; Courtine, G				Capogrosso, Marco; Milekovic, Tomislav; Borton, David; Wagner, Fabien; Moraud, Eduardo Martin; Mignardot, Jean-Baptiste; Buse, Nicolas; Gandar, Jerome; Barraud, Quentin; Xing, David; Rey, Elodie; Duis, Simone; Yang Jianzhong; Ko, Wai Kin D.; Li, Qin; Detemple, Peter; Denison, Tim; Micera, Silvestro; Bezard, Erwan; Bloch, Jocelyne; Courtine, Gregoire			A brain-spine interface alleviating gait deficits after spinal cord injury in primates	NATURE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; MOTOR CONTROL; FREE BEHAVIOR; LOCOMOTION; PARALYSIS; NEUROMODULATION; TRANSLATION; PROSTHESIS; MECHANISMS; MOVEMENT	Spinal cord injury disrupts the communication between the brain and the spinal circuits that orchestrate movement. To bypass the lesion, brain-computer interfaces(1-3) have directly linked cortical activity to electrical stimulation of muscles, and have thus restored grasping abilities after hand paralysis(1,4). Theoretically, this strategy could also restore control over leg muscle activity for walking(5). However, replicating the complex sequence of individual muscle activation patterns underlying natural and adaptive locomotor movements poses formidable conceptual and technological challenges(6,7). Recently, it was shown in rats that epidural electrical stimulation of the lumbar spinal cord can reproduce the natural activation of synergistic muscle groups producing locomotion(8-10). Here we interface leg motor cortex activity with epidural electrical stimulation protocols to establish a brain-spine interface that alleviated gait deficits after a spinal cord injury in non-human primates. Rhesus monkeys (Macaca mulatta) were implanted with an intracortical microelectrode array in the leg area of the motor cortex and with a spinal cord stimulation system composed of a spatially selective epidural implant and a pulse generator with realtime triggering capabilities. We designed and implemented wireless control systems that linked online neural decoding of extension and flexion motor states with stimulation protocols promoting these movements. These systems allowed the monkeys to behave freely without any restrictions or constraining tethered electronics. After validation of the brain-spine interface in intact (uninjured) monkeys, we performed a unilateral corticospinal tract lesion at the thoracic level. As early as six days post-injury and without prior training of the monkeys, the brain-spine interface restored weight-bearing locomotion of the paralysed leg on a treadmill and overground. The implantable components integrated in the brain-spine interface have all been approved for investigational applications in similar human research, suggesting a practical translational pathway for proof-of-concept studies in people with spinal cord injury.	[Capogrosso, Marco; Milekovic, Tomislav; Borton, David; Wagner, Fabien; Mignardot, Jean-Baptiste; Gandar, Jerome; Barraud, Quentin; Rey, Elodie; Duis, Simone; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Ctr Neuroprosthet, Lausanne, Switzerland; [Capogrosso, Marco; Milekovic, Tomislav; Borton, David; Wagner, Fabien; Mignardot, Jean-Baptiste; Gandar, Jerome; Barraud, Quentin; Rey, Elodie; Duis, Simone; Courtine, Gregoire] Swiss Fed Inst Technol EPFL, Brain Mind Inst, Sch Life Sci, Lausanne, Switzerland; [Capogrosso, Marco; Moraud, Eduardo Martin; Micera, Silvestro] Ecole Polytech Fed Lausanne, Sch Bioengn, Ctr Neuroprosthet, Lausanne, Switzerland; [Capogrosso, Marco; Moraud, Eduardo Martin; Micera, Silvestro] Ecole Polytech Fed Lausanne, Sch Bioengn, Inst Bioengn, Lausanne, Switzerland; [Borton, David; Xing, David] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Buse, Nicolas; Denison, Tim] Medtronic, Minneapolis, MN USA; [Yang Jianzhong; Ko, Wai Kin D.; Li, Qin; Bezard, Erwan] Motac Neurosci Ltd, Manchester, Lancs, England; [Li, Qin; Bezard, Erwan] China Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Detemple, Peter] Fraunhofer Inst Chem Technol ICT IMM, Mainz Inst Microtechnol, Mainz, Germany; [Micera, Silvestro] Scuola Super Sant Anna, BioRobot Inst, Pisa, Italy; [Bezard, Erwan] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Bezard, Erwan] CNRS, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France; [Bloch, Jocelyne; Courtine, Gregoire] CHU Vaudois, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Brown University; Medtronic; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Fraunhofer Gesellschaft; Scuola Superiore Sant'Anna; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Ctr Neuroprosthet, Lausanne, Switzerland.; Courtine, G (corresponding author), Swiss Fed Inst Technol EPFL, Brain Mind Inst, Sch Life Sci, Lausanne, Switzerland.; Courtine, G (corresponding author), CHU Vaudois, Lausanne, Switzerland.	gregoire.courtine@epfl.ch	Bloch, Jocelyne/A-9668-2017; Micera, Silvestro/AAD-6630-2021; Milekovic, Tomislav/R-7972-2017; courtine, gregoire/AAJ-1694-2020; Bezard, Erwan/ABD-5153-2021; Wagner, Fabien/ABC-4084-2020	Bloch, Jocelyne/0000-0002-6405-1590; Milekovic, Tomislav/0000-0001-6769-6506; courtine, gregoire/0000-0002-5744-4142; Wagner, Fabien/0000-0002-9582-6109; Denison, Timothy/0000-0002-5404-4004; Martin Moraud, Eduardo/0000-0002-6148-7065; Rey, Elodie/0000-0003-2983-719X; Barraud, Quentin/0000-0003-0894-1959; Bezard, Erwan/0000-0002-0410-4638; Capogrosso, Marco/0000-0002-0975-316X; Xing, David/0000-0001-8371-6343	Medtronic; European Community [CP-IP 258654]; International Paraplegic foundation; European Research Council [ERC 261247]; Wyss centre in Geneva; Marie Curie Fellowship [331602]; Marie Curie COFUND EPFL fellowships; Morton Cure Paralysis Fund fellowship; Swiss National Science Foundation including the National Centre of Competence in Research in Robotics; Sinergia program [CRSII3_160696]; Sino-Swiss Science and Technology Cooperation [IZLCZ3_156331]; NanoTera.ch programme (SpineRepair)	Medtronic(Medtronic); European Community(European Commission); International Paraplegic foundation; European Research Council(European Research Council (ERC)European Commission); Wyss centre in Geneva; Marie Curie Fellowship(European Commission); Marie Curie COFUND EPFL fellowships; Morton Cure Paralysis Fund fellowship; Swiss National Science Foundation including the National Centre of Competence in Research in Robotics; Sinergia program; Sino-Swiss Science and Technology Cooperation; NanoTera.ch programme (SpineRepair)	G.C. holds the International Foundation for Research in Paraplegia Chair in Spinal Cord Repair. S.M. holds the Bertarelli Foundation Chair in Translational Neuroengineering. We thank X. Rulin and C. Yunlong for providing support, taking care of the monkeys, performing behavioural training, and collecting data; E. Pirondini, N. Pavlova and P. Musienko for help with experiments; J. Courtine, I. Pitteloud, J. Rubattel, L. Dalang and R. Hasler for help with kinematic reconstruction; J. Courtine for the voice-over in video; J. Kreider for help with anatomy; and J. Laurens for discussions and photographs. The illustrations were created by Jemere Ruby. This work was supported by Medtronic, the European Community's Seventh Framework Program (CP-IP 258654, NeuWALK), the International Paraplegic foundation, a Starting Grant from the European Research Council (ERC 261247, Walk Again), the Wyss centre in Geneva, a Marie Curie Fellowship to D.B. (331602, e-WALK), Marie Curie COFUND EPFL fellowships to T.M. and F.W., a Morton Cure Paralysis Fund fellowship to T.M., and the Swiss National Science Foundation including the National Centre of Competence in Research in Robotics, the Sinergia program (CRSII3_160696), the Sino-Swiss Science and Technology Cooperation (IZLCZ3_156331), and the NanoTera.ch programme (SpineRepair).	Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Barthelemy D, 2007, J NEUROPHYSIOL, V97, P1986, DOI 10.1152/jn.00818.2006; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Courtine G, 2005, J NEUROPHYSIOL, V93, P3127, DOI 10.1152/jn.01073.2004; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Courtine G, 2015, NEURON, V86, P29, DOI 10.1016/j.neuron.2015.02.039; Danner SM, 2015, BRAIN, V138, P577, DOI 10.1093/brain/awu372; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Friedli L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5811; Gerasimenko YP, 2015, J NEUROTRAUM, V32, P1968, DOI 10.1089/neu.2015.4008; Gilja V, 2015, NAT MED, V21, P1142, DOI 10.1038/nm.3953; Ho CH, 2014, PHYS MED REH CLIN N, V25, P631, DOI 10.1016/j.pmr.2014.05.001; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Holinski BJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056008; Kapadia N, 2014, J SPINAL CORD MED, V37, P511, DOI 10.1179/2045772314Y.0000000263; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; Kuypers H. G. J. M., 2011, COMPREHENSIVE PHYSL; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; Marieb EN, 2003, HUMAN ANATOMY PHYSL, V6; Milekovic T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055235; Moraud EM, 2016, NEURON, V89, P814, DOI 10.1016/j.neuron.2016.01.009; Mushahwar VK, 2006, IEEE T NEUR SYS REH, V14, P198, DOI 10.1109/TNSRE.2006.875532; Nishimura Y, 2013, NEURON, V80, P1301, DOI 10.1016/j.neuron.2013.08.028; Rattay F, 2000, SPINAL CORD, V38, P473, DOI 10.1038/sj.sc.3101039; Shanechi MM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4237; Shenoy KV, 2014, NEURON, V84, P665, DOI 10.1016/j.neuron.2014.08.038; Sherrington CS, 1910, J PHYSIOL-LONDON, V40, P28; Shoham S, 2001, NATURE, V413, P793, DOI 10.1038/35101651; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Wenger N, 2016, NAT MED, V22, P138, DOI 10.1038/nm.4025; Wenger N, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008325; Yakovenko S, 2002, J NEUROPHYSIOL, V87, P1542, DOI 10.1152/jn.00479.2001; Yin M, 2014, NEURON, V84, P1170, DOI 10.1016/j.neuron.2014.11.010; Zimmermann JB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00087	37	313	340	23	298	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					284	+		10.1038/nature20118	http://dx.doi.org/10.1038/nature20118			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830790	Green Accepted			2022-12-28	WOS:000387318500044
J	Heemels, MT				Heemels, Marie-Therese			NEURODEGENERATIVE DISEASES	NATURE			English	Editorial Material														Heemels, Marie Therese/0000-0002-4364-3116					0	156	158	7	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					179	179		10.1038/539179a	http://dx.doi.org/10.1038/539179a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830810	Bronze			2022-12-28	WOS:000387318500027
J	Mainen, ZF; Hausser, M; Pouget, A				Mainen, Zachary F.; Hausser, Michael; Pouget, Alexandre			A better way to crack the brain	NATURE			English	Editorial Material									[Mainen, Zachary F.] Champalimaud Ctr, Res, Lisbon, Portugal; [Hausser, Michael] UCL, London WC1E 6BT, England; [Pouget, Alexandre] Univ Geneva, Neurosci, CH-1211 Geneva 4, Switzerland	Fundacao Champalimaud; University of London; University College London; University of Geneva	Mainen, ZF (corresponding author), Champalimaud Ctr, Res, Lisbon, Portugal.	zmainen@neuro.fchampalimaud.org	Hausser, Michael/AAW-6827-2020	Hausser, Michael/0000-0002-2673-8957; Pouget, Alexandre/0000-0003-3054-6365; Mainen, Zachary/0000-0001-7913-9109				Boisot M., 2011, COLLISIONS COLLABORA, DOI DOI 10.1093/ACPROF:OSO/9780199567928.001.0001; Emiliani V, 2015, J NEUROSCI, V35, P13917, DOI 10.1523/JNEUROSCI.2916-15.2015; Fregnac Y, 2014, NATURE, V513, P27, DOI 10.1038/513027a; Green ED, 2015, NATURE, V526, P29, DOI 10.1038/526029a; Hawrylycz M, 2016, P NATL ACAD SCI USA, V113, P7337, DOI 10.1073/pnas.1512901113; Hunter P, 2015, EMBO REP, V16, P685, DOI 10.15252/embr.201540571; Moreno-Bote R, 2014, NAT NEUROSCI, V17, P1410, DOI 10.1038/nn.3807; Poo MM, 2014, NATL SCI REV, V1, P12, DOI 10.1093/nsr/nwt019; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Yozwiak NL, 2015, NATURE, V518, P477, DOI 10.1038/518477a	10	14	14	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					159	161		10.1038/539159a	http://dx.doi.org/10.1038/539159a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830818	Bronze			2022-12-28	WOS:000387318500012
J	McMahon, PL; Marandi, A; Haribara, Y; Hamerly, R; Langrock, C; Tamate, S; Inagaki, T; Takesue, H; Utsunomiya, S; Aihara, K; Byer, RL; Fejer, MM; Mabuchi, H; Yamamoto, Y				McMahon, Peter L.; Marandi, Alireza; Haribara, Yoshitaka; Hamerly, Ryan; Langrock, Carsten; Tamate, Shuhei; Inagaki, Takahiro; Takesue, Hiroki; Utsunomiya, Shoko; Aihara, Kazuyuki; Byer, Robert L.; Fejer, M. M.; Mabuchi, Hideo; Yamamoto, Yoshihisa			A fully programmable 100-spin coherent Ising machine with all-to-all connections	SCIENCE			English	Article							QUANTUM; NETWORK; COMPUTATION	Unconventional, special-purpose machines may aid in accelerating the solution of some of the hardest problems in computing, such as large-scale combinatorial optimizations, by exploiting different operating mechanisms than those of standard digital computers. We present a scalable optical processor with electronic feedback that can be realized at large scale with room-temperature technology. Our prototype machine is able to find exact solutions of, or sample good approximate solutions to, a variety of hard instances of Ising problems with up to 100 spins and 10,000 spin-spin connections.	[McMahon, Peter L.; Marandi, Alireza; Hamerly, Ryan; Langrock, Carsten; Byer, Robert L.; Fejer, M. M.; Mabuchi, Hideo; Yamamoto, Yoshihisa] Stanford Univ, EL Ginzton Lab, Stanford, CA 94305 USA; [McMahon, Peter L.; Haribara, Yoshitaka; Tamate, Shuhei; Utsunomiya, Shoko] Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan; [Haribara, Yoshitaka; Aihara, Kazuyuki] Univ Tokyo, Dept Math Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Haribara, Yoshitaka; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan; [Inagaki, Takahiro; Takesue, Hiroki] NTT Basic Res Labs, 3-1 Morinosato, Atsugi, Kanagawa 2430198, Japan; [Yamamoto, Yoshihisa] Japan Sci & Technol Agcy, ImPACT Program, Chiyoda Ku, Gobancho 7, Tokyo 1020076, Japan	Stanford University; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; University of Tokyo; University of Tokyo; Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST)	McMahon, PL; Marandi, A (corresponding author), Stanford Univ, EL Ginzton Lab, Stanford, CA 94305 USA.; McMahon, PL (corresponding author), Natl Inst Informat, Chiyoda Ku, 2-1-2 Hitotsubashi, Tokyo 1018430, Japan.	pmcmahon@stanford.edu; marandi@stanford.edu	McMahon, Peter/ABI-1817-2020; Yamamoto, Yoshihisa/A-2811-2012; Fejer, Martin/AAH-3883-2020; Takesue, Hiroki/J-4514-2012; Hamerly, Ryan/GZM-8281-2022	McMahon, Peter/0000-0002-1177-9887; Yamamoto, Yoshihisa/0000-0002-4150-6804; Marandi, Alireza/0000-0002-0470-0050; Mabuchi, Hideo/0000-0002-5156-7678	Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Program of the Council of Science, Technology and Innovation (Cabinet Office, Government of Japan); Stanford Nano- and Quantum Science and Engineering Postdoctoral Fellowship	Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Program of the Council of Science, Technology and Innovation (Cabinet Office, Government of Japan); Stanford Nano- and Quantum Science and Engineering Postdoctoral Fellowship	This research was funded by the Impulsing Paradigm Change through Disruptive Technologies (ImPACT) Program of the Council of Science, Technology and Innovation (Cabinet Office, Government of Japan). P.L.M. was partially supported by a Stanford Nano- and Quantum Science and Engineering Postdoctoral Fellowship. We thank K. Leedle, A. Ceballos, K. Wen, and Z. Wang for technical assistance and M. Digonnet, B. Lantz, T. Onodera, E. Ng, T. Leleu, C. Limouse, D. Gray, G. Tabak, and N. Tezak for helpful discussions.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Boixo S, 2014, NAT PHYS, V10, P218, DOI [10.1038/nphys2900, 10.1038/NPHYS2900]; Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528; Brooke J, 1999, SCIENCE, V284, P779, DOI 10.1126/science.284.5415.779; Ercsey-Ravasz M, 2011, NAT PHYS, V7, P966, DOI [10.1038/nphys2105, 10.1038/NPHYS2105]; Farhi E, 2001, SCIENCE, V292, P472, DOI 10.1126/science.1057726; Garey M. R., 1976, Theoretical Computer Science, V1, P237, DOI 10.1016/0304-3975(76)90059-1; Haribara Y, 2016, ENTROPY-SWITZ, V18, DOI 10.3390/e18040151; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; Inagaki T, 2016, NAT PHOTONICS, V10, P415, DOI [10.1038/nphoton.2016.68, 10.1038/NPHOTON.2016.68]; Istrail S., 2000, Proceedings of the Thirty Second Annual ACM Symposium on Theory of Computing, P87, DOI 10.1145/335305.335316; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; Kadowaki T, 1998, PHYS REV E, V58, P5355, DOI 10.1103/PhysRevE.58.5355; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Lucas A, 2014, FRONT PHYS-LAUSANNE, V2, DOI 10.3389/fphy.2014.00005; Marandi A, 2014, NAT PHOTONICS, V8, P937, DOI [10.1038/nphoton.2014.249, 10.1038/NPHOTON.2014.249]; MUNRO WJ, 1995, PHYS REV A, V52, P2388, DOI 10.1103/PhysRevA.52.2388; Qian L, 2011, NATURE, V475, P368, DOI 10.1038/nature10262; Rieffel EG, 2015, QUANTUM INF PROCESS, V14, P1, DOI 10.1007/s11128-014-0892-x; Ronnow TF, 2014, SCIENCE, V345, P420, DOI 10.1126/science.1252319; Roslund J, 2014, NAT PHOTONICS, V8, P109, DOI [10.1038/nphoton.2013.340, 10.1038/NPHOTON.2013.340]; Takata K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34089; Takata K, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.043821; TANK DW, 1986, IEEE T CIRCUITS SYST, V33, P533, DOI 10.1109/TCS.1986.1085953; Wang Z, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063853	29	286	305	7	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					614	617		10.1126/science.aah5178	http://dx.doi.org/10.1126/science.aah5178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811274				2022-12-28	WOS:000386869800048
J	Sahnan, K; Lever, L; Philips, RKS				Sahnan, Kapil; Lever, Laurence; Philips, Robin K. S.			10-MINUTE CONSULTATION Anal itching	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRURITUS ANI; DIAGNOSIS; ETIOLOGY		[Sahnan, Kapil; Philips, Robin K. S.] Imperial Coll, Fac Med, London, England; [Sahnan, Kapil; Philips, Robin K. S.] St Marks Hosp, London, England; [Lever, Laurence] Northwick Pk Hosp & Clin Res Ctr, Dept Dermatol, London, England	Imperial College London; Imperial College London; Imperial College London	Sahnan, K (corresponding author), Imperial Coll, Fac Med, London, England.; Sahnan, K (corresponding author), St Marks Hosp, London, England.	ks303@doctors.org.uk	Sahnan, Kapil/W-6310-2019	Sahnan, Kapil/0000-0003-3885-5752				Al-Ghnaniem R, 2007, INT J COLORECTAL DIS, V22, P1463, DOI 10.1007/s00384-007-0325-8; Basso L, 2006, DIS COLON RECTUM, V49, P1080, DOI 10.1007/s10350-006-056-4-8; Chang MW, 2014, PEDIATRICS, V133, pE434, DOI 10.1542/peds.2013-1453; DANIEL GL, 1994, DIS COLON RECTUM, V37, P670, DOI 10.1007/BF02054410; HANNO R, 1987, DERMATOL CLIN, V5, P811, DOI 10.1016/S0733-8635(18)30725-3; JONES JE, 1988, AM FAM PHYSICIAN, V38, P159; Lacy Brian E, 2009, Curr Gastroenterol Rep, V11, P413; Lei WT, 2013, J PEDIATR-US, V163, P916, DOI 10.1016/j.jpeds.2013.03.082; Lysy J, 2003, GUT, V52, P1323, DOI 10.1136/gut.52.9.1323; MacLean J, 2010, AUST FAM PHYSICIAN, V39, P366; Markell KW, 2010, SURG CLIN N AM, V90, P125, DOI 10.1016/j.suc.2009.09.007; Nasseri YY, 2013, GASTROENTEROL CLIN N, V42, P801, DOI 10.1016/j.gtc.2013.09.002; NELSON RL, 1995, DIS COLON RECTUM, V38, P341, DOI 10.1007/BF02054218; Samalavicius NE, 2012, TECH COLOPROCTOL, V16, P295, DOI 10.1007/s10151-012-0846-1; Siddiqi S, 2008, ANN ROY COLL SURG, V90, P457, DOI 10.1308/003588408X317940; Simpson JAD, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6818; SMITH LE, 1982, DIS COLON RECTUM, V25, P358, DOI 10.1007/BF02553616	17	2	2	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2016	355								i4931	10.1136/bmj.i4931	http://dx.doi.org/10.1136/bmj.i4931			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4DC	27815254	Green Published			2022-12-28	WOS:000387318900001
J	Kaiko, GE; Ryu, SH; Koues, OI; Collins, PL; Solnica-Krezel, L; Pearce, EJ; Pearce, EL; Oltz, EM; Stappenbeck, TS				Kaiko, Gerard E.; Ryu, Stacy H.; Koues, Olivia I.; Collins, Patrick L.; Solnica-Krezel, Lilianna; Pearce, Edward J.; Pearce, Erika L.; Oltz, Eugene M.; Stappenbeck, Thaddeus S.			The Colonic Crypt Protects Stem Cells from Microbiota-Derived Metabolites (vol 165, pg 1708, 2016)	CELL			English	Correction												stappenb@wustl.edu	Kaiko, Gerard/ABC-2169-2021; Collins, Patrick/AAN-7599-2020	Kaiko, Gerard/0000-0002-3167-3174; Collins, Patrick/0000-0003-4550-4272	NIAID NIH HHS [R21 AI115734] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI115734] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		KALKO GE, 2016, CELL, V165, P1708	1	62	65	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					1137	1137		10.1016/j.cell.2016.10.034	http://dx.doi.org/10.1016/j.cell.2016.10.034			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814510	Bronze, Green Accepted			2022-12-28	WOS:000389469000028
J	[Anonymous]				[Anonymous]			NO HOLDS BARRED Margaret McCartney: Can the new regulator command doctors' confidence?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		General Medical Council, 2016, CAN BRIEF CHIEF EXC; General Medical Council, 2015, SEN MAN TEAM SAL; Mason R., 2016, GUARDIAN; Public Accounts Committee, 2016, MAN SUPPL NHS CLIN S; Public Accounts Committee, 2016, REC OF SESS	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2016	355								i5865	10.1136/bmj.i5865	http://dx.doi.org/10.1136/bmj.i5865			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CW	27811169	Bronze			2022-12-28	WOS:000387318200005
J	Hampton, T				Hampton, Tracy			NewInsights on Key Neuronal Receptor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1755	1755		10.1001/jama.2016.15860	http://dx.doi.org/10.1001/jama.2016.15860			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802534				2022-12-28	WOS:000386569300004
J	Lerner, BH; Caplan, AL				Lerner, Barron H.; Caplan, Arthur L.			Judging the Past: How History Should Inform Bioethics RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Lerner, Barron H.; Caplan, Arthur L.] NYU, Sch Med, New York, NY 10003 USA	New York University	Lerner, BH (corresponding author), NYU, Sch Med, New York, NY 10003 USA.								0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					675	675		10.7326/L16-0330	http://dx.doi.org/10.7326/L16-0330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802464				2022-12-28	WOS:000386908600018
J	Cornwall, W				Cornwall, Warren			How a figure key to new HFC pact was born	SCIENCE			English	News Item																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					402	402		10.1126/science.354.6311.402	http://dx.doi.org/10.1126/science.354.6311.402			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789820				2022-12-28	WOS:000387684400015
J	Mervis, J				Mervis, Jeffrey			AFTER THE FALL	SCIENCE			English	Editorial Material																			0	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					408	411		10.1126/science.354.6311.408	http://dx.doi.org/10.1126/science.354.6311.408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789823				2022-12-28	WOS:000387684400018
J	Keck, CW				Keck, C. William			The United States and Cuba - Turning Enemies into Partners for Health	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Keck, C. William] Med Educ Cooperat Cuba, Oakland, CA 94612 USA; [Keck, C. William] Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH 44272 USA	Northeast Ohio Medical University (NEOMED)	Keck, CW (corresponding author), Med Educ Cooperat Cuba, Oakland, CA 94612 USA.; Keck, CW (corresponding author), Northeast Ohio Med Univ, Dept Family & Community Med, Rootstown, OH 44272 USA.							[Anonymous], 2016, HHS ENG HIST HLTH CO; Berlanga J, 2013, MEDICC REV, V15, P11, DOI 10.37757/MR2013V15.N1.4; Drain PK, 2015, AM J PUBLIC HEALTH, V105, P2210, DOI 10.2105/AJPH.2015.302894; Pelaez O., 2016, HEBERPROT P REGISTRA; Rodriguez PC, 2016, CLIN CANCER RES, V22, P3782, DOI 10.1158/1078-0432.CCR-15-0855	5	12	12	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1507	1509		10.1056/NEJMp1608859	http://dx.doi.org/10.1056/NEJMp1608859			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3HF	27797312				2022-12-28	WOS:000393102500002
J	Onarheim, KH; Lander, F; Rasmussen, AR; Adamjee, R; Akyea, RK; Barber, MJ; Browne, J; Cubahiro, N; Jarvis, JD; Li, SWS; Mishra, SR; Nasab, MA; Omobo, O; Ramachandran, R; Sharma, A; Walker, A				Onarheim, Kristine Husoy; Lander, Fiona; Rasmussen, Anna Roe; Adamjee, Rehan; Akyea, Ralph Kwame; Barber, Melissa J.; Browne, Jorge; Cubahiro, Nobel; Jarvis, Jordan D.; Li, Sam Wing Sum; Mishra, Shiva Raj; Nasab, Motahareh Akhoondi; Omobo, Oluwaseun; Ramachandran, Reshma; Sharma, Abhishek; Walker, Alex		Youth Commission Essential Med	Youth demand action on the shared global challenge of access to medicines	LANCET			English	Editorial Material									[Onarheim, Kristine Husoy; Lander, Fiona; Rasmussen, Anna Roe; Adamjee, Rehan; Akyea, Ralph Kwame; Barber, Melissa J.; Browne, Jorge; Cubahiro, Nobel; Jarvis, Jordan D.; Li, Sam Wing Sum; Mishra, Shiva Raj; Nasab, Motahareh Akhoondi; Omobo, Oluwaseun; Ramachandran, Reshma; Sharma, Abhishek; Walker, Alex; Youth Commission Essential Med] Univ Bergen, POB 7800, N-5020 Bergen, Norway	University of Bergen	Onarheim, KH (corresponding author), Univ Bergen, POB 7800, N-5020 Bergen, Norway.	Kristine.Onarheim@uib.no	Akyea, Ralph Kwame/K-4979-2019; Akyea, Ralph Kwame/ABP-5358-2022; Mishra, Shiva Raj/C-4172-2014	Akyea, Ralph Kwame/0000-0003-4529-8237; Akyea, Ralph Kwame/0000-0003-4529-8237; Mishra, Shiva Raj/0000-0002-2993-3504; Li, Wing Sum/0000-0002-3502-6839	Swedish International Development Cooperation Agency; Johns Hopkins University; Robert Wood Johnson Foundation; Norwegian Forum for Global Health Research; Norwegian Agency for Development Cooperation; University of Bergen	Swedish International Development Cooperation Agency; Johns Hopkins University(Johns Hopkins University); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Norwegian Forum for Global Health Research; Norwegian Agency for Development Cooperation; University of Bergen	We declare no competing interests. The Youth Commission on Essential Medicines Policies was initiated by members of the student organisation Universities Allied for Essential Medicines. Of the members of the Youth Commission on Essential Medicines Policies, JDJ is employed at the Young Professionals Chronic Disease Network, a US non-for-profit organisation; OO worked as a consultant for WHO and for the Nigerian National Agency for Food and Drug Administration and Control; and RR received funding from the Swedish International Development Cooperation Agency, Johns Hopkins University, and the Robert Wood Johnson Foundation (pending) through her work at the IDEA initiative. We thank the Norwegian Forum for Global Health Research, the Norwegian Agency for Development Cooperation, and the University of Bergen for funding the Youth Commission on Essential Medicines Policies. The funders had no role in preparation of this Comment. We thank Dilyara Nurkhametova for her contributions to the Youth Commission on Essential Medicines Policies and extend our thanks to our secretariat, Johanne Iversen and Arwin Timmermans.	Consultative Expert Working Group on Research and Development Financing and Coordination, 2012, RES DEV MEET HLTH NE; Gotham D, 2016, LANCET GLOB HEALTH, V4, pE296, DOI 10.1016/S2214-109X(16)00066-8; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Mishra SR, 2016, LANCET DIABETES ENDO, V4, P733, DOI 10.1016/S2213-8587(16)30153-X; UN Secretary-General and Co-Chairs of the High-Level Panel, 2016, UN SECR GEN HIGH LEV; Wirtz VJ, 2016, LANCET; Youth Commission on Essential Medicines Policies, 2016, REAL ACC ESS MED ALL	7	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					345	347		10.1016/S0140-6736(16)31906-7	http://dx.doi.org/10.1016/S0140-6736(16)31906-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27832873				2022-12-28	WOS:000392804700011
J	Ness, KK; Hudson, MM; Jones, KE; Leisenring, W; Yasui, Y; Chen, Y; Stovall, M; Gibson, TM; Green, DM; Neglia, JP; Henderson, TO; Casillas, J; Ford, JS; Effinger, KE; Krull, KR; Armstrong, GT; Robison, LL; Oeffinger, KC; Nathan, PC				Ness, Kirsten K.; Hudson, Melissa M.; Jones, Kendra E.; Leisenring, Wendy; Yasui, Yutaka; Chen, Yan; Stovall, Marilyn; Gibson, Todd M.; Green, Daniel M.; Neglia, Joseph P.; Henderson, Tara O.; Casillas, Jacqueline; Ford, Jennifer S.; Effinger, Karen E.; Krull, Kevin R.; Armstrong, Gregory T.; Robison, Leslie L.; Oeffinger, Kevin C.; Nathan, Paul C.			Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; QUALITY-OF-LIFE; LONG-TERM SURVIVORS; ADULT SURVIVORS; UNITED-STATES; BACK-PAIN; RISK; INTERVENTION; ADOLESCENT; MORTALITY	Background: The effect of temporal changes in cancer therapy on health status among childhood cancer survivors has not been evaluated. Objective: To compare proportions of self-reported adverse health status outcomes among childhood cancer survivors across 3 decades. Design: Cross-sectional. (ClinicalTrials.gov: NCT01120353) Setting: 27 North American institutions. Participants: 14 566 adults, who survived for 5 or more years after initial diagnosis (median age, 27 years; range, 18 to 48 years), treated from 1970 to 1999. Measurements: Patient report of poor general or mental health, functional impairment, activity limitation, or cancer-related anxiety or pain was evaluated as a function of treatment decade, cancer treatment exposure, chronic health conditions, demographic characteristics, and health habits. Results: Despite reductions in late mortality and the proportions of survivors with severe, disabling, or life-threatening chronic health conditions (33.4% among those treated from 1970 to 1979 and 21.0% among those treated from 1990 to 1999), those reporting adverse health status did not decrease by treatment decade. Compared with survivors diagnosed in 1970 to 1979, those diagnosed in 1990 to 1999 were more likely to report poor general health (11.2% vs. 13.7%; P < 0.001) and cancer-related anxiety (13.3% vs. 15.0%; P < 0.001). From 1970 to 1979 and 1990 to 1999, the proportions of survivors reporting adverse outcomes were higher (P < 0.001) among those with leukemia (poor general health, 9.5% and 13.9%) and osteosarcoma (pain, 23.9% and 36.6%). Temporal changes in treatment exposures were not associated with changes in the proportions of survivors reporting adverse health status. Smoking, not meeting physical activity guidelines, and being either underweight or obese were associated with poor health status. Limitation: Considerable improvement in survival among children diagnosed with cancer in the 1990s compared with those diagnosed in the 1970s makes it difficult to definitively determine the effect of risk factors on later self-reported health status without considering their effect on mortality. Conclusion: Because survival rates after a diagnosis of childhood cancer have improved substantially over the past 30 years, the population of survivors now includes those who would have died in earlier decades. Self-reported health status among survivors has not improved despite evolution of treatment designed to reduce toxicities.	St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Chen, Yan] Univ Alberta, 116 St & 85 Ave, Edmonton, AB T6G 2R3, Canada; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; Univ Chicago, Chicago, IL 60637 USA; [Casillas, Jacqueline] Univ Calif Los Angeles, David Geffen Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA; Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Effinger, Karen E.] Emory Univ, 201 Dowman Dr, Atlanta, GA 30322 USA; Hosp Sick Children, Toronto, ON, Canada; [Ness, Kirsten K.; Hudson, Melissa M.; Jones, Kendra E.; Yasui, Yutaka; Gibson, Todd M.; Green, Daniel M.; Krull, Kevin R.; Armstrong, Gregory T.; Robison, Leslie L.] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,MS-735, Memphis, TN 38105 USA; [Leisenring, Wendy] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1100 Fairview Ave North, Seattle, WA 98109 USA; [Stovall, Marilyn] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Div Radiat Oncol, 1220 Holcombe Blvd, Houston, TX 77030 USA; [Neglia, Joseph P.] Univ Minnesota, Sch Med, Dept Pediat, 2450 Riverside Ave,6th Floor,East Bldg, Minneapolis, MN 55454 USA; [Henderson, Tara O.] Univ Chicago, Dept Pediat, 5721 South Maryland Ave,Rm K-160,MC8000, Chicago, IL 60637 USA; [Ford, Jennifer S.] Mem Sloan Kettering Canc Ctr, Dept Psychiat & Behav Sci, 1275 York Ave, New York, NY 10065 USA; [Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10065 USA; [Nathan, Paul C.] Hosp Sick Children, Dept Paediat, Div Haematol Oncol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada	St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; University of Alberta; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Memorial Sloan Kettering Cancer Center; Emory University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); St Jude Children's Research Hospital; Fred Hutchinson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Chicago; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Ness, KK (corresponding author), St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 262 Danny Thomas Pl,MS-735, Memphis, TN 38105 USA.	kiri.ness@stjude.org	Nathan, Paul/GRR-2377-2022; Ness, Kirsten K/N-2550-2018; Yasui, Yutaka/E-2564-2015; Robison, Leslie/N-8122-2018; Krull, Kevin R/N-3882-2018; Hudson, Melissa M/N-4441-2018; Casillas, Jackie/AAY-6765-2020; Gibson, Todd M/N-6999-2018; Armstrong, Gregory/N-8096-2018	Ness, Kirsten K/0000-0002-2084-1507; Yasui, Yutaka/0000-0002-7717-8638; Krull, Kevin R/0000-0002-0476-7001; Hudson, Melissa M/0000-0001-6984-2407; Casillas, Jackie/0000-0002-5612-4542; Gibson, Todd M/0000-0002-8718-699X; Leisenring, Wendy/0000-0001-7405-0906; Nathan, Paul/0000-0003-0334-0871; Neglia, Joseph/0000-0002-5525-0598	National Cancer Institute [CA55727]; Cancer Center Support grant [CA21765]; American Lebanese-Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765, U24CA055727] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support grant; American Lebanese-Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the National Cancer Institute (grant CA55727 [Dr. Armstrong]), with support to St. Jude Children's Research Hospital provided by the Cancer Center Support grant (CA21765 [Dr. Roberts]) and the American Lebanese-Syrian Associated Charities.	Armstrong GT, 2014, J CLIN ONCOL, V32, P1218, DOI 10.1200/JCO.2013.51.1055; Armstrong GT, 2010, J CLIN ONCOL, V28, P1224, DOI 10.1200/JCO.2009.24.4608; Bowers DC, 2012, J PEDIAT HEMATOL ONC, V34, P624, DOI 10.1097/MPH.0b013e31827080de; Braam KI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008796.pub2; Centers for Disease Control and Prevention, 2016, FACT SHEETS ALC US Y; Department of Health and Human Services. National Heart Lung and Blood Institute, 1998, CLIN GUID ID EV TREA; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Dotan A, 2010, J CHILD ORTHOP, V4, P391, DOI 10.1007/s11832-010-0270-x; Eaves ER, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0531-9; Ellison DW, 2003, EUR J PAEDIATR NEURO, V7, P53, DOI 10.1016/S1090-3798(03)00014-X; Emmons K, 2002, J CLIN ONCOL, V20, P1608, DOI 10.1200/JCO.20.6.1608; Emmons KM, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2533; Eshelman-Kent D, 2011, J CANCER SURVIV, V5, P345, DOI 10.1007/s11764-011-0192-8; Essig S, 2014, LANCET ONCOL, V15, P841, DOI 10.1016/S1470-2045(14)70265-7; Feijen EAM, 2015, J CLIN ONCOL, V33, P3774, DOI 10.1200/JCO.2015.61.5187; Gana K, 2016, J PSYCHOSOM RES, V85, P28, DOI 10.1016/j.jpsychores.2016.04.004; Green DM, 2014, PEDIATR BLOOD CANCER, V61, P53, DOI 10.1002/pbc.24679; Green DM, 2013, PEDIATR BLOOD CANCER, V60, P1083, DOI 10.1002/pbc.24487; Health. gov, 2015, PHYS ACT GUID GUID A; Hodgson DC, 2007, SEMIN RADIAT ONCOL, V17, P230, DOI 10.1016/j.semradonc.2007.02.009; Howlader N, 2014, SEER CANC STAT REV 1; Hu YY, 2015, AGE AGEING, V44, P84, DOI 10.1093/ageing/afu083; Hudson MM, 2015, J CLIN ONCOL, V33, P479, DOI 10.1200/JCO.2014.57.4863; Hudson MM, 2014, J CLIN ONCOL, V32, P2391, DOI 10.1200/JCO.2014.55.6571; Hudson MM, 2013, JAMA-J AM MED ASSOC, V309, P2371, DOI 10.1001/jama.2013.6296; Hudson MM, 2012, PEDIATR BLOOD CANCER, V58, P334, DOI 10.1002/pbc.23385; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Khan RB, 2014, J CANCER SURVIV, V8, P688, DOI 10.1007/s11764-014-0375-1; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Liu B, 2016, LANCET, V387, P874, DOI 10.1016/S0140-6736(15)01087-9; Liu Q, 2016, J CLIN ONCOL, V34, P1634, DOI 10.1200/JCO.2015.66.3567; Mueller S, 2009, NEUROTHERAPEUTICS, V6, P570, DOI 10.1016/j.nurt.2009.04.006; National Cancer Institute, 2010, NCI COMM TERM CRIT A; Naus MJ, 2009, J CLIN PSYCHOL, V65, P1350, DOI 10.1002/jclp.20622; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ozono S, 2014, JPN J CLIN ONCOL, V44, P932, DOI 10.1093/jjco/hyu102; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Phillips SM, 2015, CANCER EPIDEM BIOMAR, V24, P653, DOI 10.1158/1055-9965.EPI-14-1418; Pui CH, 2013, SEMIN HEMATOL, V50, P185, DOI 10.1053/j.seminhematol.2013.06.007; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; Reulen RC, 2007, INT J CANCER, V121, P633, DOI 10.1002/ijc.22658; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Rosas Lisa Goldman, 2012, Int J Obes (Lond), V2012, ps16; Ruggieri P, 2013, J PEDIATR ORTHOPED, V33, P244, DOI 10.1097/BPO.0b013e318286c178; SIMON MA, 1986, J BONE JOINT SURG AM, V68A, P1331, DOI 10.2106/00004623-198668090-00005; Steptoe A, 2015, LANCET, V385, P640, DOI 10.1016/S0140-6736(13)61489-0; Stokke J, 2015, PEDIATR BLOOD CANCER, V62, P1616, DOI 10.1002/pbc.25514; van Dijk IWEM, 2013, INT J RADIAT ONCOL, V85, P768, DOI 10.1016/j.ijrobp.2012.07.008; Woodruff SI, 2002, TOB CONTROL, V11, P361, DOI 10.1136/tc.11.4.361; Yuh GE, 2004, CANCER J, V10, P386, DOI 10.1097/00130404-200411000-00009; Zack MM, 2013, MMWR-MORBID MORTAL W, V62, P105	52	27	27	1	15	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					89	+		10.7326/M16-0742	http://dx.doi.org/10.7326/M16-0742			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	27820947	Green Accepted			2022-12-28	WOS:000391842600013
J	Tirosh, I; Venteicher, AS; Hebert, C; Escalante, LE; Patel, AP; Yizhak, K; Fisher, JM; Rodman, C; Mount, C; Filbin, MG; Neftel, C; Desai, N; Nyman, J; Izar, B; Luo, CC; Francis, JM; Patel, AA; Onozato, ML; Riggi, N; Livak, KJ; Gennert, D; Satija, R; Nahed, BV; Curry, WT; Martuza, RL; Mylvaganam, R; Iafrate, AJ; Frosch, MP; Golub, TR; Rivera, MN; Getz, G; Rozenblatt-Rosen, O; Cahill, DP; Monje, M; Bernstein, BE; Louis, DN; Regev, A; Suva, ML				Tirosh, Itay; Venteicher, Andrew S.; Hebert, Christine; Escalante, Leah E. .; Patel, Anoop P.; Yizhak, Keren; Fisher, Jonathan M. .; Rodman, Christopher; Mount, Christopher; Filbin, Mariella G.; Neftel, Cyril; Desai, Niyati; Nyman, Jackson; Izar, Benjamin; Luo, Christina C.; Francis, Joshua M. .; Patel, Aanand A.; Onozato, Maristela L.; Riggi, Nicolo; Livak, Kenneth J.; Gennert, Dave; Satija, Rahul; Nahed, Brian V. .; Curry, William T.; Martuza, Robert L.; Mylvaganam, Ravindra; Iafrate, A. John; Frosch, Matthew P.; Golub, Todd R.; Rivera, Miguel N. .; Getz, Gad; Rozenblatt-Rosen, Orit; Cahill, Daniel P.; Monje, Michelle; Bernstein, Bradley E. .; Louis, David N.; Regev, Aviv; Suva, Mario L.			Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma	NATURE			English	Article							EXPRESSION; MUTATIONS; CYCLE; DIFFERENTIATION; QUANTIFICATION; TUMORIGENICITY; TRANSCRIPTOME; ASTROCYTES; NEURONS; MARKERS	Although human tumours are shaped by the genetic evolution of cancer cells, evidence also suggests that they display hierarchies related to developmental pathways and epigenetic programs in which cancer stem cells (CSCs) can drive tumour growth and give rise to differentiated progeny(1). Yet, unbiased evidence for CSCs in solid human malignancies remains elusive. Here we profile 4,347 single cells from six IDH1 or IDH2 mutant human oligodendrogliomas by RNA sequencing (RNA-seq) and reconstruct their developmental programs from genome-wide expression signatures. We infer that most cancer cells are differentiated along two specialized glial programs, whereas a rare subpopulation of cells is undifferentiated and associated with a neural stem cell expression program. Cells with expression signatures for proliferation are highly enriched in this rare subpopulation, consistent with a model in which CSCs are primarily responsible for fuelling the growth of oligodendroglioma in humans. Analysis of copy number variation (CNV) shows that distinct CNV sub-clones within tumours display similar cellular hierarchies, suggesting that the architecture of oligodendroglioma is primarily dictated by developmental programs. Subclonal point mutation analysis supports a similar model, although a full phylogenetic tree would be required to definitively determine the effect of genetic evolution on the inferred hierarchies. Our single-cell analyses provide insight into the cellular architecture of oligodendrogliomas at single-cell resolution and support the cancer stem cell model, with substantial implications for disease management.	[Tirosh, Itay; Venteicher, Andrew S.; Hebert, Christine; Escalante, Leah E. .; Yizhak, Keren; Fisher, Jonathan M. .; Rodman, Christopher; Filbin, Mariella G.; Neftel, Cyril; Nyman, Jackson; Izar, Benjamin; Francis, Joshua M. .; Livak, Kenneth J.; Gennert, Dave; Satija, Rahul; Golub, Todd R.; Rivera, Miguel N. .; Getz, Gad; Rozenblatt-Rosen, Orit; Bernstein, Bradley E. .; Regev, Aviv; Suva, Mario L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Venteicher, Andrew S.; Hebert, Christine; Escalante, Leah E. .; Yizhak, Keren; Filbin, Mariella G.; Neftel, Cyril; Desai, Niyati; Luo, Christina C.; Patel, Aanand A.; Onozato, Maristela L.; Riggi, Nicolo; Mylvaganam, Ravindra; Iafrate, A. John; Frosch, Matthew P.; Rivera, Miguel N. .; Getz, Gad; Bernstein, Bradley E. .; Louis, David N.; Suva, Mario L.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Venteicher, Andrew S.; Hebert, Christine; Escalante, Leah E. .; Yizhak, Keren; Filbin, Mariella G.; Neftel, Cyril; Desai, Niyati; Luo, Christina C.; Patel, Aanand A.; Onozato, Maristela L.; Riggi, Nicolo; Mylvaganam, Ravindra; Iafrate, A. John; Frosch, Matthew P.; Rivera, Miguel N. .; Getz, Gad; Bernstein, Bradley E. .; Louis, David N.; Suva, Mario L.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Venteicher, Andrew S.; Hebert, Christine; Escalante, Leah E. .; Patel, Anoop P.; Yizhak, Keren; Filbin, Mariella G.; Neftel, Cyril; Desai, Niyati; Luo, Christina C.; Patel, Aanand A.; Onozato, Maristela L.; Riggi, Nicolo; Nahed, Brian V. .; Curry, William T.; Martuza, Robert L.; Mylvaganam, Ravindra; Iafrate, A. John; Frosch, Matthew P.; Rivera, Miguel N. .; Getz, Gad; Cahill, Daniel P.; Bernstein, Bradley E. .; Louis, David N.; Suva, Mario L.] Harvard Med Sch, Boston, MA 02114 USA; [Venteicher, Andrew S.; Patel, Anoop P.; Nahed, Brian V. .; Curry, William T.; Martuza, Robert L.; Cahill, Daniel P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Mount, Christopher; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurol, Stanford, CA 94305 USA; [Mount, Christopher; Monje, Michelle] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Mount, Christopher; Monje, Michelle] Stanford Univ, Sch Med, Dept Pediat & Pathol, Stanford, CA 94305 USA; [Filbin, Mariella G.; Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Filbin, Mariella G.; Golub, Todd R.] Childrens Hosp, Ctr Canc, Boston, MA 02215 USA; [Francis, Joshua M. .] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Golub, Todd R.; Regev, Aviv] MIT, Koch Inst, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Stanford University; Stanford University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A; Suva, ML (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Suva, ML (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Suva, ML (corresponding author), Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA.; Suva, ML (corresponding author), Harvard Med Sch, Boston, MA 02114 USA.; Regev, A (corresponding author), MIT, Koch Inst, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA.	aregev@broadinstitute.org; suva.mario@mgh.harvard.edu	Suva, Mario/AAY-7798-2020; Frosch, Matthew P/ABD-7456-2021; Rozenblatt-Rosen, Orit/HDN-4182-2022; Satija, Rahul/AAF-9564-2019; Venteicher, Andrew/AAN-5666-2021; Nahed, Brian/E-4239-2014	Suva, Mario/0000-0001-9898-5351; Frosch, Matthew P/0000-0002-3940-9861; Venteicher, Andrew/0000-0003-0643-0493; Patel, Aanand/0000-0003-0051-9956; Mount, Christopher/0000-0003-1635-2492; Nahed, Brian/0000-0001-8537-106X; Nyman, Jackson/0000-0001-6151-6930; Cahill, Daniel/0000-0003-2552-6546	National Brain Tumor Society; Smith Family Foundation; NIH-NCI SPORE on brain cancer Career Enhancement Project and Developmental Research Project; Broad Institute Broadnext10 program; American Cancer Society; MGH department of Pathology; NIH [NS065743]; American Brain Tumor Association and Neurosurgery Research and Education Foundation; Human Frontier Science Program fellowship; Rothschild fellowship; Howard Hughes Medicine Institute; Klarman Cell Observatory, STARR cancer consortium, NCI [1U24CA180922]; Koch Institute Support from the National Cancer Institute [P30-CA14051]; Ludwig Center and the Broad Institute; California Institute of Regenerative Medicine (CIRM) [RB4-06093, RN3-06510]; Virginia and D.K. Ludwig Fund for Cancer Research;  [1S10RR023440-01A1]; NATIONAL CANCER INSTITUTE [R33CA202820, P30CA014051, U24CA180922] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI118672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS065743] Funding Source: NIH RePORTER	National Brain Tumor Society; Smith Family Foundation; NIH-NCI SPORE on brain cancer Career Enhancement Project and Developmental Research Project; Broad Institute Broadnext10 program; American Cancer Society(American Cancer Society); MGH department of Pathology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association and Neurosurgery Research and Education Foundation; Human Frontier Science Program fellowship(Human Frontier Science Program); Rothschild fellowship; Howard Hughes Medicine Institute; Klarman Cell Observatory, STARR cancer consortium, NCI; Koch Institute Support from the National Cancer Institute; Ludwig Center and the Broad Institute; California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Virginia and D.K. Ludwig Fund for Cancer Research; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Gaffney for graphic support. This work was supported by grants from the National Brain Tumor Society (to M.L.S. and D.N.L.), the Smith Family Foundation (to M.L.S.), NIH-NCI SPORE on brain cancer Career Enhancement Project and Developmental Research Project (to M.L.S.), the Broad Institute Broadnext10 program (to M.L.S. and O.R.R.), the American Cancer Society (to M.L.S.) and start-up funds from the MGH department of Pathology. A.S.V. was supported by the NIH R25 fellowship (NS065743) and research grants from the American Brain Tumor Association and Neurosurgery Research and Education Foundation. I.T. was supported by a Human Frontier Science Program fellowship and a Rothschild fellowship. A.R. was supported by funds from the Howard Hughes Medicine Institute, the Klarman Cell Observatory, STARR cancer consortium, NCI grant 1U24CA180922, by the Koch Institute Support (core) grant P30-CA14051 from the National Cancer Institute, the Ludwig Center and the Broad Institute. A.R. is a scientific advisory board member for ThermoFisher Scientific and Syros Pharmaceuticals and a consultant for Driver Group. Flow cytometry and sorting services were supported by shared instrumentation grant 1S10RR023440-01A1. M.M. was supported by the California Institute of Regenerative Medicine (CIRM) grants RB4-06093 and RN3-06510 and the Virginia and D.K. Ludwig Fund for Cancer Research.	Bettegowda C, 2011, SCIENCE, V333, P1453, DOI 10.1126/science.1210557; Brat DJ, 2015, NEW ENGL J MED, V372, P2481, DOI 10.1056/NEJMoa1402121; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cibulskis K, 2011, BIOINFORMATICS, V27, P2601, DOI 10.1093/bioinformatics/btr446; Costello M, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1443; Darmanis S, 2015, P NATL ACAD SCI USA, V112, P7285, DOI 10.1073/pnas.1507125112; Feng WJ, 2013, CELL STEM CELL, V13, P62, DOI 10.1016/j.stem.2013.05.002; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115; Koyama-Nasu R, 2013, ONCOGENE, V32, P3840, DOI 10.1038/onc.2012.399; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Lange C, 2010, CELL CYCLE, V9, P1893, DOI 10.4161/cc.9.10.11598; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu C, 2011, CELL, V146, P209, DOI 10.1016/j.cell.2011.06.014; Louis, 2016, WHO CLASSIFICATION G; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Mohapatra G, 2006, J MOL DIAGN, V8, P268, DOI 10.2353/jmoldx.2006.050109; Padul V, 2015, GENE CHROMOSOME CANC, V54, P725, DOI 10.1002/gcc.22283; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ramos AH, 2015, HUM MUTAT, V36, pE2423, DOI 10.1002/humu.22771; Rheinbay E, 2013, CELL REP, V3, P1567, DOI 10.1016/j.celrep.2013.04.021; Rousseau A, 2006, J NEUROPATH EXP NEUR, V65, P1149, DOI 10.1097/01.jnen.0000248543.90304.2b; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Sugiarto S, 2011, CANCER CELL, V20, P328, DOI 10.1016/j.ccr.2011.08.011; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Suva ML, 2013, SCIENCE, V339, P1567, DOI 10.1126/science.1230184; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Zhang Y, 2016, NEURON, V89, P37, DOI 10.1016/j.neuron.2015.11.013; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	39	512	521	5	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					309	+		10.1038/nature20123	http://dx.doi.org/10.1038/nature20123			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27806376	Green Accepted, Green Published			2022-12-28	WOS:000387318500049
J	Mervis, J				Mervis, Jeffrey			BEHIND THE NUMBERS California rules US corporate research	SCIENCE			English	News Item																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					537	537		10.1126/science.354.6312.537	http://dx.doi.org/10.1126/science.354.6312.537			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811247				2022-12-28	WOS:000386869800015
J	Pfeifer, GP				Pfeifer, Gerd P.			CANCER How tobacco smoke changes the (epi)genome	SCIENCE			English	Editorial Material							P53		[Pfeifer, Gerd P.] Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA	Van Andel Institute	Pfeifer, GP (corresponding author), Van Andel Res Inst, Ctr Epigenet, Grand Rapids, MI 49503 USA.	gerd.pfeifer@vai.org						Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Hainaut P, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026179; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024	7	6	6	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					549	550		10.1126/science.aal2114	http://dx.doi.org/10.1126/science.aal2114			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811253				2022-12-28	WOS:000386869800020
J	Myers, J				Myers, Jed			Poetry's Company Where Medicine Leaves Us Alone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Myers, Jed] Univ Washington, Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Myers, J (corresponding author), Univ Washington, Psychiat & Behav Sci, Seattle, WA 98195 USA.	medjyers@hotmail.com						Guest P, 2010, ONE MORE THEORY HAPP, P125; Guest P, 2008, MY INDEX SLIGHTLY HO, V52, P76; Hall DA, 2004, 3 THING POETRY, V185, P113; Hall DA, 1998, MARINER BOOKS, V46-47, P81; Wiman C, 2013, MY BRIGHT ABYSS MEDI, P82; Wiman C, 2010, EVERY RIVEN THING, V22-23, P31	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1744	1745		10.1001/jama.2016.13618	http://dx.doi.org/10.1001/jama.2016.13618			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802524				2022-12-28	WOS:000386569300001
J	Nagendran, M; Pereira, TV; Kiew, G; Altman, DG; Maruthappu, M; Ioannidis, JPA; McCulloch, P				Nagendran, Myura; Pereira, Tiago V.; Kiew, Grace; Altman, Douglas G.; Maruthappu, Mahiben; Ioannidis, John P. A.; McCulloch, Peter			Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GUIDELINES; WASTE	OBJECTIVE To examine whether a very large effect (VLE; defined as a relative risk of <= 0.2 or >= 5) in a randomised trial could be an empirical marker that subsequent trials are unnecessary. DESIGN Meta-epidemiological assessment of existing published data on randomised trials. DATA SOURCES Cochrane Database of Systematic Reviews (2010, issue 7) with data on subsequent large trials updated to 2015, issue 12. ELIGIBILITY CRITERIA All binary outcome forest plots were selected, which contained an index randomised trial with a VLE that was nominally statistically significant (P<0.05), included a subsequent large randomised trial (>= 200 events and >= 200 non-events) for validation of the effect, assessed a primary outcome of the review, and was not a subgroup or sensitivity analysis. RESULTS Of 3082 reviews yielding 85 002 forest plots, only 44 (0.05%) satisfied the inclusion criteria. Index trials were generally small, with a median sample of 99 (median 14 events). Few index trials were rated at low risk of bias (9 of 44; 20%). The relative risk was closer to the null in the subsequent large trials in 43 of 44 cases. Subsequent large trial data failed to find a statistically significant (P<0.05) effect in the same direction in 19 cases (43%, 95% confidence interval 29% to 58%). Even when the subsequent large trials did find a significant effect in the same direction, the additional primary outcomes in most of these trials would have to be considered before deciding in favour of using the intervention. Subsequent large trial data found a statistically significant effect in the same direction in 19 of 21 cases when the index trial also had a value of P<0.001. CONCLUSIONS The frequency of VLEs followed by a large trial is vanishingly small, and where they occur they do not appear to be a reliable marker for a benefit that is reproducible and directly actionable. An empirical rule using a VLE in a randomised controlled trial as a marker that further trials are unnecessary would be neither practical nor useful. Caution should be taken when interpreting small studies with very large treatment effects.	[Nagendran, Myura] Imperial Coll London, Div Anaesthet Pain Med & Intens Care, London, England; [Pereira, Tiago V.] Hosp Alemao Oswaldo Cruz, Inst Educ & Sci, Hlth Technol Assessment Unit, Sao Paulo, Brazil; [Kiew, Grace] Univ Cambridge, Gonville & Caius Coll, Cambridge CB2 1TN, England; [Altman, Douglas G.] Ctr Stat Med, Oxford, England; [Maruthappu, Mahiben] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr, Stanford, CA 94305 USA; [McCulloch, Peter] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England	Imperial College London; University of Cambridge; University of Oxford; University of London; University College London; Stanford University; Stanford University; Stanford University; Stanford University; University of Oxford	McCulloch, P (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England.	peter.mcculloch@nds.ox.ac.uk	Ioannidis, John P. A./G-9836-2011	Kiew, Grace/0000-0002-8934-0858; McCulloch, Peter/0000-0002-3210-8273; Nagendran, Myura/0000-0002-4656-5096	Cancer Research UK [16895] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Bulley S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004604.pub3; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Djulbegovic B, 2013, NATURE, V500, P395, DOI 10.1038/500395a; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Higgins J.P.T., 2021, COCHRANE HDB SYSTEMA, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; IntHout J, 2015, J CLIN EPIDEMIOL, V68, P860, DOI 10.1016/j.jclinepi.2015.03.017; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Iwashyna TJ, 2015, AM J RESP CRIT CARE, V192, P1045, DOI 10.1164/rccm.201411-2125CP; Kurzrock R, 2013, ANN ONCOL, V24, P2471, DOI 10.1093/annonc/mdt358; McCulloch P, 2005, BRIT J SURG, V92, P1293, DOI 10.1002/bjs.4930; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Neilson JP, 2010, COCHRANE DB SYST REV, V1; Pena-Rosas JP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004736.pub3; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Prasad V, 2013, MAYO CLIN PROC, V88, P790, DOI 10.1016/j.mayocp.2013.05.012; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Reiczigel J, 2008, COMPUT STAT DATA AN, V52, P5046, DOI 10.1016/j.csda.2008.04.032; Rerkasem K, 2010, BRIT J SURG, V97, P466, DOI 10.1002/bjs.6988; Schroth R J, 2004, Cochrane Database Syst Rev, pCD003775, DOI 10.1002/14651858.CD003775.pub2; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x	23	12	12	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2016	355								i5432	10.1136/bmj.i5432	http://dx.doi.org/10.1136/bmj.i5432			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LM	27789483	hybrid, Green Published			2022-12-28	WOS:000386662000002
J	Mitchell, F				Mitchell, Fiona			Research Focus Profile: Kennedy Institute of Rheumatology, Oxford, UK	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1972	1972		10.1016/S0140-6736(16)31900-6	http://dx.doi.org/10.1016/S0140-6736(16)31900-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ6EQ	27789010				2022-12-28	WOS:000385954800013
J	Roy, V; King, L				Roy, Victor; King, Lawrence			Betting on hepatitis C: how financial speculation in drug development influences access to medicines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Roy, Victor; King, Lawrence] Univ Cambridge, Dept Sociol, Cambridge, England	University of Cambridge	Roy, V (corresponding author), Univ Cambridge, Dept Sociol, Cambridge, England.	vr260@cam.ac.uk		King, Lawrence/0000-0002-5714-406X				Alsono-Zaldivar R., 2015, MEDICARE SPENDING 9B; [Anonymous], 2015, FINANCIAL TIMES; Avorn J, 2015, NEW ENGL J MED, V372, P1877, DOI 10.1056/NEJMp1500848; Bach PB, 2015, JAMA-J AM MED ASSOC, V314, P2503, DOI 10.1001/jama.2015.16843; Barrett P, 2015, BLOOMBERG; Bartenschlager R, 2002, NAT REV DRUG DISCOV, V1, P911, DOI 10.1038/nrd942; Behnke N, 2014, NEW PATHS TO VALUE C; Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972; Brettell K, 2015, REUTERS; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Cohen J, 2015, SCIENCE, V348, P622, DOI 10.1126/science.348.6235.622; Deloitte Centre for Health Solutions, 2015, MEASURING THE RETURN; Drugs for Neglected Diseases Initiative, 2009, RES DEV DIS POOR 10; Flinn R., 2011, BLOOMBERG; Ghinea N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1284; Gilead Sciences, 2015, FQ1 2015 EARNINGS CA; Graham J., 2016, KAISER HLTH NEW 0705; Has GC, 2016, BLOOMBERG; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Langreth R., 2015, BLOOMBERG; Lazonick W., 2015, SHARE BUYBACKS FROM; Lazonick W., 2014, HARVARD BUSINESS SEP; Lazonick W, 2013, IND CORP CHANGE, V22, P1093, DOI 10.1093/icc/dtt019; Light DW, 2011, BIOSOCIETIES, V6, P34, DOI 10.1057/biosoc.2010.40; Loftus P., 2014, WALL STREET J; Loftus P., 2015, WALL STREET J; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Marshall E, 2000, SCIENCE, V290, P1870; Mazzucato M., 2013, THE ENTREPRENEURIAL; O'Neill J., 2015, BUY BACK OR PAY FORW; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Reinhardt U, 2015, JAMA-J AM MED ASSOC, V314, P981, DOI 10.1001/jama.2015.9593; Roy V, 2016, MAKING HEPATITIS C R; Sarpatwari A, 2016, NEW ENGL J MED, V374, P2301, DOI 10.1056/NEJMp1605100; Securities and Exchanges Commission, 2009, PHARMASSET 10 K FILI; Securities and Exchanges Commission, 2006, PHARM S 1 FIL; Securities and Exchanges Commission, 2011, PHARMASSET 10 K FILI; Securities and Exchanges Commission, 2011, GILEAD SCIENCES 10 K; Silverman E., 2016, STAT; Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x; Stanaway JD, 2016, LANCET, DOI [10.1016/S0140-6736(16)30579, DOI 10.1016/S0140-6736(16)30579]; Summers L, 2015, REPORT COMMISSION IN; Tirrell M, 2012, BLOOMBERG; Tirrell M., 2011, BLOOMBERG; Universities Allied for Essential Medicines, 2016, RER MAP ALT R D LAND; US Senate Committee on Finance, 2015, THE PRICE OF SOVALDI; Van Nuys K, 2015, HEALTH AFFAIR, V34, P1666, DOI 10.1377/hlthaff.2014.1193; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; Yee M., 2014, GILEAD SCI MRK HEP C	49	26	26	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2016	354								i3718	10.1136/bmj.i3718	http://dx.doi.org/10.1136/bmj.i3718			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZH	27815237				2022-12-28	WOS:000380931600002
J	Brawley, OW; Cowal, SG				Brawley, Otis W.; Cowal, Sally G.			Civil society's role in efforts to control women's cancers	LANCET			English	Editorial Material									[Brawley, Otis W.; Cowal, Sally G.] Amer Canc Soc, Atlanta, GA 30303 USA; [Brawley, Otis W.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Brawley, Otis W.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Brawley, Otis W.] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA	American Cancer Society; Emory University; Emory University; Emory University	Brawley, OW (corresponding author), Amer Canc Soc, Atlanta, GA 30303 USA.; Brawley, OW (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.; Brawley, OW (corresponding author), Emory Univ, Dept Med, Atlanta, GA 30322 USA.; Brawley, OW (corresponding author), Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA.	otis.brawley@cancer.org						American Cancer Society, 2015, GLOB CANC FACTS FIG; Bernstein L, 2008, Oncogene, V27 Suppl 2, pS3, DOI 10.1038/onc.2009.348; Denny L., 2016, LANCET; DeSantis CE, 2015, CANCER EPIDEM BIOMAR, V24, P1495, DOI 10.1158/1055-9965.EPI-15-0535; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ginsburg O., 2016, LANCET; Jemal A, 2012, CANCER-AM CANCER SOC, V118, P4372, DOI 10.1002/cncr.27410; O'Brien M, 2013, LANCET ONCOL, V14, pE176, DOI 10.1016/S1470-2045(12)70343-1; Ruff Paul, 2016, Am Soc Clin Oncol Educ Book, V35, P58, DOI 10.14694/EDBK_155975; Shulman LN, 2016, J CLIN ONCOL, V34, P69, DOI 10.1200/JCO.2015.61.8736; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024	11	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					775	776		10.1016/S0140-6736(16)31799-8	http://dx.doi.org/10.1016/S0140-6736(16)31799-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	27814966				2022-12-28	WOS:000394966400010
J	Metersky, ML; Wang, Y; Klompas, M; Eckenrode, S; Bakullari, A; Eldridge, N				Metersky, Mark L.; Wang, Yun; Klompas, Michael; Eckenrode, Sheila; Bakullari, Anila; Eldridge, Noel			Trend in Ventilator-Associated Pneumonia Rates Between 2005 and 2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							NETWORK NHSN REPORT; SAFETY		[Metersky, Mark L.] Univ Connecticut, Sch Med, Div Pulm & Crit Care Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Wang, Yun] Harvard Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Klompas, Michael] Harvard Med Sch, Dept Populat Med, Boston, MA USA; [Eckenrode, Sheila; Bakullari, Anila] Qualidigm, Wethersfield, CT USA; [Eldridge, Noel] US Dept HHS, Agcy Healthcare Res & Qual, Rockville, MD USA	University of Connecticut; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Agency for Healthcare Research & Quality	Metersky, ML (corresponding author), Univ Connecticut, Sch Med, Div Pulm & Crit Care Med, 263 Farmington Ave, Farmington, CT 06030 USA.	Metersky@uchc.edu	Klompas, Michael/Z-2415-2019					Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Klompas M, 2012, CURR OPIN INFECT DIS, V25, P176, DOI 10.1097/QCO.0b013e3283502437; Magill SS, 2013, CRIT CARE MED, V41, P2467, DOI 10.1097/CCM.0b013e3182a262db; O'Grady NP, 2012, JAMA-J AM MED ASSOC, V307, P2534, DOI 10.1001/jama.2012.6445; Wang Y, 2014, NEW ENGL J MED, V370, P341, DOI 10.1056/NEJMsa1300991	6	73	76	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2427	2429		10.1001/jama.2016.16226	http://dx.doi.org/10.1001/jama.2016.16226			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27835709	Bronze			2022-12-28	WOS:000389884600025
J	Song, ZR; Blumenthal, DM				Song, Zirui; Blumenthal, Daniel M.			Expanding Payment Reform in Medicare The Cardiology Episode-Based Payment Model	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERCUTANEOUS CORONARY INTERVENTION		[Song, Zirui; Blumenthal, Daniel M.] Massachusetts Gen Hosp, Dept Med, 55 Fruit St,Bigelow 730, Boston, MA 02114 USA; [Song, Zirui; Blumenthal, Daniel M.] Harvard Med Sch, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Song, ZR (corresponding author), Massachusetts Gen Hosp, Dept Med, 55 Fruit St,Bigelow 730, Boston, MA 02114 USA.	zirui_song@post.harvard.edu			NIA NIH HHS [F30 AG039175] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [F30AG039175] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aragam KG, 2015, J AM COLL CARDIOL, V65, P2079, DOI 10.1016/j.jacc.2015.02.063; Centers for Medicare & Medicaid Services, 2016, READM DEATHS NAT; Fanning JP, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004815.pub4; Jha AK., 2016, JAMA FORUM      0804; Joynt KE, 2012, JAMA-J AM MED ASSOC, V308, P1460, DOI 10.1001/jama.2012.12922; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Newhouse JP, 2013, JAMA-J AM MED ASSOC, V310, P1227, DOI 10.1001/jama.2013.278139	7	11	11	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1973	1974		10.1001/jama.2016.16146	http://dx.doi.org/10.1001/jama.2016.16146			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838725				2022-12-28	WOS:000387673800011
J	Kupferman, J; Polleux, F				Kupferman, Justine; Polleux, Franck			EVOLUTION Genomic remodelling in the primate brain	NATURE			English	Editorial Material							TRANSCRIPTION; OSTEOCRIN; RECEPTOR; SYNAPSE		[Kupferman, Justine; Polleux, Franck] Columbia Univ, Dept Neurosci, Mortimer B Zuckerman Mind Bruin Behav Inst, New York, NY 10032 USA; [Kupferman, Justine; Polleux, Franck] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA	Columbia University; Columbia University	Kupferman, J (corresponding author), Columbia Univ, Dept Neurosci, Mortimer B Zuckerman Mind Bruin Behav Inst, New York, NY 10032 USA.; Kupferman, J (corresponding author), Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA.	jb2524@cumc.columbia.edu; fp2304@cumc.columbia.edu		Kupferman, Justine/0000-0001-5689-4734; Polleux, Franck/0000-0003-4313-0481				Ataman B, 2016, NATURE, V539, P242, DOI 10.1038/nature20111; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Moffatt P, 2007, J BIOL CHEM, V282, P36454, DOI 10.1074/jbc.M708596200; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Subbotina E, 2015, P NATL ACAD SCI USA, V112, P16042, DOI 10.1073/pnas.1514250112; Zhao Z, 2009, P NATL ACAD SCI USA, V106, P18016, DOI 10.1073/pnas.0906880106	12	0	0	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					171	172		10.1038/539171a	http://dx.doi.org/10.1038/539171a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830798				2022-12-28	WOS:000387318500021
J	Williams, R; Salt, G; Jackson, T; Mazur, L; Briceno, N; Clapp, B; Redwood, S; Barrett, N; Rajani, R; Chiribiri, A				Williams, Rupert; Salt, Gavin; Jackson, Tom; Mazur, Leianora; Briceno, Natalia; Clapp, Brian; Redwood, Simon; Barrett, Nick; Rajani, Ronak; Chiribiri, Amedeo			Severe respiratory failure	LANCET			English	Editorial Material									[Williams, Rupert; Salt, Gavin; Jackson, Tom; Mazur, Leianora; Briceno, Natalia; Clapp, Brian; Redwood, Simon; Barrett, Nick; Rajani, Ronak; Chiribiri, Amedeo] Guys & St Thomas NHS Fdn Trust, Westminster Bridge Rd, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust	Williams, R (corresponding author), Guys & St Thomas NHS Fdn Trust, Westminster Bridge Rd, London SE1 7EH, England.	rupertwilliams@nhs.net	Chiribiri, Amedeo/T-2771-2019						0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					E12	E12		10.1016/S0140-6736(16)32083-9	http://dx.doi.org/10.1016/S0140-6736(16)32083-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8MO	27825511				2022-12-28	WOS:000386889300001
J	Bairlein, F				Bairlein, Franz			CONSERVATION Migratory birds under threat	SCIENCE			English	Editorial Material							CLIMATE-CHANGE; POPULATIONS; DECLINES		[Bairlein, Franz] Inst Avian Res, Wilhelmshaven, Germany		Bairlein, F (corresponding author), Inst Avian Res, Wilhelmshaven, Germany.	franz.bairlein@ifv-vogelwarte.de						Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brink AB, 2009, APPL GEOGR, V29, P501, DOI 10.1016/j.apgeog.2008.10.004; Brochet AL, 2016, BIRD CONSERV INT, V26, P1, DOI 10.1017/S0959270915000416; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; Hewson CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12296; Hung CM, 2014, P NATL ACAD SCI USA, V111, P10636, DOI 10.1073/pnas.1401526111; Kamp J, 2015, CONSERV BIOL, V29, P1684, DOI 10.1111/cobi.12537; Norris DR, 2004, P ROY SOC B-BIOL SCI, V271, P59, DOI 10.1098/rspb.2003.2569; Ockendon N, 2012, BIRD STUDY, V59, P111, DOI 10.1080/00063657.2011.645798; Saino N., 2012, P R SOC B, V278, P835; Stephens PA, 2016, SCIENCE, V352, P84, DOI 10.1126/science.aac4858; Thackeray SJ, 2010, GLOBAL CHANGE BIOL, V16, P3304, DOI 10.1111/j.1365-2486.2010.02165.x; van Gils JA, 2016, SCIENCE, V352, P819, DOI 10.1126/science.aad6351; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Walther BA, 2016, AFR J ECOL, V54, P268, DOI 10.1111/aje.12350; Wikelski M, 2016, SCIENCE, V352, P775, DOI 10.1126/science.aaf6544; Zalakevicius M, 2006, J ORNITHOL, V147, P326, DOI 10.1007/s10336-005-0016-6	17	79	89	7	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					547	548		10.1126/science.aah6647	http://dx.doi.org/10.1126/science.aah6647			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811252				2022-12-28	WOS:000386869800019
J	Wiech, K				Wiech, Katja			Deconstructing the sensation of pain: The influence of cognitive processes on pain perception	SCIENCE			English	Review							PLACEBO ANALGESIA; DECISION-MAKING; DEFAULT MODE; PREDICTION; BRAIN; EXPECTATIONS; PERSPECTIVE; MECHANISMS; SIGNATURE; NETWORKS	Phenomena such as placebo analgesia or pain relief through distraction highlight the powerful influence cognitive processes and learning mechanisms have on the way we perceive pain. Although contemporary models of pain acknowledge that pain is not a direct readout of nociceptive input, the neuronal processes underlying cognitive modulation are not yet fully understood. Modern concepts of perception-which include computational modeling to quantify the influence of cognitive processes-suggest that perception is critically determined by expectations and their modification through learning. Research on pain has just begun to embrace this view. Insights into these processes promise to open up new avenues to pain prevention and treatment by harnessing the power of the mind.	[Wiech, Katja] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain, Nuffield Dept Clin Neurosci, Headley Way, Oxford OX3 9DU, England; [Wiech, Katja] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Nuffield Div Anaesthet, Headley Way, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Wiech, K (corresponding author), Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct Magnet Resonance Imaging Brain, Nuffield Dept Clin Neurosci, Headley Way, Oxford OX3 9DU, England.; Wiech, K (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Nuffield Div Anaesthet, Headley Way, Oxford OX3 9DU, England.	katja.wiech@ndcn.ox.ac.uk			U.K. Medical Research Council; Medical Research Council [MR/L011719/1] Funding Source: researchfish; MRC [MR/L011719/1] Funding Source: UKRI	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	K.W. would like to thank U. Bingel, F. Eippert, T. Makin, M. Ploner, J. O'Reilly, I. Tracey, and N. Weiskopf for valuable comments and the U.K. Medical Research Council for research support.	Atlas LY, 2012, NEUROSCI LETT, V520, P140, DOI 10.1016/j.neulet.2012.03.039; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Benedetti F, 2011, NAT MED, V17, P1228, DOI 10.1038/nm.2435; Bingel U, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001244; Buchel C, 2014, NEURON, V81, P1223, DOI 10.1016/j.neuron.2014.02.042; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Crombez G, 2011, PAIN, V152, P1449, DOI 10.1016/j.pain.2011.02.028; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; Edwards MJ, 2012, BRAIN, V135, P3495, DOI 10.1093/brain/aws129; Eippert F, 2013, PLACEBO AND PAIN: FROM BENCH TO BEDSIDE, P53, DOI 10.1016/B978-0-12-397928-5.00007-6; Eippert F, 2009, SCIENCE, V326, P404, DOI 10.1126/science.1180142; Eippert F, 2009, NEURON, V63, P533, DOI 10.1016/j.neuron.2009.07.014; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Hu L, 2016, TRENDS NEUROSCI, V39, P212, DOI 10.1016/j.tins.2016.01.004; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; Kessner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109014; Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102; Krummenacher P, 2010, PAIN, V148, P368, DOI 10.1016/j.pain.2009.09.033; Kucyi A, 2015, TRENDS NEUROSCI, V38, P86, DOI 10.1016/j.tins.2014.11.006; Kucyi A, 2013, P NATL ACAD SCI USA, V110, P18692, DOI 10.1073/pnas.1312902110; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Mulder MJ, 2014, NEUROSCIENCE, V277, P872, DOI 10.1016/j.neuroscience.2014.07.031; Pecina M, 2015, MOL PSYCHIATR, V20, P416, DOI 10.1038/mp.2014.164; Ploghaus A, 2000, P NATL ACAD SCI USA, V97, P9281, DOI 10.1073/pnas.160266497; Ploner M, 2015, TRENDS COGN SCI, V19, P180, DOI 10.1016/j.tics.2015.02.007; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauschecker JP, 2015, TRENDS COGN SCI, V19, P567, DOI 10.1016/j.tics.2015.08.002; Roy M, 2014, NAT NEUROSCI, V17, P1607, DOI 10.1038/nn.3832; Salomons TV, 2004, J NEUROSCI, V24, P7199, DOI 10.1523/JNEUROSCI.1315-04.2004; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seymour B, 2005, NAT NEUROSCI, V8, P1234, DOI 10.1038/nn1527; Summerfield C, 2014, NAT REV NEUROSCI, V15, P745, DOI 10.1038/nrn3838; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Vlaeyen JWS, 2015, PAIN, V156, pS86, DOI 10.1097/j.pain.0000000000000107; Wager TD, 2013, NEW ENGL J MED, V368, P1388, DOI 10.1056/NEJMoa1204471; Wiech K, 2014, CURR BIOL, V24, pR679, DOI 10.1016/j.cub.2014.06.022; Wiech K, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00046; Woo CW, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002036; Zhang SY, 2016, CURR BIOL, V26, P52, DOI 10.1016/j.cub.2015.10.066	41	203	207	10	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					584	587		10.1126/science.aaf8934	http://dx.doi.org/10.1126/science.aaf8934			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811269	Green Submitted			2022-12-28	WOS:000386869800038
J	Anbar, AD; Till, CB; Hannah, MA				Anbar, Ariel D.; Till, Christy B.; Hannah, Mark A.			Bridge the planetary divide	NATURE			English	Editorial Material							UPPER CONTINENTAL-CRUST; EVOLUTION		[Anbar, Ariel D.; Till, Christy B.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Hannah, Mark A.] Arizona State Univ, Dept English, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Anbar, AD (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	anbar@asu.edu	Till, Christy/Y-1173-2019	Till, Christy/0000-0001-8924-2206				Aulbach S, 2016, GEOLOGY, V44, P751, DOI 10.1130/G38070.1; Catling DC., 2014, TREATISE GEOCHEMISTR, V6, P177, DOI [10.1016/B978-0-08-095975-7.01307-3, DOI 10.1016/B978-0-08-095975-7.01307-3]; CONDIE KC, 1993, CHEM GEOL, V104, P1, DOI 10.1016/0009-2541(93)90140-E; Gaschnig RM, 2016, GEOCHIM COSMOCHIM AC, V186, P316, DOI 10.1016/j.gca.2016.03.020; Hannah MA, 2016, TECH COMMUN-STC, V63, P328; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Milligan R A, 1999, Holist Nurs Pract, V13, P47; Nicklas R., 2015, GOLDSCHMIDT ABSTRACT, V2272; Tang M, 2016, SCIENCE, V351, P372, DOI 10.1126/science.aad5513; Young PA, 2014, ASTROBIOLOGY, V14, P603, DOI 10.1089/ast.2014.1143	10	3	3	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					25	27		10.1038/539025a	http://dx.doi.org/10.1038/539025a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808217	Bronze			2022-12-28	WOS:000386670100010
J	Ticona, L; Schulman, KA				Ticona, Luis; Schulman, Kevin A.			Extreme Home Makeover - The Role of Intensive Home Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ticona, Luis] Partners HealthCare Syst, Populat Hlth Management Dept, Boston, MA 02199 USA; [Schulman, Kevin A.] Harvard Sch Business, Boston, MA USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA	Partners Healthcare System; Harvard University; Duke University; Duke University	Ticona, L (corresponding author), Partners HealthCare Syst, Populat Hlth Management Dept, Boston, MA 02199 USA.							Caplan GA, 2012, MED J AUSTRALIA, V197, P512, DOI 10.5694/mja12.10480; Cryer L, 2012, HEALTH AFFAIR, V31, P1237, DOI 10.1377/hlthaff.2011.1132; Montalto M, 2010, MED J AUSTRALIA, V193, P598, DOI 10.5694/j.1326-5377.2010.tb04070.x; Ridlington E, 2008, DIAGNOSING HIGH COST; Shepperd S, 2008, COCHRANE DB SYST REV, V4	5	16	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1707	1709		10.1056/NEJMp1608301	http://dx.doi.org/10.1056/NEJMp1608301			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB0BB	27806216				2022-12-28	WOS:000387007300002
J	Legris, M; Klose, C; Burgie, ES; Rojas, CC; Neme, M; Hiltbrunner, A; Wigge, PA; Schafer, E; Vierstra, RD; Casal, JJ				Legris, Martina; Klose, Cornelia; Burgie, E. Sethe; Costigliolo Rojas, Cecilia; Neme, Maximiliano; Hiltbrunner, Andreas; Wigge, Philip A.; Schaefer, Eberhard; Vierstra, Richard D.; Casal, Jorge J.			Phytochrome B integrates light and temperature signals in Arabidopsis	SCIENCE			English	Article							RED; ENVIRONMENT; RATIO	Ambient temperature regulates many aspects of plant growth and development, but its sensors are unknown. Here, we demonstrate that the phytochrome B (phyB) photoreceptor participates in temperature perception through its temperature-dependent reversion from the active Pfr state to the inactive Pr state. Increased rates of thermal reversion upon exposing Arabidopsis seedlings to warm environments reduce both the abundance of the biologically active Pfr-Pfr dimer pool of phyB and the size of the associated nuclear bodies, even in daylight. Mathematical analysis of stem growth for seedlings expressing wild-type phyB or thermally stable variants under various combinations of light and temperature revealed that phyB is physiologically responsive to both signals. We therefore propose that in addition to its photoreceptor functions, phyB is a temperature sensor in plants.	[Legris, Martina; Costigliolo Rojas, Cecilia; Neme, Maximiliano; Casal, Jorge J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, RA-1405 Buenos Aires, DF, Argentina; [Klose, Cornelia; Hiltbrunner, Andreas; Schaefer, Eberhard] Univ Freiburg, Inst Biol 2, Schaenzlestr 1, D-79104 Freiburg, Germany; [Burgie, E. Sethe; Vierstra, Richard D.] Washington Univ, Dept Biol, Campus Box 1137,One Brookings Dr, St Louis, MO 63130 USA; [Hiltbrunner, Andreas; Schaefer, Eberhard] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Schaenzlestr 18, D-79104 Freiburg, Germany; [Wigge, Philip A.] Univ Cambridge, Sainsbury Lab, 47 Bateman St, Cambridge CB2 1LR, England; [Casal, Jorge J.] Univ Buenos Aires, Inst Invest Fisiol & Ecol Vinculadas Agr IFEVA, Fac Agron, Ave San Martin 4453, RA-1417 Buenos Aires, DF, Argentina; [Casal, Jorge J.] Consejo Nacl Invest Cient & Tecn, Ave San Martin 4453, RA-1417 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Freiburg; Washington University (WUSTL); University of Freiburg; University of Cambridge; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Casal, JJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, RA-1405 Buenos Aires, DF, Argentina.; Casal, JJ (corresponding author), Univ Buenos Aires, Inst Invest Fisiol & Ecol Vinculadas Agr IFEVA, Fac Agron, Ave San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.; Casal, JJ (corresponding author), Consejo Nacl Invest Cient & Tecn, Ave San Martin 4453, RA-1417 Buenos Aires, DF, Argentina.	casal@ifeva.edu.ar	Klose, Cornelia/AAT-5969-2020; Rojas, Cecilia Costigliolo/ABE-7389-2020; Wigge, Philip Anthony/ABD-5113-2021	Rojas, Cecilia Costigliolo/0000-0003-3075-8464; Wigge, Philip Anthony/0000-0003-4822-361X; Legris, Martina/0000-0001-6725-2198; Hiltbrunner, Andreas/0000-0003-0438-5297; Klose, Cornelia/0000-0003-0032-6556	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012-1396, PICT 2013-1444]; Alexander von Humboldt-Foundation; Universidad de Buenos Aires [20020100100437]; Fundacion Rene Baron; Excellence Initiative of the German Federal Government [EXC 294]; Excellence Initiative of the German State Government [EXC 294]; German Research Foundation (DFG) [SCHA 303/16-1, HI 1369/5-1]; U.S. National Science Foundation [MCB-1329956]; BBSRC [BB/I013350/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000610, BB/I013350/1] Funding Source: researchfish	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Alexander von Humboldt-Foundation(Alexander von Humboldt Foundation); Universidad de Buenos Aires(University of Buenos Aires); Fundacion Rene Baron; Excellence Initiative of the German Federal Government; Excellence Initiative of the German State Government; German Research Foundation (DFG)(German Research Foundation (DFG)); U.S. National Science Foundation(National Science Foundation (NSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank F. Venezia (University of Freiburg) for his valuable help with the analytical equations. This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (grants PICT 2012-1396 and PICT 2013-1444 to J.J.C.), Alexander von Humboldt-Foundation (J.J.C.), Universidad de Buenos Aires (grant 20020100100437 to J.J.C.), Fundacion Rene Baron (J.J.C.), the Excellence Initiative of the German Federal and State Governments (EXC 294, project C 20 to E.S. and A.H.), the German Research Foundation (DFG; SCHA 303/16-1 and HI 1369/5-1 to E.S. and A.H.), and the U.S. National Science Foundation (MCB-1329956 to R.D.V.). R.D.V and E.S.B. and the University of Wisconsin-Madison have filed U.S. patent application P140220US02, which relates to the use of mutants phyB<SUP>Y361F</SUP> and phyB<SUP>R582A</SUP> in agriculture. The supplementary materials contain additional data.	Adam E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027250; Trupkin SA, 2014, PLANT PHYSIOL, V165, P1698, DOI 10.1104/pp.114.242438; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Burgie ES, 2014, PLANT CELL, V26, P4568, DOI 10.1105/tpc.114.131623; Burgie ES, 2014, P NATL ACAD SCI USA, V111, P10179, DOI 10.1073/pnas.1403096111; Casal JJ, 2004, TRENDS PLANT SCI, V9, P309, DOI 10.1016/j.tplants.2004.04.007; Casal JJ, 2013, ANNU REV PLANT BIOL, V64, P403, DOI 10.1146/annurev-arplant-050312-120221; Galvao VC, 2015, CURR OPIN NEUROBIOL, V34, P46, DOI 10.1016/j.conb.2015.01.013; HOLMES MG, 1977, PHOTOCHEM PHOTOBIOL, V25, P539, DOI 10.1111/j.1751-1097.1977.tb09125.x; Jung JH, 2016, SCIENCE, V354, P886, DOI 10.1126/science.aaf6005; Klose C, 2015, NAT PLANTS, V1, P1, DOI [10.1038/nplants.2015.90, 10.1038/NPLANTS.2015.90]; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Quint M, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2015.190, 10.1038/nplants.2015.190]; Salome PA, 2010, PLANT CELL, V22, P3650, DOI 10.1105/tpc.110.079087; Salvucci ME, 2001, PLANT PHYSIOL, V127, P1053, DOI 10.1104/pp.010357; Sellaro R, 2010, PLANT PHYSIOL, V154, P401, DOI 10.1104/pp.110.160820; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Van Buskirk EK, 2012, PLANT PHYSIOL, V158, P52, DOI 10.1104/pp.111.186411; Zhang JR, 2013, PLANT PHYSIOL, V161, P1445, DOI 10.1104/pp.112.208892	19	428	448	27	223	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2016	354	6314					897	900		10.1126/science.aaf5656	http://dx.doi.org/10.1126/science.aaf5656			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0KR	27789798	Green Submitted			2022-12-28	WOS:000388531900043
J	Lumeng, JC				Lumeng, Julie C.			Infant Eating Behaviors and Risk for Overweight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILDREN; OBESITY; PREVENTION; CHILDHOOD		[Lumeng, Julie C.] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Lumeng, Julie C.] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA; [Lumeng, Julie C.] Univ Michigan, Ctr Human Growth & Dev, 300 N Ingalls St, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lumeng, JC (corresponding author), Univ Michigan, Ctr Human Growth & Dev, 300 N Ingalls St, Ann Arbor, MI 48109 USA.	jlumeng@umich.edu						AGRAS WS, 1987, J PEDIATR-US, V110, P799, DOI 10.1016/S0022-3476(87)80029-X; DEVRIES MW, 1984, AM J PSYCHIAT, V141, P1189; Lumeng JC, 2015, JAMA PEDIATR, V169, P484, DOI 10.1001/jamapediatrics.2014.3554; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Pepino MY, 2005, PAIN, V119, P210, DOI 10.1016/j.pain.2005.09.029; Saavedra JM, 2013, ANN NUTR METAB, V62, P27, DOI 10.1159/000351538; Savage JS, 2016, JAMA PEDIATR, V170, P1230, DOI 10.1001/jamapediatrics.2016.3457; Savage JS, 2016, JAMA PEDIATR, V170, P742, DOI 10.1001/jamapediatrics.2016.0445; Temple JL, 2008, AM J CLIN NUTR, V87, P1121, DOI 10.1093/ajcn/87.5.1121	9	2	2	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					2036	2037		10.1001/jama.2016.16899	http://dx.doi.org/10.1001/jama.2016.16899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838708				2022-12-28	WOS:000387673800021
J	Macey, ARM; Grama, C				Macey, Alistair R. M.; Grama, Charitra			SPOT DIAGNOSIS An ankle that just didn't look right	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Macey, Alistair R. M.; Grama, Charitra] Hairmyres Hosp, Dept Trauma & Orthopaed, Glasgow, Lanark, Scotland	University Hospital Hairmyres	Macey, ARM (corresponding author), Hairmyres Hosp, Dept Trauma & Orthopaed, Glasgow, Lanark, Scotland.	alistairmacey@nhs.net						Broca P, 1953, MEM SOC CHIR, V3, P566; Camarda L, 2016, Musculoskelet Surg, V100, P63, DOI 10.1007/s12306-015-0380-1; Rammelt S, 2015, FOOT ANKLE CLIN, V20, P253, DOI 10.1016/j.fcl.2015.02.008	3	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2016	355								i5056	10.1136/bmj.i5056	http://dx.doi.org/10.1136/bmj.i5056			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CV	27834267				2022-12-28	WOS:000388003200001
J	Wilkinson, R				Wilkinson, Ryan			GEOSCIENCE Cliffs make a hasty retreat	NATURE			English	Editorial Material														Wilkinson, Ryan/0000-0003-3280-1841					0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					173	173		10.1038/539173a	http://dx.doi.org/10.1038/539173a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830794	Bronze			2022-12-28	WOS:000387318500023
J	Lipner, SR; Scher, RK				Lipner, Shari R.; Scher, Richard K.			Long-standing Onychodystrophy in a Young Woman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lipner, Shari R.; Scher, Richard K.] Weill Cornell Med, Dept Dermatol, 1305 York Ave, New York, NY 10021 USA	Cornell University	Lipner, SR (corresponding author), Weill Cornell Med, Dept Dermatol, 1305 York Ave, New York, NY 10021 USA.	shl9032@med.cornell.edu	Lipner, Shari R./AAK-8943-2020	Lipner, Shari R./0000-0001-5913-9304				Faergemann J, 2003, BRIT J DERMATOL, V149, P1, DOI 10.1046/j.1365-2133.149.s65.4.x; Haneke E, 1999, J EUR ACAD DERMATOL, V12, pS2, DOI 10.1016/S0926-9959(99)00052-5; Lipner SR, 2016, JAMA DERMATOL, V152, P847, DOI 10.1001/jamadermatol.2016.0785; Lipner SR, 2016, CURR MED RES OPIN, V32, P865, DOI 10.1185/03007995.2016.1147026; Mikailov A, 2016, JAMA DERMATOL, V152, P276, DOI 10.1001/jamadermatol.2015.4190	5	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1915	1916		10.1001/jama.2016.16167	http://dx.doi.org/10.1001/jama.2016.16167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27824989				2022-12-28	WOS:000387116500021
J	Williams, PR; He, ZG				Williams, Philip R.; He, Zhigang			NEUROSCIENCE Building bridges to regenerate axons	SCIENCE			English	Editorial Material							SPINAL-CORD REGENERATION; TISSUE GROWTH-FACTOR; INJURY; ASTROCYTES		[He, Zhigang] Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA; Harvard Med Sch, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	He, ZG (corresponding author), Childrens Hosp, FM Kirby Neurobiol Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	zhigang.he@childrens.harvard.edu						Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Bayraktar OA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020362; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Conrad S, 2005, J NEUROSURG-SPINE, V2, P319, DOI 10.3171/spi.2005.2.3.0319; Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; He ZG, 2016, NEURON, V90, P437, DOI 10.1016/j.neuron.2016.04.022; Leask A, 2003, BIOCHEM CELL BIOL, V81, P355, DOI 10.1139/O03-069; Mokalled MH, 2016, SCIENCE, V354, P630, DOI 10.1126/science.aaf2679; Silver J, 2016, EXP NEUROL, V286, P147, DOI 10.1016/j.expneurol.2016.06.018; Silver J, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020602; White RE, 2008, EXP NEUROL, V214, P10, DOI 10.1016/j.expneurol.2008.06.012; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	15	1	1	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					544	545		10.1126/science.aal2112	http://dx.doi.org/10.1126/science.aal2112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811250				2022-12-28	WOS:000386869800017
J	Boussiotis, VA				Boussiotis, Vassiliki A.			Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							T-CELL-ACTIVATION; INHIBITORY RECEPTOR PD-1; TUMOR MICROENVIRONMENT; PROGRAMMED DEATH-1; PROTEIN STABILITY; CHRONIC INFECTION; CTLA-4 BLOCKADE; B7 FAMILY; EXPRESSION; CANCER		[Boussiotis, Vassiliki A.] Beth Israel Deaconess Med Ctr, Dept Med, Div Hematol Oncol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Boussiotis, VA (corresponding author), Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Dana 513, Boston, MA 02215 USA.	vboussio@bidmc.harvard.edu			NATIONAL CANCER INSTITUTE [R01CA183605] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA183605] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; ALLISON JP, 1995, CURR OPIN IMMUNOL, V7, P682, DOI 10.1016/0952-7915(95)80077-8; Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Carreno BM, 2002, ANNU REV IMMUNOL, V20, P29, DOI 10.1146/annurev.immunol.20.091101.091806; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen J, 2016, ANN ONCOL, V27, P409, DOI 10.1093/annonc/mdv615; CHEN LP, 1993, IMMUNOL TODAY, V14, P483, DOI 10.1016/0167-5699(93)90262-J; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Derks S, 2016, ONCOTARGET, V7, P32925, DOI 10.18632/oncotarget.9076; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Fang WF, 2014, ONCOTARGET, V5, P12189, DOI 10.18632/oncotarget.2608; Fife BT, 2009, NAT IMMUNOL, V10, P1185, DOI 10.1038/ni.1790; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Green MR, 2010, BLOOD, V116, P3268, DOI 10.1182/blood-2010-05-282780; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Honda T, 2014, IMMUNITY, V40, P235, DOI 10.1016/j.immuni.2013.11.017; ISHIDA Y, 1992, EMBO J, V11, P3887, DOI 10.1002/j.1460-2075.1992.tb05481.x; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jaudszus A, 2013, J LIPID RES, V54, P923, DOI 10.1194/jlr.P031260; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mathieu M, 2013, IMMUNOL CELL BIOL, V91, P82, DOI 10.1038/icb.2012.53; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Naidoo J, 2015, ANN ONCOL, V26, P2375, DOI 10.1093/annonc/mdv383; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Patsoukis N, 2013, MOL CELL BIOL, V33, P3091, DOI 10.1128/MCB.00319-13; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Ribas A, 2016, CANCER IMMUNOL RES, V4, P194, DOI 10.1158/2326-6066.CIR-15-0210; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Terawaki S, 2011, J IMMUNOL, V186, P2772, DOI 10.4049/jimmunol.1003208; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Tkachev V, 2015, J IMMUNOL, V194, P5789, DOI 10.4049/jimmunol.1402180; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wei F, 2013, P NATL ACAD SCI USA, V110, pE2480, DOI 10.1073/pnas.1305394110; Xiao YP, 2014, J EXP MED, V211, P943, DOI 10.1084/jem.20130790; Yokosuka T, 2012, J EXP MED, V209, P1201, DOI 10.1084/jem.20112741; Yoshida T, 2008, P NATL ACAD SCI USA, V105, P3533, DOI 10.1073/pnas.0710951105; Zinselmeyer BH, 2013, J EXP MED, V210, P757, DOI 10.1084/jem.20121416; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	68	711	774	17	265	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1767	1778		10.1056/NEJMra1514296	http://dx.doi.org/10.1056/NEJMra1514296			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806234	Green Accepted			2022-12-28	WOS:000387007300010
J	Gulland, A				Gulland, Anne			WHO launches global guidelines to stop surgical site infections	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		World Health Organization, 2016, GLOB GUID PREV SURG; World Health Organization, 2009, SURG SAF CHECKL	2	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2016	355								i5942	10.1136/bmj.i5942	http://dx.doi.org/10.1136/bmj.i5942			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CW	27810859				2022-12-28	WOS:000387318200016
J	Li, Y; Oosting, M; Smeekens, SP; Jaeger, M; Aguirre-Gamboa, R; Le, KTT; Deelen, P; Ricano-Ponce, I; Schoffelen, T; Jansen, AFM; Swertz, MA; Withoff, S; van de Vosse, E; van Deuren, M; van de Veerdonk, F; Zhernakova, A; van der Meer, JWM; Xavier, RJ; Franke, L; Joosten, LAB; Wijmenga, C; Kumar, V; Netea, MG				Li, Yang; Oosting, Marije; Smeekens, Sanne P.; Jaeger, Martin; Aguirre-Gamboa, Raul; Le, Kieu T. T.; Deelen, Patrick; Ricano-Ponce, Isis; Schoffelen, Teske; Jansen, Anne F. M.; Swertz, Morris A.; Withoff, Sebo; van de Vosse, Esther; van Deuren, Marcel; van de Veerdonk, Frank; Zhernakova, Alexandra; van der Meer, Jos W. M.; Xavier, Ramnik J.; Franke, Lude; Joosten, Leo A. B.; Wijmenga, Cisca; Kumar, Vinod; Netea, Mihai G.			A Functional Genomics Approach to Understand Variation in Cytokine Production in Humans	CELL			English	Article							HUMAN IMMUNE-SYSTEM; WIDE ASSOCIATION; GENETIC-VARIANTS; LOW-FREQUENCY; DISEASE; SUSCEPTIBILITY; HERITABILITY; AUTOIMMUNITY; MICROBIOME; COMPLEMENT	As part of the Human Functional Genomics Project, which aims to understand the factors that determine the variability of immune responses, we investigated genetic variants affecting cytokine production in response to ex vivo stimulation in two independent cohorts of 500 and 200 healthy individuals. We demonstrate a strong impact of genetic heritability on cytokine production capacity after challenge with bacterial, fungal, viral, and non-microbial stimuli. In addition to 17 novel genome-wide significant cytokine QTLs (cQTLs), our study provides a comprehensive picture of the genetic variants that influence six different cytokines in whole blood, blood mononuclear cells, and macrophages. Important biological pathways that contain cytokine QTLs map to pattern recognition receptors (TLR1-6-10 cluster), cytokine and complement inhibitors, and the kallikrein system. The cytokine QTLs show enrichment for monocyte-specific enhancers, are more often located in regions under positive selection, and are significantly enriched among SNPs associated with infections and immune-mediated diseases.	[Li, Yang; Aguirre-Gamboa, Raul; Le, Kieu T. T.; Deelen, Patrick; Ricano-Ponce, Isis; Swertz, Morris A.; Withoff, Sebo; Zhernakova, Alexandra; Franke, Lude; Wijmenga, Cisca; Kumar, Vinod] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Oosting, Marije; Smeekens, Sanne P.; Jaeger, Martin; Schoffelen, Teske; Jansen, Anne F. M.; van Deuren, Marcel; van de Veerdonk, Frank; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 HP Nijmegen, Netherlands; [Oosting, Marije; Smeekens, Sanne P.; Jaeger, Martin; Schoffelen, Teske; Jansen, Anne F. M.; van Deuren, Marcel; van de Veerdonk, Frank; van der Meer, Jos W. M.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 HP Nijmegen, Netherlands; [Deelen, Patrick; Swertz, Morris A.] Univ Groningen, Univ Med Ctr Groningen, Genom Coordinat Ctr, NL-9700 RB Groningen, Netherlands; [van de Vosse, Esther] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands; [Xavier, Ramnik J.] Harvard Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Broad Inst MIT & Harvard Univ, Cambridge, MA 02142 USA; [Wijmenga, Cisca] Univ Oslo, Oslo Univ Hosp, Dept Immunol, Rikshosp, N-0372 Oslo, Norway	University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oslo; National Hospital Norway	Li, Y; Wijmenga, C; Kumar, V (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands.; Joosten, LAB; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 HP Nijmegen, Netherlands.; Joosten, LAB; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 HP Nijmegen, Netherlands.; Wijmenga, C (corresponding author), Univ Oslo, Oslo Univ Hosp, Dept Immunol, Rikshosp, N-0372 Oslo, Norway.	y.li01@umcg.nl; leo.joosten@radboudumc.nl; c.wijmenga@umcg.nl; v.kumar@umcg.nl; mihai.netea@radboudumc.nl	Jansen, Anne/P-8310-2015; Jaeger, Martin/H-3359-2015; Joosten, Leo AB/H-3138-2015; Smeekens, Sanne/G-8307-2011; Ricaño-Ponce, Isis/ABC-5454-2020; Netea, Mihai/N-5155-2014; Kumar, Vinod/ABC-4866-2020; Li, Yang/HGT-8446-2022; Oosting, Marije/H-7437-2015; van de Vosse, Esther/HDO-0723-2022; van der Meer, Jos W.M./C-8521-2013; Deelen, Patrick/B-3566-2013; Zhernakova, Alexandra/ABA-9372-2020; Smeekens, Sanne/AAZ-2061-2021; van de Veerdonk, Frank L/C-7256-2008; van de Vosse, Esther/B-7285-2009; Deuren, Marcel/O-1846-2013; Wijmenga, Cisca/AAE-7719-2019; Franke, Lude/P-7036-2016	Jansen, Anne/0000-0002-1407-5412; Jaeger, Martin/0000-0001-6994-493X; Joosten, Leo AB/0000-0001-6166-9830; Smeekens, Sanne/0000-0002-7835-914X; Ricaño-Ponce, Isis/0000-0002-7530-9526; Kumar, Vinod/0000-0002-2775-6049; Li, Yang/0000-0003-4022-7341; van der Meer, Jos W.M./0000-0001-5120-3690; Deelen, Patrick/0000-0002-5654-3966; Smeekens, Sanne/0000-0002-7835-914X; van de Veerdonk, Frank L/0000-0002-1121-4894; van de Vosse, Esther/0000-0001-5199-3426; Wijmenga, Cisca/0000-0002-5635-1614; Franke, Lude/0000-0002-5159-8802	ERC Consolidator grant [3310372]; IN-CONTROL CVON grant [CVON2012-03]; Spinoza prize [NWO SPI 94-212, NWO SPI 92266]; ERC advanced grant (FP7/ERC grant) [2012-322698]; Dutch Digestive Diseases Foundation grant [MLDS WO11-30]; European Union Seventh Framework Programme grant (EU FP7) TANDEM project [HEALTH-F3-2012-305279]; Netherlands Organization for Scientific Research (NWO) VENI grant [863.13.011]; BBMRI-NL; Netherlands Organization for Scientific Research (NWO) [184.021.007]	ERC Consolidator grant; IN-CONTROL CVON grant; Spinoza prize; ERC advanced grant (FP7/ERC grant); Dutch Digestive Diseases Foundation grant; European Union Seventh Framework Programme grant (EU FP7) TANDEM project; Netherlands Organization for Scientific Research (NWO) VENI grant(Netherlands Organization for Scientific Research (NWO)); BBMRI-NL; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank all volunteers in the 500FG and 200FG cohorts of the Human Functional Genomics Project (HFGP) for their participation. We thank Kate McIntyre and Jackie Senior for editing the text. The HFGP is supported by an ERC Consolidator grant (3310372), an IN-CONTROL CVON grant (CVON2012-03), and a Spinoza prize (NWO SPI 94-212) to M.G.N.; an ERC advanced grant (FP/2007-2013/ERC grant 2012-322698) and a Spinoza prize (NWO SPI 92266) to C.W.; a Dutch Digestive Diseases Foundation grant (MLDS WO11-30) to C.W. and V.K.; a European Union Seventh Framework Programme grant (EU FP7) TANDEM project (HEALTH-F3-2012-305279) to C.W. and V.K.; and a Netherlands Organization for Scientific Research (NWO) VENI grant (863.13.011) to Y.L. The creation and hosting of the online database has been supported by BBMRI-NL, a research infrastructure financed by the Netherlands Organization for Scientific Research (NWO), grant number 184.021.007. We thank Edith Adriaanse, Marije van der Geest, and Marieke Bijlsma for structuring the data into the online database and the MOLGENIS open source team (Dennis Hendriksen, Erwin Winder, Bart Charbon, Fleur Kelpin, Jonathan Jetten, Mark de Haan, Tommy de Boer, David van Enckevort, Chao Pang, and Joeri van der Velde) for designing and implementing the database software.	Aguirre-Gamboa R., 2016, CELL REP; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bonder MJ, 2016, NAT GENET; Bosco MC, 2000, J IMMUNOL, V164, P3283, DOI 10.4049/jimmunol.164.6.3283; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Coeffier M, 2001, CYTOKINE, V13, P148, DOI 10.1006/cyto.2000.0813; Davenport ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140301; Deelen Patrick, 2014, BMC Res Notes, V7, P901, DOI 10.1186/1756-0500-7-901; Deelen P, 2014, EUR J HUM GENET, V22, P1321, DOI 10.1038/ejhg.2014.19; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Escudero-Esparza A, 2013, FASEB J, V27, P5083, DOI 10.1096/fj.13-230706; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Francioli LC, 2014, NAT GENET, V46, P818, DOI 10.1038/ng.3021; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Harden JL, 2016, J ALLERGY CLIN IMMUN, V137, P1830, DOI 10.1016/j.jaci.2015.09.055; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1; Kumar V, 2014, CURR OPIN IMMUNOL, V31, P51, DOI 10.1016/j.coi.2014.09.007; Kumar V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5675; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Pillai SM, 2011, J BIOL CHEM, V286, P2455, DOI 10.1074/jbc.M110.172403; Ramirez-Ortiz ZG, 2015, NAT IMMUNOL, V16, P495, DOI 10.1038/ni.3143; Ricano-Ponce I, 2016, J AUTOIMMUN, V68, P62, DOI 10.1016/j.jaut.2016.01.002; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; SCHRAMEK S, 1981, ACTA VIROL, V25, P230; Shah TS, 2012, BIOINFORMATICS, V28, P1598, DOI 10.1093/bioinformatics/bts180; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Swertz MA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S12; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; Wang WB, 2010, INT J CANCER, V126, P599, DOI 10.1002/ijc.24904; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Yamada A, 2009, BIOCHEM BIOPH RES CO, V379, P964, DOI 10.1016/j.bbrc.2008.12.187; Yamamoto H, 2014, IMMUNITY, V41, P511, DOI 10.1016/j.immuni.2014.10.002; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2012, HUM GENET, V131, P1655, DOI 10.1007/s00439-012-1199-6	47	184	184	5	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					1099	+		10.1016/j.cell.2016.10.017	http://dx.doi.org/10.1016/j.cell.2016.10.017			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814507	Green Published, Bronze			2022-12-28	WOS:000389469000025
J	Moberly, T				Moberly, Tom			Australia plans to tighten visa conditions for UK doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2016	355								i5949	10.1136/bmj.i5949	http://dx.doi.org/10.1136/bmj.i5949			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CW	27810864				2022-12-28	WOS:000387318200017
J	Navathe, AS; Emanuel, EJ				Navathe, Amol S.; Emanuel, Ezekiel J.			INNOVATIONS IN HEALTH CARE DELIVERY Physician Peer Comparisons as a Nonfinancial Strategy to Improve the Value of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIAL		[Navathe, Amol S.; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Navathe, Amol S.] Corporal Michael J Cresencz VA Med Ctr, Philadelphia, PA USA; [Emanuel, Ezekiel J.] Univ Penn, Leonard Davis Inst Hlth Econ, Wharton Sch, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Navathe, AS (corresponding author), Univ Penn, Div Hlth Policy, 423 Guardian Dr,1108 Blockley Hall, Philadelphia, PA 19106 USA.	amol@wharton.upenn.edu		Navathe, Amol/0000-0001-7182-4988	NIA NIH HHS [P30 AG034546] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Beshears J, 2015, J FINANC, V70, P1161, DOI 10.1111/jofi.12258; Emanuel EJ, 2016, JAMA-J AM MED ASSOC, V315, P1331, DOI 10.1001/jama.2016.2556; Emanuel EJ, 2016, ANN INTERN MED, V164, P114, DOI 10.7326/M15-1330; Gerber JS, 2013, JAMA-J AM MED ASSOC, V309, P2345, DOI 10.1001/jama.2013.6287; Liao JM, 2016, JAMA-J AM MED ASSOC, V316, P1151, DOI 10.1001/jama.2016.10094; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Rosenbaum L, 2015, NEW ENGL J MED, V373, P1385, DOI 10.1056/NEJMp1510094; Waldo SW, 2015, J AM COLL CARDIOL, V65, P1119, DOI 10.1016/j.jacc.2015.01.008	8	52	52	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1759	1760		10.1001/jama.2016.13739	http://dx.doi.org/10.1001/jama.2016.13739			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802553				2022-12-28	WOS:000386569300009
J	Kennel, CF; Briggs, S; Victor, DG				Kennel, Charles F.; Briggs, Stephen; Victor, David G.			Making climate science more relevant	SCIENCE			English	Editorial Material									[Kennel, Charles F.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Kennel, Charles F.] Univ Cambridge, Ctr Sci & Policy, Cambridge CB2 3BU, England; [Kennel, Charles F.] Univ Cambridge, Christs Coll, Cambridge CB2 3BU, England; [Briggs, Stephen] European Space Agcy, Didcot OX11 0FD, Oxon, England; [Briggs, Stephen] Oxford Harwell, European Ctr Space Applicat & Telecommun, Didcot OX11 0FD, Oxon, England; [Briggs, Stephen] World Meteorol Org, Global Climate Observing Syst, Steering Comm, CH-1211 Geneva, Switzerland; [Victor, David G.] Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA; [Victor, David G.] Brookings Inst, Washington, DC 20036 USA; [Victor, David G.] World Econ Forum, Global Agenda Council Governance Sustainabil, 123 Cologny, Geneva, Switzerland	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Cambridge; University of Cambridge; European Space Agency; University of California System; University of California San Diego; Brookings Institution	Victor, DG (corresponding author), Univ Calif San Diego, Sch Global Policy & Strategy, La Jolla, CA 92093 USA.; Victor, DG (corresponding author), Brookings Inst, Washington, DC 20036 USA.; Victor, DG (corresponding author), World Econ Forum, Global Agenda Council Governance Sustainabil, 123 Cologny, Geneva, Switzerland.	david.victor@ucsd.edu						Briggs S, 2015, NAT CLIM CHANGE, V5, P969, DOI 10.1038/nclimate2828; Janetos AC, 2015, FRONT ECOL ENVIRON, V13, P403, DOI 10.1890/1540-9295-13.8.403; Keohane RO, 2016, NAT CLIM CHANGE, V6, P570, DOI 10.1038/NCLIMATE2937; King D., 2015, CLIMATE CHANGE RISK; Melillo J.M., 2014, 3 NATL COMMUNICATION; Rapley C., 2016, GLOB CLIM OBS ROAD F; Street R. B., 2016, CLIM SERV, V1, P2, DOI DOI 10.1016/J.CLISER.2015.12.001; UN, 2016, MATT REL SCI REV RES; United Nations, 2015, AD PAR AGR; Victor DG, 2014, NATURE, V514, P30, DOI 10.1038/514030a; World Meteorological Organization, 2003, 2 REP AD GLOB OBS SY	11	17	17	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					421	422		10.1126/science.aag3248	http://dx.doi.org/10.1126/science.aag3248			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789831				2022-12-28	WOS:000387684400026
J	Maher, B; Anfresdesign, MS; Krzysztofiak, J				Maher, Brendan; Anfresdesign, Miquel Sureda; Krzysztofiak, Jasiek			UNDER PRESSURE	NATURE			English	Editorial Material													Sureda, Miquel/C-3410-2019	Sureda, Miquel/0000-0003-2455-4211					0	27	29	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					444	445		10.1038/538444a	http://dx.doi.org/10.1038/538444a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786225	Bronze			2022-12-28	WOS:000386654400030
J	Busse, JW; Bhandari, M; Einhorn, TA; Schemitsch, E; Heckman, JD; Tornetta, P; Leung, KS; Heels-Ansdell, D; Makosso-Kallyth, S; Della Rocca, GJ; Jones, CB; Guyatt, GH				Busse, Jason W.; Bhandari, Mohit; Einhorn, Thomas A.; Schemitsch, Emil; Heckman, James D.; Tornetta, Paul, III; Leung, Kwok-Sui; Heels-Ansdell, Diane; Makosso-Kallyth, Sun; Della Rocca, Gregory J.; Jones, Clifford B.; Guyatt, Gordon H.			Re-evaluation of low intensity pulsed ultrasound in treatment of tibial fractures (TRUST): randomized clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTICENTER; RELIABILITY; PHYSICIANS; THERAPY; COLLEGE; QUALITY	OBJECTIVE To determine whether low intensity pulsed ultrasound (LIPUS), compared with sham treatment, accelerates functional recovery and radiographic healing in patients with operatively managed tibial fractures. DESIGN A concealed, randomized, blinded, sham controlled clinical trial with a parallel group design of 501 patients, enrolled between October 2008 and September 2012, and followed for one year. SETTING 43 North American academic trauma centers. PARTICIPANTS Skeletally mature men or women with an open or closed tibial fracture amenable to intramedullary nail fixation. Exclusions comprised pilon fractures, tibial shaft fractures that extended into the joint and required reduction, pathological fractures, bilateral tibial fractures, segmental fractures, spiral fractures >7.5 cm in length, concomitant injuries that were likely to impair function for at least as long as the patient's tibial fracture, and tibial fractures that showed <25% cortical contact and >1 cm gap after surgical fixation. 3105 consecutive patients who underwent intramedullary nailing for tibial fracture were assessed, 599 were eligible and 501 provided informed consent and were enrolled. INTERVENTIONS Patients were allocated centrally to self administer daily LIPUS (n=250) or use a sham device (n=251) until their tibial fracture showed radiographic healing or until one year after intramedullary fixation. Main outcome measures Primary registry specified outcome was time to radiographic healing within one year of fixation; secondary outcome was rate of non-union. Additional protocol specified outcomes included short form-36 (SF-36) physical component summary (PCS) scores, return to work, return to household activities, return to >= 80% of function before injury, return to leisure activities, time to full weight bearing, scores on the health utilities index (mark 3), and adverse events related to the device. RESULTS SF-36 PCS data were acquired from 481/501 (96%) patients, for whom we had 2303/2886 (80%) observations, and radiographic healing data were acquired from 482/501 (96%) patients, of whom 82 were censored. Results showed no impact on SF-36 PCS scores between LIPUS and control groups (mean difference 0.55, 95% confidence interval -0.75 to 1.84; P=0.41) or for the interaction between time and treatment (P=0.30); minimal important difference is 3-5 points) or in other functional measures. There was also no difference in time to radiographic healing (hazard ratio 1.07, 95% confidence interval 0.86 to 1.34; P=0.55). There were no differences in safety outcomes between treatment groups. Patient compliance was moderate; 73% of patients administered >= 50% of all recommended treatments. CONCLUSIONS Postoperative use of LIPUS after tibial fracture fixation does not accelerate radiographic healing and fails to improve functional recovery.	[Busse, Jason W.; Bhandari, Mohit; Heels-Ansdell, Diane; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4K1, Canada; [Busse, Jason W.; Makosso-Kallyth, Sun] McMaster Univ, Dept Anesthesia, 1200 Main St West,HSC 2U1, Hamilton, ON L8S 4K1, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON L8S 4K1, Canada; [Bhandari, Mohit] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada; [Einhorn, Thomas A.; Tornetta, Paul, III] NYU, Langone Med Ctr, Dept Orthoped Surg, 550 1St Ave, New York, NY 10016 USA; [Schemitsch, Emil] Univ Western Ontario, Dept Surg, London, ON N6A 4V2, Canada; [Heckman, James D.] Dartmouth Hitchcock Med Ctr, Dept Orthoped Surg, Lebanon, NH 03766 USA; [Leung, Kwok-Sui] Chinese Univ Hong Kong, Dept Orthoped & Traumatol, Shatin, Hong Kong, Peoples R China; [Della Rocca, Gregory J.] Univ Missouri, Dept Orthoped Surg, Columbia, MO 65212 USA; [Jones, Clifford B.] Banner Univ, CORE, Ctr Orthoped Res & Educ, Phoenix, AZ 85023 USA; [Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University; McMaster University; McMaster University; New York University; NYU Langone Medical Center; Western University (University of Western Ontario); Dartmouth College; Chinese University of Hong Kong; University of Missouri System; University of Missouri Columbia; McMaster University	Busse, JW (corresponding author), McMaster Univ, Dept Anesthesia, 1200 Main St West,HSC 2U1, Hamilton, ON L8S 4K1, Canada.	bussejw@mcmaster.ca	Bhandari, Mohit/AAQ-1675-2021; Busse, Jason/CAH-3696-2022; Della Rocca, Gregory/AAM-5281-2021; Schemitsch, Emil/G-5706-2017; Madden, Kim/N-5761-2015	Busse, Jason/0000-0002-0178-8712; Schemitsch, Emil/0000-0002-6435-9069; Madden, Kim/0000-0002-2861-9636; Tornetta, Paul/0000-0002-6448-8864; Einhorn, Thomas/0000-0002-5075-4885	Canadian Institutes of Health Research (CIHR) [MCT 67815]; Smith Nephew	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Smith Nephew	This study was an investigator-initiated trial, supported by grants from the Canadian Institutes of Health Research (CIHR) (MCT 67815, Co-PIs: GH Guyatt, M Bhandari), and an industry grant from Smith & Nephew. The CIHR had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Smith & Nephew personnel reviewed initial drafts of the trial protocol and raised many issues about alternative approaches to study design. Issues regarding the protocol were resolved through negotiation between Smith & Nephew and the trial steering committee. Final decisions regarding the protocol and issues that arose during the conduct of the trial were the purview of the trial steering committee. The investigators had full access to all trial data. Smith & Nephew had no role the initial preparation of the current study manuscript but had the right to review the manuscript and make non-binding comments and suggestions.	[Anonymous], 2005, THE ORTHO PEOPLE OCT; Bhandari M, 2004, J ORTHOP TRAUMA, V18, P338, DOI 10.1097/00005131-200407000-00002; Busse JW, 2008, ACTA ORTHOP, V79, P689, DOI 10.1080/17453670810016722; Busse JW, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-206; Busse JW, 2009, J CLIN EPIDEMIOL, V62, P1210, DOI 10.1016/j.jclinepi.2009.01.014; Busse JW, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b351; Carpenter JA, 2013, STUD WORLD CHR SER, P1; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Griffin XL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008579.pub3; Heckman J D, 1997, Bull Hosp Jt Dis, V56, P63; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Kooistra BW, 2010, J ORTHOP TRAUMA, V24, pS81, DOI 10.1097/BOT.0b013e3181ca3fd1; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961, DOI 10.2106/00004623-199707000-00002; Lenzer J, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6230; Marcus HJ, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2587; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Moynihan R, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1271; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Rubin C, 2001, J BONE JOINT SURG AM, V83A, P259, DOI 10.2106/00004623-200102000-00015; Rue JPH, 2004, ORTHOPEDICS, V27, P1192, DOI 10.3928/0147-7447-20041101-18; SARMIENTO A, 1995, CLIN ORTHOP RELAT R, P8; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; Thompson M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2973; Tsumaki N, 2004, J BONE JOINT SURG AM, V86A, P2399, DOI 10.2106/00004623-200411000-00006; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Wachovia Capital Markets, 2007, EQ RES BON GROWTH ST; Ware J. E., 1997, SF 36 PHYS MENTAL HL; Wilmshurst P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2822	32	54	56	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 25	2016	355								i5351	10.1136/bmj.i5351	http://dx.doi.org/10.1136/bmj.i5351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LA	27797787	hybrid, Green Published			2022-12-28	WOS:000386660700001
J	Smith, JA; Woodcock, A				Smith, Jaclyn A.; Woodcock, Ashley			Chronic Cough	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; REFRACTORY CHRONIC COUGH; LARYNGOPHARYNGEAL REFLUX; CLINICAL-FEATURES; CHEST GUIDELINE; BILE-ACIDS; MANAGEMENT; DIAGNOSIS; THERAPY; MANIFESTATION	A 63-year-old woman presents with a 1-year history of a chronic dry cough, associated with a sensation of "irritation" in the throat. Prolonged bouts of coughing are associated with stress urinary incontinence and occasionally end with retching and vomiting. The cough is triggered by changes in temperature, strong smells (e.g., the smell of cleaning products), laughing, and prolonged talking. She has no notable medical history, reports being otherwise well, and does not smoke. She has been prescribed a bronchodilator and inhaled and nasal glucocorticoids, but has had no benefit from any of these. The results of a physical examination, chest radiography, and spirometry are normal. How would you further evaluate and manage this condition?	[Smith, Jaclyn A.; Woodcock, Ashley] Univ Manchester, Univ Hosp South Manchester, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust	Woodcock, A (corresponding author), Univ Manchester, North West Lung Res Ctr, Southmoor Rd, Manchester M23 9LT, Lancs, England.	ashley.woodcock@manchester.ac.uk		Woodcock, Ashley/0000-0002-5428-8578	GlaxoSmithKline; Almirall; Reckitt Benckiser; Glenmark; Xention; Patara Pharma; Boehringer Ingelheim; Vernalis; Afferent; Verona Pharma; Marie-Curie; MRC/Almirall; MRC/AstraZeneca; Nerre Therapeutics; Chiesi; Medical Research Council [MR/K015141/1, G0701918] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10249, NF-SI-0513-10040] Funding Source: researchfish; MRC [MR/K015141/1, G0701918] Funding Source: UKRI	GlaxoSmithKline(GlaxoSmithKline); Almirall(Almirall); Reckitt Benckiser; Glenmark; Xention; Patara Pharma(Dexcel Pharma); Boehringer Ingelheim(Boehringer Ingelheim); Vernalis; Afferent; Verona Pharma; Marie-Curie(European Commission); MRC/Almirall(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC/AstraZeneca(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nerre Therapeutics; Chiesi(Chiesi Pharmaceuticals Inc); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Dr. Smith reports receiving fees for serving on advisory boards from GlaxoSmithKline, Almirall, Reckitt Benckiser, Glenmark, Xention, Patara Pharma, Boehringer Ingelheim, and Vernalis, consulting fees from GlaxoSmithKline, Almirall, and Xention, and grant support from Afferent, Verona Pharma, Marie-Curie, MRC/Almirall, MRC/AstraZeneca, GlaxoSmithKline, Xention, and Nerre Therapeutics; and Dr. Woodcock, serving as chair of a trial steering committee for Afferent Pharmaceuticals and receiving fees for serving on an advisory board from Chiesi and lecture fees and travel support from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Abdulqawi R, 2015, LANCET, V385, P1198, DOI 10.1016/S0140-6736(14)61255-1; Badri H, 2015, AM THOR SOC 2015 INT; Birring SS, 2004, EUR RESPIR J, V23, P199, DOI 10.1183/09031936.03.00066403; Bonvini SJ, 2015, N-S ARCH PHARMACOL, V388, P401, DOI 10.1007/s00210-014-1082-1; Branski RC, 2002, LARYNGOSCOPE, V112, P1019, DOI 10.1097/00005537-200206000-00016; Brightling CE, 2000, ANN MED, V32, P446, DOI 10.3109/07853890009002019; Canning BJ, 2014, CHEST, V146, P1633, DOI 10.1378/chest.14-1481; Chang AB, 2011, COCHRANE DB SYST REV, V1; Chatkin JM, 1999, AM J RESP CRIT CARE, V159, P1810, DOI 10.1164/ajrccm.159.6.9809047; Chung KF, 2008, LANCET, V371, P1364, DOI 10.1016/S0140-6736(08)60595-4; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; Decalmer S, 2007, EUR RESPIR J, V30, P1138, DOI 10.1183/09031936.00034807; Decalmer S, 2012, CHEST, V142, P958, DOI 10.1378/chest.12-0044; Eren E, 2014, EUR ARCH OTO-RHINO-L, V271, P743, DOI 10.1007/s00405-013-2682-y; Everett Caroline F, 2007, Cough, V3, P5, DOI 10.1186/1745-9974-3-5; FELDMAN JI, 1993, ARCH OTOLARYNGOL, V119, P1042; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; French CL, 1998, ARCH INTERN MED, V158, P1657, DOI 10.1001/archinte.158.15.1657; Gibson PG, 2010, MED J AUSTRALIA, V192, P265, DOI 10.5694/j.1326-5377.2010.tb03504.x; Grabowski M, 2011, RESP MED, V105, P1257, DOI 10.1016/j.rmed.2011.04.015; Haque RA, 2005, CHEST, V127, P1710, DOI 10.1378/chest.127.5.1710; Harle A, 2015, 2015 PALL CAR ONC S; Hilton E, 2015, RESP MED, V109, P701, DOI 10.1016/j.rmed.2015.03.011; Hilton ECY, 2013, J ALLERGY CLIN IMMUN, V132, P847, DOI 10.1016/j.jaci.2013.04.042; Irwin RS, 2006, CHEST, V130, P362, DOI 10.1378/chest.130.2.362; Irwin RS, 2014, CHEST, V146, P885, DOI 10.1378/chest.14-1485; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; Irwin RS, 2006, CHEST, V129, p80S, DOI 10.1378/chest.129.1_suppl.80S; Irwin RS, 2006, CHEST, V129, P1, DOI 10.1378/chest.129.1.1; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; Jeyakumar A, 2006, LARYNGOSCOPE, V116, P2108, DOI 10.1097/01.mlg.0000244377.60334.e3; Kahrilas PJ, 2014, LUNG, V192, P39, DOI 10.1007/s00408-013-9528-7; Kahrilas PJ, 2013, CHEST, V143, P605, DOI 10.1378/chest.12-1788; Kelsall A, 2009, THORAX, V64, P393, DOI 10.1136/thx.2008.106237; McGarvey L, 2009, PULM PHARMACOL THER, V22, P59, DOI 10.1016/j.pupt.2008.11.003; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; Morice AH, 2004, EUR RESPIR J, V24, P481, DOI 10.1183/09031936.04.00027804; MORICE AH, 1994, THORAX, V49, P1024, DOI 10.1136/thx.49.10.1024; Morice AH, 2007, AM J RESP CRIT CARE, V175, P312, DOI 10.1164/rccm.200607-892OC; Morice AH, 2014, EUR RESPIR J, V44, P1149, DOI 10.1183/09031936.00217813; Oduwole O, 2014, COCHRANE DB SYST REV, V12; Pauwels A, 2012, CHEST, V141, P1568, DOI 10.1378/chest.11-1573; RAVID D, 1994, J CLIN PHARMACOL, V34, P1116, DOI 10.1002/j.1552-4604.1994.tb01989.x; Ryan NM, 2012, LANCET, V380, P1583, DOI 10.1016/S0140-6736(12)60776-4; Schappert Susan M, 2006, Vital Health Stat 13, P1; Sifrim D, 2005, GUT, V54, P449, DOI 10.1136/gut.2004.055418; Smith JA, 2010, GASTROENTEROLOGY, V139, P754, DOI 10.1053/j.gastro.2010.06.050; Smith SM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub5; Sunger K, 2013, EUR RESPIR J, V41, P277, DOI 10.1183/09031936.00190111; Vertigan AE, 2006, THORAX, V61, P1065, DOI 10.1136/thx.2006.064337; Vertigan AE, 2016, CHEST, V149, P639, DOI 10.1378/chest.15-1271; Wang Tsai-Yu, 2013, Cough, V9, P24, DOI 10.1186/1745-9974-9-24; Yousaf N, 2013, RESP MED, V107, P408, DOI 10.1016/j.rmed.2012.11.018	53	50	52	1	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1544	1551		10.1056/NEJMcp1414215	http://dx.doi.org/10.1056/NEJMcp1414215			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3HF	27797316	Green Submitted			2022-12-28	WOS:000393102500007
J	Califf, RM; Sherman, RE; Slavitt, A				Califf, Robert M.; Sherman, Rachel E.; Slavitt, Andrew			Knowing When and How to Use Medical Products A Shared Responsibility for the FDA and CMS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Califf, Robert M.; Sherman, Rachel E.] US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA; [Slavitt, Andrew] Ctr Medicare & Medicaid Serv, Baltimore, MD USA	US Food & Drug Administration (FDA); Centers for Medicare & Medicaid Services	Califf, RM (corresponding author), US FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA.	robert.califf@fda.hhs.gov						Centers for Medicare and Medicaid Services, 2014, GUID PUBL IND CMS ST; Eichler HG, 2016, NEW ENGL J MED, V374, P1807, DOI 10.1056/NEJMp1601294; Greene JA, 2012, NEW ENGL J MED, V367, P1481, DOI 10.1056/NEJMp1210007; National Research Council of the National Academies, 2011, PREC MED BUILD KNOWL	4	4	4	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2485	2486		10.1001/jama.2016.16734	http://dx.doi.org/10.1001/jama.2016.16734			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27820637				2022-12-28	WOS:000390959300012
J	Abbasi, J				Abbasi, Jennifer			As Opioid Epidemic Rages, Complementary Health Approaches to Pain Gain Traction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	12	12	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2343	2344		10.1001/jama.2016.15029	http://dx.doi.org/10.1001/jama.2016.15029			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE8OE	27806160				2022-12-28	WOS:000389884600002
J	Pauken, KE; Sammons, MA; Odorizzi, PM; Manne, S; Godec, J; Khan, O; Drake, AM; Chen, ZY; Sen, DR; Kurachi, M; Barnitz, RA; Bartman, C; Bengsch, B; Huang, AC; Schenkel, JM; Vahedi, G; Haining, WN; Berger, SL; Wherry, EJ				Pauken, Kristen E.; Sammons, Morgan A.; Odorizzi, Pamela M.; Manne, Sasikanth; Godec, Jernej; Khan, Omar; Drake, Adam M.; Chen, Zeyu; Sen, Debattama R.; Kurachi, Makoto; Barnitz, R. Anthony; Bartman, Caroline; Bengsch, Bertram; Huang, Alexander C.; Schenkel, Jason M.; Vahedi, Golnaz; Haining, W. Nicholas; Berger, Shelley L.; Wherry, E. John			Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade	SCIENCE			English	Article							CHRONIC VIRAL-INFECTION; INHIBITORY RECEPTOR PD-1; CHECKPOINT BLOCKADE; ANTIGEN; MEMORY; EXPRESSION; THERAPY; CANCER; RESPONSES; CHROMATIN	Blocking Programmed Death-1 (PD-1) can reinvigorate exhausted CD8 Tcells (TEX) andimprove control of chronic infections and cancer. However, whether blocking PD-1 can reprogram TEX into durable memory Tcells (TMEM) is unclear. We found that reinvigoration of TEX in mice by PD-L1 blockade caused minimal memory development. After blockade, reinvigorated TEX became reexhausted if antigen concentration remained high and failed to become TMEM upon antigen clearance. TEX acquired an epigenetic profile distinct from that of effector Tcells (TEFF) and TMEM cells that was minimally remodeled after PD-L1 blockade. This finding suggests that TEX are a distinct lineage of CD8 Tcells. Nevertheless, PD-1 pathway blockade resulted in transcriptional rewiring and reengagement of effector circuitry in the TEX epigenetic landscape. These data indicate that epigenetic fate inflexibility may limit current immunotherapies.	[Pauken, Kristen E.; Odorizzi, Pamela M.; Manne, Sasikanth; Khan, Omar; Chen, Zeyu; Kurachi, Makoto; Bartman, Caroline; Bengsch, Bertram; Wherry, E. John] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pauken, Kristen E.; Odorizzi, Pamela M.; Manne, Sasikanth; Khan, Omar; Chen, Zeyu; Kurachi, Makoto; Bartman, Caroline; Bengsch, Bertram; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sammons, Morgan A.; Drake, Adam M.; Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Sammons, Morgan A.; Drake, Adam M.; Vahedi, Golnaz; Berger, Shelley L.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Sammons, Morgan A.; Drake, Adam M.; Berger, Shelley L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Sammons, Morgan A.; Drake, Adam M.; Berger, Shelley L.] Univ Penn, Penn Epigenet Program, Philadelphia, PA 19104 USA; [Godec, Jernej; Barnitz, R. Anthony; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Godec, Jernej] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA USA; [Huang, Alexander C.] Univ Penn, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Huang, Alexander C.] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Schenkel, Jason M.] Univ Minnesota, Dept Microbiol & Immunol, Minneapolis, MN USA; [Vahedi, Golnaz] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA USA; [Haining, W. Nicholas] Harvard Med Sch, Childrens Hosp, Div Hematol Oncol, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Wherry, EJ (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@mail.med.upenn.edu	Sen, Debattama/AAC-5679-2020; Wherry, John/ABI-1280-2020; Pauken, Kristen E./ABA-9363-2020; Bengsch, Bertram/ABF-2142-2020; Chen, Zeyu/HGE-0239-2022; Schenkel, Jason/AAV-8184-2020	Sen, Debattama/0000-0002-0947-8284; Bengsch, Bertram/0000-0003-2552-740X; Schenkel, Jason/0000-0003-4641-6872; Berger, Shelley/0000-0001-5398-4400; Bartman, Caroline/0000-0002-2147-6003; Khan, Omar/0000-0002-7641-6163	Robertson Foundation-Cancer Research Institute Irvington Fellowship; American Cancer Society; National Institutes of Health [F30DK100159, T32 2T32CA009615-26, CA78831, AI105343, AI112521, AI082630, AI115712, AI117950, AI108545]; German Research Foundation [BE5496/1-1]; Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE [R01CA078831, T32CA009615, P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071309, R01AI115712, U19AI117950, P01AI112521, U19AI082630, P01AI108545, R01AI105343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK100159] Funding Source: NIH RePORTER	Robertson Foundation-Cancer Research Institute Irvington Fellowship; American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Parker Institute for Cancer Immunotherapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Wherry lab for discussions and critically reading the manuscript. We thank C. Surh for providing the antibody against IL-7 (anti-IL-7). The anti-IL-7 antibody is available from La Jolla Institute of Allergy and Immunology, and the IL-7 used is available from the National Cancer Institute, both under material transfer agreements with the University of Pennsylvania. The data presented in this manuscript are tabulated in the main paper and in the supplementary materials. Sequencing data are available at Gene Expression Omnibus [accession numbers GSE86796 (microarray), GSE86881 (RNA seq), and GSE86797 (ATAC seq)]. This study was supported by a Robertson Foundation-Cancer Research Institute Irvington Fellowship (K.E.P.), an American Cancer Society Postdoctoral Fellowship (M.A.S.), National Institutes of Health grant F30DK100159 (J.M.S.), German Research Foundation Fellowship BE5496/1-1 (B.B.), and National Institutes of Health grant T32 2T32CA009615-26 (A.C.H.). This work was funded by the National Institutes of Health (grant CA78831 to S.L.B. and grants AI105343, AI112521, AI082630, AI115712, AI117950, and AI108545 to E.J.W.). This research was also supported by the Parker Institute for Cancer Immunotherapy. E.J.W. has a patent licensing agreement on the PD-1 pathway. The authors declare no additional conflicts of interest.	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; Nanjappa SG, 2011, BLOOD, V117, P5123, DOI 10.1182/blood-2010-12-323154; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Ward-Kavanagh LK, 2016, IMMUNITY, V44, P1005, DOI 10.1016/j.immuni.2016.04.019; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200; Youngblood B, 2011, IMMUNITY, V35, P400, DOI 10.1016/j.immuni.2011.06.015; Zhang FQ, 2014, MOL THER, V22, P1698, DOI 10.1038/mt.2014.91	30	655	677	8	107	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1160	1165		10.1126/science.aaf2807	http://dx.doi.org/10.1126/science.aaf2807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27789795	Green Accepted, Bronze			2022-12-28	WOS:000388916400045
J	Finn, AV; Virmani, R				Finn, Aloke V.; Virmani, Renu			Biodegradable polymer drug-eluting stents: non-inferiority waiting for superiority?	LANCET			English	Editorial Material							BARE-METAL; PATHOLOGY		[Finn, Aloke V.; Virmani, Renu] CVPath Inst Inc, 19 Firstfield Rd, Gaithersburg, MD 20878 USA; [Finn, Aloke V.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	CVPath Institute; University System of Maryland; University of Maryland Baltimore	Virmani, R (corresponding author), CVPath Inst Inc, 19 Firstfield Rd, Gaithersburg, MD 20878 USA.	rvirmani@cvpath.org						Bangalore S, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6625; Finn AV, 2007, ARTERIOSCL THROM VAS, V27, P1500, DOI 10.1161/ATVBAHA.107.144220; Habib A, 2013, ARTERIOSCL THROM VAS, V33, P2425, DOI 10.1161/ATVBAHA.113.301659; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Kok MM, 2016, LANCET; Nakazawa G, 2011, J AM COLL CARDIOL, V57, P1314, DOI 10.1016/j.jacc.2011.01.011; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Taniwaki M, 2016, CIRCULATION, V133, P650, DOI 10.1161/CIRCULATIONAHA.115.019071	10	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2567	2568		10.1016/S0140-6736(16)32063-3	http://dx.doi.org/10.1016/S0140-6736(16)32063-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27806901				2022-12-28	WOS:000388516800005
J	Jung, JH; Domijan, M; Klose, C; Biswas, S; Ezer, D; Gao, MJ; Khattak, AK; Box, MS; Charoensawan, V; Cortijo, S; Kumar, M; Grant, A; Locke, JCW; Schafer, E; Jaeger, KE; Wigge, PA				Jung, Jae-Hoon; Domijan, Mirela; Klose, Cornelia; Biswas, Surojit; Ezer, Daphne; Gao, Mingjun; Khattak, Asif Khan; Box, Mathew S.; Charoensawan, Varodom; Cortijo, Sandra; Kumar, Manoj; Grant, Alastair; Locke, James C. W.; Schaefer, Eberhard; Jaeger, Katja E.; Wigge, Philip A.			Phytochromes function as thermosensors in Arabidopsis	SCIENCE			English	Article							TRANSCRIPTION FACTOR PIF4; LIGHT; GROWTH; REQUIRE; PLANTS; GENES	Plants are responsive to temperature, and some species can distinguish differences of 1 degrees C. In Arabidopsis, warmer temperature accelerates flowering and increases elongation growth (thermomorphogenesis). However, themechanisms of temperature perception are largely unknown. We describe amajor thermosensory role for the phytochromes (red light receptors) during the night. Phytochrome null plants display a constitutive warm-temperature response, and consistent with this, we show in this background that the warm-temperature transcriptome becomes derepressed at low temperatures. We found that phytochrome B (phyB) directly associateswith the promoters of key target genes in a temperature-dependent manner. The rate of phyB inactivation is proportional to temperature in the dark, enabling phytochromes to function as thermal timers that integrate temperature information over the course of the night.	[Jung, Jae-Hoon; Domijan, Mirela; Biswas, Surojit; Ezer, Daphne; Gao, Mingjun; Box, Mathew S.; Charoensawan, Varodom; Cortijo, Sandra; Kumar, Manoj; Locke, James C. W.; Jaeger, Katja E.; Wigge, Philip A.] Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England; [Klose, Cornelia; Schaefer, Eberhard] Univ Freiburg, Inst Biol 2, D-79104 Freiburg, Germany; [Khattak, Asif Khan; Grant, Alastair] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Locke, James C. W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Schaefer, Eberhard] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Wigge, Philip A.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Biswas, Surojit] Harvard Med Sch, Div Med Sci, Boston, MA USA; [Khattak, Asif Khan] Univ Peshawar, Dept Environm Sci, Peshawar 25120, Pakistan; [Charoensawan, Varodom] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok 10400, Thailand; [Wigge, Philip A.] Mahidol Univ, Integrat Computat BioSci Ctr, Bangkok 10400, Thailand	University of Cambridge; University of Freiburg; University of East Anglia; University of Cambridge; University of Freiburg; University of Cambridge; Harvard University; Harvard Medical School; University of Peshawar; Mahidol University; Mahidol University	Wigge, PA (corresponding author), Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England.; Wigge, PA (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	philip.wigge@slcu.cam.ac.uk	Klose, Cornelia/AAT-5969-2020; Wigge, Philip Anthony/ABD-5113-2021; Grant, Alastair/L-7301-2018; Kumar, Manoj/E-2750-2018	Wigge, Philip Anthony/0000-0003-4822-361X; Grant, Alastair/0000-0002-1147-2375; Kumar, Manoj/0000-0001-7689-9073; Klose, Cornelia/0000-0003-0032-6556; Locke, James/0000-0003-0670-1943; Khattak, Asif/0000-0002-4457-612X; Gao, Mingjun/0000-0002-2616-915X; Ezer, Daphne/0000-0002-1685-6909; Charoensawan, Varodom/0000-0002-2199-4126; Cortijo, Sandra/0000-0003-3291-6729	Winston Churchill Foundation of the United States; Gatsby Foundation [GAT3272/GLC, GAT3273/GLB]; Biotechnology and Biological Sciences Research Council [BB/I013350/1, BB/N010248/1]; European Research Council grant EC FP7 ERC [243140]; Deutsche Forschungsgemeinschaft [SCHA 303/16-1]; BBSRC [BB/K017152/1, BB/I013350/1, BB/N010248/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K017152/1, BBS/E/J/00000610] Funding Source: researchfish	Winston Churchill Foundation of the United States; Gatsby Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council grant EC FP7 ERC; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank C. Dean for insightful discussions. We dedicate this study to J. Chory. The data reported in this paper are deposited in the NCBI Sequence Read Archive (accession number SUB1572336) and are also in the supplementary materials. Supported by a Churchill Scholarship from the Winston Churchill Foundation of the United States (S.B.); Gatsby Foundation fellowship GAT3272/GLC (J.C.W.L.); Biotechnology and Biological Sciences Research Council responsive mode grants BB/I013350/1 and BB/N010248/1, European Research Council grant EC FP7 ERC 243140, and Gatsby Foundation fellowship GAT3273/GLB (P.A.W.); and Deutsche Forschungsgemeinschaft grant SCHA 303/16-1 (C.K., via E.S.).	Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; BORTHWICK HA, 1952, P NATL ACAD SCI USA, V38, P662, DOI 10.1073/pnas.38.8.662; Box MS, 2015, CURR BIOL, V25, P194, DOI 10.1016/j.cub.2014.10.076; BUTLER WL, 1963, PLANT PHYSIOL, V38, P514, DOI 10.1104/pp.38.5.514; Chen F, 2014, PLANT CELL, V26, P1949, DOI 10.1105/tpc.114.123950; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Filiault DL, 2008, P NATL ACAD SCI USA, V105, P3157, DOI 10.1073/pnas.0712174105; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Hennig L, 2001, J BIOL CHEM, V276, P7913, DOI 10.1074/jbc.M009793200; Hornitschek P, 2012, PLANT J, V71, P699, DOI 10.1111/j.1365-313X.2012.05033.x; Hu W, 2013, P NATL ACAD SCI USA, V110, P1542, DOI 10.1073/pnas.1221738110; Hu W, 2009, MOL PLANT, V2, P166, DOI 10.1093/mp/ssn086; Jaeger KE, 2013, PLANT CELL, V25, P820, DOI 10.1105/tpc.113.109355; Klose C, 2015, NAT PLANTS, V1, P1, DOI [10.1038/nplants.2015.90, 10.1038/NPLANTS.2015.90]; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Medzihradszky M, 2013, PLANT CELL, V25, P535, DOI 10.1105/tpc.112.106898; Mizuno T, 2014, PLANT CELL PHYSIOL, V55, P958, DOI 10.1093/pcp/pcu030; Pfeiffer A, 2014, MOL PLANT, V7, P1598, DOI 10.1093/mp/ssu087; Raschke A, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0566-6; Skene PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.09225; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Sweere U, 2001, SCIENCE, V294, P1108, DOI 10.1126/science.1065022; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Yamashino T, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23390; Zhang Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003244	30	456	483	25	310	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 18	2016	354	6314					886	889		10.1126/science.aaf6005	http://dx.doi.org/10.1126/science.aaf6005			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0KR	27789797	Green Accepted			2022-12-28	WOS:000388531900040
J	Jackson, A				Jackson, Andrew			SPINAL-CORD INJURY Neural interfaces take another step forward	NATURE			English	Editorial Material							CORTICAL CONTROL; PARALYSIS; STIMULATION; TETRAPLEGIA; DEVICES; GRASP; BRAIN; ARM		[Jackson, Andrew] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Jackson, A (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	andrew.jackson@ncl.ac.uk						Angeli CA, 2014, BRAIN, V137, P1394, DOI 10.1093/brain/awu038; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Craggs M D, 1975, Adv Neurol, V10, P91; Cyranoski D, 2016, NATURE, V532, P300, DOI 10.1038/nature.2016.20817; Ethier C, 2012, NATURE, V485, P368, DOI 10.1038/nature10987; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Jackson A, 2012, NAT REV NEUROL, V8, P690, DOI 10.1038/nrneurol.2012.219; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Zimmermann JB, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00087	12	11	14	3	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					177	+		10.1038/539177a	http://dx.doi.org/10.1038/539177a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830789				2022-12-28	WOS:000387318500026
J	Hori, M; Aghai-Khozani, H; Soter, A; Barna, D; Dax, A; Hayano, R; Kobayashi, T; Murakami, Y; Todoroki, K; Yamada, H; Horvath, D; Venturelli, L				Hori, Masaki; Aghai-Khozani, Hossein; Soter, Anna; Barna, Daniel; Dax, Andreas; Hayano, Ryugo; Kobayashi, Takumi; Murakami, Yohei; Todoroki, Koichi; Yamada, Hiroyuki; Horvath, Dezso; Venturelli, Luca			Buffer-gas cooling of antiprotonic helium to 1.5 to 1.7 K, and antiproton-to-electron mass ratio	SCIENCE			English	Article							LASER SPECTROSCOPY; ATOMIC MASS; ANTIHYDROGEN; HYDROGEN; PROTON; TRANSITIONS; CONSTANTS; FORCES; CHARGE; CPT	Charge, parity, and time reversal (CPT) symmetry implies that a particle and its antiparticle have the same mass. The antiproton-to-electron mass ratio M-(p) over bar/m(e) can be precisely determined from the single-photon transition frequencies of antiprotonic helium. We measured 13 such frequencies with laser spectroscopy to a fractional precision of 2.5 x 10(-9) to 16 x 10(-9). About 2 x 10(9) antiprotonic helium atoms were cooled to temperatures between 1.5 and 1.7 kelvin by using buffer-gas cooling in cryogenic low-pressure helium gas; the narrow thermal distribution led to the observation of sharp spectral lines of small thermal Doppler width. The deviation between the experimental frequencies and the results of three-body quantum electrodynamics calculations was reduced by a factor of 1.4 to 10 compared with previous single-photon experiments. From this, M-(p) over bar/m(e) was determined as 1836.1526734(15), which agrees with a recent proton-to-electron experimental value within 8 x 10(-10).	[Hori, Masaki; Aghai-Khozani, Hossein; Soter, Anna] Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany; [Barna, Daniel; Horvath, Dezso] MTA Wigner Res Ctr Phys, H-1525 Budapest, Hungary; [Dax, Andreas; Hayano, Ryugo; Kobayashi, Takumi; Murakami, Yohei; Todoroki, Koichi; Yamada, Hiroyuki] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Horvath, Dezso] Inst Nucl Res ATOMKI, H-4001 Debrecen, Hungary; [Venturelli, Luca] Univ Brescia, Ist Nazl Fis Nucl, Dipartimento Ingn Informaz, I-25133 Brescia, Italy; [Dax, Andreas] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Kobayashi, Takumi] Natl Inst Adv Ind Sci & Technol, NMIJ, Tsukuba, Ibaraki 3058563, Japan; [Todoroki, Koichi] NEC Corp Ltd, Minato Ku, Tokyo, Japan	Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; University of Tokyo; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; Istituto Nazionale di Fisica Nucleare (INFN); University of Brescia; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; National Institute of Advanced Industrial Science & Technology (AIST); National Metrology Institute of Japan; NEC Corporation	Hori, M (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	masaki.hori@mpq.mpg.de	Hori, Masaki/AAV-3409-2021; Soter, Anna/B-6794-2014; Kobayashi, Takumi/M-4321-2018; Hayano, Ryugo/F-7889-2012; Hori, Masaki/D-8231-2011	Hori, Masaki/0000-0002-4999-3141; Soter, Anna/0000-0002-3751-9944; Kobayashi, Takumi/0000-0002-4932-3607; Hayano, Ryugo/0000-0002-1214-7806; Hori, Masaki/0000-0002-4999-3141	Max-Planck-Gesellschaft; European Research Council (ERC-Stg); Monbukagakusho; Hungarian Research Foundation	Max-Planck-Gesellschaft(Max Planck Society); European Research Council (ERC-Stg)(European Research Council (ERC)); Monbukagakusho(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hungarian Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	We are deeply indebted to the CERN Antiproton Decelerator and Proton Synchrotron operational staff, the CERN cryogenics laboratory, the Atomic Spectroscopy And Collisions Using Slow Antiprotons (ASACUSA) collaboration, D. Bakalov, L. Dufay-Chanat, T. W. Hansch, T. Koetting, V. I. Korobov, J. Mouleyre, W. Pirkl, and O. Pirotte. This work was supported by the Max-Planck-Gesellschaft, the European Research Council (ERC-Stg), Monbukagakusho, and the Hungarian Research Foundation.	Ahmadi M, 2016, NATURE, V529, P373, DOI 10.1038/nature16491; Amole C, 2012, NATURE, V483, P439, DOI 10.1038/nature10942; Badertscher A, 1997, PHYS LETT B, V392, P278, DOI 10.1016/S0370-2693(96)01545-6; Bakalov D, 2000, PHYS REV LETT, V84, P2350, DOI 10.1103/PhysRevLett.84.2350; Beier T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.011603; Biesheuvel J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10385; Bluhm R, 1999, PHYS REV LETT, V82, P2254, DOI 10.1103/PhysRevLett.82.2254; Cassidy DB, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.012715; Doret SC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.103005; FARNHAM DL, 1995, PHYS REV LETT, V75, P3598, DOI 10.1103/PhysRevLett.75.3598; Gabrielse G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.113002; Gabrielse G, 1999, PHYS REV LETT, V82, P3198, DOI 10.1103/PhysRevLett.82.3198; HARDY WN, 1979, PHYS REV LETT, V42, P1042, DOI 10.1103/PhysRevLett.42.1042; Hayano RS, 2007, REP PROG PHYS, V70, P1995, DOI 10.1088/0034-4885/70/12/R01; Hori M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.243401; Hori M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.093401; Hori M, 2011, NATURE, V475, P484, DOI 10.1038/nature10260; Hori M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.062508; Hori M, 2009, OPT LETT, V34, P1273, DOI 10.1364/OL.34.001273; HUGHES RJ, 1992, PHYS REV LETT, V69, P578, DOI 10.1103/PhysRevLett.69.578; Korobov VI, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.022509; Korobov VI, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.052517; Korobov VI, 2015, HYPERFINE INTERACT, V233, P75, DOI 10.1007/s10751-015-1149-5; Korobov VI, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.014501; Korobov VI, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.032511; Korobov VI, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.103003; Mariazzi S, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.243401; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Murata J, 2015, CLASSICAL QUANT GRAV, V32, DOI 10.1088/0264-9381/32/3/033001; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Salumbides EJ, 2014, J MOL SPECTROSC, V300, P65, DOI 10.1016/j.jms.2014.04.003; Sturm S, 2014, NATURE, V506, P467, DOI 10.1038/nature13026; Thompson JK, 2004, NATURE, V430, P58, DOI 10.1038/nature02682; Ulmer S, 2015, NATURE, V524, P196, DOI 10.1038/nature14861; Verdu J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.093002	36	61	61	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					610	614		10.1126/science.aaf6702	http://dx.doi.org/10.1126/science.aaf6702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811273				2022-12-28	WOS:000386869800047
J	Servick, K				Servick, Kelly			PRIMED FOR PAIN	SCIENCE			English	Editorial Material																			0	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					569	571		10.1126/science.354.6312.569	http://dx.doi.org/10.1126/science.354.6312.569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811266				2022-12-28	WOS:000386869800035
J	Li, PP; Liu, SN; Lu, M; Bandyopadhyay, G; Oh, D; Imamura, T; Johnson, AMF; Sears, D; Shen, ZF; Cui, B; Kong, LJ; Hou, SC; Liang, X; Iovino, S; Watkins, SM; Ying, W; Osborn, O; Wollam, J; Brenner, M; Olefsky, JM				Li, Pingping; Liu, Shuainan; Lu, Min; Bandyopadhyay, Gautum; Oh, Dayoung; Imamura, Takeshi; Johnson, Andrew M. F.; Sears, Dorothy; Shen, Zhufang; Cui, Bing; Kong, Lijuan; Hou, Shaocong; Liang, Xiao; Iovino, Saivatore; Watkins, Steven M.; Ying, Wei; Osborn, Olivia; Wollam, Joshua; Brenner, Martin; Olefsky, Jerrold M.			Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance	CELL			English	Article							GALACTOSIDE-BINDING PROTEIN; DIET-INDUCED OBESITY; FATTY LIVER-DISEASE; ADIPOSE-TISSUE; CHRONIC INFLAMMATION; GLUT4 TRANSLOCATION; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; TNF-ALPHA; RECEPTOR	In obesity, macrophages and other immune cells accumulate in insulin target tissues, promoting a chronic inflammatory state and insulin resistance. Galectin-3 (Gal3), a lectin mainly secreted by macrophages, is elevated in both obese subjects and mice. Administration of Gal3 to mice causes insulin resistance and glucose intolerance, whereas inhibition of Gal3, through either genetic or pharmacologic loss of function, improved insulin sensitivity in obese mice. In vitro treatment with Gal3 directly enhanced macrophage chemotaxis, reduced insulin-stimulated glucose uptake in myocytes and 3T3-L1 adipocytes and impaired insulin-mediated suppression of glucose output in primary mouse hepatocytes. Importantly, we found that Gal3 can bind directly to the insulin receptor (IR) and inhibit downstream IR signaling. These observations elucidate a novel role for Gal3 in hepatocyte, adipocyte, and myocyte insulin resistance, suggesting that Gal3 can link inflammation to decreased insulin sensitivity. Inhibition of Gal3 could be a new approach to treat insulin resistance.	[Li, Pingping; Liu, Shuainan; Shen, Zhufang; Cui, Bing; Kong, Lijuan; Hou, Shaocong; Liang, Xiao] Chinese Acad Med Sci, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing 100050, Peoples R China; [Li, Pingping; Liu, Shuainan; Shen, Zhufang; Cui, Bing; Kong, Lijuan; Hou, Shaocong; Liang, Xiao] Peking Union Med Coll, Beijing 100050, Peoples R China; [Li, Pingping; Liu, Shuainan; Shen, Zhufang; Cui, Bing; Kong, Lijuan; Hou, Shaocong; Liang, Xiao] Chinese Acad Med Sci, Diabet Res Ctr, Beijing 100050, Peoples R China; [Li, Pingping; Lu, Min; Bandyopadhyay, Gautum; Oh, Dayoung; Johnson, Andrew M. F.; Sears, Dorothy; Ying, Wei; Osborn, Olivia; Wollam, Joshua; Olefsky, Jerrold M.] UC, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Lu, Min; Iovino, Saivatore; Brenner, Martin] Merck Res Labs, Diabet Early Discovery, 33 Ave Louis Pasteur, Boston, MA 02115 USA; [Imamura, Takeshi] Shiga Univ Med Sci, Pharmacol, Dept Med, 1 Tsukinowa, Otsu, Shiga 5202192, Japan; [Watkins, Steven M.] Lip Technol Inc, West Sacramento, CA 95691 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Merck & Company; Shiga University of Medical Science	Li, PP (corresponding author), Chinese Acad Med Sci, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing 100050, Peoples R China.; Li, PP (corresponding author), Peking Union Med Coll, Beijing 100050, Peoples R China.; Li, PP (corresponding author), Chinese Acad Med Sci, Diabet Res Ctr, Beijing 100050, Peoples R China.; Li, PP; Olefsky, JM (corresponding author), UC, Div Endocrinol & Metab, 9500 Gilman Dr, La Jolla, CA 92093 USA.	lipp@imm.ac.cn; jolefsky@ucsd.edu	Cui, Bing/F-3599-2018; Ying, Wei/N-5157-2016; Li, Pingping/F-1109-2019; osborn, olivia/R-1460-2018; Sears, Dorothy D/AHE-5524-2022	Cui, Bing/0000-0001-8374-7801; Li, Pingping/0000-0003-0679-270X; osborn, olivia/0000-0003-0516-7937; Sears, Dorothy D/0000-0002-9260-3540; hou, shaocong/0000-0003-0442-8138	Merck;  [DK033651];  [DK074868];  [DK-063491];  [DK-09062]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK033651, P30DK063491, R24DK090962, P01DK054441, F32DK009062, P01DK074868, R01DK033651] Funding Source: NIH RePORTER	Merck(Merck & Company); ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Fu Tong Liu from University of California, Davis for providing the Gal3 KO mice. We also thank Michael Meehl, Dmitri Pissarnitski, Payal Sheth, and Amanda Babbs for reagent generation, compound synthesis, and mass spectrometry support. This study was funded in part by grants to J.M.O. (DK033651, DK074868, DK-063491, DK-09062) and a grant from Merck.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Baek JH, 2015, ENDOCRINOLOGY, V156, P147, DOI 10.1210/en.2014-1374; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Birkenfeld AL, 2014, HEPATOLOGY, V59, P713, DOI 10.1002/hep.26672; Darrow AL, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0230-3; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Gao P, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-136; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huang J, 2005, J BIOL CHEM, V280, P42300, DOI 10.1074/jbc.M510920200; Imamura T, 1999, MOL CELL BIOL, V19, P6765; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Joo HG, 2001, J LEUKOCYTE BIOL, V69, P555; KOLTERMAN OG, 1981, J CLIN INVEST, V68, P957, DOI 10.1172/JCI110350; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Li LC, 2014, J PHARMACOL EXP THER, V351, P336, DOI 10.1124/jpet.114.218370; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Li PP, 2013, CELL, V155, P200, DOI 10.1016/j.cell.2013.08.054; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; LIU FT, 1995, AM J PATHOL, V147, P1016; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Lu M, 2010, MOL ENDOCRINOL, V24, P1413, DOI 10.1210/me.2009-0462; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; OLEFSKY JM, 1981, AM J MED, V70, P151, DOI 10.1016/0002-9343(81)90422-8; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pejnovic NN, 2013, DIABETES, V62, P1932, DOI 10.2337/db12-0222; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155; Salameh BA, 2010, BIOORGAN MED CHEM, V18, P5367, DOI 10.1016/j.bmc.2010.05.040; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Sano H, 2000, J IMMUNOL, V165, P2156, DOI 10.4049/jimmunol.165.4.2156; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; SATO S, 1994, J BIOL CHEM, V269, P4424; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Vollenweider P, 1997, ENDOCRINOLOGY, V138, P4941, DOI 10.1210/en.138.11.4941; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhong LL, 2016, DIABETOLOGIA, V59, P582, DOI 10.1007/s00125-015-3815-1	46	160	184	7	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					973	+		10.1016/j.cell.2016.10.025	http://dx.doi.org/10.1016/j.cell.2016.10.025			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814523	Bronze, Green Accepted			2022-12-28	WOS:000389469000015
J	Liu, JL; Ibi, D; Taniguchi, K; Lee, J; Herrema, H; Akosman, B; Mucka, P; Hernandez, MAS; Uyar, MF; Park, SW; Karin, M; Ozcan, U				Liu, Junli; Ibi, Dorina; Taniguchi, Koji; Lee, Jaemin; Herrema, Hilde; Akosman, Bedia; Mucka, Patrick; Hernandez, Mario Andres Salazar; Uyar, Muhemmet Fatih; Park, Sang Won; Karin, Michael; Ozcan, Umut			Inflammation Improves Glucose Homeostasis through IKK beta-XBP1s Interaction	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; DIET-INDUCED OBESITY; IKK-BETA; KAPPA-B; INSULIN SENSITIVITY; ER STRESS; ACTIVATION; RESISTANCE; EXPRESSION; PREVENTS	It is widely believed that inflammation associated with obesity has an important role in the development of type 2 diabetes. I kappa B kinase beta (IKK beta) is a crucial kinase that responds to inflammatory stimuli such as tumor necrosis factor a (TNF-alpha) by initiating a variety of intracellular signaling cascades and is considered to be a key element in the inflammation-mediated development of insulin resistance. We show here, contrary to expectation, that IKK beta-mediated inflammation is a positive regulator of hepatic glucose homeostasis. IKK beta phosphorylates the spliced form of X-Box Binding Protein 1 (XBP1s) and increases the activity of XBP1s. We have used three experimental approaches to enhance the IKK beta activity in the liver of obese mice and observed increased XBP1s activity, reduced ER stress, and a significant improvement in insulin sensitivity and consequently in glucose homeostasis. Our results reveal a beneficial role of IKK beta-mediated hepatic inflammation in glucose homeostasis.	[Liu, Junli; Ibi, Dorina; Lee, Jaemin; Herrema, Hilde; Akosman, Bedia; Mucka, Patrick; Hernandez, Mario Andres Salazar; Uyar, Muhemmet Fatih; Park, Sang Won; Ozcan, Umut] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02130 USA; [Taniguchi, Koji; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Taniguchi, Koji; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Liu, Junli] Shanghai Jiao Tong Univ, Shanghai Diabet Inst, Shanghai Key Lab Diabet Mellitus,Affiliated Peopl, Shanghai Clin Ctr Diabet,Dept Endocrinol & Metab, Shanghai 200233, Peoples R China	Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California San Diego; University of California System; University of California San Diego; Shanghai Jiao Tong University	Ozcan, U (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02130 USA.	umut.ozcan@childrens.harvard.edu	Salazar, Mario/GSN-2646-2022; Lee, Jaemin/AAP-4875-2021	Herrema, Hilde/0000-0002-0112-6348; Lee, Jaemin/0000-0002-0224-7141; AKOSMAN, BEDIA/0000-0001-6571-546X	American Diabetes Association's Career Development grant [7-09-CD-10]; Department of Medicine, Boston Children's Hospital; NIH grant [R01DK081009, R01DK098496, AI043477]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081009, R01DK098496] Funding Source: NIH RePORTER	American Diabetes Association's Career Development grant; Department of Medicine, Boston Children's Hospital; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Morris F. White and Rongya Tao for helping us to perform the hyperinsulinemic-euglycemic clamp experiments. This work was supported by funds provided to U.O. from Department of Medicine, Boston Children's Hospital, by NIH grants R01DK081009 and R01DK098496 to U.O., by the American Diabetes Association's Career Development grant #7-09-CD-10, and by NIH grant AI043477 to M.K. U.O. is a scientific founder, shareholder, and member of the scientific advisory board and board of directors of ERX Pharmaceuticals, Inc.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Awazawa M, 2011, CELL METAB, V13, P401, DOI 10.1016/j.cmet.2011.02.010; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Daya S, 2008, CLIN MICROBIOL REV, V21, P583, DOI 10.1128/CMR.00008-08; Deng YF, 2013, J CLIN INVEST, V123, P455, DOI 10.1172/JCI62819; Gao ZG, 2012, ACTA PHARMACOL SIN, V33, P182, DOI 10.1038/aps.2011.131; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Hu JP, 2005, NUCLEIC ACIDS RES, V33, P3271, DOI 10.1093/nar/gki636; Jiao P, 2012, ENDOCRINOLOGY, V153, P154, DOI 10.1210/en.2011-1346; Karin Michael, 2005, Proc Am Thorac Soc, V2, P386, DOI 10.1513/pats.200504-034SR; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Lancaster GI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10626; Lee J, 2014, J BIOL CHEM, V289, P1203, DOI 10.1074/jbc.R113.534743; Lee J, 2011, NAT MED, V17, P1251, DOI 10.1038/nm.2449; McGillicuddy FC, 2013, AM J PHYSIOL-ENDOC M, V305, pE834, DOI 10.1152/ajpendo.00297.2013; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; O'Dea E, 2009, WIRES SYST BIOL MED, V1, P107, DOI 10.1002/wsbm.30; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Ozcan L, 2009, CELL METAB, V9, P35, DOI 10.1016/j.cmet.2008.12.004; Park SW, 2013, SEMIN IMMUNOPATHOL, V35, P351, DOI 10.1007/s00281-013-0370-z; Park SW, 2010, NAT MED, V16, P429, DOI 10.1038/nm.2099; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rehman KK, 2008, MOL THER, V16, P1409, DOI 10.1038/mt.2008.116; Sadagurski M, 2010, DIABETOLOGIA, V53, P525, DOI 10.1007/s00125-009-1580-8; Senftleben U, 2002, CRIT CARE MED, V30, pS18, DOI 10.1097/00003246-200201001-00003; Shinohara H, 2005, J EXP MED, V202, P1423, DOI 10.1084/jem.20051591; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu Y., 2013, JAMA-J AM MED ASSOC, V310, P948, DOI DOI 10.1001/JAMA.2013.168118; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V450, P433, DOI 10.1016/j.bbrc.2014.05.134; Zhou YJ, 2011, NAT MED, V17, P356, DOI 10.1038/nm.2293	42	62	64	3	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					1052	+		10.1016/j.cell.2016.10.015	http://dx.doi.org/10.1016/j.cell.2016.10.015			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814504	Green Accepted, Bronze			2022-12-28	WOS:000389469000021
J	Simpkin, AL; Schwartzstein, RM				Simpkin, Arabella L.; Schwartzstein, Richard M.			Tolerating Uncertainty - The Next Medical Revolution?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Simpkin, Arabella L.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Schwartzstein, Richard M.] Harvard Med Sch, Boston, MA USA; [Schwartzstein, Richard M.] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Simpkin, AL (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.		Schwartzstein, Richard/L-4420-2019; Schwartzstein, Richard/AGO-8549-2022					Bean RB, 1950, W OSLER APHORISMS HI; Forman MB, 1931, LETT J KEATS; KASSIRER JP, 1989, NEW ENGL J MED, V320, P1489, DOI 10.1056/NEJM198906013202211; Logan RL, 1996, LANCET, V347, P595, DOI 10.1016/S0140-6736(96)91284-2	4	261	271	3	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1713	1715		10.1056/NEJMp1606402	http://dx.doi.org/10.1056/NEJMp1606402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB0BB	27806221	Green Published			2022-12-28	WOS:000387007300004
J	Ginsburg, S; Levinson, W				Ginsburg, Shiphra; Levinson, Wendy			Professional Boundaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ginsburg, Shiphra] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ginsburg, Shiphra] Wilson Ctr Res Educ, Toronto, ON, Canada; [Levinson, Wendy] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Levinson, W (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, 30 Bond St,LKSKI 339, Toronto, ON M5B 1W8, Canada.	wendy.levinson@utoronto.ca	Ginsburg, Shiphra R/C-1695-2008	Ginsburg, Shiphra R/0000-0002-4595-6650				Cohen D, 2014, OCCUP MED-OXFORD, V64, P126, DOI 10.1093/occmed/kqt163; Levinson W, 2014, INTEGRITY ACCOUNTABI; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; TheCollegeofPhysiciansandSurgeonsofOntario, 2016, PHYS TREATM SELF FAM	4	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1706	1707		10.1001/jama.2016.15753	http://dx.doi.org/10.1001/jama.2016.15753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784099				2022-12-28	WOS:000386107800037
J	Voelker, R				Voelker, Rebecca			Raccoon Roundworm Is on the Move	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1638	1638		10.1001/jama.2016.15081	http://dx.doi.org/10.1001/jama.2016.15081			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784104				2022-12-28	WOS:000386107800011
J	MacDonald, SM; Rapalino, O; Sherry, NA; Cohen, AB; Ebb, DH; Tarbell, NJ; Oakley, DH				MacDonald, Shannon M.; Rapalino, Otto; Sherry, Nicole A.; Cohen, Adam B.; Ebb, David H.; Tarbell, Nancy J.; Oakley, Derek H.			Case 32-2016: A 20-Year-Old Man with Gynecomastia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GERM-CELL TUMORS; CENTRAL-NERVOUS-SYSTEM; STEROID-INDUCED HYPOGONADISM; ADIPSIC DIABETES-INSIPIDUS; SYNCHRONOUS LESIONS; SUPRASELLAR REGION; DELAYED DIAGNOSIS; PINEAL; GERMINOMA; CHILDREN		[MacDonald, Shannon M.; Tarbell, Nancy J.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Rapalino, Otto] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sherry, Nicole A.] Massachusetts Gen Hosp, Dept Pediat Endocrinol, Boston, MA 02114 USA; [Cohen, Adam B.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Ebb, David H.] Massachusetts Gen Hosp, Dept Pediat Hematol Oncol, Boston, MA 02114 USA; [Oakley, Derek H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [MacDonald, Shannon M.; Tarbell, Nancy J.] Harvard Med Sch, Dept Radiat Oncol, Boston, MA 02115 USA; [Rapalino, Otto] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Sherry, Nicole A.] Harvard Med Sch, Dept Pediat Endocrincol, Boston, MA USA; [Cohen, Adam B.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Ebb, David H.] Harvard Med Sch, Dept Pediat Hematologyoncol, Boston, MA USA; [Oakley, Derek H.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	MacDonald, SM (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA.; MacDonald, SM (corresponding author), Harvard Med Sch, Dept Radiat Oncol, Boston, MA 02115 USA.		Oakley, Derek/ABA-4689-2020	Oakley, Derek/0000-0002-6998-9510; Rapalino, Otto/0000-0002-5038-4183; Cohen, Adam/0000-0002-6163-0562				Aizer AA, 2013, NEURO-ONCOLOGY, V15, P955, DOI 10.1093/neuonc/not050; ALLEN JC, 1994, CANCER, V74, P940, DOI 10.1002/1097-0142(19940801)74:3<940::AID-CNCR2820740323>3.0.CO;2-U; Balmaceda C, 1996, J CLIN ONCOL, V14, P2908, DOI 10.1200/JCO.1996.14.11.2908; Brasme JF, 2012, LANCET ONCOL, V13, pE445, DOI 10.1016/S1470-2045(12)70361-3; Braunstein GD, 1999, ENDOCR-RELAT CANCER, V6, P315, DOI 10.1677/erc.0.0060315; Calaminus G, 2013, NEURO-ONCOLOGY, V15, P788, DOI 10.1093/neuonc/not019; Children's Oncology Group, ACNS1123 CHILD ONC G; Coward RM, 2013, J UROLOGY, V190, P2200, DOI 10.1016/j.juro.2013.06.010; Crawford JR, 2007, NEUROLOGY, V68, P1668, DOI 10.1212/01.wnl.0000261908.36803.ac; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Eisenberg Y, 2016, ENDOCR PRACT, V22, P76, DOI 10.4158/EP15940.RA; FOREST MG, 1979, J CLIN ENDOCR METAB, V49, P284, DOI 10.1210/jcem-49-2-284; Guerini H, 2003, J NEURORADIOLOGY, V30, P46; Hattab EM, 2005, AM J SURG PATHOL, V29, P368, DOI 10.1097/01.pas.0000149709.19958.a7; Huang CH, 2005, AM J KIDNEY DIS, V45, P197, DOI 10.1053/j.ajkd.2004.09.033; Kamoshima Y, 2011, NEUROL MED-CHIR, V51, P689, DOI 10.2176/nmc.51.689; Karikari IO, 2007, PEDIATR NEUROSURG, V43, P516, DOI 10.1159/000108799; Lou X, 2012, EUR J RADIOL, V81, P1231, DOI 10.1016/j.ejrad.2011.02.059; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MacDonald SM, 2011, INT J RADIAT ONCOL, V79, P121, DOI 10.1016/j.ijrobp.2009.10.069; Mathur R, 1997, HORM RES, V48, P95, DOI 10.1159/000185497; Matsutani M, 2001, J NEURO-ONCOL, V54, P311, DOI 10.1023/A:1012743707883; Mukherjee A, 2014, CLIN IMAG, V38, P367, DOI 10.1016/j.clinimag.2013.12.005; Nagaishi M, 2011, NEUROPATHOLOGY, V31, P152, DOI 10.1111/j.1440-1789.2010.01143.x; Nakamura H, 2005, J NEURO-ONCOL, V75, P163, DOI 10.1007/s11060-005-1593-1; Nayil K, 2011, PEDIATR NEUROL, V44, P463, DOI 10.1016/j.pediatrneurol.2011.01.020; Non Lemuel, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-206390; Ogura T, 2004, PEDIATR NEUROSURG, V40, P301, DOI 10.1159/000083744; Parinaud H, 1883, ARCH NEUROL-CHICAGO, V5, P145; Phi JH, 2013, J NEUROSURG-PEDIATR, V11, P107, DOI 10.3171/2012.10.PEDS11487; Prayer D, 2004, AM J NEURORADIOL, V25, P880; Rahnema CD, 2014, FERTIL STERIL, V101, P1271, DOI 10.1016/j.fertnstert.2014.02.002; ROBINSON AG, 1985, CLIN ENDOCRINOL META, V14, P55, DOI 10.1016/S0300-595X(85)80065-7; Rodjan F, 2012, J NEURO-ONCOL, V109, P535, DOI 10.1007/s11060-012-0922-4; Scholten V, 2009, CAN J NEUROL SCI, V36, P783, DOI 10.1017/S0317167100008453; SCHWARTZ ID, 1991, ENDOCRIN METAB CLIN, V20, P153, DOI 10.1016/S0889-8529(18)30285-8; Sethi RV, 2013, J PEDIATR-US, V163, P1448, DOI 10.1016/j.jpeds.2013.06.024; Smith D, 2002, J CLIN ENDOCR METAB, V87, P4564, DOI 10.1210/jc.2002-020090; SUGIYAMA K, 1992, SURG NEUROL, V38, P114, DOI 10.1016/0090-3019(92)90088-5; SUNG DI, 1978, RADIOLOGY, V128, P745, DOI 10.1148/128.3.745; WALL MJ, 1985, J COMPUT ASSIST TOMO, V9, P381, DOI 10.1097/00004728-198503000-00032; WARA WM, 1979, CANCER, V43, P698, DOI 10.1002/1097-0142(197902)43:2<698::AID-CNCR2820430243>3.0.CO;2-Y; WHITTLE IR, 1983, J NEUROSURG, V59, P875, DOI 10.3171/jns.1983.59.5.0875; Willis SN, 2009, J IMMUNOL, V182, P3310, DOI 10.4049/jimmunol.0803424	44	1	1	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1567	1579		10.1056/NEJMcpc1610098	http://dx.doi.org/10.1056/NEJMcpc1610098			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3HF	27797319				2022-12-28	WOS:000393102500011
J	McNeill, D; Birkbeck, CD; Fukuda-Parr, S; Grover, A; Schrecker, T; Stuckler, D				McNeill, Desmond; Birkbeck, Carolyn Deere; Fukuda-Parr, Sakiko; Grover, Anand; Schrecker, Ted; Stuckler, David			Political origins of health inequities: trade and investment agreements	LANCET			English	Editorial Material							ACCESS; POLICY		[McNeill, Desmond] Univ Oslo, SUM Ctr Dev & Environm, POB 1116, N-0317 Oslo, Norway; [Birkbeck, Carolyn Deere] Univ Oxfords, Global Econ Governance Programme, Blavatnik Sch Govt, Oxford, England; [Fukuda-Parr, Sakiko] New Sch, Int Affairs Program, New York, NY USA; [Grover, Anand] Lawyers Collect, New Delhi, India; [Schrecker, Ted] Univ Durham, Sch Med Pharm & Hlth, Publ Policy & Hlth, Durham, England; [Stuckler, David] Univ Oxford, Polit Econ & Sociol, Oxford, England	University of Oslo; University of Oxford; The New School; Durham University; University of Oxford	McNeill, D (corresponding author), Univ Oslo, SUM Ctr Dev & Environm, POB 1116, N-0317 Oslo, Norway.	desmond.mcneill@sum.uio.no		mcneill, desmond/0000-0002-8948-3197; Schrecker, Ted/0000-0002-4447-5281; Stuckler, David/0000-0002-1288-8401	Wellcome Trust Investigator Award	Wellcome Trust Investigator Award(Wellcome Trust)	We declare no competing interests. DS is supported by a Wellcome Trust Investigator Award.	Columbia Center on Sustainable Investment, 2015, INV STAT DISP SETTL; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Gallagher P., 2015, INDEPENDENT; Global Agenda Council on Trade & Foreign Direct Investment, 2014, MEG REG TRAD AGR GAM; Hayne CL, 2004, J PUBLIC HEALTH POL, V25, P391, DOI 10.1057/palgrave.jphp.3190038; Ingraham C, 2014, WASHINGTON POST; Kent G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0020-7; Kerry VB, 2007, GLOBALIZATION HEALTH, V3, DOI 10.1186/1744-8603-3-3; Koivusalo M, 2009, GLOBALIZATION HLTH P, P105, DOI DOI 10.1001/JAMA.2009.1694; Krueger J, 2002, GLOBAL GOV, V8, P20; Machemedze R, 2011, IMPACT EC PARTNERSHI; Moon S, 2014, PUBLIC HEALTH, V128, P167, DOI 10.1016/j.puhe.2013.08.014; Neslen A., 2015, GUARDIAN; Ocampo JA, 2001, ECON J, V108, P1523; Offi ce of the High Commissioner for Human Rights, 2015, UN EXP VOIC ADV IMP; Ottersen OP, 2014, LANCET, V383, P630, DOI 10.1016/S0140-6736(13)62407-1; Reynolds L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2179; Robinson WI, 2004, THEORY GLOBAL CAPITA; Rodrik D., 2012, GLOBALIZATION PARADO; Rodrik D., 2015, MUDDLED CASE TRADE A; Shadlen KC, 2005, REV INT POLIT ECON, V12, P750, DOI 10.1080/09692290500339685; Stiglitz J, 2004, WORLD TRADE REV, V3, P495, DOI DOI 10.1017/S1474745604001971; Stiglitz J., 2014, NY TIMES; Sud SR, 2015, J PEDIATR-US, V166, P1303, DOI 10.1016/j.jpeds.2015.01.016; 't Hoen E, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-15; Tandon Y., 2015, TRADE IS WAR W WAR W; Thow AM, 2015, HEALTH POLICY, V119, P88, DOI 10.1016/j.healthpol.2014.08.002; United Nations, 2015, SUST DEV KNOWL PLATF; United Nations Conference on Trade and Development, 2013, GLOB VAL CHAINS INV; United Nations Conference on Trade and Development, 2015, REC TRENDS IIAS ISDS; United Nations Conference On Trade And Development, 2014, TRAD DEV REP 2014 GL; Weiss M., 2015, TRADING HLTH	32	26	26	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 18	2017	389	10070					760	762		10.1016/S0140-6736(16)31013-3	http://dx.doi.org/10.1016/S0140-6736(16)31013-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9KK	27832871	Green Submitted			2022-12-28	WOS:000394938900037
J	Sapparapu, G; Fernandez, E; Kose, N; Cao, B; Fox, JM; Bombardi, RG; Zhao, HY; Nelson, CA; Bryan, AL; Barnes, T; Davidson, E; Mysorekar, IU; Fremont, DH; Doranz, BJ; Diamond, MS; Crowe, JE				Sapparapu, Gopal; Fernandez, Estefania; Kose, Nurgun; Cao, Bin; Fox, Julie M.; Bombardi, Robin G.; Zhao, Haiyan; Nelson, Christopher A.; Bryan, Aubrey L.; Barnes, Trevor; Davidson, Edgar; Mysorekar, Indira U.; Fremont, Daved H.; Doranz, Benjamin J.; Diamond, Michael S.; Crowe, James E., Jr.			Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice	NATURE			English	Article							WEST-NILE-VIRUS; MONOCLONAL-ANTIBODIES; CROSS-REACTIVITY; INFECTION; PREGNANCY; ENHANCEMENT; PROTECTION; EXPOSURE	Zika virus (ZIKV) is an emerging mosquito-transmitted flavivirus that can cause severe disease, including congenital birth defects during pregnancy(1). To develop candidate therapeutic agents against ZIKV, we isolated a panel of human monoclonal antibodies from subjects that were previously infected with ZIKV. We show that a subset of antibodies recognize diverse epitopes on the envelope (E) protein and exhibit potent neutralizing activity. One of the most inhibitory antibodies, ZIKV-117, broadly neutralized infection of ZIKV strains corresponding to African and Asian-American lineages. Epitope mapping studies revealed that ZIKV-117 recognized a unique quaternary epitope on the E protein dimer-dimer interface. We evaluated the therapeutic efficacy of ZIKV-117 in pregnant and non-pregnant mice. Monoclonal antibody treatment markedly reduced tissue pathology, placental and fetal infection, and mortality in mice. Thus, neutralizing human antibodies can protect against maternal-fetal transmission, infection and disease, and reveal important determinants for structure-based rational vaccine design efforts.	[Sapparapu, Gopal; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Sapparapu, Gopal; Kose, Nurgun; Bombardi, Robin G.; Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Fernandez, Estefania; Zhao, Haiyan; Nelson, Christopher A.; Mysorekar, Indira U.; Fremont, Daved H.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Fox, Julie M.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Bryan, Aubrey L.; Barnes, Trevor; Davidson, Edgar; Doranz, Benjamin J.] Integral Mol, Philadelphia, PA USA; [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA.	diamond@wusm.wustl.edu; james.crowe@vanderbilt.edu	Crowe, James/B-5549-2009; Mysorekar, Indira U./GRS-4574-2022; Fox, Julie/GLQ-8895-2022; Diamond, Michael/AAH-1733-2019	Crowe, James/0000-0002-0049-1079; Mysorekar, Indira U./0000-0003-3917-8677; Diamond, Michael/0000-0002-8791-3165; Sapparapu, Gopal/0000-0001-9670-1757; Fox, Julie/0000-0003-0567-738X; PEREZ-ALBELA FERNANDEZ, EDUARDO/0000-0002-1428-6041; Fremont, Daved/0000-0002-8544-2689	US N.I.H. [R01 AI073755, R01 AI104972, HHSN272201400024C, HHSN272201400058C, HHSN272201400018C, HHSN272201200026C]; Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund; March of Dimes; N.I.H. [T32 AI007163]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073755] Funding Source: NIH RePORTER	US N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund; March of Dimes(March of Dimes); N.I.H.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Murphy, J. Govero, M. Gorman, J. Miner, R. Fong and S. Reddy for technical help and advice on experiments. This work was supported by US N.I.H. grants R01 AI073755 (to M.S.D., D.H.F and J.E.C.), R01 AI104972 (to M.S.D.), US N.I.H. contracts HHSN272201400024C (to J.E.C.), HHSN272201400058C (to B.J.D.), HHSN272201400018C (to D.H.F, M.S.D, and J.E.C) and HHSN272201200026C (CSGID; to D.H.F), and by a Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund and an Investigator award from the March of Dimes (to I.U.M.). E.F. was supported by an N.I.H. Pre-doctoral training grant award (T32 AI007163).	Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Charles A. S., 2016, PLOS CURR, V8, P1; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15; Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14; Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P716, DOI 10.1101/pdb.prot5634; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707; Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445; Nelson CA, 2014, METHODS MOL BIOL, V1140, P145, DOI 10.1007/978-1-4939-0354-2_11; Oehler E, 2014, EUROSURVEILLANCE, V19, P4; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16; Thornburg NJ, 2016, J CLIN INVEST, V126, P1482, DOI 10.1172/JCI85317; Thornburg NJ, 2013, J CLIN INVEST, V123, P4405, DOI 10.1172/JCI69377; Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157; Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004; Yu XC, 2008, J IMMUNOL METHODS, V336, P142, DOI 10.1016/j.jim.2008.04.008; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	33	271	284	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					443	+		10.1038/nature20564	http://dx.doi.org/10.1038/nature20564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27819683	Green Accepted, Bronze			2022-12-28	WOS:000389716800044
J	Cummings, RJ; Barbet, G; Bongers, G; Hartmann, BM; Gettler, K; Muniz, L; Furtado, GC; Cho, J; Lira, SA; Blander, JM				Cummings, Ryan J.; Barbet, Gaetan; Bongers, Gerold; Hartmann, Boris M.; Gettler, Kyle; Muniz, Luciana; Furtado, Glaucia C.; Cho, Judy; Lira, Sergio A.; Blander, J. Magarian			Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs	NATURE			English	Article							REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; MUCOSAL IMMUNITY; TRANSGENIC MICE; EXPRESSION; INTESTINE; GENE; MACROPHAGES; RESPONSES	Recognition and removal of apoptotic cells by professional phagocytes, including dendritic cells and macrophages, preserves immune self-tolerance and prevents chronic inflammation and autoimmune pathologies(1,2). The diverse array of phagocytes that reside within different tissues, combined with the necessarily prompt nature of apoptotic cell clearance, makes it difficult to study this process in situ. The full spectrum of functions executed by tissue-resident phagocytes in response to homeostatic apoptosis, therefore, remains unclear. Here we show that mouse apoptotic intestinal epithelial cells (IECs), which undergo continuous renewal to maintain optimal barrier and absorptive functions(3), are not merely extruded to maintain homeostatic cell numbers(4), but are also sampled by a single subset of dendritic cells and two macrophage subsets within a well-characterized network of phagocytes in the small intestinal lamina propria(5,6). Characterization of the transcriptome within each subset before and after in situ sampling of apoptotic IECs revealed gene expression signatures unique to each phagocyte, including macrophage-specific lipid metabolism and amino acid catabolism, and a dendritic-cell-specific program of regulatory CD4+ T-cell activation. A common 'suppression of inflammation' signature was noted, although the specific genes and pathways involved varied amongst dendritic cells and macrophages, reflecting specialized functions. Apoptotic IECs were trafficked to mesenteric lymph nodes exclusively by the dendritic cell subset and served as critical determinants for the induction of tolerogenic regulatory CD4+ T-cell differentiation. Several of the genes that were differentially expressed by phagocytes bearing apoptotic IECs overlapped with susceptibility genes for inflammatory bowel disease(7). Collectively, these findings provide new insights into the consequences of apoptotic cell sampling, advance our understanding of how homeostasis is maintained within the mucosa and set the stage for development of novel therapeutics to alleviate chronic inflammatory diseases such as inflammatory bowel disease.	[Cummings, Ryan J.; Barbet, Gaetan; Bongers, Gerold; Muniz, Luciana; Furtado, Glaucia C.; Cho, Judy; Lira, Sergio A.; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Cummings, Ryan J.; Barbet, Gaetan; Bongers, Gerold; Muniz, Luciana; Furtado, Glaucia C.; Cho, Judy; Lira, Sergio A.; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Hartmann, Boris M.] Icahn Sch Med Mt Sinai, Ctr Translat Syst Biol, Dept Neurol, New York, NY 10029 USA; [Gettler, Kyle] Yale Sch Med, Dept Genet, New Haven, CT 06520 USA; [Muniz, Luciana; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, New York, NY 10029 USA; [Cho, Judy] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Lira, Sergio A.; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Blander, J. Magarian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Blander, J. Magarian] Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol,Jill Roberts Inst Inflam, Joan & Sanford I Weill Dept Med,Div Gastroenterol, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cornell University	Lira, SA; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.; Lira, SA; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA.; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, New York, NY 10029 USA.; Lira, SA; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA.; Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Blander, JM (corresponding author), Cornell Univ, Weill Cornell Med, Dept Microbiol & Immunol,Jill Roberts Inst Inflam, Joan & Sanford I Weill Dept Med,Div Gastroenterol, New York, NY 10021 USA.	Sergio.lira@mssm.edu; JMBlander@med.cornell.edu	Barbet, Gaetan/ABB-5618-2020; Hartmann, Boris M./A-6121-2010; Bongers, Gerold/B-6503-2013; Barbet, Gaetan/AAJ-1675-2021	Hartmann, Boris M./0000-0002-5649-6776; Bongers, Gerold/0000-0002-3187-120X; Barbet, Gaetan/0000-0002-0152-3650; Blander, Julie Magarian/0000-0001-9207-1700	NIH [AI095245, AI123284, DK072201, 2T32A1007605-11, 5T32DK007792-12, 5P01DK072201-09, 5R01CA161373-04]; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Award; NIAID [HHSN272201000054C, U19 AI117873, R01 DK092235, U01 DK62429, U01 DK062422]; philanthropic SUCCESS; Sanford J. Grossman Charitable Trust; CCFA [330239]; SUCCESS; Jenna and Paul Segal grant; NATIONAL CANCER INSTITUTE [R01CA161373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095245, U19AI117873, R01AI123284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111862, U01DK062422, T32DK007792, P01DK072201, U01DK062429, R01DK092235] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Award; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); philanthropic SUCCESS; Sanford J. Grossman Charitable Trust; CCFA; SUCCESS; Jenna and Paul Segal grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to S. V. Chittur and M. Kuentzel, SUNY at the Albany Center for Functional Genomics. We thank M. Bogunovic at Pennsylvania State University, S. Jung at the Weizmann Institute of Science, Blander Laboratory members, J. Ochando and C. Bare at the Icahn School of Medicine Flow Cytometry Core, and M. A. Blander and S. J. Blander for discussions, help, and support. This work was supported by institutional seed funds to J.M.B. J.M.B. and her laboratory were supported by NIH grants AI095245, AI123284, DK072201, the Burroughs Wellcome Fund, and the Leukemia and Lymphoma Society. R.J.C. was supported by NIH training grants 2T32A1007605-11 and 5T32DK007792-12. G.Ba. was supported by the Crohn's and Colitis Foundation of America (CCFA) Research Fellowship Award. B.M.H: NIAID contract HHSN272201000054C and U19 AI117873. J.C.: R01 DK092235, U01 DK62429, U01 DK062422, philanthropic SUCCESS, Sanford J. Grossman Charitable Trust. S.A.L. and G.C.F.: NIH 5P01DK072201-09 and 5R01CA161373-04, CCFA 330239, and SUCCESS. G.Bo.: Jenna and Paul Segal grant.	Arbore G, 2016, EUR J IMMUNOL, V46, P1563, DOI 10.1002/eji.201546131; Bekiaris V, 2014, IMMUNOL REV, V260, P86, DOI 10.1111/imr.12194; Blander JM, 2016, FEBS J, V283, P2720, DOI 10.1111/febs.13771; Blander JM, 2014, NAT REV IMMUNOL, V14, P601, DOI 10.1038/nri3720; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bongers G, 2014, J EXP MED, V211, P457, DOI 10.1084/jem.20131587; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; Cummings RJ, 2012, J IMMUNOL, V189, P4247, DOI 10.4049/jimmunol.1201371; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; Fang W.F., 2014, PLOS ONE, V9; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Gross M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00254; Guo X, 2013, J NUTR BIOCHEM, V24, P770, DOI 10.1016/j.jnutbio.2012.04.007; Guo Z, 2008, INT IMMUNOL, V20, P307, DOI 10.1093/intimm/dxm143; Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim GHE, 2014, TRAFFIC, V15, P1143, DOI 10.1111/tra.12199; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Lee MS, 2013, NAT IMMUNOL, V14, P346, DOI 10.1038/ni.2535; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Moon CM, 2013, J GASTROEN HEPATOL, V28, P1588, DOI 10.1111/jgh.12214; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	35	126	127	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					565	+		10.1038/nature20138	http://dx.doi.org/10.1038/nature20138			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27828940	Green Accepted			2022-12-28	WOS:000388520600044
J	Weeks, WB				Weeks, William B.			Hailey	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Weeks, William B.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Weeks, William B.] Geisel Sch Med, Hanover, NH 03755 USA; [Weeks, William B.] Palmer Coll Chiropract, Davenport, IA 52803 USA; [Weeks, William B.] Aix Marseille Univ, Marseille, France	Dartmouth College; Dartmouth College; UDICE-French Research Universities; Aix-Marseille Universite	Weeks, WB (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA.; Weeks, WB (corresponding author), Geisel Sch Med, Hanover, NH 03755 USA.; Weeks, WB (corresponding author), Palmer Coll Chiropract, Davenport, IA 52803 USA.	wbw@dartmouth.edu	Weeks, WB/G-7436-2014						0	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1975	1976		10.1001/jama.2016.10251	http://dx.doi.org/10.1001/jama.2016.10251			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838720				2022-12-28	WOS:000387673800012
J	Rimmer, A				Rimmer, Abi			How is the new junior doctor contract working in practice?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2016	355								i5906	10.1136/bmj.i5906	http://dx.doi.org/10.1136/bmj.i5906			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4DC	27815247				2022-12-28	WOS:000387318900005
J	Gargiulo, G; Windecker, S; da Costa, BR; Feres, F; Hong, MK; Gilard, M; Kim, HS; Colombo, A; Bhatt, DL; Kim, BK; Morice, MC; Park, KW; Chieffo, A; Palmerini, T; Stone, GW; Valgimigli, M				Gargiulo, Giuseppe; Windecker, Stephan; da Costa, Bruno R.; Feres, Fausto; Hong, Myeong-Ki; Gilard, Martine; Kim, Hyo-Soo; Colombo, Antonio; Bhatt, Deepak L.; Kim, Byeong-Keuk; Morice, Marie-Claude; Park, Kyung Woo; Chieffo, Alaide; Palmerini, Tullio; Stone, Gregg W.; Valgimigli, Marco			Short term versus long term dual antiplatelet therapy after implantation of drug eluting stent in patients with or without diabetes: systematic review and meta-analysis of individual participant data from randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PERCUTANEOUS CORONARY INTERVENTION; OPTIMAL DURATION; MYOCARDIAL-INFARCTION; FOLLOW-UP; OUTCOMES; GUIDELINES; MELLITUS; EFFICACY; CLOPIDOGREL; STRATEGY	OBJECTIVE To compare clinical outcomes between short term (up to 6 months) and long term (12 months) dual antiplatelet therapy (DAPT) after placement of a drug eluting stent in patients with and without diabetes. DESIGN Individual participant data meta-analysis. Cox proportional regression models stratified by trial were used to assess the impact of diabetes on outcomes. DATA SOURCE Medline, Embase, and Cochrane databases and proceedings of international meetings searched for randomised controlled trials comparing durations of DAPT after placement of a drug eluting stent. Individual patient data pooled from six DAPT trials. PRIMARY OUTCOME Primary study outcome was one year risk of major adverse cardiac events (MACE), defined as cardiac death, myocardial infarction, or definite/probable stent thrombosis. All analyses were conducted by intention to treat. RESULTS Six trials including 11 473 randomised patients were pooled. Of these patients, 3681 (32.1%) had diabetes and 7708 (67.2%) did not (mean age 63.7 (SD 9.9) and 62.8 (SD 10.1), respectively), and in 84 (0.7%) the information was missing. Diabetes was an independent predictor of MACE (hazard ratio 2.30, 95% confidence interval 1.01 to 5.27; P=0.048 At one year follow-up, long term DAPT was not associated with a decreased risk of MACE compared with short term DAPT in patients with (1.05, 0.62 to 1.76; P=0.86) or without (0.97, 0.67 to 1.39; P=0.85) diabetes (P=0.33 for interaction). The risk of myocardial infarction did not differ between the two DAPT regimens (0.95, 0.58 to 1.54; P=0.82; for those with diabetes and 1.15, 0.68 to 1.94; P=0.60; for those without diabetes (P=0.84 for interaction). There was a lower risk of definite/probable stent thrombosis with long term DAPT among patients with (0.26, 0.09 to 0.80; P=0.02) than without (1.42, 0.68 to 2.98; P=0.35) diabetes, with positive interaction testing (P=0.04 for interaction), although the landmark analysis showed a trend towards benefit in both groups. Long term DAPT was associated with higher rates of major or minor bleeding, irrespective of diabetes (P=0.37 for interaction). CONCLUSIONS Although the presence of diabetes emerged as an independent predictor of MACE after implantation of a drug eluting stent, compared with short term DAPT, long term DAPT did not reduce the risk of MACE but increased the risk of bleeding among patients with stents with and without diabetes.	[Gargiulo, Giuseppe; Windecker, Stephan; da Costa, Bruno R.; Valgimigli, Marco] Univ Bern, Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Gargiulo, Giuseppe] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy; [da Costa, Bruno R.] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Feres, Fausto] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Hong, Myeong-Ki; Kim, Byeong-Keuk] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Gilard, Martine; Morice, Marie-Claude] CHU Cavale Blanche, Dept Cardiol, Brest, France; [Kim, Hyo-Soo; Park, Kyung Woo] Seoul Natl Univ Hosp, Cardiovasc Ctr, Dept Internal Med, Seoul, South Korea; [Colombo, Antonio; Chieffo, Alaide] Ist Sci San Raffaele, Intervent Cardiol Unit, Milan, Italy; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA; [Palmerini, Tullio] Univ Bologna, Dipartimento Cardiotoracovasc, Bologna, Italy; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA	University of Bern; University Hospital of Bern; University of Naples Federico II; University of Bern; Instituto Dante Pazzanese de Cardiologia; Yonsei University; Yonsei University Health System; CHU Brest; Seoul National University (SNU); Seoul National University Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Bologna; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF)	Valgimigli, M (corresponding author), Univ Bern, Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland.	marco.valgimigli@insel.ch	GARGIULO, Giuseppe/AAC-2336-2022; Colombo, Antonio/N-2960-2015; Park, Kyung Woo/AAX-3046-2020; Valgimigli, Marco/AAE-9103-2019; Palmerini, Tullio/K-4543-2016; Gargiulo, Giuseppe/AAC-2356-2022	GARGIULO, Giuseppe/0000-0003-4395-6742; Colombo, Antonio/0000-0002-2940-2455; Valgimigli, Marco/0000-0002-4353-7110; Gilard, Martine/0000-0002-2794-7953; chieffo, alaide/0000-0002-3505-9112; R. da Costa, Bruno/0000-0002-1786-6332; Kim, Byeong-Keuk/0000-0003-2493-066X; Hong, Myeong-Ki/0000-0002-2090-2031				Alabas OA, 2017, J EPIDEMIOL COMMUN H, V71, P25, DOI 10.1136/jech-2016-207402; Armstrong Ehrin J, 2014, J Diabetes Sci Technol, V8, P581, DOI 10.1177/1932296813517058; Bangalore S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5170; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bhatt DL, 2016, J AM COLL CARDIOL, V67, P2732, DOI 10.1016/j.jacc.2016.03.529; Bhatt DL, 2012, LANCET, V380, P1453, DOI 10.1016/S0140-6736(12)61021-6; Bittl JA, 2015, J AM COLL CARDIOL, V66, P1102, DOI 10.1016/j.jacc.2015.06.1338; BOVILL EG, 1991, ANN INTERN MED, V115, P256, DOI 10.7326/0003-4819-115-4-256; Capodanno D, 2015, J AM COLL CARDIOL, V66, P1639, DOI 10.1016/j.jacc.2015.05.085; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Crowther MJ, 2014, STAT MED, V33, P3844, DOI 10.1002/sim.6191; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; da Costa BR, 2014, EUR HEART J, V35, P3336, DOI 10.1093/eurheartj/ehu424; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Gilard M, 2015, J AM COLL CARDIOL, V65, P777, DOI 10.1016/j.jacc.2014.11.008; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; Han Y, 2016, CIRC-CARDIOVASC INTE, V9, pe3145, DOI [10.1161/CIRCINTERVENTIONS.115.003145, DOI 10.1161/CIRCINTERVENTIONS.115.003145]; Hong SJ, 2016, JACC-CARDIOVASC INTE, V9, P1438, DOI 10.1016/j.jcin.2016.04.036; Jung JH, 2015, DIABETES METAB J, V39, P95, DOI 10.4093/dmj.2015.39.2.95; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Koskinas KC, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003255; Lee CW, 2014, CIRCULATION, V129, P304, DOI 10.1161/CIRCULATIONAHA.113.003303; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Meredith IT, 2016, CIRCULATION, V133, P1772, DOI 10.1161/CIRCULATIONAHA.115.016783; Montalescot G, 2015, J AM COLL CARDIOL, V66, P832, DOI 10.1016/j.jacc.2015.05.053; NAVARESE E, 2015, BMJ-BRIT MED J, V350, DOI DOI 10.1136/BMJ.H1618; Palmerini T, 2016, EUR HEART J, V37, P353, DOI 10.1093/eurheartj/ehv712; Palmerini T, 2015, LANCET, V385, P2371, DOI 10.1016/S0140-6736(15)60263-X; Palmerini T, 2015, J AM COLL CARDIOL, V65, P1092, DOI 10.1016/j.jacc.2014.12.046; Rondeau V, 2008, STAT MED, V27, P1894, DOI 10.1002/sim.3161; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Santilli F, 2015, PROSTAG OTH LIPID M, V120, P28, DOI 10.1016/j.prostaglandins.2015.05.002; Schulz-Schupke S, 2015, EUR HEART J, V36, P1252, DOI 10.1093/eurheartj/ehu523; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Thukkani AK, 2015, J AM COLL CARDIOL, V66, P1091, DOI 10.1016/j.jacc.2015.06.1339; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Valgimigli M, 2015, EUR HEART J, V36, P1219, DOI 10.1093/eurheartj/ehv053; Valgimigli M, 2015, EUROINTERVENTION, V11, P68, DOI 10.4244/EIJV11I1A11; Valgimigli M, 2014, JACC-CARDIOVASC INTE, V7, P20, DOI 10.1016/j.jcin.2013.09.008; Valgimigli M, 2013, EUR HEART J, V34, P909, DOI 10.1093/eurheartj/ehs460; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Van Belle E, 2002, J AM COLL CARDIOL, V40, P410, DOI 10.1016/S0735-1097(02)01971-X; Windecker S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3859; Windecker S, 2015, EUROINTERVENTION, V10, P1024, DOI 10.4244/EIJY14M09_01	51	46	47	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2016	355								i5483	10.1136/bmj.i5483	http://dx.doi.org/10.1136/bmj.i5483			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CW	27811064	Green Published, hybrid			2022-12-28	WOS:000387318200001
J	Ladurner, R; Straight, AF				Ladurner, Rene; Straight, Aaron F.			MIS12/MIND Control at the Kinetochore	CELL			English	Editorial Material							CENP-T; ARCHITECTURE; PLATFORM	Kinetochores are complex multiprotein machines that link chromosomes to dynamic microtubules for chromosome segregation. Two studies in Cell reveal the structure of the human MIS12 and budding yeast MIND kinetochore complexes and the regulatory mechanisms that enable them to link chromosomes to microtubules during mitosis.	[Ladurner, Rene; Straight, Aaron F.] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	Stanford University	Straight, AF (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	astraigh@stanford.edu		Ladurner, Rene/0000-0001-9261-7304; Straight, Aaron/0000-0001-5885-7881				Dimitrova YN, 2016, CELL, V167, P1014, DOI 10.1016/j.cell.2016.10.011; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Kim S, 2015, J CELL BIOL, V208, P181, DOI 10.1083/jcb.201407074; London N, 2014, NAT REV MOL CELL BIO, V15, P735, DOI 10.1038/nrm3888; Malvezzi F, 2013, EMBO J, V32, P409, DOI 10.1038/emboj.2012.356; Nishino T, 2013, EMBO J, V32, P424, DOI 10.1038/emboj.2012.348; Petrovic A, 2016, CELL, V167, P1028, DOI 10.1016/j.cell.2016.10.005; Rago F, 2015, CURR BIOL, V25, P671, DOI 10.1016/j.cub.2015.01.059; Weir JR, 2016, NATURE, V537, P249, DOI 10.1038/nature19333; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100	10	3	3	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					889	891		10.1016/j.cell.2016.10.036	http://dx.doi.org/10.1016/j.cell.2016.10.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814517	Bronze			2022-12-28	WOS:000389469000007
J	ter Horst, R; Jaeger, M; Smeekens, SP; Oosting, M; Swertz, MA; Li, Y; Kumar, V; Diavatopoulos, DA; Jansen, AFM; Lemmers, H; Toenhake-Dijkstra, H; van Herwaarden, AE; Janssen, M; van der Molen, RG; Joosten, I; Sweep, FCGJ; Smit, JW; Netea-Maier, RT; Koenders, MMJF; Xavier, RJ; van der Meer, JWM; Dinarello, CA; Pavelka, N; Wijmenga, C; Notebaart, RA; Joosten, LAB; Netea, MG				ter Horst, Rob; Jaeger, Martin; Smeekens, Sanne P.; Oosting, Marije; Swertz, Morris A.; Li, Yang; Kumar, Vinod; Diavatopoulos, Dimitri A.; Jansen, Anne F. M.; Lemmers, Heidi; Toenhake-Dijkstra, Helga; van Herwaarden, Antonius E.; Janssen, Matthijs; van der Molen, Renate G.; Joosten, Irma; Sweep, Fred C. G. J.; Smit, Johannes W.; Netea-Maier, Romana T.; Koenders, Mieke M. J. F.; Xavier, Ramnik J.; van der Meer, Jos W. M.; Dinarello, Charles A.; Pavelka, Norman; Wijmenga, Cisca; Notebaart, Richard A.; Joosten, Leo A. B.; Netea, Mihai G.			Host and Environmental Factors Influencing Individual Human Cytokine Responses	CELL			English	Article							C-REACTIVE PROTEIN; BODY-MASS INDEX; PROGESTERONE-RECEPTOR IMMUNOREACTIVITY; ORGAN-TRANSPLANT RECIPIENTS; MULTIPLE-SCLEROSIS; IMMUNE-SYSTEM; ORAL-CONTRACEPTIVES; GENDER-DIFFERENCES; DIABETES-MELLITUS; SERUM-LEVELS	Differences in susceptibility to immune-mediated diseases are determined by variability in immune responses. In three studies within the Human Functional Genomics Project, we assessed the effect of environmental and non-genetic host factors of the genetic make-up of the host and of the intestinal microbiome on the cytokine responses in humans. We analyzed the association of these factors with circulating mediators and with six cytokines after stimulation with 19 bacterial, fungal, viral, and non-microbial metabolic stimuli in 534 healthy subjects. In this first study, we show a strong impact of non-genetic host factors (e.g., age and gender) on cytokine production and circulating mediators. Additionally, annual seasonality is found to be an important environmental factor influencing cytokine production. Alpha-1-antitrypsin concentrations partially mediate the seasonality of cytokine responses, whereas the effect of vitamin D levels is limited. The complete dataset has been made publicly available as a comprehensive resource for future studies.	[ter Horst, Rob; Jaeger, Martin; Smeekens, Sanne P.; Oosting, Marije; Jansen, Anne F. M.; Lemmers, Heidi; Toenhake-Dijkstra, Helga; Smit, Johannes W.; Netea-Maier, Romana T.; van der Meer, Jos W. M.; Dinarello, Charles A.; Pavelka, Norman; Notebaart, Richard A.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Gelderland, Netherlands; [ter Horst, Rob; Jaeger, Martin; Smeekens, Sanne P.; Oosting, Marije; Jansen, Anne F. M.; Lemmers, Heidi; Toenhake-Dijkstra, Helga; Smit, Johannes W.; Netea-Maier, Romana T.; van der Meer, Jos W. M.; Dinarello, Charles A.; Pavelka, Norman; Notebaart, Richard A.; Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboudumc, Ctr Infect Dis, NL-6500 HB Nijmegen, Gelderland, Netherlands; [Swertz, Morris A.; Li, Yang; Kumar, Vinod; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Diavatopoulos, Dimitri A.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6500 HB Nijmegen, Gelderland, Netherlands; [Diavatopoulos, Dimitri A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, NL-6500 HB Nijmegen, Gelderland, Netherlands; [van Herwaarden, Antonius E.; van der Molen, Renate G.; Joosten, Irma; Sweep, Fred C. G. J.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6500 HB Nijmegen, Gelderland, Netherlands; [Smit, Johannes W.; Netea-Maier, Romana T.] Radboud Univ Nijmegen, Med Ctr, Div Endocrinol, NL-6500 HB Nijmegen, Gelderland, Netherlands; [Koenders, Mieke M. J. F.] Elkerliek Hosp, Clin Chem, NL-5700 AB Helmond, Noord Brabant, Netherlands; [Xavier, Ramnik J.] Broad Inst Massachusetts Inst Technol MIT, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Harvard Univ, Cambridge, MA 02142 USA; [Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Cambridge, MA 02139 USA; [Dinarello, Charles A.] Univ Colorado Denver, Div Med, Aurora, CO 80045 USA; [Pavelka, Norman] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Janssen, Matthijs] Rijnstate Hosp, Dept Rheumatol, NL-6815 AD Arnhem, Gelderland, Netherlands; [Wijmenga, Cisca] Univ Oslo, Oslo Univ Hosp, Ctr Immune Regulat, N-0027 Oslo, Norway; [Wijmenga, Cisca] Univ Oslo, Oslo Univ Hosp, Dept Immunol, N-0027 Oslo, Norway	Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Rijnstate Hospital; University of Oslo; University of Oslo	Joosten, LAB; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Gelderland, Netherlands.; Joosten, LAB; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboudumc, Ctr Infect Dis, NL-6500 HB Nijmegen, Gelderland, Netherlands.	leo.joosten@radboudumc.nl; mihai.netea@radboudumc.nl	Sweep, C.G.J./H-8096-2014; Pavelka, Norman/G-4577-2018; Dinarello, Charles/C-8524-2013; Joosten, Leo AB/H-3138-2015; Netea-Maier, R.T./L-4543-2015; Jansen, Anne/P-8310-2015; Smeekens, Sanne/AAZ-2061-2021; van der Meer, Jos W.M./C-8521-2013; Wijmenga, Cisca/AAE-7719-2019; Smit, J.W.A./H-8091-2014; Netea, Mihai/N-5155-2014; Smeekens, Sanne/G-8307-2011; Jaeger, Martin/H-3359-2015; Kumar, Vinod/ABC-4866-2020; Janssen, Matthijs/AAZ-2784-2020; Horst, Rob Ter/G-3536-2016; Oosting, Marije/H-7437-2015; van der Molen, Renate G/I-2398-2014; Joosten, Irma/N-4418-2013; Diavatopoulos, Dimitri A/L-4269-2015; Li, Yang/HGT-8446-2022	Sweep, C.G.J./0000-0003-1103-3070; Pavelka, Norman/0000-0003-4542-9970; Joosten, Leo AB/0000-0001-6166-9830; Jansen, Anne/0000-0002-1407-5412; Smeekens, Sanne/0000-0002-7835-914X; van der Meer, Jos W.M./0000-0001-5120-3690; Wijmenga, Cisca/0000-0002-5635-1614; Smit, J.W.A./0000-0003-1052-9314; Smeekens, Sanne/0000-0002-7835-914X; Jaeger, Martin/0000-0001-6994-493X; Kumar, Vinod/0000-0002-2775-6049; Horst, Rob Ter/0000-0003-0576-5873; van der Molen, Renate G/0000-0003-3113-6587; Joosten, Irma/0000-0003-2950-4977; Diavatopoulos, Dimitri A/0000-0001-7065-7807; Li, Yang/0000-0003-4022-7341	ERC Consolidator Grant [310372]; Spinoza grant [94-212]; IN-CONTROL CVON grant [CVON2012-03]; ERC Advanced Grant (ERC) [2012-322698]; Spinoza Prize [NWO SPI 92-266]; Dutch Digestive Diseases Foundation [MLDS WO11-30]; European Union's Seventh Framework Programme (EU FP7) TANDEM project [HEALTH-F3-2012-305279]; Netherlands Organization for Scientific Research (NWO) VENI grant [863.13.011]; Interleukin Foundation; NIH grant [AI15614]; STW grant [STW13546]; BBMRI-NL; Netherlands Organization for Scientific Research (NWO) [184.021.007]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015614, R56AI015614] Funding Source: NIH RePORTER	ERC Consolidator Grant; Spinoza grant; IN-CONTROL CVON grant; ERC Advanced Grant (ERC); Spinoza Prize; Dutch Digestive Diseases Foundation; European Union's Seventh Framework Programme (EU FP7) TANDEM project; Netherlands Organization for Scientific Research (NWO) VENI grant(Netherlands Organization for Scientific Research (NWO)); Interleukin Foundation; NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); STW grant; BBMRI-NL; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank all volunteers from the 500FG cohort of the Human Functional Genomics Study for participation in the study. The HFGP is supported by an ERC Consolidator Grant (310372), A Spinoza grant (94-212) and IN-CONTROL CVON grant to M.G.N. (CVON2012-03), an ERC Advanced Grant (ERC grant 2012-322698) and a Spinoza Prize (NWO SPI 92-266) both to C.W., the Dutch Digestive Diseases Foundation (MLDS WO11-30 to C.W. and V.K.), the European Union's Seventh Framework Programme (EU FP7) TANDEM project (HEALTH-F3-2012-305279 to C.W. and V.K.), Netherlands Organization for Scientific Research (NWO) VENI grant (863.13.011 to Y.L.), and the Interleukin Foundation and NIH grant AI15614 to C.A.D. S.P.S. was financially supported by an STW grant (STW13546). The creation and hosting of the online Database has been supported by BBMRI-NL, a research infrastructure financed by the Netherlands Organization for Scientific Research (NWO), grant number 184.021.007. We thank Edith Adriaanse, Marije van der Geest, and Marieke Bijlsma voor for structuring the data into the online Database, and we thank the MOLGENIS open source team, Morris Swertz, Dennis Hendriksen, Erwin Winder, Bart Charbon, Fleur Kelpin, Jonathan Jetten, Mark de Haan, Tommy de Boer, David van Enckevort, Chao Pang, and Joeri van der Velde for designing and implementing the Database software. We thank Isak W. Tengesdal for operating the Ella (TM) microfluidic analyzer (Bio-Techne) and A.J. Olthaar for excellent technical assistance with the Vitamin D and hormone measurements. The authors thank Mark Gresnigt for helping to construct the list of genes involved in cytokine production. We thank Kiki Schraa and Inge van den Munckhof for measuring IL-6 in the validation cohort. We would also like to thank Nathan E. Lewis for his helpful comments on the manuscript. We additionally thank Ana Felix, Marie Van den Broeck, and Joao Santon for providing the figure icons "Obesity'', "Male Aging''/"Female Aging'', and "Mouse'', respectively, as deposited on https://thenounproject.com. Charles A. Dinarello is a member of the Bio-Techne Company Board which owns R and D Systems.	Aguirre-Gamboa R., 2016, CELL REP; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson P, 2008, NAT IMMUNOL, V9, P353, DOI 10.1038/ni1584; Auguie B, 2017, GRIDEXTRA MISCELLANE; Baylis Daniel, 2013, Longev Healthspan, V2, P8, DOI 10.1186/2046-2395-2-8; Behre HM, 1997, CLIN ENDOCRINOL, V47, P237, DOI 10.1046/j.1365-2265.1997.2681067.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergin DA, 2012, ARCH IMMUNOL THER EX, V60, P81, DOI 10.1007/s00005-012-0162-5; Bernstein ED, 1998, AGE, V21, P137, DOI 10.1007/s11357-998-0024-6; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bikle D, 2009, J CLIN ENDOCR METAB, V94, P26, DOI 10.1210/jc.2008-1454; Blot SI, 2002, AM J MED, V113, P480, DOI 10.1016/S0002-9343(02)01248-2; Bonsall DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140678; Bottner A, 2004, J CLIN ENDOCR METAB, V89, P4053, DOI 10.1210/jc.2004-0303; Buchbinder S, 2008, SCAND J CLIN LAB INV, V68, P140, DOI 10.1080/00365510701487727; CASSIDY JT, 1974, J CHRON DIS, V27, P507, DOI 10.1016/0021-9681(74)90026-5; Cauci S, 2008, OBSTET GYNECOL, V111, P857, DOI 10.1097/AOG.0b013e31816a2476; Charnock-Jones DS, 2000, HUM REPROD, V15, P85, DOI 10.1093/humrep/15.suppl_3.85; Clark TA, 2002, CURR OPIN INFECT DIS, V15, P569, DOI 10.1097/00001432-200212000-00003; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; De Jong S, 2014, HUM MOL GENET, V23, P2721, DOI 10.1093/hmg/ddt665; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Ferrando-Martinez S, 2011, AGE, V33, P197, DOI 10.1007/s11357-010-9170-8; Fishman JA, 1998, NEW ENGL J MED, V338, P1741, DOI 10.1056/NEJM199806113382407; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Gaffen SL, 2004, ARTHRITIS RES THER, V6, P240, DOI 10.1186/ar1444; Gandhi R, 2010, J NEUROIMMUNOL, V221, P7, DOI 10.1016/j.jneuroim.2009.10.015; Geer EB, 2009, GENDER MED, V6, P60, DOI 10.1016/j.genm.2009.02.002; Gold R, 2008, AM J PATHOL, V172, P8, DOI 10.2353/ajpath.2008.070862; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Grandgirard D, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/312476; Guarner V, 2012, AGING DIS, V3, P269; Hellstrom L, 2000, J INTERN MED, V247, P457, DOI 10.1046/j.1365-2796.2000.00678.x; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hwang LY, 2015, AM J REPROD IMMUNOL, V74, P228, DOI 10.1111/aji.12401; Jafarzadeh Abdollah, 2010, Braz. oral res., V24, P21, DOI 10.1590/S1806-83242010000100004; Janssen N, 2016, J GERONTOL A-BIOL, V71, P1117, DOI 10.1093/gerona/glv119; Joosten LAB, 2016, ANN RHEUM DIS, V75, P1219, DOI 10.1136/annrheumdis-2014-206966; Joosten LAB, 2010, ARTHRITIS RHEUM-US, V62, P3237, DOI 10.1002/art.27667; Kantor ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067833; Khaodhiar L, 2004, JPEN-PARENTER ENTER, V28, P410, DOI 10.1177/0148607104028006410; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Khoo AL, 2012, CRIT REV MICROBIOL, V38, P122, DOI 10.3109/1040841X.2011.622716; Khoo AL, 2011, IMMUNOLOGY, V134, P459, DOI 10.1111/j.1365-2567.2011.03507.x; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kovacic JC, 2011, CIRCULATION, V123, P1900, DOI 10.1161/CIRCULATIONAHA.110.009118; Kovacic JC, 2011, CIRCULATION, V123, P1650, DOI 10.1161/CIRCULATIONAHA.110.007021; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lofgren E, 2007, J VIROL, V81, P5429, DOI 10.1128/JVI.01680-06; Macpherson AM, 1999, HUM REPROD, V14, P3080, DOI 10.1093/humrep/14.12.3080; Martinon Fabio, 2010, Curr Rheumatol Rep, V12, P135, DOI 10.1007/s11926-010-0092-3; MCCREA KA, 1994, AM J RESP CRIT CARE, V150, P696, DOI 10.1164/ajrccm.150.3.8087340; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; Mosley RL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009381; Nielsen NO, 2013, AM J HUM BIOL, V25, P20, DOI 10.1002/ajhb.22332; Obiandu C, 2013, Niger J Physiol Sci, V28, P23; Oertelt-Prigione S, 2012, AUTOIMMUN REV, V11, pA479, DOI 10.1016/j.autrev.2011.11.022; Oosting M, 2016, CELL HOST MICROBE; Oosting M, 2015, CYTOKINE, V76, P465, DOI 10.1016/j.cyto.2015.08.005; Opstad TB, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-110; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; RodriguezSegade S, 1996, CLIN CHEM, V42, P1064; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Scott ME, 2013, INT J CANCER, V133, P1187, DOI 10.1002/ijc.28119; Siervo M, 2012, NUTRITION, V28, P262, DOI 10.1016/j.nut.2011.06.007; Soderberg S, 2001, INT J OBESITY, V25, P98, DOI 10.1038/sj.ijo.0801467; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007; Swertz MA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S12-S12; Szablewski L, 2014, INT IMMUNOPHARMACOL, V22, P182, DOI 10.1016/j.intimp.2014.06.033; Towfighi A, 2009, ARCH INTERN MED, V169, P1762, DOI 10.1001/archinternmed.2009.318; van der Meer JWM, 2015, MOL IMMUNOL, V68, P40, DOI 10.1016/j.molimm.2015.06.019; van Rooijen M, 2006, J THROMB HAEMOST, V4, P77, DOI 10.1111/j.1538-7836.2005.01690.x; Von Aulock S, 2006, J INTERF CYTOK RES, V26, P887, DOI 10.1089/jir.2006.26.887; Weber-Mzell D, 2004, EUR J CLIN INVEST, V34, P224, DOI 10.1111/j.1365-2362.2004.01311.x; Weinberger B, 2008, CLIN INFECT DIS, V46, P1078, DOI 10.1086/529197; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Ybarra J, 2008, DIABETES METAB, V34, P75, DOI 10.1016/j.diabet.2007.10.006; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Yu HH, 2016, IMMUNOBIOLOGY, V221, P650, DOI 10.1016/j.imbio.2016.01.004	94	261	263	4	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					1111	+		10.1016/j.cell.2016.10.018	http://dx.doi.org/10.1016/j.cell.2016.10.018			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814508	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000389469000026
J	Ferguson, MWJ				Ferguson, Mark W. J.			Fewer numbers, better science	NATURE			English	Editorial Material							BIOMEDICAL-RESEARCH					mark.ferguson@sfi.ie		Benedictus, Rinze/0000-0002-8156-8137				Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; [Anonymous], 2016, BUILD SUCC LEARN EXP; [Anonymous], 2016, AMSTERDAM CALL ACTIO; de Rijcke S, 2016, RES EVALUAT, V25, P161, DOI 10.1093/reseval/rvv038; Dijstelbloem H., 2013, SCI TRANSITION; Hicks D, 2015, NATURE, V520, P429, DOI 10.1038/520429a; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Schatz G, 2014, NAT REV MOL CELL BIO, V15, P423, DOI 10.1038/nrm3807; Wouters P., 2015, METRIC TIDE LIT REV	10	63	64	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					453	455		10.1038/538453a	http://dx.doi.org/10.1038/538453a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786219	Bronze, Green Submitted			2022-12-28	WOS:000386654400033
J	Kitamura, T; Kiyohara, K; Sakai, T; Matsuyama, T; Hatakeyama, T; Shimamoto, T; Izawa, J; Fujii, T; Nishiyama, C; Kawamura, T; Iwami, T				Kitamura, Tetsuhisa; Kiyohara, Kosuke; Sakai, Tomohiko; Matsuyama, Tasuku; Hatakeyama, Toshihiro; Shimamoto, Tomonari; Izawa, Junichi; Fujii, Tomoko; Nishiyama, Chika; Kawamura, Takashi; Iwami, Taku			Public-Access Defibrillation and Out-of-Hospital Cardiac Arrest in Japan	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; EUROPEAN RESUSCITATION COUNCIL; EMERGENCY CARDIOVASCULAR CARE; AMERICAN-HEART-ASSOCIATION; INTERNATIONAL LIAISON COMMITTEE; CARDIOPULMONARY-RESUSCITATION; STROKE FOUNDATION; SOUTHERN AFRICA; LAY RESCUERS; SURVIVAL	BACKGROUND Early defibrillation plays a key role in improving survival in patients with out-of-hospital cardiac arrests due to ventricular fibrillation (ventricular-fibrillation cardiac arrests), and the use of publicly accessible automated external defibrillators (AEDs) can help to reduce the time to defibrillation for such patients. However, the effect of dissemination of public-access AEDs for ventricular-fibrillation cardiac arrest at the population level has not been extensively investigated. METHODS From a nationwide, prospective, population-based registry of patients with out-of-hospital cardiac arrest in Japan, we identified patients from 2005 through 2013 with bystander-witnessed ventricular-fibrillation arrests of presumed cardiac origin in whom resuscitation was attempted. The primary outcome m easure was survival at 1 month with a favorable neurologic outcome (Cerebral Performance Category of 1 or 2, on a scale from 1 [good cerebral performance] to 5 [death or brain death]). The number of patients in whom survival with a favorable neurologic outcome was attributable to public-access defibrillation was estimated. RESULTS Of 43,762 patients with bystander-witnessed ventricular-fibrillation arrests of cardiac origin, 4499 (10.3%) received public-access defibrillation. The percentage of patients receiving public-access defibrillation increased from 1.1% in 2005 to 16.5% in 2013 (P<0.001 for trend). The percentage of patients who were alive at 1 month with a favorable neurologic outcome was significantly higher with public-access defibrillation than without public-access defibrillation (38.5% vs. 18.2%; adjusted odds ratio after propensity-score matching, 1.99; 95% confidence interval, 1.80 to 2.19). The estimated number of survivors in whom survival with a favorable neurologic outcome was attributed to public-access defibrillation increased from 6 in 2005 to 201 in 2013 (P<0.001 for trend). CONCLUSIONS In Japan, increased use of public-access defibrillation by bystanders was associated with an increase in the number of survivors with a favorable neurologic outcome after out-of-hospital ventricular-fibrillation cardiac arrest.	[Kitamura, Tetsuhisa] Osaka Univ, Div Environm Med & Populat Sci, Dept Social & Environm Med, Grad Sch Med, Osaka, Japan; [Kiyohara, Kosuke] Tokyo Womens Med Univ, Dept Publ Hlth, Tokyo, Japan; [Sakai, Tomohiko] Osaka Univ, Grad Sch Med, Dept Traumatol & Acute Crit Med, Suita, Osaka, Japan; [Matsuyama, Tasuku] Kyoto Prefectural Univ Med, Dept Emergency Med, Kyoto, Japan; [Hatakeyama, Toshihiro; Shimamoto, Tomonari; Izawa, Junichi; Fujii, Tomoko; Kawamura, Takashi; Iwami, Taku] Kyoto Univ, Hlth Serv, Kyoto, Japan; [Nishiyama, Chika] Kyoto Univ, Dept Crit Care Nursing, Grad Sch Med, Kyoto, Japan; [Nishiyama, Chika] Kyoto Univ, Sch Hlth Sci, Kyoto, Japan	Osaka University; Tokyo Women's Medical University; Osaka University; Kyoto Prefectural University of Medicine; Kyoto University; Kyoto University; Kyoto University	Iwami, T (corresponding author), Kyoto Univ, Hlth Serv, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	iwami.taku.8w@kyoto-u.ac.jp	IWAMI, Taku/HCH-0599-2022; Izawa, Junichi/L-2308-2019; Kitamura, Tetsuhisa/AAA-2555-2020; Kiyohara, Kosuke/ABD-5652-2020; SHIMAMOTO, Tomonari/HCH-1365-2022	IWAMI, Taku/0000-0002-4150-7065; Izawa, Junichi/0000-0003-1920-8218; Kitamura, Tetsuhisa/0000-0003-0107-0580; Kiyohara, Kosuke/0000-0003-0644-6129; FUJII, Tomoko/0000-0003-3854-4081				[Anonymous], 2015, REP STUD SOC SYST DE; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Brooks B, 2015, HEART, V101, P967, DOI 10.1136/heartjnl-2015-307624; Brooks SC, 2013, ANN EMERG MED, V61, P530, DOI 10.1016/j.annemergmed.2012.10.037; Chan TCY, 2013, CIRCULATION, V127, P1801, DOI 10.1161/CIRCULATIONAHA.113.001953; Committee on Dissemination of Public-Access AEDs of the Japanese Circulation Society, 2015, REC DEPL CRIT PUBL A; Cram P, 2005, J GEN INTERN MED, V20, P251, DOI 10.1111/j.1525-1497.2005.40247.x; Fire and Disaster Management Agency of Japan, 2015, 2006 REP ADV EM MED; Fire and Disaster Management Agency of Japan, 2015, EFF 1 AID CARD MON A; Folke F, 2010, CIRCULATION, V122, P623, DOI 10.1161/CIRCULATIONAHA.109.924423; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hansen CM, 2015, JAMA-J AM MED ASSOC, V314, P255, DOI 10.1001/jama.2015.7938; Hansen CM, 2013, CIRCULATION, V128, P2224, DOI 10.1161/CIRCULATIONAHA.113.003066; Hara M, 2015, CIRC-CARDIOVASC QUAL, V8, P277, DOI 10.1161/CIRCOUTCOMES.115.001864; Hasselqvist-Ax I, 2015, NEW ENGL J MED, V372, P2307, DOI 10.1056/NEJMoa1405796; Hazinski MF, 2015, CIRCULATION, V132, pS2, DOI 10.1161/CIR.0000000000000270; Hinchey PR, 2010, ANN EMERG MED, V56, P348, DOI 10.1016/j.annemergmed.2010.01.036; Isaacs E, 2000, ANN EMERG MED, V35, P147, DOI 10.1016/S0196-0644(00)70134-X; Iwami T, 2015, CIRCULATION, V132, P415, DOI 10.1161/CIRCULATIONAHA.114.014905; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Japan Resuscitation Council, 2011, 2010 JAP GUID EM CAR; Jorgenson DB, 2013, RESUSCITATION, V84, P149, DOI 10.1016/j.resuscitation.2012.09.033; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Levy MJ, 2013, PREHOSP DISASTER MED, V28, P342, DOI 10.1017/S1049023X13000411; MacDonald RD, 2001, ANN EMERG MED, V38, P262, DOI 10.1067/mem.2001.117953; Monsieurs KG, 2015, RESUSCITATION, V95, P1, DOI 10.1016/j.resuscitation.2015.07.038; Moon S, 2015, RESUSCITATION, V89, P43, DOI 10.1016/j.resuscitation.2014.10.029; Murakami Y, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000533; Neumar RW, 2015, CIRCULATION, V132, pS315, DOI 10.1161/CIR.0000000000000252; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Rea T, 2011, RESUSCITATION, V82, P995, DOI 10.1016/j.resuscitation.2011.04.011; Rea TD, 2006, CIRCULATION, V114, P2760, DOI 10.1161/CIRCULATIONAHA.106.654715; Ringh M, 2015, NEW ENGL J MED, V372, P2316, DOI 10.1056/NEJMoa1406038; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Weisfeldt ML, 2011, NEW ENGL J MED, V364, P313, DOI 10.1056/NEJMoa1010663; Weisfeldt ML, 2010, J AM COLL CARDIOL, V55, P1712, DOI 10.1016/j.jacc.2009.11.077; Wissenberg M, 2013, JAMA-J AM MED ASSOC, V310, P1377, DOI 10.1001/jama.2013.278483; Zijlstra JA, 2014, RESUSCITATION, V85, P1444, DOI 10.1016/j.resuscitation.2014.07.020	39	168	174	1	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2016	375	17					1649	1659		10.1056/NEJMsa1600011	http://dx.doi.org/10.1056/NEJMsa1600011			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2DX	27783922	Green Published			2022-12-28	WOS:000387168900011
J	Oni, T; Sciarrino, F; Adesso, G; Knight, R				Oni, Tolu; Sciarrino, Fabio; Adesso, Gerardo; Knight, Rob			Let researchers try new paths	NATURE			English	Editorial Material									[Oni, Tolu] Univ Cape Town, Cape Town, South Africa; [Sciarrino, Fabio] Sapienza Univ Rome, Rome, Italy; [Adesso, Gerardo] Univ Nottingham, Math Phys, Nottingham, England; [Knight, Rob] Univ Calif San Diego, Comp Sci & Engn, La Jolla, CA 92093 USA	University of Cape Town; Sapienza University Rome; University of Nottingham; University of California System; University of California San Diego	Oni, T (corresponding author), Univ Cape Town, Cape Town, South Africa.	tolullah.oni@uct.ac.za	Adesso, Gerardo/B-2880-2010	Adesso, Gerardo/0000-0001-7136-3755; Knight, Rob/0000-0002-0975-9019; Oni, Tolu/0000-0003-4499-1910					0	3	4	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					451	453		10.1038/538451a	http://dx.doi.org/10.1038/538451a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786218	Green Accepted, Bronze			2022-12-28	WOS:000386654400032
J	Fastenberg, J; Nassar, M				Fastenberg, Judd; Nassar, Michel			First Branchial Cleft Cyst	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fastenberg, Judd] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Nassar, Michel] Childrens Hosp Montefiore, Bronx, NY USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Childrens Hospital at Montefiore	Fastenberg, J (corresponding author), Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA.	jfastenb@montefiore.org	fastenberg, judd/AAQ-5874-2020	fastenberg, judd/0000-0002-4162-0500					0	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					E33	E33		10.1056/NEJMicm1503044	http://dx.doi.org/10.1056/NEJMicm1503044			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3HF	27797306				2022-12-28	WOS:000393102500010
J	Wirtz, VJ; Hogerzeil, HV; Gray, AL; Bigdeli, M; de Joncheere, CP; Ewen, MA; Gyansa-Lutterodt, M; Jing, S; Luiza, VL; Mbindyo, RM; Moller, H; Moucheraud, C; Pecoul, B; Rago, L; Rashidian, A; Ross-Degnan, D; Stephens, PN; Teerawattananon, Y; 't Hoen, EFM; Wagner, AK; Yadav, P; Reich, MR				Wirtz, Veronika J.; Hogerzeil, Hans V.; Gray, Andrew L.; Bigdeli, Maryam; de Joncheere, Cornelis P.; Ewen, Margaret A.; Gyansa-Lutterodt, Martha; Jing, Sun; Luiza, Vera L.; Mbindyo, Regina M.; Moller, Helene; Moucheraud, Corrina; Pecoul, Bernard; Rago, Lembit; Rashidian, Arash; Ross-Degnan, Dennis; Stephens, Peter N.; Teerawattananon, Yot; 't Hoen, Ellen F. M.; Wagner, Anita K.; Yadav, Prashant; Reich, Michael R.			Essential medicines for universal health coverage	LANCET			English	Review							MIDDLE-INCOME COUNTRIES; BUDGET IMPACT ANALYSIS; ANTIRETROVIRAL MEDICINES; SUBSTANDARD MEDICINES; IMPROVE ACCESS; COUNTERFEIT ARTESUNATE; PRESCRIBING INDICATORS; REGULATORY AUTHORITY; NEGLECTED DISEASES; COST-EFFECTIVENESS		[Wirtz, Veronika J.] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Dept Global Hlth, Boston, MA 02118 USA; [Hogerzeil, Hans V.; 't Hoen, Ellen F. M.] Univ Groningen, Univ Med Ctr Groningen, Global Hlth Unit, Groningen, Netherlands; [Gray, Andrew L.] Univ KwaZulu Natal, Div Pharmacol, Discipline Pharmaceut Sci, Durban, South Africa; [de Joncheere, Cornelis P.] WHO, Dept Essential Med & Hlth Prod, Geneva, Switzerland; [Rago, Lembit] WHO, Regulat Med & Other Hlth Technol, Geneva, Switzerland; [Bigdeli, Maryam] WHO, Geneva, Switzerland; [Ewen, Margaret A.] Hlth Act Int, Amsterdam, Netherlands; [Gyansa-Lutterodt, Martha] Minist Hlth, Accra, Ghana; [Jing, Sun] Peking Union Med Coll, Sch Publ Hlth, Beijing, Peoples R China; [Luiza, Vera L.] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil; [Mbindyo, Regina M.] WHO, Country Off, Nairobi, Kenya; [Moller, Helene] United Nations Childrens Fund, Supply Div, Copenhagen, Denmark; [Moucheraud, Corrina] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Los Angeles, CA USA; [Pecoul, Bernard] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Rashidian, Arash] WHO, Eastern Mediterranean Reg, Dept Informat Evidence & Res, Cairo, Egypt; [Rashidian, Arash] Univ Tehran Med Sci, Sch Publ Hlth, Tehran, Iran; [Ross-Degnan, Dennis; Wagner, Anita K.] WHO, Eastern Mediterranean Reg, Res, Cairo, Egypt; [Ross-Degnan, Dennis; Wagner, Anita K.] Harvard Med Sch, Boston, MA USA; [Ross-Degnan, Dennis] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Stephens, Peter N.] IMS Hlth, London, England; [Teerawattananon, Yot] Thai Minist Publ Hlth, HITAP, Nonthaburi, Thailand; [Yadav, Prashant] Univ Michigan, William Davidson Inst, Ann Arbor, MI 48109 USA; [Reich, Michael R.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Boston University; University of Groningen; University of Kwazulu Natal; World Health Organization; World Health Organization; World Health Organization; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Fundacao Oswaldo Cruz; World Health Organization; University of California System; University of California Los Angeles; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Tehran University of Medical Sciences; Egyptian Knowledge Bank (EKB); World Health Organization Egypt; World Health Organization; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Ministry of Public Health - Thailand; University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health	Wirtz, VJ (corresponding author), Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Dept Global Hlth, Boston, MA 02118 USA.	vwirtz@bu.edu	Rago, Lembit/AAF-4732-2019; Wirtz, Veornika/AAG-9712-2019; Luiza, Vera Lucia/F-6070-2012; Gray, Andrew/F-2104-2013	Luiza, Vera Lucia/0000-0001-6245-7522; Yadav, Prashant/0000-0001-7836-6641; Rashidian, Arash/0000-0002-4005-5183; Mbindyo, Regina/0000-0001-8011-7580; Wirtz, Veronika J./0000-0002-0863-8768; Teerawattananon, Yot/0000-0003-2217-2930; Gray, Andrew/0000-0001-7815-8180	Bill & Melinda Gates Foundation; World Health Organization; University Medical Centre Groningen; Boston University	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); World Health Organization(World Health Organization); University Medical Centre Groningen; Boston University	We are very grateful to the many experts who contributed to the production of this report. We thank The Lancet, in particular Pam Das, Senior Executive Editor, for her guidance in the process. We are also extremely grateful to Anya Levy Guyer for her editorial assistance throughout the process. Many researchers have generously contributed their time, eff orts, and unpublished data to the work of the Commission. We thank Amey N Shroff (University of Michigan), Nattha Tritasavit (Health Intervention and Technology Assessment Program, Thai Ministry of Public Health), Tessa Hermens (NPS MedicineWise), Michael Deats (World Health Organization), Peter Hall (Concept Foundation), Nikita V de Jong (University Medical Centre Groningen), Thomas Layloff (Management Sciences for Health), Patrick H Lukulay (United States Pharmacopeial Convention), Zafar Mirza (World Health Organization), Paul Newton (Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit), Sten Olsson (Uppsala Monitoring Centre), Michaella Latkovic (Boston University School of Public Health), Steven Crimaldi (Boston University School of Public Health), Jaime Espin (Escuela Andaluza de Salud Publica), Jean-Pierre Sallet (Axios International), Vusi C Dlamini (KwaZulu-Natal Department of Health) is thanked for providing medicines consumption data, and all external reviewers for their constructive comments. Finally, we thank the University Medical Centre Groningen of the University of Groningen, Netherlands, and the Health Foundation, UK, for providing the Lancet Commission with meeting venues. The work of the Commission was funded by the Bill & Melinda Gates Foundation, World Health Organization, the University Medical Centre Groningen, Boston University, and by all the academic institutions and other organisations that have generously allowed their staff to devote time to the work of the Commission.	Access Campaign MSF, 2016, UNT WEB ANT PRIC RED; Access to Medicine Foundation, ACC MED IND 2014; Access to Medicines Foundation, 2014, ACC MED IND 2014; Access to Medicines Foundation, 2015 METH 2016 ACC M; Achariam T, 2015, THE SUN DAILY   1020; Adamson PC, 2014, NAT REV CLIN ONCOL, V11, P732, DOI 10.1038/nrclinonc.2014.149; Agitha T. G., 2013, J INTELL PROP RTS, V18, P491; Agrawal S, 2013, NEW ENGL J MED, V368, P2054, DOI 10.1056/NEJMp1303523; Ainger J., BLOOMBERG; Alghannam AFA, 2014, INTEGR PHARM RES PRA, V3, P71, DOI 10.2147/IPRP.S63690; Alliance GAVI, 2014, GAVI ALL 2013 ANN PR; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; Alpern JD, 2016, NEW ENGL J MED, V374, P1904, DOI 10.1056/NEJMp1601559; Anderson BO, 2008, CANCER-AM CANCER SOC, V113, P2221, DOI 10.1002/cncr.23844; [Anonymous], 1978, LANCET, V1, P423; [Anonymous], 2015, HLTH GLANC 2015; [Anonymous], 2014, ECONOMIST; [Anonymous], 2015, REV PRESCRIRE, V35, P132; Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Association of Southeastern Nations, 2014, ASEAN DEV MUT REC AR; Australian Government Department of Health, QUAL US MED; Awad A. I., 2007, Eastern Mediterranean Health Journal, V13, P1202; Bach P, 2012, NY TIMES; Bach PB, 2015, JAMA-J AM MED ASSOC, V314, P2503, DOI 10.1001/jama.2015.16843; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Balasegaram M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001831; Bannenberg W, 2011, PHARM REFORM GUIDE I; Baruwa E, 2008, LIT REV COSTING SUPP; Bauschke R, 2012, HEALTH POLICY, V104, P12, DOI 10.1016/j.healthpol.2011.10.009; Belfrage B, 2015, EUR J CLIN PHARMACOL, V71, P363, DOI 10.1007/s00228-014-1792-9; Beran D, LANCET DIABET ENDOCR, V4, P275; Berman P, 2011, HLTH SYSTEM STRENGTH; Bigdeli M, 2014, MED HLTH SYSTEMS ADV; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Bigdeli Maryam, 2015, J Pharm Policy Pract, V8, P8, DOI 10.1186/s40545-015-0028-4; Bill & Melinda Gates Foundation, 2013, PARTN RED COST BAYER; Bogdanich WFDA, 2007, NY TIMES; Bollyky TJ, 2014, REPORT SAFETY SURVEI; Boulet P, PROCUREMENT PATENTED; Bovens M., EUROPEAN GOVERNANCE; Bredenkamp C, 2015, SOC SCI MED, V145, P243, DOI 10.1016/j.socscimed.2015.07.025; Brennan Z., 2016, COUNTERFEIT VERSIONS; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2004, AM J PUBLIC HEALTH, V94, P406, DOI 10.2105/AJPH.94.3.406; Bulfone L, 2009, VALUE HEALTH, V12, pS28, DOI 10.1111/j.1524-4733.2009.00556.x; Burns W, 2006, B WORLD HEALTH ORGAN, V84, P689; Burrone E, 2015, LANCET HIV, V2, pE362, DOI 10.1016/S2352-3018(15)00157-5; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Cameron A, COST SAVINGS SWITCHI; Cameron A, 2011, B WORLD HEALTH ORGAN, V89, P412, DOI 10.2471/BLT.10.084327; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Chalkidou K, 2016, B WORLD HEALTH ORGAN, V94, P462, DOI 10.2471/BLT.15.155721; Chhatwal J, 2015, ANN INTERN MED, V162, P397, DOI 10.7326/M14-1336; Chootipongchaivat S, 2015, FACTORS CONDUCIVE DE; Clinton Health Access Initiative (CHAI), 2015, STAT ANT DRUG MARK L; Commission on Intellectual Property Rights Innovation and Public Health (CIPIH), 2006, PUBL HLTH INN INT PR; CORNIPS C, 2010, INT J RISK SAF MED, V22, P77, DOI DOI 10.3233/JRS-2010-0496; Crow D, 2016, FINANCIAL TIMES; da Silva RM, 2015, CIENC SAUDE COLETIVA, V20, P2943, DOI 10.1590/1413-812320152010.17352014; DAP, 2020, SCREEN SHOTS HOSP WE; Dellepiane N, 2015, VACCINE, V33, P52, DOI 10.1016/j.vaccine.2013.11.066; Dentico N, 2005, PLOS MED, V2, P96, DOI 10.1371/journal.pmed.0020014; Department of Health & Human Services, WARN LETT; DeVries TPGM., 1994, GUIDE GOOD PRESCRIBI; Dickens T., 2011, WORLD MED SITUATION; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DIMASI JA, 1991, J HEALTH ECON, V10, P107, DOI 10.1016/0167-6296(91)90001-4; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Doctors without Borders, CAMP ACC MED; Dong LF, 2008, J ANTIMICROB CHEMOTH, V62, P410, DOI 10.1093/jac/dkn153; Doshi P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4665; Drugs for Neglected Diseases initiative, BUS PLAN 2015 2023; Drugs for Neglected Diseases initiative, 2013, INN APPR R D NEGL PA; Drummond M, 2013, VALUE HEALTH, V16, pS7, DOI 10.1016/j.jval.2012.10.007; Drummond M, 2012, INT J TECHNOL ASSESS, V28, P159, DOI 10.1017/S0266462312000098; Durairaj V, 2010, 41 WHO; Effective Practice and Organisation of Care (EPOC), 2015, SUGG RISK BIAS CRIT; Effective Practice and Organisation of Care (EPOC), 2013, WHAT STUD DES SHOULD; Elizabeth Glaser Pediatric AIDS Foundation, AB PED AIDS; Espin J., HTA EMERGING COUNTRI; EUnetHTA, 2012, JOINT ACT WP4 POL HT; European Medicines Agency, ART 58 APPL REG PROC; European Medicines Agency, PAED REG EU; European Medicines Agency, FALS MED; Evans DB, 2012, LANCET, V380, P864, DOI 10.1016/S0140-6736(12)61483-4; Experts in Chronic Myeloid Leukemia, 2013, Blood, V121, P4439, DOI 10.1182/blood-2013-03-490003; Ferrario Alessandra, 2014, J Pharm Policy Pract, V7, P4, DOI 10.1186/2052-3211-7-4; Finney E, 2011, CHILDRENS MED SITUAT; Fletcher N., 2015, THE GUARDIAN    0919; Food and Drug Administration, FDAS ROL PREC MED; Ford N, 2007, AIDS, V21, pS21, DOI 10.1097/01.aids.0000279703.78685.a6; Fox M, 2014, NBC NEWS; Frieden T R, 2007, WORLD HOSP HLTH SERV, V43, P30; Fromm MF, 2013, EUR J CLIN PHARMACOL, V69, P975, DOI 10.1007/s00228-012-1425-0; Frost LJ, 2008, ACCESS DO GOOD HLTH; Gaffney A, 2015, REGULATORY EXPLAINER; Gagnon Marc-Andre, 2015, Prescrire Int, V24, P192; Garabedian LF, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001686; Gilead, 2015, CHRON HEP C TREATM E; Gilson L, 2012, HEALTH POLICY PLANN, V27, pi64, DOI 10.1093/heapol/czs007; Global Alliance for TB Drug Development, 2001, EX SUMM EC TB DRUG D; Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, 2011, CANC MED PRIC LOW MI; Gomez-Dantes O, 2012, B WORLD HEALTH ORGAN, V90, P788, DOI 10.2471/BLT.12.106633; Gosden T, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002215; Gostin L O, 2013, COUNTERING PROBLEM F; Government of India, 1970, PAT ACT SECT 3 WH D; Government of the Netherlands Ministry of Health Welfare and Sport, BEN RESP US MED; Grant R, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5950; Gray A, 2015, WHOHISHGFCASESTUDY15; Gray AL, 2015, INT J CLIN PHARM-NET, V37, P717, DOI 10.1007/s11096-015-0156-6; Gray AL, 2015, LANCET, V386, P1601, DOI 10.1016/S0140-6736(15)00514-0; Greene JA, 2011, BIOSOCIETIES, V6, P10, DOI 10.1057/biosoc.2010.39; Gustafsson LL, 2011, BASIC CLIN PHARMACOL, V108, P224, DOI 10.1111/j.1742-7843.2011.00682.x; Hajjou M, 2015, AM J TROP MED HYG, V92, P68, DOI 10.4269/ajtmh.14-0535; Hajjou M, 2013, J PHARMACEUT BIOMED, V74, P47, DOI 10.1016/j.jpba.2012.09.016; Hall C, 2012, PATHOG GLOB HEALTH, V106, P73, DOI 10.1179/204777312X13419245939485; Hall PE, 2016, WHO DRUG INFORM, V30, P35; Hamilton WL, 2016, HEALTH POLICY PLANN, V31, P1448, DOI 10.1093/heapol/czw062; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hardon A, 1992, DRUGS POLICY DEV COU; Harvard Medical School and Harvard Pilgrim Healthcare/WHO, 2006, WHOTCM20062 HARV MED; Health Action International, 2016, FACT FICT WHAT HEALT; Health Action International, 2016, INS PRIC PROF; Health IMS, 2015, GLOB US MED 2020; Heller PS, 2006, HEALTH POLICY PLANN, V21, P75, DOI 10.1093/heapol/czj013; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Heymann DL, 2013, LANCET, V381, P779, DOI 10.1016/S0140-6736(13)60185-3; Hill A, 2016, CONTRIBUTION UN SECR; Hillen JB, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0984-9; Hirschler B., 2015, REUTERS         1001; Hirschler B., GLAXOSMITHKLINE BOSS; Ho NT, 2015, AM J TROP MED HYG, V92, P24, DOI 10.4269/ajtmh.14-0392; Hogerzeil HV, 2006, B WORLD HEALTH ORGAN, V84, P371, DOI 10.2471/BLT.06.031153; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; Hollande F, 2016, LANCET, V387, P2173, DOI 10.1016/S0140-6736(16)30393-2; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Holloway KA, 2015, PAEDIATR INT CHILD H, V35, P5, DOI 10.1179/2046905514Y.0000000115; Hoppu Kalle, 2011, Handb Exp Pharmacol, V205, P353, DOI 10.1007/978-3-642-20195-0_18; Hotez P, 2013, DIS NEXT DOOR WORLDS; Huang Y., 2004, SARS EPIDEMIC ITS AF; Hubbard T, 2004, PLOS BIOL, V2, P147, DOI 10.1371/journal.pbio.0020052; Hunt P, 2006, A61338, P19; IAEA, 2014, RES, DOI DOI 10.1002/2014JD022002; IDRI, 2015, IDRI SAN PAST TEAM P; IMS Health Institute for Healthcare Informatics, 2015, GLOB MED US 2020 OUT; IMS Institute for Healthcare Informatics, 2015, GLOB US MED OUTL 201; INRUD, INT C IMPR US MED 19; Institute for Safe Medication Practices, ISMP HIGH AL MED; International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, ICH GUID; International Federation of Pharmaceutical Manufacturers and Associations, DEV WORLD HLTH PARTN; International Network of Agencies for Health Technology Assessment (INAHTA), INAHTA MEMB LIST; Iyengar S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002032; Jahnke RWO, 2001, DRUG INF J, V35, P941; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Jennings G, 2011, GLOBAL VILLAGE  1005; Johnson & Johnson, OUR CRED VAL; Johnston A, 2014, BRIT J CLIN PHARMACO, V78, P218, DOI 10.1111/bcp.12298; Joint United Nations Programme on HIV/AIDS, 2015, AIDS CHANG EV MDG 6; Jones S., 2015, BR J HEALTHC MANAG, V21, P21, DOI DOI 10.12968/BJHC.2015.21.1.21; Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258; Juhlin K, 2015, DRUG SAFETY, V38, P373, DOI 10.1007/s40264-015-0271-2; Kaale E, 2014, TROP MED INT HEALTH, V19, P747, DOI 10.1111/tmi.12303; Kamal-Yanni MM, 2012, LANCET, V379, P309, DOI 10.1016/S0140-6736(12)60040-3; Kanji N, 1992, DRUGS POLICY DEV COU; Kaplan W., 2013, PRIORITY MED EUROPE; Kaplan W, 2004, WHOEDMPAR20047, VWHO/EDM/PAR//2004.7; Kaplan WA, 2005, LOCAL PRODUCTION PHA; Kaplan WA, 2011, LOCAL PRODUCTION ACC; Kaplan WA, 2012, HEALTH POLICY, V106, P211, DOI 10.1016/j.healthpol.2012.04.015; Katrein F, 2015, CAD SAUDE PUBLICA, V31, P1416, DOI 10.1590/0102-311X00083614; Kelly JC, 2016, MEDSCAPE MED NEWS; Kenber J, 2016, TIMES; Kessides I, 2009, WPS4915 WORLD BANK D; Khatib R, 2016, LANCET, V387, P61, DOI 10.1016/S0140-6736(15)00469-9; Kiddell-Monroe R, 2015, REROUTE MAP ALTERNAT; King M, 1966, MED CARE DEV COUNTRI; Kingkaew P, 2012, VALUE HEALTH, V15, pS20, DOI 10.1016/j.jval.2011.11.015; Kohler JC, 2016, CORRUPTION PHARM SEC; Kosack S, 2014, ANNU REV POLIT SCI, V17, P65, DOI 10.1146/annurev-polisci-032210-144356; Kovacs S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090601; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Langerlov P, 2001, FAM PRACT, V18, P528, DOI 10.1093/fampra/18.5.528; Leach B, 2005, PRESCRIPTION HLTH DE; Levy AR, 2010, PHARMACOECONOMICS, V28, P813, DOI 10.2165/11536150-000000000-00000; Lexchin J, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-24; Li R, 2016, HEALTH SYST REFORM, V2, P71, DOI 10.1080/23288604.2015.1123338; Light DW, 2011, BIOSOCIETIES, V6, P34, DOI 10.1057/biosoc.2010.40; Lipska KJ, 2014, JAMA-J AM MED ASSOC, V311, P2331, DOI 10.1001/jama.2014.6316; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Loftus P., 2015, WALL STREET J; Love J., 2014, KEI COMMENT NEW TUFT; Love J, 2005, HLTH EC DRUGS TCM SE, V18; Lu Y, 2011, WORLD MED SITUATION; Lund BC, 2015, J AM GERIATR SOC, V63, P1601, DOI 10.1111/jgs.13560; Lyons J., 2012, MIRROR          0803; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; MacKenzie R, 2008, J ROY SOC MED, V101, P305, DOI 10.1258/jrsm.2008.070289; Malebona PM, 2014, 134 SESS WHO EX BOAR; Malpani R., 2009, J GENERIC MED, V6, P206, DOI DOI 10.1057/JGM.2009.13; Management Sciences for Health, 2013, SYST IMPR ACC PHARM; Management Sciences for Health, 2012, MAN ACC MED HLTH TEC; Maqbool S, 2015, NEWS; Mayor S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1208; McCabe C, 2005, BRIT MED J, V331, P1016, DOI 10.1136/bmj.331.7523.1016; McDonald SA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0564-6; McEwen J, 2012, DRUG SAFETY, V35, P667, DOI 10.2165/11599860-000000000-00000; McKee S., 2012, PHARMATIMES     0807; McNeil DG, 2015, NEW YORK TIMES  1215; MDG Gap Task Force, 2015, REP 2015 MILL DEV GO; Medecins Sans Frontieres, UNT WEB ANT PRIC RED; Medecins Sans Frontieres, 2015, HLTH GROUPS ASK SEN; Medecins Sans Frontieres (MSF), 2016, DR TB DRUGS MICR SOU; Medicine Transparency Alliance, PHARM SECT SCAN; Medicines Patent Pool, PROGR ACH MED PAT PO; Medicines Patent Pool, 2015, MED PAT POOL EXP MAN; Medicines Transparency Alliance, REV PIL; Meikle J, 2005, GUARDIAN; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; Mestre-Ferrandiz J, 2012, R D COST NEW MED; Mills A, 2016, HEALTH SYST REFORM, V2, P20, DOI 10.1080/23288604.2016.1124173; Ministerio de Salud, 1972, VAD OFF MED BAS SECT; Mission for Essential Drugs and Supplies, QUAL ASS OV; Moberly T., 2011, EXCLUSIVE PCTS BLACK; Mohara A, 2012, VALUE HEALTH, V15, pS95, DOI 10.1016/j.jval.2011.11.016; Moon S, 2012, SCIENTIST; Moon S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001218; Moon S, 2011, GLOBALIZATION HEALTH, V7, DOI 10.1186/1744-8603-7-39; Mukhopadhyay R, 2007, ANAL CHEM, V79, P5522, DOI 10.1021/ac071943i; National Health and Family Planning Commission China, HLTH FAM PLANN DEV S; Neumann PJ, 2015, NEW ENGL J MED, V373, P2595, DOI 10.1056/NEJMp1512009; Newton PN, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000052; Nguyen HT, 2012, TROP MED INT HEALTH, V17, P1552, DOI 10.1111/j.1365-3156.2012.03081.x; Niens LM, 2012, B WORLD HEALTH ORGAN, V90, P219, DOI 10.2471/BLT.10.084087; Niessen LW, 2016, LANCET, V387, P9, DOI 10.1016/S0140-6736(15)00552-8; Nikogosian H, 2010, B WORLD HEALTH ORGAN, V88, P83, DOI 10.2471/BLT.10.075895; Norris P, 2005, DRUG PROMOTION WHAT; Novartis Silverman E., 2016, STATNEWS        0614; NPS, NPS MEDICINEWISE ANN; NPS Medicine Wise, 2014, NPS MEDICINEWISE 201; O'Sullivan A, 2009, ISPOR CONNECT, V15, P6; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; OECD, 2013, DELSAHEAWDHWP20134 O; Oh J, 2015, HEALTH SYST REFORM, V1, P62, DOI 10.4161/23288604.2014.991218; OHCHR, 2011, GUIDING PRINCIPLES B; Olivier J, 2015, LANCET, V386, P1765, DOI 10.1016/S0140-6736(15)60251-3; Olski TM, 2011, EUR J CLIN PHARMACOL, V67, P245, DOI 10.1007/s00228-011-0997-4; Onukwugha A, 2015, NAFDACS WAR FAKE DRU; Organisation for Economic Co-operation and Development, 2012, PROGR MAD IMPL OECD; Organisation for Economic Co-operation and Development, INF EXCH COMP COMP L; Organization for Economic Corporation and Development, 2015, HLTH GLANC 2015; Outterson K, 2014, NEW BUSINESS MODELS; Oyugui E, STRUCTURAL ADJUSTMEN; Paediatric ARV Procurement Working Group, 2015, WHO AMDS M PHARM CO; Pal SN, 2013, DRUG SAFETY, V36, P75, DOI 10.1007/s40264-012-0014-6; Papathanasiou P, 2016, DRUG DISCOV TODAY, V21, P1806, DOI 10.1016/j.drudis.2016.06.025; Paris V, 2013, DELSAHEAWDHWP20134 O; Patel A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-297; Patel A, 2010, HEALTH POLICY PLANN, V25, P61, DOI 10.1093/heapol/czp039; PBS Information Management Section Pharmaceutical Policy Branch, EXP PRESCR 12 MONTHS; Pecoul B, FDA VOUCHER LEISHMAN; Pedrique B, 2013, LANCET GLOB HEALTH, V1, pE371, DOI 10.1016/S2214-109X(13)70078-0; Perehudoff SK, B WHO IN PRESS; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Pharmaceutical Commerce, 2014, IMS I PROJ GLOB PHAR; Pharmaceutical Services Ministry of Health, 2015, NEW HOL MED; PhRMA, 2015, BIOPH RES IND 2015 P; Pinheiro ED, 2014, ANTIVIR THER, V19, P49, DOI 10.3851/IMP2900; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Prescrire, 2012, WHO BEN EUR PAED REG; Purmonen TT, 2010, INT J TECHNOL ASSESS, V26, P163, DOI 10.1017/S0266462310000103; Rago L, 2008, DRUG BENEFITS AND RISKS: INTERNATIONAL TEXTBOOK OF CLINICAL PHARMACOLOGY, P65; Ranieri N, 2014, AM J TROP MED HYG, V91, P920, DOI 10.4269/ajtmh.13-0644; Ratanawijitrasin S, 2002, EFFECTIVE DRUG REGUL; Rawlins M., 2012, HLTH SERV J, V122, P18; Reich MR, 2016, LANCET, V387, P811, DOI 10.1016/S0140-6736(15)60002-2; REICH MR, 1987, HEALTH POLICY, V8, P39, DOI 10.1016/0168-8510(87)90129-1; Renschler JP, 2015, AM J TROP MED HYG, V92, P119, DOI 10.4269/ajtmh.14-0725; Rentz ED, 2008, B WORLD HEALTH ORGAN, V86, P749; Reproductive Health Supplies Coalition, 2012, COAL SUPP IN TRIGG M; Reproductive Health Supplies Coalition, 2013, SINGL ROD IMPL NOW M; Reproductive Health Supplies Coalition, 2016, DMPA IM DEM FOR METH; Ricci C, 2008, ANAL CHIM ACTA, V623, P178, DOI 10.1016/j.aca.2008.06.007; Risha P, 2006, J AOAC INT, V89, P1300; Roberts MJ., 2004, GETTING HLTH REFORM; Roberts MJ, 2011, PHARM REFORM GUIDE I; ROSSDEGNAN D, 1992, SOC SCI MED, V35, P1329, DOI 10.1016/0277-9536(92)90037-Q; Rossow I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1615-7; Rowe A, 2015, HLTH CARE PROVIDER P; Ruppenthal LR, 2010, LAT AM J PHARM, V29, P22; Russo G, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/s12992-014-0070-z; Sachs J, 2015, HUFFINGTON POST; Saint Raymond Agnes, 2010, Expert Rev Clin Pharmacol, V3, P593, DOI 10.1586/ecp.10.38; Sam T, R D PHARM IND PERSPE; Pinto CDS, 2010, REV SAUDE PUBL, V44, P611, DOI 10.1590/S0034-89102010005000021; Sarley D, 2009, ESTIMATING GLOBAL IN; Saxenian H, 2015, HEALTH POLICY PLANN, V30, P197, DOI 10.1093/heapol/czu003; Schnipper LE, 2015, J CLIN ONCOL, V33, P2563, DOI 10.1200/JCO.2015.61.6706; Schwarzkopf L, 2015, LUNG CANCER, V90, P274, DOI 10.1016/j.lungcan.2015.09.005; Secretariat NAFTA, 2014, N AM FREE TRAD AGR N; Shakarishvili G., 2010, GLOBAL HLTH GOVERNAN, V3, P1; Shin JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119931; Shretta R, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0530-1; Smith J, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0178-4; Smits KPJ, 2016, NEPHROL DIAL TRANSPL; So AD, 2008, PLOS BIOL, V6, P2078, DOI 10.1371/journal.pbio.0060262; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Stedman-Bryce G, 2015, MED TRANSPARENCY ALL; Stephens P, 2011, WORLD MED SITUATION; Stocks SJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5501; Stop TB, ROADMAP MDR TB SCALE; Stover J, 2015, CONSOLIDATED FORECAS; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Sulston J, 2004, NEGL DIS GROUP M PEN; Sun J, 2016, J MED ECON, V19, P881, DOI 10.1080/13696998.2016.1181641; Sun J, 2016, TROP MED INT HEALTH, V21, P263, DOI 10.1111/tmi.12636; Sun J, 2015, J GLOB ANTIMICROB RE, V3, P95, DOI 10.1016/j.jgar.2015.03.001; Swinburn B, 2015, LANCET, V385, P2534, DOI 10.1016/S0140-6736(14)61747-5; 't Hoen E, 2013, J PUBLIC HEALTH POL, V34, P370, DOI 10.1057/jphp.2013.21; 't Hoen EFM, 2016, LANCET, V387, P2272, DOI 10.1016/S0140-6736(16)30656-0; 't Hoen EFM, 2014, J PUBLIC HEALTH POL, V35, P137, DOI 10.1057/jphp.2013.53; Taylor R, 2009, NPR091114; Teerawattananon Y, 2015, VACCINE, V33, pA11, DOI 10.1016/j.vaccine.2014.12.050; The Commission on Health Research for Development, 1990, HLTH RES ESS LINK EQ; The Global Fund and PEPFAR, 2014, GLOB FUND PEPFAR ARV; The Global Fund to Fight AIDS. Tuberculosis and Malaria, 2012, TUB MAL GUID GLOB FU; 'tHoen E, PRIVATE PATENTS PUBL; Thomas SK, 2013, BRIT J CLIN PHARMACO, V76, P797, DOI 10.1111/bcp.12087; Tominaga T, 2012, CLIN PHARMACOL THER, V92, P349, DOI 10.1038/clpt.2012.90; Torjesen I, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3012; Trouiller P, 2001, TROP MED INT HEALTH, V6, P945, DOI 10.1046/j.1365-3156.2001.00803.x; UN, 2000, EC1220004 UN EC SOC; UN, 2011, GUID PRINC BUS HUM R; UN, 2015, MILL DEV GOAL 8 TAK; UN, 2014, MILL DEV GOAL REP 20; UN, 2001, SGSM7779REV1 UN; UN, 2011, 2011 HIGH LEV M PREV; UN, GOAL 3 ENS HLTH LIV; UN, 2008, A63263 UN GEN ASS, P6; UN, 2016, UN SECR GEN HIGH LEV; UN, 2015, WE CAN END POV MILL; UN Commission on Life-Saving Commodities for Women and Children, 2012, COMM REP; UNITAID, 2014, TUB MED TECHN MARK L; UNITAID, 2014, TRANSP PARTN AGR IMP; UNITAID, 2016, GLOB MAL DIAGN ART T; United Nations, 2015, SUST DEV GOALS; United Nations, 1980, UNCTADTT33; United Nations Economic and Social Council, 2000, GEN COMM NO 14 RIGHT; United Nations General Assembly, 2006, A61338 UN GEN ASS; United States Government Publishing Office, 112 C US 2 SESS; Uppsala Monitoring Centre, 2015, NAT PHARM GUID; US Government Accountability Office, 2012, GAO12371R; US Senate Committee on Finance, WYD GRASSL SOV INV F; Van Amelsvoort V, 1970, STANDARD NOTES TANZA; van Onselen L., TPP IP CHAPTER DISAS; Velasquez G, 2011, RETHINKING GLOBAL HL; Vian T, 2008, HEALTH POLICY PLANN, V23, P83, DOI 10.1093/heapol/czm048; Viergever RF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008932; Vogler S, 2010, RATIONAL USE MED EUR; Vogler S, 2010, PHARM HLTH INFORM RE; Volmink Jimmy, 2007, COCHRANE DB SYST REV, V4, DOI [DOI 10.1002/14651858.CD003343.PUB4, 10.1002/14651858.CD003343.pub4]; Wagner AK, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-357; Wagner AK, 2011, HEALTH POLICY, V100, P151, DOI 10.1016/j.healthpol.2010.08.004; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; Waning B, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-35; Waning B, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-9; Waning B, 2009, B WORLD HEALTH ORGAN, V87, P520, DOI 10.2471/BLT.08.058925; Ward JW, 2015, NEW ENGL J MED, V373, P2678, DOI 10.1056/NEJMe1513245; Weekes LM, 2005, BRIT J CLIN PHARMACO, V59, P112, DOI 10.1111/j.1365-2125.2005.02231.x; WHO, 2015, WHO TECH REP SER, V994, P1; WHO, 2012, PROMOTING ACCESS TO MEDICAL TECHNOLOGIES AND INNOVATION: INTERSECTIONS BETWEEN PUBLIC HEALTH, INTELLECTUAL PROPERTY AND TRADE, P1; WHO, 2010, WOR HEALT REP, P1; WHO, 2011, GLOB STRAT PLAN ACT; WHO, 2003, WHO POL PERSP MED NO; WHO, ACC AFF ESS MED; WHO, 2010, PHARM EXP 2010; WHO, GLOB PRIC REP MECH; WHO, WHAT IS UN HLTH COV; WHO, ESS MED HLTH PROD; WHO, 2014, WHO DRUG INFORM, V28, P303; WHO, 1988, DEV IMPL NAT DRUG PO; WHO, 2015, QAS13526REV6 WHO; WHO, CALL PART GLOB ANT R; WHO, 2012, PHARM SECT COUNTR PR; WHO, 1988, GUID DEV IMPL NAT DR; WHO, 2007, TECHNICAL REPORT SER, V950; WHO, 2015, 1 WHO WORLD BANK; WHO, 2011, WORLD MED SIT REP; WHO, 2008, MAN HOUS SURV MEAS A; WHO, PURS HIGH QUAL DOTS; WHO, 2002, IMP PHARM SAF MON ME; WHO, 2015, INT PHARM; WHO, WHO LIST PREQ MED PR; WHO, 2011, SCAL ACT NONC DIS MU; WHO, 2012, AL NO 125 CONT IS IS; WHO, 2007, MOD QUAL ASS SYST PR; WHO, 1988, ETH CRIT MED DRUG PR; WHO, 1985, C EXP NAIR 25 29 NOV; WHO, 2010, ASS MED REG SYST SUB; WHO, 2015, GLOB ACT PLAN ANT RE; WHO, 2016, GLOB HLTH SECT STRAT; WHO, TARG 9 PROV ESS MED; WHO, 2002, ESS MED WHO MOD LIST; WHO, EV GOOD GOV MED PROG; WHO, 2011, SURV QUAL SEL ANT ME; WHO, ESS MED; WHO, 2007, EV BUS STRENGTH HLTH; WHO, 2002, TECHNICAL REPORT SER, V914; WHO, 2007, WHA60 WHO; WHO, 2015, GLOB REF LIST 100 CO; WHO, 2012, RES DEV MEET HLTH NE; WHO, 2010, 14 INT C DRUG REG AU; WHO, 2015, WHO LIST PREQ QUAL C; WHO, 2015, UN HLTH COV; WHO, 1977, TECHNICAL REPORT SER; WHO, WHOS GLOB NCD ACT PL; WHO, PUBL HLTH INN INT PR; WHO, 2016, DEF SSFFC MED PROD; WHO, INT C DRUG REG AUTH; WHO, 2009, CONSTR SCAL HLTH REL; WHO, TRIL STUD PROM ACC M; WHO, 1993, WHO EDM RES SER; WHO, 2012, WHOIVB1204; WHO, EXP REV PAN; WHO, 2015, PAT SIT KEY PROD TRE; WHO, GLOB HLTH EXP DAT; WHO, 2016, RHTSAVALERT32016 WHO; WHO Consultative Expert Working Group on Research and Development (CEWG), 2012, FIN COORD RES DEV ME; WHO/Ecumenical Pharmaceutical Network, 2006, WHOPSMPAR20062 EC PH; WHO/Health Action International, 2011, REV SER PHARM PRIC P; WHO/Health Action International, 2008, WHOPSMPAR20083 HLTH; WHO/Health Action International, 2016, 7 WHO BOST U SCH PUB; Whyte P, 2013, WHO HAI PROJECT MEDI; William Davidson Institute, 2015, ACT FOR MAL CAS MAN; Wilson KR, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-20; Wirtz V, 2016, GLOBAL MARKET SITUAT; World Bank, GDP PER CAP CURR US; World Health Assembly, 2014, WHA67; World Health Organization, 2015, PUBLIC HLTH IMPLICAT; World Health Organization, 2015, WHO GUID COUNTR PHAR; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization, 2001, MACR HLTH INV HLTH E; World Health Organization and Health Action International, 2009, UND RESP PHARM PROM; World Health Organization/Health Action International, 2011, REV SER PHARM PRIC P; Xiao YH, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001556; Yadzeck AS, 2016, HLTH SYSTEMS REFORM, V2, P102; Yu H, 2016, J PHARMACEUT BIOMED, V125, P85, DOI 10.1016/j.jpba.2016.03.018; Zopf S, 2016, WORLD J HEPATOL, V8, P139, DOI 10.4254/wjh.v8.i3.139	448	255	261	6	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					403	476		10.1016/S0140-6736(16)31599-9	http://dx.doi.org/10.1016/S0140-6736(16)31599-9			74	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27832874	Green Published, Bronze			2022-12-28	WOS:000392804700037
J	Shortell, SM; Rittenhouse, D				Shortell, Stephen M.; Rittenhouse, Diane			The Most Critical Health Care Issues for the Next President to Address	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Shortell, Stephen M.] Univ Calif Berkeley, Sch Publ Hlth, 50 Univ Hall, Berkeley, CA 94720 USA; [Rittenhouse, Diane] Univ Calif San Francisco, Dept Family Med, 500 Parnassus Ave,Room MU 308-E, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco	Shortell, SM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, 50 Univ Hall, Berkeley, CA 94720 USA.							Bradley E., 2013, AM HLTH CARE PARADOX; Clinton H, 2016, N ENGL J MED; Curtis CJ, 2016, AM J PUBLIC HEALTH, V106, P1815, DOI 10.2105/AJPH.2016.303397; Jost TS, 2015, KEY PROPOSALS STRENG; Kocot S. L., 2016, HLTH AFFAIRS BLOG; Lavizzo-Mourey R, 2016, JAMA-J AM MED ASSOC, V315, P1335, DOI 10.1001/jama.2016.1732; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Oberlander J, 2016, NEW ENGL J MED, V375, P1309, DOI 10.1056/NEJMp1610712; Partnership for a Healthier America, 2016, 2015 ANN PROGR REP; Shortell SM, 2013, JAMA-J AM MED ASSOC, V309, P1121, DOI 10.1001/jama.2013.887	10	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					816	+		10.7326/M16-2471	http://dx.doi.org/10.7326/M16-2471			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0KO	27802502				2022-12-28	WOS:000389263900013
J	Bhindi, R; Allahwala, UK				Bhindi, Ravinay; Allahwala, Usaid K.			Optical coherence tomography: not quite ready	LANCET			English	Editorial Material							INTERVENTION		[Bhindi, Ravinay; Allahwala, Usaid K.] Royal North Shore Hosp, Dept Cardiol, Sydney, NSW 2065, Australia	Royal North Shore Hospital	Bhindi, R (corresponding author), Royal North Shore Hosp, Dept Cardiol, Sydney, NSW 2065, Australia.	ravinay.bhindi@sydney.edu.au		Allahwala, Usaid/0000-0001-7178-4744				Ali ZA, 2016, LANCET; Doi H, 2009, JACC-CARDIOVASC INTE, V2, P1269, DOI 10.1016/j.jcin.2009.10.005; Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882; Prail F, 2015, JACC-CARDIOVASC IMAG, V8, P1297, DOI 10.1016/j.jcmg.2015.08.013; Prati F, 2012, EUROINTERVENTION, V8, P823, DOI 10.4244/EIJV8I7A125	5	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2569	2570		10.1016/S0140-6736(16)32062-1	http://dx.doi.org/10.1016/S0140-6736(16)32062-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ED0EW	27806899				2022-12-28	WOS:000388516800006
J	Camillone, N				Camillone, Nicholas, III			NANOSCIENCE Single-molecule instant replay	NATURE			English	Editorial Material							SCANNING-TUNNELING-MICROSCOPY; SUBMILLIMETER WAVELENGTHS; OPTICAL-PROPERTIES; SPECTROSCOPY		[Camillone, Nicholas, III] Brookhaven Natl Lab, Div Chem, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Camillone, N (corresponding author), Brookhaven Natl Lab, Div Chem, Upton, NY 11973 USA.	nicholas@bnl.gov	Huber, Rupert/N-4126-2018	Huber, Rupert/0000-0001-6617-9283				BARO AM, 1984, PHYS REV LETT, V52, P1304, DOI 10.1103/PhysRevLett.52.1304; BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57; Chiang S, 1997, CHEM REV, V97, P1083, DOI 10.1021/cr940555a; Cocker TL, 2016, NATURE, V539, P263, DOI 10.1038/nature19816; Cocker TL, 2013, NAT PHOTONICS, V7, P620, DOI [10.1038/nphoton.2013.151, 10.1038/NPHOTON.2013.151]; Dey S, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4800965; Furusawa K, 2012, J RAMAN SPECTROSC, V43, P656, DOI 10.1002/jrs.3151; Gerstner V, 2000, J APPL PHYS, V88, P4851, DOI 10.1063/1.1290706; HANSMA PK, 1987, J APPL PHYS, V61, pR1, DOI 10.1063/1.338189; Jahng J, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913853; Lee J, 2014, ACS NANO, V8, P54, DOI 10.1021/nn405335h; Lienau C., 2014, ATTOSECOND NANOPHYSI, P281; Muller M, 2016, ACS PHOTONICS, V3, P611, DOI 10.1021/acsphotonics.5b00710; Nishiyama Y, 2015, J PHYS CHEM C, V119, P16215, DOI 10.1021/acs.jpcc.5b03341; ORDAL MA, 1988, APPL OPTICS, V27, P1203, DOI 10.1364/AO.27.001203; ORDAL MA, 1987, APPL OPTICS, V26, P744, DOI 10.1364/AO.26.000744; Petek H, 2014, ACS NANO, V8, P5, DOI 10.1021/nn4064538; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Terada Y, 2010, NAT PHOTONICS, V4, P869, DOI 10.1038/nphoton.2010.235; Wu SW, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.085444	20	0	0	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					170	171		10.1038/539170a	http://dx.doi.org/10.1038/539170a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830801				2022-12-28	WOS:000387318500020
J	Voelker, R				Voelker, Rebecca			Another Birthday? Keep Moving	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1860	1860		10.1001/jama.2016.15625	http://dx.doi.org/10.1001/jama.2016.15625			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27825016				2022-12-28	WOS:000387116500007
J	Sukkar, L; Hong, DQ; Wong, MG; Badve, SV; Rogers, K; Perkovic, V; Walsh, M; Yu, XQ; Hillis, GS; Gallagher, M; Jardine, M				Sukkar, Louisa; Hong, Daqing; Wong, Muh Geot; Badve, Sunil V.; Rogers, Kris; Perkovic, Vlado; Walsh, Michael; Yu, Xueqing; Hillis, Graham S.; Gallagher, Martin; Jardine, Meg			Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BYPASS GRAFT-SURGERY; TRIAL SEQUENTIAL-ANALYSIS; ACUTE KIDNEY INJURY; CORONARY-ARTERY; MYOCARDIAL INJURY; REPERFUSION; PROTECTION; OCCLUSION	OBJECTIVE To summarise the benefits and harms of ischaemic conditioning on major clinical outcomes in various settings. DESIGN Systematic review and meta-analysis. DATA SOURCES Medline, Embase, Cochrane databases, and International Clinical Trials Registry platform from inception through October 2015. STUDY SELECTION All randomised controlled comparisons of the effect of ischaemic conditioning on clinical outcomes were included. DATA EXTRACTION Two authors independently extracted data from individual reports. Reports of multiple intervention arms were treated as separate trials. Random effects models were used to calculate summary estimates for all cause mortality and other pre-specified clinical outcomes. All cause mortality and secondary outcomes with P<0.1 were examined for study quality by using the GRADE assessment tool, the effect of pre-specified characteristics by using meta-regression and Cochran C test, and trial sequential analysis by using the Copenhagen Trial Unit method. RESULTS 85 reports of 89 randomised comparisons were identified, with a median 80 (interquartile range 60-149) participants and median 1 (range 1 day-72 months) month intended duration. Ischaemic conditioning had no effect on all cause mortality (68 comparisons; 424 events; 11 619 participants; risk ratio 0.96, 95% confidence interval 0.80 to 1.16; P=0.68; moderate quality evidence) regardless of the clinical setting in which it was used or the particular intervention related characteristics. Ischaemic conditioning may reduce the rates of some secondary outcomes including stroke (18 trials; 5995 participants; 149 events; risk ratio 0.72, 0.52 to 1.00; P=0.048; very low quality evidence) and acute kidney injury (36 trials; 8493 participants; 1443 events; risk ratio 0.83, 0.71 to 0.97; P=0.02; low quality evidence), although the benefits seem to be confined to nonsurgical settings and to mild episodes of acute kidney injury only. CONCLUSIONS Ischaemic conditioning has no overall effect on the risk of death. Possible effects on stroke and acute kidney injury are uncertain given methodological concerns and low event rates. Adoption of ischaemic conditioning cannot be recommended for routine use unless further high quality and well powered evidence shows benefit.	[Sukkar, Louisa; Hong, Daqing; Wong, Muh Geot; Badve, Sunil V.; Rogers, Kris; Perkovic, Vlado; Hillis, Graham S.; Gallagher, Martin; Jardine, Meg] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia; [Sukkar, Louisa; Gallagher, Martin] Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia; [Hong, Daqing] Sichuan Acad Med Sci, Div Nephrol, Chengdu, Peoples R China; [Hong, Daqing] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China; [Badve, Sunil V.] St George Hosp, Kogarah, NSW, Australia; [Walsh, Michael] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Walsh, Michael] McMaster Univ, Dept Clin Epidemiol, Hamilton, ON, Canada; [Walsh, Michael] McMaster Univ, Dept Biostat, Hamilton, ON, Canada; [Walsh, Michael] Populat Hlth Res Inst, Hamilton, ON, Canada; [Yu, Xueqing] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China; [Hillis, Graham S.] Univ Western Australia, Crawley, WA, Australia; [Jardine, Meg] Concord Repatriat Gen Hosp, Sydney, NSW, Australia	George Institute for Global Health; University of Sydney; University of Sydney; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; St George Hospital; McMaster University; McMaster University; McMaster University; Population Health Research Institute; Sun Yat Sen University; University of Western Australia; Concord Repatriation General Hospital	Gallagher, M (corresponding author), Univ Sydney, George Inst Global Hlth, Sydney, NSW 2050, Australia.; Gallagher, M (corresponding author), Univ Sydney, Concord Clin Sch, Sydney, NSW, Australia.	mgallagher@georgeinstitute.org.au	Badve, Sunil/F-9049-2010; Jardine, Meg/AAS-1864-2020; Walsh, Michael/ABE-1278-2021; Jardine, Meg/AFR-1699-2022; Perkovic, Vlado/AAY-1933-2021	Badve, Sunil/0000-0003-2269-312X; Jardine, Meg/0000-0002-0160-2375; Walsh, Michael/0000-0001-8292-2014; Jardine, Meg/0000-0002-0160-2375; Sukkar, Louisa/0000-0001-7409-2938; Gallagher, Martin/0000-0001-9187-6187	Australian postgraduate award; George Institute for Global Health; Youth Science and Technology Creative Research Groups of Sichuan Province scholarship; National Health and Medical Research Council of Australia; Canadian Institutes of Health Research; National Heart Foundation	Australian postgraduate award(Australian Government); George Institute for Global Health; Youth Science and Technology Creative Research Groups of Sichuan Province scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Heart Foundation(National Heart Foundation of Australia)	There was no specific funding source for this study. LS was supported by an Australian postgraduate award and a George Institute for Global Health postgraduate scholarship. DH is supported by a Youth Science and Technology Creative Research Groups of Sichuan Province scholarship. VP is supported by a senior research fellowship from the National Health and Medical Research Council of Australia. MGW was supported by a new investigator award from the Canadian Institutes of Health Research. MJ was supported by a career development fellowship from the National Health and Medical Research Council of Australia and by the National Heart Foundation.	Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; EARLE D P, 1960, Trans Am Clin Climatol Assoc, V72, P24; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Garg AX, 2014, JAMA-J AM MED ASSOC, V311, P2191, DOI 10.1001/jama.2014.4952; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Healy DA, 2014, DATABASE ABSTRACTS R, V2, P20; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hillis LD, 2011, J AM COLL CARDIOL, V58, pE123, DOI 10.1016/j.jacc.2011.08.009; JENNINGS RB, 1960, ARCH PATHOL, V70, P68; KALTENBACH JP, 1960, CIRC RES, V8, P207, DOI 10.1161/01.RES.8.1.207; Kottenberg E, 2012, ACTA ANAESTH SCAND, V56, P30, DOI 10.1111/j.1399-6576.2011.02585.x; Landoni G, 2007, J CARDIOTHOR VASC AN, V21, P502, DOI 10.1053/j.jvca.2007.02.013; Lavi S, 2014, CIRC-CARDIOVASC INTE, V7, P225, DOI 10.1161/CIRCINTERVENTIONS.113.000948; Le Page S, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0467-8; Luo WJ, 2011, CARDIOL YOUNG, V21, P266, DOI 10.1017/S1047951110001915; MCCLANAHAN TB, 1993, FASEB J, V7, pA118; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; SIMKHOVICH BZ, 1993, CORONARY ARTERY DIS, V4, P387, DOI 10.1097/00019501-199304000-00011; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wu QP, 2011, CIRC J, V75, P1885, DOI 10.1253/circj.CJ-10-1130; Yang Y, 2014, AM J KIDNEY DIS, V64, P574, DOI 10.1053/j.ajkd.2014.04.029; Yu CH, 2006, CAN J ANAESTH, V53, P906, DOI 10.1007/BF03022834; Zeng XX, 2014, CLIN J AM SOC NEPHRO, V9, P12, DOI 10.2215/CJN.02730313; Zhao BC, 2016, INT J CARDIOL, V203, P842, DOI 10.1016/j.ijcard.2015.11.081; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	32	19	19	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2016	355								i5599	10.1136/bmj.i5599	http://dx.doi.org/10.1136/bmj.i5599			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CQ	27821641	Green Published, hybrid			2022-12-28	WOS:000388002700001
J	Johnson, BC; Blair, DM; Collins, GS; Melosh, HJ; Freed, AM; Taylor, GJ; Head, JW; Wieczorek, MA; Andrews-Hanna, JC; Nimmo, F; Keane, JT; Miljkovic, K; Soderblom, JM; Zuber, MT				Johnson, Brandon C.; Blair, David M.; Collins, Gareth S.; Melosh, H. Jay; Freed, Andrew M.; Taylor, G. Jeffrey; Head, James W.; Wieczorek, Mark A.; Andrews-Hanna, Jeffrey C.; Nimmo, Francis; Keane, James T.; Miljkovic, Katarina; Soderblom, Jason M.; Zuber, Maria T.			Formation of the Orientale lunar multiring basin	SCIENCE			English	Article							HYDROCODE SIMULATIONS; GRAVITY RECOVERY; IMPACT BASINS; MASCON BASINS; MOON; CRATER; MISSION; GEOLOGY; ORIGIN; FAULTS	Multiring basins, large impact craters characterized by multiple concentric topographic rings, dominate the stratigraphy, tectonics, and crustal structure of the Moon. Using a hydrocode, we simulated the formation of the Orientale multiring basin, producing a subsurface structure consistent with high-resolution gravity data from the Gravity Recovery and Interior Laboratory (GRAIL) spacecraft. The simulated impact produced a transient crater, similar to 390 kilometers in diameter, that was not maintained because of subsequent gravitational collapse. Our simulations indicate that the flow of warm weak material at depth was crucial to the formation of the basin's outer rings, which are large normal faults that formed at different times during the collapse stage. The key parameters controlling ring location and spacing are impactor diameter and lunar thermal gradients.	[Johnson, Brandon C.; Miljkovic, Katarina; Soderblom, Jason M.; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Blair, David M.] MIT, Haystack Observ, Route 40, Westford, MA 01886 USA; [Collins, Gareth S.] Imperial Coll London, Dept Earth Sci & Engn, Impacts & Astromaterials Res Ctr, London SW7 2AZ, England; [Melosh, H. Jay; Freed, Andrew M.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Taylor, G. Jeffrey] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Johnson, Brandon C.; Head, James W.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Wieczorek, Mark A.] Univ Paris Diderot, Sorbonne Paris Cite, Inst Phys Globe Paris, F-75205 Paris 13, France; [Andrews-Hanna, Jeffrey C.] Southwest Res Inst, Boulder, CO 80302 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Keane, James T.] Univ Arizona, Lunar & Planetary Lab, Dept Planetary Sci, Tucson, AZ 85721 USA; [Miljkovic, Katarina] Curtin Univ, Dept Appl Geol, Perth, WA 6102, Australia	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Imperial College London; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Hawaii System; Brown University; UDICE-French Research Universities; Universite Paris Cite; Southwest Research Institute; University of California System; University of California Santa Cruz; University of Arizona; Curtin University	Johnson, BC (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.; Johnson, BC (corresponding author), Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA.	brandon_johnson@brown.edu	Keane, James/AAI-5137-2020; Wieczorek, Mark A/G-6427-2010; Miljkovic, Katarina/D-4844-2013	Wieczorek, Mark A/0000-0001-7007-4222; Miljkovic, Katarina/0000-0001-8644-8903; Soderblom, Jason/0000-0003-3715-6407	GRAIL mission; NASA Discovery Program; UK Science and Technology Facilities Council [ST/N000803/1]; Science and Technology Facilities Council [ST/J001260/1, ST/N000803/1] Funding Source: researchfish; STFC [ST/N000803/1, ST/J001260/1] Funding Source: UKRI	GRAIL mission; NASA Discovery Program(National Aeronautics & Space Administration (NASA)); UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank two anonymous reviewers for their thoughtful reviews; the developers of iSALE (www.isale-code.de/redmine/projects/iSALE), including K. Wunnemann, D. Elbeshausen, and B. Ivanov; and all those involved with the development and operations of the GRAIL spacecraft and the collection and reduction of the GRAIL data. This work was funded by the GRAIL mission, which is supported by the NASA Discovery Program and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory, California Institute of Technology. G.S.C. was funded by UK Science and Technology Facilities Council grant ST/N000803/1. At present, iSALE is not publicly available. It is distributed on a case-by-case basis to academic users in the impact community, strictly for noncommercial use. Scientists interested in using or developing iSALE should see www.isale-code.de/redmine/projects/isale/wiki/Terms_of_use for a description of application requirements. Model output has been published at the Harvard Dataverse, doi:10.7910/DVN/BH9UXW.	Amsden A.A., 1980, LA8095 LOS AL NAT LA; Baker DMH, 2011, ICARUS, V214, P377, DOI 10.1016/j.icarus.2011.05.030; Baldwin R. B., 1972, Physics of the Earth and Planetary Interiors, V6, P327, DOI 10.1016/0031-9201(72)90056-8; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P2415, DOI 10.1029/JB090iB14p12415; Byrne PK, 2015, EARTH PLANET SC LETT, V427, P183, DOI 10.1016/j.epsl.2015.06.022; Cheek LC, 2013, J GEOPHYS RES-PLANET, V118, P1805, DOI 10.1002/jgre.20126; Collins GS, 2014, J GEOPHYS RES-PLANET, V119, P2600, DOI 10.1002/2014JE004708; Collins GS, 2004, METEORIT PLANET SCI, V39, P217, DOI 10.1111/j.1945-5100.2004.tb00337.x; Collins GS, 2002, ICARUS, V157, P24, DOI 10.1006/icar.2002.6822; Freed AM, 2014, J GEOPHYS RES-PLANET, V119, P2378, DOI 10.1002/2014JE004657; Head JW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041790; Head J. W., 1974, Moon, V11, P327, DOI 10.1007/BF00589168; HODGES CA, 1978, ICARUS, V34, P294, DOI 10.1016/0019-1035(78)90169-0; Ivanov BA, 2010, GEOL SOC AM SPEC PAP, V465, P29, DOI 10.1130/2010.2465(03); Kattoum YN, 2013, ICARUS, V226, P694, DOI 10.1016/j.icarus.2013.06.025; Laneuville M, 2013, J GEOPHYS RES-PLANET, V118, P1435, DOI 10.1002/jgre.20103; Le Feuvre M, 2011, ICARUS, V214, P1, DOI 10.1016/j.icarus.2011.03.010; Melosh HJ, 2013, SCIENCE, V340, P1552, DOI [10.1126/science.1235768, 10.1126/science.1238663]; MELOSH HJ, 1978, GEOPHYS RES LETT, V5, P985, DOI 10.1029/GL005i011p00985; Miljkovic K, 2013, SCIENCE, V342, P724, DOI 10.1126/science.1243224; Montesi LGJ, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000465; Nahm AL, 2013, J GEOPHYS RES-PLANET, V118, P190, DOI 10.1002/jgre.20045; Potter RWK, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052981; Potter RWK, 2015, ICARUS, V261, P91, DOI 10.1016/j.icarus.2015.08.009; Potter RWK, 2013, J GEOPHYS RES-PLANET, V118, P963, DOI 10.1002/jgre.20080; Smith DE, 2017, ICARUS, V283, P70, DOI 10.1016/j.icarus.2016.06.006; Spudis PD, 2014, J GEOPHYS RES-PLANET, V119, P19, DOI 10.1002/2013JE004521; Taylor GJ, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0242; Vaughan WM, 2013, ICARUS, V223, P749, DOI 10.1016/j.icarus.2013.01.017; Wieczorek MA, 1999, ICARUS, V139, P246, DOI 10.1006/icar.1999.6102; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Wunnemann K, 2006, ICARUS, V180, P514, DOI 10.1016/j.icarus.2005.10.013; Zhu MH, 2015, J GEOPHYS RES-PLANET, V120, P2118, DOI 10.1002/2015JE004827; Zuber MT, 2016, SCIENCE, V354, P438, DOI 10.1126/science.aag0519; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507	35	44	45	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					441	444		10.1126/science.aag0518	http://dx.doi.org/10.1126/science.aag0518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789836	Green Submitted			2022-12-28	WOS:000387684400035
J	Terasaki, M				Terasaki, Mark			A finer look at a fine cellular meshwork	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM		[Terasaki, Mark] Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA	University of Connecticut	Terasaki, M (corresponding author), Univ Connecticut, Ctr Hlth, Dept Cell Biol, Farmington, CT 06030 USA.	terasaki@uchc.edu						Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Nixon-Abell J, 2016, SCIENCE, V354, DOI 10.1126/science.aaf3928; PORTER KR, 1953, ANAT REC, V117, P685, DOI 10.1002/ar.1091170403; PORTER KR, 1945, J EXP MED, V81, P233, DOI 10.1084/jem.81.3.233; Presley R, 1997, NATURE, V389, P440, DOI 10.1038/38891; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wang S., 2016, ELIFE, DOI [10.7554/eLife.e18605, DOI 10.7554/ELIFE.E18605]	10	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					415	416		10.1126/science.aal0052	http://dx.doi.org/10.1126/science.aal0052			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789827				2022-12-28	WOS:000387684400022
J	Sharma, DC				Sharma, Dinesh C.			India's anti-sex-selection law faces new challenges	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1971	1971		10.1016/S0140-6736(16)31899-2	http://dx.doi.org/10.1016/S0140-6736(16)31899-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ6EQ	27789009				2022-12-28	WOS:000385954800012
J	Sliwa, K				Sliwa, Karen			The heart of Africa: succeeding against the odds	LANCET			English	Article							CARDIOLOGY WORKING GROUP; PERIPARTUM CARDIOMYOPATHY; FAILURE ASSOCIATION; EUROPEAN-SOCIETY; SOUTH-AFRICA; TUBERCULOUS PERICARDITIS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; CAPE-TOWN; SOWETO	South Africa and other areas of sub-Saharan Africa have in the past 20 years undergone rapid demographical changes, largely due to urbanisation and changes in lifestyle. This rapid change has led to a marked increase in specifi c cardiac conditions, such as hypertensive heart disease and coronary artery disease (with the highest prevalence in the middle-aged population), in conjunction with a range of other heart diseases, which are historically common in Africa-eg, rheumatic heart disease, cardiomyopathies, and unoperated congenital heart disease. The short supply of well-equipped screening facilities, late diagnosis, and inadequate care at primary, secondary, and tertiary levels have led to a large burden of patients with poorly treated heart failure. Excellent progress has been made in the understanding of the epidemiology, sociodemographical factors, effect of urbanisation, and pathophysiology of cardiac conditions, such as peripartum cardiomyopathy, rheumatic heart disease, and tuberculous pericarditis, which are common in sub-Saharan Africa. This progress has been achieved largely through several studies, such as the Heart of Soweto, THESUS, REMEDY, BA-HEF, Abeokuta-HF, and the PAPUCO studies. Studies on the suitable therapeutic management of several heart conditions have also been done or are underway. In this Lecture, I provide a personal perspective on the evolving burden of cardiac disease, as witnessed since my appointment at Chris Hani Baragwanath Hospital, in Soweto, South Africa, in 1992, which was also the year that the referendum to end apartheid in South Africa was held. Subsequently, a network of cardiologists was formed under the umbrella of the Heart of Africa Studies and the Pan African Cardiac Society. Furthermore, I summarise the major gaps in the health-care system dealing with the colliding epidemic of communicable and non-communicable heart diseases, including cardiac diseases common in peripartum women. I also touch on the fantastic opportunities available for doing meaningful research with enthusiastic colleagues and, thereby, having a large eff ect, despite the need to be highly innovative in finding much needed funding support.	[Sliwa, Karen] Univ Cape Town, Hatter Inst Cardiovasc Res Africa, South African Med Res Council, Interuniv Cape Heart Grp, Cape Town, South Africa; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Dept Med, Cape Town, South Africa; [Sliwa, Karen] Australian Catholic Univ, Fac Hlth Sci, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Sliwa, Karen] Univ Witwatersrand, Soweto Cardiovasc Res Grp, Johannesburg, South Africa	South African Medical Research Council; University of Cape Town; University of Cape Town; Australian Catholic University; University of Witwatersrand	Sliwa, K (corresponding author), Univ Cape Town, Groote Schuur Hosp, Hatter Inst Cardiovasc Res Africa, Dept Med, ZA-7925 Cape Town, South Africa.	karen.sliwa-hahnle@uct.ac.za		Sliwa, Karen/0000-0002-8272-0911	Hatter Institute for Cardiovascular Research in Africa from The University of Cape Town; Medical Research Council SA; National Research Foundation SA; Maurice Hatter Foundation; SERVIER Laboratories; National Institute of Health Fogarty Programme [TW008330-01A1]; Australian Government Centre of Excellence (NHMRC) [1044897]; Momentum Research (USA); FOGARTY INTERNATIONAL CENTER [D43TW008330] Funding Source: NIH RePORTER	Hatter Institute for Cardiovascular Research in Africa from The University of Cape Town; Medical Research Council SA(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Research Foundation SA(National Research Foundation of Korea); Maurice Hatter Foundation; SERVIER Laboratories; National Institute of Health Fogarty Programme; Australian Government Centre of Excellence (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Momentum Research (USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	I acknowledge the support of Mrs Sylvia Dennis, Hatter Institute for Cardiovascular Research in Africa, in preparing this manuscript. I acknowledge support for the Hatter Institute for Cardiovascular Research in Africa from The University of Cape Town, the Medical Research Council SA, the National Research Foundation SA, Maurice Hatter Foundation, SERVIER Laboratories, Momentum Research (USA), the National Institute of Health Fogarty Programme (TW008330-01A1), and the Australian Government Centre of Excellence (NHMRC 1044897) grant to reduce inequality in heart disease.	Arany Z, 2016, CIRCULATION, V133, P1397, DOI 10.1161/CIRCULATIONAHA.115.020491; Bauersachs J, 2016, EUR J HEART FAIL, V18, P1096, DOI 10.1002/ejhf.586; Damasceno A, 2012, ARCH INTERN MED, V172, P1386, DOI 10.1001/archinternmed.2012.3310; Doughty RN, 2014, EUR HEART J-CARD IMG, V15, P341, DOI 10.1093/ehjci/jet240; Dzudie A, 2008, EUR J HEART FAIL, V10, P367, DOI 10.1016/j.ejheart.2008.02.009; Engel ME, 2015, HEART, V101, P1389, DOI 10.1136/heartjnl-2015-307444; Ettarh RR, 2015, CARDIOVASC DIAGN THE, V5, P311, DOI 10.3978/j.issn.2223-3652.2015.07.04; Evans T, 2016, LANCET, V387, P2482, DOI 10.1016/S0140-6736(16)30238-0; Haghikia A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0366-9; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hilfiker-Kleiner D, 2015, EUR HEART J, V36, P1090, DOI 10.1093/eurheartj/ehv009; Hilfiker-Kleiner D, 2014, NAT REV CARDIOL, V11, P364, DOI 10.1038/nrcardio.2014.37; Huisman HW, 2013, AM J HYPERTENS, V26, P68, DOI 10.1093/ajh/hps007; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Katz AA, 2014, SAMJ S AFR MED J, V104, P111, DOI 10.7196/SAMJ.7639; Khatib R, 2016, LANCET, V387, P61, DOI 10.1016/S0140-6736(15)00469-9; Kruger H Salome, 2003, Cardiovasc J S Afr, V14, P16; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Makubi A, 2015, HEART, V101, P592, DOI 10.1136/heartjnl-2014-306890; Malan L, 2008, BIOL PSYCHOL, V79, P323, DOI 10.1016/j.biopsycho.2008.07.007; Mayosi BM, 2014, NEW ENGL J MED, V371, P1121, DOI 10.1056/NEJMoa1407380; Mayosi B.M., 2002, COCHRANE DB SYST REV, V4), DOI [10.1002/14651858.CD000526, DOI 10.1002/14651858.CD000526]; Mayosi BM, 2008, SAMJ S AFR MED J, V98, P36; Nel G, 2014, EUR HEART J, V35, P2700; Nieminen MS, 2008, EUR J HEART FAIL, V10, P222, DOI 10.1016/j.ejheart.2008.02.014; Ntsekhe M, 2013, HEART FAIL REV, V18, P367, DOI 10.1007/s10741-012-9310-6; Ogah OS, 2015, J CLIN HYPERTENS, V17, P263, DOI 10.1111/jch.12496; Ogah OS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113032; Ojji D, 2013, EUR J HEART FAIL, V15, P835, DOI 10.1093/eurjhf/hft061; Peer N, 2015, EUR J PREV CARDIOL, V22, P1036, DOI 10.1177/2047487314549744; Peer N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078567; Ricke-Hoch M, 2014, CARDIOVASC RES, V101, P587, DOI 10.1093/cvr/cvu010; Sliwa K, 2006, EUR HEART J, V27, P441, DOI 10.1093/eurheartj/ehi481; Sliwa K, 2000, J AM COLL CARDIOL, V35, P701, DOI 10.1016/S0735-1097(99)00624-5; Sliwa K, 2016, HEART AFRICA CLIN PR, P1; Sliwa K, 2015, HEART FAILURE COMPAN, P410; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; Sliwa K, 2016, EUR J HEART FAIL, V18, P1248, DOI 10.1002/ejhf.581; Sliwa K, 2016, CARDIOVASC J AFR, V27, P188, DOI 10.5830/CVJA-2016-063; Sliwa K, 2016, LANCET, V387, P2072, DOI 10.1016/S0140-6736(16)30391-9; Sliwa K, 2016, CIRCULATION, V133, P1199, DOI 10.1161/CIRCULATIONAHA.114.008730; Sliwa K, 2014, EUR J HEART FAIL, V16, P583, DOI 10.1002/ejhf.68; Sliwa K, 2014, EUR HEART J, V35, P680, DOI 10.1093/eurheartj/eht485; Sliwa K, 2013, EUR HEART J, V34, P3151, DOI 10.1093/eurheartj/eht393; Sliwa K, 2013, INT J CARDIOL, V167, P2204, DOI 10.1016/j.ijcard.2012.06.005; Sliwa K, 2013, HEART, V99, P1317, DOI 10.1136/heartjnl-2013-303592; Sliwa K, 2012, CIRCULATION, V125, P3060, DOI 10.1161/CIRCULATIONAHA.112.114199; Sliwa K, 2012, EUR HEART J, V33, P866, DOI 10.1093/eurheartj/ehr398; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Sliwa K, 2010, CIRCULATION, V121, P1465, DOI 10.1161/CIRCULATIONAHA.109.901496; Sliwa K, 2010, EUR HEART J, V31, P719, DOI 10.1093/eurheartj/ehp530; Soma-Pillay P, 2008, SAMJ S AFR MED J, V98, P553; Soma-Pillay P, 2016, CARDIOVASC J AFR, V27, P1; Stewart S., 2016, HEART AFRICA CLIN PR, DOI [10.1002/9781119097136, DOI 10.1002/9781119097136]; Stewart S, 2011, EUR J HEART FAIL, V13, P1070, DOI 10.1093/eurjhf/hfr108; Stewart S, 2011, EUR HEART J, V32, P492, DOI 10.1093/eurheartj/ehq439; Stewart S, 2008, CIRCULATION, V118, P2360, DOI 10.1161/CIRCULATIONAHA.108.786244; Thienemann F, 2016, INT J CARDIOL, V221, P205, DOI 10.1016/j.ijcard.2016.06.242; Thienemann F, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005950; Tibazarwa K, 2009, INT J CARDIOL, V132, P233, DOI 10.1016/j.ijcard.2007.11.067; Uthman OA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006340; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177; Zuhlke L, 2015, EUR HEART J, V36, P1115, DOI 10.1093/eurheartj/ehu449	65	9	9	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					E28	E36		10.1016/S0140-6736(16)31660-9	http://dx.doi.org/10.1016/S0140-6736(16)31660-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27793430				2022-12-28	WOS:000390112300001
J	Sassone-Corsi, M; Nuccio, SP; Liu, H; Hernandez, D; Vu, CT; Takahashi, AA; Edwards, RA; Raffatellu, M				Sassone-Corsi, Martina; Nuccio, Sean-Paul; Liu, Henry; Hernandez, Dulcemaria; Vu, Christine T.; Takahashi, Amy A.; Edwards, Robert A.; Raffatellu, Manuela			Microcins mediate competition among Enterobacteriaceae in the inflamed gut	NATURE			English	Article							COLONIZATION RESISTANCE; COLI; TYPHIMURIUM; PEPTIDES; GROWTH	The Enterobacteriaceae are a family of Gram-negative bacteria that include commensal organisms as well as primary and opportunistic pathogens that are among the leading causes of morbidity and mortality worldwide. Although Enterobacteriaceae often comprise less than 1% of a healthy intestine's microbiota(1), some of these organisms can bloom in the inflamed gut(2-5); expansion of enterobacteria is a hallmark of microbial imbalance known as dysbiosis(6). Microcins are small secreted proteins that possess antimicrobial activity in vitro(7,8), but whose role in vivo has been unclear. Here we demonstrate that microcins enable the probiotic bacterium Escherichia coli Nissle 1917 EcN) to limit the expansion of competing Enterobacteriaceae including pathogens and pathobionts) during intestinal inflammation. Microcin-producing EcN limits the growth of competitors in the inflamed intestine, including commensal E. coli, adherent-invasive E. coli and the related pathogen Salmonella enterica. Moreover, only therapeutic administration of the wild-type, microcin-producing EcN to mice previously infected with S. enterica substantially reduced intestinal colonization by the pathogen. Our work provides the first evidence that microcins mediate inter-and intraspecies competition among the Enterobacteriaceae in the inflamed gut. Moreover, we show that microcins can act as narrow-spectrum therapeutics to inhibit enteric pathogens and reduce enterobacterial blooms.	[Sassone-Corsi, Martina; Nuccio, Sean-Paul; Liu, Henry; Hernandez, Dulcemaria; Vu, Christine T.; Takahashi, Amy A.; Raffatellu, Manuela] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Sassone-Corsi, Martina; Nuccio, Sean-Paul; Edwards, Robert A.; Raffatellu, Manuela] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA; [Edwards, Robert A.] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Raffatellu, M (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.; Raffatellu, M (corresponding author), Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA.	manuelar@uci.edu		Sassone-Corsi, Martina/0000-0002-4137-8371; Nuccio, Sean-Paul/0000-0002-9683-9278; Raffatellu, Manuela/0000-0001-6487-4215	Public Health Service [AI083663, AI126277, AI101784, AI114625, AI105374, DK058057]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114625, R01AI126277, R21AI105374, R01AI083663, R21AI101784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058057] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to acknowledge E. Nolan for critically reading the manuscript, J. Behnsen for setting up the Raffatellu laboratory germ-free mouse facility, and M. Valeri, A. Perez-Lopez, V. Diaz-Ochoa and E. Hoover for contributing to the maintenance of the germ-free facility. We would also like to thank W. Zhu and S. Winter for providing us with the protocol for cleaning up DNA stool samples from DSS. and M. Rolston at the UC Davis Host-Microbe Systems Biology Core for processing samples for Illumina MiSeq Analysis. We would like to acknowledge the students of the 2015 Summer course 'Frontiers in Host Microbe Interactions'. Marine Biology Laboratory, who helped with the generation of one dataset for the manuscript. Work in the laboratory of M.R. is supported by Public Health Service Grants AI083663, AI126277, AI101784, AI114625, AI105374, and DK058057. M.R. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund.	BAQUERO F, 1984, FEMS MICROBIOL LETT, V23, P117; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Eaves-Pyles T, 2008, INT J MED MICROBIOL, V298, P397, DOI 10.1016/j.ijmm.2007.05.011; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Jacobi CA, 2011, DIGEST DIS, V29, P600, DOI 10.1159/000333307; Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608; Kommineni S, 2015, NATURE, V526, P719, DOI 10.1038/nature15524; Leong D, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00683, 10.3389/fmicb.2014.00436, 10.3389/fmicb.2014.00241]; Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503; Nolan EM, 2008, BIOCHEMISTRY-US, V47, P9289, DOI 10.1021/bi800826j; Patzer SI, 2003, MICROBIOL-SGM, V149, P2557, DOI 10.1099/mic.0.26396-0; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rebuffat S, 2004, CURR PROTEIN PEPT SC, V5, P383, DOI 10.2174/1389203043379611; Rebuffat S, 2012, BIOCHEM SOC T, V40, P1456, DOI 10.1042/BST20120183; Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169; Stecher B, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0008-2014; Vassiliadis G, 2010, ANTIMICROB AGENTS CH, V54, P288, DOI 10.1128/AAC.00744-09; Winter SE, 2014, CELL MICROBIOL, V16, P179, DOI 10.1111/cmi.12245; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Zheng TF, 2014, J AM CHEM SOC, V136, P9677, DOI 10.1021/ja503911p	28	248	261	15	150	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 8	2016	540	7632					280	+		10.1038/nature20557	http://dx.doi.org/10.1038/nature20557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE4CF	27798599	Green Accepted			2022-12-28	WOS:000389548700059
J	Taylor, JP; Brown, RH; Cleveland, DW				Taylor, J. Paul; Brown, Robert H., Jr.; Cleveland, Don W.			Decoding ALS: from genes to mechanism	NATURE			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; DIPEPTIDE-REPEAT PROTEINS; FRONTOTEMPORAL LOBAR DEGENERATION; C9ORF72 HEXANUCLEOTIDE REPEAT; SUPEROXIDE-DISMUTASE GENE; PRION-LIKE PROPAGATION; RNA-BINDING PROTEINS; BAC TRANSGENIC MICE; FAMILIAL ALS	Amyotrophic lateral sclerosis (ALS) is a progressive and uniformly fatal neurodegenerative disease. A plethora of genetic factors have been identified that drive the degeneration of motor neurons in ALS, increase susceptibility to the disease or influence the rate of its progression. Emerging themes include dysfunction in RNA metabolism and protein homeostasis, with specific defects in nucleocytoplasmic trafficking, the induction of stress at the endoplasmic reticulum and impaired dynamics of ribonucleoprotein bodies such as RNA granules that assemble through liquid-liquid phase separation. Extraordinary progress in understanding the biology of ALS provides new reasons for optimism that meaningful therapies will be identified.	[Taylor, J. Paul] St Jude Childrens Res Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA; [Taylor, J. Paul] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA; [Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Cleveland, Don W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Massachusetts System; University of Massachusetts Worcester; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, 332 N Lauderdale St, Memphis, TN 38105 USA.; Taylor, JP (corresponding author), St Jude Childrens Res Hosp, Dept Cell & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA.; Brown, RH (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01655 USA.; Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.; Cleveland, DW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jpaul.taylor@stjude.org; robert.brown@umassmed.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349; Cleveland, Don/0000-0002-1934-3682	Howard Hughes Medical Institute; US National Institute of Neurological Disorders and Stroke (NINDS); American Lebanese Syrian Associated Charities; Target ALS; US ALS Association; NINDS; ALS Association; ALS Finding a Cure; ALS ONE; Angel Fund for ALS Research; Project ALS; Ludwig Institute for Cancer Research; NINDS [R01 NS27036]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R35NS097974, R01NS027036] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); US National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Target ALS; US ALS Association; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ALS Association; ALS Finding a Cure; ALS ONE; Angel Fund for ALS Research; Project ALS; Ludwig Institute for Cancer Research; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We apologize for the many studies we were unable to cite because of space limitations. The authors gratefully acknowledge the artwork and editorial assistance provided by N. Nedelsky and H.-J. Kim and the provision of histopathology images by J. Ravits and S. Saberi. J.P.T. receives support from the Howard Hughes Medical Institute, the US National Institute of Neurological Disorders and Stroke (NINDS), the American Lebanese Syrian Associated Charities, Target ALS and the US ALS Association. R.H.B. receives support from NINDS, the ALS Association, ALS Finding a Cure, ALS ONE, the Angel Fund for ALS Research and Project ALS. D.W.C. receives salary support from the Ludwig Institute for Cancer Research and is supported by funding from NINDS (R01 NS27036), the ALS Association and Target ALS.	Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Al-Sarraj S, 2011, ACTA NEUROPATHOL, V122, P691, DOI 10.1007/s00401-011-0911-2; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Atanasio A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23204; Ayers JI, 2016, ACTA NEUROPATHOL, V131, P103, DOI 10.1007/s00401-015-1514-0; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Brown RH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3533; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Buratti E, 2009, ADV GENET, V66, P1, DOI 10.1016/S0065-2660(09)66001-6; Burberry A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6038; Burguete AS, 2015, ELIFE, V4, DOI [10.7554/eLife.0881, 10.7554/eLife.08881]; Chanson JB, 2010, NEURODEGENER DIS, V7, P260, DOI 10.1159/000273591; Chen HJ, 2010, J BIOL CHEM, V285, P40266, DOI 10.1074/jbc.M110.161398; Chen XJ, 2007, J NEUROSCI, V27, P14515, DOI 10.1523/JNEUROSCI.4338-07.2007; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; CLEVELAND DW, 1995, NATURE, V378, P342, DOI 10.1038/378342a0; Cloutier F, 2015, J MOL NEUROSCI, V56, P102, DOI 10.1007/s12031-014-0471-8; Cooper-Knock J, 2015, ACTA NEUROPATHOL, V130, P63, DOI 10.1007/s00401-015-1429-9; Cooper-Knock J, 2012, BRAIN, V135, P751, DOI 10.1093/brain/awr365; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Emde A, 2015, EMBO J, V34, P2633, DOI 10.15252/embj.201490493; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gamez J, 2006, J NEUROL SCI, V247, P21, DOI 10.1016/j.jns.2006.03.006; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Huelga SC, 2012, CELL REP, V1, P167, DOI 10.1016/j.celrep.2012.02.001; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Ishiguro A, 2016, GENES CELLS, V21, P466, DOI 10.1111/gtc.12352; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Jovicic A, 2015, NAT NEUROSCI, V18, P1226, DOI 10.1038/nn.4085; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Koppers M, 2015, ANN NEUROL, V78, P426, DOI 10.1002/ana.24453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwon I, 2014, SCIENCE, V345, P1139, DOI 10.1126/science.1254917; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lagier-Tourenne C, 2012, NAT NEUROSCI, V15, P1488, DOI 10.1038/nn.3230; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lee JG, 2016, NAT CELL BIOL, V18, P765, DOI 10.1038/ncb3372; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Lee YJ, 2012, NATURE, V487, P443, DOI 10.1038/nature11314; Lepore AC, 2008, NAT NEUROSCI, V11, P1294, DOI 10.1038/nn.2210; Lim SM, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0075-6; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Ling JP, 2015, SCIENCE, V349, P650, DOI 10.1126/science.aab0983; Lippa CF, 2009, ARCH NEUROL-CHICAGO, V66, P1483, DOI 10.1001/archneurol.2009.277; Liu Q., 2016, NEUROLOGY; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Mackenzie IRA, 2015, ACTA NEUROPATHOL, V130, P845, DOI 10.1007/s00401-015-1476-2; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Morita M, 2006, NEUROLOGY, V66, P839, DOI 10.1212/01.wnl.0000200048.53766.b4; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Parone PA, 2013, J NEUROSCI, V33, P4657, DOI 10.1523/JNEUROSCI.1119-12.2013; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Perlson E, 2009, J NEUROSCI, V29, P9903, DOI 10.1523/JNEUROSCI.0813-09.2009; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Ramaswami M, 2013, CELL, V154, P727, DOI 10.1016/j.cell.2013.07.038; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Salajegheh M, 2009, MUSCLE NERVE, V40, P19, DOI 10.1002/mus.21386; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Schludi MH, 2015, ACTA NEUROPATHOL, V130, P537, DOI 10.1007/s00401-015-1450-z; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Shang YL, 2016, BRAIN RES, V1647, P65, DOI 10.1016/j.brainres.2016.03.036; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Smith BN, 2014, NEURON, V84, P324, DOI 10.1016/j.neuron.2014.09.027; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Taylor JP, 2014, NATURE, V507, P175, DOI 10.1038/nature13067; Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0; Tollervey JR, 2011, NAT NEUROSCI, V14, P452, DOI 10.1038/nn.2778; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Valdez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093140; Van Damme P, 2007, P NATL ACAD SCI USA, V104, P14825, DOI 10.1073/pnas.0705046104; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Vance C, 2006, BRAIN, V129, P868, DOI 10.1093/brain/awl030; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Waite A. J., NEUROBIOL AGING, V35; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Webster CP, 2016, EMBO J, V35, P1656, DOI 10.15252/embj.201694401; Wen XM, 2014, NEURON, V84, P1213, DOI 10.1016/j.neuron.2014.12.010; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Yamakawa M, 2015, HUM MOL GENET, V24, P1630, DOI 10.1093/hmg/ddu576; Yamanaka K, 2008, P NATL ACAD SCI USA, V105, P7594, DOI 10.1073/pnas.0802556105; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973; Zhang YJ, 2016, NAT NEUROSCI, V19, P668, DOI 10.1038/nn.4272; Zhang YJ, 2014, ACTA NEUROPATHOL, V128, P505, DOI 10.1007/s00401-014-1336-5; Zhang ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076055; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	147	1056	1078	35	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					197	206		10.1038/nature20413	http://dx.doi.org/10.1038/nature20413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830784	Green Accepted			2022-12-28	WOS:000387318500030
J	Legato, MJ; Johnson, PA; Manson, JE				Legato, Marianne J.; Johnson, Paula A.; Manson, JoAnn E.			Consideration of Sex Differences in Medicine to Improve Health Care and Patient Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK-FACTOR; GENDER; PERSPECTIVES; TRIAL		[Legato, Marianne J.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Johnson, Paula A.] Wellesley Coll, Wellesley, MA 02181 USA; [Manson, JoAnn E.] Harvard Med Sch, Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, Boston, MA USA; [Manson, JoAnn E.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Columbia University; Wellesley College; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Manson, JE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, 900 Commonwealth Ave,Third Floor, Boston, MA 02215 USA.	jmanson@rics.bwh.harvard.edu						Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Garcia M, 2016, CIRC RES, V118, P1273, DOI 10.1161/CIRCRESAHA.116.307547; Ghali JK, 2002, CIRCULATION, V105, P1585, DOI 10.1161/01.CIR.0000012546.20194.33; Lundberg V, 1997, J INTERN MED, V241, P485; MAKKAR RR, 1993, JAMA-J AM MED ASSOC, V270, P2590, DOI 10.1001/jama.270.21.2590; Niewada M, 2005, NEUROEPIDEMIOLOGY, V24, P123, DOI 10.1159/000082999; OS I, 1992, LANCET, V339, P372, DOI 10.1016/0140-6736(92)91694-4; Wing LMH, 2003, NEW ENGL J MED, V348, P583, DOI 10.1056/NEJMoa021716; Wolbrette DL, 2003, AM J CARDIOL, V91, p39D, DOI 10.1016/S0002-9149(02)03378-7	9	90	90	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1865	1866		10.1001/jama.2016.13995	http://dx.doi.org/10.1001/jama.2016.13995			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27802499				2022-12-28	WOS:000387116500009
J	Chen, TY; Robinson, LF; Beasley, MP; Claxton, LM; Andersen, MB; Gregoire, LJ; Wadham, J; Fornari, DJ; Harpp, KS				Chen, Tianyu; Robinson, Laura F.; Beasley, Matthew P.; Claxton, Louis M.; Andersen, Morten B.; Gregoire, Lauren J.; Wadham, Jemma; Fornari, Daniel J.; Harpp, Karen S.			Ocean mixing and ice-sheet control of seawater U-234/U-238 during the last deglaciation	SCIENCE			English	Article							SEA-LEVEL; OVERTURNING CIRCULATION; GLACIAL MAXIMUM; HOLOCENE; COLLAPSE; BENEATH; CORALS; BUDGET; MODEL; WATER	Seawater U-234/U-238 provides global-scale information about continental weathering and is vital for marine uranium-series geochronology. Existing evidence supports an increase in U-234/U-238 since the last glacial period, but the timing and amplitude of its variability has been poorly constrained. Here we report two seawater U-234/U-238 records based on well-preserved deep-sea corals from the low-latitude Atlantic and Pacific Oceans. The Atlantic U-234/U-238 started to increase before major sea-level rise and overshot the modern value by 3 per mil during the early deglaciation. Deglacial U-234/U-238 in the Pacific converged with that in the Atlantic after the abrupt resumption of Atlantic meridional overturning. We suggest that ocean mixing and early deglacial release of excess U-234 from enhanced subglacial melting of the Northern Hemisphere ice sheets have driven the observed U-234/U-238 evolution.	[Chen, Tianyu; Robinson, Laura F.; Beasley, Matthew P.; Claxton, Louis M.] Univ Bristol, Sch Earth Sci, Bristol Isotope Grp, Bristol, Avon, England; [Andersen, Morten B.] ETH, Dept Earth Sci, Inst Geochem & Petr, Zurich, Switzerland; [Andersen, Morten B.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, S Glam, Wales; [Gregoire, Lauren J.] Univ Leeds, Sch Earth & Environm, Leeds, W Yorkshire, England; [Wadham, Jemma] Univ Bristol, Sch Geog Sci, Bristol Glaciol Ctr, Bristol, Avon, England; [Fornari, Daniel J.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Harpp, Karen S.] Colgate Univ, Dept Geol, 13 Oak Dr, Hamilton, NY 13346 USA	University of Bristol; Swiss Federal Institutes of Technology Domain; ETH Zurich; Cardiff University; University of Leeds; University of Bristol; Woods Hole Oceanographic Institution; Colgate University	Chen, TY (corresponding author), Univ Bristol, Sch Earth Sci, Bristol Isotope Grp, Bristol, Avon, England.	tc14502@bristol.ac.uk	Wadham, Jemma L/G-3138-2014; Gregoire, Lauren J/A-7005-2011	Gregoire, Lauren J/0000-0003-0258-7282; Robinson, Laura/0000-0001-6811-0140	European Research Council; Natural Environment Research Council; Philip Leverhulme Trust; U.S. National Science Foundation; Marie Curie Reintegration Grant; NOAA (National Oceanic and Atmospheric Administration) Ocean Exploration Trust; Natural Environment Research Council [NE/H023879/1, NE/N003861/1] Funding Source: researchfish; NERC [NE/N003861/1, NE/H023879/1] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Philip Leverhulme Trust; U.S. National Science Foundation(National Science Foundation (NSF)); Marie Curie Reintegration Grant(European Commission); NOAA (National Oceanic and Atmospheric Administration) Ocean Exploration Trust; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Data related to this work are available in the supplementary materials. Insightful comments from two anonymous reviewers helped us improve the manuscript. We thank C. Taylor and C. Coath for help in the laboratory. This study was funded by the European Research Council, the Natural Environment Research Council, the Philip Leverhulme Trust, the U.S. National Science Foundation, a Marie Curie Reintegration Grant, and the NOAA (National Oceanic and Atmospheric Administration) Ocean Exploration Trust. We also thank the Charles Darwin Foundation, Galapagos National Park, and INOCAR (Instituto Oceanografico de la Armada) for making the Galapagos sampling possible.	Andersen MB, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003318; Andersen MB, 2009, GEOCHIM COSMOCHIM AC, V73, P4124, DOI 10.1016/j.gca.2009.04.020; Bohm E, 2015, NATURE, V517, P73, DOI 10.1038/nature14059; Chabaux F, 2003, REV MINERAL GEOCHEM, V52, P533, DOI 10.2113/0520533; Clark PU, 2012, P NATL ACAD SCI USA, V109, pE1134, DOI 10.1073/pnas.1116619109; Cutler KB, 2004, RADIOCARBON, V46, P1127, DOI 10.1017/S0033822200033063; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Dunk RM, 2002, CHEM GEOL, V190, P45, DOI 10.1016/S0009-2541(02)00110-9; Esat TM, 2006, GEOCHIM COSMOCHIM AC, V70, P4140, DOI 10.1016/j.gca.2006.06.013; Esat TM, 2010, GEOCHIM COSMOCHIM AC, V74, P7008, DOI 10.1016/j.gca.2010.09.007; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Gregoire LJ, 2012, NATURE, V487, P219, DOI 10.1038/nature11257; Hawkings J, 2016, GLOBAL BIOGEOCHEM CY, V30, P191, DOI 10.1002/2015GB005237; Henderson GM, 2006, CHEM GEOL, V226, P298, DOI 10.1016/j.chemgeo.2005.09.026; Henderson GM, 2002, EARTH PLANET SC LETT, V199, P97, DOI 10.1016/S0012-821X(02)00556-3; Jaccard SL, 2012, NAT GEOSCI, V5, P151, DOI [10.1038/ngeo1352, 10.1038/NGEO1352]; KIGOSHI K, 1971, SCIENCE, V173, P47, DOI 10.1126/science.173.3991.47; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Le Brocq AM, 2013, NAT GEOSCI, V6, P945, DOI [10.1038/ngeo1977, 10.1038/NGEO1977]; Lynch-Stieglitz J, 2014, NAT GEOSCI, V7, P144, DOI [10.1038/ngeo2045, 10.1038/NGEO2045]; Marshall SJ, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015192; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Mikucki JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7831; Peltier WR, 2015, J GEOPHYS RES-SOL EA, V120, P450, DOI 10.1002/2014JB011176; Raiswell R, 2008, GEOCHEM T, V9, DOI 10.1186/1467-4866-9-7; Robinson LF, 2004, SCIENCE, V305, P851, DOI 10.1126/science.1099673; Simon MH, 2015, PALEOCEANOGRAPHY, V30, P1318, DOI 10.1002/2015PA002842; Stokes CR, 2016, NATURE, V530, P322, DOI 10.1038/nature16947; Thompson WG, 2011, NAT GEOSCI, V4, P684, DOI [10.1038/ngeo1253, 10.1038/NGEO1253]; Tissot FLH, 2015, GEOCHIM COSMOCHIM AC, V167, P113, DOI 10.1016/j.gca.2015.06.034; Ullman DJ, 2015, NAT GEOSCI, V8, P534, DOI [10.1038/ngeo2463, 10.1038/NGEO2463]; Yokoyama Y, 2016, P NATL ACAD SCI USA, V113, P2354, DOI 10.1073/pnas.1516908113; Zhou JZ, 2005, CHEM GEOL, V221, P1, DOI 10.1016/j.chemgeo.2005.02.005	33	27	27	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					626	629		10.1126/science.aag1015	http://dx.doi.org/10.1126/science.aag1015			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811276	Green Submitted, Green Accepted			2022-12-28	WOS:000386869800051
J	Cornwall, W				Cornwall, Warren			CLIMATE CHANGE Sea ice shrinks in step with carbon emissions	SCIENCE			English	News Item																			0	3	3	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					533	534		10.1126/science.354.6312.533	http://dx.doi.org/10.1126/science.354.6312.533			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811243				2022-12-28	WOS:000386869800011
J	Kyriacou, DN; Lewis, RJ				Kyriacou, Demetrios N.; Lewis, Roger J.			Confounding by Indication in Clinical Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kyriacou, Demetrios N.] Northwestern Univ, Dept Emergency Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Kyriacou, Demetrios N.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Lewis, Roger J.] Harbor UCLA Med Ctr, Dept Emergency Med, Los Angeles, CA USA; [Lewis, Roger J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kyriacou, DN (corresponding author), Northwestern Univ, Feinberg Sch Med, 211 Ontario St,Ste 200, Chicago, IL 60611 USA.	d-kyriacou@northwestern.edu						Andersen LW, 2016, JAMA-J AM MED ASSOC, V316, P1786, DOI 10.1001/jama.2016.14486; Black N, 1996, BRIT MED J, V312, P1215; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Haukoos JS, 2015, JAMA-J AM MED ASSOC, V314, P1637, DOI 10.1001/jama.2015.13480; McNamee R, 2003, OCCUP ENVIRON MED, V60, P227, DOI 10.1136/oem.60.3.227; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Szklo M, 2014, EPIDEMIOLOGY BASICS; Tolles J, 2016, JAMA-J AM MED ASSOC, V316, P533, DOI 10.1001/jama.2016.7653	9	216	218	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1818	1819		10.1001/jama.2016.16435	http://dx.doi.org/10.1001/jama.2016.16435			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802529				2022-12-28	WOS:000386569300021
J	[Anonymous]				[Anonymous]			Buprenorphine Implants (Probuphine) for Opioid Dependence (Reprinted from The Medical Letter on Drugs and Therapeutics, vol 58, pg 94, 2016)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 2016, MED LETT DRUGS THER, V58, P94; [Anonymous], 2016, Med Lett Drugs Ther, V58, pe46; [Anonymous], 2016, MED LETT DRUGS THER, V58, P47; [Anonymous], 2015, MED LETT DRUGS THER, V57, P19; Mattick RP, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002207.pub3; Rosenthal R., 2016, COLL PROBL DRUG DEP	6	4	5	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1820	1821		10.1001/jama.2016.10899	http://dx.doi.org/10.1001/jama.2016.10899			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802544				2022-12-28	WOS:000386569300022
J	Mervis, J				Mervis, Jeffrey			Name that offender? It depends	SCIENCE			English	Editorial Material																			0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					410	410		10.1126/science.354.6311.410	http://dx.doi.org/10.1126/science.354.6311.410			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789824				2022-12-28	WOS:000387684400019
J	Abbasi, J				Abbasi, Jennifer			Expert Panel Makes Cancer Moonshot Funding Recommendations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1636	1636		10.1001/jama.2016.15478	http://dx.doi.org/10.1001/jama.2016.15478			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784080				2022-12-28	WOS:000386107800005
J	Govero, J; Esakky, P; Scheaffer, SM; Fernandez, E; Drury, A; Platt, DJ; Gorman, MJ; Richner, JM; Caine, EA; Salazar, V; Moley, KH; Diamond, MS				Govero, Jennifer; Esakky, Prabagaran; Scheaffer, Suzanne M.; Fernandez, Estefania; Drury, Andrea; Platt, Derek J.; Gorman, Matthew J.; Richner, Justin M.; Caine, Elizabeth A.; Salazar, Vanessa; Moley, Kelle H.; Diamond, Michael S.			Zika virus infection damages the testes in mice	NATURE			English	Article							SEXUAL TRANSMISSION; RECEPTOR; SEMEN; SPERMATOGENESIS; MODEL	Infection of pregnant women with Zika virus (ZIKV) can cause congenital malformations including microcephaly, which has focused global attention on this emerging pathogen(1). In addition to transmission by mosquitoes, ZIKV can be detected in the seminal fluid of affected males for extended periods of time and transmitted sexually(2). Here, using a mouse-adapted African ZIKV strain (Dakar 41519), we evaluated the consequences of infection in the male reproductive tract of mice. We observed persistence of ZIKV, but not the closely related dengue virus (DENV), in the testis and epididymis of male mice, and this was associated with tissue injury that caused diminished testosterone and inhibin B levels and oligospermia. ZIKV preferentially infected spermatogonia, primary spermatocytes and Sertoli cells in the testis, resulting in cell death and destruction of the seminiferous tubules. Less damage was caused by a contemporary Asian ZIKV strain (H/PF/2013), in part because this virus replicates less efficiently in mice. The extent to which these observations in mice translate to humans remains unclear, but longitudinal studies of sperm function and viability in ZIKV-infected humans seem warranted.	[Govero, Jennifer; Richner, Justin M.; Caine, Elizabeth A.; Salazar, Vanessa; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Esakky, Prabagaran; Scheaffer, Suzanne M.; Drury, Andrea; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Fernandez, Estefania; Gorman, Matthew J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Platt, Derek J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Moley, Kelle H.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.	moleyk@wustl.edu; diamond@wusm.wustl.edu	amsalu, ribka/G-8780-2019; Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Salazar, Vanessa/0000-0002-1947-6039; Richner, Justin/0000-0002-5344-118X; Platt, Derek/0000-0003-0766-4590; PEREZ-ALBELA FERNANDEZ, EDUARDO/0000-0002-1428-6041; ESAKKY, PRABAGARAN/0000-0003-4688-2427	NIH [R01 AI073755, R01 AI104972, R01 HD065435, R01HD083895, T32 AI007163]; Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences [UL1 TR000448]; Washington University Institute of Clinical and Translational Sciences from the National Institute of General Medical Sciences [P41 GM103422-35]; Veteran Affairs Office of Research and Development [IO1BX007080]; Eunice Kennedy Shriver NICHD/NIH (NCTRI) [P50-HD28934]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065435, P50HD028934, R01HD083895] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083019, R01AI104972, T32AI007163, R01AI073755, T32AI007172, R01AI101400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington University Institute of Clinical and Translational Sciences from the National Center for Advancing Translational Sciences; Washington University Institute of Clinical and Translational Sciences from the National Institute of General Medical Sciences; Veteran Affairs Office of Research and Development; Eunice Kennedy Shriver NICHD/NIH (NCTRI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH grants (R01 AI073755 and R01 AI104972 to M.S.D., R01 HD065435 and R01HD083895 to K.H.M., and T32 AI007163 (E.F.)) supported this work. This work was supported by the Washington University Institute of Clinical and Translational Sciences (UL1 TR000448 from the National Center for Advancing Translational Sciences and P41 GM103422-35 from the National Institute of General Medical Sciences to K.H.M.), as well as a grant from the Veteran Affairs Office of Research and Development IO1BX007080 to K.H.M.). The authors thank J. Miner, T. Pierson, P.A. Felder and J. Halabi for technical assistance, manuscript review and data analysis. The testosterone and inhibin B assays were processed by the University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core, which is supported by the Eunice Kennedy Shriver NICHD/NIH (NCTRI) Grant P50-HD28934.	Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Esakky P, 2013, REPROD SCI, V20, P238, DOI 10.1177/1933719112452939; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hansen DA, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.108845; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Le Goffic R, 2003, J VIROL, V77, P3297, DOI 10.1128/JVI.77.5.3297-3300.2003; Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X; Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0; Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Morrow CMK, 2007, ANN NY ACAD SCI, V1120, P144, DOI 10.1196/annals.1411.005; Mullen TE, 2003, AIDS RES HUM RETROV, V19, P235, DOI 10.1089/088922203763315740; Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Oehler E, 2013, EUROSURVEILLANCE, V19, P20720, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002; Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025; Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9; Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507; Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020	35	346	360	8	99	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633					438	+		10.1038/nature20556	http://dx.doi.org/10.1038/nature20556			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27798603	Green Accepted, Bronze			2022-12-28	WOS:000389716800043
J	Robertson, C; Kesselheim, AS				Robertson, Christopher; Kesselheim, Aaron S.			Regulating Off-Label Promotion - A Critical Test	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Robertson, Christopher] Univ Arizona, Regulatory Sci Program, Tucson, AZ 85721 USA; [Robertson, Christopher] Univ Arizona, James E Rogers Coll Law, Tucson, AZ 85721 USA; [Robertson, Christopher] NYU, Sch Law, New York, NY 10003 USA; [Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, 75 Francis St, Boston, MA 02115 USA; [Kesselheim, Aaron S.] Harvard Med Sch, Boston, MA USA	University of Arizona; University of Arizona; New York University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Robertson, C (corresponding author), Univ Arizona, Regulatory Sci Program, Tucson, AZ 85721 USA.; Robertson, C (corresponding author), Univ Arizona, James E Rogers Coll Law, Tucson, AZ 85721 USA.; Robertson, C (corresponding author), NYU, Sch Law, New York, NY 10003 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Hey SP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001978; [Pharmaceutical Research and Manufacturers of America Biotechnology Innovation Organization], 2016, PRINC RESP SHAR TRUT; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Robertson C, 2014, BOSTON U LAW REV, V94, P545; Wang B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4679	5	10	10	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 15	2016	375	24					2313	2315		10.1056/NEJMp1611755	http://dx.doi.org/10.1056/NEJMp1611755			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF0SO	27805841	Green Published			2022-12-28	WOS:000390036500001
J	Han, CZ; Juncadella, IJ; Kinchen, JM; Buckley, MW; Klibanov, AL; Dryden, K; Onengut-Gumuscu, S; Erdbrugger, U; Turner, SD; Shim, YM; Tung, KS; Ravichandran, KS				Han, Claudia Z.; Juncadella, Ignacio J.; Kinchen, Jason M.; Buckley, Monica W.; Klibanov, Alexander L.; Dryden, Kelly; Onengut-Gumuscu, Suna; Erdbruegger, Uta; Turner, Stephen D.; Shim, Yun M.; Tung, Kenneth S.; Ravichandran, Kodi S.			Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation	NATURE			English	Article							EPITHELIAL-CELLS; IN-VIVO; APOPTOTIC CELLS; CRE/LOXP SYSTEM; GROWTH; RECEPTOR; MICE; ASTHMA; REQUIREMENT; HOMEOSTASIS	Professional phagocytes (such as macrophages(1)) and nonprofessional phagocytes(2-8) (such as epithelial cells) clear billions of apoptotic cells and particles on a daily basis(9). Although professional and non-professional macrophages reside in proximity in most tissues, whether they communicate with each other during cell clearance, and how this might affect inflammation, is not known(10). Here we show that macrophages, through the release of a soluble growth factor and microvesicles, alter the type of particles engulfed by non-professional phagocytes and influence their inflammatory response. During phagocytosis of apoptotic cells or in response to inflammation-associated cytokines, macrophages released insulin-like growth factor 1 (IGF-1). The binding of IGF-1 to its receptor on non-professional phagocytes redirected their phagocytosis, such that uptake of larger apoptotic cells was reduced whereas engulfment of microvesicles was increased. IGF-1 did not alter engulfment by macrophages. Macrophages also released microvesicles, whose uptake by epithelial cells was enhanced by IGF-1 and led to decreased inflammatory responses by epithelial cells. Consistent with these observations, deletion of IGF-1 receptor in airway epithelial cells led to exacerbated lung inflammation after allergen exposure. These genetic and functional studies reveal that IGF-1-and microvesicle-dependent communication between macrophages and epithelial cells can critically influence the magnitude of tissue inflammation in vivo.	[Han, Claudia Z.; Juncadella, Ignacio J.; Kinchen, Jason M.; Buckley, Monica W.; Ravichandran, Kodi S.] Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22903 USA; [Han, Claudia Z.; Buckley, Monica W.; Ravichandran, Kodi S.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA; [Klibanov, Alexander L.; Shim, Yun M.; Tung, Kenneth S.] Univ Virginia, Dept Med, Charlottesville, VA 22903 USA; [Klibanov, Alexander L.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22903 USA; [Dryden, Kelly] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA; [Onengut-Gumuscu, Suna] Univ Virginia, Div Endocrinol & Metab, Dept Med, Charlottesville, VA 22903 USA; [Onengut-Gumuscu, Suna] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22903 USA; [Erdbruegger, Uta] Univ Virginia, Dept Med, Div Nephrol, Charlottesville, VA 22903 USA; [Turner, Stephen D.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22903 USA; [Tung, Kenneth S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Ravichandran, KS (corresponding author), Univ Virginia, Ctr Cell Clearance, Charlottesville, VA 22903 USA.; Ravichandran, KS (corresponding author), Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22903 USA.	ravi@virginia.edu	Kinchen, Jason/ABC-5663-2021; Shim, Yun Michael/N-2049-2017; Turner, Stephen/GXM-4654-2022	Shim, Yun Michael/0000-0002-3780-3371; Turner, Stephen/0000-0001-9140-9028; Ravichandran, Kodi/0000-0001-9049-1410; Kinchen, Jason/0000-0001-8430-2265	NIGMS [GM064709]; NIMH [MH096484]; NHLBI [P01HL120840, HL132287, HL091127]; Center for Cell Signalling at the University of Virginia; NIH [T32 GM008136, T32 AI007496, T32 GM007267];  [K23 HL12610]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL091127, R41HL115965, P01HL120840, R01HL132287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007496, R01AI041236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136, R01GM064709, T32GM007267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH096484] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Center for Cell Signalling at the University of Virginia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank members of the Ravichandran laboratory for discussions and critical reading of manuscript; S. Arandjelovic, K. Penberthy, and L. Haney for scoring histology slides, and J. Perry for assistance with generation of the heat map, and the UVa Flow Cytometry Core and the UVa Molecular Electron Microscopy Core. This work is supported by grants to K.S.R. from the NIGMS (GM064709), NIMH (MH096484), NHLBI (P01HL120840), and Center for Cell Signalling at the University of Virginia, NHLBI (HL132287 and HL091127) to Y.M.S. and K23 HL12610 to U.E. Additional support was provided via the NIH Training Grants T32 GM008136 (Cell and Molecular Biology) to C.Z.H.; T32 AI007496 (Immunology) to C.Z.H., M.W.B., and I.J.J.; and T32 GM007267 (MSTP) to M.W.B.	Bissonnette EY, 2014, J ASTHMA, V51, P119, DOI 10.3109/02770903.2013.860164; Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Burstyn-Cohen T, 2012, NEURON, V76, P1123, DOI 10.1016/j.neuron.2012.10.015; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chamberland A, 2009, EXP LUNG RES, V35, P399, DOI 10.1080/01902140902745174; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Elliott MR, 2010, NATURE, V467, P333, DOI 10.1038/nature09356; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Green DR, 2011, IMMUNITY, V35, P441, DOI 10.1016/j.immuni.2011.10.003; Gregory CD, 2010, APOPTOSIS, V15, P1029, DOI 10.1007/s10495-010-0485-9; Hahn YS, 2003, J IMMUNOL, V171, P3170, DOI 10.4049/jimmunol.171.6.3170; Hetrick B, 2013, CHEM BIOL, V20, P701, DOI 10.1016/j.chembiol.2013.03.019; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; LeRoith D, 2000, ENDOCRINOLOGY, V141, P1287, DOI 10.1210/en.141.4.1287; Leverrier Y, 2001, CURR BIOL, V11, P195, DOI 10.1016/S0960-9822(01)00047-1; Liu JL, 2000, P SOC EXP BIOL MED, V223, P344, DOI 10.1046/j.1525-1373.2000.22349.x; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Lu ZJ, 2011, NAT CELL BIOL, V13, P1076, DOI 10.1038/ncb2299; MARINI M, 1992, J ALLERGY CLIN IMMUN, V89, P1001, DOI 10.1016/0091-6749(92)90223-O; Mesa KR, 2015, NATURE, V522, P94, DOI 10.1038/nature14306; Mulvihill MJ, 2009, FUTURE MED CHEM, V1, P1153, DOI 10.4155/FMC.09.89; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Schlam D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9623; Smith TJ, 2010, PHARMACOL REV, V62, P199, DOI 10.1124/pr.109.002469; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Tosello-Trampont AC, 2001, J BIOL CHEM, V276, P13797, DOI 10.1074/jbc.M011238200; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wood W, 2000, DEVELOPMENT, V127, P5245; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yarmola EG, 2000, J BIOL CHEM, V275, P28120; YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	41	132	139	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					570	+		10.1038/nature20141	http://dx.doi.org/10.1038/nature20141			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27820945	Green Accepted			2022-12-28	WOS:000388520600045
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING What now for Obamacare?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Kamerow, Douglas] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA.; Kamerow, D (corresponding author), Georgetown Univ, Family Med, Washington, DC 20057 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Goldstein A., 2016, WASHINGTON POST; Haberkorn J., 2016, POLITICO; McCarthy M, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6045; McCaskill ND, 2016, POLITICO	4	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2016	355								i6063	10.1136/bmj.i6063	http://dx.doi.org/10.1136/bmj.i6063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CV	27834265				2022-12-28	WOS:000388003200011
J	Alexandrov, LB; Ju, YS; Haase, K; Van Loo, P; Martincorena, I; Nik-Zainal, S; Totoki, Y; Fujimoto, A; Nakagawa, H; Shibata, T; Campbell, PJ; Vineis, P; Phillips, DH; Stratton, MR				Alexandrov, Ludmil B.; Ju, Young Seok; Haase, Kerstin; Van Loo, Peter; Martincorena, Inigo; Nik-Zainal, Serena; Totoki, Yasushi; Fujimoto, Akihiro; Nakagawa, Hidewaki; Shibata, Tatsuhiro; Campbell, Peter J.; Vineis, Paolo; Phillips, David H.; Stratton, Michael R.			Mutational signatures associated with tobacco smoking in human cancer	SCIENCE			English	Article							LUNG-CANCER; PROTEIN ADDUCTS; HUMAN TISSUES; DNA; CARCINOGENS; LANDSCAPE; PATTERNS; EXPOSURE; HOTSPOTS; GENOMES	Tobacco smoking increases the risk of at least 17 classes of human cancer. We analyzed somatic mutations and DNA methylation in 5243 cancers of types for which tobacco smoking confers an elevated risk. Smoking is associated with increased mutation burdens of multiple distinct mutational signatures, which contribute to different extents in different cancers. One of these signatures, mainly found in cancers derived from tissues directly exposed to tobacco smoke, is attributable to misreplication of DNA damage caused by tobacco carcinogens. Others likely reflect indirect activation of DNA editing by APOBEC cytidine deaminases and of an endogenous clocklike mutational process. Smoking is associated with limited differences in methylation. The results are consistent with the proposition that smoking increases cancer risk by increasing the somatic mutation load, although direct evidence for this mechanism is lacking in some smoking-related cancer types.	[Alexandrov, Ludmil B.] Los Alamos Natl Lab, Theoret Biol & Biophys T 6, Los Alamos, NM 87545 USA; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA; [Alexandrov, Ludmil B.] Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87102 USA; [Ju, Young Seok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea; [Haase, Kerstin; Van Loo, Peter] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Van Loo, Peter] Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Martincorena, Inigo; Nik-Zainal, Serena; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England; [Nik-Zainal, Serena] Addenbrookes Hosp Natl Hlth Serv Trust, Dept Med Genet, Cambridge, England; [Totoki, Yasushi] Natl Canc Ctr, Res Inst, Div Canc Genom, Chuo Ku, Tokyo, Japan; [Fujimoto, Akihiro; Nakagawa, Hidewaki] RIKEN, Ctr Integrat Med Sci, Lab Genome Sequencing Anal, Tokyo, Japan; [Fujimoto, Akihiro] Kyoto Univ, Grad Sch Med, Dept Drug Discovery Med, Kyoto 6068507, Japan; [Shibata, Tatsuhiro] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Lab Mol Med,Minato Ku, Tokyo, Japan; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 0XY, England; [Vineis, Paolo] Human Genet Fdn, I-10126 Turin, Italy; [Vineis, Paolo] Imperial Coll London, Ctr Environm & Hlth, Sch Publ Hlth, PHE,MRC,Dept Epidemiol & Biostat, Norfolk Pl, London W2 1PG, England; [Phillips, David H.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Analyt & Environm Sci Div, Franklin Wilkins Bldg,150 Stamford St, London SE1 9NH, England	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of New Mexico; Korea Advanced Institute of Science & Technology (KAIST); Francis Crick Institute; KU Leuven; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; National Cancer Center - Japan; RIKEN; Kyoto University; University of Tokyo; University of Cambridge; Imperial College London; University of London; King's College London	Alexandrov, LB (corresponding author), Los Alamos Natl Lab, Theoret Biol & Biophys T 6, Los Alamos, NM 87545 USA.; Alexandrov, LB (corresponding author), Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87545 USA.; Alexandrov, LB (corresponding author), Univ New Mexico, Ctr Comprehens Canc, Albuquerque, NM 87102 USA.; Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England.	lba@lanl.gov; mrs@sanger.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Ju, Young Seok/E-1324-2012; Nik-Zainal, Serena/ABD-4437-2020; Shibata, Tatsuhiro/AAO-1278-2021; Haase, Kerstin/AAQ-2768-2020; Shibata, Tatsuhiro/ABA-8234-2020	Alexandrov, Ludmil/0000-0003-3596-4515; Ju, Young Seok/0000-0002-5514-4189; Haase, Kerstin/0000-0002-0944-5618; Martincorena, Inigo/0000-0003-1122-4416; Van Loo, Peter/0000-0003-0292-1949; Phillips, David/0000-0001-8509-3485	Wellcome Trust [098051, WT100183MA, WT088340MA, FC001202, 101126/Z/13/Z, 101126/B/13/Z]; GRAIL; J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory; U.S. Department of Energy (DOE) National Nuclear Security Administration [DE-AC52-06NA25396]; National Nuclear Security Administration of the DOE; Francis Crick Institute - Cancer Research UK [FC001202]; UK MRC [FC001202]; Cancer Research UK [C313/A14329]; National Institute for Health Research (NIHR) Health Protection Research Unit in Health Impact of Environmental Hazards at King's College London; PHE; European Commission [308610-FP7]; Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development [15ck0106094h0002]; National Cancer Center Research and Development Funds [26-A-5]; Cancer Research UK [14329] Funding Source: researchfish; The Francis Crick Institute [10202] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); GRAIL; J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory; U.S. Department of Energy (DOE) National Nuclear Security Administration(National Nuclear Security AdministrationUnited States Department of Energy (DOE)); National Nuclear Security Administration of the DOE; Francis Crick Institute - Cancer Research UK; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); National Institute for Health Research (NIHR) Health Protection Research Unit in Health Impact of Environmental Hazards at King's College London; PHE; European Commission(European CommissionEuropean Commission Joint Research Centre); Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); National Cancer Center Research and Development Funds; Cancer Research UK(Cancer Research UK); The Francis Crick Institute	This work was supported by the Wellcome Trust (grant 098051). S.N.-Z. is a Wellcome-Beit Prize Fellow and is supported through a Wellcome Trust Intermediate Fellowship (grant WT100183MA). P.J.C. is personally funded through a Wellcome Trust Senior Clinical Research Fellowship (grant WT088340MA). M.R.S. is a paid advisor for GRAIL, a company developing technologies for sequencing of circulating tumor DNA for the purpose of early cancer detection. L.B.A. is personally supported through a J. Robert Oppenheimer Fellowship at Los Alamos National Laboratory. This research used resources provided by the Los Alamos National Laboratory Institutional Computing Program, which is supported by the U.S. Department of Energy (DOE) National Nuclear Security Administration under contract no. DE-AC52-06NA25396. Research performed at Los Alamos National Laboratory was carried out under the auspices of the National Nuclear Security Administration of the DOE. This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (grant FC001202), the UK MRC (grant FC001202), and the Wellcome Trust (grant FC001202). P.V.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation's support toward the establishment of The Francis Crick Institute. D.H.P. is funded by Cancer Research UK (grant C313/A14329), the Wellcome Trust (grants 101126/Z/13/Z and 101126/B/13/Z), the National Institute for Health Research (NIHR) Health Protection Research Unit in Health Impact of Environmental Hazards at King's College London in partnership with PHE [the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, or PHE], and by the project EXPOSOMICS (grant agreement 308610-FP7) (European Commission). P.V. was partially supported by the project EXPOSOMICS (grant agreement 308610-FP7) (European Commission). Y.T. and T.S. are supported by the Practical Research for Innovative Cancer Control from Japan Agency for Medical Research and Development (grant 15ck0106094h0002) and National Cancer Center Research and Development Funds (26-A-5). We thank The Cancer Genome Atlas, the International Cancer Genome Consortium, and the authors of all studies cited in table S1 for providing free access to their somatic mutational data.	Agudo A, 2012, J CLIN ONCOL, V30, P4550, DOI 10.1200/JCO.2011.41.0183; Alexandrov LB, 2015, SCIENCE, V350, DOI 10.1126/science.aad7363; Alexandrov LB, 2015, NAT GENET, V47, P1402, DOI 10.1038/ng.3441; Alexandrov LB, 2014, CURR OPIN GENET DEV, V24, P52, DOI 10.1016/j.gde.2013.11.014; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alexandrov LB, 2013, CELL REP, V3, P246, DOI 10.1016/j.celrep.2012.12.008; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Fujimoto A, 2016, NAT GENET, V48, P500, DOI 10.1038/ng.3547; Govindan R, 2012, CELL, V150, P1121, DOI 10.1016/j.cell.2012.08.024; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kim J, 2016, NAT GENET, V48, P600, DOI 10.1038/ng.3557; Le Calvez F, 2005, CANCER RES, V65, P5076, DOI 10.1158/0008-5472.CAN-05-0551; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Pesch B, 2012, INT J CANCER, V131, P1210, DOI 10.1002/ijc.27339; Pfeifer GP, 1998, ENVIRON MOL MUTAGEN, V31, P197, DOI 10.1002/(SICI)1098-2280(1998)31:3<197::AID-EM1>3.0.CO;2-I; Phillips, 2002, CANC HDB, P293; Phillips DH, 2012, INT J CANCER, V131, P2733, DOI 10.1002/ijc.27827; Phillips DH, 2002, CARCINOGENESIS, V23, P1979, DOI 10.1093/carcin/23.12.1979; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Rubin H, 2002, ONCOGENE, V21, P7392, DOI 10.1038/sj.onc.1205800; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Smith LE, 2000, JNCI-J NATL CANCER I, V92, P803, DOI 10.1093/jnci/92.10.803; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Swanton C, 2015, CANCER DISCOV, V5, P704, DOI 10.1158/2159-8290.CD-15-0344; Teschendorff AE, 2015, JAMA ONCOL, V1, P476, DOI 10.1001/jamaoncol.2015.1053; Tomasetti C, 2015, P NATL ACAD SCI USA, V112, P118, DOI 10.1073/pnas.1421839112	31	551	561	12	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					618	622		10.1126/science.aag0299	http://dx.doi.org/10.1126/science.aag0299			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811275	Green Submitted, Green Accepted			2022-12-28	WOS:000386869800049
J	Naumann, EA; Fitzgerald, JE; Dunn, TW; Rihel, J; Sompolinsky, H; Engert, F				Naumann, Eva A.; Fitzgerald, James E.; Dunn, Timothy W.; Rihel, Jason; Sompolinsky, Haim; Engert, Florian			From Whole-Brain Data to Functional Circuit Models: The Zebrafish Optomotor Response	CELL			English	Article							SPINAL PROJECTION NEURONS; CAENORHABDITIS-ELEGANS; LARVAL ZEBRAFISH; NEURAL CIRCUIT; EYE-MOVEMENTS; GROUND PLAN; BEHAVIOR; DROSOPHILA; HINDBRAIN; MOTION	Detailed descriptions of brain-scale sensorimotor circuits underlying vertebrate behavior remain elusive. Recent advances in zebrafish neuroscience offer new opportunities to dissect such circuits via whole-brain imaging, behavioral analysis, functional perturbations, and network modeling. Here, we harness these tools to generate a brain-scale circuit model of the optomotor response, an orienting behavior evoked by visual motion. We show that such motion is processed by diverse neural response types distributed across multiple brain regions. To transform sensory input into action, these regions sequentially integrate eye- and direction-specific sensory streams, refine representations via interhemispheric inhibition, and demix locomotor instructions to independently drive turning and forward swimming. While experiments revealed many neural response types throughout the brain, modeling identified the dimensions of functional connectivity most critical for the behavior. We thus reveal how distributed neurons collaborate to generate behavior and illustrate a paradigm for distilling functional circuit models from whole-brain data.	[Naumann, Eva A.; Dunn, Timothy W.; Engert, Florian] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Fitzgerald, James E.; Dunn, Timothy W.; Sompolinsky, Haim; Engert, Florian] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Naumann, Eva A.; Rihel, Jason] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Sompolinsky, Haim] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Sompolinsky, Haim] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	Harvard University; Harvard University; University of London; University College London; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Engert, F (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Engert, F (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	florian@mcb.harvard.edu	Fitzgerald, James E/E-6569-2012; Rihel, Jason/G-7106-2011; Zebrafish, UCL/A-3125-2009; Sompolinsky, Haim/ABB-8398-2021	Fitzgerald, James E/0000-0002-0949-4188; Rihel, Jason/0000-0003-4067-2066; Naumann, Eva Aimable/0000-0002-7215-4717	Swartz Foundation; NIH [U01NS090449, DP1 NS082121, R24NS086601]; Simons Foundation [325207]; European Research Council [282027 ZFISHSLEEP]; Marie Curie Fellowship [PIIF-GA-2012-328847]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS086601, DP1NS082121, U01NS090449] Funding Source: NIH RePORTER	Swartz Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; European Research Council(European Research Council (ERC)European Commission); Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Michael Orger for providing Tg(alpha-tubulin:PA-GFP) fish and Michael Orger, Drew Robson, and Jennifer Li for providing Tg(elavl3:GCaMP5G) fish. Misha Ahrens, Isaac Bianco, and Martin Haesemeyer helped with useful discussions. Furthermore, we thank Ruben Portugues, Mariela Petkova, Andrew Bolton, Bence Olveczky, and Alexander Schier for reading the manuscript and providing feedback. We thank Adam Kampff for help with software development and rig design. We acknowledge financial support from the Swartz Foundation; NIH grants U01NS090449, DP1 NS082121, and R24NS086601; the Simons Foundation SCGB#325207; the European Research Council (grant 282027 ZFISHSLEEP); and the Marie Curie Fellowship (grant PIIF-GA-2012-328847).	Ahrens MB, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00104; Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V405, P1, DOI 10.1113/jphysiol.1988.sp017319; Bianco IH, 2015, CURR BIOL, V25, P831, DOI 10.1016/j.cub.2015.01.042; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; Bounoutas A, 2007, PFLUG ARCH EUR J PHY, V454, P691, DOI 10.1007/s00424-006-0187-x; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chedotal A, 2014, TRENDS NEUROSCI, V37, P551, DOI 10.1016/j.tins.2014.08.009; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dunn TW, 2016, ELIFE, V5, DOI 10.7554/eLife.12741; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fink AJP, 2014, NATURE, V509, P43, DOI 10.1038/nature13276; Fisher D, 2013, NEURON, V79, P987, DOI 10.1016/j.neuron.2013.06.041; FITE KV, 1985, BRAIN BEHAV EVOLUT, V26, P71, DOI 10.1159/000118769; Gamlin PDR, 2006, PROG BRAIN RES, V151, P379, DOI 10.1016/S0079-6123(05)51012-4; Gao PR, 2015, CURR OPIN NEUROBIOL, V32, P148, DOI 10.1016/j.conb.2015.04.003; GIOLLI RA, 1984, J COMP NEUROL, V227, P228, DOI 10.1002/cne.902270208; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Heiligenberg W., 1991, NEURAL NETS ELECT FI; Huang KH, 2013, CURR BIOL, V23, P1566, DOI 10.1016/j.cub.2013.06.044; Kato S, 2015, CELL, V163, P656, DOI 10.1016/j.cell.2015.09.034; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; KOONTZ MA, 1985, J COMP NEUROL, V236, P42, DOI 10.1002/cne.902360105; Korn H, 2005, NEURON, V47, P13, DOI 10.1016/j.neuron.2005.05.019; Koyama M, 2011, P NATL ACAD SCI USA, V108, P1170, DOI 10.1073/pnas.1012189108; Kubo F, 2014, NEURON, V81, P1344, DOI 10.1016/j.neuron.2014.02.043; Lee MM, 2015, J NEUROSCI, V35, P7903, DOI 10.1523/JNEUROSCI.3045-14.2015; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Mauss AS, 2015, CELL, V162, P351, DOI 10.1016/j.cell.2015.06.035; O'Leary T, 2015, CURR OPIN NEUROBIOL, V32, P87, DOI 10.1016/j.conb.2015.01.006; Ohyama T, 2015, NATURE, V520, P633, DOI 10.1038/nature14297; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Portugues R, 2014, NEURON, V81, P1328, DOI 10.1016/j.neuron.2014.01.019; Randlett O, 2015, NAT METHODS, V12, P1039, DOI 10.1038/NMETH.3581; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Robles E, 2014, CURR BIOL, V24, P2085, DOI 10.1016/j.cub.2014.07.080; Roeser T, 2003, J NEUROSCI, V23, P3726; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryczko D, 2013, CURR PHARM DESIGN, V19, P4448, DOI 10.2174/1381612811319240011; Sassa T, 2007, DEV DYNAM, V236, P706, DOI 10.1002/dvdy.21084; SCALIA F, 1972, J COMP NEUROL, V145, P223, DOI 10.1002/cne.901450208; Severi KE, 2014, NEURON, V83, P692, DOI 10.1016/j.neuron.2014.06.032; Silies M, 2014, ANNU REV NEUROSCI, V37, P307, DOI 10.1146/annurev-neuro-071013-013931; Sompolinsky H, 2014, CURR OPIN NEUROBIOL, V25, pXIII, DOI 10.1016/j.conb.2014.02.002; Sun WS, 2014, J COMP NEUROL, V522, P3960, DOI 10.1002/cne.23602; VANEGAS H, 1983, BRAIN RES REV, V6, P117, DOI 10.1016/0165-0173(83)90036-X; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320	51	125	126	3	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					947	+		10.1016/j.cell.2016.10.019	http://dx.doi.org/10.1016/j.cell.2016.10.019			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814522	Green Accepted, Bronze			2022-12-28	WOS:000389469000013
J	Levine, NM				Levine, Naomi M.			Putting the spotlight on organic sulfur	SCIENCE			English	Editorial Material							OCEANIC PHYTOPLANKTON; DMSP		[Levine, Naomi M.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Levine, Naomi M.] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Levine, NM (corresponding author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.; Levine, NM (corresponding author), Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	n.levine@usc.edu		Levine, Naomi/0000-0002-4963-0535				Bucciarelli E, 2013, LIMNOL OCEANOGR, V58, P1667, DOI 10.4319/lo.2013.58.5.1667; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Durham BP, 2015, P NATL ACAD SCI USA, V112, P453, DOI 10.1073/pnas.1413137112; Hansell D.A., 2013, MAR SCI, V5, P202; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Johnson WM, 2016, ISME J, V10, P2304, DOI 10.1038/ismej.2016.6; Keller M.D., 1989, ACS (American Chemical Society) Symposium Series, P167; Ksionzek KB, 2016, SCIENCE, V354, P456, DOI 10.1126/science.aaf7796; Levine NM, 2016, ENVIRON CHEM, V13, P302, DOI 10.1071/EN15045; Moran MA, 2016, P NATL ACAD SCI USA, V113, P3143, DOI 10.1073/pnas.1514645113; Seymour JR, 2010, SCIENCE, V329, P342, DOI 10.1126/science.1188418; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659	15	13	13	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					418	419		10.1126/science.aai8650	http://dx.doi.org/10.1126/science.aai8650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789829				2022-12-28	WOS:000387684400024
J	Patel, CH; Powell, JD				Patel, Chirag H.; Powell, Jonathan D.			Warburg meets epigenetics	SCIENCE			English	Editorial Material							T-CELL RESPONSES; EFFECTOR FUNCTION; METABOLISM; GLYCOLYSIS; GLUCOSE		[Patel, Chirag H.; Powell, Jonathan D.] Johns Hopkins Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Immunol CRB Rm 443, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Powell, JD (corresponding author), Johns Hopkins Sch Med, Bloomberg Kimmel Inst Canc Immunotherapy, Immunol CRB Rm 443, Baltimore, MD 21287 USA.	poweljo@jhmi.edu			NIAID NIH HHS [T32 AI007247] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Donnelly RP, 2015, MOL IMMUNOL, V68, P513, DOI 10.1016/j.molimm.2015.07.034; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Lee CF, 2015, CELL REP, V13, P760, DOI 10.1016/j.celrep.2015.09.036; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Warburg O, 1924, BIOCHEM Z, V152, P319; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835	14	5	6	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					419	420		10.1126/science.aak9776	http://dx.doi.org/10.1126/science.aak9776			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789830				2022-12-28	WOS:000387684400025
J	Daniller, A				Daniller, Andrew			Divisive campaigning damages democracy	NATURE			English	Editorial Material									[Daniller, Andrew] Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA	University of Pennsylvania	Daniller, A (corresponding author), Univ Penn, Annenberg Sch Commun, Philadelphia, PA 19104 USA.	adaniller@asc.upenn.edu							0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					429	429		10.1038/538429a	http://dx.doi.org/10.1038/538429a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786217	Bronze			2022-12-28	WOS:000386654400022
J	Tobin, JJ; Kratter, KM; Persson, MV; Looney, LW; Dunham, MM; Segura-Cox, D; Li, ZY; Chandler, CJ; Sadavoy, SI; Harris, RJ; Melis, C; Perez, LM				Tobin, John J.; Kratter, Kaitlin M.; Persson, Magnus V.; Looney, Leslie W.; Dunham, Michael M.; Segura-Cox, Dominique; Li, Zhi-Yun; Chandler, Claire J.; Sadavoy, Sarah I.; Harris, Robert J.; Melis, Carl; Perez, Laura M.			A triple protostar system formed via fragmentation of a gravitationally unstable disk	NATURE			English	Article							PERSEUS MOLECULAR CLOUD; STAR-FORMING REGIONS; CLASS-I SOURCES; CIRCUMSTELLAR DISKS; BROWN DWARF; PROTOPLANETARY DISK; YOUNGEST PROTOSTARS; STELLAR-SYSTEMS; KEPLERIAN DISK; GIANT PLANETS	Binary and multiple star systems are a frequent outcome of the star formation process(1,2) and as a result almost half of all stars with masses similar to that of the Sun have at least one companion star(3). Theoretical studies indicate that there are two main pathways that can operate concurrently to form binary/multiple star systems: large-scale fragmentation of turbulent gas cores and filaments(4,5) or smaller-scale fragmentation of a massive protostellar disk due to gravitational instability(6,7). Observational evidence for turbulent fragmentation on scales of more than 1,000 astronomical units has recently emerged(8,9). Previous evidence for disk fragmentation was limited to inferences based on the separations of more-evolved pre-main sequence and protostellar multiple systems(10-13). The triple protostar system L1448 IRS3B is an ideal system with which to search for evidence of disk fragmentation as it is in an early phase of the star formation process, it is likely to be less than 150,000 years old(14) and all of the protostars in the system are separated by less than 200 astronomical units. Here we report observations of dust and molecular gas emission that reveal a disk with a spiral structure surrounding the three protostars. Two protostars near the centre of the disk are separated by 61 astronomical units and a tertiary protostar is coincident with a spiral arm in the outer disk at a separation of 183 astronomical units(13). The inferred mass of the central pair of protostellar objects is approximately one solar mass, while the disk surrounding the three protostars has a total mass of around 0.30 solar masses. The tertiary protostar itself has a minimum mass of about 0.085 solar masses. We demonstrate that the disk around L1448 IRS3B appears susceptible to disk fragmentation at radii between 150 and 320 astronomical units, overlapping with the location of the tertiary protostar. This is consistent with models for a protostellar disk that has recently undergone gravitational instability, spawning one or two companion stars.	[Tobin, John J.] Univ Oklahoma, Homer L Dodge Dept Phys & Astron, 440 W Brooks St, Norman, OK 73019 USA; [Tobin, John J.; Persson, Magnus V.] Leiden Univ, Leiden Observ, POB 9513, NL-2300 RA Leiden, Netherlands; [Kratter, Kaitlin M.] Univ Arizona, Dept Astron, 933 N Cherry Ave, Tucson, AZ 85721 USA; [Kratter, Kaitlin M.] Univ Arizona, Steward Observ, 933 N Cherry Ave, Tucson, AZ 85721 USA; [Persson, Magnus V.] Chalmers Univ Technol, Dept Earth & Space Sci, Onsala Space Observ, S-43992 Onsala, Sweden; [Looney, Leslie W.; Segura-Cox, Dominique; Harris, Robert J.] Univ Illinois, Dept Astron, Urbana, IL 61801 USA; [Dunham, Michael M.] SUNY Coll Fredonia, Dept Phys, Fredonia, NY 14063 USA; [Li, Zhi-Yun] Univ Virginia, Dept Astron, Charlottesville, VA 22903 USA; [Chandler, Claire J.] Natl Radio Astron Observ, POB O, Socorro, NM 87801 USA; [Sadavoy, Sarah I.] Max Planck Inst Astron, Konigstuhl 17, D-69117 Heidelberg, Germany; [Melis, Carl] Univ Calif San Diego, Ctr Astrophys & Space Sci, San Diego, CA 92093 USA; [Perez, Laura M.] Max Planck Inst Radio Astron, Hugel 69, D-53121 Bonn, Germany	University of Oklahoma System; University of Oklahoma - Norman; Leiden University; Leiden University - Excl LUMC; University of Arizona; University of Arizona; Chalmers University of Technology; University of Illinois System; University of Illinois Urbana-Champaign; State University of New York (SUNY) System; SUNY Fredonia; University of Virginia; National Radio Astronomy Observatory (NRAO); Max Planck Society; University of California System; University of California San Diego; Max Planck Society	Tobin, JJ (corresponding author), Univ Oklahoma, Homer L Dodge Dept Phys & Astron, 440 W Brooks St, Norman, OK 73019 USA.; Tobin, JJ (corresponding author), Leiden Univ, Leiden Observ, POB 9513, NL-2300 RA Leiden, Netherlands.	jjtobin@ou.edu	Persson, Magnus/I-5522-2019; Perez, Laura M/L-1640-2018	Persson, Magnus/0000-0002-1100-5734; Perez, Laura M/0000-0002-1199-9564; Kratter, Kaitlin/0000-0001-5253-1338; Segura-Cox, Dominique/0000-0003-3172-6763; Looney, Leslie/0000-0002-4540-6587	University of Oklahoma; Homer L. Dodge endowed chair; Netherlands Organisation for Scientific Research (NWO) [639.041.439]; National Science Foundation [AST-1410174]; ERC [614264]; A-ERC grant [291141]; CHEMPLAN; NSF [AST-1139950, 313083]; NSF/NRAO [AST-0836064]; NSF from the NRAO [SOSPA2-021]; NASA [NNX14AB38G]; Division Of Astronomical Sciences [1410174] Funding Source: National Science Foundation	University of Oklahoma; Homer L. Dodge endowed chair; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Science Foundation(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); A-ERC grant; CHEMPLAN; NSF(National Science Foundation (NSF)); NSF/NRAO(National Science Foundation (NSF)); NSF from the NRAO; NASA(National Aeronautics & Space Administration (NASA)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J.J.T acknowledges support from the University of Oklahoma, the Homer L. Dodge endowed chair, and grant 639.041.439 from the Netherlands Organisation for Scientific Research (NWO). K.M.K. is supported in part by the National Science Foundation under grant AST-1410174. M.V.P. is supported by ERC consolidator grant 614264 and A-ERC grant 291141 CHEMPLAN. L.W.L and D.S.-C. acknowledge support from NSF AST-1139950 and NSF/NRAO AST-0836064. D.S.-C. acknowledges support for this work was provided by the NSF through award SOSPA2-021 from the NRAO. Z.-Y.L. is supported in part by NSF ASTI 313083 and NASA NNX14AB38G. This paper makes use of the following ALMA data: ADS/JAO.ALMA#2013.1.00031.S. ALMA is a partnership of [SO (representing its member states), NSF (USA) and NINS (Japan), together with NRC (Canada), NSC and ASIAA (Taiwan), and KASI (Republic of Korea), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by [SO. AUI/NRAO and NAOJ. The National Radio Astronomy Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc This research made use of APLpy, an open-source plotting package for Python hosted at http://aplpygithub.com. This research also made use of Astropy, a community-developed core Python package for Astronomy (Astropy Collaboration, 2013; http://www.astropy.org).	ADAMS FC, 1989, ASTROPHYS J, V347, P959, DOI 10.1086/168187; ANDRE P, 1993, ASTROPHYS J, V406, P122, DOI 10.1086/172425; Andrews SM, 2010, ASTROPHYS J, V723, P1241, DOI 10.1088/0004-637X/723/2/1241; Anglada G, 1998, ASTRON J, V116, P2953, DOI 10.1086/300637; Ansdell M, 2016, ASTROPHYS J, V828, DOI 10.3847/0004-637X/828/1/46; Baraffe I, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425481; Bate MR, 2012, MON NOT R ASTRON SOC, V419, P3115, DOI 10.1111/j.1365-2966.2011.19955.x; BECKWITH SVW, 1990, ASTRON J, V99, P924, DOI 10.1086/115385; Bergin EA, 2013, NATURE, V493, P644, DOI 10.1038/nature11805; BOHLIN RC, 1978, ASTROPHYS J, V224, P132, DOI 10.1086/156357; Boley AC, 2010, ICARUS, V207, P509, DOI 10.1016/j.icarus.2010.01.015; BONNELL IA, 1994, MON NOT R ASTRON SOC, V271, P999, DOI 10.1093/mnras/271.4.999; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Connelley MS, 2008, ASTRON J, V135, P2526, DOI 10.1088/0004-6256/135/6/2526; Dipierro G, 2014, MON NOT R ASTRON SOC, V444, P1919, DOI 10.1093/mnras/stu1584; Duchene G, 2013, ANNU REV ASTRON ASTR, V51, P269, DOI 10.1146/annurev-astro-081710-102602; Enoch ML, 2009, ASTROPHYS J, V692, P973, DOI 10.1088/0004-637X/692/2/973; Fisher RT, 2004, ASTROPHYS J, V600, P769, DOI 10.1086/380111; Gammie CF, 2001, ASTROPHYS J, V553, P174, DOI 10.1086/320631; Harsono D, 2014, ASTRON ASTROPHYS, V562, DOI 10.1051/0004-6361/201322646; Hirota T, 2011, PUBL ASTRON SOC JPN, V63, P1, DOI 10.1093/pasj/63.1.1; Jorgensen JK, 2009, ASTRON ASTROPHYS, V507, P861, DOI 10.1051/0004-6361/200912325; KISELEVA LG, 1994, MON NOT R ASTRON SOC, V270, P936, DOI 10.1093/mnras/270.4.936; Kratter KM, 2008, ASTROPHYS J, V681, P375, DOI 10.1086/587543; Kratter KM, 2010, ASTROPHYS J, V708, P1585, DOI 10.1088/0004-637X/708/2/1585; Kraus AL, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/8; Lee KI, 2016, ASTROPHYS J LETT, V820, DOI 10.3847/2041-8205/820/1/L2; Lee KI, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/2/114; Lodato G, 2011, MON NOT R ASTRON SOC, V413, P2735, DOI 10.1111/j.1365-2966.2011.18344.x; Looney LW, 2000, ASTROPHYS J, V529, P477, DOI 10.1086/308239; Maret S., 2015, THINDISK 1 0 COMPUTE; Matzner CD, 2005, ASTROPHYS J, V628, P817, DOI 10.1086/430813; McMullin JP, 2007, ASTR SOC P, V376, P127; Meru F, 2011, MON NOT R ASTRON SOC, V411, pL1, DOI 10.1111/j.1745-3933.2010.00978.x; Murillo NM, 2016, ASTRON ASTROPHYS, V592, DOI 10.1051/0004-6361/201628247; Offner SSR, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/53; Ohashi N, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/131; OSSENKOPF V, 1994, ASTRON ASTROPHYS, V291, P943; Oya Y, 2016, ASTROPHYS J, V824, DOI 10.3847/0004-637X/824/2/88; Oya Y, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/59; Oya Y, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/152; Paardekooper SJ, 2012, MON NOT R ASTRON SOC, V421, P3286, DOI 10.1111/j.1365-2966.2012.20553.x; Padoan P, 2004, ASTROPHYS J, V617, P559, DOI 10.1086/345413; Perez LM, 2016, SCIENCE, V353, P1519, DOI 10.1126/science.aaf8296; Perez LM, 2012, ASTROPHYS J LETT, V760, DOI 10.1088/2041-8205/760/1/L17; Persson MV, 2016, ASTRON ASTROPHYS, V590, DOI 10.1051/0004-6361/201527666; Pineda JE, 2015, NATURE, V518, P213, DOI 10.1038/nature14166; POLLACK JB, 1985, ICARUS, V64, P471, DOI 10.1016/0019-1035(85)90069-7; Rafikov RR, 2005, ASTROPHYS J, V621, pL69, DOI 10.1086/428899; Raghavan D, 2010, ASTROPHYS J SUPPL S, V190, P1, DOI 10.1088/0067-0049/190/1/1; Reipurth B., 2014, PROTOSTARS PLANETS, P267, DOI DOI 10.2458/AZU_UAPRESS_9780816531240-CH012; Rice WKM, 2005, MON NOT R ASTRON SOC, V364, pL56, DOI 10.1111/j.1745-3933.2005.00105.x; Sakai N, 2014, ASTROPHYS J LETT, V791, DOI 10.1088/2041-8205/791/2/L38; Sakai N, 2014, NATURE, V507, P78, DOI 10.1038/nature13000; Seifried D, 2016, MON NOT R ASTRON SOC, V459, P1892, DOI 10.1093/mnras/stw785; Semenov D, 2003, ASTRON ASTROPHYS, V410, P611, DOI 10.1051/0004-6361:20031279; SHU FH, 1977, ASTROPHYS J, V214, P488, DOI 10.1086/155274; Takakuwa S, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/1/52; TEREBEY S, 1984, ASTROPHYS J, V286, P529, DOI 10.1086/162628; Testi L., 2014, PROTOSTARS PLANETS, P339, DOI [DOI 10.2458/AZU_UAPRESS_9780816531240-CH015, 10.2458/azu_uapress_9780816531240-ch015]; Tobin JJ, 2016, ASTROPHYS J, V818, DOI 10.3847/0004-637X/818/1/73; Tobin JJ, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/1/48; Tobin JJ, 2012, NATURE, V492, P83, DOI 10.1038/nature11610; Tokovinin A, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/2/52; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Valtonen M., 2008, DYNAMICAL EVOLUTION, V246, pA209; Wakelam V, 2005, ASTRON ASTROPHYS, V437, P149, DOI 10.1051/0004-6361:20042566; Whitney BA, 2003, ASTROPHYS J, V591, P1049, DOI 10.1086/375415; Williams JP, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/59	73	146	146	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					483	+		10.1038/nature20094	http://dx.doi.org/10.1038/nature20094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5IY	27786204	Green Submitted, Green Published			2022-12-28	WOS:000386654400051
J	Bastiampillai, T; Sharfstein, SS; Allison, S				Bastiampillai, Tarun; Sharfstein, Steven S.; Allison, Stephen			Increase in US Suicide Rates and the Critical Decline in Psychiatric Beds	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bastiampillai, Tarun] South Australian Hlth & Med Res Inst, Mind & Brain, Adelaide, SA, Australia; [Bastiampillai, Tarun; Allison, Stephen] Flinders Univ S Australia, Sch Med, Discipline Psychiat, Adelaide, SA, Australia; [Sharfstein, Steven S.] Shepherd Pratt Hlth Syst, Baltimore, MD USA	South Australian Health & Medical Research Institute (SAHMRI); Flinders University South Australia	Bastiampillai, T (corresponding author), South Australian Hlth & Med Res Inst, North Terrace, Adelaide, SA 5000, Australia.	tarun.bastiampillai@sa.gov.au	Bastiampillai, Tarun/ABD-9238-2021	Bastiampillai, Tarun/0000-0002-6931-2913; Allison, Stephen/0000-0002-9264-5310				Curtin SC, 2016, INCREASE SUICIDE US; Olfson M, 2016, JAMA PSYCHIAT, V73, P1119, DOI 10.1001/jamapsychiatry.2016.2035; Olfson M, 2016, PSYCHIAT SERV, V67, P152, DOI 10.1176/appi.ps.201500324; Rockett IRH, 2015, JAMA PSYCHIAT, V72, P1069, DOI 10.1001/jamapsychiatry.2015.1418; Sisti DA, 2015, JAMA-J AM MED ASSOC, V313, P243, DOI 10.1001/jama.2014.16088; Turecki G, 2016, LANCET, V387, P1227, DOI 10.1016/S0140-6736(15)00234-2; Yoon J, 2009, HEALTH SERV RES, V44, P1385, DOI 10.1111/j.1475-6773.2009.00986.x; Young AH, 2007, BRIT J PSYCHIAT, V191, P474, DOI 10.1192/bjp.bp.107.043133	8	45	45	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 27	2016	316	24					2591	2592		10.1001/jama.2016.16989	http://dx.doi.org/10.1001/jama.2016.16989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG5UN	27812693				2022-12-28	WOS:000391110200007
J	Grande, D; Armstrong, K				Grande, David; Armstrong, Katrina			Will Physicians Vote?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital	Grande, D (corresponding author), Univ Penn, Perelman Sch Med, Div Gen Internal Med, 3641 Locust Walk,Colonial Penn Ctr 407, Philadelphia, PA 19104 USA.	dgrande@wharton.upenn.edu	Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735				Grande D, 2007, J GEN INTERN MED, V22, P585, DOI 10.1007/s11606-007-0105-8; Grande D, 2008, J GEN INTERN MED, V23, P1987, DOI 10.1007/s11606-008-0811-x; Hager M, 2008, REVISITING MED SCH E; Himmelstein DU, 2016, AM J PUBLIC HEALTH, V106, P449, DOI 10.2105/AJPH.2015.302997; Miller P, 2016, AM POLIT RES, V44, P28, DOI 10.1177/1532673X15586618; Patel MS, 2014, ACAD MED, V89, P1375, DOI 10.1097/ACM.0000000000000408; Perkins O., 2015, TOP 10 TABOO TOPICS; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x	8	3	3	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					814	+		10.7326/M16-2470	http://dx.doi.org/10.7326/M16-2470			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE0KO	27802503				2022-12-28	WOS:000389263900012
J	Sen, DR; Kaminski, J; Barnitz, RA; Kurachi, M; Gerdemann, U; Yates, KB; Tsao, HW; Godec, J; LaFleur, MW; Brown, FD; Tonnerre, P; Chung, RT; Tully, DC; Allen, TM; Frahm, N; Lauer, GM; Wherry, EJ; Yosef, N; Haining, WN				Sen, Debattama R.; Kaminski, James; Barnitz, R. Anthony; Kurachi, Makoto; Gerdemann, Ulrike; Yates, Kathleen B.; Tsao, Hsiao-Wei; Godec, Jernej; LaFleur, Martin W.; Brown, Flavian D.; Tonnerre, Pierre; Chung, Raymond T.; Tully, Damien C.; Allen, Todd M.; Frahm, Nicole; Lauer, Georg M.; Wherry, E. John; Yosef, Nir; Haining, W. Nicholas			The epigenetic landscape of T cell exhaustion	SCIENCE			English	Article							CHRONIC VIRAL-INFECTION; REGULATORY DNA; CHROMATIN	Exhausted T cells in cancer and chronic viral infection express distinctive patterns of genes, including sustained expression of programmed cell death protein 1 (PD-1). However, the regulation of gene expression in exhausted T cells is poorly understood. Here, we define the accessible chromatin landscape in exhausted CD8(+) T cells and show that it is distinct from functional memory CD8(+) T cells. Exhausted CD8(+) T cells in humans and a mouse model of chronic viral infection acquire a state-specific epigenetic landscape organized into functional modules of enhancers. Genome editing shows that PD-1 expression is regulated in part by an exhaustion-specific enhancer that contains essential RAR, T-bet, and Sox3 motifs. Functional enhancer maps may offer targets for genome editing that alter gene expression preferentially in exhausted CD8(+) T cells.	[Sen, Debattama R.; Barnitz, R. Anthony; Gerdemann, Ulrike; Yates, Kathleen B.; Tsao, Hsiao-Wei; Godec, Jernej; LaFleur, Martin W.; Brown, Flavian D.; Haining, W. Nicholas] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Sen, Debattama R.; Godec, Jernej; LaFleur, Martin W.; Brown, Flavian D.] Harvard Med Sch, Div Med Sci, Boston, MA 02115 USA; [Kaminski, James; Yosef, Nir] Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA; [Kurachi, Makoto; Wherry, E. John] Univ Penn, Inst Immunol, Philadelphia, PA 19104 USA; [Kurachi, Makoto; Wherry, E. John] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA; [Tonnerre, Pierre; Chung, Raymond T.; Lauer, Georg M.] Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02115 USA; [Tonnerre, Pierre; Chung, Raymond T.; Lauer, Georg M.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Liver, Boston, MA 02115 USA; [Tully, Damien C.; Allen, Todd M.; Yosef, Nir] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02139 USA; [Tully, Damien C.; Allen, Todd M.; Yosef, Nir] Harvard Univ, Boston, MA 02139 USA; [Frahm, Nicole] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Yosef, Nir] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, Boston, MA 02115 USA; [Haining, W. Nicholas] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Fred Hutchinson Cancer Center; University of California System; University of California Berkeley; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Haining, WN (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.; Yosef, N (corresponding author), Univ Calif Berkeley, Ctr Computat Biol, Berkeley, CA 94720 USA.; Yosef, N (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02139 USA.; Yosef, N (corresponding author), Harvard Univ, Boston, MA 02139 USA.; Yosef, N (corresponding author), Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA.; Haining, WN (corresponding author), Childrens Hosp, Div Pediat Hematol & Oncol, Boston, MA 02115 USA.; Haining, WN (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02142 USA.	niryosef@berkeley.edu; nicholas_haining@dfci.harvard.edu	Sen, Debattama/AAC-5679-2020; Wherry, John/ABI-1280-2020; Allen, Todd/F-5473-2011; Tonnerre, Pierre/AAA-1631-2020; Lauer, Georg/J-1467-2018	Sen, Debattama/0000-0002-0947-8284; Allen, Todd/0000-0002-6609-1318; Tonnerre, Pierre/0000-0002-1719-9736; Lauer, Georg/0000-0002-9792-4271; Tully, Damien/0000-0002-7620-9340; Gerdemann, Ulrike/0000-0002-3600-0366	NIH [AI115712, AI091493, AI082630, 1R21AI078809-01, UM1 AI068618]; BRAIN Initiative from the NIH [MH105979, HG007910]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI115712, UM1AI068618, R01AI091493, R21AI078809, U19AI082630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH105979] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRAIN Initiative from the NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank members of the Yosef and Haining laboratories for their input, the research subjects for their participation, and J. Doench and the entire Genetic Perturbation Platform at the Broad Institute for their advice on Cas9-mediated screening technology. The authors are grateful for input from the Cancer Center for Genome Discovery. The data reported in this manuscript are tabulated in the main paper and in the supplementary materials. Genome-wide data generated in this study can be accessed via GEO accession no. GSE87646. This research was supported by AI115712, AI091493, and AI082630 to W.N.H. from the NIH; by the BRAIN Initiative grants MH105979 and HG007910 from the NIH to N.Y.; and by 1R21AI078809-01 and UM1 AI068618 from the NIH to N.F. The authors declare no potential conflicts of interest. D.R.S., J.K., N.Y., E.J.W., and W.N.H. are inventors on a patent application (U.S. Patent Application no. 62/310,903) held and submitted by Dana-Farber Cancer Institute.	Austin JW, 2014, J IMMUNOL, V192, P4876, DOI 10.4049/jimmunol.1302750; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Farh K. K., NATURE, V518, P337; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Schumann K, 2015, P NATL ACAD SCI USA, V112, P10437, DOI 10.1073/pnas.1512503112; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vierstra J, 2015, NAT METHODS, V12, P927, DOI [10.1038/NMETH.3554, 10.1038/nmeth.3554]; Vierstra J, 2014, SCIENCE, V346, P1007, DOI 10.1126/science.1246426; Villar D, 2015, CELL, V160, P554, DOI 10.1016/j.cell.2015.01.006; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	22	494	509	11	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1165	1169		10.1126/science.aae0491	http://dx.doi.org/10.1126/science.aae0491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27789799	Green Accepted			2022-12-28	WOS:000388916400046
J	von Birgelen, C; Kok, MM; van der Heijden, LC; Danse, PW; Schotborgh, CE; Scholte, M; Gin, RMTJ; Somi, S; van Houwelingen, KG; Stoel, MG; de Man, FHAF; Louwerenburg, JW; Hartmann, M; Zocca, P; Linssen, GCM; van der Palen, J; Doggen, CJM; Lowik, MM				von Birgelen, Clemens; Kok, Marlies M.; van der Heijden, Liefke C.; Danse, Peter W.; Schotborgh, Carl E.; Scholte, Martijn; Gin, R. Melvyn Tjon Joe; Somi, Samer; van Houwelingen, K. G.; Stoel, M. G.; de Man, Frits H. A. F.; Louwerenburg, J. (Hans) W.; Hartmann, Marc; Zocca, Paolo; Linssen, Gerard C. M.; van der Palen, Job; Doggen, Carine J. M.; Lowik, Marije M.			Very thin strut biodegradable polymer everolimus-eluting and sirolimus-eluting stents versus durable polymer zotarolimus-eluting stents in allcomers with coronary artery disease (BIO-RESORT): a three-arm, randomised, non-inferiority trial	LANCET			English	Article							BARE-METAL STENTS; COMPREHENSIVE NETWORK METAANALYSIS; MYOCARDIAL-INFARCTION; UNSELECTED PATIENTS; INTERVENTION SORT; COATED STENT; SAFETY; THROMBOSIS; EFFICACY; COATINGS	Background In patients with coronary artery disease, treated with durable polymer-coated drug-eluting stents, the life-long presence of the polymer might delay arterial healing. Novel very thin strut biodegradable polymer stents, which leave only a bare metal stent after polymer resorption, might improve long-term outcome. We investigated in allcomers the safety and efficacy of three stents eluting either everolimus, sirolimus, or zotarolimus, often clinically used but never compared, of which the biodegradable polymer everolimus-eluting stent was never before assessed in allcomers. Methods The large-scale, investigator-initiated, multicentre, assessor and patient blinded, three-arm, randomised, BIO-RESORT non-inferiority trial was done at four clinical sites in the Netherlands. All-comer patients were aged 18 years or older, capable of providing informed consent, and required a percutaneous coronary intervention with drug-eluting stent implantation according to clinical guidelines or the operators' judgment. Exclusion criteria were: participation in another randomised drug or device study before reaching the primary endpoint of that study; planned surgery necessitating interruption of dual antiplatelet therapy within the first 6 months; known intolerance to components of the investigational product or medication required; uncertainty about the adherence to follow-up procedures or an assumed life expectancy of less than 1 year; or known pregnancy. Web-based computer-generated allocation sequences randomly assigned patients (1: 1: 1) to treatment with very thin strut biodegradable polymer everolimus-eluting or sirolimus-eluting stents (which differ substantially in type, amount, distribution, and resorption speed of their respective coating), or thin strut durable polymer zotarolimus-eluting stents. The primary endpoint was a composite of safety (cardiac death or target vessel-related myocardial infarction) and efficacy (target vessel revascularisation) at 12 months of follow up with a very thin strut biodegradable polymer of either everolimus-eluting or sirolimus-eluting stents, compared with durable polymer zotarolimus-eluting stents, analysed by intention to treat (non-inferiority margin 3.5%). This trial was registered with ClinicalTrials.gov, number NCT01674803. Findings From Dec 21, 2012, to Aug 24, 2015, 3514 patients were enrolled and analysed, of whom 2449 (70%) had acute coronary syndromes, which included 1073 (31%) ST-elevation myocardial infarctions. 12 month follow-up of 3490 (99%) patients (three lost to follow-up; 21 withdrawals) was available. The primary endpoint was met by 55 (5%) of 1172 patients assigned to everolimus-eluting stents, 55 (5%) of 1169 assigned to sirolimus-eluting stents and 63 (5%) of 1173 assigned to zotarolimus-eluting stents. Non-inferiority of the everolimus-eluting stents and sirolimus-eluting stents compared with zotarolimus-eluting stents was confirmed (both -0.7% absolute risk difference, 95% CI -2.4 to 1.1; upper limit of one sided 95% CI 0.8%, p(non-inferiority) < 0.0001). Definite stent thrombosis (defined by the Academic Research Consortium) occurred in four (0.3%) of 1172 patients who were allocated to everolimus-eluting stents, four (0.3%) of 1169 patients who were allocated to sirolimus-eluting stents, and three (0.3%) of 1173 patients who were allocated to zotarolimus-eluting stents (log-rank p= 0.70 for both comparisons with zotarolimus-eluting stents). Interpretation At 12 month follow-up, both very thin strut drug-eluting stents with dissimilar biodegradable polymer coatings (eluting either everolimus or sirolimus) were non-inferior to the durable polymer stent (eluting zotarolimus) in treating allcomers with a high proportion of patients with acute coronary syndromes. The absence of a loss of 1 year safety and efficacy with the use of these two biodegradable polymer-coated stents is a prerequisite before assessing their potential longer-term benefits.	[von Birgelen, Clemens; Kok, Marlies M.; van der Heijden, Liefke C.; van Houwelingen, K. G.; Stoel, M. G.; de Man, Frits H. A. F.; Louwerenburg, J. (Hans) W.; Hartmann, Marc; Zocca, Paolo; Lowik, Marije M.] Med Spectrum Twente, Thoraxctr Twente, Dept Cardiol, Enschede, Netherlands; [van der Palen, Job] Med Spectrum Twente, Dept Epidemiol, Enschede, Netherlands; [von Birgelen, Clemens; Doggen, Carine J. M.] Univ Twente, Dept Hlth Technol & Serv Res, MIRA Inst Tech Med & Biomed Technol, Enschede, Netherlands; [van der Palen, Job] Univ Twente, Dept Res Methodol Measurement & Data Anal, Enschede, Netherlands; [Danse, Peter W.; Gin, R. Melvyn Tjon Joe] Rijnstate Hosp, Dept Cardiol, Arnhem, Netherlands; [Schotborgh, Carl E.; Somi, Samer] Haga Hosp, Dept Cardiol, The Hague, Netherlands; [Scholte, Martijn] Albert Schweitzer Hosp, Dept Cardiol, Dordrecht, Netherlands; [Linssen, Gerard C. M.] Hosp Grp Twente, Dept Cardiol, Almelo, Netherlands; [Linssen, Gerard C. M.] Hosp Grp Twente, Dept Cardiol, Hengelo, Netherlands	Medical Spectrum Twente; Medical Spectrum Twente; University of Twente; University of Twente; Rijnstate Hospital; Haga Hospital; Albert Schweitzer Ziekenhuis	von Birgelen, C (corresponding author), Med Spectrum Twente, Thoraxctr Twente, POB 50000, NL-7500 KA Enschede, Netherlands.	c.vonbirgelen@mst.nl		van der Palen, Job/0000-0003-1071-6769; Zocca, Paolo/0000-0003-2726-480X	Biotronik; Boston Scientific; Medtronic	Biotronik; Boston Scientific(Boston Scientific); Medtronic(Medtronic)	We thank our patients for their confidence and willingness to participate in this randomised trial. We gratefully acknowledge the invaluable support of this trial by the cardiologists and the staff of the research departments, catheterisation laboratories, wards, and administrative departments of the study centres and referring hospitals, and by the general physicians and pharmacists of our patients. Biotronik, Boston Scientific, and Medtronic equally supported this investigator-initiated study and the present 1 year follow-up.	Basalus MWZ, 2013, EUROINTERVENTION, V9, P302, DOI 10.4244/EIJV9I3A51; Byrne RA, 2011, J AM COLL CARDIOL, V58, P1325, DOI 10.1016/j.jacc.2011.06.027; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; D'Agostino RB, 2003, STAT MED, V22, P169, DOI 10.1002/sim.1425; Hamon M, 2013, EUROINTERVENTION, V8, P1006, DOI 10.4244/EIJV8I9A155; Jensen LO, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003610; Joner M, 2006, J AM COLL CARDIOL, V48, P193, DOI 10.1016/j.jacc.2006.03.042; Kaiser C, 2015, CIRCULATION, V131, P74, DOI 10.1161/CIRCULATIONAHA.114.013520; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kereiakes DJ, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.002372; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Lam MK, 2014, AM HEART J, V167, P445, DOI 10.1016/j.ahj.2013.11.014; Meredith IT, 2012, J AM COLL CARDIOL, V59, P1362, DOI 10.1016/j.jacc.2011.12.016; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Otsuka F, 2015, JACC-CARDIOVASC INTE, V8, P1248, DOI 10.1016/j.jcin.2015.03.029; Otsuka F, 2014, CIRCULATION, V129, P211, DOI 10.1161/CIRCULATIONAHA.113.001790; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Palmerini T, 2012, LANCET, V379, P1393, DOI 10.1016/S0140-6736(12)60324-9; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Raungaard B, 2015, LANCET, V385, P1527, DOI 10.1016/S0140-6736(14)61794-3; Saito S, 2014, EUR HEART J, V35, P2021, DOI 10.1093/eurheartj/ehu210; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2010, NEW ENGL J MED, V363, P136, DOI 10.1056/NEJMoa1004130; Smits PC, 2013, LANCET, V381, P651, DOI 10.1016/S0140-6736(12)61852-2; Stefanini GG, 2014, HEART, V100, P1051, DOI 10.1136/heartjnl-2012-303522; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Stefanini GG, 2012, EUR HEART J, V33, P1214, DOI 10.1093/eurheartj/ehs086; von Birgelen C, 2014, LANCET, V383, P413, DOI 10.1016/S0140-6736(13)62037-1; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Vranckx P, 2010, EUROINTERVENTION, V5, P871, DOI 10.4244/EIJV5I7A146; Windecker S, 2008, LANCET, V372, P1163, DOI 10.1016/S0140-6736(08)61244-1; Windecker S, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001441	34	181	182	2	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2607	2617		10.1016/S0140-6736(16)31920-1	http://dx.doi.org/10.1016/S0140-6736(16)31920-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED0EW	27806902				2022-12-28	WOS:000388516800029
J	Hebert-Chatelain, E; Desprez, T; Serrat, R; Bellocchio, L; Soria-Gomez, E; Busquets-Garcia, A; Zottola, ACP; Delamarre, A; Cannich, A; Vincent, P; Varilh, M; Robin, LM; Terral, G; Garcia-Fernandez, MD; Colavita, M; Mazier, W; Drago, F; Puente, N; Reguero, L; Elezgarai, I; Dupuy, JW; Cota, D; Lopez-Rodriguez, ML; Barreda-Gomez, G; Massa, F; Grandes, P; Benard, G; Marsicano, G				Hebert-Chatelain, Etienne; Desprez, Tifany; Serrat, Roman; Bellocchio, Luigi; Soria-Gomez, Edgar; Busquets-Garcia, Arnau; Zottola, Antonio Christian Pagano; Delamarre, Anna; Cannich, Astrid; Vincent, Peggy; Varilh, Marjorie; Robin, Laurie M.; Terral, Geoffrey; Dolores Garcia-Fernandez, M.; Colavita, Michelangelo; Mazier, Wilfrid; Drago, Filippo; Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Dupuy, Jean-William; Cota, Daniela; Lopez-Rodriguez, Maria-Luz; Barreda-Gomez, Gabriel; Massa, Federico; Grandes, Pedro; Benard, Giovanni; Marsicano, Giovanni			A cannabinoid link between mitochondria and memory	NATURE			English	Article							SOLUBLE ADENYLYL-CYCLASE; ENDOCANNABINOID SYSTEM; OXIDATIVE-PHOSPHORYLATION; SUBCELLULAR-LOCALIZATION; CATALYTIC SUBUNIT; BRAIN; PROTEINS; NEURONS; METABOLISM; RECEPTORS	Cellular activity in the brain depends on the high energetic support provided by mitochondria, the cell organelles which use energy sources to generate ATP(1-4). Acute cannabinoid intoxication induces amnesia in humans and animals(5,6), and the activation of type-1 cannabinoid receptors present at brain mitochondria membranes (mtCB(1)) can directly alter mitochondrial energetic activity(7-9). Although the pathological impact of chronic mitochondrial dysfunctions in the brain is well established(1,2), the involvement of acute modulation of mitochondrial activity in high brain functions, including learning and memory, is unknown. Here, we show that acute cannabinoid-induced memory impairment in mice requires activation of hippocampal mtCB(1) receptors. Genetic exclusion of CB1 receptors from hippocampal mitochondria prevents cannabinoid-induced reduction of mitochondrial mobility, synaptic transmission and memory formation. mtCB(1) receptors signal through intra-mitochondrial G alpha(i) protein activation and consequent inhibition of soluble-adenylyl cyclase (sAC). The resulting inhibition of protein kinase A (PKA)-dependent phosphorylation of specific subunits of the mitochondrial electron transport system eventually leads to decreased cellular respiration. Hippocampal inhibition of sAC activity or manipulation of intra-mitochondrial PKA signalling or phosphorylation of the Complex I subunit NDUFS2 inhibit bioenergetic and amnesic effects of cannabinoids. Thus, the G protein-coupled mtCB(1) receptors regulate memory processes via modulation of mitochondrial energy metabolism. By directly linking mitochondrial activity to memory formation, these data reveal that bioenergetic processes are primary acute regulators of cognitive functions.	[Hebert-Chatelain, Etienne; Desprez, Tifany; Serrat, Roman; Bellocchio, Luigi; Soria-Gomez, Edgar; Busquets-Garcia, Arnau; Zottola, Antonio Christian Pagano; Delamarre, Anna; Cannich, Astrid; Vincent, Peggy; Varilh, Marjorie; Robin, Laurie M.; Terral, Geoffrey; Colavita, Michelangelo; Mazier, Wilfrid; Cota, Daniela; Massa, Federico; Benard, Giovanni; Marsicano, Giovanni] NeuroCtr Magendie, INSERM U1215, F-33077 Bordeaux, France; [Hebert-Chatelain, Etienne; Desprez, Tifany; Serrat, Roman; Bellocchio, Luigi; Soria-Gomez, Edgar; Busquets-Garcia, Arnau; Zottola, Antonio Christian Pagano; Delamarre, Anna; Cannich, Astrid; Vincent, Peggy; Varilh, Marjorie; Robin, Laurie M.; Terral, Geoffrey; Colavita, Michelangelo; Mazier, Wilfrid; Cota, Daniela; Massa, Federico; Benard, Giovanni; Marsicano, Giovanni] Univ Bordeaux, NeuroCtr Magendie, F-33077 Bordeaux, France; [Hebert-Chatelain, Etienne] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada; [Bellocchio, Luigi] Univ Complutense, Dept Biochem & Mol Biol 1, E-28040 Madrid, Spain; [Dolores Garcia-Fernandez, M.; Barreda-Gomez, Gabriel] IMG Pharma Biotech SL, Dept Res & Dev, Derio 48160, Spain; [Dolores Garcia-Fernandez, M.] Univ Basque Country UPV EHU, Fac Med & Dent, Dept Pharmacol, Leioa 48940, Spain; [Colavita, Michelangelo; Drago, Filippo] Univ Catania, Pharmacol Sect, Dept Biomed & Biotechnol Sci, I-95124 Catania, Italy; [Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Grandes, Pedro] Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Neurosci, Leioa 48940, Spain; [Puente, Nagore; Reguero, Leire; Elezgarai, Izaskun; Grandes, Pedro] Achucarro Basque Ctr Neurosci, Bizkaia Sci & Technol Pk,Bldg 205, Zamudio 48170, Spain; [Dupuy, Jean-William] Univ Bordeaux, Ctr Genom Fonct, Plateforme Proteome, F-33077 Bordeaux, France; [Lopez-Rodriguez, Maria-Luz] Univ Complutense, Dept Organ Chem, E-28040 Madrid, Spain; [Grandes, Pedro] Univ Victoria, Div Med Sci, Victoria, BC V8W 2Y2, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Moncton; Complutense University of Madrid; University of Basque Country; University of Catania; University of Basque Country; UDICE-French Research Universities; Universite de Bordeaux; Complutense University of Madrid; University of Victoria	Marsicano, G (corresponding author), NeuroCtr Magendie, INSERM U1215, F-33077 Bordeaux, France.; Marsicano, G (corresponding author), Univ Bordeaux, NeuroCtr Magendie, F-33077 Bordeaux, France.	giovanni.marsicano@inserm.fr	Drago, Francesco/H-7563-2019; Bénard, Giovanni/M-3485-2014; Drago, Filippo/AAC-5090-2022; Busquets-Garcia, Arnau/Y-5856-2019; Dupuy, Jean-William JWD/F-5335-2012; Grandes, Pedro/AAA-1627-2019; Barreda-Gómez, Gabriel/AAJ-7829-2021; Massa, Federico/C-5697-2011; Lopez-Rodriguez, Maria L/S-6342-2016; Soria-Gomez, Edgar/AAH-3567-2019; Reñé, Román Serrat/A-2500-2017; Busquets-Garcia, Arnau/A-7307-2018; Grandes, Pedro/H-7494-2015; Reguero, Leire/H-6865-2015; Elezgarai, Izaskun/H-7076-2015	Bénard, Giovanni/0000-0003-0036-9425; Busquets-Garcia, Arnau/0000-0002-7100-8873; Dupuy, Jean-William JWD/0000-0002-2448-4797; Barreda-Gómez, Gabriel/0000-0002-8330-1567; Massa, Federico/0000-0002-9427-3418; Lopez-Rodriguez, Maria L/0000-0001-8607-1085; Soria-Gomez, Edgar/0000-0002-1361-5915; Reñé, Román Serrat/0000-0001-5530-2135; Busquets-Garcia, Arnau/0000-0002-7100-8873; Mazier, Wilfrid/0000-0001-5434-7542; GARCIA FERNANDEZ, M. Dolores/0000-0001-6519-7594; Marsicano, Giovanni/0000-0003-3804-1951; Delamarre, Anna/0000-0002-5916-7433; Cota, Daniela/0000-0002-6909-2156; Grandes, Pedro/0000-0003-3947-4230; Terral, Geoffrey/0000-0001-5253-8855; Reguero, Leire/0000-0002-0267-5568; Elezgarai, Izaskun/0000-0003-0880-8058	INSERM; EU-Fp7 (PAINCAGE [HEALTH-603191, FP7-PEOPLE-2013-1EF-623638]; European Research Council (Endofood) [ERC-2010-StG-260515, ERC-2014-PoC-640923]; Fondation pour la Recherche Medicate [DRM20101220445, SPF20121226369, ARF20140129235]; Fondation pour la Recherche en Psychiatrie et en Sante Mentale (FRPSM); Human Frontiers Science Program [RGP0036/2014]; Region Aquitaine; AFM Telethon Trampoline Grant [16474]; Agence Nationale de la Recherche (ANR Blanc NeuroNutriSens) [ANR-13-BSV4-0006]; BRAIN [ANR-10-LABX-0043, ANR-10-IDEX-03-02]; Dulbecco Telethon Institute post-doc fellowship; NSERC [RGPIN-2015-05880]; Fyssen Foundation; EMBO post-doc fellowship; CONACyT; Zabalduz pre-doc fellowship; Basque Government [11764-13]; MINECO/FEDER [SAF2015-65034-R]; University of the Basque Country [UPV/EHU UF111/41]; Red de Trastornos Adictivos Instituto de Salud Carlos III [RD12/0028/0004, RD16/0017/0012]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); EU-Fp7 (PAINCAGE; European Research Council (Endofood)(European Research Council (ERC)); Fondation pour la Recherche Medicate(Fondation pour la Recherche Medicale); Fondation pour la Recherche en Psychiatrie et en Sante Mentale (FRPSM); Human Frontiers Science Program(Human Frontier Science Program); Region Aquitaine(Region Nouvelle-Aquitaine); AFM Telethon Trampoline Grant; Agence Nationale de la Recherche (ANR Blanc NeuroNutriSens)(French National Research Agency (ANR)); BRAIN; Dulbecco Telethon Institute post-doc fellowship(Fondazione Telethon); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fyssen Foundation; EMBO post-doc fellowship; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Zabalduz pre-doc fellowship; Basque Government(Basque Government); MINECO/FEDER; University of the Basque Country; Red de Trastornos Adictivos Instituto de Salud Carlos III(Instituto de Salud Carlos III)	We thank D. Gonzales, N. Aubailly and all the personnel of the Animal Facility of the NeuroCentre Magendie, M. Biguerie of the technical service of the NeuroCentre Magendie, the personnel from the Bordeaux Imaging Center and V. Morales for continuous help. We thank G. Manfredi (Cornell University) for the sAC-HA, A. Feliciello (University of Napoli) for anti-AKAP121 antiserum and for AKAP121 shRNA, and M. Montcouquiol, N. Piguel (INSERM 01215, Bordeaux) and R. Rossignol (University of Bordeaux) for help with experiments. We thank F. Francia, P V. Piazza, A. Bacci, G. Ferreira, F. Chaouloff and M. Guzman for critical reading and the members of Marsicano's laboratory for discussions. This work was supported by INSERM (G.M., D.C.), EU-Fp7 (PAINCAGE, HEALTH-603191, G.M. and FP7-PEOPLE-2013-1EF-623638, A.B.-G.), European Research Council (Endofood, ERC-2010-StG-260515 and CannaPreg, ERC-2014-PoC-640923, G.M.), Fondation pour la Recherche Medicate (DRM20101220445, G.M., SPF20121226369, R.S. and ARF20140129235, L.B.), Fondation pour la Recherche en Psychiatrie et en Sante Mentale (FRPSM, G.M.), Human Frontiers Science Program (RGP0036/2014, G.M.), Region Aquitaine (G.M.), AFM Telethon Trampoline Grant (16474, G.B), Agence Nationale de la Recherche (ANR Blanc NeuroNutriSens ANR-13-BSV4-0006, G.M. D.C., BRAIN ANR-10-LABX-0043. G.M., D.C., F.M. and ANR-10-IDEX-03-02, A.B.-G.), Dulbecco Telethon Institute post-doc fellowship (E.H.-C.), NSERC (RGPIN-2015-05880, E.H.-C.), Fyssen Foundation (E.S.-G.), EMBO post-doc fellowship (L.B.), CONACyT (E.S.-G.), Zabalduz pre-doc fellowship (M.D.G.-F.), the Basque Government (11764-13, PG.), MINECO/FEDER (SAF2015-65034-R, PG.), University of the Basque Country (UPV/EHU UF111/41. PG.), Red de Trastornos Adictivos Instituto de Salud Carlos III (RD12/0028/0004, RD16/0017/0012, P.G.).	Acin-Perez R, 2009, EMBO MOL MED, V1, P392, DOI 10.1002/emmm.200900046; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Beninca C, 2014, CELL SIGNAL, V26, P1135, DOI 10.1016/j.cellsig.2014.01.009; Bockaert J, 2015, PHYSIOL REV, V95, P1157, DOI 10.1152/physrev.00038.2014; Boesmans W, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01300.x; Broyd SJ, 2016, BIOL PSYCHIAT, V79, P557, DOI 10.1016/j.biopsych.2015.12.002; Busquets-Garcia A, 2011, BIOL PSYCHIAT, V70, P479, DOI 10.1016/j.biopsych.2011.04.022; Chatelain EH, 2011, CELL MOL LIFE SCI, V68, P2603, DOI 10.1007/s00018-010-0573-6; Chen Q, 1997, J BIOL CHEM, V272, P15247, DOI 10.1074/jbc.272.24.15247; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Chiarlone A, 2014, P NATL ACAD SCI USA, V111, P8257, DOI 10.1073/pnas.1400988111; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Courchet J, 2013, CELL, V153, P1510, DOI 10.1016/j.cell.2013.05.021; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Hebert-Chatelain E, 2014, MOL METAB, V3, P495, DOI 10.1016/j.molmet.2014.03.007; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Jose C, 2011, BBA-BIOENERGETICS, V1807, P707, DOI 10.1016/j.bbabio.2010.12.002; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Lin AL, 2013, J CEREBR BLOOD F MET, V33, P1605, DOI 10.1038/jcbfm.2013.116; Livigni A, 2006, MOL BIOL CELL, V17, P263, DOI 10.1091/mbc.e05-09-0827; Lopez-Domenech G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1829; Lyssand JS, 2007, FEBS LETT, V581, P5765, DOI 10.1016/j.febslet.2007.11.044; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marsicano G, 2009, CURR TOP BEHAV NEURO, V1, P201, DOI 10.1007/978-3-540-88955-7_8; Martin-Couce L, 2012, ANGEW CHEM INT EDIT, V51, P6896, DOI 10.1002/anie.201200467; Mattson MP, 2008, NEURON, V60, P748, DOI 10.1016/j.neuron.2008.10.010; McClure C., 2011, JOVE-J VIS EXP, V27, pe3348, DOI DOI 10.3791/3348; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Narayana N, 1997, BIOCHEMISTRY-US, V36, P4438, DOI 10.1021/bi961947+; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Niswender CM, 2005, GENESIS, V43, P109, DOI 10.1002/gene.20159; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Pocaly M, 2008, PROTEOMICS, V8, P2394, DOI 10.1002/pmic.200701035; Puighermanal E, 2013, NEUROPSYCHOPHARMACOL, V38, P1334, DOI 10.1038/npp.2013.31; Puighermanal E, 2009, NAT NEUROSCI, V12, P1152, DOI 10.1038/nn.2369; Rangaraju V, 2014, CELL, V156, P825, DOI 10.1016/j.cell.2013.12.042; Rodriguez-Puertas R., 2009, Patent EP, Patent No. [2048534 A1, 2048534]; RodriguezPuertas R., 2013, Patent US, Patent No. [8017346 B2, 8017346]; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Soria-Gomez E, 2014, NAT NEUROSCI, V17, P407, DOI 10.1038/nn.3647; Zala D, 2013, CELL, V152, P479, DOI 10.1016/j.cell.2012.12.029	48	221	224	4	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					555	+		10.1038/nature20127	http://dx.doi.org/10.1038/nature20127			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27828947				2022-12-28	WOS:000388520600042
J	Ma, ZG; Stork, T; Bergles, DE; Freeman, MR				Ma, Zhiguo; Stork, Tobias; Bergles, Dwight E.; Freeman, Marc R.			Neuromodulators signal through astrocytes to alter neural circuit activity and behaviour	NATURE			English	Article							DROSOPHILA-MELANOGASTER; TYRAMINE-RECEPTOR; CALCIUM WAVES; MECHANICAL STIMULATION; CORTICAL ASTROCYTES; NEURONAL-ACTIVITY; GLUTAMATE; NETWORKS; GLIOTRANSMITTERS; OSCILLATIONS	Astrocytes associate with synapses throughout the brain and express receptors for neurotransmitters that can increase intracellular calcium (Ca2+)(1-3). Astrocytic Ca2+ signalling has been proposed to modulate neural circuit activity(4), but the pathways that regulate these events are poorly defined and in vivo evidence linking changes in astrocyte Ca2+ levels to alterations in neurotransmission or behaviour is limited. Here we show that Drosophila astrocytes exhibit activity-regulated Ca2+ signalling in vivo. Tyramine and octopamine released from neurons expressing tyrosine decarboxylase 2 (Tdc2) signal directly to astrocytes to stimulate Ca2+ increases through the octopamine/tyramine receptor (Oct-TyrR) and the transient receptor potential (TRP) channel Water witch (Wtrw), and astrocytes in turn modulate downstream dopaminergic neurons. Application of tyramine or octopamine to live preparations silenced dopaminergic neurons and this inhibition required astrocytic Oct-TyrR and Wtrw. Increasing astrocyte Ca2+ signalling was sufficient to silence dopaminergic neuron activity, which was mediated by astrocyte endocytic function and adenosine receptors. Selective disruption of Oct-TyrR or Wtrw expression in astrocytes blocked astrocytic Ca2+ signalling and profoundly altered olfactory-driven chemotaxis and touch-induced startle responses. Our work identifies Oct-TyrR and Wtrw as key components of the astrocytic Ca2+ signalling machinery, provides direct evidence that octopamine- and tyramine-based neuromodulation can be mediated by astrocytes, and demonstrates that astrocytes are essential for multiple sensory-driven behaviours in Drosophila.	[Ma, Zhiguo; Stork, Tobias; Freeman, Marc R.] Univ Massachusetts, Dept Neurobiol, Sch Med, Worcester, MA 01605 USA; [Ma, Zhiguo; Stork, Tobias; Freeman, Marc R.] Univ Massachusetts, Howard Hughes Med Inst, Sch Med, Worcester, MA 01605 USA; [Bergles, Dwight E.] Johns Hopkins Univ, Solomon H Snyder Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; [Freeman, Marc R.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Johns Hopkins University; Oregon Health & Science University	Freeman, MR (corresponding author), Univ Massachusetts, Dept Neurobiol, Sch Med, Worcester, MA 01605 USA.; Freeman, MR (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Sch Med, Worcester, MA 01605 USA.; Freeman, MR (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA.	freemmar@ohsu.edu	Bergles, Dwight/U-8343-2019	Bergles, Dwight/0000-0002-7133-7378; Freeman, Marc/0000-0003-3481-3715	NINDS [R01 NS053538]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS053538, R01NS053538] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank our colleagues, the Vienna Drosophila RNAi Center and the Bloomington Stock Center for providing fly stocks, members of the Freeman laboratory for comments on the manuscript and A. Sheehan for generating the wtrw::gfp construct. This work was supported by NINDS grant R01 NS053538 (to M.R.F.). During the period of this study M.R.F. was an Investigator with the Howard Hughes Medical Institute.	Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Brody T, 2000, J CELL BIOL, V150, pF83, DOI 10.1083/jcb.150.2.F83; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Ding FF, 2013, CELL CALCIUM, V54, P387, DOI 10.1016/j.ceca.2013.09.001; Doherty J, 2009, J NEUROSCI, V29, P4768, DOI 10.1523/JNEUROSCI.5951-08.2009; DUFFY S, 1995, J NEUROSCI, V15, P5535; FATATIS A, 1992, GLIA, V5, P95, DOI 10.1002/glia.440050203; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khakh BS, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020404; Kutsukake M, 2000, GENE, V245, P31, DOI 10.1016/S0378-1119(99)00569-7; Lalo U, 2014, BIOCHEM SOC T, V42, P1275, DOI 10.1042/BST20140163; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newman EA, 2003, J NEUROSCI, V23, P1659, DOI 10.1523/jneurosci.23-05-01659.2003; Nimmerjahn A, 2009, NEURON, V62, P400, DOI 10.1016/j.neuron.2009.03.019; Nitabach MN, 2005, J NEUROBIOL, V62, P1, DOI 10.1002/neu.20053; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; Porter JT, 1996, J NEUROSCI, V16, P5073; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; SALM AK, 1990, GLIA, V3, P529, DOI 10.1002/glia.440030612; SAUDOU F, 1990, EMBO J, V9, P3611, DOI 10.1002/j.1460-2075.1990.tb07572.x; Shigetomi E, 2013, J NEUROSCI, V33, P10143, DOI 10.1523/JNEUROSCI.5779-12.2013; SMITH SJ, 1992, PROG BRAIN RES, V94, P119; Srinivasan R, 2015, NAT NEUROSCI, V18, P708, DOI 10.1038/nn.4001; Vomel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001848; Zhou YT, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-39	29	128	130	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					428	432		10.1038/nature20145	http://dx.doi.org/10.1038/nature20145			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27828941	Green Accepted			2022-12-28	WOS:000388161700054
J	Papageorghiou, AT; Ohuma, EO; Gravett, MG; Hirst, J; da Silveira, MF; Lambert, A; Carvalho, M; Jaffer, YA; Altman, DG; Noble, JA; Bertino, E; Purwar, M; Pang, RY; Ismail, LC; Victora, C; Bhutta, ZA; Kennedy, SH; Villar, J				Papageorghiou, Aris T.; Ohuma, Eric O.; Gravett, Michael G.; Hirst, Jane; da Silveira, Mariangela F.; Lambert, Ann; Carvalho, Maria; Jaffer, Yasmin A.; Altman, Douglas G.; Noble, Julia A.; Bertino, Enrico; Purwar, Manorama; Pang, Ruyan; Ismail, Leila Cheikh; Victora, Cesar; Bhutta, Zulfiqar A.; Kennedy, Stephen H.; Villar, Jose		Int Fetal Newborn Growth Consortiu	International standards for symphysis-fundal height based on serial measurements from the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: prospective cohort study in eight countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE; PREDICTION; CURVE; WOMEN; INFANTS; WEIGHT; LENGTH; BIRTH; CHART; POPULATION	OBJECTIVE To create international symphysis-fundal height standards derived from pregnancies of healthy women with good maternal and perinatal outcomes. DESIGN Prospective longitudinal observational study. SETTING Eight geographically diverse urban regions in Brazil, China, India, Italy, Kenya, Oman, United Kingdom, and United States. PARTICIPANTS Healthy, well nourished pregnant women enrolled into the Fetal Growth Longitudinal Study component of the INTERGROWTH-21st Project at 9-14 weeks' gestation, and followed up until birth. MAIN OUTCOME MEASURES Symphysis-fundal height was measured every five weeks from 14 weeks' gestation until birth using standardised methods and dedicated research staff who were blinded to the symphysis-fundal height measurements by turning the tape measure so that numbers were not visible during examination. The best fitting curve was selected using second degree fractional polynomials and further modelled in a multilevel framework to account for the longitudinal design of the study. RESULTS Of 13 108 women screened in the first trimester, 4607 (35.1%) met the study entry criteria. Of the eligible women, 4321 (93.8%) had pregnancies without major complications and delivered live singletons without congenital malformations. The median number of symphysis-fundal height measurements was 5.0 (range 1-7); 3976 (92.0%) women had four or more measurements. Symphysis-fundal height measurements increased almost linearly with gestational age; data were used to determine fitted 3rd, 50th, and 97th centile curves, which showed excellent agreement with observed values. CONCLUSIONS This study presents international standards to measure symphysis-fundal height as a first level screening tool for fetal growth disturbances.	[Papageorghiou, Aris T.; Ohuma, Eric O.; Hirst, Jane; Lambert, Ann; Ismail, Leila Cheikh; Kennedy, Stephen H.; Villar, Jose] Univ Oxford, Green Templeton Coll, Nuffield Dept Obstet & Gynaecol, Oxford, England; [Papageorghiou, Aris T.; Ohuma, Eric O.; Hirst, Jane; Lambert, Ann; Ismail, Leila Cheikh; Kennedy, Stephen H.; Villar, Jose] Univ Oxford, Green Templeton Coll, Oxford Maternal & Perinatal Hlth Inst, Oxford, England; [Ohuma, Eric O.; Altman, Douglas G.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [Gravett, Michael G.] Swedish Med Ctr, Ctr Perinatal Studies, Seattle, WA USA; [Gravett, Michael G.] Global Alliance Prevent Prematur & Stillbirth, Seattle, WA USA; [da Silveira, Mariangela F.] Univ Fed Pelotas, Dept Maternoinfantil, Pelotas, RS, Brazil; [da Silveira, Mariangela F.; Victora, Cesar] Univ Fed Pelotas, Programa Posgrad Epidemiol, Pelotas, RS, Brazil; [Carvalho, Maria] Aga Khan Univ, Fac Hlth Sci, Nairobi, Kenya; [Jaffer, Yasmin A.] Minist Hlth, Dept Family & Community Hlth, Muscat, Oman; [Noble, Julia A.] Univ Oxford, Dept Engn Sci, Oxford, England; [Bertino, Enrico] Univ Turin, Dipartimento Sci Pediat & Adolescenza, Cattedra Neonatol, Turin, Italy; [Purwar, Manorama] Ketkar Hosp, Nagpur INTERGROWTH Res Ctr 21, Nagpur, Maharashtra, India; [Pang, Ruyan] Peking Univ, Sch Publ Hlth, Beijing, Peoples R China; [Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi, Pakistan	University of Oxford; University of Oxford; University of Oxford; Swedish Medical Center; Universidade Federal de Pelotas; Universidade Federal de Pelotas; Aga Khan University; University of Oxford; University of Turin; Peking University; Aga Khan University	Papageorghiou, AT (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Oxford OX3 9DU, England.	aris.papageorghiou@obs-gyn.ox.ac.uk	Hirst, Jane Elizabeth/L-8863-2019; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Hirst, Jane/AAM-9891-2020; Silveira, Mariangela F/L-6868-2013; Bhutta, Zulfiqar/L-7822-2015	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Hirst, Jane/0000-0002-0176-2651; Silveira, Mariangela F/0000-0002-3551-9713; Noble, Alison/0000-0002-3060-3772; Cheikh Ismail, Leila/0000-0003-3048-7481; BERTINO, Enrico/0000-0002-6369-9352; Bhutta, Zulfiqar/0000-0003-0637-599X; Papageorghiou, Aris T./0000-0001-8143-2232	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This project was supported by the Bill & Melinda Gates Foundation to the University of Oxford. The sponsor played no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	[Anonymous], 2013, J GYNECOL OBST BIO R, V42, P1018, DOI 10.1016/j.jgyn.2013.09.023; AZZIZ R, 1988, INT J GYNECOL OBSTET, V26, P81, DOI 10.1016/0020-7292(88)90200-7; BAILEY SM, 1989, BRIT J OBSTET GYNAEC, V96, P1266, DOI 10.1111/j.1471-0528.1989.tb03223.x; BELIZAN JM, 1978, AM J OBSTET GYNECOL, V131, P643, DOI 10.1016/0002-9378(78)90824-4; BERGSTROM S, 1989, J TROP PEDIATRICS, V35, P27, DOI 10.1093/tropej/35.1.27; Burton F, 2013, BJOG-INT J OBSTET GY, V120, P77, DOI 10.1111/1471-0528.12030; Freire DMC, 2006, REV BRAS GINECOL OBS, V28, P3, DOI 10.1590/S0100-72032006000100002; Freire DMC, 2010, REV SAUDE PUBL, V44, P1031, DOI 10.1590/S0034-89102010005000044; CALVERT JP, 1982, BRIT MED J, V285, P846, DOI 10.1136/bmj.285.6345.846; Challis K, 2002, TROP MED INT HEALTH, V7, P678, DOI 10.1046/j.1365-3156.2002.00907.x; de Onis M, 2006, ACTA PAEDIATR, V95, P5, DOI 10.1080/08035320500495373; Deeluea J, 2013, ISRN OBSTET GYNECOL, V2013; Deeluea J, 2013, ISRN OBSTET GYNECOL, V2013; Ebite LE, 2009, J OBSTET GYNAECOL, V29, P605, DOI 10.1080/01443610903118254; Goto E, 2013, J EPIDEMIOL COMMUN H, V67, P999, DOI 10.1136/jech-2012-202141; HAKANSSON A, 1995, ACTA OBSTET GYN SCAN, V74, P682, DOI 10.3109/00016349509021174; Imdad A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S1; Ioannou C, 2013, BJOG-INT J OBSTET GY, V120, P38, DOI 10.1111/1471-0528.12056; Ismail LC, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i555; Jensen OH, 1991, ACTA OBSTET GYN SCAN, V70, P13, DOI 10.3109/00016349109006170; KISERUD T, 1986, ACTA OBSTET GYN SCAN, V65, P713, DOI 10.3109/00016348609161487; MARTINELLI S., 2001, RBGO, V23, P235, DOI DOI 10.1590/S0100-72032001000400006; Medhat W M, 1991, J Egypt Public Health Assoc, V66, P305; MUNJANJA SP, 1987, CENT AFR J MED, V33, P29; National Institute for Health and Care Excellence, 2016, ANT CAR UNC PREGN; OGUNRANTI JO, 1990, INT J GYNECOL OBSTET, V33, P299, DOI 10.1016/0020-7292(90)90514-L; Ohuma E, 2013, ESTIMATION GESTATION, P13; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Papageorghiou AT, 2013, BJOG-INT J OBSTET GY, V120, P27, DOI 10.1111/1471-0528.12313; Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2; PERSSON B, 1986, BRIT J OBSTET GYNAEC, V93, P206, DOI 10.1111/j.1471-0528.1986.tb07894.x; Peter JR, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008136.pub3; QUARANTA P, 1981, BRIT J OBSTET GYNAEC, V88, P115, DOI 10.1111/j.1471-0528.1981.tb00952.x; Royal College of Obstetricians and Gynaecologists, 2013, INV MAN SMALL FOR GE; STEINGROMSDOTTIR T, 1995, ACTA OBSTET GYN SCAN, V74, P346, DOI 10.3109/00016349509024426; Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047; Villar J, 2016, LANCET, V387, P844, DOI 10.1016/S0140-6736(16)00384-6; Villar J, 2015, LANCET GLOB HEALTH, V3, pE681, DOI 10.1016/S2214-109X(15)00163-1; Villar J, 2014, LANCET DIABETES ENDO, V2, P781, DOI 10.1016/S2213-8587(14)70121-4; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; WALRAVEN GEL, 1995, EUR J OBSTET GYN R B, V60, P149, DOI 10.1016/0028-2243(95)02097-C; Wanyonyi SZ, 2014, ULTRASOUND OBST GYN, V44, P649, DOI 10.1002/uog.13376; WESTIN B, 1977, ACTA OBSTET GYN SCAN, V56, P273, DOI 10.3109/00016347709154978; World Health Organization, 1995, WHO TECH REP SER, V854, P1; Wright JD, 2013, OBSTET GYNECOL, V121, P1217, DOI [10.1097/AOG.0b013e31828ec686, 10.1097/01.AOG.0000429658.85846.f9]	45	46	48	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2016	355								i5662	10.1136/bmj.i5662	http://dx.doi.org/10.1136/bmj.i5662			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CQ	27821614	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000388002700002
J	Snyder, A				Snyder, Alison			Allen Roses	LANCET			English	Biographical-Item																		ROSES A, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2232	2232		10.1016/S0140-6736(16)32081-5	http://dx.doi.org/10.1016/S0140-6736(16)32081-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8MO	27831470	Bronze			2022-12-28	WOS:000386889300018
J	Ji, RR; Chamessian, A; Zhang, YQ				Ji, Ru-Rong; Chamessian, Alexander; Zhang, Yu-Qiu			Pain regulation by non-neuronal cells and inflammation	SCIENCE			English	Review							NEUROPATHIC PAIN; SPINAL-CORD; SENSORY NEURONS; NOCICEPTIVE NEURONS; IMMUNE-SYSTEM; NERVE INJURY; CANCER PAIN; ACTIVATION; MICROGLIA; HYPERSENSITIVITY	Acute pain is protective and a cardinal feature of inflammation. Chronic pain after arthritis, nerve injury, cancer, and chemotherapy is associated with chronic neuroinflammation, a local inflammation in the peripheral or central nervous system. Accumulating evidence suggests that non-neuronal cells such as immune cells, glial cells, keratinocytes, cancer cells, and stem cells play active roles in the pathogenesis and resolution of pain. We review how non-neuronal cells interact with nociceptive neurons by secreting neuroactive signaling molecules that modulate pain. Recent studies also suggest that bacterial infections regulate pain through direct actions on sensory neurons, and specific receptors are present in nociceptors to detect danger signals from infections. We also discuss new therapeutic strategies to control neuroinflammation for the prevention and treatment of chronic pain.	[Ji, Ru-Rong; Chamessian, Alexander] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Ji, Ru-Rong] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Zhang, Yu-Qiu] Fudan Univ, Inst Neurobiol, Inst Brain Sci, Shanghai 200032, Peoples R China; [Zhang, Yu-Qiu] Fudan Univ, Collaborat Innovat Ctr Brain Sci, State Key Lab Med Neurobiol, Shanghai 200032, Peoples R China	Duke University; Duke University; Fudan University; Fudan University	Ji, RR (corresponding author), Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA.; Ji, RR (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ru-rong.ji@duke.edu	Zhang, Yu-Qiu/CAF-6295-2022; Zhang, Yu-Qiu/AAS-2516-2020; Ji, Ru-Rong/L-7070-2017	Ji, Ru-Rong/0000-0002-9355-3688	NIH [DE17794, DE22743, NS87988]; National Natural Science Foundation of China [31420103903]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022743, R01DE017794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS091779, R01NS087988] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Our research is supported by NIH (R01 grants DE17794, DE22743, and NS87988 to R.-R.J.) and National Natural Science Foundation of China (grant 31420103903 to Y.-Q.Z and R.-R.J.). All the figures have not been published before.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Baumbauer KM, 2015, ELIFE, V4, DOI 10.7554/eLife.09674; Berta T, 2014, J CLIN INVEST, V124, P1173, DOI 10.1172/JCI72230; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Calvo M, 2012, LANCET NEUROL, V11, P629, DOI 10.1016/S1474-4422(12)70134-5; Chen G, 2015, J CLIN INVEST, V125, P3226, DOI 10.1172/JCI80883; Chen G, 2014, BRAIN, V137, P2193, DOI 10.1093/brain/awu140; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Christianson CA, 2011, PAIN, V152, P2881, DOI 10.1016/j.pain.2011.09.020; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Clark AK, 2015, J NEUROSCI, V35, P4552, DOI 10.1523/JNEUROSCI.2061-14.2015; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; da Silva MD, 2015, MOL NEUROBIOL, V51, P19, DOI 10.1007/s12035-014-8790-x; Denk F, 2016, CELL REP, V15, P1771, DOI 10.1016/j.celrep.2016.04.063; Diogenes A, 2011, J DENT RES, V90, P759, DOI 10.1177/0022034511400225; Fell GL, 2014, CELL, V157, P1527, DOI 10.1016/j.cell.2014.04.032; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Ghasemlou N, 2015, P NATL ACAD SCI USA, V112, pE6808, DOI 10.1073/pnas.1501372112; Gold MS, 2010, NAT MED, V16, P1248, DOI 10.1038/nm.2235; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Grace PM, 2014, NAT REV IMMUNOL, V14, P217, DOI 10.1038/nri3621; Gritsch S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6472; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Guo W, 2011, STEM CELLS, V29, P1294, DOI 10.1002/stem.667; Ji RR, 2014, NAT REV DRUG DISCOV, V13, P533, DOI 10.1038/nrd4334; Ji RR, 2013, PAIN, V154, pS10, DOI 10.1016/j.pain.2013.06.022; Jiang BC, 2016, J CLIN INVEST, V126, P745, DOI 10.1172/JCI81950; Kawasaki Y, 2008, J NEUROSCI, V28, P5189, DOI 10.1523/JNEUROSCI.3338-07.2008; Kim DS, 2012, J NEUROSCI, V32, P8977, DOI 10.1523/JNEUROSCI.6494-11.2012; Kim SK, 2016, J CLIN INVEST, V126, P1983, DOI 10.1172/JCI82859; Li Y, 2015, J NEUROSCI, V35, P13487, DOI 10.1523/JNEUROSCI.1956-15.2015; Liu T, 2010, NAT NEUROSCI, V13, P1460, DOI 10.1038/nn.2683; Liu XJ, 2014, CELL RES, V24, P1374, DOI 10.1038/cr.2014.106; Mantyh P, 2013, PAIN, V154, pS54, DOI 10.1016/j.pain.2013.07.044; Marion E, 2014, CELL, V157, P1565, DOI 10.1016/j.cell.2014.04.040; Moore C, 2013, P NATL ACAD SCI USA, V110, pE3225, DOI 10.1073/pnas.1312933110; Old EA, 2014, J CLIN INVEST, V124, P2023, DOI 10.1172/JCI71389; Park CK, 2014, NEURON, V82, P47, DOI 10.1016/j.neuron.2014.02.011; Peng JY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12029; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Selvaraj D, 2015, CANCER CELL, V27, P780, DOI 10.1016/j.ccell.2015.04.017; Shi YQ, 2016, MOL PAIN, V12, DOI 10.1177/1744806916656845; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Vicuna L, 2015, NAT MED, V21, P518, DOI 10.1038/nm.3852; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Willemen HLDM, 2014, J PAIN, V15, P496, DOI 10.1016/j.jpain.2014.01.491; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Xanthos DN, 2014, NAT REV NEUROSCI, V15, P43, DOI 10.1038/nrn3617; Xu Q, 2013, J NEUROSCI, V33, P19099, DOI 10.1523/JNEUROSCI.4852-12.2013; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Xu ZZ, 2013, ANN NEUROL, V74, P490, DOI 10.1002/ana.23928; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yang Y, 2015, J NEUROSCI, V35, P7950, DOI 10.1523/JNEUROSCI.5250-14.2015; Zarpelon AC, 2016, FASEB J, V30, P54, DOI 10.1096/fj.14-267146; Zelenka M, 2005, PAIN, V116, P257, DOI 10.1016/j.pain.2005.04.018; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	68	602	626	20	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					572	577		10.1126/science.aaf8924	http://dx.doi.org/10.1126/science.aaf8924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811267	Green Published, Green Accepted			2022-12-28	WOS:000386869800036
J	Song, L; Huang, SSC; Wise, A; Castanon, R; Nery, JR; Chen, HM; Watanabe, M; Thomas, J; Bar-Joseph, Z; Ecker, JR				Song, Liang; Huang, Shao-shan Carol; Wise, Aaron; Castanon, Rosa; Nery, Joseph R.; Chen, Huaming; Watanabe, Marina; Thomas, Jerushah; Bar-Joseph, Ziv; Ecker, Joseph R.			A transcription factor hierarchy defines an environmental stress response network	SCIENCE			English	Article							CHIP-SEQ; BIOCONDUCTOR PACKAGE; FUNCTIONAL ELEMENTS; REGULATORY NETWORKS; POSITIVE REGULATOR; GENE-EXPRESSION; SEED DORMANCY; GENOME; ENCODE; TOLERANCE		[Song, Liang; Huang, Shao-shan Carol; Watanabe, Marina; Thomas, Jerushah; Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Wise, Aaron; Bar-Joseph, Ziv] Carnegie Mellon Univ, Sch Comp Sci, Computat Biol Dept, Pittsburgh, PA 15213 USA; [Castanon, Rosa; Nery, Joseph R.; Chen, Huaming; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Ecker, Joseph R.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Carnegie Mellon University; Salk Institute; Howard Hughes Medical Institute; Salk Institute	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA.; Ecker, JR (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.	ecker@salk.edu	Bar-Joseph, Ziv/GWN-2754-2022; Ecker, Joseph R/B-9144-2008; Nery, Joseph/AAE-8422-2019	Ecker, Joseph R/0000-0001-5799-5895; Nery, Joseph/0000-0003-0153-5659; Chen, Huaming/0000-0001-5289-7882	Salk Pioneer Postdoctoral Fellowships; Gordon and Betty Moore Foundation [GBMF 3034]; NSF [MCB-1024999, DBI-1356505]; NIH [U01 HL122626-01]; Direct For Biological Sciences [1356505] Funding Source: National Science Foundation	Salk Pioneer Postdoctoral Fellowships; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank F. Turck and K. N. Chang for discussions of the ChIP procedures; J. Alonso for discussions of the recombineering procedures; J. Chory, N. Fedoroff, and M. Zander for comments; C. Serrano, J. P. Saldierna, and A. Nasamran for cloning and plant maintenance; U. Pedmale and M. Xie for sharing plasmids; and J. Simon for assistance with graphics. L.S. and S.C.H. were supported by Salk Pioneer Postdoctoral Fellowships. This work was supported by grants from the Gordon and Betty Moore Foundation (GBMF 3034 to J.R.E), NSF (MCB-1024999 to J.R.E. and DBI-1356505 to Z.B.-J.), and NIH (U01 HL122626-01 to Z.B.-J.). J.R.E. is an investigator of the HHMI. All of the reported RNA-Seq and ChIP-seq data has been deposited at the National Center for Biotechnology Information (Gene Expression Omnibus accession no. GSE80568). Genome browser tracks and motifs of our data set can be viewed at www.ABAtf.net.	Alonso J. M., 2015, METHODS MOL BIOL, V1227; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Celli Fabrizio, 2015, F1000Res, V4, P110, DOI 10.12688/f1000research.6354.1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cumbie JS, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0087-1; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Fresno C, 2013, BIOINFORMATICS, V29, P2810, DOI 10.1093/bioinformatics/btt487; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Gene Ontology Consortium, 2015, Nucleic Acids Res, V43, pD1049, DOI 10.1093/nar/gku1179; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Jensen MK, 2013, FEBS OPEN BIO, V3, P321, DOI 10.1016/j.fob.2013.07.006; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Kersey PJ, 2014, NUCLEIC ACIDS RES, V42, pD546, DOI 10.1093/nar/gkt979; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohno M, 2012, MOL BIOL REP, V39, P911, DOI 10.1007/s11033-011-0816-0; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kumimoto RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059481; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee IC, 2011, PLANT CELL PHYSIOL, V52, P651, DOI 10.1093/pcp/pcr026; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Lim CW, 2012, PLANT SCI, V187, P83, DOI 10.1016/j.plantsci.2012.01.013; Lumba S, 2014, DEV CELL, V29, P360, DOI 10.1016/j.devcel.2014.04.004; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; McLeay RC, 2012, BIOINFORMATICS, V28, P2789, DOI 10.1093/bioinformatics/bts529; Moreno-Risueno MA, 2015, SCIENCE, V350, P426, DOI 10.1126/science.aad1171; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Oldfield AJ, 2014, MOL CELL, V55, P708, DOI 10.1016/j.molcel.2014.07.005; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Park SY, 2015, NATURE, V520, P545, DOI 10.1038/nature14123; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Petrillo E, 2014, SCIENCE, V344, P427, DOI 10.1126/science.1250322; Piskurewicz U, 2009, PLANT SIGNAL BEHAV, V4, P63, DOI 10.4161/psb.4.1.7331; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Schulz MH, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-104; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Song Liang, 2016, Curr Protoc Plant Biol, V1, P293, DOI 10.1002/cppb.20014; Stark R., 2015, DIFFBIND DIFFERENTIA; Sugimoto K, 2010, P NATL ACAD SCI USA, V107, P5792, DOI 10.1073/pnas.0911965107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wise A, 2015, J COMPUT BIOL, V22, P324, DOI 10.1089/cmb.2015.0010; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103; Zhang ZL, 2011, P NATL ACAD SCI USA, V108, P2160, DOI 10.1073/pnas.1012232108; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	66	257	260	4	156	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312							aag1550	10.1126/science.aag1550	http://dx.doi.org/10.1126/science.aag1550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811239	Green Accepted			2022-12-28	WOS:000386869800042
J	Borsanyi, S; Fodor, Z; Guenther, J; Kampert, KH; Katz, SD; Kawanai, T; Kovacs, TG; Mages, SW; Pasztor, A; Pittler, F; Redondo, J; Ringwald, A; Szabo, KK				Borsanyi, S.; Fodor, Z.; Guenther, J.; Kampert, K. -H.; Katz, S. D.; Kawanai, T.; Kovacs, T. G.; Mages, S. W.; Pasztor, A.; Pittler, F.; Redondo, J.; Ringwald, A.; Szabo, K. K.			Calculation of the axion mass based on high-temperature lattice quantum chromodynamics	NATURE			English	Article							QCD	Unlike the electroweak sector of the standard model of particle physics, quantum chromodynamics (QCD) is surprisingly symmetric under time reversal. As there is no obvious reason for QCD being so symmetric, this phenomenon poses a theoretical problem, often referred to as the strong CP problem. The most attractive solution for this(1) requires the existence of a new particle, the axion(2,3)-a promising dark-matter candidate. Here we determine the axion mass using lattice QCD, assuming that these particles are the dominant component of dark matter. The key quantities of the calculation are the equation of state of the Universe and the temperature dependence of the topological susceptibility of QCD, a quantity that is notoriously difficult to calculate4-8, especially in the most relevant high-temperature region (up to several gigaelectronvolts). But by splitting the vacuum into different sectors and re-defining the fermionic determinants, its controlled calculation becomes feasible. Thus, our twofold prediction helps most cosmological calculations(9) to describe the evolution of the early Universe by using the equation of state, and may be decisive for guiding experiments looking for dark-matter axions. In the next couple of years, it should be possible to confirm or rule out post-inflation axions experimentally, depending on whether the axion mass is found to be as predicted here. Alternatively, in a pre-inflation scenario, our calculation determines the universal axionic angle that corresponds to the initial condition of our Universe.	[Borsanyi, S.; Fodor, Z.; Guenther, J.; Kampert, K. -H.; Pasztor, A.; Szabo, K. K.] Univ Wuppertal, Dept Phys, D-42119 Wuppertal, Germany; [Fodor, Z.; Kawanai, T.; Mages, S. W.; Szabo, K. K.] Forschungszentrum Julich, Julich Supercomp Ctr, D-52428 Julich, Germany; [Fodor, Z.; Katz, S. D.; Pittler, F.] Eotvos Lorand Univ, Inst Theoret Phys, H-1117 Budapest, Hungary; [Katz, S. D.; Pittler, F.] MTA ELTE Lendulet Lattice Gauge Theory Res Grp, H-1117 Budapest, Hungary; [Kovacs, T. G.] Hungarian Acad Sci, Inst Nucl Res, H-4026 Debrecen, Hungary; [Redondo, J.] Univ Zaragoza, E-50009 Zaragoza, Spain; [Redondo, J.] Max Planck Inst Phys & Astrophys, D-80803 Munich, Germany; [Ringwald, A.] DESY, D-22607 Hamburg, Germany	University of Wuppertal; Helmholtz Association; Research Center Julich; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute for Nuclear Research; University of Zaragoza; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Fodor, Z (corresponding author), Univ Wuppertal, Dept Phys, D-42119 Wuppertal, Germany.; Fodor, Z (corresponding author), Forschungszentrum Julich, Julich Supercomp Ctr, D-52428 Julich, Germany.; Fodor, Z (corresponding author), Eotvos Lorand Univ, Inst Theoret Phys, H-1117 Budapest, Hungary.	fodor@bodri.elte.hu	Pásztor, Attila/AAC-8507-2019; Katz, Sandor D/A-4154-2011; Redondo, Javier/H-9362-2015	Pásztor, Attila/0000-0002-6016-3069; Mages, Simon/0000-0003-1447-6811; Katz, Sandor/0000-0001-6524-2965; Redondo, Javier/0000-0002-1044-8197	DFG [SFB/TR55]; OTKA [OTKA-K-113034]; Hungarian Academy of Sciences under 'Lendulet' [LP 2011-011]; Ramon y Cajal Fellowship; MINECO/FEDER [FPA2015-65745-P]	DFG(German Research Foundation (DFG)); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences under 'Lendulet'; Ramon y Cajal Fellowship(Spanish Government); MINECO/FEDER(Spanish Government)	We thank M. Dierigl, M. Giordano, S. Krieg, D. Nogradi and B. Toth for discussions. This project was funded by the DFG (grant SFB/TR55) and by OTKA (grant OTKA-K-113034). T.G.K. is supported by the Hungarian Academy of Sciences under 'Lendulet' grant no. LP 2011-011. The work of J.R. is supported by the Ramon y Cajal Fellowship 2012-10597 and by FPA2015-65745-P (MINECO/FEDER). The computations were performed on JUQUEEN at Forschungszentrum Julich, on SuperMUC at Leibniz Supercomputing Centre in Munchen, on Hazel Hen at the High Performance Computing Center in Stuttgart, on QPACE in Wuppertal and on GPU clusters in Wuppertal, Budapest and Debrecen.	Andersen JO, 2011, PHYS LETT B, V696, P468, DOI 10.1016/j.physletb.2010.12.070; Aoki Y, 2006, NATURE, V443, P675, DOI 10.1038/nature05120; Aoki Y, 2009, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2009/06/088; Berkowitz E, 2015, PHYS REV D, V92, DOI 10.1103/PhysRevD.92.034507; Bonati C, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2016)155; Borsanyi S, 2016, PHYS LETT B, V752, P175, DOI 10.1016/j.physletb.2015.11.020; Borsanyi S, 2015, SCIENCE, V347, P1452, DOI 10.1126/science.1257050; Borsanyi S, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP07(2012)056; Borsanyi S, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2012)010; Borsanyi S, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2010)073; DeGrand T, 2003, PHYS REV D, V67, DOI 10.1103/PhysRevD.67.054501; DeGrand T, 1997, NUCL PHYS B, V505, P417, DOI 10.1016/S0550-3213(97)00480-X; Durr S, 2008, SCIENCE, V322, P1224, DOI 10.1126/science.1163233; Durr S, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.094502; Durr S, 2006, P SCI, V2005; Frison J, 2016, J HIGH ENERGY PHYS, DOI 10.1007/JHEP09(2016)021; KOGUT J, 1975, PHYS REV D, V11, P395, DOI 10.1103/PhysRevD.11.395; Laio A., 2015, J HIGH ENERGY PHYS, V2016, P89; Luscher M, 2014, J HIGH ENERGY PHYS, DOI 10.1007/JHEP03(2014)092; Luscher M, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2010)071; Luscher M., 2011, J HIGH ENERGY PHYS, V2011; Mages S., 2015, PREPRINT; Morningstar C, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.054501; Neuberger H, 1998, PHYS LETT B, V417, P141, DOI 10.1016/S0370-2693(97)01368-3; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; PECCEI RD, 1977, PHYS REV LETT, V38, P1440, DOI 10.1103/PhysRevLett.38.1440; Petreczky P., 2016, PHYS LETT B; Ringwald A, 1999, PHYS LETT B, V459, P249, DOI 10.1016/S0370-2693(99)00682-6; Trunin A, 2016, J PHYS CONF SER, V668, DOI 10.1088/1742-6596/668/1/012123; Wantz O, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.123508; WEINBERG S, 1978, PHYS REV LETT, V40, P223, DOI 10.1103/PhysRevLett.40.223; WILCZEK F, 1978, PHYS REV LETT, V40, P279, DOI 10.1103/PhysRevLett.40.279; WILSON KG, 1974, PHYS REV D, V10, P2445, DOI 10.1103/PhysRevD.10.2445	34	347	347	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					69	+		10.1038/nature20115	http://dx.doi.org/10.1038/nature20115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808190	Green Accepted, Green Published			2022-12-28	WOS:000386670100030
J	Gandhi, TK				Gandhi, Tejal K.			Safety Lessons from the NIH Clinical Center	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gandhi, Tejal K.] Natl Patient Safety Fdn, Boston, MA 02210 USA		Gandhi, TK (corresponding author), Natl Patient Safety Fdn, Boston, MA 02210 USA.							Agency for Healthcare Research and Quality, 2016, HOSP SURV PAT SAF CU; [Anonymous], 2016, CLIN PERFORMANCE MET; Clinical Center Working Group of the Advisory Committee to the Director, 2016, RED RISK PROM PAT SA; National Patient Safety Foundation, 2015, FREE HARM ACCELERATI	4	3	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1705	1707		10.1056/NEJMp1609208	http://dx.doi.org/10.1056/NEJMp1609208			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB0BB	27806220	Bronze			2022-12-28	WOS:000387007300001
J	Johns, DM; Bayer, R				Johns, David Merritt; Bayer, Ronald			The Paradox of Authority - Transformation of the USPSTF under the Affordable Care Act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICES TASK-FORCE		[Johns, David Merritt; Bayer, Ronald] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA	Columbia University	Johns, DM (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY 10027 USA.							*I MED, 2000, EXT MED COV PREV OTH; MCGINNIS J M, 1990, Journal of General Internal Medicine, V5, pS11, DOI 10.1007/BF02600832; Pauly MV, 2014, HEALTH AFFAIR, V33, P2034, DOI 10.1377/hlthaff.2013.0873; Woolf SH, 1996, ANNU REV PUBL HEALTH, V17, P511, DOI 10.1146/annurev.pu.17.050196.002455; Woolf SH, 2013, JAMA-J AM MED ASSOC, V309, P1899, DOI 10.1001/jama.2013.3448	5	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1710	1712		10.1056/NEJMp1607267	http://dx.doi.org/10.1056/NEJMp1607267			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB0BB	27806217				2022-12-28	WOS:000387007300003
J	[Anonymous]				[Anonymous]			THE PLIGHT OF YOUNG SCIENTISTS	NATURE			English	Editorial Material																			0	3	3	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					443	443		10.1038/538443a	http://dx.doi.org/10.1038/538443a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786228	Bronze			2022-12-28	WOS:000386654400029
J	Voelker, R				Voelker, Rebecca			Prediabetes Is Being Overlooked	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1638	1638		10.1001/jama.2016.15042	http://dx.doi.org/10.1001/jama.2016.15042			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784103				2022-12-28	WOS:000386107800010
J	Denny, L; de Sanjose, S; Mutebi, M; Anderson, BO; Kim, J; Jeronimo, J; Herrero, R; Yeates, K; Ginsburg, O; Sankaranarayanan, R				Denny, Lynette; de Sanjose, Silvia; Mutebi, Miriam; Anderson, Benjamin O.; Kim, Jane; Jeronimo, Jose; Herrero, Rolando; Yeates, Karen; Ginsburg, Ophira; Sankaranarayanan, Rengaswamy			Interventions to close the divide for women with breast and cervical cancer between low-income and middle-income countries and high-income countries	LANCET			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; LOW-RESOURCE SETTINGS; INTERNATIONAL INCIDENCE RATES; COST-EFFECTIVENESS; GUIDELINE IMPLEMENTATION; RANDOMIZED-TRIAL; SELF-COLLECTION; HEALTH-CARE; TRENDS; PREVENTION	Breast and cervical cancers are the commonest cancers diagnosed in women living in low-income and middle-income countries (LMICs), where opportunities for prevention, early detection, or both, are few. Yet several cost-effective interventions could be used to reduce the burden of these two cancers in resource-limited environments. Population-wide vaccination against human papillomavirus (HPV) linked to cervical screening, at least once, for adult women has the potential to reduce the incidence of cervical cancer substantially. Strategies such as visual inspection with acetic acid and testing for oncogenic HPV types could make prevention of cervical cancer programmatically feasible. These two cancers need not be viewed as inevitably fatal, and can be cured, particularly if detected and treated at an early stage. Investing in the health of girls and women is an investment in the development of nations and their futures. Here we explore ways to lessen the divide between LMICs and high-income countries for breast and cervical cancers.	[Denny, Lynette] Univ Cape Town, Dept Obstet & Gynaecol, Cape Town, South Africa; [Mutebi, Miriam] Univ Cape Town, Dept Surg, Cape Town, South Africa; Groote Schuur Hosp, Cape Town, South Africa; [de Sanjose, Silvia] IDIBELL, Catalan Inst Oncol, Canc Epidemiol Res Programme, Barcelona, Spain; [de Sanjose, Silvia] CIBERESP, Barcelona, Spain; [Mutebi, Miriam] Aga Khan Univ, Dept Surg, Nairobi, Kenya; [Anderson, Benjamin O.] Univ Washington, Div Publ Hlth Sci, Dept Surg & Global Hlth Med, Seattle, WA 98195 USA; [Anderson, Benjamin O.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Kim, Jane] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Jeronimo, Jose] PATH, Seattle, WA USA; [Herrero, Rolando] Int Agcy Res Canc, Prevent & Implementat Grp, Lyon, France; [Yeates, Karen] Queens Univ, Dept Med, Kingston, ON, Canada; [Ginsburg, Ophira] Univ Toronto, Dalla Lana Sch Publ Hlth, Fac Med, Inst Canc Policy,Womens Coll Res Inst, Toronto, ON, Canada; [Ginsburg, Ophira] WHO, Geneva, Switzerland; [Sankaranarayanan, Rengaswamy] Int Agcy Res Canc, Screening Grp, Lyon, France	University of Cape Town; University of Cape Town; University of Cape Town; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Aga Khan University; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; International Agency for Research on Cancer (IARC); Queens University - Canada; University of Toronto; University Toronto Affiliates; Womens College Hospital; World Health Organization; World Health Organization; International Agency for Research on Cancer (IARC)	Denny, L (corresponding author), Univ Cape Town, Groote Schuur Hosp, Dept Obstet & Gynaecol, H45,Old Main Bldg, ZA-7925 Cape Town, South Africa.	lynette.denny@uct.ac.za		Ginsburg, Ophira/0000-0002-1384-2675	Susan G Komen for the Cure [SAC110001]	Susan G Komen for the Cure(Susan G. Komen Breast Cancer Foundation)	BOA receives salary support from Susan G Komen for the Cure (SAC110001). The opinions expressed in this Series are those of the authors and do not necessarily represent an official position of the organisations with which they are affiliated.	Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Anderson BO, 2008, CANCER-AM CANCER SOC, V113, P2221, DOI 10.1002/cncr.23844; Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6; [Anonymous], 1986, BMJ-BRIT MED J, V293, P659; Arrossi S, 2015, LANCET GLOB HEALTH, V3, pE85, DOI 10.1016/S2214-109X(14)70354-7; Asthana Smita, 2014, Indian J Public Health, V58, P5, DOI 10.4103/0019-557X.128150; Baldur-Felskov B, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt460; Baum M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f385; Berg WA, 2004, RADIOL CLIN N AM, V42, P845, DOI 10.1016/j.rcl.2004.04.003; Berg WA, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv367; Bevers TB, 2016, NCCN CLIN PRACTICE G; Blumenthal PD, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.12.031; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Campos NG, 2015, PAPILLOMAVIRUS RES, V1, P38, DOI 10.1016/j.pvr.2015.05.003; Campos NG, 2015, INT J CANCER, V137, P2208, DOI 10.1002/ijc.29594; Campos NG, 2015, INT J CANCER, V137, P893, DOI 10.1002/ijc.29438; CHU KC, 1988, JNCI-J NATL CANCER I, V80, P1125, DOI 10.1093/jnci/80.14.1125; CSDH, 2008, CLOS GAP GEN HLTH EQ; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; de Sanjose S, 2012, Vaccine, V30 Suppl 4, pD1, DOI 10.1016/S0264-410X(12)01435-1; DeGregorio GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157319; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Dhillon PK, 2011, BRIT J CANCER, V105, P723, DOI 10.1038/bjc.2011.301; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Einstein MH, 2014, J CLIN MICROBIOL, V52, P2089, DOI 10.1128/JCM.00176-14; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Garland SM, 2016, CLIN INFECT DIS, V63, P519, DOI 10.1093/cid/ciw354; Ginsburg O., 2016, LANCET; Ginsburg OM, 2014, ONCOLOGIST, V19, P177, DOI 10.1634/theoncologist.2013-0314; Goldie SJ, 2001, JAMA-J AM MED ASSOC, V285, P3107, DOI 10.1001/jama.285.24.3107; Goldie SJ, 2008, VACCINE, V26, P4080, DOI 10.1016/j.vaccine.2008.04.053; Gustafsson L, 1997, CANCER CAUSE CONTROL, V8, P755, DOI 10.1023/A:1018435522475; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; HAKAMA M, 1988, CANCER SURV, V7, P403; Herweijer E, 2016, INT J CANCER, V138, P2867, DOI 10.1002/ijc.30035; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; Irwin K L, 1991, Bull Pan Am Health Organ, V25, P16; Jit M, 2014, LANCET GLOB HEALTH, V2, pE406, DOI 10.1016/S2214-109X(14)70237-2; Joura E, 2015, NEW ENGL J MED, V372, P2568, DOI 10.1056/NEJMc1504359; Kardinah D, 2014, INT J CANCER, V134, P1250, DOI 10.1002/ijc.28442; Kuhn L, 2016, EUROGIN 2016; Kuhn L, 2016, 4 ANN S GLOB CANC RE; LAARA E, 1987, LANCET, V1, P1247; Lauby-Secretan B, 2015, NEW ENGL J MED, V372, P2353, DOI 10.1056/NEJMsr1504363; Lazcano-Ponce E, 2014, INT J CANCER, V135, P109, DOI 10.1002/ijc.28639; Lehtinen M, 2012, LANCET ONCOL, V13, P89, DOI 10.1016/S1470-2045(11)70286-8; Lopes LV, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1092-9; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Mittra I, 2010, INT J CANCER, V126, P976, DOI 10.1002/ijc.24840; Murillo R, 2008, VACCINE, V26, pL37, DOI 10.1016/j.vaccine.2008.06.013; Murillo R, 2016, INT J CANCER, V138, P705, DOI 10.1002/ijc.29801; Niens LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095836; Ohuchi N, 2016, LANCET, V387, P341, DOI 10.1016/S0140-6736(15)00774-6; Okonkwo QL, 2008, JNCI-J NATL CANCER I, V100, P1290, DOI 10.1093/jnci/djn292; Parham GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122169; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Ross E, 2008, SOC WORK HEALTH CARE, V46, P15, DOI 10.1300/J010v4602_02; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-3; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sankaranarayanan R, 2011, JNCI-J NATL CANCER I, V103, P1476, DOI 10.1093/jnci/djr304; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Schiller JT, 2012, VACCINE, V30, pF123, DOI 10.1016/j.vaccine.2012.04.108; Semiglazov VF, 1999, CANC STRATEGY, V1, P145; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; Shyyan R, 2008, CANCER-AM CANCER SOC, V113, P2257, DOI 10.1002/cncr.23840; Smigal C, 2006, CA-CANCER J CLIN, V56, P168, DOI 10.3322/canjclin.56.3.168; Swaminathan R. S. V., 2014, CANC REGISTRATION CH; Swaminathan R, 2009, CANCER EPIDEMIOL, V33, P89, DOI 10.1016/j.canep.2009.06.012; Tabrizi SN, 2014, LANCET INFECT DIS, V14, P958, DOI 10.1016/S1473-3099(14)70841-2; [The International Telephone Union (ITU) WHO], 2012, GUID COUNTR JOIN M H; The World Bank, 2016, HLTH EXP TOT GDP; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Tohno E, 2009, BREAST CANCER-TOKYO, V16, P18, DOI 10.1007/s12282-008-0082-8; Torres-Rueda S, 2016, SEX REPROD HEALTHC, V7, P46, DOI 10.1016/j.srhc.2015.11.006; Unger-Saldana K, 2014, WORLD J CLIN ONCOL, V5, P465, DOI 10.5306/wjco.v5.i3.465; Vaccarella S, 2013, EUR J CANCER, V49, P3262, DOI 10.1016/j.ejca.2013.04.024; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; WHO, 2016, WHO MOD ESS MED LIST; World Health Organization, 2014, WHO POS PAP MAMM SCR; World Health Organization and International Agency for Research on Cancer, 2012, PREV CERV CANC SCREE; Yeates Karen E, 2016, J Glob Oncol, V2, P356, DOI 10.1200/JGO.2015.001768; Zelle SG, 2012, TROP MED INT HEALTH, V17, P1031, DOI 10.1111/j.1365-3156.2012.03021.x; Zhao FH, 2012, J NATL CANCER I, V104, P178, DOI 10.1093/jnci/djr532	87	113	115	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					861	870		10.1016/S0140-6736(16)31795-0	http://dx.doi.org/10.1016/S0140-6736(16)31795-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9UU	27814963				2022-12-28	WOS:000394966400038
J	Shekelle, PG; Newberry, SJ; FitzGerald, JD; Motala, A; O'Hanlon, CE; Tariq, A; Okunogbe, A; Han, D; Shanman, R				Shekelle, Paul G.; Newberry, Sydne J.; FitzGerald, John D.; Motala, Aneesa; O'Hanlon, Claire E.; Tariq, Abdul; Okunogbe, Adeyemi; Han, Dan; Shanman, Roberta			Management of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Review							SERUM URATE LEVELS; CUTANEOUS ADVERSE-REACTIONS; DOUBLE-BLIND TRIAL; TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON SYNDROME; INDUCED DRESS SYNDROME; CHINESE PATIENTS; OPEN-LABEL; ADRENOCORTICOTROPIC HORMONE; TRIAMCINOLONE ACETONIDE	Background: Gout is a common type of inflammatory arthritis in patients seen by primary care physicians. Purpose: To review evidence about treatment of acute gout attacks, management of hyperuricemia to prevent attacks, and discontinuation of medications for chronic gout in adults. Data Sources: Multiple electronic databases from January 2010 to March 2016, reference mining, and pharmaceutical manufacturers. Study Selection: Studies of drugs approved by the U.S. Food and Drug Administration and commonly prescribed by primary care physicians, randomized trials for effectiveness, and trials and observational studies for adverse events. Data Extraction: Data extraction was performed by one reviewer and checked by a second reviewer. Study quality was assessed by 2 independent reviewers. Strength-of-evidence assessment was done by group discussion. Data Synthesis: High-strength evidence from 28 trials (only 3 of which were placebo-controlled) shows that colchicine, nonsteroidal anti-inflammatory drugs (NSAIDs), and corticosteroids reduce pain in patients with acute gout. Moderate-strength evidence suggests that low-dose colchicine is as effective as high-dose colchicine and causes fewer gastrointestinal adverse events. Moderate-strength evidence suggests that uratelowering therapy (allopurinol or febuxostat) reduces long-term risk for acute gout attacks after 1 year or more. High-strength evidence shows that prophylaxis with daily colchicine or NSAIDs reduces the risk for acute gout attacks by at least half in patients starting urate-lowering therapy, and moderate-strength evidence indicates that duration of prophylaxis should be longer than 8 weeks. Although lower urate levels reduce risk for recurrent acute attacks, treatment to a specific target level has not been tested. Limitation: Few studies of acute gout treatments, no placebo-controlled trials of management of hyperuricemia lasting longer than 6 months, and few studies in primary care populations. Conclusion: Colchicine, NSAIDs, and corticosteroids relieve pain in adults with acute gout. Urate-lowering therapy decreases serum urate levels and reduces risk for acute gout attacks.	[Shekelle, Paul G.; Newberry, Sydne J.; Motala, Aneesa; O'Hanlon, Claire E.; Tariq, Abdul; Han, Dan; Shanman, Roberta] RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA; [FitzGerald, John D.] Calif State Univ Los Angeles, David Geffen Sch Med, Rehabil Ctr, Room 32-59,1000 Veteran Ave, Los Angeles, CA 90095 USA; [Okunogbe, Adeyemi] RAND Corp, 1200 South Hayes St, Arlington, VA 22202 USA	RAND Corporation; California State University System; California State University Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RAND Corporation	Shekelle, PG (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	shekelle@rand.org	FitzGerald, John Dermot/T-5539-2018; Okunogbe, Adeyemi/GSN-2029-2022	FitzGerald, John Dermot/0000-0002-8419-7538; , Adeyemi/0000-0002-7486-5176	AHRQ [290-2012-00006I]; U.S. Department of Health and Human Services	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services	This project was funded under contract 290-2012-00006I from the AHRQ, U.S. Department of Health and Human Services.	Agency for Healthcare Research and Quality, 2014, AHRQ PUBLICATION, V10; AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; ALLOWAY JA, 1993, J RHEUMATOL, V20, P111; ALTMAN RD, 1988, J RHEUMATOL, V15, P1422; AXELROD D, 1988, ARTHRITIS RHEUM-US, V31, P803, DOI 10.1002/art.1780310618; Bardin T, 2016, JOINT BONE SPINE, V83, P314, DOI 10.1016/j.jbspin.2015.07.011; Bardin T, 2014, ARTHRITIS RHEUMATOL, V66, pS68; Becker MA, 2013, DIABETES OBES METAB, V15, P1049, DOI 10.1111/dom.12135; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2008, NUCLEOS NUCLEOT NUCL, V27, P585, DOI 10.1080/15257770802136032; Becker MA, 2005, ARTHRITIS RHEUM, V52, P916, DOI 10.1002/art.20935; Becker MA, 2015, SEMIN ARTHRITIS RHEU, V45, P174, DOI 10.1016/j.semarthrit.2015.05.005; Becker MA, 2013, ARTHRITIS RHEUM-US, V65, pS502; Becker MA, 2011, NUCLEOS NUCLEOT NUCL, V30, P1011, DOI 10.1080/15257770.2011.603715; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Becker MA, 2009, J RHEUMATOL, V36, P1273, DOI 10.3899/jrheum.080814; Borstad GC, 2004, J RHEUMATOL, V31, P2429; BUTLER RC, 1985, BRIT J CLIN PHARMACO, V20, P511, DOI 10.1111/j.1365-2125.1985.tb05110.x; Castrejon I, 2015, RHEUMATOL INT, V35, P1127, DOI 10.1007/s00296-014-3189-6; Chaudrey K, 2013, AM J GASTROENTEROL, V108, pS153, DOI 10.14309/00000434-201310001-00519; Chen I-Hung, 2005, Kaohsiung Journal of Medical Sciences, V21, P228; Cheng L, 2015, BRIT J DERMATOL, V173, P555, DOI 10.1111/bjd.13688; Cheng TT, 2004, CLIN THER, V26, P399, DOI 10.1016/S0149-2918(04)90035-5; Chohan S, 2012, ARTHRIT CARE RES, V64, P256, DOI 10.1002/acr.20680; Chung WH, 2015, ANN RHEUM DIS, V74, P2157, DOI 10.1136/annrheumdis-2014-205577; Dennison EM, 2015, ARCH OSTEOPOROS, V10, DOI 10.1007/s11657-015-0241-4; DOUGLAS G, 1970, Annals of Physical Medicine, V10, P275; EBERL R, 1983, ARZNEIMITTEL-FORSCH, V33-1, P641; Faruque LI, 2013, SEMIN ARTHRITIS RHEU, V43, P367, DOI 10.1016/j.semarthrit.2013.05.004; Firestein GS, 2012, KELLEYS TXB RHEUMATO, V1, P1545; Garcia de la Torre I, 1987, INVEST MED INT, V14, P92; Geronikolou Styliani A, 2014, Vesalius, V20, P95; GIBSON T, 1982, ANN RHEUM DIS, V41, P59, DOI 10.1136/ard.41.1.59; Gilchrist MJ, 2011, J GEN INTERN MED, V26, pS423; Goldfarb DS, 2011, J RHEUMATOL, V38, P1385, DOI 10.3899/jrheum.101156; Guy C, 2014, FUND CLIN PHARMACOL, V28, P65; Halpern R, 2009, JCR-J CLIN RHEUMATOL, V15, P3, DOI 10.1097/RHU.0b013e3181945d2c; Hamburger MI, 2012, ARTHRITIS RHEUM-US, V64, pS808; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holland R, 2015, INTERN MED J, V45, P189, DOI 10.1111/imj.12661; HOLLINGWORTH P, 1980, ANN RHEUM DIS, V39, P529, DOI 10.1136/ard.39.5.529-a; Huang XF, 2014, INT J RHEUM DIS, V17, P679, DOI 10.1111/1756-185X.12266; Ibie NC, 2014, J INVEST MED, V62, P504; Jackson RL, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-11; Janssens HJEM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005521.pub2; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kamatani N, 2011, JCR-J CLIN RHEUMATOL, V17, pS50, DOI 10.1097/RHU.0b013e31822541d0; Karimzadeh H, 2006, J RES MED SCI, V11, P104; Khanna D, 2012, ARTHRIT CARE RES, V64, P1431, DOI 10.1002/acr.21772; Khanna PP, 2013, ANN RHEUM DIS, V72, P770; Khanna PP, 2014, SEMIN ARTHRITIS RHEU, V44, P31, DOI 10.1016/j.semarthrit.2014.02.003; Kim SC, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.01.013; Ko TM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4848; Ko TM, 2014, CLIN TRANSL ALLER S3, V4, P2; Krishnan E, 2013, J RHEUMATOL, V40, P1166, DOI 10.3899/jrheum.121061; Kumar A, 1996, BRIT MED J, V312, P173; KYDD AS, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.cd010457.pub2, DOI 10.1002/14651858]; Latourte A, 2014, RHEUMATOLOGY, V53, P1920, DOI 10.1093/rheumatology/keu157; LEDERMAN R, 1990, Advances in Therapy, V7, P344; Lee MH, 2012, INTERN MED J, V42, P411, DOI 10.1111/j.1445-5994.2011.02567.x; Li T, 2013, CHINESE MED J-PEKING, V126, P1867, DOI 10.3760/cma.j.issn.0366-6999.20122892; Liu Y, 2015, MED J CHINESE PEOPLE, V40; LOEBL WY, 1974, ANN RHEUM DIS, V33, P304, DOI 10.1136/ard.33.4.304; LOMEN PL, 1986, AM J MED, V80, P134, DOI 10.1016/0002-9343(86)90131-2; LUPTON GP, 1979, J AM ACAD DERMATOL, V1, P365, DOI 10.1016/S0190-9622(79)70031-4; MACCAGNO A, 1991, CURR MED RES OPIN, V12, P423, DOI 10.1185/03007999109111513; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; Manara M, 2013, REUMATISMO, V65, P4, DOI 10.4081/reumatismo.2013.4; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; PAULUS HE, 1974, ARTHRITIS RHEUM-US, V17, P609, DOI 10.1002/art.1780170517; Perez-Ruiz F, 2006, ARTHRIT RHEUM-ARTHR, V55, P786, DOI 10.1002/art.22232; Perez-Ruiz F, 2011, ARTHRITIS RHEUM-US, V63, P4002, DOI 10.1002/art.30649; Rainer TH, 2016, ANN INTERN MED, V164, P464, DOI 10.7326/M14-2070; Ramasamy SN, 2013, DRUG SAFETY, V36, P953, DOI 10.1007/s40264-013-0084-0; Rubin BR, 2004, ARTHRITIS RHEUM-US, V50, P598, DOI 10.1002/art.20007; RUNDLES RW, 1966, ANN INTERN MED, V64, P229, DOI 10.7326/0003-4819-64-2-229; RUOTSI A, 1978, SCAND J RHEUMATOL, P15; Saag KG, 2013, ARTHRITIS RHEUM-US, V65, pS498; Sarawate CA, 2006, JCR-J CLIN RHEUMATOL, V12, P61, DOI 10.1097/01.rhu.0000209882.50228.9f; Schumacher HR, 2009, RHEUMATOLOGY, V48, P188, DOI 10.1093/rheumatology/ken457; Schumacher HR, 2012, J RHEUMATOL, V39, P1859, DOI 10.3899/jrheum.110916; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Schumacher HR, 2002, BMJ-BRIT MED J, V324, P1488, DOI 10.1136/bmj.324.7352.1488; SCOTT JT, 1966, ANN RHEUM DIS, V25, P623, DOI 10.1136/ard.25.Suppl_6.623; Seth R, 2014, J RHEUMATOL, V41, P42, DOI 10.3899/jrheum.140461; Seth R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006077.pub3; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shekelle PG, 2016, AHRQ PUBLICATION; SHRESTHA M, 1995, ANN EMERG MED, V26, P682, DOI 10.1016/S0196-0644(95)70037-4; SIEGEL LB, 1994, J RHEUMATOL, V21, P1325; SIEGMETH W, 1976, WIEN KLIN WOCHENSCHR, V88, P535; Singh JA, 2014, ARTHRITIS RHEUMATOL, V66, pS71; Stamp LK, 2012, ARTHRITIS RHEUM-US, V64, P2529, DOI 10.1002/art.34488; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Tayar JH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008653.pub2; Taylor TH, 2012, AM J MED, V125, P1126, DOI 10.1016/j.amjmed.2012.05.025; Terkeltaub R, 2015, ANN RHEUM DIS, V74, P771, DOI 10.1136/annrheumdis-2015-eular.1188; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; van Durme CMPG, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010120.pub2; van Echteld I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006190.pub2; van Echteld IA, 2014, J RHEUMATOL, V41, P48, DOI 10.3899/jrheum.140462; WEINER GI, 1979, ARTHRITIS RHEUM, V22, P425, DOI 10.1002/art.1780220420; Weiss KM, 2011, ANN ALLERG ASTHMA IM, V107, pA26; Wells AF, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-15; Wortmann RL, 2010, CLIN THER, V32, P2386, DOI 10.1016/j.clinthera.2011.01.008; Wu EQ, 2009, J RHEUMATOL, V36, P1032, DOI 10.3899/jrheum.080487; Xu SY, 2015, INT J RHEUM DIS, V18, P669, DOI 10.1111/1756-185X.12648; Yang CY, 2015, JAMA INTERN MED, V175, P1550, DOI 10.1001/jamainternmed.2015.3536; Yaylaci S, 2012, INDIAN J PHARMACOL, V44, P412, DOI 10.4103/0253-7613.96351; Ye P, 2013, CLIN THER, V35, P180, DOI 10.1016/j.clinthera.2012.12.011; Yu KH, 2016, SCAND J RHEUMATOL, V45, P304, DOI 10.3109/03009742.2015.1099729; Zhang SB, 2016, CLIN RHEUMATOL, V35, P151, DOI 10.1007/s10067-015-2991-1; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang YK, 2014, INT J CLIN PRACT, V68, P633, DOI 10.1111/ijcp.12359; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520; Zleik N, 2013, ARTHRITIS RHEUM-US, V65, pS853	119	52	63	1	34	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					37	+		10.7326/M16-0461	http://dx.doi.org/10.7326/M16-0461			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	27802478				2022-12-28	WOS:000391467900007
J	Abbasi, J				Abbasi, Jennifer			Do Apollo Astronaut Deaths Shine a Light on Deep Space Radiation and Cardiovascular Disease?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2469	2470		10.1001/jama.2016.12601	http://dx.doi.org/10.1001/jama.2016.12601			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27829076				2022-12-28	WOS:000390959300002
J	Liu, L; Oza, S; Hogan, D; Chu, Y; Perin, J; Zhu, J; Lawn, JE; Cousens, S; Mathers, C; Black, RE				Liu, Li; Oza, Shefali; Hogan, Dan; Chu, Yue; Perin, Jamie; Zhu, Jun; Lawn, Joy E.; Cousens, Simon; Mathers, Colin; Black, Robert E.			Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals	LANCET			English	Article							INJECTABLE PROCAINE BENZYLPENICILLIN; CHILDREN YOUNGER; OPEN-LABEL; CHILDHOOD; GENTAMICIN; COUNTDOWN; PROGRESS; INFANTS; DEATHS; HEALTH	Background Despite remarkable progress in the improvement of child survival between 1990 and 2015, the Millennium Development Goal (MDG) 4 target of a two-thirds reduction of under-5 mortality rate (U5MR) was not achieved globally. In this paper, we updated our annual estimates of child mortality by cause to 2000-15 to reflect on progress toward the MDG 4 and consider implications for the Sustainable Development Goals (SDG) target for child survival. Methods We increased the estimation input data for causes of deaths by 43% among neonates and 23% among 1-59-month-olds, respectively. We used adequate vital registration (VR) data where available, and modelled cause-specific mortality fractions applying multinomial logistic regressions using adequate VR for low U5MR countries and verbal autopsy data for high U5MR countries. We updated the estimation to use Plasmodium falciparum parasite rate in place of malaria index in the modelling of malaria deaths; to use adjusted empirical estimates instead of modelled estimates for China; and to consider the effects of pneumococcal conjugate vaccine and rotavirus vaccine in the estimation. Findings In 2015, among the 5 . 9 million under-5 deaths, 2 . 7 million occurred in the neonatal period. The leading under-5 causes were preterm birth complications (1 . 055 million [95% uncertainty range (UR) 0 . 935-1 . 179]), pneumonia (0 . 921 million [0 . 812-1 . 117]), and intrapartum-related events (0 . 691 million [0 . 598-0 . 778]). In the two MDG regions with the most under-5 deaths, the leading cause was pneumonia in sub-Saharan Africa and preterm birth complications in southern Asia. Reductions in mortality rates for pneumonia, diarrhoea, neonatal intrapartum-related events, malaria, and measles were responsible for 61% of the total reduction of 35 per 1000 livebirths in U5MR in 2000-15. Stratified by U5MR, pneumonia was the leading cause in countries with very high U5MR. Preterm birth complications and pneumonia were both important in high, medium high, and medium child mortality countries; whereas congenital abnormalities was the most important cause in countries with low and very low U5MR. Interpretation In the SDG era, countries are advised to prioritise child survival policy and programmes based on their child cause-of-death composition. Continued and enhanced efforts to scale up proven life-saving interventions are needed to achieve the SDG child survival target.	[Liu, Li] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA; [Liu, Li; Chu, Yue; Perin, Jamie; Black, Robert E.] Johns Hopkins Bloomberg, Inst Int Programs, Dept Int Hlth, Baltimore, MD USA; [Oza, Shefali; Lawn, Joy E.; Cousens, Simon] London Sch Hyg & Trop Med, London, England; [Hogan, Dan; Mathers, Colin] WHO, Dept Hlth Stat & Informat, Geneva, Switzerland; [Zhu, Jun] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Natl Off Maternal & Child Hlth Surveillance China, Chengdu, Peoples R China; [Zhu, Jun] Sichuan Univ, Lab Birth Defects & Related Dis Women & Children, Minist Educ, Chengdu, Sichuan, Peoples R China	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Sichuan University; Sichuan University	Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD 21205 USA.; Liu, L (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Inst Int Programs, Baltimore 21205, MD USA.	lliu26@jhu.edu	liu, li/HGC-0900-2022; Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443; Mathers, Colin/0000-0002-0617-6731; Oza, Shefali/0000-0001-5872-486X	Bill & Melinda Gates Foundation on Maternal and Child Epidemiology Estimation	Bill & Melinda Gates Foundation on Maternal and Child Epidemiology Estimation	The study was supported by a grant from the Bill & Melinda Gates Foundation on Maternal and Child Epidemiology Estimation. Throughout the development of the estimates, technical inputs were provided by WHO staff, including Doris Ma Fat for causes of deaths in countries with adequate vital registration system, and Richard Cibulskis and Cristin Alexis Fergus for the estimates of Plasmodium falciparum parasite rate and general comments on malaria estimates. We thank Yipu Chen, Yujiang Chen, Mignote Solomon Haile, Hailun Liang, Ping Yeh, and Zihe Zheng for help with the systematic review of verbal autopsy studies used in the post-neonatal VAMCM; Yujiang Chen for her help in preparing some tables and figures for the paper; and all researchers who provided additional study information for their verbal autopsy studies.	Afnan-Holmes H, 2015, LANCET GLOB HEALTH, V3, pE396, DOI 10.1016/S2214-109X(15)00059-5; Alonge O, 2014, ARCH DIS CHILD, V99, P62, DOI 10.1136/archdischild-2013-304177; Amouzou A, 2012, LANCET, V380, P1169, DOI 10.1016/S0140-6736(12)61376-2; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Bassat Q, 2013, LANCET GLOB HEALTH, V1, pE125, DOI 10.1016/S2214-109X(13)70037-8; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Black RE, 2016, LANCET, V388, P2811, DOI 10.1016/S0140-6736(16)00738-8; Cheung YTD, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-835; Davis S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S21; Efron B, 2003, STAT SCI, V18, P135, DOI 10.1214/ss/1063994968; Ford L, 2015, LEADERS PLEDGE 25BN; Friedman HS., 2013, CAUSAL INFERENCE MIL; Glass RI, 2012, JAMA-J AM MED ASSOC, V308, P141, DOI 10.1001/jama.2012.7357; Hall P, 2004, J AM STAT ASSOC, V99, P1015, DOI 10.1198/016214504000000548; He C, LANCET GLOB IN PRESS; Horton R, 2016, LANCET, V387, P1982, DOI 10.1016/S0140-6736(16)30306-3; Kamath-Rayne BD, 2015, MATERN CHILD HLTH J, V19, P1853, DOI 10.1007/s10995-015-1699-9; Lamberti LM, 2016, PEDIATR INFECT DIS J, V35, P992, DOI 10.1097/INF.0000000000001232; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lorenzetti L., 2015, WORLDS 1 MALARIA VAC; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; National Institute of Allergy and Infectious Diseases, 2015, QUEST ANSW START TRE; Oestergaard MZ, 2013, INT J EPIDEMIOL, V42, P645, DOI 10.1093/ije/dyt059; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002056, 10.1371/journal.pmed.1002116]; Tshefu A, SIMPLIFIED ANTIBIOTI; Tshefu A, 2015, LANCET, V385, P1758, DOI 10.1016/S0140-6736(14)62285-6; UN, 2015, SUSTAINABLE DEV GOAL; United Nations, 2015, SUST DEV KNOWL PLATF; United Nations Department of Economic and Social Affairs Population Division, 2015, WORLD POP PROSP 2015; United Nations General Assembly, 2000, UN MILL DECL RES; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson N, 2015, DEMOGRAPHY, V52, P1671, DOI 10.1007/s13524-015-0427-9; World Health Organization, 2015, GUID MAN POSS SER BA; World Health Organization, 2015, WHO REC PREV TRE MAT; You D, 2015, REPORT 2015 ESTIMATE; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	41	1596	1661	17	227	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					3027	3035		10.1016/S0140-6736(16)31593-8	http://dx.doi.org/10.1016/S0140-6736(16)31593-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF1VF	27839855	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000390112300035
J	Voelker, R				Voelker, Rebecca			"Artificial Pancreas" Is Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1957	1957		10.1001/jama.2016.16344	http://dx.doi.org/10.1001/jama.2016.16344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838705				2022-12-28	WOS:000387673800005
J	Riek, R; Eisenberg, DS				Riek, Roland; Eisenberg, David S.			The activities of amyloids from a structural perspective	NATURE			English	Review							ATOMIC-RESOLUTION STRUCTURE; CREUTZFELDT-JAKOB-DISEASE; ALPHA-SYNUCLEIN FIBRILS; REGISTER BETA-SHEETS; HUMAN PRION PROTEIN; X-RAY-DIFFRACTION; ALZHEIMERS-DISEASE; MUTANT P53; IN-VITRO; HUMAN TRANSTHYRETIN	The aggregation of proteins into structures known as amyloids is observed in many neurodegenerative diseases, including Alzheimer's disease. Amyloids are composed of pairs of tightly interacting, many stranded and repetitive intermolecular beta-sheets, which form the cross-beta-sheet structure. This structure enables amyloids to grow by recruitment of the same protein and its repetition can transform a weak biological activity into a potent one through cooperativity and avidity. Amyloids therefore have the potential to self-replicate and can adapt to the environment, yielding cell-to-cell transmissibility, prion infectivity and toxicity.	[Riek, Roland] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Phys Chem Lab, CH-8093 Zurich, Switzerland; [Eisenberg, David S.] UCLA DOE Inst, Los Angeles, CA 90095 USA; [Eisenberg, David S.] Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of Energy (DOE); Howard Hughes Medical Institute	Riek, R (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Phys Chem Lab, CH-8093 Zurich, Switzerland.; Eisenberg, DS (corresponding author), UCLA DOE Inst, Los Angeles, CA 90095 USA.; Eisenberg, DS (corresponding author), Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	roland.riek@phys.chem.ethz.ch; david@mbi.ucla.edu		Riek, Roland/0000-0002-6333-066X	Swiss National Science Foundation (SNSF); US National Institutes of Health; Howard Hughes Medical Institute; SNSF Sinergia grant; NATIONAL INSTITUTE ON AGING [R01AG029430] Funding Source: NIH RePORTER	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); SNSF Sinergia grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. Comiotto and M. Sawaya for making figures and the Swiss National Science Foundation (SNSF), the US National Institutes of Health and the Howard Hughes Medical Institute for continuing support of our research, including an SNSF Sinergia grant to R.R.	Abedini A, 2016, ELIFE, V5, DOI 10.7554/eLife.12977; Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Ankarcrona M, 2016, J INTERN MED, V280, P177, DOI 10.1111/joim.12506; Apostol MI, 2011, BIOCHEMISTRY-US, V50, P2456, DOI 10.1021/bi101803k; Apostol MI, 2010, J BIOL CHEM, V285, P29671, DOI 10.1074/jbc.C110.158303; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Asakura S, 1970, Adv Biophys, V1, P99; Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Balbirnie M, 2001, P NATL ACAD SCI USA, V98, P2375, DOI 10.1073/pnas.041617698; Birk J, 2009, J CELL SCI, V122, P3994, DOI 10.1242/jcs.051136; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Cali I, 2006, BRAIN, V129, P2266, DOI 10.1093/brain/awl224; Cali I, 2009, BRAIN, V132, P2643, DOI 10.1093/brain/awp196; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Colletier JP, 2011, P NATL ACAD SCI USA, V108, P16938, DOI 10.1073/pnas.1112600108; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Colvin MT, 2016, J AM CHEM SOC, V138, P9663, DOI 10.1021/jacs.6b05129; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; Daskalov A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004158; Edskes HK, 1999, P NATL ACAD SCI USA, V96, P1498, DOI 10.1073/pnas.96.4.1498; Egorov VV, 2014, PRION, V8, P100, DOI 10.4161/pri.27501; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Eisele YS, 2015, NAT REV DRUG DISCOV, V14, P759, DOI 10.1038/nrd4593; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Eisenberg DS, 2016, P NATL ACAD SCI USA, V113, P9398, DOI 10.1073/pnas.1610806113; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Groveman BR, 2014, J BIOL CHEM, V289, P24129, DOI 10.1074/jbc.M114.578344; GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Hurshman AR, 2004, BIOCHEMISTRY-US, V43, P7365, DOI 10.1021/bi049621l; Ivanova MI, 2009, P NATL ACAD SCI USA, V106, P18990, DOI 10.1073/pnas.0910080106; Jan A, 2011, J BIOL CHEM, V286, P8585, DOI 10.1074/jbc.M110.172411; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Jones EM, 2011, J BIOL CHEM, V286, P42777, DOI 10.1074/jbc.M111.302539; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Knight SD, 2013, BIOCHEMISTRY-US, V52, P7523, DOI 10.1021/bi400908x; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Laganowsky A, 2012, SCIENCE, V335, P1228, DOI 10.1126/science.1213151; Landreh M, 2016, J INTERN MED, V280, P164, DOI 10.1111/joim.12500; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Liu C, 2012, P NATL ACAD SCI USA, V109, P20913, DOI 10.1073/pnas.1218792109; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Maury CPJ, 2009, J INTERN MED, V265, P329, DOI 10.1111/j.1365-2796.2008.02068.x; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09349; Muller H, 2014, PRION, V8, P344, DOI 10.4161/19336896.2014.983754; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Oosawa F., 1975, THERMODYNAMICS POLYM; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ravotti F, 2016, NMR ASSIGN, V10, P269; Reynolds NP, 2011, J AM CHEM SOC, V133, P19366, DOI 10.1021/ja2029848; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Riek R, 2006, NATURE, V444, P429, DOI 10.1038/444429a; Riek R, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a023515; Ritter C, 2005, NATURE, V435, P844, DOI 10.1038/nature03793; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Saelices L, 2015, J BIOL CHEM, V290, P28932, DOI 10.1074/jbc.M115.659912; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Serio TR, 2001, ADV PROTEIN CHEM, V57, P335; Seuring C, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001451; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Silva JL, 2014, TRENDS BIOCHEM SCI, V39, P260, DOI 10.1016/j.tibs.2014.04.001; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sipe JD, 2014, AMYLOID, V21, P221, DOI 10.3109/13506129.2014.964858; Soragni A, 2016, CANCER CELL, V29, P90, DOI 10.1016/j.ccell.2015.12.002; Soriaga AB, 2016, J PHYS CHEM B, V120, P5810, DOI 10.1021/acs.jpcb.5b09981; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Terry C, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160035; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Tsemekhman K, 2007, PROTEIN SCI, V16, P761, DOI 10.1110/ps.062609607; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; van der Wel PCA, 2007, J AM CHEM SOC, V129, P5117, DOI 10.1021/ja068633m; Vazquez-Fernandez E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005835; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Walti MA, 2016, P NATL ACAD SCI USA, V113, pE4976, DOI 10.1073/pnas.1600749113; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wang L, 2010, ANGEW CHEM INT EDIT, V49, P3904, DOI 10.1002/anie.201000068; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839; Weissmann C, 2005, CELL, V122, P165, DOI 10.1016/j.cell.2005.07.001; Weissmann C, 2011, EMBO REP, V12, P1109, DOI 10.1038/embor.2011.192; Wickner RB, 2001, ADV PROTEIN CHEM, V57, P313; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wiltzius JJW, 2009, PROTEIN SCI, V18, P1521, DOI 10.1002/pro.145; Wu JW, 2016, NAT NEUROSCI, V19, P1085, DOI 10.1038/nn.4328; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546	137	290	292	10	268	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					227	235		10.1038/nature20416	http://dx.doi.org/10.1038/nature20416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830791				2022-12-28	WOS:000387318500033
J	Schmidt, D; Boyd, PW				Schmidt, Daniela; Boyd, Philip W.			Forecast ocean variability	NATURE			English	Editorial Material									[Schmidt, Daniela] Univ Bristol, Sch Earth Sci, Palaeobiol, Bristol BS8 1TH, Avon, England; [Boyd, Philip W.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	University of Bristol; University of Tasmania	Schmidt, D (corresponding author), Univ Bristol, Sch Earth Sci, Palaeobiol, Bristol BS8 1TH, Avon, England.	d.schmidt@bristol.ac.uk	Boyd, Philip W/J-7624-2014	Boyd, Philip W/0000-0001-7850-1911; Schmidt, Daniela/0000-0001-8419-2721				Boyd PW, 2016, GLOBAL CHANGE BIOL, V22, P2633, DOI 10.1111/gcb.13287; Field C.B., 2012, MAN RISKS EXTR EV DI, P582, DOI DOI 10.1017/CBO9781139177245.; Hawkins E, 2014, NATURE, V511, pE3, DOI 10.1038/nature13523; Hobday AJ, 2014, REV FISH BIOL FISHER, V24, P415, DOI 10.1007/s11160-013-9326-6; Hoegh-Guldberg O, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1655; Mora C, 2013, NATURE, V502, P183, DOI 10.1038/nature12540; Portner HO, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P411; Xie SP, 2016, NAT CLIM CHANGE, V6, P345, DOI 10.1038/nclimate2973	9	4	4	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					162	163		10.1038/539162a	http://dx.doi.org/10.1038/539162a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830825	Green Submitted, Bronze			2022-12-28	WOS:000387318500013
J	Lyon, J				Lyon, Jeff			Senator Confronts FDA Over Laboratory Tests	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1859	1859		10.1001/jama.2016.16237	http://dx.doi.org/10.1001/jama.2016.16237			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27824992				2022-12-28	WOS:000387116500005
J	Krishnaswamy, A				Krishnaswamy, Arjun			Building connections	SCIENCE			English	Editorial Material							NERVE		[Krishnaswamy, Arjun] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Krishnaswamy, Arjun] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Krishnaswamy, A (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.; Krishnaswamy, A (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	akrish@mcb.harvard.edu						de Wit J, 2016, NAT REV NEUROSCI, V17, P22, DOI 10.1038/nrn.2015.3; Duan X, 2014, CELL, V158, P793, DOI 10.1016/j.cell.2014.06.047; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Krishnaswamy A, 2015, NATURE, V524, P466, DOI 10.1038/nature14682; Langley JN, 1892, PHILOS T R SOC LON B, V183, P85; Sanes JR, 2015, ANNU REV NEUROSCI, V38, P221, DOI 10.1146/annurev-neuro-071714-034120; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Sperry RW, 1943, J COMP NEUROL, V79, P33, DOI 10.1002/cne.900790104; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703	9	1	1	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312								10.1126/science.aak9763	http://dx.doi.org/10.1126/science.aak9763			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811260				2022-12-28	WOS:000386869800027
J	Wei, PC; Bhattacharya, S; He, J; Neeleshwar, S; Podila, R; Chen, YY; Rao, AM				Wei, Pai-Chun; Bhattacharya, S.; He, J.; Neeleshwar, S.; Podila, R.; Chen, Y. Y.; Rao, A. M.			The intrinsic thermal conductivity of SnSe	NATURE			English	Letter							THERMOELECTRIC PERFORMANCE; FIGURE; MERIT		[Wei, Pai-Chun; Chen, Y. Y.] Acad Sinica, Inst Phys, Taipei 11529, Taiwan; [Bhattacharya, S.; He, J.; Podila, R.; Rao, A. M.] Clemson Univ, Clemson Nanomat Inst, Clemson, SC 29634 USA; [Bhattacharya, S.; He, J.; Podila, R.; Rao, A. M.] Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA; [Neeleshwar, S.] Guru Gobind Singh GGS Indraprastha Univ, Univ Sch Basic & Appl Sci, New Delhi, India	Academia Sinica - Taiwan; Clemson University; Clemson University; GGS Indraprastha University	Bhattacharya, S (corresponding author), Clemson Univ, Clemson Nanomat Inst, Clemson, SC 29634 USA.; Bhattacharya, S (corresponding author), Clemson Univ, Dept Phys & Astron, Clemson, SC 29634 USA.	bbhatta@g.clemson.edu; cheny2@phys.sinica.edu.tw; arao@clemson.edu	Chen, Yang-Yuan/AAP-5019-2021; Podila, Ramakrishna/H-6226-2012; He, Jian/C-5341-2011; Sonnathi, Neeleshwar/AAX-3133-2021	Podila, Ramakrishna/0000-0003-0472-2361; He, Jian/0000-0002-6377-3022; Wei, Pai-Chun/0000-0003-2225-7280				Adouby K, 1998, Z KRISTALLOGR, V213, P343, DOI 10.1524/zkri.1998.213.6.343; AVILOV AS, 1979, KRISTALLOGRAFIYA+, V24, P874; Bera T., PREPRINT; CHATTOPADHYAY T, 1986, J PHYS CHEM SOLIDS, V47, P879, DOI 10.1016/0022-3697(86)90059-4; Chen CL, 2014, J MATER CHEM A, V2, P11171, DOI 10.1039/c4ta01643b; Chere EK, 2016, J MATER CHEM A, V4, P1848, DOI 10.1039/c5ta08847j; Han YM, 2015, J MATER CHEM A, V3, P4555, DOI 10.1039/c4ta06955b; Leng HQ, 2016, RSC ADV, V6, P9112, DOI 10.1039/c5ra19469e; Leng HQ, 2016, J ELECTRON MATER, V45, P527, DOI 10.1007/s11664-015-4143-4; Li Y, 2016, J ALLOY COMPD, V669, P224, DOI 10.1016/j.jallcom.2016.01.258; Li YL, 2015, ENERGIES, V8, P6275, DOI 10.3390/en8076275; Ortiz BR, 2015, PHYS CHEM CHEM PHYS, V17, P19410, DOI 10.1039/c5cp02174j; Peng KL, 2016, ENERG ENVIRON SCI, V9, P454, DOI 10.1039/c5ee03366g; Sassi S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880817; Serrano-Sanchez F, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913260; SPITZER DP, 1970, J PHYS CHEM SOLIDS, V31, P19, DOI 10.1016/0022-3697(70)90284-2; WASSCHER JD, 1963, SOLID STATE ELECTRON, V6, P261, DOI 10.1016/0038-1101(63)90083-2; Wei TR, 2015, PHYS CHEM CHEM PHYS, V17, P30102, DOI 10.1039/c5cp05510e; Zhang Q, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500360; Zhao LD, 2016, SCIENCE, V351, P141, DOI 10.1126/science.aad3749; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184	21	114	115	6	324	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					E1	E2		10.1038/nature19832	http://dx.doi.org/10.1038/nature19832			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808195				2022-12-28	WOS:000386670100001
J	Dyer, C				Dyer, Clare			Trusts risk litigation payouts by not adopting full consent process, warns college	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dyer C, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1414; Royal College of Surgeons, 2016, CONS SUPP DEC MAK A	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2016	355								i5840	10.1136/bmj.i5840	http://dx.doi.org/10.1136/bmj.i5840			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CP	27802937				2022-12-28	WOS:000387317200003
J	Abbasi, J				Abbasi, Jennifer			Social Determinants of Chronic Disease Get NIH Attention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1636	1636		10.1001/jama.2016.15480	http://dx.doi.org/10.1001/jama.2016.15480			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784081				2022-12-28	WOS:000386107800006
J	Witty, A				Witty, Andrew			Scaling up for universal health coverage	LANCET			English	Editorial Material									[Witty, Andrew] GlaxoSmithKline, GSK House, Brentford TW8 9GS, England	GlaxoSmithKline	Witty, A (corresponding author), GlaxoSmithKline, GSK House, Brentford TW8 9GS, England.	uk.directorate@gsk.com						Access to Medicine Index, 2014, 2014 IND OV RANK; GlaxoSmithKline, 2014, GSK PUBL POL POS APP; GlaxoSmithKline, 2014, GSK PUBL POL POS TIE; GlaxoSmithKline, 2014, GSK PUBL POL POS UN; GSK, INT PRESCR; GSK, 2016, GSK EXP GRAD APPR PA; Medicines Patent Pool, PAT LIC DAT; Pender J, 2016, UN HIGH LEVEL PANEL; WHO, 2016, MED REG SUPP; Wirtz VJ, 2016, LANCET; World Health Organization, 2011, TRAD MED GLOB SIT IS	11	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					343	345		10.1016/S0140-6736(16)31903-1	http://dx.doi.org/10.1016/S0140-6736(16)31903-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27832877				2022-12-28	WOS:000392804700010
J	Nakada, Y; Canseco, DC; Thet, S; Abdisalaam, S; Asaithamby, A; Santos, CX; Shah, AM; Zhang, H; Faber, JE; Kinter, MT; Szweda, LI; Xing, C; Hu, ZP; Deberardinis, RJ; Schiattarella, G; Hill, JA; Oz, O; Lu, ZG; Zhang, CC; Kimura, W; Sadek, HA				Nakada, Yuji; Canseco, Diana C.; Thet, SuWannee; Abdisalaam, Salim; Asaithamby, Aroumougame; Santos, Celio X.; Shah, Ajay M.; Zhang, Hua; Faber, James E.; Kinter, Michael T.; Szweda, Luke I.; Xing, Chao; Hu, Zeping; Deberardinis, Ralph J. .; Schiattarella, Gabriele; Hill, Joseph A.; Oz, Orhan; Lu, Zhigang; Zhang, Cheng Cheng; Kimura, Wataru; Sadek, Hesham A.			Hypoxia induces heart regeneration in adult mice	NATURE			English	Article							CELL-CYCLE ARREST; STEM-CELLS; ALPHA-KETOGLUTARATE; MOUSE HEART; CARDIOMYOCYTES; ZEBRAFISH; 5-BROMODEOXYURIDINE; PROLIFERATION; CARBOXYLATION; METABOLISM	The adult mammalian heart is incapable of regeneration following cardiomyocyte loss, which underpins the lasting and severe effects of cardiomyopathy. Recently, it has become clear that the mammalian heart is not a post-mitotic organ. For example, the neonatal heart is capable of regenerating lost myocardium(1), and the adult heart is capable of modest self-renewal(2,3). In both of these scenarios, cardiomyocyte renewal occurs via the proliferation of pre-existing cardiomyocytes, and is regulated by aerobic-respiration-mediated oxidative DNA damage(4,5). Therefore, we reasoned that inhibiting aerobic respiration by inducing systemic hypoxaemia would alleviate oxidative DNA damage, thereby inducing cardiomyocyte proliferation in adult mammals. Here we report that, in mice, gradual exposure to severe systemic hypoxaemia, in which inspired oxygen is gradually decreased by 1% and maintained at 7% for 2 weeks, results in inhibition of oxidative metabolism, decreased reactive oxygen species production and oxidative DNA damage, and reactivation of cardiomyocyte mitosis. Notably, we find that exposure to hypoxaemia 1 week after induction of myocardial infarction induces a robust regenerative response with decreased myocardial fibrosis and improvement of left ventricular systolic function. Genetic fate-mapping analysis confirms that the newly formed myocardium is derived from pre-existing cardiomyocytes. These results demonstrate that the endogenous regenerative properties of the adult mammalian heart can be reactivated by exposure to gradual systemic hypoxaemia, and highlight the potential therapeutic role of hypoxia in regenerative medicine.	[Nakada, Yuji; Canseco, Diana C.; Thet, SuWannee; Schiattarella, Gabriele; Hill, Joseph A.; Kimura, Wataru; Sadek, Hesham A.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Abdisalaam, Salim; Asaithamby, Aroumougame] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Santos, Celio X.; Shah, Ajay M.] Kings Coll London, Div Cardiovasc, BHF Ctr Res Excellence, Fac Med,James Black Ctr, London SE5 9NU, England; [Zhang, Hua; Faber, James E.] Univ N Carolina, McAllister Heart Inst, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Kinter, Michael T.; Szweda, Luke I.] Oklahoma Med Res Fdn, Free Radical Biol & Aging Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Xing, Chao] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Hu, Zeping; Deberardinis, Ralph J. .] Univ Texas Southwestern Med Ctr Dallas, Res Inst, Childrens Med Ctr, Dallas, TX 75390 USA; [Oz, Orhan] Univ Texas Southwestern Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Lu, Zhigang; Zhang, Cheng Cheng] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol & Dev Biol, Dallas, TX 75390 USA; [Kimura, Wataru] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan; [Sadek, Hesham A.] Univ Texas Southwestern Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; King's College London; University of North Carolina; University of North Carolina Chapel Hill; Oklahoma Medical Research Foundation; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kimura, W; Sadek, HA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.; Kimura, W (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058577, Japan.; Sadek, HA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.	wataru.kimura@utsouthwestern.edu; hesham.sadek@utsouthwestern.edu	Schiattarella, Gabriele/Z-2624-2019; Hu, Zeping/F-6205-2010; Oz, Orhan/GVT-7264-2022; Schiattarella, Gabriele G/M-9506-2017; Zhang, Cheng/GRS-8698-2022	Schiattarella, Gabriele/0000-0002-7582-7171; Hu, Zeping/0000-0003-4146-7750; Schiattarella, Gabriele G/0000-0002-7582-7171; Shah, Ajay/0000-0002-6547-0631; Lu, Zhigang/0000-0002-2880-7848; Xing, Chao/0000-0002-1838-0502; Kinter, Michael/0000-0001-7409-8918; Kimura, Wataru/0000-0001-6548-6353	NIH [1R01HL115275-01, UL1TR001105]; Center for Regenerative Science and Medicine; British Heart Foundation [CH/1999001/11735]; British Heart Foundation [RG/13/11/30384] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Regenerative Science and Medicine; British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the McDermott Center Sequencing and Bioinformatics Cores for sequencing and analysis, J. Richardson and J. Shelton for assistance with histology, G. Jay for assistance with the hypoxia protocol, K. Nham for help with coronary imaging and A. Darehshouri for assistance with electron microscopy. This work is supported by the NIH (grant 1R01HL115275-01) (H.A.S.), and Center for Regenerative Science and Medicine. C.X.S. was partially supported by NIH grant UL1TR001105. A.M.S. is supported by the British Heart Foundation (CH/1999001/11735).	Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; Bergmann O, 2015, CELL, V161, P1566, DOI 10.1016/j.cell.2015.05.026; DJORDJEVIC B, 1960, J EXP MED, V112, P509, DOI 10.1084/jem.112.3.509; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kasai H, 1983, Nucleic Acids Symp Ser, P165; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Kimura W, 2015, NATURE, V523, P226, DOI 10.1038/nature14582; Kobs RW, 2005, AM J PHYSIOL-HEART C, V288, pH1209, DOI 10.1152/ajpheart.01129.2003; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; LOFFLER M, 1992, BIOCHEM PHARMACOL, V43, P2281, DOI 10.1016/0006-2952(92)90188-O; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; MORRIS SM, 1991, MUTAT RES, V258, P161, DOI 10.1016/0165-1110(91)90007-I; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Murray TVA, 2015, J MOL CELL CARDIOL, V79, P54, DOI 10.1016/j.yjmcc.2014.10.017; Perales-Clemente E, 2014, ANTIOXID REDOX SIGN, V21, P1648, DOI 10.1089/ars.2014.6000; Poleshko AG, 2014, B EXP BIOL MED+, V157, P167, DOI 10.1007/s10517-014-2516-y; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Roach RC, 2001, J EXP BIOL, V204, P3161; SAFFHILL R, 1985, CHROMOSOMA, V92, P218, DOI 10.1007/BF00348697; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; Subramanian RK, 2013, INDIAN J PHARMACOL, V45, DOI 10.4103/0253-7613.106451; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; VICARIO C, 1990, BIOL NEONATE, V57, P119; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108	28	388	397	13	181	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 12	2017	541	7636					222	+		10.1038/nature20173	http://dx.doi.org/10.1038/nature20173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN6PI	27798600				2022-12-28	WOS:000396125500042
J	Wu, JT; Peak, CM; Leung, GM; Lipsitch, M				Wu, Joseph T.; Peak, Corey M.; Leung, Gabriel M.; Lipsitch, Marc			Fractional dosing of yellow fever vaccine to extend supply: a modelling study	LANCET			English	Article							EPIDEMIC; OUTBREAK; SPREAD; ANGOLA; VECTOR; VIRUS	Background The ongoing yellow fever epidemic in Angola strains the global vaccine supply, prompting WHO to adopt dose sparing for its vaccination campaign in Kinshasa, Democratic Republic of the Congo, in July-August, 2016. Although a 5-fold fractional-dose vaccine is similar to standard-dose vaccine in safety and immunogenicity, effi cacy is untested. There is an urgent need to ensure the robustness of fractional-dose vaccination by elucidation of the conditions under which dose fractionation would reduce transmission. Methods We estimate the eff ective reproductive number for yellow fever in Angola using disease natural history and case report data. With simple mathematical models of yellow fever transmission, we calculate the infection attack rate (the proportion of population infected over the course of an epidemic) with various levels of transmissibility and 5-fold fractional-dose vaccine effi cacy for two vaccination scenarios, ie, random vaccination in a hypothetical population that is completely susceptible, and the Kinshasa vaccination campaign in July-August, 2016, with diff erent age cutoff for fractional-dose vaccines. Findings We estimate the eff ective reproductive number early in the Angola outbreak was between 5.2 and 7.1. If vaccine action is all-or-nothing (ie, a proportion of vaccine recipients receive complete protection [VE] and the remainder receive no protection), n-fold fractionation can greatly reduce infection attack rate as long as VE exceeds 1/ n. This benefi t threshold becomes more stringent if vaccine action is leaky (ie, the susceptibility of each vaccine recipient is reduced by a factor that is equal to the vaccine effi cacy). The age cutoff for fractional-dose vaccines chosen by WHO for the Kinshasa vaccination campaign (2 years) provides the largest reduction in infection attack rate if the effi cacy of 5-fold fractional-dose vaccines exceeds 20%. Interpretation Dose fractionation is an eff ective strategy for reduction of the infection attack rate that would be robust with a large margin for error in case fractional-dose VE is lower than expected.	[Wu, Joseph T.; Leung, Gabriel M.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China; [Peak, Corey M.; Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Ctr Communicable Dis Dynam, Boston, MA USA; [Lipsitch, Marc] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA	University of Hong Kong; World Health Organization; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Wu, JT (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, WHO Collaborating Ctr Infect Dis Epidemiol & Cont, Hong Kong, Hong Kong, Peoples R China.	joewu@hku.hk	Peak, Corey M/H-5998-2019; Wu, Joseph/ABD-5880-2021; Wu, Joseph Tsz Kei/C-4450-2009	Peak, Corey M/0000-0001-6150-5318; Leung, Gabriel/0000-0002-2503-6283; Wu, Joseph Tsz Kei/0000-0002-3155-5987	NIH-MIDAS; HMRF-Hong Kong; National Institute of General Medical Sciences [U54GM088558]; National Research Service Award [T32AI007535-16A1]; Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NIH-MIDAS; HMRF-Hong Kong; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	NIH-MIDAS, HMRF-Hong Kong.; We wish to honor the memory of the late Jack Woodall, a leading figure in the infectious disease community who strongly supported dose fractionation and who kindly provided comments on a draft of this manuscript. We also thank Rebecca Grais for comments on an earlier draft and Alejandro Costa and the students of EPI 260 for helpful discussions. This study was funded by Cooperative Agreement U54GM088558 from the National Institute of General Medical Sciences, National Research Service Award T32AI007535-16A1, and a commissioned grant from the Health and Medical Research Fund from the Government of the Hong Kong Special Administrative Region. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997; Brearley L, 2013, VACCINE, V31, pB103, DOI 10.1016/j.vaccine.2012.11.088; Campi-Azevedo AC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-391; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Fine P, 2011, CLIN INFECT DIS, V52, P911, DOI 10.1093/cid/cir007; Halloran ME., 2010, DESIGN ANAL VACCINE; Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048; Hickling J, 2013, PATH            0418; Hindle E, 1930, LANCET, V2, P835; Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432; Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782; Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7; RADCLIFFE J, 1984, MATH BIOSCI, V70, P123, DOI 10.1016/0025-5564(84)90094-4; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; Ross A, 2016, REUTERS; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; Schnirring L, 2016, CIDRAP NEWS; SMITH PG, 1984, INT J EPIDEMIOL, V13, P87, DOI 10.1093/ije/13.1.87; Staples J. Erin, 2010, Morbidity and Mortality Weekly Report, V59, P1; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; WHO, 2016, SIT REP ZIK VIR MICR; WHO. Expert committee on biological standardization, 2008, EXP COMM BIOL STAND; Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001; World Health Organization, 2014, RAP FIELD ENT ASS YE; World Health Organization, 2016, YELL FEV VACC CAMP D; World Health Organization, 2016, YELL FEV OUTBR ANG S	26	49	49	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2904	2911		10.1016/S0140-6736(16)31838-4	http://dx.doi.org/10.1016/S0140-6736(16)31838-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FU	27837923	Green Accepted, Green Submitted			2022-12-28	WOS:000389631700035
J	Lee, JE; Westrate, LM; Wu, HX; Page, C; Voeltz, GK				Lee, Jason E.; Westrate, Laura M.; Wu, Haoxi; Page, Cynthia; Voeltz, Gia K.			Multiple dynamin family members collaborate to drive mitochondrial division	NATURE			English	Article							FISSION; DRP1; RECRUITMENT; GTPASE; CELL; ENDOCYTOSIS; TOMOGRAPHY; MORPHOLOGY; EFFICIENT; DNM1P	Mitochondria cannot be generated de novo; they must grow, replicate their genome, and divide in order to be inherited by each daughter cell during mitosis. Mitochondrial division is a structural challenge that requires the substantial remodelling of membrane morphology(1-3). Although division factors differ across organisms, the need for multiple constriction steps and a dynamin-related protein (Drp1, Dnm1 in yeast) has been conserved(4-6). In mammalian cells, mitochondrial division has been shown to proceed with at least two sequential constriction steps: the endoplasmic reticulum and actin must first collaborate to generate constrictions suitable for Drp1 assembly on the mitochondrial outer membrane; Drp1 then further constricts membranes until mitochondrial fission occurs(2,7-9). In vitro experiments, however, indicate that Drp1 does not have the dynamic range to complete membrane fission(7). In contrast to Drp1, the neuron-specific classical dynamin dynamin-1 (Dyn1) has been shown to assemble on narrower lipid profiles and facilitate spontaneous membrane fission upon GTP hydrolysis(10,11). Here we report that the ubiquitously expressed classical dynamin-2 (Dyn2) is a fundamental component of the mitochondrial division machinery. A combination of live-cell and electron microscopy in three different mammalian cell lines reveals that Dyn2 works in concert with Drp1 to orchestrate sequential constriction events that build up to division. Our work underscores the biophysical limitations of Drp1 and positions Dyn2, which has intrinsic membrane fission properties, at the final step of mitochondrial division.	[Lee, Jason E.; Westrate, Laura M.; Wu, Haoxi; Page, Cynthia; Voeltz, Gia K.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Voeltz, GK (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	gia.voeltz@colorado.edu		LEE, JASON/0000-0001-5757-5954; Wu, Haoxi/0000-0002-0986-3094	National Institutes of Health [GM083977, F32CA174158, F32GM116371, T32GM08759]; NATIONAL CANCER INSTITUTE [F32CA174158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, F32GM116371, R01GM079097, R01GM083977, P01GM105537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Ozzello for sectioning cells for electron microscopy analysis; A. Cheng, J. Ryoo and D. G. Drubin for providing the genome-edited Dyn2-GFP Sk-Mel2 cell line; J. R. Friedman, D. Dambournet, and K. C. Cook for critical reading of the manuscript; and A. Hoenger and M. West for helpful discussions. Electron microscopy was performed at the University of Colorado, Boulder electron microscopy services core facility. Super-resolution microscopy in the Department of Molecular, Cellular, and Developmental Biology was made possible by equipment supplements R01 GM79097 (D. Xue) and P01 GM105537 (M. Winey). This work is supported by grants from the National Institutes of Health to G.K.V. (GM083977), J.E.L. (F32CA174158), L.M.W. (F32GM116371) and to H.W. (T32GM08759).	Bui HT, 2013, CURR BIOL, V23, pR891, DOI 10.1016/j.cub.2013.08.040; Burger KNJ, 2000, BIOCHEMISTRY-US, V39, P12485, DOI 10.1021/bi000971r; Chanez AL, 2006, J CELL SCI, V119, P2968, DOI 10.1242/jcs.03023; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; GOLDSTEIN S, 1984, EXP CELL RES, V154, P101, DOI 10.1016/0014-4827(84)90671-2; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Kim HW, 2012, J ELECTRON MICROSC, V61, P127, DOI 10.1093/jmicro/dfs001; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Legesse-Miller A, 2003, MOL BIOL CELL, V14, P1953, DOI 10.1091/mbc.E02-10-0657; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; Miyagishima S, 2003, PLANT CELL, V15, P655, DOI 10.1105/tpc.009373; Morlot S, 2013, ANNU REV BIOPHYS, V42, P629, DOI 10.1146/annurev-biophys-050511-102247; Nishida K, 2003, P NATL ACAD SCI USA, V100, P2146, DOI 10.1073/pnas.0436886100; O'Toole ET, 2007, METHOD CELL BIOL, V79, P125, DOI 10.1016/S0091-679X(06)79005-7; Osellame L. D., 2016, J CELL SCI; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333; Prudent J, 2016, CURR BIOL, V26, pR207, DOI 10.1016/j.cub.2016.01.009; Purkanti R, 2015, P NATL ACAD SCI USA, V112, P2800, DOI 10.1073/pnas.1407163112; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Schiel JA, 2011, J CELL SCI, V124, P1411, DOI 10.1242/jcs.081448; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Thompson HM, 2002, CURR BIOL, V12, P2111, DOI 10.1016/S0960-9822(02)01390-8; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894	36	289	296	3	77	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					139	+		10.1038/nature20555	http://dx.doi.org/10.1038/nature20555			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27798601	Green Accepted			2022-12-28	WOS:000388916600064
J	Gurwitz, JH; Go, AS; Fortmann, SP				Gurwitz, Jerry H.; Go, Alan S.; Fortmann, Stephen P.			Statins for Primary Prevention in Older Adults Uncertainty and the Need for More Evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK		[Gurwitz, Jerry H.] Univ Massachusetts, Sch Med, Fallon Hlth & Reliant Med Grp, Meyers Primary Care Inst, Worcester, MA USA; [Gurwitz, Jerry H.] Univ Massachusetts, Sch Med, Div Geriatr Med, Worcester, MA USA; [Go, Alan S.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [Go, Alan S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Go, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Fortmann, Stephen P.] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; [Fortmann, Stephen P.] Oregon Hlth & Sci Univ, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Kaiser Permanente; Oregon Health & Science University	Gurwitz, JH (corresponding author), Meyers Primary Care Inst, 630 Plantat St, Worcester, MA 01605 USA.	jgurwitz@meyersprimary.org	Go, Alan S./AAE-7745-2019		NATIONAL INSTITUTE ON AGING [R24AG045050] Funding Source: NIH RePORTER; NIA NIH HHS [R24 AG045050] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Glynn RJ, 2010, ANN INTERN MED, V152, P488, DOI 10.7326/0003-4819-152-8-201004200-00005; Ito MK, 2014, J CLIN LIPIDOL, V8, P69, DOI 10.1016/j.jacl.2013.10.006; Kantor ED, 2015, JAMA-J AM MED ASSOC, V314, P1818, DOI 10.1001/jama.2015.13766; Odden MC, 2015, ANN INTERN MED, V162, P533, DOI 10.7326/M14-1430; Ott BR, 2015, J GEN INTERN MED, V30, P348, DOI 10.1007/s11606-014-3115-3; Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176	9	55	55	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1971	1972		10.1001/jama.2016.15212	http://dx.doi.org/10.1001/jama.2016.15212			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838724	Green Accepted			2022-12-28	WOS:000387673800010
J	Voelker, R				Voelker, Rebecca			Safe Relief for Teething Symptoms	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1957	1957		10.1001/jama.2016.16350	http://dx.doi.org/10.1001/jama.2016.16350			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838706				2022-12-28	WOS:000387673800006
J	Drake, T; Hanna, L; Davies, M				Drake, Tamsin; Hanna, Luke; Davies, Melissa			10-MINUTE CONSULTATION Haematospermia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEMOSPERMIA		[Drake, Tamsin; Hanna, Luke] Royal Bournemouth Hosp, Bournemouth, Dorset, England; [Davies, Melissa] Salisbury Dist Hosp, Dept Urol, Salisbury, Wilts, England	Salisbury District Hospital	Drake, T (corresponding author), Royal Bournemouth Hosp, Bournemouth, Dorset, England.	tamsindrake@hotmail.com						Ahmad I, 2007, J UROLOGY, V177, P1613, DOI 10.1016/j.juro.2007.01.004; FLETCHER MS, 1981, BRIT J UROL, V53, P669, DOI 10.1111/j.1464-410X.1981.tb03287.x; Han M, 2004, J UROLOGY, V172, P2189, DOI 10.1097/01.ju.0000144565.76243.b1; Kumar AA, 2011, J CLIN UROL, V4, P202, DOI 10.1016/j.bjmsu.2011.02.005; Kumar P, 2006, ANN ROY COLL SURG, V88, P339, DOI 10.1308/003588406X114749; Leocadio DE, 2009, INT UROL NEPHROL, V41, P77, DOI 10.1007/s11255-008-9409-9; Manoharan M, 2007, PROSTATE CANCER P D, V10, P283, DOI 10.1038/sj.pcan.4500955; MULHALL JP, 1995, UROLOGY, V46, P463, DOI 10.1016/S0090-4295(99)80256-8; Ng YH, 2013, SURG-J R COLL SURG E, V11, P35, DOI 10.1016/j.surge.2012.04.004; Stefanovic KB, 2009, AM FAM PHYSICIAN, V80, P1421	10	4	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2016	355								i5124	10.1136/bmj.i5124	http://dx.doi.org/10.1136/bmj.i5124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CV	27834274				2022-12-28	WOS:000388003200002
J	Tabashnik, BE				Tabashnik, Bruce E.			BIOTECHNOLOGY Tips for battling billion-dollar beetles	SCIENCE			English	Editorial Material							RESISTANCE; CORN		[Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	University of Arizona	Tabashnik, BE (corresponding author), Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA.	brucet@cals.arizona.edu						Andow DA, 2016, J ECON ENTOMOL, V109, P1, DOI 10.1093/jee/tov238; Carriere Y, 2016, TRENDS BIOTECHNOL, V34, P291, DOI 10.1016/j.tibtech.2015.12.011; Gassmann AJ, 2016, J ECON ENTOMOL, V109, P1872, DOI 10.1093/jee/tow110; Gray ME, 2009, ANNU REV ENTOMOL, V54, P303, DOI 10.1146/annurev.ento.54.110807.090434; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Jakka SRK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27860; National Academies-National Research Council, 2016, GENETICALLY ENG CROP; Sanchis V, 2011, AGRON SUSTAIN DEV, V31, P217, DOI 10.1051/agro/2010027; Schellenberger U, 2016, SCIENCE, V354, P634, DOI 10.1126/science.aaf6056; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; USDA Economic Research Service, AD GEN ENG CROPS US; Zukoff SN, 2016, J ECON ENTOMOL, V109, P1387, DOI 10.1093/jee/tow073	14	18	19	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					552	553		10.1126/science.aag101	http://dx.doi.org/10.1126/science.aag101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811255				2022-12-28	WOS:000386869800022
J	Tzou, KY; Chiang, YT				Tzou, Kai-Yi; Chiang, Yi-Te			Emphysematous Cystitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tzou, Kai-Yi; Chiang, Yi-Te] Taipei Med Univ, Shuang Ho Hosp, Taipei 23561, Taiwan	Taipei Medical University; Shuang Ho Hospital	Tzou, KY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Taipei 23561, Taiwan.	shhuror@gmail.com							0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1779	1779		10.1056/NEJMicm1509543	http://dx.doi.org/10.1056/NEJMicm1509543			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806219				2022-12-28	WOS:000387007300011
J	Hackett, SR; Zanotelli, VRT; Xu, WX; Goya, J; Park, JO; Perlman, DH; Gibney, PA; Botstein, D; Storey, JD; Rabinowitz, JD				Hackett, Sean R.; Zanotelli, Vito R. T.; Xu, Wenxin; Goya, Jonathan; Park, Junyoung O.; Perlman, David H.; Gibney, Patrick A.; Botstein, David; Storey, John D.; Rabinowitz, Joshua D.			Systems-level analysis of mechanisms regulating yeast metabolic flux	SCIENCE			English	Article							CENTRAL CARBON METABOLISM; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; TRANSCRIPTIONAL REGULATION; BIOMASS COMPOSITION; GLYCOLYTIC-ENZYMES; FEEDBACK-CONTROL; PYRUVATE-KINASE; GROWTH-RATE; QUANTITATION	Cellular metabolic fluxes are determined by enzyme activities and metabolite abundances. Biochemical approaches reveal the impact of specific substrates or regulators on enzyme kinetics but do not capture the extent to which metabolite and enzyme concentrations vary across physiological states and, therefore, how cellular reactions are regulated. We measured enzyme and metabolite concentrations and metabolic fluxes across 25 steady-state yeast cultures. We then assessed the extent to which flux can be explained by a Michaelis-Menten relationship between enzyme, substrate, product, and potential regulator concentrations. This revealed three previously unrecognized instances of cross-pathway regulation, which we biochemically verified. One of these involved inhibition of pyruvate kinase by citrate, which accumulated and thereby curtailed glycolytic outflow in nitrogen-limited yeast. Overall, substrate concentrations were the strongest driver of the net rates of cellular metabolic reactions, with metabolite concentrations collectively having more than double the physiological impact of enzymes.	[Hackett, Sean R.; Xu, Wenxin; Goya, Jonathan; Park, Junyoung O.; Gibney, Patrick A.; Botstein, David; Storey, John D.; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Zanotelli, Vito R. T.] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Xu, Wenxin; Perlman, David H.; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Gibney, Patrick A.; Botstein, David; Storey, John D.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Storey, John D.] Princeton Univ, Ctr Stat & Machine Learning, Princeton, NJ 08544 USA	Princeton University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Princeton University; Princeton University; Princeton University	Rabinowitz, JD (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.; Rabinowitz, JD (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	joshr@genomics.princeton.edu	Rabinowitz, Joshua/GPP-4019-2022; Park, Junyoung/AAL-8090-2020	Rabinowitz, Joshua/0000-0002-1247-4727; Zanotelli, Vito Riccardo Tomaso/0000-0001-7268-311X; Storey, John/0000-0001-5992-402X; Park, Jun/0000-0001-9869-8993	U.S. Department of Energy (DOE) [DE-SC0012461, DE-AC05-06OR23100]; NIH [R01CA16359-01A1, GM046406, GM071508, R01HG002913]; Agilent Technologies	U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agilent Technologies	Data described in the paper are presented in table S9. This research was supported by grants from the U.S. Department of Energy (DOE) (DE-SC0012461; Office of Science Graduate Fellowship DE-AC05-06OR23100 to S.R.H.), NIH (R01CA16359-01A1, GM046406, and GM071508; R01HG002913 to J.D.S), and Agilent Technologies (Thought Leader Awards to J.D.R. and D.B.).	[Anonymous], 2015, GUR OPT REF MAN; Aung Hnin W, 2013, Ind Biotechnol (New Rochelle N Y), V9, P215; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Berg JM, 2006, BIOCHEMISTRY; Boer VM, 2010, MOL BIOL CELL, V21, P198, DOI 10.1091/mbc.E09-07-0597; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Caspi R, 2014, NUCLEIC ACIDS RES, V42, pD459, DOI 10.1093/nar/gkt1103; Chassagnole C, 2002, BIOTECHNOL BIOENG, V79, P53, DOI 10.1002/bit.10288; Chen H, 2006, GENE DEV, V20, P1150, DOI 10.1101/gad.1411806; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Chubukov V, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.66; CornishBowden A, 1995, BIOORG CHEM, V23, P439, DOI 10.1006/bioo.1995.1030; Costenoble R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.122; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Degtyarenko K, 2008, NUCLEIC ACIDS RES, V36, pD344, DOI 10.1093/nar/gkm791; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/nchembio.685, 10.1038/NCHEMBIO.685]; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Fell D., 1997, UNDERSTANDING CONTRO; Fendt SM, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.11; Fiedler D, 2009, CELL, V136, P952, DOI 10.1016/j.cell.2008.12.039; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; FOOTE J, 1981, J BIOL CHEM, V256, P1428; Fraenkel D. G., 2011, YEAST INTERMEDIARY M; Frick O, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-30; Furdui C, 2004, J BIOL CHEM, V279, P45618, DOI 10.1074/jbc.M404753200; Gerosa L, 2015, CELL SYST, V1, P270, DOI 10.1016/j.cels.2015.09.008; Gerosa L, 2011, CURR OPIN BIOTECH, V22, P566, DOI 10.1016/j.copbio.2011.04.016; Greenberg AJ, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.96; Hauf J, 2000, ENZYME MICROB TECH, V26, P688, DOI 10.1016/S0141-0229(00)00160-5; Huberts DHEW, 2012, FEMS YEAST RES, V12, P118, DOI 10.1111/j.1567-1364.2011.00767.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Johnson KA, 2013, FEBS LETT, V587, P2753, DOI 10.1016/j.febslet.2013.07.012; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Jouhten P, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-60; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kamphorst JJ, 2011, ANAL CHEM, V83, P9114, DOI 10.1021/ac202220b; KHOO JC, 1970, J BIOL CHEM, V245, P4163; KITAMOTO K, 1988, J BACTERIOL, V170, P2683, DOI 10.1128/jb.170.6.2683-2686.1988; Kochanowski K, 2013, CURR OPIN BIOTECH, V24, P987, DOI 10.1016/j.copbio.2013.03.014; Koebmann BJ, 2002, J BACTERIOL, V184, P3909, DOI 10.1128/JB.184.14.3909-3916.2002; Lange HC, 2001, BIOTECHNOL BIOENG, V75, P334, DOI 10.1002/bit.10054; Lewis IA, 2009, MAGN RESON CHEM, V47, pS123, DOI 10.1002/mrc.2526; Li Y, 1996, J BIOL CHEM, V271, P28038, DOI 10.1074/jbc.271.45.28038; LIAO JC, 1993, BIOTECHNOL PROGR, V9, P221, DOI 10.1021/bp00021a001; Liebermeister W, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-41; Link H, 2013, NAT BIOTECHNOL, V31, P357, DOI 10.1038/nbt.2489; Lynch M., 1998, GENETICS ANAL QUANTI; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Majtan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105290; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; Mlakar T, 2006, APPL ENVIRON MICROB, V72, P4515, DOI 10.1128/AEM.00539-06; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Neuser F, 2000, BIOL CHEM, V381, P349, DOI 10.1515/BC.2000.046; Noor E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003098; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park JO, 2016, NAT CHEM BIOL, V12, P482, DOI [10.1038/NCHEMBIO.2077, 10.1038/nchembio.2077]; Pedreno S, 2012, BIOCHEMISTRY-US, V51, P8027, DOI 10.1021/bi300808b; PON NG, 1967, ANAL BIOCHEM, V19, P272, DOI 10.1016/0003-2697(67)90163-7; Pramanik J, 1997, BIOTECHNOL BIOENG, V56, P398, DOI 10.1002/(SICI)1097-0290(19971120)56:4<398::AID-BIT6>3.0.CO;2-J; Ramanagoudr-Bhojappa R, 2013, J BIOL CHEM, V288, P16185, DOI 10.1074/jbc.M113.470013; Rizzi M, 1997, BIOTECHNOL BIOENG, V55, P592; Robinson DG, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv636; Rohwer J., 2006, P 2 INT S EXP STAND, P175; Schaefer J., 2010, R PACKAGE VERSION 15; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Schulz JC, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005602; Schulze U., 1995, THESIS; Sekine T, 2007, APPL ENVIRON MICROB, V73, P4011, DOI 10.1128/AEM.00730-07; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Tummler K, 2014, FEBS J, V281, P549, DOI 10.1111/febs.12525; Valgepea K, 2013, MOL BIOSYST, V9, P2344, DOI 10.1039/c3mb70119k; van Heerden JH, 2014, SCIENCE, V343, P987, DOI 10.1126/science.1245114; VANDERCAMMEN A, 1989, EUR J BIOCHEM, V182, P613, DOI 10.1111/j.1432-1033.1989.tb14870.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; WYNGAARDEN JB, 1959, NATURE, V183, P747, DOI 10.1038/183747a0; Xu YF, 2012, MOL CELL, V48, P52, DOI 10.1016/j.molcel.2012.07.013; Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zampar GG, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.11; Zhu J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001301	87	145	146	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311							aaf2786	10.1126/science.aaf2786	http://dx.doi.org/10.1126/science.aaf2786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789812	Green Accepted			2022-12-28	WOS:000387684400031
J	Rossignol, P; Pitt, B; Thompson, A; Zannad, F				Rossignol, Patrick; Pitt, Bertram; Thompson, Aliza; Zannad, Faiez			Roadmap for cardiovascular prevention trials in chronic kidney disease	LANCET			English	Editorial Material							EVENTS		[Rossignol, Patrick; Zannad, Faiez] Univ Lorraine, CHU Nancy, Ctr Invest Clin Plurithemat, Inserm 1433, F-54500 Vandoeuvre Les Nancy, France; [Rossignol, Patrick; Zannad, Faiez] F CRIN INI CRCT Cardiovasc & Renal Clin Trialists, Nancy, France; [Rossignol, Patrick] Assoc Lorraine Traitement Insuffisance Renale, Nancy, France; [Pitt, Bertram] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Thompson, Aliza] US FDA, Div Cardiovasc & Renal Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA	CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; University of Michigan System; University of Michigan; US Food & Drug Administration (FDA)	Rossignol, P (corresponding author), Univ Lorraine, CHU Nancy, Ctr Invest Clin Plurithemat, Inserm 1433, F-54500 Vandoeuvre Les Nancy, France.; Rossignol, P (corresponding author), F CRIN INI CRCT Cardiovasc & Renal Clin Trialists, Nancy, France.; Rossignol, P (corresponding author), Assoc Lorraine Traitement Insuffisance Renale, Nancy, France.	p.rossignol@chru-nancy.fr	Zannad, Faiez/K-4649-2019					Badiou S, 2016, CLIN BIOCHEM, V49, P1195, DOI 10.1016/j.clinbiochem.2016.05.015; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Green D, 2011, AM J KIDNEY DIS, V57, P921, DOI 10.1053/j.ajkd.2011.02.376; Hicks KA, 2015, CIRCULATION, V132, P302, DOI 10.1161/CIR.0000000000000156; Konstantinidis I, 2016, JAMA INTERN MED, V176, P121, DOI 10.1001/jamainternmed.2015.6102; Ortiz A, 2014, LANCET, V383, P1831, DOI 10.1016/S0140-6736(14)60384-6; Rossignol P, 2012, HYPERTENSION, V60, P339, DOI 10.1161/HYPERTENSIONAHA.111.190397; Sandoval Y, 2016, CLIN CHEM, V62, P631, DOI 10.1373/clinchem.2015.251835; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Vanholder R, 2016, LANCET DIABETES ENDO, V4, P360, DOI 10.1016/S2213-8587(16)00033-4; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657	12	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1964	1966		10.1016/S0140-6736(16)31331-9	http://dx.doi.org/10.1016/S0140-6736(16)31331-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27789005				2022-12-28	WOS:000385954800008
J	Finkelstein, AN; Taubman, SL; Allen, HL; Wright, BJ; Baicker, K				Finkelstein, Amy N.; Taubman, Sarah L.; Allen, Heidi L.; Wright, Bill J.; Baicker, Katherine			Effect of Medicaid Coverage on ED Use - Further Evidence from Oregon's Experiment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-INSURANCE EXPERIMENT		[Finkelstein, Amy N.] Dept Econ, Cambridge, MA 02142 USA; [Finkelstein, Amy N.; Baicker, Katherine] Abdul Latif Jameel Poverty Act Lab J PAL, Cambridge, MA 02142 USA; [Finkelstein, Amy N.; Taubman, Sarah L.; Baicker, Katherine] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Baicker, Katherine] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA; [Allen, Heidi L.] Columbia Univ, Sch Social Work, New York, NY USA; [Wright, Bill J.] Providence Hlth & Serv, Portland, OR USA	National Bureau of Economic Research; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Finkelstein, AN (corresponding author), Dept Econ, Cambridge, MA 02142 USA.; Finkelstein, AN (corresponding author), Abdul Latif Jameel Poverty Act Lab J PAL, Cambridge, MA 02142 USA.; Finkelstein, AN (corresponding author), Natl Bur Econ Res, Cambridge, MA 02138 USA.				NIA NIH HHS [RC2 AG036631, R01 AG034151] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG034151, RC2AG036631] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baicker K, 2014, AM ECON REV, V104, P322, DOI 10.1257/aer.104.5.322; Baicker K, 2013, NEW ENGL J MED, V368, P1713, DOI 10.1056/NEJMsa1212321; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; Komaroff AL, 2014, NEJM J WATCH; Taubman SL, 2014, SCIENCE, V343, P263, DOI 10.1126/science.1246183	5	66	66	2	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1505	1507		10.1056/NEJMp1609533	http://dx.doi.org/10.1056/NEJMp1609533			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3HF	27797307	Green Published			2022-12-28	WOS:000393102500001
J	Stone, GW; Sabik, JF; Serruys, PW; Simonton, CA; Genereux, P; Puskas, J; Kandzari, DE; Morice, MC; Lembo, N; Brown, WM; Taggart, DP; Banning, A; Merkely, B; Horkay, F; Boonstra, PW; van Boven, AJ; Ungi, I; Bogats, G; Mansour, S; Noiseux, N; Sabate, M; Pomar, J; Hickey, M; Gershlick, A; Buszman, P; Bochenek, A; Schampaert, E; Page, P; Dressler, O; Kosmidou, I; Mehran, R; Pocock, SJ; Kappetein, AP				Stone, G. W.; Sabik, J. F.; Serruys, P. W.; Simonton, C. A.; Genereux, P.; Puskas, J.; Kandzari, D. E.; Morice, M. -C.; Lembo, N.; Brown, W. M., III; Taggart, D. P.; Banning, A.; Merkely, B.; Horkay, F.; Boonstra, P. W.; van Boven, A. J.; Ungi, I.; Bogats, G.; Mansour, S.; Noiseux, N.; Sabate, M.; Pomar, J.; Hickey, M.; Gershlick, A.; Buszman, P.; Bochenek, A.; Schampaert, E.; Page, P.; Dressler, O.; Kosmidou, I.; Mehran, R.; Pocock, S. J.; Kappetein, A. P.		EXCEL Trial Investigators	Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAVASCULAR ULTRASOUND GUIDANCE; GRAFT-SURGERY; RANDOMIZED-TRIAL; 5-YEAR OUTCOMES; CLINICAL IMPACT; FOLLOW-UP; INTERVENTION; SYNERGY; SYNTAX; TAXUS	BACKGROUND Patients with obstructive left main coronary artery disease are usually treated with coronary-artery bypass grafting (CABG). Randomized trials have suggested that drug-eluting stents may be an acceptable alternative to CABG in selected patients with left main coronary disease. METHODS We randomly assigned 1905 eligible patients with left main coronary artery disease of low or intermediate anatomical complexity to undergo either percutaneous coronary intervention (PCI) with fluoropolymer-based cobalt-chromium everolimus-eluting stents (PCI group, 948 patients) or CABG (CABG group, 957 patients). Anatomic complexity was assessed at the sites and defined by a Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score of 32 or lower (the SYNTAX score reflects a comprehensive angiographic assessment of the coronary vasculature, with 0 as the lowest score and higher scores [ no upper limit] indicating more complex coronary anatomy). The primary end point was the rate of a composite of death from any cause, stroke, or myocardial infarction at 3 years, and the trial was powered for noninferiority testing of the primary end point (noninferiority margin, 4.2 percentage points). Major secondary end points included the rate of a composite of death from any cause, stroke, or myocardial infarction at 30 days and the rate of a composite of death, stroke, myocardial infarction, or ischemia-driven revascularization at 3 years. Event rates were based on Kaplan-Meier estimates in time-to-first-event analyses. RESULTS At 3 years, a primary end-point event had occurred in 15.4% of the patients in the PCI group and in 14.7% of the patients in the CABG group (difference, 0.7 percentage points; upper 97.5% confidence limit, 4.0 percentage points; P = 0.02 for noninferiority; hazard ratio, 1.00; 95% confidence interval, 0.79 to 1.26; P = 0.98 for superiority). The secondary end-point event of death, stroke, or myocardial infarction at 30 days occurred in 4.9% of the patients in the PCI group and in 7.9% in the CABG group (P< 0.001 for noninferiority, P = 0.008 for superiority). The secondary end-point event of death, stroke, myocardial infarction, or ischemia-driven revascularization at 3 years occurred in 23.1% of the patients in the PCI group and in 19.1% in the CABG group (P = 0.01 for noninferiority, P = 0.10 for superiority). CONCLUSIONS In patients with left main coronary artery disease and low or intermediate SYNTAX scores by site assessment, PCI with everolimus-eluting stents was noninferior to CABG with respect to the rate of the composite end point of death, stroke, or myocardial infarction at 3 years. (Funded by Abbott Vascular; EXCEL ClinicalTrials.gov number, NCT01205776.)	[Stone, G. W.] New York Presbyterian Hosp, New York, NY USA; [Stone, G. W.] Columbia Univ, Med Ctr, New York, NY USA; [Stone, G. W.; Genereux, P.; Dressler, O.; Kosmidou, I.; Mehran, R.] Cardiovasc Res Fdn, New York, NY USA; [Puskas, J.; Mehran, R.] Mt Sinai Med Ctr, New York, NY USA; [Sabik, J. F.] Cleveland Clin Fdn, Cleveland, OH USA; [Serruys, P. W.] Imperial Coll London, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London, England; [Pocock, S. J.] London Sch Hyg & Trop Med, London, England; [Taggart, D. P.; Banning, A.] Oxford Univ Hosp, Oxford, England; [Hickey, M.; Gershlick, A.] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Simonton, C. A.] Abbott Vasc, Santa Clara, CA USA; [Genereux, P.; Schampaert, E.; Page, P.] Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Mansour, S.; Noiseux, N.] Univ Montreal, Ctr Hosp, Hop Hotel Dieu Montreal, Montreal, PQ, Canada; [Kandzari, D. E.; Lembo, N.; Brown, W. M., III] Piedmont Hosp, Atlanta, GA USA; [Morice, M. -C.] Hop Prive Jacques Cartier, Ramsay Gen Sante, Massy, France; [Merkely, B.; Horkay, F.] Semmelweis Univ, Budapest, Hungary; [Ungi, I.; Bogats, G.] Univ Szeged, Szeged, Hungary; [Boonstra, P. W.; van Boven, A. J.] Med Ctr Leeuwarden, Leeuwarden, Netherlands; [Kappetein, A. P.] Erasmus MC, Rotterdam, Netherlands; [Sabate, M.; Pomar, J.] Hosp Clin Barcelona, Barcelona, Spain; [Buszman, P.; Bochenek, A.] Med Univ Silesia, Katowice, Poland; [Buszman, P.; Bochenek, A.] Amer Heart Poland, Ustron, Poland	NewYork-Presbyterian Hospital; Columbia University; Cardiovascular Research Foundation (CRF); Icahn School of Medicine at Mount Sinai; Cleveland Clinic Foundation; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University Hospitals of Leicester NHS Trust; University of Leicester; Universite de Montreal; Universite de Montreal; Jacques Cartier Private Hospital; Semmelweis University; Szeged University; Medical Center Leeuwarden; Erasmus University Rotterdam; Erasmus MC; University of Barcelona; Hospital Clinic de Barcelona; Medical University Silesia	Stone, GW (corresponding author), Columbia Univ, Med Ctr, Cardiovasc Res Fdn, 1700 Broadway,8th Fl, New York, NY 10019 USA.	gs2184@columbia.edu	Borger, Michael/AAX-1514-2020; Sabate, Manel/AAX-7245-2021; clark, Stephen/N-1748-2019; Buszman, Pawel/AAX-9336-2020; Mehran, Roxana/ABF-4160-2021; banning, adrian p/AAF-7229-2021; Kubica, Jacek/D-6906-2014	Borger, Michael/0000-0003-1046-1364; clark, Stephen/0000-0002-2193-4705; Kubica, Jacek/0000-0001-8250-754X; Banning, Adrian/0000-0002-2842-7861; Merkely, Bela/0000-0001-6514-0723; Juthier, Francis/0000-0002-5072-9073; CARRIE, didier/0000-0003-2479-8144; Kupatt, Christian/0000-0002-3611-1218; VAN BELLE, ERIC/0000-0001-6509-443X; patrick, nataf/0000-0002-8412-6182; Bochenek, Andrzej/0000-0002-3046-3001; Buszman, Pawel/0000-0002-2511-4077; Kosmidou, Ioanna/0000-0003-2736-1191; Sabate Tenas, Manel/0000-0002-2316-3705; Engelman, Daniel/0000-0003-4346-5492; Ehsan, Afshin/0000-0003-1470-6760	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Funded by Abbott Vascular	Ahn JM, 2015, J AM COLL CARDIOL, V65, P2198, DOI 10.1016/j.jacc.2015.03.033; [Anonymous], 2012, J AM COLL CARDIOL, V59, P2125, DOI 10.1016/j.jacc.2012.03.016; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Capodanno D, 2011, J AM COLL CARDIOL, V58, P1426, DOI 10.1016/j.jacc.2011.07.005; Cavalcante R, 2016, J AM COLL CARDIOL, V68, P999, DOI 10.1016/j.jacc.2016.06.024; COMNOUGUE C, 1993, STAT MED, V12, P1353, DOI 10.1002/sim.4780121407; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Hernandez JM, 2014, JACC-CARDIOVASC INTE, V7, P244, DOI 10.1016/j.jcin.2013.09.014; Farooq V, 2013, J AM COLL CARDIOL, V62, P2360, DOI 10.1016/j.jacc.2013.07.106; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Kappetein AP, 2016, EUROINTERVENTION, V12, P861, DOI 10.4244/EIJV12I7A141; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Ong ATL, 2006, AM HEART J, V151, P1194, DOI 10.1016/j.ahj.2005.07.017; Palmerini T, 2014, J AM COLL CARDIOL, V63, P299, DOI 10.1016/j.jacc.2013.09.061; Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Ware JH, 1997, NEW ENGL J MED, V337, P1159, DOI 10.1056/NEJM199710163371610; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wittes J, 2001, CURR CONTR TRIALS C, V2, P59, DOI 10.1186/CVM-2-1-059	23	669	693	2	64	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 8	2016	375	23					2223	2235		10.1056/NEJMoa1610227	http://dx.doi.org/10.1056/NEJMoa1610227			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0ZQ	27797291	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000389310000005
J	Newton, K; Wickliffe, KE; Maltzman, A; Dugger, DL; Strasser, A; Pham, VC; Lill, JR; Roose-Girma, M; Warming, S; Solon, M; Ngu, H; Webster, JD; Dixit, VM				Newton, Kim; Wickliffe, Katherine E.; Maltzman, Allie; Dugger, Debra L.; Strasser, Andreas; Pham, Victoria C.; Lill, Jennie R.; Roose-Girma, Merone; Warming, Soren; Solon, Margaret; Ngu, Hai; Webster, Joshua D.; Dixit, Vishva M.			RIPK1 inhibits ZBP1-driven necroptosis during development	NATURE			English	Article							KAPPA-B ACTIVATION; TNF-ALPHA; PROGRAMMED NECROSIS; CELL-DEATH; APOPTOSIS; INFLAMMATION; INNATE; TRIF; PHOSPHORYLATION; UBIQUITINATION	Receptor-interacting protein kinase 1 (RIPK1) promotes cell survival-mice lacking RIPK1 die perinatally, exhibiting aberrant caspase-8-dependent apoptosis and mixed lineage kinase-like (MLKL)-dependent necroptosis(1-3). However, mice expressing catalytically inactive RIPK1 are viable(2,4,5), and an ill-defined pro-survival function for the RIPK1 scaffold has therefore been proposed. Here we show that the RIP homotypic interaction motif (RHIM) in RIPK1 prevents the RHIM-containing adaptor protein ZBP1 (Z-DNA binding protein 1; also known as DAI or DLM1) from activating RIPK3 upstream of MLKL. Ripk1(RHIM/RHIM) mice that expressed mutant RIPK1 with critical RHIM residues IQIG mutated to AAAA died around birth and exhibited RIPK3 autophosphorylation on Thr231 and Ser232, which is a hallmark of necroptosis(6), in the skin and thymus. Blocking necroptosis with catalytically inactive RIPK3(D161N), RHIM mutant RIPK3, RIPK3 deficiency, or MLKL deficiency prevented lethality in Ripk1(RHIM/RHIM) mice. Loss of ZBP1, which engages RIPK3 in response to certain viruses(7,8) but previously had no defined role in development, also prevented perinatal lethality in Ripk1(RHIM/RHIM) mice. Consistent with the RHIM of RIPK1 functioning as a brake that prevents ZBP1 from engaging the RIPK3 RHIM, ZBP1 interacted with RIPK3 in Ripk1(RHIM/RHIM)Mlkl(-/-) macrophages, but not in wild-type, Mlkl(-/-) or Ripk1(RHIM/RHIM)Ripk3(RHIM/RHIM) macrophages. Collectively, these findings indicate that the RHIM of RIPK1 is critical for preventing ZBP1/RIPK3/MLKL-dependent necroptosis during development.	[Newton, Kim; Wickliffe, Katherine E.; Maltzman, Allie; Dugger, Debra L.; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA; [Strasser, Andreas] Walter & Eliza Hall Inst Med Res, Mol Genet Canc Div, 1G Royal Parade, Parkville, Vic 3052, Australia; [Strasser, Andreas] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Pham, Victoria C.; Lill, Jennie R.] Genentech Inc, Dept Prote & Biol Resources, 1 DNA Way, San Francisco, CA 94080 USA; [Roose-Girma, Merone; Warming, Soren] Genentech Inc, Dept Mol Biol, 1 DNA Way, San Francisco, CA 94080 USA; [Solon, Margaret; Ngu, Hai; Webster, Joshua D.] Genentech Inc, Dept Pathol, 1 DNA Way, San Francisco, CA 94080 USA	Roche Holding; Genentech; Walter & Eliza Hall Institute; University of Melbourne; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Newton, K; Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	knewton@gene.com; dixit@gene.com	dixit, vishva m/A-4496-2012; Warming, Soren/ABD-5729-2021; Strasser, Andreas/C-7581-2013	dixit, vishva m/0000-0001-6983-0326; Strasser, Andreas/0000-0002-5020-4891; Warming, Soren/0000-0002-5721-0741				Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Chen WZ, 2013, J BIOL CHEM, V288, P16247, DOI 10.1074/jbc.M112.435545; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Ermolaeva MA, 2008, NAT IMMUNOL, V9, P1037, DOI 10.1038/ni.1638; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kearney CJ, 2014, FEBS J, V281, P4921, DOI 10.1111/febs.13034; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Newton K, 2016, ANNU REV BIOCHEM, V85, P743, DOI 10.1146/annurev-biochem-060815-014830; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Orozco S, 2014, CELL DEATH DIFFER, V21, P1511, DOI 10.1038/cdd.2014.76; Pobezinskaya YL, 2008, NAT IMMUNOL, V9, P1047, DOI 10.1038/ni.1639; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Wu XN, 2014, CELL DEATH DIFFER, V21, P1709, DOI 10.1038/cdd.2014.77; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	32	206	208	4	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					129	+		10.1038/nature20559	http://dx.doi.org/10.1038/nature20559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27819682				2022-12-28	WOS:000388916600062
J	Funato, H; Miyoshi, C; Fujiyama, T; Kanda, T; Kanda, T; Sato, M; Wang, ZQ; Ma, J; Nakane, S; Tomita, J; Ikkyu, A; Kakizaki, M; Hotta-Hirashima, N; Kanno, S; Komiya, H; Asano, F; Honda, T; Kim, SJ; Harano, K; Muramoto, H; Yonezawa, T; Mizuno, S; Miyazaki, S; Connor, L; Kumar, V; Miura, I; Suzuki, T; Watanabe, A; Abe, M; Sugiyama, F; Takahashi, S; Sakimura, K; Hayashi, Y; Liu, QH; Kume, K; Wakana, S; Takahashi, JS; Yanagisawa, M				Funato, Hiromasa; Miyoshi, Chika; Fujiyama, Tomoyuki; Kanda, Takeshi; Kanda, Takeshi; Sato, Makito; Wang, Zhiqiang; Ma, Jing; Nakane, Shin; Tomita, Jun; Ikkyu, Aya; Kakizaki, Miyo; Hotta-Hirashima, Noriko; Kanno, Satomi; Komiya, Haruna; Asano, Fuyuki; Honda, Takato; Kim, Staci J.; Harano, Kanako; Muramoto, Hiroki; Yonezawa, Toshiya; Mizuno, Seiya; Miyazaki, Shinichi; Connor, Linzi; Kumar, Vivek; Miura, Ikuo; Suzuki, Tomohiro; Watanabe, Atsushi; Abe, Manabu; Sugiyama, Fumihiro; Takahashi, Satoru; Sakimura, Kenji; Hayashi, Yu; Liu, Qinghua; Kume, Kazuhiko; Wakana, Shigeharu; Takahashi, Joseph S.; Yanagisawa, Masashi			Forward-genetics analysis of sleep in randomly mutagenized mice	NATURE			English	Article							SALT-INDUCIBLE KINASE; REM-SLEEP; NEURONAL EXCITABILITY; CIRCADIAN PACEMAKER; GABAERGIC NEURONS; CLOCK GENE; AROUSAL; MUTANTS; CIRCUIT; RHYTHMS	Sleep is conserved from invertebrates to vertebrates, and is tightly regulated in a homeostatic manner. The molecular and cellular mechanisms that determine the amount of rapid eye movement sleep (REMS) and non-REMS (NREMS) remain unknown. Here we identify two dominant mutations that affect sleep and wakefulness by using an electroencephalogram/electromyogram-based screen of randomly mutagenized mice. A splicing mutation in the Sik3 protein kinase gene causes a profound decrease in total wake time, owing to an increase in inherent sleep need. Sleep deprivation affects phosphorylation of regulatory sites on the kinase, suggesting a role for SIK3 in the homeostatic regulation of sleep amount. Sik3 orthologues also regulate sleep in fruitflies and roundworms. A missense, gain-of-function mutation in the sodium leak channel NALCN reduces the total amount and episode duration of REMS, apparently by increasing the excitability of REMS-inhibiting neurons. Our results substantiate the use of a forward-genetics approach for studying sleep behaviours in mice, and demonstrate the role of SIK3 and NALCN in regulating the amount of NREMS and REMS, respectively.	[Funato, Hiromasa; Miyoshi, Chika; Fujiyama, Tomoyuki; Kanda, Takeshi; Kanda, Takeshi; Sato, Makito; Wang, Zhiqiang; Ikkyu, Aya; Kakizaki, Miyo; Hotta-Hirashima, Noriko; Kanno, Satomi; Komiya, Haruna; Asano, Fuyuki; Honda, Takato; Kim, Staci J.; Harano, Kanako; Muramoto, Hiroki; Yonezawa, Toshiya; Miyazaki, Shinichi; Connor, Linzi; Hayashi, Yu; Liu, Qinghua; Takahashi, Joseph S.; Yanagisawa, Masashi] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan; [Funato, Hiromasa] Toho Univ, Dept Anat, Fac Med, Ota Ku, Tokyo 1438540, Japan; [Sato, Makito; Yanagisawa, Masashi] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Nakane, Shin; Tomita, Jun; Kume, Kazuhiko] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Neuropharmacol, Nagoya, Aichi 4678603, Japan; [Mizuno, Seiya; Sugiyama, Fumihiro; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Tsukuba, Ibaraki 3058575, Japan; [Kumar, Vivek; Takahashi, Joseph S.] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Kumar, Vivek] Jackson Lab, Bar Harbor, ME 04609 USA; [Miura, Ikuo; Suzuki, Tomohiro; Wakana, Shigeharu] RIKEN Bioresource Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki 3050074, Japan; [Watanabe, Atsushi] Natl Ctr Geriatr & Gerontol, Lab Res Adv, Obu, Aichi 4748511, Japan; [Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; [Hayashi, Yu] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan; [Liu, Qinghua] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Takahashi, Joseph S.; Yanagisawa, Masashi] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yanagisawa, Masashi] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Texas System; University of Texas Southwestern Medical Center Dallas; Nagoya City University; University of Tsukuba; University of Texas System; University of Texas Southwestern Medical Center Dallas; Jackson Laboratory; RIKEN; National Center for Geriatrics & Gerontology; Niigata University; Japan Science & Technology Agency (JST); University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tsukuba	Funato, H; Takahashi, JS; Yanagisawa, M (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki 3058575, Japan.; Yanagisawa, M (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.; Takahashi, JS (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.; Takahashi, JS; Yanagisawa, M (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.; Yanagisawa, M (corresponding author), Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Tsukuba, Ibaraki 3058575, Japan.	funato.hiromasa.km@u.tsukuba.ac.jp; joseph.takahashi@utsouthwestern.edu; yanagisawa.masa.fu@u.tsukuba.ac.jp	Takahashi, Joseph S/E-8482-2012; Watanabe, Atsushi/AAU-8018-2020; Hayashi, Yu/AAF-5179-2019; Abe, Manabu/A-9221-2008; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Hayashi, Yu/0000-0001-5007-4532; Takahashi, Joseph S./0000-0003-0384-8878; Honda, Takato/0000-0002-3327-8282; Fujiyama, Tomoyuki/0000-0001-6420-2283; Connor, Linzi/0000-0002-6036-6261; Kume, Kazuhiko/0000-0003-4232-1657; Funato, Hiromasa/0000-0002-2787-9700; Sakimura, Kenji/0000-0002-8091-8879; Kim, Staci J./0000-0001-9932-255X; Miyoshi, Chika/0000-0002-7109-1777; Asano, Fuyuki/0000-0002-9287-2011; Miyazaki, Shinichi/0000-0002-6949-1077	World Premier International Research Center Initiative from MEXT; JSPS KAKENHI [26220207, 16K15187, 26507003, 15K18966, 00635089, 16K18358, 15J06369, 16K18583]; MEXT KAKENHI [15H05935]; Welch Foundation [I-1608]; NIH [GM111367]; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from JSPS; Uehara Memorial Foundation; Takeda Science Foundation; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111367] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26870077, 16H00588, 16H00590, 26507008, 26250024, 16H04650] Funding Source: KAKEN	World Premier International Research Center Initiative from MEXT; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from JSPS; Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank all Yanagisawa/Funato laboratory and WPI-IIIS members, especially T. Motoike, A. Matsui, Y. Goto, M. Takahashi and K. Taniguchi for technical assistance and their participation in the early stage of this project, M. Lazarus, R. W. Greene and K. E. Vogt for discussion and comments on this manuscript. J.S.T. is an investigator and M.Y. is a former investigator of the Howard Hughes Medical Institute. This work was supported by the World Premier International Research Center Initiative from MEXT to M.Y., JSPS KAKENHI (grant number 26220207 to M.Y., H.F., T.K.; 16K15187 to H.F.; 26507003 to C.M., H.F.; 15K18966, 00635089 to T.F.; 16K18358 to T.K.; 15J06369 to T.H.; 16K18583 to M.S.), MEXT KAKENHI (grant number; 15H05935 to M.Y., H.F.), Welch Foundation (grant number; I-1608 to Q.L.), NIH (grant number; GM111367 to Q.L.), Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program) from JSPS to M.Y., research grants from Uehara Memorial Foundation to M.Y., and from Takeda Science Foundation to M.Y. Nematode strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We thank A. Hart and H. Huang for technical advices on nematode quiescence measurement, Y. lino for providing plasmids, M. Ikawa for providing EGxxFP plasmid, and M. Montminy and J. B. Thomas for fly stocks.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Berggreen C, 2012, CELL SIGNAL, V24, P1863, DOI 10.1016/j.cellsig.2012.05.001; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Crochet S, 2006, EUR J NEUROSCI, V24, P1404, DOI 10.1111/j.1460-9568.2006.04995.x; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Franken P, 2001, J NEUROSCI, V21, P2610, DOI 10.1523/JNEUROSCI.21-08-02610.2001; Hayashi Y, 2015, SCIENCE, V350, P957, DOI 10.1126/science.aad1023; Herrera CG, 2016, NAT NEUROSCI, V19, P290, DOI 10.1038/nn.4209; Joiner WJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003605; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; KRISHNAN KS, 1990, P NATL ACAD SCI USA, V87, P8632, DOI 10.1073/pnas.87.21.8632; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; Lear BC, 2005, NEURON, V48, P965, DOI 10.1016/j.neuron.2005.10.030; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Lu J, 2006, NATURE, V441, P589, DOI 10.1038/nature04767; Luppi PH, 2011, SLEEP MED REV, V15, P153, DOI 10.1016/j.smrv.2010.08.002; Raizen DM, 2008, NATURE, V451, P569, DOI 10.1038/nature06535; Ren DJ, 2011, NEURON, V72, P899, DOI 10.1016/j.neuron.2011.12.007; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sapin E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004272; Suzuki A, 2013, P NATL ACAD SCI USA, V110, P10288, DOI 10.1073/pnas.1308295110; Takahashi JS, 2008, SCIENCE, V322, P909, DOI 10.1126/science.1158822; Takemori H, 2008, J STEROID BIOCHEM, V108, P287, DOI 10.1016/j.jsbmb.2007.09.006; Vyazovskiy VV, 2011, NATURE, V472, P443, DOI 10.1038/nature10009; Weber F, 2016, NATURE, V538, P51, DOI 10.1038/nature19773; Weber F, 2015, NATURE, V526, P435, DOI 10.1038/nature14979; Xu M, 2015, NAT NEUROSCI, V18, P1641, DOI 10.1038/nn.4143	34	137	138	5	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					378	383		10.1038/nature20142	http://dx.doi.org/10.1038/nature20142			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27806374	Green Accepted			2022-12-28	WOS:000388161700044
J	Friedrich, MJ				Friedrich, M. J.			Growing Numbers of Refugees Worldwide Are Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1956	1956		10.1001/jama.2016.16533	http://dx.doi.org/10.1001/jama.2016.16533			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838730				2022-12-28	WOS:000387673800004
J	Appleby, J				Appleby, John			DATA BRIEFING Dentistry: should it be in the NHS at all?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, London W1G 7LP, England		Appleby, J (corresponding author), Nuffield Trust, London W1G 7LP, England.	john.appleby@nuffieldtrust.org.uk						British Dental Association, 2012, DIAM SERV 60 YEARS N; Gray PG, 1970, ADULT DENT HLTH ENGL; Health and Social Care Information Centre, 2015, 4 HLTH SOC CAR INF C; Health and Social Care Information Centre, 2011, ACC BARR CAR REP AD; Health and Social Care Information Centre, 2011, OR HLTH FUNCT REP AD; NHS Digital, 2016, NHS DENT STAT ENGL 2	6	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2016	355								i5986	10.1136/bmj.i5986	http://dx.doi.org/10.1136/bmj.i5986			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CV	27834273				2022-12-28	WOS:000388003200006
J	Dance, A				Dance, Amber			THE REAL-TIME TECHNICOLOUR LIVING BRAIN	NATURE			English	Editorial Material							FUNCTIONAL CONNECTIVITY; MOUSE-BRAIN; MICROSCOPY											Bauer AQ, 2014, NEUROIMAGE, V99, P388, DOI 10.1016/j.neuroimage.2014.05.051; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; Bouchard MB, 2015, NAT PHOTONICS, V9, P113, DOI [10.1038/NPHOTON.2014.323, 10.1038/nphoton.2014.323]; Horton NG, 2013, NAT PHOTONICS, V7, P205, DOI [10.1038/NPHOTON.2012.336, 10.1038/nphoton.2012.336]; Malvache A, 2016, SCIENCE, V353, P1280, DOI 10.1126/science.aaf3319; Naga Srinivas Nadella K. M., 2016, NATURE METHODS; Ozbay BN, 2015, OPT LETT, V40, P2553, DOI 10.1364/OL.40.002553; Sofroniew NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14472; Tsai PS, 2015, OPT EXPRESS, V23, P13833, DOI 10.1364/OE.23.013833; White BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016322; Yang WJ, 2016, NEURON, V89, P269, DOI 10.1016/j.neuron.2015.12.012; Zou P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5625	12	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					315	318		10.1038/539315a	http://dx.doi.org/10.1038/539315a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830796				2022-12-28	WOS:000387318500053
J	de Haas, M; Thurik, FF; van der Ploeg, CPB; Veldhuisen, B; Hirschberg, H; Soussan, AA; Woortmeijer, H; Abbink, F; Page-Christiaens, GCML; Scheffer, PG; van der Schoot, CE				de Haas, Masja; Thurik, Florentine F.; van der Ploeg, Catharina P. B.; Veldhuisen, Barbera; Hirschberg, Hoang; Soussan, Aicha Ait; Woortmeijer, Heleen; Abbink, Frithjofna; Page-Christiaens, Godelieve C. M. L.; Scheffer, Peter G.; van der Schoot, C. Ellen			Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEGATIVE PREGNANT-WOMEN; HEMOLYTIC-DISEASE; RHESUS-D; PRENATAL-DIAGNOSIS; COST-EFFECTIVENESS; MATERNAL PLASMA; DNA; FETUS; BENEFITS; VARIANT	OBJECTIVE To determine the accuracy of non-invasive fetal testing for the RHD gene in week 27 of pregnancy as part of an antenatal screening programme to restrict anti-D immunoglobulin use to women carrying a child positive for RHD. DESIGN Prospectively monitoring of fetal RHD testing accuracy compared with serological cord blood typing on introduction of the test. Fetal RHD testing was performed with a duplex real time quantitative polymerase chain reaction, with cell-free fetal DNA isolated from 1 mL of maternal plasma The study period was between 4 July 2011 and 7 October 2012. The proportion of women participating in screening was determined. SETTING Nationwide screening programme, the Netherlands. Tests are performed in a centralised setting. PARTICIPANTS 25 789 RhD negative pregnant women. MAIN OUTCOME MEASURES Sensitivity, specificity, false negative rate, and false positive rate of fetal RHD testing compared with serological cord blood typing; proportion of technical failures; and compliance to the screening programme. RESULTS A fetal RHD test result and serological cord blood result were available for 25 789 pregnancies. Sensitivity for detection of fetal RHD was 99.94% (95% confidence interval 99.89% to 99.97%) and specificity was 97.74% (97.43% to 98.02%). Nine false negative results for fetal RHD testing were registered (0.03%, 95% confidence interval 0.01% to 0.06%). In two cases these were due to technical failures. False positive fetal RHD testing results were registered for 225 samples (0.87%, 0.76% to 0.99%). Weak RhD expression was shown in 22 of these cases, justifying anti-D immunoglobulin use. The negative and positive predictive values were 99.91% (95% confidence interval 99.82% to 99.95%) and 98.60% (98.40% to 98.77%), respectively. More than 98% of the women participated in the screening programme. CONCLUSIONS Fetal RHD testing in week 27 of pregnancy as part of a national antenatal screening programme is highly reliable and can be used to target both antenatal and postnatal anti-D immunoglobulin use.	[de Haas, Masja; Thurik, Florentine F.; Veldhuisen, Barbera; Soussan, Aicha Ait; van der Schoot, C. Ellen] Sanquin Res, Dept Expt Immunohematol, POB 9190, NL-1006 AD Amsterdam, Netherlands; [de Haas, Masja; Thurik, Florentine F.; Veldhuisen, Barbera; Soussan, Aicha Ait; van der Schoot, C. Ellen] Univ Amsterdam, Acad Med Ctr, Landsteiner Lab, Amsterdam, Netherlands; [de Haas, Masja] Sanquin Res, Ctr Clin Transfus Res, Amsterdam, Netherlands; [de Haas, Masja] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands; [de Haas, Masja; Veldhuisen, Barbera; Woortmeijer, Heleen] Sanquin Res, Dept Immunohematol Diagnost Serv, Amsterdam, Netherlands; [Thurik, Florentine F.; Page-Christiaens, Godelieve C. M. L.; Scheffer, Peter G.] Univ Med Ctr Utrecht, Div Woman & Baby, Dept Obstet, Utrecht, Netherlands; [van der Ploeg, Catharina P. B.] Netherlands Org Appl Sci Res, Dept Child Hlth, Leiden, Netherlands; [Hirschberg, Hoang] Natl Inst Publ Hlth & Environm, Serv Vaccine Provis & Prevent Programs, Bilthoven, Netherlands; [Abbink, Frithjofna] Natl Inst Publ Hlth & Environm, Ctr Populat Screening, Bilthoven, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Netherlands Organization Applied Science Research; Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment	van der Schoot, CE (corresponding author), Sanquin Res, Dept Expt Immunohematol, POB 9190, NL-1006 AD Amsterdam, Netherlands.	e.vanderschoot@sanquin.nl		Scheffer, Peter/0000-0001-9253-5341				Avent ND, 2000, BLOOD, V95, P375, DOI 10.1182/blood.V95.2.375; Bianchi DW, 2005, OBSTET GYNECOL, V106, P841, DOI 10.1097/01.AOG.0000179477.59385.93; Bolton-Maggs PHB, 2013, BJOG-INT J OBSTET GY, V120, P873, DOI 10.1111/1471-0528.12175; Chitty LS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5243; Clausen FB, 2014, PRENATAL DIAG, V34, P1000, DOI 10.1002/pd.4419; Clausen FB, 2012, TRANSFUSION, V52, P752, DOI 10.1111/j.1537-2995.2011.03362.x; Crowther CA, 2000, COCHRANE DB SYST REV, V2000, P2; Daniels G., 2013, HUMAN BLOOD GROUPS, V185, DOI [10.1002/9781118493595, DOI 10.1002/9781118493595]; de Haas M, 2015, VOX SANG, V109, P99, DOI 10.1111/vox.12265; Duplantie J, 2013, J OBSTET GYNAECOL CA, V35, P730, DOI 10.1016/S1701-2163(15)30864-1; Faas BHW, 1998, LANCET, V352, P1196, DOI 10.1016/S0140-6736(05)60534-X; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Grootkerk-Tax MGHM, 2006, TRANSFUSION, V46, P2142, DOI 10.1111/j.1537-2995.2006.01044.x; Haer-Wigman L, 2013, TRANSFUSION, V53, P1559, DOI 10.1111/j.1537-2995.2012.03919.x; Hawk AF, 2013, OBSTET GYNECOL, V122, P579, DOI 10.1097/AOG.0b013e31829f8814; Health Council of the Netherlands, 2009, HLTH COUNC NETH PUBL, V13E; Kent J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-87; Koelewijn JM, 2008, TRANSFUSION, V48, P1721, DOI 10.1111/j.1537-2995.2008.01742.x; Legler TJ, 2007, PRENATAL DIAG, V27, P824, DOI 10.1002/pd.1783; Legler TJ, 2009, TRANSFUS MED HEMOTH, V36, P189, DOI 10.1159/000216580; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Ma KK, 2016, J MATERN-FETAL NEO M, V29, P1866, DOI 10.3109/14767058.2015.1066773; Muller SP, 2008, TRANSFUSION, V48, P2292, DOI 10.1111/j.1537-2995.2008.01843.x; Neovius M, 2016, BJOG-INT J OBSTET GY, V123, P1337, DOI 10.1111/1471-0528.13801; Oxenford K, 2013, PRENATAL DIAG, V33, P688, DOI 10.1002/pd.4135; Pilgrim H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13100; Scheffer PG, 2011, BJOG-INT J OBSTET GY, V118, P1340, DOI 10.1111/j.1471-0528.2011.03028.x; Stegmann TC, 2016, BRIT J HAEMATOL, V173, P469, DOI 10.1111/bjh.13960; Szczepura A, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-5; Teitelbaum L, 2015, ULTRASOUND OBST GYN, V45, P84, DOI 10.1002/uog.14723; Thurik FF, 2015, PRENATAL DIAG, V35, P754, DOI 10.1002/pd.4600; Urbaniak SJ, 2000, BLOOD REV, V14, P44, DOI 10.1054/blre.1999.0123; van der Ploeg CPB, 2014, RIVM TNO 2014; Van der Schoot CE, 2006, TRANSFUS CLIN BIOL, V13, P53, DOI 10.1016/j.tracli.2006.02.021; Wikman AT, 2012, OBSTET GYNECOL, V120, P227, DOI 10.1097/AOG.0b013e31825d33d9	37	32	32	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 7	2016	355								i5789	10.1136/bmj.i5789	http://dx.doi.org/10.1136/bmj.i5789			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CQ	27821701	hybrid, Green Published			2022-12-28	WOS:000388002700003
J	Glisenti, P; Rakusa, J; Albrecht, R; Luedi, MM				Glisenti, Paolo; Rakusa, Julia; Albrecht, Roland; Luedi, Markus M.			Negative pressure pulmonary oedema with haemorrhage after 5-minute avalanche burial	LANCET			English	Editorial Material									[Glisenti, Paolo; Albrecht, Roland; Luedi, Markus M.] Swiss Air Rescue Rega, Helicopter Base 9, Plazza Aviat 6, CH-7503 Samedan, Switzerland; [Rakusa, Julia] Spital Oberengadin, Dept Internal Med, Samedan, Switzerland; [Luedi, Markus M.] Univ Bern, Bern Univ Hosp Inselspital, Dept Anaesthesiol & Pain Med, Bern, Switzerland	University of Bern; University Hospital of Bern	Glisenti, P (corresponding author), Swiss Air Rescue Rega, Helicopter Base 9, Plazza Aviat 6, CH-7503 Samedan, Switzerland.	paolo.glisenti@rega.ch		Luedi, Markus/0000-0002-9049-2584				Bhattacharya M, 2016, CHEST, V150, P927, DOI 10.1016/j.chest.2016.03.043; OSWALT CE, 1977, JAMA-J AM MED ASSOC, V238, P1833, DOI 10.1001/jama.238.17.1833; Schwartz DR, 1999, CHEST, V115, P1194, DOI 10.1378/chest.115.4.1194; Sumann G, 2012, HIGH ALT MED BIOL, V13, P295, DOI 10.1089/ham.2012.1072; Udeshi A, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.12.014	5	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2321	2322		10.1016/S0140-6736(16)31010-8	http://dx.doi.org/10.1016/S0140-6736(16)31010-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8MO	27825509				2022-12-28	WOS:000386889300037
J	Ubachs, W				Ubachs, Wim			PHYSICS A testing time for antimatter	SCIENCE			English	Editorial Material							ANTIPROTONIC HELIUM		[Ubachs, Wim] Vrije Univ, Dept Phys, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Ubachs, W (corresponding author), Vrije Univ, Dept Phys, Boelelaan 1081, NL-1081 HV Amsterdam, Netherlands.	w.m.g.ubachs@vu.nl	Ubachs, Wim/F-5649-2011; Ubachs, W./K-3256-2019	Ubachs, Wim/0000-0001-7840-3756; Ubachs, W./0000-0001-7840-3756				Biesheuvel J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10385; Hayano RS, 2007, REP PROG PHYS, V70, P1995, DOI 10.1088/0034-4885/70/12/R01; Hori M, 2016, SCIENCE, V354, P610, DOI 10.1126/science.aaf6702; Korobov VI, 2015, HYPERFINE INTERACT, V233, P75, DOI 10.1007/s10751-015-1149-5; Korobov VI, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.103003; Niu ML, 2014, J MOL SPECTROSC, V300, P44, DOI 10.1016/j.jms.2014.03.011; Pachucki K, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.062510; Reinhold E, 2005, MOL PHYS, V103, P1329, DOI 10.1080/00268970500050621; Ubachs W, 2016, J MOL SPECTROSC, V320, P1, DOI 10.1016/j.jms.2015.12.003; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949	11	0	0	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					546	547		10.1126/science.aah6215	http://dx.doi.org/10.1126/science.aah6215			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811251	Green Submitted			2022-12-28	WOS:000386869800018
J	Diehl, WE; Lin, AE; Grubaugh, ND; Carvalho, LM; Kim, K; Kyawe, PP; McCauley, SM; Donnard, E; Kucukural, A; McDonel, P; Schaffner, SF; Garber, M; Rambaut, A; Andersen, KG; Sabeti, PC; Luban, J				Diehl, William E.; Lin, Aaron E.; Grubaugh, Nathan D.; Carvalho, Luiz Max; Kim, Kyusik; Kyawe, Pyae Phyo; McCauley, Sean M.; Donnard, Elisa; Kucukural, Alper; McDonel, Patrick; Schaffner, Stephen F.; Garber, Manuel; Rambaut, Andrew; Andersen, Kristian G.; Sabeti, Pardis C.; Luban, Jeremy			Ebola Virus Glycoprotein with Increased Infectivity Dominated the 2013-2016 Epidemic	CELL			English	Article							NIEMANN-PICK C1; HEMORRHAGIC-FEVER; INFLUENZA-VIRUS; CYNOMOLGUS MACAQUES; LENTIVIRAL VECTORS; RECEPTOR-BINDING; DENDRITIC CELLS; FRUIT BATS; VIRAL LOAD; TRANSMISSION	The magnitude of the 2013-2016 Ebola virus disease (EVD) epidemic enabled an unprecedented number of viral mutations to occur over successive human-to- human transmission events, increasing the probability that adaptation to the human host occurred during the outbreak. We investigated one nonsynonymous mutation, Ebola virus (EBOV) glycoprotein (GP) mutant A82V, for its effect on viral infectivity. This mutation, located at the NPC1-binding site on EBOV GP, occurred early in the 2013-2016 outbreak and rose to high frequency. We found that GP-A82V had heightened ability to infect primate cells, including human dendritic cells. The increased infectivity was restricted to cells that have primate-specific NPC1 sequences at the EBOV interface, suggesting that this mutation was indeed an adaptation to the human host. GP-A82V was associated with increased mortality, consistent with the hypothesis that the heightened intrinsic infectivity of GP-A82V contributed to disease severity during the EVD epidemic.	[Diehl, William E.; Kim, Kyusik; McCauley, Sean M.; Donnard, Elisa; Kucukural, Alper; McDonel, Patrick; Garber, Manuel; Luban, Jeremy] Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA; [Lin, Aaron E.; Schaffner, Stephen F.; Andersen, Kristian G.; Sabeti, Pardis C.] Broad Inst Harvard & MIT, 75 Ames St, Cambridge, MA 02142 USA; [Lin, Aaron E.; Schaffner, Stephen F.; Sabeti, Pardis C.] Harvard Univ, 52 Oxford St, Cambridge, MA 02138 USA; [Grubaugh, Nathan D.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Carvalho, Luiz Max; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Kings Bldg,West Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland; [Kyawe, Pyae Phyo] Univ Massachusetts, Sch Med, Dept Med, 55 Lake Ave North, Worcester, MA 01605 USA; [Donnard, Elisa; Kucukural, Alper; McDonel, Patrick; Garber, Manuel] Univ Massachusetts, Sch Med, Program Bioinformat & Integrat Biol, Worcester, MA 01655 USA; [Andersen, Kristian G.] Scripps Translat Sci Inst, 3344 North Torrey Pines Court, La Jolla, CA 92037 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Scripps Research Institute; University of Edinburgh; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Scripps Research Institute	Luban, J (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.; Andersen, KG; Sabeti, PC (corresponding author), Broad Inst Harvard & MIT, 75 Ames St, Cambridge, MA 02142 USA.; Sabeti, PC (corresponding author), Harvard Univ, 52 Oxford St, Cambridge, MA 02138 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Translat Sci Inst, 3344 North Torrey Pines Court, La Jolla, CA 92037 USA.	andersen@scripps.edu; pardis@broadinstitute.org; jeremy.luban@umassmed.edu	Rambaut, Andrew/B-2481-2009; Carvalho, Luiz Max F/J-6446-2014; Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011; Kucukural, Alper/T-3563-2018; Carvalho, Luiz Max/AAC-8266-2020; Lin, Aaron/AAL-1625-2021; Kucukural, Alper/AAJ-7758-2020	Rambaut, Andrew/0000-0003-4337-3707; Carvalho, Luiz Max F/0000-0001-5736-5578; Kucukural, Alper/0000-0001-9983-394X; Carvalho, Luiz Max/0000-0001-5736-5578; Kucukural, Alper/0000-0001-9983-394X; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X; Grubaugh, Nathan/0000-0003-2031-1933; Kim, Kyusik/0000-0001-9217-673X; Schaffner, Stephen/0000-0001-6699-3568; Lin, Aaron/0000-0001-7400-4125; Diehl, William/0000-0001-7943-1214; Luban, Jeremy/0000-0001-5650-4054; Donnard, Elisa/0000-0002-8834-8110	NIH [NIDA DP1DA034990, NIAID R01AI111809, NHGRI 1U01HG007910, 5T32AI007244-33, NCATS UL1TR001114, NIAID HHSN272201400048C, NIAID U19AI110818]; Howard Hughes Medical Investigator award; European Union Seventh Framework Programme [FP7] [278433-PREDEMICS]; National Science Foundation [DGE 1144152]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453, UL1TR001114] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007910] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI111809, T32AI007244, U19AI110818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA034990] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Investigator award; European Union Seventh Framework Programme [FP7]; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We wish to thank Andrew Orry for assistance with the homology modeling and Greg Towers for MDTF cells. This work was supported by NIH grants NIDA DP1DA034990 and NIAID R01AI111809 to J.L., NHGRI 1U01HG007910 to M.G. and J.L., 5T32AI007244-33 to N.D.G., NCATS UL1TR001114 and NIAID HHSN272201400048C to K.G.A., Howard Hughes Medical Investigator award and NIAID U19AI110818 to P.C.S., and European Union Seventh Framework Programme [FP7/2007-2013] Grant No 278433-PREDEMICS to A.R. This material is based upon work supported by the National Science Foundation under grant no. DGE 1144152 (A.E.L.). Some reagents were constructed from NIH grant U19AI110818 (P.C.S.). K.G.A. is a PEW Biomedical Scholar.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Albarino CG, 2016, VIROLOGY, V496, P237, DOI 10.1016/j.virol.2016.06.011; Alexander KA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003652; Arias A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew016; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bausch DG, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003056; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Bivand R., 2016, TOOLS READING HANDLI; BOWEN ETW, 1977, LANCET, V1, P571; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; CDC, 2016, OUTBR CHRON EB VIR D; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; de La Vega MA, 2015, J CLIN INVEST, V125, P4421, DOI 10.1172/JCI83162; Diehl WE, 2008, J VIROL, V82, P11140, DOI 10.1128/JVI.00269-08; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; Dunham EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9000; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 1995, VIRUS RES, V39, P129, DOI 10.1016/0168-1702(95)00080-1; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Hayman DTS, 2012, EMERG INFECT DIS, V18, P1207, DOI 10.3201/eid1807.111654; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; JOHNSON KM, 1977, LANCET, V1, P569; Kaletsky RL, 2007, J VIROL, V81, P13378, DOI 10.1128/JVI.01170-07; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Krishnan A, 2012, VIRUSES-BASEL, V4, P2471, DOI 10.3390/v4112471; Kugelman JR, 2015, EMERG INFECT DIS, V21, P1135, DOI 10.3201/eid2107.150522; Kuhn JH, 2010, ARCH VIROL, V155, P2083, DOI 10.1007/s00705-010-0814-x; Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Li J, 2016, INT J INFECT DIS, V42, P34, DOI 10.1016/j.ijid.2015.10.021; Li WH, 2005, EMBO J, V24, P1634, DOI 10.1038/sj.emboj.7600640; Manicassamy B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-75; Marzi A, 2015, EMERG INFECT DIS, V21, P1777, DOI 10.3201/eid2110.150259; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Negre D, 2000, GENE THER, V7, P1613, DOI 10.1038/sj.gt.3301292; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08; PATTYN S, 1977, LANCET, V1, P573; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; R Development Core Team, 2009, R LANG ENV STAT COMP; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Reinhard C, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-12; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612; Smither SJ, 2016, J INFECT DIS, V214, pS268, DOI 10.1093/infdis/jiw145; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Tscherne DM, 2010, J VIROL METHODS, V163, P336, DOI 10.1016/j.jviromet.2009.10.020; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013; Volchkov VE, 2001, SCIENCE, V291, P1965, DOI 10.1126/science.1057269; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; World Health Organisation, 2016, EB SIT REP 30 MARCH; Xu R, 2010, J VIROL, V84, P1715, DOI 10.1128/JVI.02162-09; Zhang XY, 2002, MOL THER, V5, P555, DOI 10.1006/mthe.2002.0585; Zhao YG, 2016, FEBS LETT, V590, P605, DOI 10.1002/1873-3468.12089	79	121	126	1	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					1088	+		10.1016/j.cell.2016.10.014	http://dx.doi.org/10.1016/j.cell.2016.10.014			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814506	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000389469000024
J	Fowler, MG; Qin, M; Fiscus, SA; Currier, JS; Flynn, PM; Chipato, T; McIntyre, J; Gnanashanmugam, D; Siberry, GK; Coletti, AS; Taha, TE; Klingman, KL; Martinson, FE; Owor, M; Violari, A; Moodley, D; Theron, GB; Bhosale, R; Bobat, R; Chi, BH; Strehlau, R; Mlay, P; Loftis, AJ; Browning, R; Fenton, T; Purdue, L; Basar, M; Shapiro, DE; Mofenson, LM				Fowler, M. G.; Qin, M.; Fiscus, S. A.; Currier, J. S.; Flynn, P. M.; Chipato, T.; McIntyre, J.; Gnanashanmugam, D.; Siberry, G. K.; Coletti, A. S.; Taha, T. E.; Klingman, K. L.; Martinson, F. E.; Owor, M.; Violari, A.; Moodley, D.; Theron, G. B.; Bhosale, R.; Bobat, R.; Chi, B. H.; Strehlau, R.; Mlay, P.; Loftis, A. J.; Browning, R.; Fenton, T.; Purdue, L.; Basar, M.; Shapiro, D. E.; Mofenson, L. M.		IMPAACT 1077BF 1077FF PROMISE Stud	Benefits and Risks of Antiretroviral Therapy for Perinatal HIV Prevention	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; ADVERSE BIRTH OUTCOMES; INFECTED WOMEN; PROGESTERONE LEVELS; LOPINAVIR EXPOSURE; PRETERM DELIVERY; CHILD-MORTALITY; PREGNANCY; PROTEASE; LOPINAVIR/RITONAVIR	BACKGROUND Randomized-trial data on the risks and benefits of antiretroviral therapy (ART) as compared with zidovudine and single-dose nevirapine to prevent transmission of the human immunodeficiency virus (HIV) in HIV-infected pregnant women with high CD4 counts are lacking. METHODS We randomly assigned HIV-infected women at 14 or more weeks of gestation with CD4 counts of at least 350 cells per cubic millimeter to zidovudine and single-dose nevirapine plus a 1-to-2-week postpartum "tail" of tenofovir and emtricitabine (zidovudine alone); zidovudine, lamivudine, and lopinavir-ritonavir (zidovudine-based ART); or tenofovir, emtricitabine, and lopinavir-ritonavir (tenofovir-based ART). The primary outcomes were HIV transmission at 1 week of age in the infant and maternal and infant safety. RESULTS The median CD4 count was 530 cells per cubic millimeter among 3490 primarily black African HIV-infected women enrolled at a median of 26 weeks of gestation (interquartile range, 21 to 30). The rate of transmission was significantly lower with ART than with zidovudine alone (0.5% in the combined ART groups vs. 1.8%; difference, -1.3 percentage points; repeated confidence interval, -2.1 to -0.4). However, the rate of maternal grade 2 to 4 adverse events was significantly higher with zidovudine-based ART than with zidovudine alone (21.1% vs. 17.3%, P = 0.008), and the rate of grade 2 to 4 abnormal blood chemical values was higher with tenofovir-based ART than with zidovudine alone (2.9% vs. 0.8%, P = 0.03). Adverse events did not differ significantly between the ART groups (P > 0.99). A birth weight of less than 2500 g was more frequent with zidovudine-based ART than with zidovudine alone (23.0% vs. 12.0%, P < 0.001) and was more frequent with tenofovir-based ART than with zidovudine alone (16.9% vs. 8.9%, P = 0.004); preterm delivery before 37 weeks was more frequent with zidovudine-based ART than with zidovudine alone (20.5% vs. 13.1%, P < 0.001). Tenofovir-based ART was associated with higher rates than zidovudine-based ART of very preterm delivery before 34 weeks (6.0% vs. 2.6%, P = 0.04) and early infant death (4.4% vs. 0.6%, P = 0.001), but there were no significant differences between tenofovir-based ART and zidovudine alone (P = 0.10 and P = 0.43). The rate of HIV-free survival was highest among infants whose mothers received zidovudine-based ART. CONCLUSIONS Antenatal ART resulted in significantly lower rates of early HIV transmission than zidovudine alone but a higher risk of adverse maternal and neonatal outcomes. (Funded by the National Institutes of Health; PROMISE ClinicalTrials.gov numbers, NCT01061151 and NCT01253538.)	[Fowler, M. G.] Johns Hopkins Univ, Sch Med, Dept Pathol, 600 N Wolfe St,443 Carnegie, Baltimore, MD 21287 USA; [Taha, T. E.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gnanashanmugam, D.; Klingman, K. L.; Browning, R.; Purdue, L.] NIAID, Div Aids, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Siberry, G. K.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Qin, M.; Fenton, T.; Shapiro, D. E.] Harvard TH Chan Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA USA; [Fiscus, S. A.; Loftis, A. J.] Univ N Carolina, Sch Med, Retrovirol Core Lab, Chapel Hill, NC 27599 USA; [Coletti, A. S.] FHI 360, Durham, NC USA; [Currier, J. S.] Univ Calif Los Angeles, Ctr Clin AIDS Res & Educ, Los Angeles, CA USA; [Flynn, P. M.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Chipato, T.] Univ Zimbabwe, Coll Hlth Sci, Dept Obstet & Gynecol, Harare, Zimbabwe; [McIntyre, J.] Univ Witwatersrand, Fac Hlth Sci, Anova Hlth Inst, Perinatal HIV Res, Johannesburg, South Africa; [Violari, A.] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit, Johannesburg, South Africa; [Strehlau, R.] Empilweni Serv & Res Unit, Johannesburg, South Africa; [McIntyre, J.] Univ Cape Town, Sch Publ Hlth & Family Med, ZA-7700 Rondebosch, South Africa; [Theron, G. B.] Univ Stellenbosch, Dept Obstet & Gynaecol, Cape Town, South Africa; [Moodley, D.] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa Umlazi Clin R, Nelson R Mandela Sch Med, Durban, South Africa; [Bobat, R.] Univ KwaZulu Natal, Durban Paediat HIV, Nelson R Mandela Sch Med, Durban, South Africa; [Martinson, F. E.] Univ North Carolina Project Kamuzu Cent Hosp Tidz, Lilongwe, Malawi; [Owor, M.] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Bhosale, R.] BJ Med Coll, Dept Obstet & Gynecol, Pune, Maharashtra, India; [Chi, B. H.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Mlay, P.] Kilimanjaro Christian Med Center Duke Univ Collab, Moshi, Tanzania; [Basar, M.] Frontier Sci & Technol Res Fdn Inc, Amherst, NY USA; [Mofenson, L. M.] Elizabeth Glaser Pediat AIDS Fdn, Washington, DC USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; FHI 360; University of California System; University of California Los Angeles; St Jude Children's Research Hospital; University of Zimbabwe; University of Witwatersrand; University of Witwatersrand; University of Cape Town; Stellenbosch University; University of Kwazulu Natal; University of Kwazulu Natal; Makerere University; B.J. Govt. Medical College & Sassoon General Hospitals, Pune; Kilimanjaro Christian Medical Centre; Frontier Science Foundation	Fowler, MG (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, 600 N Wolfe St,443 Carnegie, Baltimore, MD 21287 USA.	mgfowler@mujhu.org	Mofenson, Lynne/P-9631-2019; Moodley, Dhayendre/U-6802-2019; Flynn, Patricia M/N-8146-2018; Strehlau, Renate/AAX-9074-2021	Mofenson, Lynne/0000-0002-2818-9808; Strehlau, Renate/0000-0001-9113-6584; Taha, Taha/0000-0001-9814-4894; Nematadzira, Teacler/0000-0003-4786-1396	National Institute of Allergy and Infectious Diseases of the NIH [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Mental Health; Janssen; Gilead Sciences; ViiV Healthcare; National Institute of Allergy and Infectious Diseases of the NIH [UM1AI068632, UM1AI068616, UM1AI106716]; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Mental Health; Janssen; Gilead Sciences; ViiV Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069424, UM1AI069453, UM1AI106716, UM1AI069518, UM1AI069463, UM1AI068616, UM1AI069436, UM1AI068632, UM1AI069530, UM1AI069536, P30AI050410, UM1AI069423] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Gilead Sciences(Gilead Sciences); ViiV Healthcare; National Institute of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Gilead Sciences(Gilead Sciences); ViiV Healthcare; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the National Institute of Allergy and Infectious Diseases of the NIH under award numbers UM1AI068632 (IMPAACT LOC), UM1AI068616 (IMPAACT SDMC), and UM1AI106716 (IMPAACT LC), with cofunding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institute of Mental Health.r Dr. Violari reports receiving consulting fees from Janssen and grant support from Gilead Sciences and ViiV Healthcare, all paid to her institution. No other potential conflict of interest relevant to this article was reported.	Caritis SN, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.008; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; CONNOR EM, 1994, NEW ENGL J MED, V331, P1173, DOI 10.1056/NEJM199411033311801; Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases, 2009, DIV AIDS RABL GRAD S; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Kearney BP, 2006, JAIDS-J ACQ IMM DEF, V43, P278, DOI 10.1097/01.qai.0000243103.03265.2b; Kiser JJ, 2008, CLIN PHARMACOL THER, V83, P265, DOI 10.1038/sj.clpt.6100269; Kourtis AP, 2011, J INFECT DIS, V204, P493, DOI 10.1093/infdis/jir318; Li N, 2016, J INFECT DIS, V213, P1057, DOI 10.1093/infdis/jiv389; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Marchant T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001292; Mirochnick M, 2008, JAIDS-J ACQ IMM DEF, V49, P485, DOI 10.1097/QAI.0b013e318186edd0; Mofenson LM, 2016, J INFECT DIS, V213, P1051, DOI 10.1093/infdis/jiv390; Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, 2016, RECOMMENDATIONS FOR; Papp E, 2016, J INFECT DIS, V213, P1532, DOI 10.1093/infdis/jiw004; Papp E, 2015, J INFECT DIS, V211, P10, DOI 10.1093/infdis/jiu393; Powis KM, 2015, J INFECT DIS, V211, P4, DOI 10.1093/infdis/jiu397; Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307; Pruvost A, 2009, ANTIMICROB AGENTS CH, V53, P1937, DOI 10.1128/AAC.01064-08; Sibiude J, 2012, CLIN INFECT DIS, V54, P1348, DOI 10.1093/cid/cis198; Stek AM, 2006, AIDS, V20, P1931, DOI 10.1097/01.aids.0000247114.43714.90; Taha TE, 2012, JAIDS-J ACQ IMM DEF, V61, P226, DOI 10.1097/QAI.0b013e3182618eea; Watts DH, 2013, J INFECT DIS, V207, P612, DOI 10.1093/infdis/jis728; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2021, ANT DRUGS TREAT PREG; Zash R, 2016, JAIDS-J ACQ IMM DEF, V71, P428, DOI 10.1097/QAI.0000000000000847	27	219	221	4	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1726	1737		10.1056/NEJMoa1511691	http://dx.doi.org/10.1056/NEJMoa1511691			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806243	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000387007300006
J	Hwang, TJ; Kesselheim, AS				Hwang, Thomas J.; Kesselheim, Aaron S.			Public referendum on drug prices in the US: will it bring relief?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Dept Med,Med, Boston, MA 02120 USA; Harvard Med Sch, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, Dept Med,Med, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666; Hwang, Thomas/0000-0003-0717-1497				Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Brennan T, 2014, JAMA-J AM MED ASSOC, V312, P593, DOI 10.1001/jama.2014.8897; California Public Employees Retirement System (CalPERS). Pension and health benefits committee, 2016, MEMORANDUM DRUG PRIC; Casassus B, 2015, LANCET, V385, P1279, DOI 10.1016/S0140-6736(15)60667-5; Chalkidou K, 2011, HEALTH ECON POLICY L, V6, P43, DOI 10.1017/S174413310999034X; Conti RM, 2016, NEW ENGL J MED, V374, P703, DOI 10.1056/NEJMp1515068; Cox C, 2016, JAMA-J AM MED ASSOC, V315, P1326, DOI [10.1001/jama.2016.2646, DOI 10.1001/JAMA.2016.2646]; European Commission, 2015, STUD ENH CROSS COUNT; European Commission, 2013, EXT REF PRIC MED PRO; Ghinea N, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1284; Hiltzik M., 2016, LOS ANGELES TIMES; Legislative Analyst's Office, 2016, HEAR HAND STAT PRESC; OECD, 2008, PHARM PRIC POL GLOB; Pharmacy Benefit Management Institute, 2016, PRESCR DRUG BEN COST; Prasad V, 2016, MAYO CLIN PROC, V91, P707, DOI 10.1016/j.mayocp.2016.04.028; Sarpatwari A, 2016, NEW ENGL J MED, V374, P2301, DOI 10.1056/NEJMp1605100; Somashekhar S, 2014, WASHINGTON POST; US Centers for Medicare and Medicaid Services, 2016, MED COV OUTP PRESCR; US Centers for Medicare and Medicaid Services, MED DRUG REB PROGR U; US Congressional Budget Office, 2005, PRIC BRAND NAM DRUGS; US Congressional Budget Office, 2007, PRESCR DRUG PRIC PRI; US Department of Veterans Affairs Health Economics Resource Center, 2016, DET COST PHARM COST; US Government Accountability Office, 2014, PRESCR DRUGS COMP D	23	6	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2016	355								i5657	10.1136/bmj.i5657	http://dx.doi.org/10.1136/bmj.i5657			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CM	27799143				2022-12-28	WOS:000387316800001
J	Lane, R				Lane, Richard			Profile Marc Feldmann: a trailblazer of modern immunology	LANCET			English	Biographical-Item																		FELDMANN M, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1973	1973		10.1016/S0140-6736(16)31857-8	http://dx.doi.org/10.1016/S0140-6736(16)31857-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27789011				2022-12-28	WOS:000385954800014
J	Ocampo, V; Haider, S				Ocampo, Vanessa; Haider, Shariq			Cutaneous Lupus - "The Pimple That Never Went Away"	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ocampo, Vanessa] Univ Toronto, Toronto, ON, Canada; [Haider, Shariq] McMaster Univ, Hamilton, ON, Canada	University of Toronto; McMaster University	Ocampo, V (corresponding author), Univ Toronto, Toronto, ON, Canada.	vanessa.ocampo@medportal.ca							0	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1566	1566		10.1056/NEJMicm1407057	http://dx.doi.org/10.1056/NEJMicm1407057			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3HF	27797305				2022-12-28	WOS:000393102500009
J	Ghinea, N; Lipworth, W; Day, R; Hill, A; Dore, GJ; Danta, M				Ghinea, Narcyz; Lipworth, Wendy; Day, Richard; Hill, Andrew; Dore, Gregory J.; Danta, Mark			Importation of generic hepatitis C therapies: bridging the gap between price and access in high-income countries	LANCET			English	Editorial Material							GENOTYPE 1 INFECTION; VIRUS-INFECTION; INJECT DRUGS; CHRONIC HCV; SOFOSBUVIR; RIBAVIRIN; ABT-450/R-OMBITASVIR; LEDIPASVIR; DASABUVIR; DACLATASVIR		[Ghinea, Narcyz; Lipworth, Wendy] Univ Sydney, Ctr Values Eth & Law Med, Med Fdn Bldg K25, Sydney, NSW 2006, Australia; [Day, Richard] St Vincents Hosp, Sch Clin, Clin Pharmacol & Toxicol Therapeut Ctr, Darlinghurst, NSW, Australia; [Danta, Mark] St Vincents Hosp, Sch Clin, Fac Med, Darlinghurst, NSW, Australia; [Hill, Andrew] St Stephens AIDS Trust, Chelsea & Westminster Hosp, London, England; [Dore, Gregory J.] UNSW Australia, Viral Hepatitis Clin Res Program, Kirby Inst, Sydney, NSW, Australia	University of Sydney; St Vincents Hospital Sydney; St Vincents Hospital Sydney; Imperial College London; University of New South Wales Sydney; Kirby Institute	Ghinea, N (corresponding author), Univ Sydney, Ctr Values Eth & Law Med, Med Fdn Bldg K25, Sydney, NSW 2006, Australia.	narcyz.ghinea@sydney.edu.au	Dore, Gregory John/ABD-5665-2021; Day, Richard/D-8699-2011	Dore, Gregory John/0000-0002-4741-2622; Day, Richard/0000-0002-6045-6937; Ghinea, Narcyz/0000-0002-1457-7252; Lipworth, Wendy/0000-0002-0234-657X	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funding through a grant from the National Health and Medical Research Council. The funding body had no role in the writing or decision to submit for publication.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; [Anonymous], 2015, REUTERS; Asselah T, 2011, LIVER INT; Australian Society of HIV and Hepatitis, 2015, IMP GEN HCV DRUGS; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Dickson N, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2043; Dore GJ, 2014, J VIRAL HEPATITIS, V21, P1, DOI 10.1111/jvh.12253; El-Serag HB, 2016, HEPATOLOGY, V64, P130, DOI 10.1002/hep.28535; Farwell J., 2015, BANGOR DAILY NE 0224; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Fick M, 2014, REUTERS; FixHepC, 2015, CUR HEP C SOF LED DA; Freeman J, 2016, INT LIV C BARC; Gilead sciences, 2015, GIL SCI ANN 4 QUART; Gilead sciences, 2016, GIL SCI ANN 4 QUART; Gotham D, 2016, INT AIDS C DURB; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Grebely J, 2014, ANTIVIR RES, V104, P62, DOI 10.1016/j.antiviral.2014.01.002; Hill A, 2016, J VIRUS ERAD, V2, P28; Hoen E., 2014, ACCESS CANC TREATMEN; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Leroy V, 2016, HEPATOLOGY, V63, P1430, DOI 10.1002/hep.28473; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Martin NK, 2013, HEPATOLOGY, V58, P1598, DOI 10.1002/hep.26431; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Medicines Patet Pool, 2015, MPP LIC DACL DCV; Minister for Health, 2015, TURNB GOV INV 1 BILL; NHS England, 2015, 1000 MOR PAT BE CUR; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; 't Hoen EFM, 2016, LANCET, V387, P2272, DOI 10.1016/S0140-6736(16)30656-0; The Kirby Institute, 2016, HEP B C AUSTR ANN SU; Therapeutic Goods Administration, 2016, WARN LETT PROM PRESC; United States Senate Committee on Finance, 2015, WYD GRASSL SOV INV F; US Food and Drug Administration, 2015, IMP OF DRUGS; Weisman R., 2016, BOSTON GLOBE; WHO, 2015, WHO MOV IMPR ACC LIF; World Health Organization, 2015, 19 WHO MOD LIST ESS; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785	44	28	29	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1268	1272		10.1016/S0140-6736(16)32051-7	http://dx.doi.org/10.1016/S0140-6736(16)32051-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	27832868				2022-12-28	WOS:000397143700038
J	Bretthauer, M; Kaminski, MF; Hassan, C; Kalager, M; Holme, O; Hoff, G; Loberg, M; Regula, J; Castells, A; Adami, HO				Bretthauer, Michael; Kaminski, Michal F.; Hassan, Cesare; Kalager, Mette; Holme, Oyvind; Hoff, Geir; Loberg, Magnus; Regula, Jaroslaw; Castells, Antoni; Adami, Hans-Olov			America, We Are Confused: The Updated US Preventive Services Task Force Recommendation on Colorectal Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RANDOMIZED CLINICAL-TRIAL; COLONOSCOPY; SIGMOIDOSCOPY		Univ Oslo, Oslo Univ Hosp, Oslo, Norway; Canc Registry Norway, Oslo, Norway; Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; Inst Oncol, Warsaw, Poland; Nuovo Regina Margherita Hosp, Rome, Italy; Sorlandet Hosp, Kristiansand, Norway; Telemark Hosp, Skien, Norway; Hosp Clin Barcelona, Barcelona, Spain; Karolinska Inst, Stockholm, Sweden; [Bretthauer, Michael; Holme, Oyvind; Loberg, Magnus; Adami, Hans-Olov] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, POB 1089 Blindern, N-0316 Oslo, Norway; [Bretthauer, Michael; Holme, Oyvind; Loberg, Magnus; Adami, Hans-Olov] Univ Oslo, Inst Hlth & Soc, Dept Transplantat Med, POB 1089 Blindern, N-0316 Oslo, Norway; [Bretthauer, Michael; Holme, Oyvind; Loberg, Magnus; Adami, Hans-Olov] Univ Oslo, KG Jebsen Ctr Colorectal Canc, POB 1089 Blindern, N-0316 Oslo, Norway; [Kaminski, Michal F.; Regula, Jaroslaw] Maria Sklodowska Curie Mem Canc Ctr, Dept Gastroenterol Oncol & Canc Prevent, Roentgen St 5, PL-02781 Warsaw, Poland; [Hassan, Cesare] Nuovo Regina Margherita Hosp, Dept Gastroenterol, Via Morosini 30, I-00153 Rome, Italy; [Kalager, Mette] Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, POB 1072 Blindern, N-0316 Oslo, Norway; [Kalager, Mette] Univ Oslo, Inst Hlth & Soc, Dept Transplantat Med, POB 1072 Blindern, N-0316 Oslo, Norway; [Kalager, Mette] Univ Oslo, KG Jebsen Ctr Colorectal Canc, POB 1072 Blindern, N-0316 Oslo, Norway; [Hoff, Geir] Telemark Hosp, Dept Res, Vindalskroken 17, N-3728 Skien, Norway; [Castells, Antoni] Hosp Clin Barcelona, Inst Digest & Metab, Villarroel 170, Barcelona 08036, Spain	University of Oslo; University of Oslo; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Poliambulatorio Nuovo Regina Margherita; Telemark Hospital Trust; University of Barcelona; Hospital Clinic de Barcelona; Karolinska Institutet; University of Oslo; University of Oslo; University of Oslo; Maria Sklodowska-Curie National Research Institute of Oncology; Poliambulatorio Nuovo Regina Margherita; University of Oslo; University of Oslo; University of Oslo; Telemark Hospital Trust; University of Barcelona; Hospital Clinic de Barcelona	Bretthauer, M (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Hlth Management & Hlth Econ, POB 1089 Blindern, N-0316 Oslo, Norway.; Bretthauer, M (corresponding author), Univ Oslo, Inst Hlth & Soc, Dept Transplantat Med, POB 1089 Blindern, N-0316 Oslo, Norway.; Bretthauer, M (corresponding author), Univ Oslo, KG Jebsen Ctr Colorectal Canc, POB 1089 Blindern, N-0316 Oslo, Norway.		Kaminski, Michal F./AFN-3411-2022; Castells, Antoni/ABC-1002-2021; hassan, cesare/H-2844-2012; Loberg, Magnus/F-1152-2016	Castells, Antoni/0000-0001-8431-2033; hassan, cesare/0000-0001-7167-1459; Loberg, Magnus/0000-0003-2231-1304; Kaminski, Michal/0000-0002-9714-6457; Regula, Jaroslaw/0000-0001-7071-3151				Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989; Bretthauer M, 2016, JAMA INTERN MED, V176, P894, DOI 10.1001/jamainternmed.2016.0960; Holme O, 2014, JAMA-J AM MED ASSOC, V312, P606, DOI 10.1001/jama.2014.8266; Kaminski MF, 2015, ENDOSCOPY, V47, P1144, DOI 10.1055/s-0034-1392769; Pitkaniemi J, 2015, BMJ OPEN GASTROENTER, V2, DOI 10.1136/bmjgast-2015-000034; Quintero E, 2012, NEW ENGL J MED, V366, P697, DOI [10.1056/NEJMoa1108895, 10.1056/NEJMx150040]; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; von Karsa L., 2011, EUROPEAN GUIDELINES, V1st, DOI [10.2772/15379, DOI 10.2772/15379]	8	8	8	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					139	+		10.7326/M16-1805	http://dx.doi.org/10.7326/M16-1805			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	27820949				2022-12-28	WOS:000391842600019
J	Cuk, M; Hamilton, DP; Lock, SJ; Stewart, ST				Cuk, Matija; Hamilton, Douglas P.; Lock, Simon J.; Stewart, Sarah T.			Tidal evolution of the Moon from a high-obliquity, high - angular - momentum Earth	NATURE			English	Article							GIANT IMPACT; LUNAR; ORIGIN; ECCENTRICITY; INCLINATION; SYSTEM; OCEAN	In the giant-impact hypothesis for lunar origin, the Moon accreted from an equatorial circum-terrestrial disk; however, the current lunar orbital inclination of five degrees requires a subsequent dynamical process that is still unclear(1-3). In addition, the giant impact theory has been challenged by the Moon's unexpectedly Earth-like isotopic composition(4,5). Here we show that tidal dissipation due to lunar obliquity was an important effect during the Moon's tidal evolution, and the lunar inclination in the past must have been very large, defying theoretical explanations. We present a tidal evolution model starting with the Moon in an equatorial orbit around an initially fast-spinning, high-obliquity Earth, which is a probable outcome of giant impacts. Using numerical modelling, we show that the solar perturbations on the Moon's orbit naturally induce a large lunar inclination and remove angular momentum from the Earth-Moon system. Our tidal evolution model supports recent high-angular-momentum, giant-impact scenarios to explain the Moon's isotopic composition(6-8) and provides a new pathway to reach Earth's climatically favourable low obliquity.	[Cuk, Matija] SETI Inst, Carl Sagan Ctr, 189 North Bernardo Ave, Mountain View, CA 94043 USA; [Hamilton, Douglas P.] Univ Maryland, Dept Astron, Phys Sci Complex, College Pk, MD 20742 USA; [Lock, Simon J.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA; [Stewart, Sarah T.] Univ Calif Davis, Dept Earth & Planetary Sci, One Shields Ave, Davis, CA 95616 USA	University System of Maryland; University of Maryland College Park; Harvard University; University of California System; University of California Davis	Cuk, M (corresponding author), SETI Inst, Carl Sagan Ctr, 189 North Bernardo Ave, Mountain View, CA 94043 USA.	mcuk@seti.org		Cuk, Matija/0000-0003-1226-7960; Lock, Simon/0000-0001-5365-9616; Stewart, Sarah/0000-0001-9606-1593	NASA [NNX15AH65G]	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA's Emerging Worlds programme, award NNX15AH65G.	Atobe K, 2007, ICARUS, V188, P1, DOI 10.1016/j.icarus.2006.11.022; Burkhardt C., 2015, ISTOTOPIC COMPOSITIO, P1; Cameron A. G. W., 1976, LUNAR SCI, V7, P120; Canup RM, 2001, NATURE, V412, P708, DOI 10.1038/35089010; Canup RM, 2012, SCIENCE, V338, P1052, DOI 10.1126/science.1226073; Chen EMA, 2016, ICARUS, V275, P132, DOI 10.1016/j.icarus.2016.04.012; CHYBA CF, 1989, ASTRON ASTROPHYS, V219, pL23; Cuk M, 2012, SCIENCE, V338, P1047, DOI 10.1126/science.1225542; Garrick-Bethell I, 2006, SCIENCE, V313, P652, DOI 10.1126/science.1128237; GOLDREIC.P, 1966, REV GEOPHYS, V4, P411, DOI 10.1029/RG004i004p00411; Keane JT, 2014, GEOPHYS RES LETT, V41, P6610, DOI 10.1002/2014GL061195; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Lock S.J., 2016, LUNAR PLANET SCI C, P2881; Meier MMM, 2012, NAT GEOSCI, V5, P240, DOI 10.1038/ngeo1434; Melosh HJ, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2013.0168; Nicholson P. D., 2008, IRREGULAR SATELLITES, P411; Pahlevan K, 2007, EARTH PLANET SC LETT, V262, P438, DOI 10.1016/j.epsl.2007.07.055; Pahlevan K, 2015, NATURE, V527, P492, DOI 10.1038/nature16137; Rubincam DP, 2016, ICARUS, V266, P24, DOI 10.1016/j.icarus.2015.10.024; Tamayo D, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/3/54; TOUMA J, 1994, ASTRON J, V108, P1943, DOI 10.1086/117209; Touma J, 1998, ASTRON J, V115, P1653, DOI 10.1086/300312; Tremaine S, 2009, ASTRON J, V137, P3706, DOI 10.1088/0004-6256/137/3/3706; Tyler RH, 2008, NATURE, V456, P770, DOI 10.1038/nature07571; Ward WR, 2000, NATURE, V403, P741, DOI 10.1038/35001516; WARD WR, 1975, SCIENCE, V189, P377, DOI 10.1126/science.189.4200.377; Wisdom J, 2015, ICARUS, V256, P138, DOI 10.1016/j.icarus.2015.02.025; Young ED, 2016, SCIENCE, V351, P493, DOI 10.1126/science.aad0525	30	53	53	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					402	406		10.1038/nature19846	http://dx.doi.org/10.1038/nature19846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27799656	Green Submitted			2022-12-28	WOS:000388161700048
J	Schonenberger, S; Uhlmann, L; Hacke, W; Schieber, S; Mundiyanapurath, S; Purrucker, JC; Nagel, S; Klose, C; Pfaff, J; Bendszus, M; Ringleb, PA; Kieser, M; Mohlenbruch, MA; Bosel, J				Schoenenberger, Silvia; Uhlmann, Lorenz; Hacke, Werner; Schieber, Simon; Mundiyanapurath, Sibu; Purrucker, Jan C.; Nagel, Simon; Klose, Christina; Pfaff, Johannes; Bendszus, Martin; Ringleb, Peter A.; Kieser, Meinhard; Moehlenbruch, Markus A.; Boesel, Julian			Effect of Conscious Sedation vs General Anesthesia on Early Neurological Improvement Among Patients With Ischemic Stroke Undergoing Endovascular Thrombectomy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MECHANICAL THROMBECTOMY; CONSENSUS STATEMENT; MANAGEMENT; THERAPY; INTUBATION; METAANALYSIS; OUTCOMES; UPDATE; IMPACT; SCALE	IMPORTANCE Optimal management of sedation and airway during thrombectomy for acute ischemic stroke is controversial due to lack of evidence from randomized trials. OBJECTIVE To assess whether conscious sedation is superior to general anesthesia for early neurological improvement among patients receiving stroke thrombectomy. DESIGN, SETTING, AND PARTICIPANTS SIESTA (Sedation vs Intubation for Endovascular Stroke Treatment), a single-center, randomized, parallel-group, open-label treatment trial with blinded outcome evaluation conducted at Heidelberg University Hospital in Germany (April 2014-February 2016) included 150 patients with acute ischemic stroke in the anterior circulation, higher National Institutes of Health Stroke Scale (NIHSS) score (>10), and isolated/combined occlusion at any level of the internal carotid or middle cerebral artery. INTERVENTION Patients were randomly assigned to an intubated general anesthesia group (n = 73) or a nonintubated conscious sedation group (n = 77) during stroke thrombectomy. MAIN OUTCOMES AND MEASURES Primary outcome was early neurological improvement on the NIHSS after 24 hours (0-42 [none to most severe neurological deficits; a 4-point difference considered clinically relevant]). Secondary outcomes were functional outcome by modified Rankin Scale (mRS) after 3 months (0-6 [symptom free to dead]), mortality, and peri-interventional parameters of feasibility and safety. RESULTS Among 150 patients (60 women [40%]; mean age, 71.5 years; median NIHSS score, 17), primary outcome was not significantly different between the general anesthesia group (mean NIHSS score, 16.8 at admission vs 13.6 after 24 hours; difference, -3.2 points [95% CI, -5.6 to -0.8]) vs the conscious sedation group (mean NIHSS score, 17.2 at admission vs 13.6 after 24 hour; difference, -3.6 points [95% CI, -5.5 to -1.7]); mean difference between groups, -0.4 (95% CI, -3.4 to 2.7; P = .82). Of 47 prespecified secondary outcomes analyzed, 41 showed no significant differences. In the general anesthesia vs the conscious sedation group, substantial patient movement was less frequent (0% vs 9.1%; difference, 9.1%; P = .008), but postinterventional complications were more frequent for hypothermia (32.9% vs 9.1%; P < .001), delayed extubation (49.3% vs 6.5%; P < .001), and pneumonia (13.7% vs 3.9%; P = .03). More patients were functionally independent (unadjusted mRS score, 0 to 2 after 3 months [37.0% in the general anesthesia group vs 18.2% in the conscious sedation group P = .01]). There were no differences in mortality at 3 months (24.7% in both groups). CONCLUSIONS AND RELEVANCE Among patients with acute ischemic stroke in the anterior circulation undergoing thrombectomy, conscious sedation vs general anesthesia did not result in greater improvement in neurological status at hours. The study do not support an advantage for the use of conscious sedation.	[Schoenenberger, Silvia; Hacke, Werner; Schieber, Simon; Mundiyanapurath, Sibu; Purrucker, Jan C.; Nagel, Simon; Ringleb, Peter A.; Boesel, Julian] Univ Heidelberg Hosp, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany; [Uhlmann, Lorenz; Klose, Christina; Kieser, Meinhard] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Pfaff, Johannes; Bendszus, Martin; Moehlenbruch, Markus A.] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Bosel, J (corresponding author), Univ Heidelberg Hosp, Dept Neurol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	julian.boesel@med.uni-heidelberg.de	Uhlmann, Lorenz/AAL-9839-2020; Hacke, Werner/ABE-8661-2020; Pfaff, Johannes Alex Rolf/P-6272-2019; Demchuk, Andrew M/E-1103-2012; Nagel, Simon/AAB-9266-2022	Pfaff, Johannes Alex Rolf/0000-0003-0672-5718; Demchuk, Andrew M/0000-0002-4930-7789; Nagel, Simon/0000-0003-2471-6647; Mundiyanapurath, Sibu/0000-0003-4637-4641	Julian Bosel	Julian Bosel	The study was performed with departmental funding only. No external funding was available. The cost for the statistical analysis of the Institute of Biometry and Informatics ((sic) 6000 in total) were financed by personal research funds of Julian Bosel.	Abou-Chebl A, 2010, STROKE, V41, P1175, DOI 10.1161/STROKEAHA.109.574129; ABT K, 1987, METHOD INFORM MED, V26, P77; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Berkhemer OA, 2016, NEUROLOGY, V87, P656, DOI 10.1212/WNL.0000000000002976; Bracard S, 2016, LANCET NEUROL, V15, P1138, DOI 10.1016/S1474-4422(16)30177-6; Brinjikji W, 2015, AM J NEURORADIOL, V36, P525, DOI 10.3174/ajnr.A4159; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Davis MJ, 2012, ANESTHESIOLOGY, V116, P396, DOI 10.1097/ALN.0b013e318242a5d2; EDWARDS DF, 1995, STROKE, V26, P1852, DOI 10.1161/01.STR.26.10.1852; Emiru Tenbit, 2014, J Vasc Interv Neurol, V7, P30; Friede T, 2011, PHARM STAT, V10, P8, DOI 10.1002/pst.398; Froehler MT, 2012, NEUROLOGY, V79, pS167, DOI 10.1212/WNL.0b013e31826959c2; Furlan AJ, 2015, NEW ENGL J MED, V372, P2347, DOI 10.1056/NEJMe1503217; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; GUENTHER WC, 1981, AM STAT, V35, P243, DOI 10.2307/2683297; Hassan AE, 2013, AM J NEURORADIOL, V34, P1375, DOI 10.3174/ajnr.A3385; Hassan AE, 2012, NEUROCRIT CARE, V16, P246, DOI 10.1007/s12028-011-9638-0; Henden PL, 2015, STROKE, V46, P2678, DOI 10.1161/STROKEAHA.115.009808; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Langner S, 2013, ROFO-FORTSCHR RONTG, V185, P320, DOI 10.1055/s-0032-1330361; Li FH, 2014, J NEUROSURG ANESTH, V26, P286, DOI 10.1097/ANA.0000000000000031; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; McDonagh David L, 2010, Front Neurol, V1, P118, DOI 10.3389/fneur.2010.00118; McDonald JS, 2015, J NEUROINTERV SURG, V7, P789, DOI 10.1136/neurintsurg-2014-011373; Mundiyanapurath S, 2016, J NEUROINTERV SURG, V8, P335, DOI 10.1136/neurintsurg-2014-011523; Nam HS, 2009, J NEUROL SCI, V281, P69, DOI 10.1016/j.jns.2009.02.365; Nichols C, 2010, J NEUROINTERV SURG, V2, P67, DOI 10.1136/jnis.2009.001768; Nikoubashman O, 2016, AM J NEURORADIOL, V37, P1074, DOI 10.3174/ajnr.A4680; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Schonenberger S, 2015, INT J STROKE, V10, P969, DOI 10.1111/ijs.12488; Singer OC, 2015, ANN NEUROL, V77, P415, DOI 10.1002/ana.24336; Spilker J, 1997, J Neurosci Nurs, V29, P384; Takahashi C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00170; Talke PO, 2014, J NEUROSURG ANESTH, V26, P95, DOI 10.1097/ANA.0000000000000042; Tomsick T, 2008, AM J NEURORADIOL, V29, P582, DOI 10.3174/ajnr.A0843; Wahlgren N, 2016, INT J STROKE, V11, P134, DOI 10.1177/1747493015609778; Wilson JTL, 2002, STROKE, V33, P2243, DOI 10.1161/01.STR.0000027437.22450.BD	40	282	296	2	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1986	1996		10.1001/jama.2016.16623	http://dx.doi.org/10.1001/jama.2016.16623			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27785516	Bronze			2022-12-28	WOS:000387673800017
J	Wise, J				Wise, Jacqui			High intensity statins are associated with greatest reduction in mortality	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Bonow RO, 2016, JAMA CARDIOL     NOV, DOI [10.1001/jamacardio.2016.29118, DOI 10.1001/JAMACARDIO.2016.29118]; Rodriguez F, 2017, JAMA CARDIOL, V2, P47, DOI 10.1001/jamacardio.2016.4052	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2016	355								i6048	10.1136/bmj.i6048	http://dx.doi.org/10.1136/bmj.i6048			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CV	27834276				2022-12-28	WOS:000388003200009
J	Voelker, R				Voelker, Rebecca			Older Adults' Falls Take High Toll	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1860	1860		10.1001/jama.2016.15623	http://dx.doi.org/10.1001/jama.2016.15623			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27825015				2022-12-28	WOS:000387116500006
J	Evrony, GD				Evrony, Gilad D.			One brain, many genomes	SCIENCE			English	Editorial Material							COPY-NUMBER VARIATION; SINGLE-CELL; SOMATIC MOSAICISM; HUMAN NEURONS; MUTATION; EXPRESSIVITY; TECHNOLOGIES; EVOLUTION; DISEASE; GENE		[Evrony, Gilad D.] Harvard Med Sch, Boston, MA 02115 USA; [Evrony, Gilad D.] Mt Sinai Hosp, New York, NY 10029 USA	Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Evrony, GD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Evrony, GD (corresponding author), Mt Sinai Hosp, New York, NY 10029 USA.	g.evrony@gmail.com		Evrony, Gilad/0000-0001-7621-2630	NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alzualde A, 2010, AM J MED GENET B, V153B, P1283, DOI 10.1002/ajmg.b.31099; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Cai XY, 2014, CELL REP, V8, P1280, DOI 10.1016/j.celrep.2014.07.043; Castronovo P, 2010, CLIN GENET, V78, P560, DOI 10.1111/j.1399-0004.2010.01408.x; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Depienne C, 2010, J MED GENET, V47, P404, DOI 10.1136/jmg.2009.074328; Evrony GD, 2016, ELIFE, V5, DOI 10.7554/eLife.12966; Evrony GD, 2015, NEURON, V85, P49, DOI 10.1016/j.neuron.2014.12.028; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gleeson JG, 2000, AM J HUM GENET, V67, P574, DOI 10.1086/303043; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Lodato MA, 2015, SCIENCE, V350, P94, DOI 10.1126/science.aab1785; McConnell MJ, 2013, SCIENCE, V342, P632, DOI 10.1126/science.1243472; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Poduri A, 2013, SCIENCE, V341, P43, DOI 10.1126/science.1237758; Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Topcu M, 2002, EUR J HUM GENET, V10, P77, DOI 10.1038/sj.ejhg.5200745; Wang JB, 2012, CELL, V150, P402, DOI 10.1016/j.cell.2012.06.030; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005	21	8	8	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					557	558		10.1126/science.aak9761	http://dx.doi.org/10.1126/science.aak9761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811258	Green Accepted			2022-12-28	WOS:000386869800025
J	Miller, G				Miller, Greg			POT AND PAIN	SCIENCE			English	Editorial Material																			0	7	7	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					566	568		10.1126/science.354.6312.566	http://dx.doi.org/10.1126/science.354.6312.566			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811265				2022-12-28	WOS:000386869800034
J	Loeb, A				Loeb, Avi			Good data are not enough	NATURE			English	Editorial Material									[Loeb, Avi] Harvard Univ, Dept Astron, Cambridge, MA 02138 USA	Harvard University	Loeb, A (corresponding author), Harvard Univ, Dept Astron, Cambridge, MA 02138 USA.	aloeb@cfa.harvard.edu						Anglada-Escude G, 2016, NATURE, V536, P437, DOI 10.1038/nature19106; Bousso R, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.063510; Dressing CD, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/45; Guillochon J, 2015, ASTROPHYS J LETT, V811, DOI 10.1088/2041-8205/811/2/L20; Hawking SW, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.231301; Loeb A, 2016, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2016/08/040; VILENKIN A, 1995, PHYS REV LETT, V74, P846, DOI 10.1103/PhysRevLett.74.846; WEINBERG S, 1987, PHYS REV LETT, V59, P2607, DOI 10.1103/PhysRevLett.59.2607	8	4	4	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					23	25		10.1038/539023a	http://dx.doi.org/10.1038/539023a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808212	Bronze			2022-12-28	WOS:000386670100053
J	Chang, Z; Lichtenstein, P; Langstrom, N; Larsson, H; Fazel, S				Chang, Zheng; Lichtenstein, Paul; Langstrom, Niklas; Larsson, Henrik; Fazel, Seena			Association Between Prescription of Major Psychotropic Medications and Violent Reoffending After Prison Release	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; MENTAL-ILLNESS; PSYCHIATRIC-DISORDERS; BIPOLAR DISORDER; SUBSTANCE-ABUSE; SCHIZOPHRENIA; CRIMINALITY; POPULATION; RECIDIVISM; REDUCTION	IMPORTANCE Individuals released from prison have high rates of violent reoffending, and there is uncertainty about whether pharmacological treatments reduce reoffending risk. OBJECTIVE To investigate the associations between major classes of psychotropic medications and violent reoffending. DESIGN, SETTING, AND PARTICIPANTS This cohort study included all released prisoners in Sweden from July 1, 2005, to December 31, 2010, through linkage of population-based registers. Rates of violent reoffending during medicated periods were compared with rates during nonmedicated periods using within-individual analyses. Follow-up ended December 31, 2013. EXPOSURES Periods with or without dispensed prescription of psychotropic medications (antipsychotics, antidepressants, psychostimulants, drugs used in addictive disorders, and antiepileptic drugs) after prison release. Prison-based psychological treatments were investigated as a secondary exposure. MAIN OUTCOMES AND MEASURES Violent crime after release from prison. RESULTS The cohort included 22 275 released prisoners (mean [SD] age, 38 [13] years; 91.9% male). During follow-up (median, 4.6 years; interquartile range, 3.0-6.4 years), 4031 individuals (18.1%) had 5653 violent reoffenses. The within-individual hazard ratio (HR) associated with dispensed antipsychotics was 0.58 (95% CI, 0.39-0.88), based on 100 events in 1596 person-years during medicated periods and 1044 events in 11 026 person-years during nonmedicated periods, equating to a risk difference of 39.7 (95% CI, 11.3-57.7) fewer violent reoffenses per 1000 person-years. The within-individual HR associated with dispensed psychostimulants was 0.62 (95% CI, 0.40-0.98), based on 94 events in 1648 person-years during medicated periods and 513 events in 4553 person-years during nonmedicated periods, equating to a risk difference of 42.8 (95% CI, 2.2-67.6) fewer violent reoffenses per 1000 person-years. The within-individual HR associated with dispensed drugs for addictive disorders was 0.48 (95% CI, 0.23-0.97), based on 46 events in 1168 person-years during medicated periods and 1103 events in 15 725 person-years during nonmedicated periods, equating to a risk difference of 36.4 (95% CI, 2.1-54.0) fewer violent reoffenses per 1000 person-years. In contrast, antidepressants and antiepileptics were not significantly associated with violent reoffending rates (HR = 1.09 [95% CI, 0.83-1.43] and 1.14 [95% CI, 0.79-1.65], respectively). The most common prison-based program was psychological treatments for substance abuse, associated with an HR of 0.75 (95% CI, 0.63-0.89), which equated to a risk difference of 23.2 (95% CI, 10.3-34.1) fewer violent reoffenses per 1000 person-years. CONCLUSIONS AND RELEVANCE Among released prisoners in Sweden, rates of violent reoffending were lower during periods when individiduals were dispensed antipsychotics, psychostimulants, and drugs for addictive disorders, compared with periods in which they were not dispensed these medications. Further research is needed to understand the causal nature of this association.	[Chang, Zheng; Lichtenstein, Paul; Langstrom, Niklas; Larsson, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chang, Zheng; Fazel, Seena] Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England; [Langstrom, Niklas] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Larsson, Henrik] Univ Orebro, Sch Med Sci, Orebro, Sweden	Karolinska Institutet; University of Oxford; Uppsala University; Orebro University	Fazel, S (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	seena.fazel@psych.ox.ac.uk	Fazel, Seena/B-5307-2008; Langstrom, Niklas/C-5615-2009; Larsson, Henrik/GYD-5161-2022	Fazel, Seena/0000-0002-5383-5365; Langstrom, Niklas/0000-0002-2686-6799; 	Wellcome Trust [095806]; Swedish Research Council [2011-2492, 2013-2280]; Swedish Research Council for Health, Working Life and Welfare [2012-1678, 2014-2780]; Swedish Initiative for Research on Microdata in the Social and Medical Sciences [340-2013-5867]; European Union [602768]; National Institute of Mental Health [1R01MH102221]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH102221] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Initiative for Research on Microdata in the Social and Medical Sciences; European Union(European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the Wellcome Trust (095806), the Swedish Research Council (2011-2492 and 2013-2280), the Swedish Research Council for Health, Working Life and Welfare (2012-1678 and 2014-2780), the Swedish Initiative for Research on Microdata in the Social and Medical Sciences (340-2013-5867), the European Union Seventh Framework Programme (602768), and the National Institute of Mental Health (1R01MH102221).	Andrews DA, 2010, PSYCHOLOGY OF CRIMINAL CONDUCT, 5TH EDITION, P1; [Anonymous], WORLD PRISON POPULAT; [Anonymous], 1999, PRISON J, DOI DOI 10.1177/0032885599079004003; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Brennan PA, 2000, ARCH GEN PSYCHIAT, V57, P494, DOI 10.1001/archpsyc.57.5.494; Bulloch AGM, 2010, SOC PSYCH PSYCH EPID, V45, P47, DOI 10.1007/s00127-009-0041-5; Chandler RK, 2009, JAMA-J AM MED ASSOC, V301, P183, DOI 10.1001/jama.2008.976; Chang Z, 2015, LANCET PSYCHIAT, V2, P891, DOI 10.1016/S2215-0366(15)00234-5; Chang Z, 2014, JAMA PSYCHIAT, V71, P319, DOI 10.1001/jamapsychiatry.2013.4174; Chang Z, 2013, JAMA PSYCHIAT, V70, P311, DOI 10.1001/jamapsychiatry.2013.287; Coid JW, 2013, JAMA PSYCHIAT, V70, P465, DOI 10.1001/jamapsychiatry.2013.12; Cooper Alexia D, RECIDIVISM PRISONERS; Correctional Service Canada, OFF REH CORR PROGR; Dailey LF, 2005, J CLIN PSYCHIAT, V66, P477; Fazel S, 2006, ADDICTION, V101, P181, DOI 10.1111/j.1360-0443.2006.01316.x; Fazel S., 2012, British Journal of Psychiatry, V200, P364, DOI 10.1192/bjp.bp.111.096370; Fazel S, 2014, LANCET, V384, P1206, DOI 10.1016/S0140-6736(14)60379-2; Fazel S, 2009, JAMA-J AM MED ASSOC, V301, P2016, DOI 10.1001/jama.2009.675; Frankle WG, 2001, AM J PSYCHIAT, V158, P270, DOI 10.1176/appi.ajp.158.2.270; Gibbons RD, 2010, ANNU REV PUBL HEALTH, V31, P419, DOI 10.1146/annurev.publhealth.012809.103649; Ginsberg Y, 2014, PRIM CARE COMPANION, V16; Huhn M, 2014, JAMA PSYCHIAT, V71, P706, DOI 10.1001/jamapsychiatry.2014.112; Keers R, 2014, AM J PSYCHIAT, V171, P332, DOI 10.1176/appi.ajp.2013.13010134; Lamb HR, 2014, J AM ACAD PSYCHIATRY, V42, P489; Leucht S, 2012, LANCET, V379, P2063, DOI 10.1016/S0140-6736(12)60239-6; Lichtenstein P, 2012, NEW ENGL J MED, V367, P2006, DOI 10.1056/NEJMoa1203241; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; McGuire J, 2008, PHILOS T R SOC B, V363, P2577, DOI 10.1098/rstb.2008.0035; McMurran Mary, 2007, Crim Behav Ment Health, V17, P225, DOI 10.1002/cbm.662; Ministry-of-Justice, 2012, COMP REOFF STAT AN; MITCHELL O, 2007, J EXPT CRIMINOLOGY, V0003; National Council of Crime Prevention, 2011, KRIM 2010; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Rich JD, 2015, LANCET, V386, P350, DOI 10.1016/S0140-6736(14)62338-2; Skeem JL, 2011, LAW HUMAN BEHAV, V35, P110, DOI 10.1007/s10979-010-9223-7; Webb RT, 2014, J CLIN PSYCHIAT, V75, pE809, DOI 10.4088/JCP.13m08899; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294	37	58	57	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1798	1807		10.1001/jama.2016.15380	http://dx.doi.org/10.1001/jama.2016.15380			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA4GP	27802545	Green Accepted, Green Published			2022-12-28	WOS:000386569300019
J	Clery, D				Clery, Daniel			Mars lander crash adds to 2020 rover worries	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					397	398		10.1126/science.354.6311.397	http://dx.doi.org/10.1126/science.354.6311.397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789816				2022-12-28	WOS:000387684400011
J	de Manuel, M; Kuhlwilm, M; Frandsen, P; Sousa, VC; Desai, T; Prado-Martinez, J; Hernandez-Rodriguez, J; Dupanloup, I; Lao, O; Hallast, P; Schmidt, JM; Heredia-Genestar, JM; Benazzo, A; Barbujani, G; Peter, BM; Kuderna, LFK; Casals, F; Angedakin, S; Arandjelovic, M; Boesch, C; Kuhl, H; Vigilant, L; Langergraber, K; Novembre, J; Gut, M; Gut, I; Navarro, A; Carlsen, F; Andres, AM; Siegismund, HR; Scally, A; Excoffier, L; Tyler-Smith, C; Castellano, S; Xue, YL; Hvilsom, C; Marques-Bonet, T				de Manuel, Marc; Kuhlwilm, Martin; Frandsen, Peter; Sousa, Vitor C.; Desai, Tariq; Prado-Martinez, Javier; Hernandez-Rodriguez, Jessica; Dupanloup, Isabelle; Lao, Oscar; Hallast, Pille; Schmidt, Joshua M.; Maria Heredia-Genestar, Jose; Benazzo, Andrea; Barbujani, Guido; Peter, Benjamin M.; Kuderna, Lukas F. K.; Casals, Ferran; Angedakin, Samuel; Arandjelovic, Mimi; Boesch, Christophe; Kuehl, Hjalmar; Vigilant, Linda; Langergraber, Kevin; Novembre, John; Gut, Marta; Gut, Ivo; Navarro, Arcadi; Carlsen, Frands; Andres, Aida M.; Siegismund, Hans. R.; Scally, Aylwyn; Excoffier, Laurent; Tyler-Smith, Chris; Castellano, Sergi; Xue, Yali; Hvilsom, Christina; Marques-Bonet, Tomas			Chimpanzee genomic diversity reveals ancient admixture with bonobos	SCIENCE			English	Article							POPULATION HISTORY; PAN-TROGLODYTES; NEANDERTHAL; SEQUENCE; HUMANS	Our closest living relatives, chimpanzees and bonobos, have a complex demographic history. We analyzed the high-coverage whole genomes of 75 wild-born chimpanzees and bonobos from 10 countries in Africa. We found that chimpanzee population substructure makes genetic information a good predictor of geographic origin at country and regional scales. Multiple lines of evidence suggest that gene flow occurred from bonobos into the ancestors of central and eastern chimpanzees between 200,000 and 550,000 years ago, probably with subsequent spread into Nigeria-Cameroon chimpanzees. Together with another, possibly more recent contact (after 200,000 years ago), bonobos contributed less than 1% to the central chimpanzee genomes. Admixture thus appears to have been widespread during hominid evolution.	[de Manuel, Marc; Kuhlwilm, Martin; Prado-Martinez, Javier; Hernandez-Rodriguez, Jessica; Maria Heredia-Genestar, Jose; Kuderna, Lukas F. K.; Casals, Ferran; Navarro, Arcadi; Marques-Bonet, Tomas] Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona Biomed Res Pk,Doctor Aiguader 88, Barcelona 08003, Catalonia, Spain; [Frandsen, Peter; Siegismund, Hans. R.] Univ Copenhagen, Dept Biol, Sect Computat & RNA Biol, DK-2200 Copenhagen, Denmark; [Frandsen, Peter; Carlsen, Frands; Hvilsom, Christina] Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, DK-2000 Frederiksberg, Denmark; [Sousa, Vitor C.; Dupanloup, Isabelle; Excoffier, Laurent] Univ Bern, Computat & Mol Populat Genet, Inst Ecol & Evolut, CH-3012 Bern, Switzerland; [Sousa, Vitor C.; Dupanloup, Isabelle; Excoffier, Laurent] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Desai, Tariq; Scally, Aylwyn] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Prado-Martinez, Javier; Hallast, Pille; Tyler-Smith, Chris; Xue, Yali] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Hinxton CB10 1SA, England; [Lao, Oscar; Gut, Marta; Gut, Ivo; Navarro, Arcadi; Marques-Bonet, Tomas] Barcelona Inst Sci & Technol, Natl Ctr Genom Anal, Ctr Genom Regulat, Barcelona 08028, Spain; [Lao, Oscar] Univ Pompeu Fabra, Barcelona 08003, Spain; [Hallast, Pille] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Schmidt, Joshua M.; Andres, Aida M.; Castellano, Sergi] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Benazzo, Andrea; Barbujani, Guido] Univ Ferrara, Dept Life Sci & Biotechnol, I-44121 Ferrara, Italy; [Peter, Benjamin M.; Novembre, John] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Angedakin, Samuel; Arandjelovic, Mimi; Boesch, Christophe; Kuehl, Hjalmar; Vigilant, Linda] Max Planck Inst Evolutionary Anthropol, Dept Primatol, D-04103 Leipzig, Germany; [Langergraber, Kevin] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Langergraber, Kevin] Arizona State Univ, Inst Human Origins, Tempe, AZ 85287 USA; [Navarro, Arcadi; Marques-Bonet, Tomas] ICREA, Barcelona 08010, Catalonia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University; University of Copenhagen; University of Bern; Swiss Institute of Bioinformatics; University of Cambridge; Wellcome Trust Sanger Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Tartu; Max Planck Society; University of Ferrara; University of Chicago; Max Planck Society; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; ICREA	Marques-Bonet, T (corresponding author), Univ Pompeu Fabra, CSIC, Inst Biol Evolut, Barcelona Biomed Res Pk,Doctor Aiguader 88, Barcelona 08003, Catalonia, Spain.; Hvilsom, C (corresponding author), Copenhagen Zoo, Ctr Zoo & Wild Anim Hlth, DK-2000 Frederiksberg, Denmark.; Marques-Bonet, T (corresponding author), Barcelona Inst Sci & Technol, Natl Ctr Genom Anal, Ctr Genom Regulat, Barcelona 08028, Spain.; Marques-Bonet, T (corresponding author), ICREA, Barcelona 08010, Catalonia, Spain.	ch@zoo.dk; tomas.marques@upf.edu	Marques-Bonet, Tomas/ABF-3734-2020; Casals, Ferran/H-4347-2015; Sousa, Vitor C/P-1871-2016; Excoffier, Laurent/D-3498-2013; Barbujani, Guido/ABE-9998-2020; Andres, Aida/B-4088-2014; Gut, Ivo/ABF-3188-2020; Frandsen, Peter/O-3698-2019; Dupanloup, Isabelle/O-8609-2017; Schmidt, Joshua M/A-9941-2013; Dupanloup, Isabelle/AAD-5372-2020; Prado-Martinez, Javier/AAA-6341-2020; Castellano, Sergi/A-7437-2016; Lao, Oscar/N-9930-2017	Marques-Bonet, Tomas/0000-0002-5597-3075; Casals, Ferran/0000-0002-8941-0369; Sousa, Vitor C/0000-0003-3575-0875; Excoffier, Laurent/0000-0002-7507-6494; Barbujani, Guido/0000-0001-7854-6669; Andres, Aida/0000-0002-8590-9672; Gut, Ivo/0000-0001-7219-632X; Frandsen, Peter/0000-0001-7131-0944; Dupanloup, Isabelle/0000-0002-9258-6963; Schmidt, Joshua M/0000-0002-5862-7389; Prado-Martinez, Javier/0000-0001-5402-2721; Castellano, Sergi/0000-0002-5819-4210; Kuhlwilm, Martin/0000-0002-0115-1797; Hernandez-Rodriguez, Jessica/0000-0002-0402-286X; Hallast, Pille/0000-0002-0588-3987; Hvilsom, Christina/0000-0001-7870-6888; Lao, Oscar/0000-0002-8525-9649; Arandjelovic, Mimi/0000-0001-8920-9684; Kuderna, Lukas/0000-0002-9992-9295; Heredia-Genestar, Jose Maria/0000-0002-7970-5016	Formacio de personal Investigador fellowship from Generalitat de Catalunya [FI_B01111]; Deutsche Forschungsgemeinschaft fellowship [KU 3467/1-1]; Swiss National Science Foundation [31003A-143393, 310030B-16660]; Gates Cambridge Trust; Ramon y Cajal grant from Ministerio de Economia y Competitividad (MINECO) [RYC-2013-14797]; MINECO grant [BFU2015-68759-P]; Estonian Research Council [PUT1036]; Max Planck Society; Wellcome Trust [098051]; Maria de Maeztu Programme [MDM-2014-0370]; Isaac Newton Trust/Wellcome Trust Institutional Strategic Support Fund Joint Research Grant; U.S. NIH [U01CA198933, MH106874]; Swiss National Science Foundation postdoctoral fellowship; MINECO [BFU2015-68649-P, BFU2014-55090-P, BFU2015-7116-ERC, BFU2015-6215-ERCU01]; Krekeler Foundation; ICREA Funding Source: Custom; NATIONAL CANCER INSTITUTE [U01CA198933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH106874] Funding Source: NIH RePORTER	Formacio de personal Investigador fellowship from Generalitat de Catalunya; Deutsche Forschungsgemeinschaft fellowship(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gates Cambridge Trust; Ramon y Cajal grant from Ministerio de Economia y Competitividad (MINECO); MINECO grant(Spanish Government); Estonian Research Council(Estonian Research Council); Max Planck Society(Max Planck SocietyFoundation CELLEX); Wellcome Trust(Wellcome TrustEuropean Commission); Maria de Maeztu Programme; Isaac Newton Trust/Wellcome Trust Institutional Strategic Support Fund Joint Research Grant; U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation postdoctoral fellowship(Swiss National Science Foundation (SNSF)); MINECO(Spanish Government); Krekeler Foundation; ICREA(ICREA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All sequence data have been submitted to the European Nucleotide Archive and are available under accession code PRJEB15086. We greatly appreciate all the sample providers: Centre de Conservation pour Chimpanzes, Chimfunshi Wildlife Orphanage Trust, Centre de Primatologie, Centre International de Recherches Medicales de Franceville, Jeunes Animaux Confisques Au Katanga, Ngamba Island Chimpanzee Sanctuary, Sweetwaters Chimpanzee Sanctuary, Stichting AAP, Bioparc Valencia, Edinburgh Zoo, Furuviksparken, Kolmardens Djurpark, Zoo de Barcelona, Parc le Pal, Zoo Aquarium de Madrid, Zoo Parc de Beauval, and Zoo Zurich. We respectfully thank the Agence Nationale des Parcs Nationaux (Gabon), Centre National de la Recherche Scientifique (Gabon), Uganda National Council for Science and Technology, and the Ugandan Wildlife Authority for permission to collect fecal samples in Gabon and Uganda. We particularly thank K. Prufer for advice on technical aspects; M. Meyer and A. Weihmann for helping with the capture of fecal samples; M. J. Hubisz for advice on ARGweaver; and J. Bertranpetit, C. Lalueza-Fox, M. Mondal, and S. Han for reading the manuscript and providing valuable comments. M.d.M. is supported by a Formacio de personal Investigador fellowship from Generalitat de Catalunya (FI_B01111). M.K. is supported by a Deutsche Forschungsgemeinschaft fellowship (KU 3467/1-1). V.C.S., I.D., and L.E. are supported by Swiss National Science Foundation grants 31003A-143393 and 310030B-16660. T.D. is funded by the Gates Cambridge Trust. O.L. is supported by a Ramon y Cajal grant from Ministerio de Economia y Competitividad (MINECO) (RYC-2013-14797) and MINECO grant BFU2015-68759-P [Fondo Europeo de Desarrollo Region (FEDER)]. P.H. is supported by Estonian Research Council grant PUT1036. J.M.S., A.M.A., and S.C. are funded by the Max Planck Society. J.P.-M., C.T.-S., and Y.X. were supported by The Wellcome Trust (098051). J. M. H.-G. is supported by the Maria de Maeztu Programme (MDM-2014-0370). A. S. is supported by an Isaac Newton Trust/Wellcome Trust Institutional Strategic Support Fund Joint Research Grant. J.N. had support from a U.S. NIH U01CA198933 grant, and B.M.P. is supported by a Swiss National Science Foundation postdoctoral fellowship. A.N. is supported by MINECO grant BFU2015-68649-P. The collection of fecal samples was supported by the Max Planck Society and Krekeler Foundation's generous funding for the Pan African Programme. T.M.-B. thanks ICREA; the European Molecular Biology Organization Young Investigator Programme 2013; MINECO grants BFU2014-55090-P (FEDER), BFU2015-7116-ERC, and BFU2015-6215-ERCU01; U.S. NIH grant MH106874; Fundacio Zoo Barcelona; and Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement de la Generalitat de Catalunya for the support to his laboratory.	Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; Caswell JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000057; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Fischer A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021605; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Funfstuck T, 2015, AM J PHYS ANTHROPOL, V156, P181, DOI 10.1002/ajpa.22638; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hvilsom C, 2014, PRIMATES, V55, P101, DOI 10.1007/s10329-013-0373-3; Kuhlwilm M, 2016, NATURE, V530, P429, DOI 10.1038/nature16544; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lobon I, 2016, GENOME BIOL EVOL, V8, P2020, DOI 10.1093/gbe/evw124; McBrearty S, 2005, NATURE, V437, P105, DOI 10.1038/nature04008; McVicker G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000471; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prufer K, 2012, NATURE, V486, P527, DOI 10.1038/nature11128; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; VERVAECKE H, 1992, MAMMALIA, V56, P667; Wasser SK, 2015, SCIENCE, V349, P84, DOI 10.1126/science.aaa2457; Won YJ, 2005, MOL BIOL EVOL, V22, P297, DOI 10.1093/molbev/msi017	24	133	139	4	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					477	481		10.1126/science.aag2602	http://dx.doi.org/10.1126/science.aag2602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789843	Green Accepted, Green Submitted			2022-12-28	WOS:000387684400044
J	Hirose, Y; Kaida, H				Hirose, Yasumitsu; Kaida, Hayato			Emphysematous Pyelonephritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hirose, Yasumitsu] Kurume Univ, Sch Med, Kurume, Fukuoka, Japan; [Kaida, Hayato] Kindai Univ, Osakasayama, Japan	Kurume University	Hirose, Y (corresponding author), Kurume Univ, Sch Med, Kurume, Fukuoka, Japan.	shinnichiizm@piano.ocn.ne.jp							0	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2016	375	17					1671	1671		10.1056/NEJMicm1501812	http://dx.doi.org/10.1056/NEJMicm1501812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB2DX	27783923				2022-12-28	WOS:000387168900013
J	Telford, RJ; Chipperfield, JD; Birks, HH; Birks, HJB				Telford, Richard J.; Chipperfield, Joseph D.; Birks, Hilary H.; Birks, H. John B.			How foreign is the past?	NATURE			English	Letter							BAYES APPROACH		[Telford, Richard J.; Chipperfield, Joseph D.; Birks, Hilary H.; Birks, H. John B.] Univ Bergen, Dept Biol, POB 7803, N-5020 Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London WC1E 6BT, England	University of Bergen; University of London; University College London	Telford, RJ (corresponding author), Univ Bergen, Dept Biol, POB 7803, N-5020 Bergen, Norway.	richard.telford@uib.no	Graves, Gary R/P-1003-2017; Eronen, Jussi T./B-7978-2013; McGill, Brian J/A-3476-2008; Blois, Jessica/G-5893-2011; Telford, Richard/AAD-2249-2019; Chipperfield, Joseph/A-8280-2018	Graves, Gary R/0000-0003-1406-5246; Eronen, Jussi T./0000-0002-0390-8044; McGill, Brian J/0000-0002-0850-1913; Blois, Jessica/0000-0003-4048-177X; Telford, Richard/0000-0001-9826-3076; Chipperfield, Joseph/0000-0003-3314-0846	Direct For Biological Sciences [1257625] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Gotelli NJ, 2010, OECOLOGIA, V162, P463, DOI 10.1007/s00442-009-1474-y; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Lyons SK, 2016, NATURE, V529, P80, DOI 10.1038/nature16447; Plummer M., 2003, P 3 INT WORKSH DISTR; Sanderson JG, 2015, PATTERNS NATURE ANAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; von Gagern M, 2015, ACTA OECOL, V69, P137, DOI 10.1016/j.actao.2015.10.003	7	4	4	3	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					E1	U26		10.1038/nature20096	http://dx.doi.org/10.1038/nature20096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5IY	27786205				2022-12-28	WOS:000386654400001
J	Mclean, K				Mclean, Kathy			NHS STAFFING The locum cap is working but we still have a long way to go	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												enquiries@improvement.nhs.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2016	355								i5737	10.1136/bmj.i5737	http://dx.doi.org/10.1136/bmj.i5737			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LG	27784711				2022-12-28	WOS:000386661400011
J	Slomski, A				Slomski, Anita			Caring for Realistic Infant Simulators Does Not Deter Teenage Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1637	1637		10.1001/jama.2016.15434	http://dx.doi.org/10.1001/jama.2016.15434			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784094				2022-12-28	WOS:000386107800008
J	Lin, J; Kumari, S; Kim, C; Van, TM; Wachsmuth, L; Polykratis, A; Pasparakis, M				Lin, Juan; Kumari, Snehlata; Kim, Chun; Van, Trieu-My; Wachsmuth, Laurens; Polykratis, Apostolos; Pasparakis, Manolis			RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation	NATURE			English	Article							CELL-DEATH; PROGRAMMED NECROSIS; INNATE; HOMEOSTASIS; ACTIVATION; CASPASE-8; MICE	Receptor-interacting protein kinase 1 (RIPK1) regulates cell death and inflammation through kinase-dependent and -independent functions(1-7). RIPK1 kinase activity induces caspase-8-dependent apoptosis and RIPK3 and mixed lineage kinase like (MLKL)-dependent necroptosis(8-13). In addition, RIPK1 inhibits apoptosis and necroptosis through kinase-independent functions, which are important for late embryonic development and the prevention of inflammation in epithelial barriers(14-18). The mechanism by which RIPK1 counteracts RIPK3-MLKL-mediated necroptosis has remained unknown. Here we show that RIPK1 prevents skin inflammation by inhibiting activation of RIPK3-MLKL-dependent necroptosis mediated by Z-DNA binding protein 1 (ZBP1, also known as DAI or DLM1). ZBP1 deficiency inhibited keratinocyte necroptosis and skin inflammation in mice with epidermis-specific RIPK1 knockout. Moreover, mutation of the conserved RIP homotypic interaction motif (RHIM) of endogenous mouse RIPK1 (RIPK1(mRHIM)) caused perinatal lethality that was prevented by RIPK3, MLKL or ZBP1 deficiency. Furthermore, mice expressing only RIPK1(mRHIM) in keratinocytes developed skin inflammation that was abrogated by MLKL or ZBP1 deficiency. Mechanistically, ZBP1 interacted strongly with phosphorylated RIPK3 in cells expressing RIPK1(mRHIM), suggesting that the RIPK1 RHIM prevents ZBP1 from binding and activating RIPK3. Collectively, these results show that RIPK1 prevents perinatal death as well as skin inflammation in adult mice by inhibiting ZBP1-induced necroptosis. Furthermore, these findings identify ZBP1 as a critical mediator of inflammation beyond its previously known role in antiviral defence and suggest that ZBP1 might be implicated in the pathogenesis of necroptosis-associated inflammatory diseases.	[Lin, Juan; Kumari, Snehlata; Kim, Chun; Van, Trieu-My; Wachsmuth, Laurens; Polykratis, Apostolos; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50931 Cologne, Germany; [Lin, Juan; Kumari, Snehlata; Kim, Chun; Van, Trieu-My; Wachsmuth, Laurens; Polykratis, Apostolos; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50931 Cologne, Germany.; Pasparakis, M (corresponding author), Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany.	pasparakis@uni-koeln.de	Pasparakis, Manolis/N-4350-2019; Kumari, Snehlata/ABA-5739-2020; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Kumari, Snehlata/0000-0002-4971-3162; Pasparakis, Manolis/0000-0002-9870-0966; Wachsmuth, Laurens/0000-0003-1701-9384; Polykratis, Apostolos/0000-0001-6720-3302; Kim, Chun/0000-0001-9497-708X	ERC [323040]; DFG [SFB829, SFB670]; Humboldt research fellowship; EMBO	ERC(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); Humboldt research fellowship(Alexander von Humboldt Foundation); EMBO(European Molecular Biology Organization (EMBO))	We thank Genentech and V. Dixit for Ripk3<SUP>-/-</SUP> mice, S. Akira for Zbp1<SUP>-/-</SUP> mice, and J. Han for lentiviral vectors. We thank B. Zevnik, P. Jankowski and S. Assenmacher at the CECAD Transgenic Core Facility for CRISPR/Cas9 mutagenesis in mouse zygotes and C. Uthoff-Hachenberg, J. Buchholz, E. Mahlberg and B. Kuhnel for excellent technical assistance. Research reported in this publication was supported by funding from the ERC (grant agreement no. 323040) and the DFG (SFB829 and SFB670). J.L. was supported by a Humboldt research fellowship and C.K. was supported by a Humboldt research fellowship and an EMBO long-term fellowship.	Berger SB, 2014, J IMMUNOL, V192, P5476, DOI 10.4049/jimmunol.1400499; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Fu YN, 1999, GENE, V240, P157, DOI 10.1016/S0378-1119(99)00419-9; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Kaiser WJ, 2008, J IMMUNOL, V181, P6427, DOI 10.4049/jimmunol.181.9.6427; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Meng LJ, 2015, P NATL ACAD SCI USA, V112, P11007, DOI 10.1073/pnas.1514730112; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Newton K, 2015, TRENDS CELL BIOL, V25, P347, DOI 10.1016/j.tcb.2015.01.001; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Takahashi N, 2014, NATURE, V513, P95, DOI 10.1038/nature13706; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2012.01.016, 10.1016/j.chom.2019.09.004]; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Weinlich R, 2014, MOL CELL, V56, P469, DOI 10.1016/j.molcel.2014.11.001	32	203	206	4	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 1	2016	540	7631					124	+		10.1038/nature20558	http://dx.doi.org/10.1038/nature20558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5UA	27819681	Green Accepted			2022-12-28	WOS:000388916600061
J	Byrne, RA; Kastrati, A				Byrne, Robert A.; Kastrati, Adnan			Disappearing scaffolds, dissolving expectations	LANCET			English	Editorial Material							BIORESORBABLE VASCULAR SCAFFOLDS; CORONARY; STENTS		[Byrne, Robert A.] Klin Tech Univ Munchen, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany; DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany	German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Byrne, RA (corresponding author), Klin Tech Univ Munchen, Deutsch Herzzentrum Munchen, D-80636 Munich, Germany.	byrne@dhm.mhn.de	, Kastrati/Y-2389-2019; Byrne, Robert/C-3902-2016	Byrne, Robert/0000-0001-5224-6393				Byrne RA, 2015, EUR HEART J, V36, P2608, DOI 10.1093/eurheartj/ehv203; Capodanno D, 2015, EUROINTERVENTION, V10, P1144, DOI 10.4244/EIJY14M07_11; Cassese S, 2016, LANCET, V387, P537, DOI 10.1016/S0140-6736(15)00979-4; Ellis SG, 2015, NEW ENGL J MED, V373, P1905, DOI 10.1056/NEJMoa1509038; Hoppmann P, 2016, CATHETER CARDIO INTE, V87, P822, DOI 10.1002/ccd.26346; Onuma Y, 2016, EUROINTERVENTION, V12, P1090, DOI 10.4244/EIJY16M09_01; Otsuka F, 2015, EUR HEART J, V36, P2147, DOI 10.1093/eurheartj/ehv205; Puricel S, 2016, J AM COLL CARDIOL, V67, P921, DOI 10.1016/j.jacc.2015.12.019; Serruys PW, 2016, EUROINTERVENTION, V12, P693, DOI 10.4244/EIJV12I6A111; Serruys PW, 2016, LANCET; Yamaji K, 2010, CIRC-CARDIOVASC INTE, V3, P468, DOI 10.1161/CIRCINTERVENTIONS.110.958249	11	3	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2451	2452		10.1016/S0140-6736(16)32068-2	http://dx.doi.org/10.1016/S0140-6736(16)32068-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC5IA	27806898				2022-12-28	WOS:000388166300004
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, K; Epling, JW; Garcia, FAR; Gillman, MW; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; LeFevre, ML; Mangione, CM; Phillips, WR; Owens, DK; Phipps, MG; Pignone, MP				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, KarinaW.; Epling, John W., Jr.; Garcia, Francisco A. R.; Gillman, Matthew W.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; LeFevre, Michael L.; Mangione, Carol M.; Phillips, William R.; Owens, Douglas K.; Phipps, Maureen G.; Pignone, Michael P.		US Preventive Serv Task Force	Statin Use for the Primary Prevention of Cardiovascular Disease in Adults US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							CORONARY-HEART-DISEASE; 2013 ACC/AHA GUIDELINE; DIABETES-MELLITUS; RISK; CHOLESTEROL; WOMEN; EVENTS; INTERVENTIONS; DYSLIPIDEMIA; MORTALITY	IMPORTANCE Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States, accounting for 1 of every 3 deaths among adults. OBJECTIVE To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on the benefits and harms of screening for and treatment of dyslipidemia in adults 21 years and older; the benefits and harms of statin use in reducing CVD events and mortality in adults without a history of CVD events; whether the benefits of statin use vary by subgroup, clinical characteristics, or dosage; and the benefits of various treatment strategies in adults 40 years and older without a history of CVD events. CONCLUSIONS AND RECOMMENDATIONS The USPSTF recommends initiating use of low-to moderate-dose statins in adults aged 40 to 75 years without a history of CVD who have 1 or more CVD risk factors (dyslipidemia, diabetes, hypertension, or smoking) and a calculated 10-year CVD event risk of 10% or greater (B recommendation). The USPSTF recommends that clinicians selectively offer low-to moderate-dose statins to adults aged 40 to 75 years without a history of CVD who have 1 or more CVD risk factors and a calculated 10-year CVD event risk of 7.5% to 10% (C recommendation). The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of initiating statin use in adults 76 years and older (I statement).	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Davidson, KarinaW.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew W.] Harvard Med Sch, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Gillman, Matthew W.] NIH, Bldg 10, Bethesda, MD 20892 USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [LeFevre, Michael L.] Univ Missouri, Columbia, MO 65211 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ Texas Austin, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Iowa; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; National Institutes of Health (NIH) - USA; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of Missouri System; University of Missouri Columbia; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Stanford University; Brown University; University of Texas System; University of Texas Austin	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Phillips, William R./V-1065-2017; Davidson, Karina/AAG-2388-2019; Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022	Phillips, William R./0000-0003-2802-4349; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X	USPSTF	USPSTF	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	AMDA-The Society for Post-Acute and Long-Term Care Medicine, 2015, 10 THINGS PHYS PAT S; American Heart Association and American College of Cardiology, 2014, POOL COH EQ CARD RIS; Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V316, P625, DOI 10.1001/jama.2016.9852; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Calonge N, 2009, ANN INTERN MED, V151, P474, DOI 10.7326/0003-4819-151-7-200910060-00008; Chou R, 2016, AHRQ PUBLICATION; Chou R, 2016, JAMA-J AM MED ASSOC, V316, P2008, DOI 10.1001/jama.2015.15629; Chou R, 2016, ANN INTERN MED, V165, P560, DOI 10.7326/M16-0946; Cook NR, 2014, JAMA INTERN MED, V174, P1964, DOI 10.1001/jamainternmed.2014.5336; Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; DeFilippis AP, 2015, ANN INTERN MED, V162, P266, DOI 10.7326/M14-1281; Dehmer SP, 2015, AHRQ PUBLICATION, V15-05229-EF-1; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Fang Jing, 2011, Morbidity and Mortality Weekly Report, V60, P1377; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Gu Qiuping, 2014, NCHS Data Brief, P1; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Jick SS, 2004, BRIT J CLIN PHARMACO, V58, P303, DOI 10.1111/j.1365-2125.2004.02142.x; Johansen ME, 2015, JAMA INTERN MED, V175, P1715, DOI 10.1001/jamainternmed.2015.4302; Kissel CK, 2012, CAN J CARDIOL, V28, P251, DOI 10.1016/j.cjca.2011.12.008; Lopez-Jimenez F, 2014, MAYO CLIN PROC, V89, P1257, DOI 10.1016/j.mayocp.2014.06.016; Mensah GA, 2007, HEALTH AFFAIR, V26, P38, DOI 10.1377/hlthaff.26.1.38; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Minino Arialdi M, 2013, NCHS Data Brief, P1; Moyer VA, 2012, ANN INTERN MED, V157, P512, DOI 10.7326/0003-4819-157-7-201210020-00514; Moyer VA, 2012, ANN INTERN MED, V157, P367, DOI 10.7326/0003-4819-157-5-201209040-00486; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; NICE, 2016, CLIN GUID CG181 CARD; Rana JS, 2016, J AM COLL CARDIOL, V67, P2118, DOI 10.1016/j.jacc.2016.02.055; Richardson K, 2013, ANN INTERN MED, V159, P688, DOI 10.7326/0003-4819-159-10-201311190-00007; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Schatz IJ, 2001, LANCET, V358, P351, DOI 10.1016/S0140-6736(01)05553-2; Sever PS, 2003, LANCET, V361, P1149, DOI 10.1016/S0140-6736(03)12948-0; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345; Siu AL, 2015, ANN INTERN MED, V163, P778, DOI 10.7326/M15-2223; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9; Yusuf S, 2016, NEW ENGL J MED, V374, P2021, DOI 10.1056/NEJMoa1600176	44	399	404	3	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1997	2007		10.1001/jama.2016.15450	http://dx.doi.org/10.1001/jama.2016.15450			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838723				2022-12-28	WOS:000387673800018
J	Nelson, S				Nelson, Sarah			Geneticists should offer data to participants	NATURE			English	Editorial Material									[Nelson, Sarah] Univ Washington, Inst Publ Hlth Genet, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Nelson, S (corresponding author), Univ Washington, Inst Publ Hlth Genet, Seattle, WA 98195 USA.	sarahcn@uw.edu	Nelson, Sarah Catherine/AAN-9814-2020	Nelson, Sarah Catherine/0000-0002-2109-6465					0	8	8	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					7	7		10.1038/539007a	http://dx.doi.org/10.1038/539007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5OJ	27808206	Bronze			2022-12-28	WOS:000386670100006
J	Rimmer, A				Rimmer, Abi			GMC independence is a great British compromise	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		Rimer A, 2016, BMA ANN M GMC SHOULD	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2016	355								i5905	10.1136/bmj.i5905	http://dx.doi.org/10.1136/bmj.i5905			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CU	27806956				2022-12-28	WOS:000387317900015
J	Hampton, T				Hampton, Tracy			Water Bear Genome Uncovers Novel Stress-Tolerant Proteins	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1755	1755		10.1001/jama.2016.15523	http://dx.doi.org/10.1001/jama.2016.15523			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802533				2022-12-28	WOS:000386569300003
J	Voelker, R				Voelker, Rebecca			Relief for Ear Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1756	1756		10.1001/jama.2016.15574	http://dx.doi.org/10.1001/jama.2016.15574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802528				2022-12-28	WOS:000386569300008
J	Mann, A				Mann, Adam			Hunt for Planet Nine heats up	SCIENCE			English	News Item																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					399	400		10.1126/science.354.6311.399	http://dx.doi.org/10.1126/science.354.6311.399			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789818				2022-12-28	WOS:000387684400013
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Base care on need, not age	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Age UK, EQ ACT WHAT IT MEANS; Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; Bardsley M, 2013, EVALUATING INTEGRATE; Blumenthal D, 2016, NEW ENGL J MED, V375, P909, DOI 10.1056/NEJMp1608511; British Geriatrics Society College of Emergency Medicine Society of Acute Medicine, 2012, SILV BOOK QUAL CAR O; Centre for Policy on Ageing, 2016, SEL READ AG AG DISCR; Darzi A., 2016, TIMES; Edwards N., 2014, COMMUNITY SERVICES T; McMurdo MET, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f867; National Audit Office, 2000, INP ADM BED MAN NHS; NHS Benchmarking Network, 2015, OLD PEOPL AC SETT BE; NHS Confederation, 2010, DEAL DOWNT; NHS England, 2013, NHS BEL PEOPL CALL A; Oliver D., 2016, WHAT COMMUNITY SERVI; Purdy S, 2012, INTERVENTIONS REDUCE; RAVEN R J, 1988, American Museum Novitates, P1; Trust N. Health Foundation, 2014, QUALITYWATCH FOC A E; Wright O., 2013, INDEPENDENT	18	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2016	355								i5788	10.1136/bmj.i5788	http://dx.doi.org/10.1136/bmj.i5788			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LR	27793814	Green Published, Bronze			2022-12-28	WOS:000386662600005
J	Rimmer, A				Rimmer, Abi			Why can't the NHS value junior staff the way top companies do?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4449	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2016	355								i5740	10.1136/bmj.i5740	http://dx.doi.org/10.1136/bmj.i5740			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LG	27784658				2022-12-28	WOS:000386661400012
J	Hedberg, AE				Hedberg, Alexandra E.			Do You Dare to Dharma?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS; SUICIDE; BURNOUT		[Hedberg, Alexandra E.] Northwestern Feinberg Sch Med, Dept Psychiat, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hedberg, AE (corresponding author), Northwestern Feinberg Sch Med, Dept Psychiat, Chicago, IL 60611 USA.	aerhedberg@gmail.com						Center C, 2003, JAMA-J AM MED ASSOC, V289, P3161, DOI 10.1001/jama.289.23.3161; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2011, ACAD MED, V86, P801, DOI 10.1097/ACM.0b013e31821da481; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Epstein RM, 2013, ACAD MED, V88, P301, DOI 10.1097/ACM.0b013e318280cff0; Goenka SN, 2014, VIPASSANA NEWSLETTER; Goenka SN, 2010, DISCOURSE SUMMARIES; Krasner MS, 2009, JAMA-J AM MED ASSOC, V302, P1284, DOI 10.1001/jama.2009.1384; Schernhammer ES, 2004, AM J PSYCHIAT, V161, P2295, DOI 10.1176/appi.ajp.161.12.2295; Shapiro SL, 2000, ACAD MED, V75, P748, DOI 10.1097/00001888-200007000-00023	10	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1677	1678		10.1001/jama.2016.8526	http://dx.doi.org/10.1001/jama.2016.8526			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784098				2022-12-28	WOS:000386107800031
J	Rousseau, C; Jean, S; Gamache, P; Lebel, S; Mac-Way, F; Biertho, L; Michou, L; Gagnon, C				Rousseau, Catherine; Jean, Sonia; Gamache, Philippe; Lebel, Stefane; Mac-Way, Fabrice; Biertho, Laurent; Michou, Laetitia; Gagnon, Claudia			Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GASTRIC BYPASS-SURGERY; BONE-MINERAL DENSITY; MORBIDLY OBESE-PATIENTS; BODY-MASS INDEX; PARATHYROID-HORMONE; METABOLIC-ACIDOSIS; WEIGHT-LOSS; LIFE-STYLE; VITAMIN; INTERVENTION	OBJECTIVE To investigate whether bariatric surgery increases the risk of fracture. Design Retrospective nested case-control study. Setting Patients who underwent bariatric surgery in the province of Quebec, Canada, between 2001 and 2014, selected using healthcare administrative databases. Participants 12 676 patients who underwent bariatric surgery, age and sex matched with 38 028 obese and 126 760 non-obese controls. Main outcome measures Incidence and sites of fracture in patients who had undergone bariatric surgery compared with obese and non-obese controls. Fracture risk was also compared before and after surgery (index date) within each group and by type of surgery from 2006 to 2014. Multivariate conditional Poisson regression models were adjusted for fracture history, number of comorbidities, sociomaterial deprivation, and area of residence. Results Before surgery, patients undergoing bariatric surgery (9169 (72.3%) women; mean age 42 (SD 11) years) were more likely to fracture (1326; 10.5%) than were obese (3065; 8.1%) or non-obese (8329; 6.6%) controls. A mean of 4.4 years after surgery, bariatric patients were more susceptible to fracture (514; 4.1%) than were obese (1013; 2.7%) and non-obese (3008; 2.4%) controls. Postoperative adjusted fracture risk was higher in the bariatric group than in the obese (relative risk 1.38, 95% confidence interval 1.23 to 1.55) and non-obese (1.44, 1.29 to 1.59) groups. Before surgery, the risk of distal lower limb fracture was higher, upper limb fracture risk was lower, and risk of clinical spine, hip, femur, or pelvic fractures was similar in the bariatric and obese groups compared with the non-obese group. After surgery, risk of distal lower limb fracture decreased (relative risk 0.66, 0.56 to 0.78), whereas risk of upper limb (1.64, 1.40 to 1.93), clinical spine (1.78, 1.08 to 2.93), pelvic, hip, or femur (2.52, 1.78 to 3.59) fractures increased. The increase in risk of fracture reached significance only for biliopancreatic diversion. CONCLUSIONS Patients undergoing bariatric surgery were more likely to have fractures than were obese or non-obese controls, and this risk remained higher after surgery. Fracture risk was site specific, changing from a pattern associated with obesity to a pattern typical of osteoporosis after surgery. Only biliopancreatic diversion was clearly associated with fracture risk; however, results for Roux-en-Y gastric bypass and sleeve gastrectomy remain inconclusive. Fracture risk assessment and management should be part of bariatric care.	[Rousseau, Catherine; Mac-Way, Fabrice; Michou, Laetitia; Gagnon, Claudia] CHU Quebec, Res Ctr, Endocrinol & Nephrol Unit, Quebec City, PQ G1V 4G2, Canada; [Rousseau, Catherine; Jean, Sonia; Mac-Way, Fabrice; Michou, Laetitia; Gagnon, Claudia] Univ Laval, Dept Med, Quebec City, PQ G1V 0A6, Canada; [Jean, Sonia; Gamache, Philippe] Inst Natl Sante Publ Quebec, Quebec City, PQ G1V 5B3, Canada; [Lebel, Stefane; Biertho, Laurent] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ G1V 4G5, Canada; [Gagnon, Claudia] Inst Nutr & Funct Foods, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University; Institut national de sante publique du Quebec (INSPQ); Laval University; Quebec Heart & Lung Institute	Gagnon, C (corresponding author), CHU Quebec, Res Ctr, Endocrinol & Nephrol Unit, Quebec City, PQ G1V 4G2, Canada.; Gagnon, C (corresponding author), Univ Laval, Dept Med, Quebec City, PQ G1V 0A6, Canada.; Gagnon, C (corresponding author), Inst Nutr & Funct Foods, Quebec City, PQ G1V 0A6, Canada.	claudia.gagnon@crchudequebec.ulaval.ca		Michou, Laetitia/0000-0002-8364-4164	Department of Medicine, Laval University; Fondation du CHU de Quebec; Fonds de la recherche du Quebec-Sante (FRQ-S); KRESCENT program of the Kidney Foundation of Canada	Department of Medicine, Laval University; Fondation du CHU de Quebec; Fonds de la recherche du Quebec-Sante (FRQ-S); KRESCENT program of the Kidney Foundation of Canada(Canadian Institutes of Health Research (CIHR))	CR is supported by a scholarship from the Department of Medicine, Laval University and from the Fondation du CHU de Quebec. CG and FM-W are supported by scholarships from the Fonds de la recherche du Quebec-Sante (FRQ-S). FM-W is also supported by a scholarship from the KRESCENT program of the Kidney Foundation of Canada.	Abegg K, 2013, AM J PHYSIOL-REG I, V305, pR999, DOI 10.1152/ajpregu.00038.2013; Angrisani L, 2015, OBES SURG, V25, P1822, DOI 10.1007/s11695-015-1657-z; Armstrong MEG, 2012, BONE, V50, P1394, DOI 10.1016/j.bone.2012.03.014; Baillot A, 2016, OBES SURG, V26, P2602, DOI 10.1007/s11695-016-2153-9; Berarducci A, 2009, APPL NURS RES, V22, P35, DOI 10.1016/j.apnr.2007.03.004; Blais C, 2014, CHRON DIS INJ CAN, V34, P226; Bruno C, 2010, J CLIN ENDOCR METAB, V95, P159, DOI 10.1210/jc.2009-0265; Canales BK, 2014, SURG OBES RELAT DIS, V10, P878, DOI 10.1016/j.soard.2014.01.021; Carrasco F, 2009, OBES SURG, V19, P41, DOI 10.1007/s11695-008-9638-0; Chaston TB, 2007, INT J OBESITY, V31, P743, DOI 10.1038/sj.ijo.0803483; Coates PS, 2004, J CLIN ENDOCR METAB, V89, P1061, DOI 10.1210/jc.2003-031756; COMPSTON JE, 1984, GASTROENTEROLOGY, V87, P350; Compston J, 2013, CURR OSTEOPOROS REP, V11, P30, DOI 10.1007/s11914-012-0127-y; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Cooper PL, 1999, INT J OBESITY, V23, P382, DOI 10.1038/sj.ijo.0800830; Corbeil P, 2001, IEEE T NEUR SYS REH, V9, P126, DOI 10.1109/7333.928572; Courcoulas AP, 2015, JAMA SURG, V150, P931, DOI 10.1001/jamasurg.2015.1534; Cummings DE, 2016, DIABETOLOGIA, V59, P945, DOI 10.1007/s00125-016-3903-x; Duan YB, 1999, J CLIN ENDOCR METAB, V84, P718, DOI 10.1210/jc.84.2.718; Dunstan MJD, 2015, OBES SURG, V25, P648, DOI 10.1007/s11695-014-1425-5; Epstein S, 2016, OSTEOPOROSIS INT, V27, P1931, DOI 10.1007/s00198-015-3454-x; Fleischer J, 2008, J CLIN ENDOCR METAB, V93, P3735, DOI 10.1210/jc.2008-0481; Folli F, 2012, INT J OBESITY, V36, P1373, DOI 10.1038/ijo.2012.115; Golob AL, 2015, MED CLIN N AM, V99, P587, DOI 10.1016/j.mcna.2015.01.010; Grethen E, 2011, J CLIN ENDOCR METAB, V96, P1320, DOI 10.1210/jc.2010-2202; Hage MP, 2014, OSTEOPOROSIS INT, V25, P423, DOI 10.1007/s00198-013-2480-9; Heber D, 2010, J CLIN ENDOCR METAB, V95, P4823, DOI 10.1210/jc.2009-2128; Ikramuddin S, 2015, LANCET DIABETES ENDO, V3, P413, DOI 10.1016/S2213-8587(15)00089-3; Johansson H, 2014, J BONE MINER RES, V29, P223, DOI 10.1002/jbmr.2017; Johnson JM, 2005, J GASTROINTEST SURG, V9, P1106, DOI 10.1016/j.gassur.2005.07.012; Karsenty G, 2006, CELL METAB, V4, P341, DOI 10.1016/j.cmet.2006.10.008; Kim J, 2016, SURG OBES RELAT DIS, V12, P453, DOI 10.1016/j.soard.2015.11.021; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lalmohamed A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5085; Lebel S, 2016, SURG OBES RELAT DIS; Lu CW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002087; Marceau P, 2002, J GASTROINTEST SURG, V6, P690, DOI 10.1016/S1091-255X(01)00086-5; Marceau P, 2015, OBES SURG, V25, P1584, DOI 10.1007/s11695-015-1599-5; Martin BJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-70; Mechanick JI, 2013, SURG OBES RELAT DIS, V9, P159, DOI 10.1016/j.soard.2012.12.010; Modi AC, 2013, OBESITY, V21, pE190, DOI 10.1002/oby.20031; Muschitz C, 2016, J BONE MINER RES, V31, P672, DOI 10.1002/jbmr.2707; Muschitz C, 2015, J CLIN ENDOCR METAB, V100, P891, DOI 10.1210/jc.2014-3367; Nakamura KM, 2014, OSTEOPOROSIS INT, V25, P151, DOI 10.1007/s00198-013-2463-x; Pampalon R, 2012, CAN J PUBLIC HEALTH, V103, pS17, DOI 10.1007/BF03403824; PARFITT AM, 1985, BONE, V6, P211, DOI 10.1016/8756-3282(85)90003-1; Piche ME, 2015, CAN J CARDIOL, V31, DOI 10.1016/j.cjca.2014.12.014; Prieto-Alhambra D, 2012, J BONE MINER RES, V27, P294, DOI 10.1002/jbmr.1466; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Robert M, 2015, SURG OBES RELAT DIS, V11, P798, DOI 10.1016/j.soard.2014.12.016; Sanchez A, 2016, OBES SURG, V26, P361, DOI 10.1007/s11695-015-1773-9; Scibora LM, 2014, DIABETES OBES METAB, V16, P1204, DOI 10.1111/dom.12363; SILVERBERG SJ, 1989, J BONE MINER RES, V4, P283, DOI 10.1002/jbmr.5650040302; Sjostrom CD, 1999, OBES RES, V7, P477; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sjostrom L, 2009, LANCET ONCOL, V10, P653, DOI 10.1016/S1470-2045(09)70159-7; Soltani S, 2016, OSTEOPOROSIS INT, V27, P2655, DOI 10.1007/s00198-016-3617-4; Stein EM, 2013, J CLIN ENDOCR METAB, V98, P541, DOI 10.1210/jc.2012-2394; Sundh D, 2016, J BONE MINER RES, V31, P749, DOI 10.1002/jbmr.2747; Tarantino U, 2015, J BONE JOINT SURG AM, V97A, P429, DOI 10.2106/JBJS.N.00648; Yu EW, 2015, J CLIN ENDOCR METAB, V100, P1452, DOI 10.1210/jc.2014-4341; Yu EW, 2014, J BONE MINER RES, V29, P1507, DOI 10.1002/jbmr.2226	62	134	140	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2016	354								i3794	10.1136/bmj.i3794	http://dx.doi.org/10.1136/bmj.i3794			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZH	27814663	Green Published, hybrid			2022-12-28	WOS:000380931600003
J	Ginsburg, O; Bray, F; Coleman, MP; Vanderpuye, V; Eniu, A; Kotha, SR; Sarker, M; Huong, TT; Allemani, C; Dvaladze, A; Gralow, J; Yeates, K; Taylor, C; Oomman, N; Krishnan, S; Sullivan, R; Kombe, D; Blas, MM; Parham, G; Kassami, N; Conteh, L				Ginsburg, Ophira; Bray, Freddie; Coleman, Michel P.; Vanderpuye, Verna; Eniu, Alexandru; Kotha, S. Rani; Sarker, Malabika; Tran Thanh Huong; Allemani, Claudia; Dvaladze, Allison; Gralow, Julie; Yeates, Karen; Taylor, Carolyn; Oomman, Nandini; Krishnan, Suneeta; Sullivan, Richard; Kombe, Dominista; Blas, Magaly M.; Parham, Groesbeck; Kassami, Natasha; Conteh, Lesong			The global burden of women's cancers: a grand challenge in global health	LANCET			English	Article							BREAST-CANCER; CERVICAL-CANCER; HUMAN-PAPILLOMAVIRUS; SYSTEMATIC ANALYSIS; MATERNAL MORTALITY; INDIGENOUS PEOPLE; AFRICAN-AMERICAN; INCIDENCE RATES; WHITE WOMEN; NEW-ZEALAND	Every year, more than 2 million women worldwide are diagnosed with breast or cervical cancer, yet where a woman lives, her socioeconomic status, and agency largely determines whether she will develop one of these cancers and will ultimately survive. In regions with scarce resources, fragile or fragmented health systems, cancer contributes to the cycle of poverty. Proven and cost-effective interventions are available for both these common cancers, yet for so many women access to these is beyond reach. These inequities highlight the urgent need in low-income and middle-income countries for sustainable investments in the entire continuum of cancer control, from prevention to palliative care, and in the development of high-quality population-based cancer registries. In this first paper of the Series on health, equity, and women's cancers, we describe the burden of breast and cervical cancer, with an emphasis on global and regional trends in incidence, mortality, and survival, and the consequences, especially in socioeconomically disadvantaged women in different settings.	[Ginsburg, Ophira] Univ Toronto, Dalla Lana Sch Publ Hlth, Fac Med, Womens Coll Res Inst, Toronto, ON, Canada; [Ginsburg, Ophira] WHO, Geneva, Switzerland; [Bray, Freddie] Int Agcy Res Canc, Canc Surveillance Sect, Lyon, France; [Coleman, Michel P.; Allemani, Claudia] London Sch Hyg & Trop Med, Canc Survival Grp, Dept Noncommunicable Dis Epidemiol, London, England; [Vanderpuye, Verna] Korlebu Teaching Hosp, Natl Ctr Radiotherapy, Accra, Ghana; [Eniu, Alexandru] Canc Inst Ion Chiricuta, Cluj Napoca, Romania; [Kotha, S. Rani] Univ Toronto, Inst Global Hlth Equ & Innovat, Toronto, ON, Canada; [Sarker, Malabika] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Tran Thanh Huong] Hanoi Med Univ, Hanoi, Vietnam; [Tran Thanh Huong] Natl Inst Canc Control, Hanoi, Vietnam; [Dvaladze, Allison; Gralow, Julie] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA 98195 USA; [Yeates, Karen] Queens Univ, Off Global Hlth, Fac Hlth Sci, Kingston, ON, Canada; [Taylor, Carolyn] Global Focus Canc, Port Chester, NY USA; [Krishnan, Suneeta] Res Triangle Inst Global India Pvt Ltd, New Delhi, India; [Krishnan, Suneeta] St Johns Res Inst, Bengarulu, India; [Sullivan, Richard] Kings Hlth Partners Comprehens Canc Ctr, Inst Canc Policy, London, England; [Sullivan, Richard] Kings Hlth Partners, Kings Ctr Global Hlth, London, England; [Sullivan, Richard] Kings Coll London, London, England; [Kombe, Dominista] Ocean Rd Canc Ctr, Dar Es Salaam, Tanzania; [Blas, Magaly M.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Parham, Groesbeck] Univ N Carolina, Dept Obstet & Gynecol, Chapel Hill, NC USA; [Parham, Groesbeck] Univ Zambia, Lusaka, Zambia; [Kassami, Natasha; Conteh, Lesong] Imperial Coll London, Sch Publ Hlth, Hlth Econ Grp, London, England; Univ Toronto, Womens Coll Hosp, Toronto, ON M5S 1B2, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; World Health Organization; World Health Organization; International Agency for Research on Cancer (IARC); University of London; London School of Hygiene & Tropical Medicine; Oncology Institute Prof. Dr. Ion Chiricuta; University of Toronto; Bangladesh Rural Advancement Committee BRAC; BRAC University; Hanoi Medical University; Fred Hutchinson Cancer Center; Seattle Cancer Care Alliance; University of Washington; University of Washington Seattle; Queens University - Canada; Research Triangle Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; University of London; King's College London; University of London; King's College London; Universidad Peruana Cayetano Heredia; University of North Carolina; University of North Carolina Chapel Hill; University of Zambia; Imperial College London; University of Toronto; University Toronto Affiliates; Womens College Hospital	Ginsburg, O (corresponding author), Univ Toronto, Womens Coll Hosp, 75 Grenville St, Toronto, ON M5S 1B2, Canada.	ophira.ginsburg@wchospital.ca	Eniu, Alexandru/ABD-1687-2020; Conteh, Lesong/ABE-9550-2020	Eniu, Alexandru/0000-0001-6666-5599; Conteh, Lesong/0000-0002-0719-3672; Sullivan, Richard/0000-0002-6435-1825; Bray, Freddie/0000-0002-3248-7787; Ginsburg, Ophira/0000-0002-1384-2675; Coleman, Michel/0000-0001-8940-3807; Sarker, Malabika/0000-0001-7293-8805	Canadian Institutes for Health Research; Institute for Global Health Equity and Innovation; Dalla Lana School of Public Health, University of Toronto (Toronto, ON, Canada); Cancer Research UK [11700, 16148, 18525] Funding Source: researchfish; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Institute for Global Health Equity and Innovation; Dalla Lana School of Public Health, University of Toronto (Toronto, ON, Canada); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The opinions expressed here are those of the authors and do not necessarily represent an official position of the organisations with which they are affiliated. OG had partial funding from the Canadian Institutes for Health Research, the Institute for Global Health Equity and Innovation, and the Dalla Lana School of Public Health, University of Toronto (Toronto, ON, Canada). We thank Mathieu Laversanne (IARC, Lyon, France) for development of selected figures in this report. We also thank Sabiha Merchant (Women's College Hospital, Toronto, Canada) for her assistance planning and coordinating the Toronto author's meeting.	Abbass E., 2011, Eastern Mediterranean Health Journal, V17, P930; Abdulrahman GO Jnr, 2012, J CANCER EPIDEMIOL, V2012, DOI 10.1155/2012/915610; Adesunkanmi ARK, 2006, BREAST, V15, P399, DOI 10.1016/j.breast.2005.06.008; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Alliance for Cervical Cancer Prevention, 2004, CAS INV CERV CANC PR, V3; [Anonymous], 2009, LANCET, V374, P1567, DOI 10.1016/S0140-6736(09)61930-9; [Anonymous], 2014, WORLD CANC REPORT 20; [Anonymous], 2009, CURR ONCOL; Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4; Arrossi S, 2007, GYNECOL ONCOL, V105, P335, DOI 10.1016/j.ygyno.2006.12.010; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Bazile J, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S1; Beaulieu N, 2009, BREAKAWAY GLOBAL BUR; Beral V, 2012, LANCET ONCOL, V13, P1141, DOI 10.1016/S1470-2045(12)70425-4; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Berraho M, 2012, ASIAN PAC J CANCER P, V13, P3159, DOI 10.7314/APJCP.2012.13.7.3159; Bewtra C, 2010, INT J CANC RES, V6, P154; Bigby JA, 2005, CANCER CAUSE CONTROL, V16, P35, DOI 10.1007/s10552-004-1263-1; Boncz I, 2014, VALUE HEALTH, V17, pA735, DOI 10.1016/j.jval.2014.08.105; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Boutayeb Saber, 2010, Cost Eff Resour Alloc, V8, P16, DOI 10.1186/1478-7547-8-16; Braitstein P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070054; Bray F, 2015, INT J CANCER, V137, P2060, DOI 10.1002/ijc.29670; Bray F, 2013, VACCINE, V31, pH32, DOI 10.1016/j.vaccine.2013.02.071; Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Burstein HJ, 2010, J CLIN ONCOL, V28, P3784, DOI 10.1200/JOP.000082; Bustreo F, 2012, B WORLD HEALTH ORGAN, V90, P478, DOI 10.2471/BLT.12.103549; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Centers for Disease Control and Prevention (CDC), HPV ASS CANC DIAGN A; Cherny NI, 2014, ANN ONCOL         S4, V25, piv39; Chlebowski RT, 2005, JNCI-J NATL CANCER I, V97, P439, DOI 10.1093/jnci/dji064; Chokunonga E, 2013, INT J CANCER, V133, P721, DOI 10.1002/ijc.28063; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Davari M, 2013, INT J PREVENTIVE MED, V4, P748; De Angelis R, 2014, LANCET ONCOL, V15, P23, DOI 10.1016/S1470-2045(13)70546-1; Denny L., 2016, LANCET; Denslow SA, 2014, INT J STD AIDS, V25, P163, DOI 10.1177/0956462413491735; DeSantis C, 2011, CANCER EPIDEM BIOMAR, V20, P733, DOI 10.1158/1055-9965.EPI-11-0061; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gelband H, 2015, DIS CONTROL PRIORITI, V3, DOI [10.1596/978-1-4648-0349-9, DOI 10.1596/978-1-4648-0349-9]; Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2; Ginsburg O., 2016, LANCET; Ginsburg OM, 2015, CURR ONCOL, V22, P97, DOI 10.3747/co.22.2359; Ginsburg OM, 2011, BREAST J, V17, P289, DOI 10.1111/j.1524-4741.2011.01067.x; Goldhaber-Fiebert Jeremy D, 2006, Cost Eff Resour Alloc, V4, P13, DOI 10.1186/1478-7547-4-13; Gomez SL, 2010, AM J PUBLIC HEALTH, V100, P861, DOI 10.2105/AJPH.2009.176651; Gustafsson L, 1997, INT J CANCER, V71, P159, DOI 10.1002/(SICI)1097-0215(19970410)71:2<159::AID-IJC6>3.0.CO;2-#; Hailu A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-69; Hausman R, 2012, GLOBAL GENDER GAP RE; International Labour Organization, 2008, GLOB EMPL TRENDS WOM; Iqbal J, 2015, JAMA-J AM MED ASSOC, V313, P165, DOI 10.1001/jama.2014.17322; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Janu-Llopis E., GLOBAL EC BURDEN NON; Javid SH, 2014, CANCER-AM CANCER SOC, V120, P2183, DOI 10.1002/cncr.28683; John RM, GLOBAL EC COSTS CANC; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kimman M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0433-1; Knaul FM., 2012, CLOSING CANC DIVIDE, P29; Knaul FM, 2014, CANC CONTROL, V11, P50; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Lofters AK, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-20; Maringe C, 2015, BRIT J CANCER, V113, P173, DOI 10.1038/bjc.2015.182; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Maskarinec G, 2011, WOMENS HEALTH, V7, P677, DOI [10.2217/WHE.11.67, 10.2217/whe.11.67]; Moore SP, 2015, LANCET ONCOL, V16, P1483, DOI 10.1016/S1470-2045(15)00232-6; Moore SP, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-517; Moore SP, 2014, CANCER MED-US, V3, P70, DOI 10.1002/cam4.134; Moucheraud C, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S1-S4; Newman LA, 2006, J CLIN ONCOL, V24, P1342, DOI 10.1200/JCO.2005.03.3472; Newmann SJ, 2005, CANCER CAUSE CONTROL, V16, P63, DOI 10.1007/s10552-004-1290-y; Lan NH, 2013, GLOBAL HEALTH ACTION, V6, P32, DOI 10.3402/gha.v6i0.18872; Othieno-Abinya NA, 2015, AFR J CANC, V7, P41; Pakseresht S, 2011, INDIAN J CANCER, V48, P428, DOI 10.4103/0019-509X.92263; Plummer M, 2012, INT J CANCER, V130, P2638, DOI 10.1002/ijc.26250; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Rambau Peter F, 2011, BMC Res Notes, V4, P214, DOI 10.1186/1756-0500-4-214; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Sankaranarayanan R, 2010, LANCET ONCOL, V11, P165, DOI 10.1016/S1470-2045(09)70335-3; Shannon GD, 2011, MATURITAS, V70, P234, DOI 10.1016/j.maturitas.2011.07.019; Silber JH, 2013, JAMA-J AM MED ASSOC, V310, P389, DOI 10.1001/jama.2013.8272; Singh Gopal K, 2012, Int J MCH AIDS, V1, P17; Soerjomataram I, 2012, LANCET, V380, P1840, DOI 10.1016/S0140-6736(12)60919-2; Sreedevi A, 2015, INT J WOMENS HEALTH, V7, P405, DOI 10.2147/IJWH.S50001; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Szczepura A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-346; Tao L, 2015, CANCER EPIDEM BIOMAR, V24, P1039, DOI 10.1158/1055-9965.EPI-15-0243; UN Secretary Generals Message, 2016, WORLD CANC DAY; UNAIDS, 2016, HPV HIV CERV CANC LE; UNDP, 1994, HUMAN DEV REPORT; United Nations Population Fund (UNFPA), 2016, MAT HLTH; Valery PC, 2006, LANCET, V367, P1842, DOI 10.1016/S0140-6736(06)68806-5; van Bogaert LJJ, 2011, INT J GYNECOL CANCER, V21, P363, DOI 10.1097/IGC.0b013e3182094d78; Vasilevska M, 2012, J PUBLIC HEALTH POL, V33, P148, DOI 10.1057/jphp.2012.8; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wabinga HR, 2014, INT J CANCER, V135, P432, DOI 10.1002/ijc.28661; Walters S, 2015, BRIT J CANCER, V113, P848, DOI 10.1038/bjc.2015.265; WHITEHEAD M, 1992, INT J HEALTH SERV, V22, P429, DOI 10.2190/986L-LHQ6-2VTE-YRRN; WHO, ESS MED SEL MED TREA; WHO, EV WOM EV CHILD GLOB; Woodward M, 2014, ASIA-PAC J CLIN ONCO, V10, P43; World Health Organization, 2009, WHO GUID ID EC CONS; World Health Organization, 2013, GLOB ACT PLAN PREV C; Worldwide Palliative Care Alliance & World Health Organization, 2014, GLOBAL ATLAS PALLIAT; Zaidi AA, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-60; Zeeshan Y, 2010, EUR J MED RES, V15, P197	110	482	508	11	171	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					847	860		10.1016/S0140-6736(16)31392-7	http://dx.doi.org/10.1016/S0140-6736(16)31392-7			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL9UU	27814965	Green Submitted, Green Accepted			2022-12-28	WOS:000394966400037
J	Newberry, SJ; FitzGerald, JD; Motala, A; Booth, M; Maglione, MA; Han, D; Tariq, A; O'Hanlon, CE; Shanman, R; Dudley, W; Shekelle, PG				Newberry, Sydne J.; FitzGerald, John D.; Motala, Aneesa; Booth, Marika; Maglione, Margaret A.; Han, Dan; Tariq, Abdul; O'Hanlon, Claire E.; Shanman, Roberta; Dudley, Whitney; Shekelle, Paul G.			Diagnosis of Gout: A Systematic Review in Support of an American College of Physicians Clinical Practice Guideline	ANNALS OF INTERNAL MEDICINE			English	Review							DUAL-ENERGY CT; EVIDENCE-BASED RECOMMENDATIONS; SYNOVIAL-FLUID EXAMINATION; CLASSIFICATION CRITERIA; URATE CRYSTAL; PRIMARY-CARE; ARTHRITIS; IDENTIFICATION; JOINT; REPRODUCIBILITY	Background: Alternative strategies exist for diagnosing gout that do not rely solely on the documentation of monosodium urate (MSU) crystals. Purpose: To summarize evidence regarding the accuracy of clinical tests and classification algorithms compared with that of a reference standard of MSU crystals in joint aspirate for diagnosing gout. Data Sources: Several electronic databases from inception to 29 February 2016. Study Selection: 21 prospective cohort, cross-sectional, and case-control studies including participants with joint inflammation and no previous definitive gout diagnosis who had MSU analysis of joint aspirate. Data Extraction: Data extraction and risk-of-bias assessment by 2 reviewers independently; overall strength of evidence (SOE) judgment by group. Data Synthesis: Recently developed algorithms including clinical, laboratory, and imaging criteria demonstrated good sensitivity (up to 88%) and fair to good specificity (up to 96%) for diagnosing gout (moderate SOE). Three studies of dual-energy computed tomography (DECT) showed sensitivities of 85% to 100% and specificities of 83% to 92% for diagnosing gout (low SOE). Six studies of ultrasonography showed sensitivities of 37% to 100% and specificities of 68% to 97%, depending on the ultrasonography signs assessed (pooled sensitivity and specificity for the double contour sign: 74% [95% CI, 52% to 88%] and 88% [CI, 68% to 96%], respectively [low SOE]). Limitation: Important study heterogeneity and selection bias; scant evidence in primary and urgent care settings and in patients with conditions that may be confused with or occur with gout. Conclusion: Multidimensional algorithms, which must be validated in primary and urgent care settings, may help clinicians make a provisional diagnosis of gout. Although DECT and ultrasonography also show promise for gout diagnosis, accessibility to these methods may be limited.	[Newberry, Sydne J.; FitzGerald, John D.; Motala, Aneesa; Booth, Marika; Maglione, Margaret A.; Han, Dan; Tariq, Abdul; O'Hanlon, Claire E.; Shanman, Roberta; Dudley, Whitney; Shekelle, Paul G.] RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA	RAND Corporation	Newberry, SJ (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	sydnen@rand.org	FitzGerald, John Dermot/T-5539-2018	FitzGerald, John Dermot/0000-0002-8419-7538	AHRQ [290-2012-00006I]; U.S. Department of Health and Human Services	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services	The evidence report was funded under contract 290-2012-00006I from the AHRQ, U.S. Department of Health and Human Services.	Agency for Healthcare Research and Quality, 2014, EV BAS PRACT CTR SYS; Aggarwal R, 2015, ARTHRIT CARE RES, V67, P891, DOI 10.1002/acr.22583; [Anonymous], 2014, AHRQ PUBLICATION, V10(12)-EHC063-EF; Bongartz T, 2015, ANN RHEUM DIS, V74, P1072, DOI 10.1136/annrheumdis-2013-205095; Glazebrook KN, 2011, RADIOLOGY, V261, P516, DOI 10.1148/radiol.11102485; Graf SW, 2013, CLIN RHEUMATOL, V32, P225, DOI 10.1007/s10067-012-2107-0; Harrold LR, 2013, RHEUMATOLOGY, V52, P1623, DOI 10.1093/rheumatology/ket158; HASSELBACHER P, 1987, ARTHRITIS RHEUM, V30, P637, DOI 10.1002/art.1780300606; Hunder GG, 1998, ANN INTERN MED, V129, P417, DOI 10.7326/0003-4819-129-5-199809010-00013; Huppertz A, 2014, RHEUMATOL INT, V34, P763, DOI 10.1007/s00296-014-2979-1; Janssens HJEM, 2010, ARCH INTERN MED, V170, P1120, DOI 10.1001/archinternmed.2010.196; Janssens HJEM, 2010, ANN RHEUM DIS, V69, P1255, DOI 10.1136/ard.2009.123687; Jatuworapruk K, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002730; Khosla S, 2009, FOOT ANKLE INT, V30, P886, DOI 10.3113/FAI.2009.0886; Kienhorst LBE, 2015, RHEUMATOLOGY, V54, P609, DOI 10.1093/rheumatology/keu378; Kienhorst LBE, 2014, JOINT BONE SPINE, V81, P342, DOI 10.1016/j.jbspin.2013.12.001; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Lai KL, 2011, J MED ULTRASOUND, V19, P7, DOI 10.1016/j.jmu.2011.01.003; Lamers-Karnebeek FBG, 2014, CLIN RHEUMATOL, V33, P555, DOI 10.1007/s10067-014-2505-6; Loffler C, 2015, J RHEUMATOL, V42, P513, DOI 10.3899/jrheum.140634; Malik A, 2009, JCR-J CLIN RHEUMATOL, V15, P22, DOI 10.1097/RHU.0b013e3181945b79; MCGILL NW, 1991, AUST NZ J MED, V21, P710, DOI 10.1111/j.1445-5994.1991.tb01374.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Neogi T, 2015, ARTHRITIS RHEUMATOL, V67, P2557, DOI 10.1002/art.39254; Newberry SJ, 2016, AHRQ PUBLICATION, V15-EHC026-EF; Owens D, 2008, Ir Med J, V101, P147; Park JW, 2014, KOREAN J INTERN MED, V29, P361, DOI 10.3904/kjim.2014.29.3.361; Pascal Z, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0701-7; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rettenbacher T, 2008, EUR RADIOL, V18, P621, DOI 10.1007/s00330-007-0802-z; Richette P, 2015, ANN RHEUM DIS, V74, P1684, DOI 10.1136/annrheumdis-2013-204976; Santaguida PL, 2012, J GEN INTERN MED, V27, pS33, DOI 10.1007/s11606-012-2030-8; SCHUMACHER HR, 1986, ARTHRITIS RHEUM, V29, P770, DOI 10.1002/art.1780290610; Segal JB, 1999, ARTHRIT CARE RES, V12, P376, DOI 10.1002/1529-0131(199912)12:6<376::AID-ART5>3.0.CO;2-5; Sivera F, 2014, ANN RHEUM DIS, V73, P328, DOI 10.1136/annrheumdis-2013-203325; Taylor WJ, 2016, J RHEUMATOL, V43, P150, DOI 10.3899/jrheum.150684; Taylor WJ, 2016, ANN RHEUM DIS, V75, P178, DOI 10.1136/annrheumdis-2014-206364; Taylor WJ, 2015, ARTHRIT CARE RES, V67, P1304, DOI 10.1002/acr.22585; Vazquez-Mellado J, 2012, CLIN RHEUMATOL, V31, P429, DOI 10.1007/s10067-011-1873-4; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320; Whiting P, 2011, J CLIN EPIDEMIOL, V64, P602, DOI 10.1016/j.jclinepi.2010.07.006; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; Zhu YY, 2011, ARTHRITIS RHEUM-US, V63, P3136, DOI 10.1002/art.30520	44	26	29	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					27	+		10.7326/M16-0462	http://dx.doi.org/10.7326/M16-0462			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	27802505				2022-12-28	WOS:000391467900006
J	Harpaz, R; Dahl, RM; Dooling, KL				Harpaz, Rafael; Dahl, Rebecca M.; Dooling, Kathleen L.			Prevalence of Immunosuppression Among US Adults, 2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DISEASES		[Harpaz, Rafael; Dahl, Rebecca M.; Dooling, Kathleen L.] US Ctr Dis Control & Prevent, Div Viral Dis, 1600 Clifton Rd,Mailstop A-34, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Harpaz, R (corresponding author), US Ctr Dis Control & Prevent, Div Viral Dis, 1600 Clifton Rd,Mailstop A-34, Atlanta, GA 30329 USA.	rzh6@cdc.gov						Institute of Medicine Committee on Emerging Microbial Threats to Health Emerging Infections, 1992, EM INF MICR THREATS; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Novosad SA, 2014, CLIN INFECT DIS, V58, P1587, DOI 10.1093/cid/ciu104; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355	5	106	109	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 20	2016	316	23					2547	2548		10.1001/jama.2016.16477	http://dx.doi.org/10.1001/jama.2016.16477			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3QH	27792809	Bronze			2022-12-28	WOS:000390959300023
J	Mack, M; Holmes, DR				Mack, Michael; Holmes, David R.			Randomised trials in left main disease: a NOBLE effort	LANCET			English	Editorial Material							5-YEAR OUTCOMES; SURGERY		[Mack, Michael] Baylor Scott & White Hlth, 3110 Allied Dr, Plano, TX 75093 USA; Mayo Clin, Rochester, MN USA	Baylor Health Care System; Mayo Clinic	Mack, M (corresponding author), Baylor Scott & White Hlth, 3110 Allied Dr, Plano, TX 75093 USA.	michael.mack@bswhealth.org						Ahn JM, 2015, J AM COLL CARDIOL, V65, P2198, DOI 10.1016/j.jacc.2015.03.033; Buszman PE, 2016, JACC-CARDIOVASC INTE, V9, P318, DOI 10.1016/j.jcin.2015.10.044; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Makikallio T, 2016, LANCET, V388, P2742; Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	6	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2715	2716		10.1016/S0140-6736(16)32067-0	http://dx.doi.org/10.1016/S0140-6736(16)32067-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	27810311				2022-12-28	WOS:000389629800004
J	Dever, DP; Bak, RO; Reinisch, A; Camarena, J; Washington, G; Nicolas, CE; Pavel-Dinu, M; Saxena, N; Wilkens, AB; Mantri, S; Uchida, N; Hendel, A; Narla, A; Majeti, R; Weinberg, KI; Porteus, MH				Dever, Daniel P.; Bak, Rasmus O.; Reinisch, Andreas; Camarena, Joab; Washington, Gabriel; Nicolas, Carmencita E.; Pavel-Dinu, Mara; Saxena, Nivi; Wilkens, Alec B.; Mantri, Sruthi; Uchida, Nobuko; Hendel, Ayal; Narla, Anupama; Majeti, Ravindra; Weinberg, Kenneth I.; Porteus, Matthew H.			CRISPR/Cas9 beta-globin gene targeting in human haematopoietic stem cells	NATURE			English	Article							HOMOLOGOUS RECOMBINATION; DONOR LYMPHOCYTES; PROGENITOR CELLS; MESSENGER-RNA; THERAPY; TRANSPLANTATION; ENDONUCLEASE	The beta-haemoglobinopathies, such as sickle cell disease and beta-thalassaemia, are caused by mutations in the beta-globin (HBB) gene and affect millions of people worldwide. Ex vivo gene correction in patient-derived haematopoietic stem cells followed by autologous transplantation could be used to cure beta-haemoglobinopathies. Here we present a CRISPR/Cas9 gene-editing system that combines Cas9 ribonucleoproteins and adeno-associated viral vector delivery of a homologous donor to achieve homologous recombination at the HBB gene in haematopoietic stem cells. Notably, we devise an enrichment model to purify a population of haematopoietic stem and progenitor cells with more than 90% targeted integration. We also show efficient correction of the Glu6Val mutation responsible for sickle cell disease by using patient-derived stem and progenitor cells that, after differentiation into erythrocytes, express adult beta-globin (HbA) messenger RNA, which confirms intact transcriptional regulation of edited HBB alleles. Collectively, these preclimical studies outline a CRISPR-based methodology for targeting haematopoietic stem cells by homologous recombination at the HBB locus to advance the development of next-generation therapies for beta-haemoglobinopathies.	[Dever, Daniel P.; Bak, Rasmus O.; Camarena, Joab; Washington, Gabriel; Nicolas, Carmencita E.; Pavel-Dinu, Mara; Saxena, Nivi; Wilkens, Alec B.; Mantri, Sruthi; Hendel, Ayal; Weinberg, Kenneth I.; Porteus, Matthew H.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Reinisch, Andreas; Majeti, Ravindra] Stanford Univ, Inst Canc, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Reinisch, Andreas; Majeti, Ravindra] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Uchida, Nobuko] Stem Cells Inc, 7707 Gateway Blvd,Suite 140, Newark, CA 94560 USA; [Narla, Anupama] Stanford Univ, Sch Med, Dept Pediat, Div Hematol Oncol, Stanford, CA 94035 USA; [Uchida, Nobuko] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Porteus, MH (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.	mporteus@stanford.edu	Hendel, Ayal/GMW-7991-2022; Bak, Rasmus O./AAH-9748-2021	Bak, Rasmus O./0000-0002-7383-0297; Hendel, Ayal/0000-0002-3388-6202; Reinisch, Andreas/0000-0001-9333-7689; Majeti, Ravindra/0000-0002-5814-0984; Camarena, Joab/0000-0002-3102-5820	Stanford Child Health Research Institute (CHRI); Danish Council for Independent Research, Medical Sciences [DFF-1333-00106B, DFF-1331-00735B]; Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; NIH [PN2EY018244, R01-AI097320, R01-AI120766]; Austrian Science Fund (FWF) [J 3358] Funding Source: researchfish; NATIONAL EYE INSTITUTE [PN2EY018244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI120766, R01AI097320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	Stanford Child Health Research Institute (CHRI); Danish Council for Independent Research, Medical Sciences(Det Frie Forskningsrad (DFF)); Amon Carter Foundation; Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	D.P.D. was supported by a Stanford Child Health Research Institute (CHRI) Grant and Postdoctoral Award. R.O.B. was supported by an Individual Postdoctoral grant (DFF-1333-00106B) and a Sapere Aude, Research Talent grant (DFF-1331-00735B), both from the Danish Council for Independent Research, Medical Sciences. M.H.P. acknowledges the support of the Amon Carter Foundation, the Laurie Kraus Lacob Faculty Scholar Award in Pediatric Translational Research and NIH grant support PN2EY018244, R01-AI097320 and R01-AI120766. We thank D. Russell for the pDGM6 plasmid, H.-P. Kiem for scAAV6, G. de Alencastro and M. Kay for help with AAV production, the Binns Program for Cord Blood Research at Stanford University for cord-blood-derived CD34<SUP>+</SUP> HSPCs. We also thank Lonza (A. Toell and G. Alberts) for donating the LV unit for performing large-scale genome-editing studies. We further thank members of the Porteus laboratory, D. DiGiusto and M. G. Roncarolo for input, comments and discussion.	Barzel A, 2015, NATURE, V517, P360, DOI 10.1038/nature13864; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; Bonini C, 2003, NAT MED, V9, P367, DOI 10.1038/nm0403-367; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Ciceri F, 2009, LANCET ONCOL, V10, P489, DOI 10.1016/S1470-2045(09)70074-9; De Ravin SS, 2016, NAT BIOTECHNOL, V34, P424, DOI 10.1038/nbt.3513; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Dulmovits BM, 2016, BLOOD, V127, P1481, DOI 10.1182/blood-2015-09-667923; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; Gu A, 2014, HUM GENE THER METHOD, V25, P221, DOI 10.1089/hgtb.2014.043; Hendel A, 2015, NAT BIOTECHNOL, V33, P985, DOI 10.1038/nbt.3290; Hoban MD, 2016, BLOOD, V127, P839, DOI 10.1182/blood-2015-09-618587; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu JP, 2013, BLOOD, V121, P3246, DOI 10.1182/blood-2013-01-476390; Hubbard N, 2016, BLOOD, V127, P2513, DOI 10.1182/blood-2015-11-683235; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Levasseur DN, 2004, J BIOL CHEM, V279, P27518, DOI 10.1074/jbc.M402578200; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Miller DG, 2004, NAT GENET, V36, P767, DOI 10.1038/ng1380; Mukherjee S, 2013, GENE, V525, P174, DOI 10.1016/j.gene.2013.03.098; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Naldini L, 2011, NAT REV GENET, V12, P301, DOI 10.1038/nrg2985; Oliveira G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8265; Porteus M, 2016, ANNU REV PHARMACOL, V56, P163, DOI 10.1146/annurev-pharmtox-010814-124454; Porteus MH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0859-y; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Romero Z, 2013, J CLIN INVEST, V123, P3317, DOI 10.1172/JCI67930; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; Sather BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5530; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; Voit RA, 2014, NUCLEIC ACIDS RES, V42, P1365, DOI 10.1093/nar/gkt947; Wang JB, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1121; Wang JB, 2015, NAT BIOTECHNOL, V33, P1256, DOI 10.1038/nbt.3408; Woods NB, 2006, NATURE, V440, P1123, DOI 10.1038/4401123a	42	482	517	19	297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					384	389		10.1038/nature20134	http://dx.doi.org/10.1038/nature20134			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27820943	Green Accepted			2022-12-28	WOS:000388161700045
J	Friedrich, MJ				Friedrich, M. J.			UN Leaders Commit to Fight Antimicrobial Resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1956	1956		10.1001/jama.2016.16531	http://dx.doi.org/10.1001/jama.2016.16531			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838729				2022-12-28	WOS:000387673800003
J	Brucato, A; Imazio, M; Gattorno, M; Lazaros, G; Maestroni, S; Carraro, M; Finetti, M; Cumetti, D; Carobbio, A; Ruperto, N; Marcolongo, R; Lorini, M; Rimini, A; Valenti, A; Erre, GL; Sormani, MP; Belli, R; Gaita, F; Martini, A				Brucato, Antonio; Imazio, Massimo; Gattorno, Marco; Lazaros, George; Maestroni, Silvia; Carraro, Mara; Finetti, Martina; Cumetti, Davide; Carobbio, Alessandra; Ruperto, Nicolino; Marcolongo, Renzo; Lorini, Monia; Rimini, Alessandro; Valenti, Anna; Erre, Gian Luca; Sormani, Maria Pia; Belli, Riccardo; Gaita, Fiorenzo; Martini, Alberto			Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence The AIRTRIP Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR ANTAGONIST ANAKINRA; CONSTRICTIVE PERICARDITIS; RHEUMATOID-ARTHRITIS; MANAGEMENT; SAFETY; EFFICACY; MUTATION	IMPORTANCE Anakinra, an interleukin 1 beta recombinant receptor antagonist, may have potential to treat colchicine-resistant and corticosteroid-dependent recurrent pericarditis. OBJECTIVE To determine the efficacy of anakinra for colchicine-resistant and corticosteroid-dependent recurrent pericarditis. DESIGN, SETTING, AND PARTICIPANTS The Anakinra-Treatment of Recurrent Idiopathic Pericarditis (AIRTRIP) double-blind, placebo-controlled, randomized withdrawal trial (open label with anakinra followed by a double-blind withdrawal step with anakinra or placebo until recurrent pericarditis occurred) conducted among 21 consecutive patients enrolled at 3 Italian referral centers between June and November 2014 (end of follow-up, October 2015). Included patients had recurrent pericarditis (with >= 3 previous recurrences), elevation of C-reactive protein, colchicine resistance, and corticosteroid dependence. INTERVENTIONS Anakinra was administered at 2 mg/kg per day, up to 100 mg, for 2 months, then patients who responded with resolution of pericarditis were randomized to continue anakinra (n = 11) or switch to placebo (n = 10) for 6 months or until a pericarditis recurrence. MAIN OUTCOMES AND MEASURES The primary outcomes were recurrent pericarditis and time to recurrence after randomization. RESULTS Eleven patients (7 female) randomized to anakinra had a mean age of 46.5 (SD, 16.3) years; 10 patients (7 female) randomized to placebo had a mean age of 44 (SD, 12.5) years. All patients were followed up for 12 months. Median follow-up was 14 (range, 12-17) months. Recurrent pericarditis occurred in 9 of 10 patients (90%; incidence rate, 2.06% of patients per year) assigned to placebo and 2 of 11 patients (18.2%; incidence rate, 0.11% of patients per year) assigned to anakinra, for an incidence rate difference of -1.95%(95% CI, -3.3% to -0.6%). Median flare-free survival (time to flare) was 72 (interquartile range, 64-150) days after randomization in the placebo group and was not reached in the anakinra group (P <. 001). During anakinra treatment, 20 of 21 patients (95.2%) experienced transient local skin reactions: 1 (4.8%) herpes zoster, 3 (14.3%) transaminase elevation, and 1 (4.8%) ischemic optic neuropathy. No patient permanently discontinued the active drug. No adverse events occurred during placebo treatment. CONCLUSION AND RELEVANCE In this preliminary study of patients with recurrent pericarditis with colchicine resistance and corticosteroid dependence, the use of anakinra compared with placebo reduced the risk of recurrence over a median of 14 months. Larger studies are needed to replicate these findings as well as to assess safety and longer-term efficacy.	[Brucato, Antonio; Maestroni, Silvia; Cumetti, Davide; Carobbio, Alessandra; Lorini, Monia; Valenti, Anna] Osped Papa Giovanni XXIII, Div Internal Med, Res Fdn, Bergamo, Italy; [Brucato, Antonio; Maestroni, Silvia; Cumetti, Davide; Carobbio, Alessandra; Lorini, Monia; Valenti, Anna] Osped Papa Giovanni XXIII, Clin Pharmacol, Bergamo, Italy; [Imazio, Massimo; Lazaros, George; Carraro, Mara; Belli, Riccardo] Univ Turin, Dept Cardiol, Maria Vittoria Hosp, Turin, Italy; [Imazio, Massimo; Lazaros, George; Carraro, Mara; Belli, Riccardo] Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy; [Gattorno, Marco; Finetti, Martina; Ruperto, Nicolino; Rimini, Alessandro; Sormani, Maria Pia; Martini, Alberto] IRCCS Ist G Gaslini, Pediat 2, Genoa, Italy; [Lazaros, George] Univ Athens, Dept Cardiol, Sch Med, Hippokration Hosp, Athens, Greece; [Marcolongo, Renzo] Azienda Osped Univ, Dept Med, Clin Immunol, Padua, Italy; [Erre, Gian Luca] Azienda Osped Univ Sassari, Reumatol, Sassari, Italy; [Gaita, Fiorenzo] Univ Cardiol Div, Dept Med Sci, Citta Sci & Salute, Turin, Italy; [Martini, Alberto] Univ Genoa, Genoa, Italy	ASST Papa Giovanni XXIII; ASST Papa Giovanni XXIII; Maria Vittoria Hospital; University of Turin; University of Turin; University of Genoa; IRCCS Istituto Giannina Gaslini; Athens Medical School; Hippokration General Hospital; National & Kapodistrian University of Athens; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Sassari; A.O.U. Citta della Salute e della Scienza di Torino; University of Genoa	Imazio, M (corresponding author), Univ Turin, Dept Publ Hlth & Pediat, Turin, Italy.; Imazio, M (corresponding author), Univ Turin, Univ Cardiol, AOU Citta Salute Sci & Torino, Turin, Italy.	massimo_imazio@yahoo.it	rimini, alessandro/AAA-9439-2021; Sormani, Maria Pia/ABH-8756-2020; Erre, Gian Luca/C-7907-2017; Ruperto, Nicolino/K-3349-2018; brucato, antonio/U-6879-2019; Carobbio, Alessandra/G-8407-2016; Gattorno, Marco/AAL-2974-2020	rimini, alessandro/0000-0002-2545-9235; Erre, Gian Luca/0000-0001-6818-7666; Ruperto, Nicolino/0000-0001-8407-7782; brucato, antonio/0000-0002-7566-5600; Carobbio, Alessandra/0000-0001-9664-7084; Gattorno, Marco/0000-0003-0704-1916; SORMANI, MARIA PIA/0000-0001-6892-104X; Imazio, Massimo/0000-0002-5722-0245; MARTINI, Alberto/0000-0001-7642-1459	SOBI (Sweden)	SOBI (Sweden)	SOBI (Sweden) provided anakinra and placebo as part of unrestricted institutional grant.	Adler Y, 2015, EUR HEART J, V36, P2921, DOI 10.1093/eurheartj/ehv318; Brucato A, 2015, CLIN EXP RHEUMATOL, V33, P946; Campion GV, 1996, ARTHRITIS RHEUM, V39, P1092, DOI 10.1002/art.1780390704; Cantarini L, 2010, CLIN EXP RHEUMATOL, V28, P802; Cantarini L, 2013, CLIN REV ALLERG IMMU, V44, P6, DOI 10.1007/s12016-010-8219-x; D'Elia E, 2015, CLIN EXP RHEUMATOL, V33, P294; Emmi G, 2014, CLIN EXP RHEUMATOL, V32, P297; Filocamo G, 2010, J RHEUMATOL, V37, P1534, DOI 10.3899/jrheum.091474; Finetti M, 2014, J PEDIATR-US, V164, P1425, DOI 10.1016/j.jpeds.2014.01.065; Fleischmann R. M., 2003, Rheumatology (Oxford), V42, pii29, DOI 10.1093/rheumatology/keg330; Imazio M, 2016, JAMA-J AM MED ASSOC, V315, P90, DOI 10.1001/jama.2015.16998; Imazio M, 2015, JAMA-J AM MED ASSOC, V314, P1498, DOI 10.1001/jama.2015.12763; Imazio M, 2014, LANCET, V383, P2232, DOI 10.1016/S0140-6736(13)62709-9; Imazio M, 2013, NEW ENGL J MED, V369, P1522, DOI 10.1056/NEJMoa1208536; Imazio M, 2011, ANN INTERN MED, V155, P409, DOI 10.7326/0003-4819-155-7-201110040-00359; Jain S, 2015, AM J CARDIOL, V116, P1277, DOI 10.1016/j.amjcard.2015.07.047; Kaiser C, 2012, RHEUMATOL INT, V32, P295, DOI 10.1007/s00296-011-2096-3; Lazaros G, 2016, J CARDIOVASC MED, V17, P256, DOI 10.2459/JCM.0000000000000266; Lazaros G, 2014, ANN RHEUM DIS, V73, P2215, DOI 10.1136/annrheumdis-2014-205990; LeWinter MM, 2014, NEW ENGL J MED, V371, P2410, DOI 10.1056/NEJMcp1404070; Massardier C, 2014, INT J CARDIOL, V177, pE75, DOI 10.1016/j.ijcard.2014.09.192; Picco P, 2009, ARTHRITIS RHEUM-US, V60, P264, DOI 10.1002/art.24174; Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188; Scardapane A, 2013, PEDIATR CARDIOL, V34, P1989, DOI 10.1007/s00246-012-0532-0; Scott Ian C, 2011, J Cardiol Cases, V4, pe93, DOI 10.1016/j.jccase.2011.07.003; Woodrick RS, 2011, NAT REV RHEUMATOL, V7, P639, DOI 10.1038/nrrheum.2011.145	26	172	176	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1906	1912		10.1001/jama.2016.15826	http://dx.doi.org/10.1001/jama.2016.15826			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27825009	Green Published			2022-12-28	WOS:000387116500019
J	Hofmann, R; Bode, JW				Hofmann, Raphael; Bode, Jeffrey W.			CHEMICAL BIOLOGY A radical approach to posttranslational mutagenesis	SCIENCE			English	Editorial Material							GENERAL-METHOD; PROTEINS; DEHYDROALANINE; HISTONES; PEPTIDES; LIGATION		[Hofmann, Raphael; Bode, Jeffrey W.] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Bode, JW (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Organ Chem Lab, CH-8093 Zurich, Switzerland.	bode@org.chem.ethz.ch		Hofmann, Raphael/0000-0002-9769-6555				Chalker JM, 2011, CHEM SCI, V2, P1666, DOI 10.1039/c1sc00185j; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Harmand TJ, 2016, NAT PROTOC, V11, P1130, DOI 10.1038/nprot.2016.052; Junutula JR, 2008, NAT BIOTECHNOL, V26, P925, DOI 10.1038/nbt.1480; Lee S, 2013, ANGEW CHEM INT EDIT, V52, P5771, DOI 10.1002/anie.201300531; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; Seebeck FP, 2006, J AM CHEM SOC, V128, P7150, DOI 10.1021/ja060966w; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Wang J, 2007, ANGEW CHEM INT EDIT, V46, P6849, DOI 10.1002/anie.200702305; Wright TH, 2016, SCIENCE, V354, DOI 10.1126/science.aag1465; Yang A, 2016, SCIENCE, V354, P623, DOI 10.1126/science.aah4428; You YO, 2009, ACS CHEM BIOL, V4, P379, DOI 10.1021/cb800309v	13	2	2	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					553	554		10.1126/science.aai8788	http://dx.doi.org/10.1126/science.aai8788			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811256				2022-12-28	WOS:000386869800023
J	Peirs, C; Seal, RP				Peirs, Cedric; Seal, Rebecca P.			Neural circuits for pain: Recent advances and current views	SCIENCE			English	Review							INDUCED NEUROPATHIC PAIN; SENSING ION CHANNELS; SENSORY NEURONS; DORSAL-HORN; SPINAL-CORD; MECHANICAL ALLODYNIA; FUNCTIONAL-ORGANIZATION; TOUCH RECEPTORS; ANION GRADIENT; NERVE INJURY	The mammalian nervous system encodes many different forms of pain, from those that arise as a result of short-term low-grade interactions with noxious thermal, chemical, or mechanical sources to more serious forms of pain induced by trauma and disease. In this Review, we highlight recent advances in our understanding of the neural circuits that encode these types of pain. Promising therapeutic strategies based on recent advances are also highlighted.	[Peirs, Cedric; Seal, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Neurobiol, 3501 Fifth Ave,BST3, Pittsburgh, PA 15213 USA; [Peirs, Cedric; Seal, Rebecca P.] Univ Pittsburgh, Sch Med, Dept Otolaryngol, 3501 Fifth Ave,BST3, Pittsburgh, PA 15213 USA; [Peirs, Cedric; Seal, Rebecca P.] Univ Pittsburgh, Sch Med, Pittsburgh Ctr Pain Res, 200 Lothrop St, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Seal, RP (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, 3501 Fifth Ave,BST3, Pittsburgh, PA 15213 USA.; Seal, RP (corresponding author), Univ Pittsburgh, Sch Med, Dept Otolaryngol, 3501 Fifth Ave,BST3, Pittsburgh, PA 15213 USA.; Seal, RP (corresponding author), Univ Pittsburgh, Sch Med, Pittsburgh Ctr Pain Res, 200 Lothrop St, Pittsburgh, PA 15213 USA.	rpseal@pitt.edu		Peirs, Cedric/0000-0002-2296-0323	Rita Allen Foundation; American Pain Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS084191] Funding Source: NIH RePORTER	Rita Allen Foundation; American Pain Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided by the Rita Allen Foundation and the American Pain Society to R.P.S.	Abraira VE, 2013, NEURON, V79, P618, DOI 10.1016/j.neuron.2013.07.051; Agudo J, 2015, NAT BIOTECHNOL, V33, P1287, DOI 10.1038/nbt.3386; Baumbauer KM, 2015, ELIFE, V4, DOI 10.7554/eLife.09674; Beggs S, 2012, NAT NEUROSCI, V15, P1068, DOI 10.1038/nn.3155; Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Braz J, 2014, NEURON, V82, P522, DOI 10.1016/j.neuron.2014.01.018; Braz JM, 2012, NEURON, V74, P663, DOI 10.1016/j.neuron.2012.02.033; Brenneis C, 2013, J NEUROSCI, V33, P315, DOI 10.1523/JNEUROSCI.2804-12.2013; Carvalho OP, 2011, J MED GENET, V48, P131, DOI 10.1136/jmg.2010.081455; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chiu IM, 2014, ELIFE, V3, DOI 10.7554/eLife.04660; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Daou I, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0140-15.2016; Delfini MC, 2013, CELL REP, V5, P378, DOI 10.1016/j.celrep.2013.09.013; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Eijkelkamp N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2673; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; Hughes DI, 2012, J PHYSIOL-LONDON, V590, P3927, DOI 10.1113/jphysiol.2012.235655; Iyer SM, 2014, NAT BIOTECHNOL, V32, P274, DOI 10.1038/nbt.2834; Jensen TS, 2014, LANCET NEUROL, V13, P924, DOI 10.1016/S1474-4422(14)70102-4; Julius D, 2015, CURR OPIN NEUROBIOL, V34, pV, DOI 10.1016/j.conb.2015.07.001; Kahle KT, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad0163; Knowlton WM, 2013, J NEUROSCI, V33, P2837, DOI 10.1523/JNEUROSCI.1943-12.2013; Koga K, 2015, NEURON, V85, P377, DOI 10.1016/j.neuron.2014.12.021; Krishnan A, 2016, ELIFE, V5, DOI 10.7554/eLife.15166; Lee JH, 2014, CELL, V157, P1393, DOI 10.1016/j.cell.2014.03.064; Li CL, 2016, CELL RES, V26, P83, DOI 10.1038/cr.2015.149; Li LY, 2016, CELL REP, V15, P1376, DOI 10.1016/j.celrep.2016.04.039; Li LS, 2011, CELL, V147, P1615, DOI 10.1016/j.cell.2011.11.027; Lu Y, 2013, J CLIN INVEST, V123, P4050, DOI 10.1172/JCI70026; Maksimovic S, 2014, NATURE, V509, P617, DOI 10.1038/nature13250; McCoy ES, 2013, NEURON, V78, P138, DOI 10.1016/j.neuron.2013.01.030; McCoy ES, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036355; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Minett MS, 2014, CELL REP, V6, P301, DOI 10.1016/j.celrep.2013.12.033; Miraucourt LS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001116; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Pang ZX, 2015, PAIN, V156, P656, DOI 10.1097/j.pain.0000000000000092; Peirs C, 2015, NEURON, V87, P797, DOI 10.1016/j.neuron.2015.07.029; Petitjean H, 2015, CELL REP, V13, P1246, DOI 10.1016/j.celrep.2015.09.080; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Roudaut Y, 2012, CHANNELS, V6, P234, DOI 10.4161/chan.22213; Sabatowski R, 2004, CURR PHARM DESIGN, V10, P701, DOI 10.2174/1381612043452974; Sakai A, 2013, BRAIN, V136, P2738, DOI 10.1093/brain/awt191; Salomons TV, 2016, JAMA NEUROL, V73, P755, DOI 10.1001/jamaneurol.2016.0653; Samad OA, 2013, MOL THER, V21, P49, DOI 10.1038/mt.2012.169; Schwartz N, 2014, SCIENCE, V345, P535, DOI 10.1126/science.1253994; Schweinhardt P, 2010, J CLIN INVEST, V120, P3788, DOI 10.1172/JCI43498; Seal RP, 2009, NATURE, V462, P651, DOI 10.1038/nature08505; Sharif-Naeini R, 2015, PROG MOL BIOL TRANSL, V131, P53, DOI 10.1016/bs.pmbts.2014.11.011; Sorge RE, 2015, NAT NEUROSCI, V18, P1081, DOI 10.1038/nn.4053; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Torsney C, 2006, J NEUROSCI, V26, P1833, DOI 10.1523/JNEUROSCI.4584-05.2006; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Xu H, 2008, J NEUROSCI, V28, P7445, DOI 10.1523/JNEUROSCI.1812-08.2008; Xu ZZ, 2015, NAT MED, V21, P1326, DOI 10.1038/nm.3978; Yang SL, 2013, P NATL ACAD SCI USA, V110, P17534, DOI 10.1073/pnas.1306285110; Yasaka T, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-3; Zeilhofer HU, 2012, PHYSIOL REV, V92, P193, DOI 10.1152/physrev.00043.2010; Zimmerman A, 2014, SCIENCE, V346, P950, DOI 10.1126/science.1254229	68	203	205	6	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					578	584		10.1126/science.aaf8933	http://dx.doi.org/10.1126/science.aaf8933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811268				2022-12-28	WOS:000386869800037
J	Nayan, M; Hamilton, RJ; Macdonald, EM; Li, Q; Mamdani, MM; Earle, CC; Kulkarni, GS; Jarvi, KA; Juurlink, DN				Nayan, Madhur; Hamilton, Robert J.; Macdonald, Erin M.; Li, Qing; Mamdani, Muhammad M.; Earle, Craig C.; Kulkarni, Girish S.; Jarvi, Keith A.; Juurlink, David N.		Canadian Drug Safety Effectiveness	Vasectomy and risk of prostate cancer: population based matched cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HORMONE LEVELS; BREAST-CANCER; MEN; METAANALYSIS; ASSOCIATION; MORTALITY; SURVIVAL; REGISTRY	OBJECTIVE To determine the association between vasectomy and prostate cancer, adjusting for measures of health seeking behaviour. DESIGN Population based matched cohort study. SETTING Multiple validated healthcare databases in Ontario, Canada, 1994-2012. PARTICIPANTS 326 607 men aged 20 to 65 who had undergone vasectomy were identified through physician billing codes and matched 1: 1 on age (within two years), year of cohort entry, comorbidity score, and geographical region to men who did not undergo a vasectomy. MAIN OUTCOMES MEASURES The primary outcome was incident prostate cancer. Secondary outcomes were prostate cancer related grade, stage, and mortality. RESULTS 3462 incident cases of prostate cancer were identified after a median follow-up of 10.9 years: 1843 (53.2%) in the vasectomy group and 1619 (46.8%) in the non-vasectomy group. In unadjusted analysis, vasectomy was associated with a slightly increased risk of incident prostate cancer (hazard ratio 1.13, 95% confidence interval 1.05 to 1.20). After adjustment for measures of health seeking behaviour, however, no association remained (adjusted hazard ratio 1.02, 95% confidence interval 0.95 to 1.09). Moreover, no association was found between vasectomy and high grade prostate cancer (adjusted odds ratio 1.05, 95% confidence interval 0.67 to 1.66), advanced stage prostate cancer (adjusted odds ratio 1.04, 0.81 to 1.34), or mortality (adjusted hazard ratio 1.06, 0.60 to 1.85). CONCLUSION The findings do not support an independent association between vasectomy and prostate cancer.	[Nayan, Madhur; Hamilton, Robert J.; Kulkarni, Girish S.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg, Div Urol, 610 Univ Ave 3-130, Toronto, ON M5G 2M9, Canada; [Nayan, Madhur; Hamilton, Robert J.; Kulkarni, Girish S.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, 610 Univ Ave 3-130, Toronto, ON M5G 2M9, Canada; [Nayan, Madhur; Hamilton, Robert J.; Kulkarni, Girish S.] Univ Toronto, 610 Univ Ave 3-130, Toronto, ON M5G 2M9, Canada; [Macdonald, Erin M.; Li, Qing; Mamdani, Muhammad M.; Earle, Craig C.; Kulkarni, Girish S.; Juurlink, David N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Earle, Craig C.] Ontario Inst Canc Res, Toronto, ON, Canada; [Jarvi, Keith A.] Univ Toronto, Mt Sinai Hosp, Dept Surg, Div Urol, Toronto, ON, Canada; [Jarvi, Keith A.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada; [Jarvi, Keith A.] Mt Sinai Hosp, Lunenfeld Tannenbaum Res Inst, Toronto, ON, Canada; [Juurlink, David N.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Internal Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Nayan, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg, Div Urol, 610 Univ Ave 3-130, Toronto, ON M5G 2M9, Canada.; Nayan, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, Div Urol, 610 Univ Ave 3-130, Toronto, ON M5G 2M9, Canada.; Nayan, M (corresponding author), Univ Toronto, 610 Univ Ave 3-130, Toronto, ON M5G 2M9, Canada.	madhur.nayan@mail.utoronto.ca			Canadian Drug Safety and Effectiveness Research Network; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Eaton scholar award, Department of Medicine, University of Toronto	Canadian Drug Safety and Effectiveness Research Network; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Eaton scholar award, Department of Medicine, University of Toronto	This study was supported in part by a grant from the Canadian Drug Safety and Effectiveness Research Network, and by the Institute for Clinical Evaluative Sciences, a non-profit research institute sponsored by the Ontario Ministry of Health and Long-Term Care. DNJ is supported by the Eaton scholar award, Department of Medicine, University of Toronto. The opinions, results, and conclusions reported in this paper are those of the authors and are independent of the funding sources. No endorsement by the Institute for Clinical Evaluative Sciences or the Ontario Ministry of Health and Long-Term Care is intended or should be inferred. Parts of this material are based on data and information compiled and provided by Canadian Institute for Health Information. The analyses, conclusions, opinions, and statements expressed herein, however, are those of the authors, and not necessarily those of the Canadian Institute for Health Information.	[Anonymous], AUA RESP STUD LINK V; Atzema CL, 2016, ANN NEUROL, V79, P32, DOI 10.1002/ana.24521; Austin PC, 2011, MED CARE, V49, P932, DOI 10.1097/MLR.0b013e318215d5e2; Bakalar N., 2014, VASECTOMY MAY INCREA; Brenner DR, 2009, CHRONIC DIS CAN, V30, P16; Chacko JA, 2002, J UROLOGY, V168, P1408, DOI 10.1016/S0022-5347(05)64461-8; Cox B, 2002, JAMA-J AM MED ASSOC, V287, P3110, DOI 10.1001/jama.287.23.3110; DELATORRE B, 1983, INT J ANDROL, V6, P125; Eisenberg ML, 2009, UROLOGY, V74, P1020, DOI 10.1016/j.urology.2009.06.042; Emard JF, 2001, HEALTH PLACE, V7, P131, DOI 10.1016/S1353-8292(01)00005-3; FARLEY TMM, 1993, B WORLD HEALTH ORGAN, V71, P413; Gann PH, 1996, J NATL CANCER I, V88, P1118, DOI 10.1093/jnci/88.16.1118; GIOVANNUCCI E, 1993, JAMA-J AM MED ASSOC, V269, P873, DOI 10.1001/jama.269.7.873; GIOVANNUCCI E, 1993, JAMA-J AM MED ASSOC, V269, P878, DOI 10.1001/jama.269.7.878; GLAVIND K, 1990, International Urology and Nephrology, V22, P553, DOI 10.1007/BF02549744; Goldacre MJ, 2005, FERTIL STERIL, V84, P1438, DOI 10.1016/j.fertnstert.2005.04.052; Hall S, 2006, J CLIN EPIDEMIOL, V59, P67, DOI 10.1016/j.jclinepi.2005.05.001; HAYES RB, 1993, AM J EPIDEMIOL, V137, P263, DOI 10.1093/oxfordjournals.aje.a116673; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; Holt SK, 2008, J UROLOGY, V180, P2565, DOI 10.1016/j.juro.2008.08.042; HONDA GD, 1988, BRIT J CANCER, V57, P326, DOI 10.1038/bjc.1988.74; HSING AW, 1994, CANCER EPIDEM BIOMAR, V3, P285; Jacobstein R, 2005, VASECTOMY SAFE CONVE; Jamieson DJ, 2004, OBSTET GYNECOL, V103, P848, DOI 10.1097/01.AOG.0000123246.11511.e4; JOHN EM, 1995, J NATL CANCER I, V87, P662, DOI 10.1093/jnci/87.9.662; Juurlink D, 2006, CANADIAN I HLTH INFO; Lega IC, 2013, DIABETES CARE, V36, P3018, DOI 10.2337/dc12-2535; Leitzmann MF, 2004, JAMA-J AM MED ASSOC, V291, P1578, DOI 10.1001/jama.291.13.1578; Lesko SM, 1999, J UROLOGY, V161, P1848, DOI 10.1016/S0022-5347(05)68824-6; Liu LH, 2015, ANDROLOGY-US, V3, P643, DOI 10.1111/andr.12040; Liu LH, 2001, J NATL CANCER I, V93, P705, DOI 10.1093/jnci/93.9.705; Lynge E, 2002, J UROLOGY, V168, P488, DOI 10.1016/S0022-5347(05)64664-2; Margel D, 2013, J CLIN ONCOL, V31, P3069, DOI 10.1200/JCO.2012.46.7043; McGregor SE, 2007, AM J GASTROENTEROL, V102, P1727, DOI 10.1111/j.1572-0241.2007.01217.x; METTLIN C, 1990, AM J EPIDEMIOL, V132, P1056, DOI 10.1093/oxfordjournals.aje.a115747; MO ZN, 1995, J UROLOGY, V154, P2065, DOI 10.1016/S0022-5347(01)66696-5; Nayan M, 2016, PHARMACOL RES, V113, P468, DOI 10.1016/j.phrs.2016.09.027; Nutt M, 2016, RES REP UROL, V8, P85, DOI 10.2147/RRU.S71325; Ontario Ministry of Finance, 2014, ONT POP PROJ 2013 20, P2013; Pile JM, 2009, UROL CLIN N AM, V36, P295, DOI 10.1016/j.ucl.2009.05.006; Platz EA, 1997, INT J EPIDEMIOL, V26, P933, DOI 10.1093/ije/26.5.933; REINBERG A, 1988, FERTIL STERIL, V49, P309; Rohrmann S, 2005, CANCER CAUSE CONTROL, V16, P1189, DOI 10.1007/s10552-005-0304-8; ROSENBERG L, 1990, AM J EPIDEMIOL, V132, P1051, DOI 10.1093/oxfordjournals.aje.a115746; ROSENBERG L, 1994, AM J EPIDEMIOL, V140, P431, DOI 10.1093/oxfordjournals.aje.a117265; Rosenblatt KA, 2001, AM J EPIDEMIOL, V153, P1152, DOI 10.1093/aje/153.12.1152; Schwingl PJ, 2009, CONTRACEPTION, V79, P363, DOI 10.1016/j.contraception.2008.11.015; Shang YG, 2015, SCI REP-UK, V5, DOI 10.1038/srep09920; Sharlip ID, 2012, J UROLOGY, V188, P2482, DOI 10.1016/j.juro.2012.09.080; Shih G, 2011, CONTRACEPTION, V83, P310, DOI 10.1016/j.contraception.2010.08.019; Siddiqui MM, 2014, J CLIN ONCOL, V32, P3033, DOI 10.1200/JCO.2013.54.8446; SIDNEY S, 1991, CANCER CAUSE CONTROL, V2, P113, DOI 10.1007/BF00053130; SKEGG DCG, 1976, BRIT MED J, V1, P621, DOI 10.1136/bmj.1.6010.621; Stanford JL, 1999, CANCER EPIDEM BIOMAR, V8, P881; Trussell J, 2009, CONTRACEPTION, V79, P5, DOI 10.1016/j.contraception.2008.08.003; Walsh TJ, 2010, CANCER-AM CANCER SOC, V116, P2140, DOI 10.1002/cncr.25075; Zhu KM, 1996, AM J EPIDEMIOL, V144, P717, DOI 10.1093/oxfordjournals.aje.a008994	57	18	19	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2016	355								i5546	10.1136/bmj.i5546	http://dx.doi.org/10.1136/bmj.i5546			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CW	27811008	Green Published, hybrid			2022-12-28	WOS:000387318200002
J	Pfeffer, MA; McMurray, JJV				Pfeffer, Marc A.; McMurray, John J. V.			Lessons in Uncertainty and Humility - Clinical Trials Involving Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HIGH BLOOD-PRESSURE; MORBIDITY; MORTALITY; RISK; AMLODIPINE; OUTCOMES; PLACEBO; HEART		[Pfeffer, Marc A.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA; [McMurray, John J. V.] Univ Glasgow, British Heart Failure Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Glasgow	Pfeffer, MA (corresponding author), Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA.	mpfeffer@rics.bwh.harvard.edu	mcmurray, John/B-2467-2013	mcmurray, John/0000-0002-6317-3975				AMERY A, 1985, LANCET, V1, P1349; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; [Anonymous], 1980, LANCET, V1, P1261; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Benavente OR, 2013, LANCET, V382, P507, DOI 10.1016/S0140-6736(13)60852-1; Califf RM, 2002, CIRCULATION, V106, P1015, DOI 10.1161/01.CIR.0000023260.78078.BB; CHALMERS TC, 1983, NEW ENGL J MED, V309, P1358, DOI 10.1056/NEJM198312013092204; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Eisenstein EL, 2005, AM HEART J, V149, P482, DOI 10.1016/j.ahj.2004.04.049; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Grady C, 2015, NEW ENGL J MED, V372, P855, DOI 10.1056/NEJMra1411250; GREENBERG G, 1985, BMJ-BRIT MED J, V291, P97; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hypertension Detection and Follow-up Program Cooperative Group, 1979, JAMA-J AM MED ASSOC, V242, P2562, DOI DOI 10.1001/JAMA.242.23.2562; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Jones DW, 2002, HYPERTENSION, V39, P941, DOI 10.1161/01.HYP.0000018303.61360.28; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Turnbull F, 2003, LANCET, V362, P1527; Veterans Administration Cooperative Study Group, 1970, JAMA-J AM MED ASSOC, V213, P1143, DOI DOI 10.1001/JAMA.1970.03170330025003	34	25	25	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1756	1766		10.1056/NEJMra1510067	http://dx.doi.org/10.1056/NEJMra1510067			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806228	Green Accepted			2022-12-28	WOS:000387007300009
J	Sim, SS; Sun, JT				Sim, Shyh-Shyong; Sun, Jen-Tang			Ocular Flutter in the Serotonin Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sim, Shyh-Shyong; Sun, Jen-Tang] Far Eastern Mem Hosp, New Taipei, Taiwan	Far Eastern Memorial Hospital	Sim, SS (corresponding author), Far Eastern Mem Hosp, New Taipei, Taiwan.	vin_shyong@hotmail.com	Sim, Shyh Shyong/ABC-9238-2021						0	2	3	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					E38	E38		10.1056/NEJMicm1506066	http://dx.doi.org/10.1056/NEJMicm1506066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806222				2022-12-28	WOS:000387007300012
J	[Anonymous]				[Anonymous]			Barry William Serpell Obituary (vol 355, i5613, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		SERPELL BW, 2016, BMJ-BRIT MED J, V355, DOI DOI 10.1136/BMJ.I5613	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2016	355								i5851	10.1136/bmj.i5851	http://dx.doi.org/10.1136/bmj.i5851			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CP	27802936	Green Published, Bronze			2022-12-28	WOS:000387317200006
J	Alvarez, DD; Giacomini, D; Yang, SM; Trinchero, MF; Temprana, SG; Buttner, KA; Beltramone, N; Schinder, AF				Alvarez, Diego D.; Giacomini, Damiana; Min Yang, Sung; Trinchero, Mariela F.; Temprana, Silvio G.; Buttner, Karina A.; Beltramone, Natalia; Schinder, Alejandro F.			A disynaptic feedback network activated by experience promotes the integration of new granule cells	SCIENCE			English	Article							NEWLY GENERATED NEURONS; CRITICAL PERIOD; ADULT HIPPOCAMPUS; TRANSGENIC MICE; NEUROGENESIS; DIFFERENTIATION; MATURATION	Experience shapes the development and connectivity of adult-born granule cells (GCs) through mechanisms that are poorly understood. We examined the remodeling of dentate gyrus microcircuits in mice in an enriched environment (EE). Short exposure to EE during early development of new GCs accelerated their functional integration. This effect was mimicked by in vivo chemogenetic activation of a limited population of mature GCs. Slice recordings showed that mature GCs recruit parvalbumin g-aminobutyric acid-releasing interneurons (PV-INs) that feed back onto developing GCs. Accordingly, chemogenetic stimulation of PV-INs or direct depolarization of developing GCs accelerated GC integration, whereas inactivation of PV-INs prevented the effects of EE. Our results reveal a mechanism for dynamic remodeling in which experience activates dentate networks that "prime" young GCs through a disynaptic feedback loop mediated by PV-INs.	[Alvarez, Diego D.; Giacomini, Damiana; Min Yang, Sung; Trinchero, Mariela F.; Temprana, Silvio G.; Buttner, Karina A.; Beltramone, Natalia; Schinder, Alejandro F.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Plasticidad Neuronal, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Schinder, AF (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, Fdn Inst Leloir, Lab Plasticidad Neuronal, Ave Patricias Argentinas 435,C1405BWE, Buenos Aires, DF, Argentina.	aschinder@leloir.org.ar		Temprana, Silvio Gabriel/0000-0002-0836-5042; Alvarez, Diego/0000-0001-6356-4514	CONICET fellowships; Howard Hughes Medical Institute SIRS grant [55007652]; Argentine Agency for the Promotion of Science and Technology grant [PICT2013-1685]; NIH grant FIRCA [R03TW008607-01]; FOGARTY INTERNATIONAL CENTER [R03TW008607] Funding Source: NIH RePORTER	CONICET fellowships(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Howard Hughes Medical Institute SIRS grant; Argentine Agency for the Promotion of Science and Technology grant; NIH grant FIRCA; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	We thank S. Arber and M. Soledad Esposito for providing AAV-hM4Di and AAV-PSAM-5HT3 particles and for invaluable advice on their use, M. C. Monzon Salinas for technical help, S. Sternson for PSEM<SUP>308</SUP>, B. Roth for the hM3Dq and hM4Di constructs, G. Davies Sala for preliminary experiments using retroviral expression of hM3Dq, J. Johnson for Ascl1<SUP>CreERT2</SUP> mice, S. Arber for PV<SUP>Cre</SUP> mice, members of the A.F.S. and G. Lanuza labs for insightful discussions, and V. Piatti for critical comments on the manuscript. D.G. and A.F.S. are investigators of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). Supported CONICET fellowships (D.D.A., S.M.Y., M.F.T., and S.G.T.), Howard Hughes Medical Institute SIRS grant 55007652 (A.F.S.), Argentine Agency for the Promotion of Science and Technology grant PICT2013-1685, and NIH grant FIRCA R03TW008607-01. The data reported in this manuscript are tabulated in the main paper and the supplementary materials. Author contributions: D.D.A. and D.G. contributed to the concept, designed and performed the experiments, analyzed the data, and wrote the manuscript; S.M.Y. and S.G.T. performed electrophysiological recordings and analyzed the data; M.F.T. and K.A.B. contributed to experiments involving enriched environment and analyzed the data; N.B. prepared retroviruses; and A.F.S. contributed to the concept, designed the experiments, analyzed the data, wrote the manuscript, and provided financial support.	Abrous DN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018952; Acsady L, 1998, J NEUROSCI, V18, P3386; Alexander GM, 2009, NEURON, V63, P27, DOI 10.1016/j.neuron.2009.06.014; Andersen J, 2014, NEURON, V83, P1085, DOI 10.1016/j.neuron.2014.08.004; Bergami M, 2015, NEURON, V85, P710, DOI 10.1016/j.neuron.2015.01.001; Chancey JH, 2013, J NEUROSCI, V33, P6614, DOI 10.1523/JNEUROSCI.0781-13.2013; Chawla MK, 2005, HIPPOCAMPUS, V15, P579, DOI 10.1002/hipo.20091; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Gage FH, 2013, NEURON, V80, P588, DOI 10.1016/j.neuron.2013.10.037; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Heigele S, 2016, NAT NEUROSCI, V19, P263, DOI 10.1038/nn.4218; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018472; Kropff E, 2015, CURR OPIN NEUROBIOL, V35, P21, DOI 10.1016/j.conb.2015.06.002; Lepousez G, 2015, NEURON, V86, P387, DOI 10.1016/j.neuron.2015.01.002; Leutgeb S, 2005, CURR OPIN NEUROBIOL, V15, P738, DOI 10.1016/j.conb.2005.10.002; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Marin-Burgin A, 2012, SCIENCE, V335, P1238, DOI 10.1126/science.1214956; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Piatti VC, 2011, J NEUROSCI, V31, P7715, DOI 10.1523/JNEUROSCI.1380-11.2011; Snyder JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048757; Song J, 2013, NAT NEUROSCI, V16, P1728, DOI 10.1038/nn.3572; Song J, 2012, NATURE, V489, P150, DOI 10.1038/nature11306; Stachniak TJ, 2014, NEURON, V82, P797, DOI 10.1016/j.neuron.2014.04.008; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Temprana SG, 2015, NEURON, V85, P116, DOI 10.1016/j.neuron.2014.11.023; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vivar C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2101; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Waterhouse EG, 2012, J NEUROSCI, V32, P14318, DOI 10.1523/JNEUROSCI.0709-12.2012; Wu MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018978; Yang SM, 2015, J NEUROSCI, V35, P15379, DOI 10.1523/JNEUROSCI.2345-15.2015	37	79	80	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					459	465		10.1126/science.aaf2156	http://dx.doi.org/10.1126/science.aaf2156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789840				2022-12-28	WOS:000387684400040
J	Nazeeruddin, MK				Nazeeruddin, Mohammad K.			In Retrospect Twenty-five years of low-cost solar cells	NATURE			English	Editorial Material							ORGANOMETAL HALIDE PEROVSKITES; SENSITIZERS; CONVERSION; LIGHT	In 1991, an energy-efficient solar cell was reported that was both simple in design and relatively inexpensive. This invention has since inspired the development of solar cells that have even higher efficiencies.	[Nazeeruddin, Mohammad K.] Swiss Fed Inst Technol, Inst Chem Sci & Engn, Grp Mol Engn Funct Mat, CH-1951 Sion, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Nazeeruddin, MK (corresponding author), Swiss Fed Inst Technol, Inst Chem Sci & Engn, Grp Mol Engn Funct Mat, CH-1951 Sion, Switzerland.	mdkhaja.nazeeruddin@epfl.ch	Nazeeruddin, Mohammad K/B-1323-2008	Nazeeruddin, Mohammad K/0000-0001-5955-4786				Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936; Burschka J, 2011, J AM CHEM SOC, V133, P18042, DOI 10.1021/ja207367t; International Energy Agency, 2016, WORLD EN OUTL SPEC R; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Mathew S, 2014, NAT CHEM, V6, P242, DOI [10.1038/NCHEM.1861, 10.1038/nchem.1861]; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Sum TC, 2014, ENERG ENVIRON SCI, V7, P2518, DOI 10.1039/c4ee00673a; World Energy Council, 2013, WORLD EN SCEN	10	56	58	5	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					463	464		10.1038/538463a	http://dx.doi.org/10.1038/538463a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786213				2022-12-28	WOS:000386654400043
J	Byass, P				Byass, Peter			Child mortality is (estimated to be) falling	LANCET			English	Editorial Material									[Byass, Peter] Umea Univ, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden; [Byass, Peter] Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr Stellenbosch Univ, Stellenbosch, South Africa	Umea University; Stellenbosch University	Byass, P (corresponding author), Umea Univ, Umea Ctr Global Hlth Res Epidemiol & Global Hlth, Dept Publ Hlth & Clin Med, S-90187 Umea, Sweden.; Byass, P (corresponding author), Univ Stellenbosch, Stellenbosch Inst Adv Study STIAS, Wallenberg Res Ctr Stellenbosch Univ, Stellenbosch, South Africa.	peter.byass@umu.se						AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2; Black MM, 2016, LANCET; Byass P, 2016, LANCET GLOB HEALTH, V4, pE785, DOI 10.1016/S2214-109X(16)30203-0; Byass P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001926; Byass P, 2011, LANCET, V378, P1119, DOI 10.1016/S0140-6736(11)61419-0; Byass P, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000155; International society for developmental origins of health and disease DOHAD, 2015, CAP TOWN MAN; Liu L, 2016, LANCET; Lo S, 2015, LANCET, V386, P1313, DOI 10.1016/S0140-6736(15)60305-1; United Nations, 2015, TRANSF OUR WORLD 202; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6	12	8	8	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 17	2016	388	10063					2965	2967		10.1016/S0140-6736(16)32169-9	http://dx.doi.org/10.1016/S0140-6736(16)32169-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EF1VF	27839856	hybrid, Green Submitted			2022-12-28	WOS:000390112300008
J	Ataman, B; Boulting, GL; Harmin, DA; Yang, MG; Baker-Salisbury, M; Yap, EL; Malik, AN; Mei, K; Rubin, AA; Spiegel, I; Durresi, E; Sharma, N; Hu, LDS; Pletikos, M; Griffith, EC; Partlow, JN; Stevens, CR; Adli, M; Chahrour, M; Sestan, N; Walsh, CA; Berezovskii, VK; Livingstone, MS; Greenberg, ME				Ataman, Bulent; Boulting, Gabriella L.; Harmin, David A.; Yang, Marty G.; Baker-Salisbury, Mollie; Yap, Ee-Lynn; Malik, Athar N.; Mei, Kevin; Rubin, Alex A.; Spiegel, Ivo; Durresi, Ershela; Sharma, Nikhil; Hu, Linda S.; Pletikos, Mihovil; Griffith, Eric C. .; Partlow, Jennifer N.; Stevens, Christine R.; Adli, Mazhar; Chahrour, Maria; Sestan, Nenad; Walsh, Christopher A.; Berezovskii, Vladimir K.; Livingstone, Margaret S.; Greenberg, Michael E.			Evolution of Osteocrin as an activity-regulated factor in the primate brain	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENE-EXPRESSION; CORTICAL INHIBITION; CEREBRAL-CORTEX; STRIATE CORTEX; VISUAL-CORTEX; STEM-CELLS; NEURONS; TRANSCRIPTION; ENHANCERS	Sensory stimuli drive the maturation and function of the mammalian nervous system in part through the activation of gene expression networks that regulate synapse development and plasticity. These networks have primarily been studied in mice, and it is not known whether there are species-or clade-specific activity-regulated genes that control features of brain development and function. Here we use transcriptional profiling of human fetal brain cultures to identify an activity-dependent secreted factor, Osteocrin (OSTN), that is induced by membrane depolarization of human but not mouse neurons. We find that OSTN has been repurposed in primates through the evolutionary acquisition of DNA regulatory elements that bind the activity-regulated transcription factor MEF2. In addition, we demonstrate that OSTN is expressed in primate neocortex and restricts activity-dependent dendritic growth in human neurons. These findings suggest that, in response to sensory input, OSTN regulates features of neuronal structure and function that are unique to primates.	[Ataman, Bulent; Boulting, Gabriella L.; Harmin, David A.; Yang, Marty G.; Baker-Salisbury, Mollie; Yap, Ee-Lynn; Malik, Athar N.; Mei, Kevin; Rubin, Alex A.; Spiegel, Ivo; Durresi, Ershela; Sharma, Nikhil; Hu, Linda S.; Griffith, Eric C. .; Berezovskii, Vladimir K.; Livingstone, Margaret S.; Greenberg, Michael E.] Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA; [Pletikos, Mihovil; Sestan, Nenad] Yale Sch Med, Dept Neurosci, New Haven, CT 06510 USA; [Pletikos, Mihovil; Sestan, Nenad] Yale Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Partlow, Jennifer N.; Walsh, Christopher A.] Harvard Med Sch, Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Stevens, Christine R.] Broad Inst & Harvard, Cambridge, MA 02142 USA; [Adli, Mazhar] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; [Chahrour, Maria] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, MvDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Yale University; Yale University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Virginia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Greenberg, ME (corresponding author), Harvard Med Sch, Dept Neurobiol, Boston, MA 02115 USA.	meg@hms.harvard.edu	Berezovskii, Vladimir/B-9866-2013; Berezovskii, Vladimir/AAB-5253-2022	Berezovskii, Vladimir/0000-0003-4077-3940; Livingstone, Margaret/0000-0002-1950-0123; Griffith, Eric/0000-0003-0428-3215; Durresi, Ershela/0000-0002-1708-6889; Baker-Salisbury, Mollie/0000-0003-2495-6886; Boulting, Gabriella/0000-0003-2012-1259; Chahrour, Maria/0000-0002-3174-1480; Mei, Kevin/0000-0002-5406-198X; Spiegel, Ivo/0000-0003-0979-1358; Malik, Athar N./0000-0002-1545-4107	NIH [P50MH106933, 1RC2MH089952, 5F32NS086270, EY16187, EY12196, T32GM007753]; Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis; NATIONAL EYE INSTITUTE [P30EY012196, R01EY016187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH106933, RC2MH089952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS086270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank E. Curran, T. Hartmann, P. Schade, P. Zhang, J. M. Gray, M. Hemberg, X. Adiconis, J. Z. Levin, J. Zieg, D. R. Hochbaum, T. J. Cherry and M. M. Andzelm for their technical assistance or advice. This work was supported by grants from the NIH: P50MH106933 and 1RC2MH089952 (M.E.G.), 5F32NS086270 (G.L.B.), EY16187 (M.S.L.), EY12196 (V.K.B.), and T32GM007753 (A.N.M. and E.D.). B.A. is supported by The Ellen R. and Melvin J. Gordon Center for the Cure and Treatment of Paralysis.	Andzelm MM, 2015, NEURON, V86, P247, DOI 10.1016/j.neuron.2015.02.038; Banzet S, 2007, BIOCHEM BIOPH RES CO, V353, P713, DOI 10.1016/j.bbrc.2006.12.074; Berry BJ, 2015, BIOTECHNOL PROGR, V31, P1613, DOI 10.1002/btpr.2160; Bienvenu T, 2013, NEUROGENETICS, V14, P71, DOI 10.1007/s10048-012-0344-7; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Bufill E, 2011, AM J HUM BIOL, V23, P729, DOI 10.1002/ajhb.21225; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; GOSSETT LA, 1989, MOL CELL BIOL, V9, P5022, DOI 10.1128/MCB.9.11.5022; Gray JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089673; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Herculano-Houzel S, 2012, PROG BRAIN RES, V195, P325, DOI 10.1016/B978-0-444-53860-4.00015-5; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980; Kaas JH, 2012, PROG BRAIN RES, V195, P91, DOI 10.1016/B978-0-444-53860-4.00005-2; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kolb H., 1995, WEBVISION ORG RETINA; Kostovic I, 2010, ACTA PAEDIATR, V99, P1119, DOI 10.1111/j.1651-2227.2010.01811.x; Kwan KY, 2012, CELL, V149, P899, DOI 10.1016/j.cell.2012.02.060; LUND JS, 1991, J COMP NEUROL, V309, P129, DOI 10.1002/cne.903090109; Malik AN, 2014, NAT NEUROSCI, V17, P1330, DOI 10.1038/nn.3808; Mardinly AR, 2016, NATURE, V531, P371, DOI 10.1038/nature17187; Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Moffatt P, 2007, J BIOL CHEM, V282, P36454, DOI 10.1074/jbc.M708596200; MOLLIVER ME, 1973, BRAIN RES, V50, P403, DOI 10.1016/0006-8993(73)90741-5; Moore AR, 2014, P NATL ACAD SCI USA, V111, pE3919, DOI 10.1073/pnas.1405253111; O'Leary T, 2010, J PHYSIOL-LONDON, V588, P157, DOI 10.1113/jphysiol.2009.181024; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Spiegel I, 2014, CELL, V157, P1216, DOI 10.1016/j.cell.2014.03.058; Srinivasan S, 2015, P NATL ACAD SCI USA, V112, P7815, DOI 10.1073/pnas.1509282112; Subbotina E, 2015, P NATL ACAD SCI USA, V112, P16042, DOI 10.1073/pnas.1514250112; Takahata T, 2009, P NATL ACAD SCI USA, V106, P12151, DOI 10.1073/pnas.0905092106; Tochitani S, 2001, EUR J NEUROSCI, V13, P297, DOI 10.1046/j.0953-816X.2000.01390.x; Zweier M, 2010, HUM MUTAT, V31, P722, DOI 10.1002/humu.21253	45	68	73	0	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					242	+		10.1038/nature20111	http://dx.doi.org/10.1038/nature20111			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830782	Green Accepted			2022-12-28	WOS:000387318500035
J	Sinnott, JD; Howlett, DC				Sinnott, Joseph Dalby; Howlett, David C.			SPOT DIAGNOSIS Abdominal pain after colonoscopy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Joseph Dalby] East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, England; [Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, England		Sinnott, JD (corresponding author), East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, England.	j.d.sinnott@gmail.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2016	355								i5505	10.1136/bmj.i5505	http://dx.doi.org/10.1136/bmj.i5505			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CV	27834279				2022-12-28	WOS:000388003200003
J	Lyon, J				Lyon, Jeff			Regulating Personal Care Products	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1859	1859		10.1001/jama.2016.15973	http://dx.doi.org/10.1001/jama.2016.15973			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27824990				2022-12-28	WOS:000387116500003
J	Weston, G				Weston, Gabriel			Theatre A radical musical	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2227	2228		10.1016/S0140-6736(16)32078-5	http://dx.doi.org/10.1016/S0140-6736(16)32078-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	EA8MO	27831466				2022-12-28	WOS:000386889300015
J	Clark, LW; Feng, L; Chin, C				Clark, Logan W.; Feng, Lei; Chin, Cheng			Universal space-time scaling symmetry in the dynamics of bosons across a quantum phase transition	SCIENCE			English	Article							BOSE-EINSTEIN CONDENSATE; BREAKING; DOMAINS	The dynamics of many-body systems spanning condensed matter, cosmology, and beyond are hypothesized to be universal when the systems cross continuous phase transitions. The universal dynamics are expected to satisfy a scaling symmetry of space and time with the crossing rate, inspired by the Kibble-Zurek mechanism. We test this symmetry based on Bose condensates in a shaken optical lattice. Shaking the lattice drives condensates across an effectively ferromagnetic quantum phase transition. After crossing the critical point, the condensates manifest delayed growth of spin fluctuations and develop antiferromagnetic spatial correlations resulting from the sub-Poisson distribution of the spacing between topological defects. The fluctuations and correlations are invariant in scaled space-time coordinates, in support of the scaling symmetry of quantum critical dynamics.	[Clark, Logan W.] Univ Chicago, Enrico Fermi Inst, James Franck Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Clark, LW (corresponding author), Univ Chicago, Enrico Fermi Inst, James Franck Inst, Chicago, IL 60637 USA.	lwclark@uchicago.edu		Feng, Lei/0000-0001-8102-3420	National Defense Science and Engineering Graduate Fellowship; Nambu Fellowship; NSF Materials Research Science and Engineering Centers [DMR-1420709]; NSF [PHY-1511696]; Army Research Office-Multidisciplinary Research Initiative [W911NF-14-1-0003]	National Defense Science and Engineering Graduate Fellowship; Nambu Fellowship; NSF Materials Research Science and Engineering Centers(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Army Research Office-Multidisciplinary Research Initiative	We thank L.-C. Ha, C. V. Parker, B. M. Anderson, B. J. DeSalvo, A. Polkovnikov, S. Sachdev, and Q. Zhou for helpful discussions. L.W.C. was supported by a National Defense Science and Engineering Graduate Fellowship and a Nambu Fellowship. This work was supported by NSF Materials Research Science and Engineering Centers (DMR-1420709), NSF grant PHY-1511696, and Army Research Office-Multidisciplinary Research Initiative grant W911NF-14-1-0003. The data presented in this paper are available upon request to C.C. (cchin@uchicago.edu).	Anquez M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.155301; Baumann K, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.140402; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Braun S, 2015, P NATL ACAD SCI USA, V112, P3641, DOI 10.1073/pnas.1408861112; Chandran A, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.064304; Chen D, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.235304; CHUANG I, 1991, SCIENCE, V251, P1336, DOI 10.1126/science.251.4999.1336; Corman L, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.135302; del Campo A, 2014, INT J MOD PHYS A, V29, DOI 10.1142/S0217751X1430018X; Dziarmaga J, 2010, ADV PHYS, V59, P1063, DOI 10.1080/00018732.2010.514702; Francuz A, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.075134; Gemelke N, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.170404; Ha LC, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.055301; Jotzu G, 2014, NATURE, V515, P237, DOI 10.1038/nature13915; KIBBLE TWB, 1976, J PHYS A-MATH GEN, V9, P1387, DOI 10.1088/0305-4470/9/8/029; Kolodrubetz M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.015701; Lamporesi G, 2013, NAT PHYS, V9, P655, DOI 10.1038/NPHYS2734; Lignier H, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220403; Meldgin C, 2016, NAT PHYS, V12, P646, DOI [10.1038/nphys3695, 10.1038/NPHYS3695]; Navon N, 2015, SCIENCE, V347, P167, DOI 10.1126/science.1258676; Nicklas E, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.245301; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Polkovnikov A, 2011, REV MOD PHYS, V83, P863, DOI 10.1103/RevModPhys.83.863; Sadler LE, 2006, NATURE, V443, P312, DOI 10.1038/nature05094; Struck J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.225304; Struck J, 2011, SCIENCE, V333, P996, DOI 10.1126/science.1207239; Veatch SL, 2007, P NATL ACAD SCI USA, V104, P17650, DOI 10.1073/pnas.0703513104; Weiler CN, 2008, NATURE, V455, P948, DOI 10.1038/nature07334; Xu J, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/50003; Zheng W, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.155303; Zhou Q, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.245702; ZUREK WH, 1985, NATURE, V317, P505, DOI 10.1038/317505a0	32	95	97	2	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					606	610		10.1126/science.aaf9657	http://dx.doi.org/10.1126/science.aaf9657			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811272	Green Submitted			2022-12-28	WOS:000386869800046
J	Wise, J				Wise, Jacqui			Dietitians have important role in mental health team, say researchers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Teasdale S, 2016, BR J PSYCHIAT	1	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 3	2016	355								i5913	10.1136/bmj.i5913	http://dx.doi.org/10.1136/bmj.i5913			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CW	27811007				2022-12-28	WOS:000387318200012
J	Dwivedi, RC; Kenway, B; Haribaskaran, K; Jani, P				Dwivedi, Raghav C.; Kenway, Bruno; Haribaskaran, K.; Jani, Piyush			CASE REVIEW Lamb ingestion and odynophagia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COMPUTED-TOMOGRAPHY; MANAGEMENT; BONE		[Dwivedi, Raghav C.; Haribaskaran, K.; Jani, Piyush] Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Dept Otolaryngol Head & Neck Surg, Cambridge, England; [Kenway, Bruno] Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Dept Otolaryngol Head & Neck Surg, Ear Nose & Throat Surg, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Dwivedi, RC (corresponding author), Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Dept Otolaryngol Head & Neck Surg, Cambridge, England.	raghav.rmh@gmail.com						BRAVERMAN I, 1993, J OTOLARYNGOL, V22, P311; Chee LWJ, 1999, ANN OTO RHINOL LARYN, V108, P177, DOI 10.1177/000348949910800213; Chen Ching Yuan, 2011, Am J Otolaryngol, V32, P253, DOI 10.1016/j.amjoto.2010.02.006; Cheng YC, 2009, AM J OTOLARYNG, V30, P203, DOI 10.1016/j.amjoto.2008.03.004; De Lucas EM, 2004, ACTA RADIOL, V45, P369, DOI 10.1080/02841850410005516; Eliashar R, 1999, ANN OTO RHINOL LARYN, V108, P708, DOI 10.1177/000348949910800717; EVANS RM, 1992, CLIN RADIOL, V46, P121, DOI 10.1016/S0009-9260(05)80316-2; Kanne JP, 2004, AM J ROENTGENOL, V182, P802, DOI 10.2214/ajr.182.3.1820802; Karnwal A, 2008, J LARYNGOL OTOL, V122, P845, DOI 10.1017/S0022215107000497; Kulamarva G, 2006, J LARYNGOL OTOL, V120, P1081, DOI 10.1017/S0022215106002568; Leong H K, 1987, Singapore Med J, V28, P162; Virk JS, 2012, EMERG RADIOL, V19, P255, DOI 10.1007/s10140-012-1026-3	12	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2016	355								i5506	10.1136/bmj.i5506	http://dx.doi.org/10.1136/bmj.i5506			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CU	27806949				2022-12-28	WOS:000387317900002
J	Voelker, R				Voelker, Rebecca			First DMD Drug Gains Approval	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1756	1756		10.1001/jama.2016.15537	http://dx.doi.org/10.1001/jama.2016.15537			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802526				2022-12-28	WOS:000386569300006
J	Adams, HL; Howlett, DC				Adams, H. L.; Howlett, David C.			SPOT DIAGNOSIS An incidental finding	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Adams, H. L.] Brighton & Sussex Univ Hosp, Brighton, E Sussex, England; [Howlett, David C.] East Sussex Healthcare NHS Trust, Dept Radiol, Eastbourne, England	Brighton and Sussex University Hospitals NHS Trust	Adams, HL (corresponding author), Brighton & Sussex Univ Hosp, Brighton, E Sussex, England.	h.l.adams@doctors.org.uk						Alevritis EM, 2003, SOUTH MED J, V96, P888, DOI 10.1097/01.SMJ.0000073269.49575.DF	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2016	355								i5419	10.1136/bmj.i5419	http://dx.doi.org/10.1136/bmj.i5419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LG	27784713				2022-12-28	WOS:000386661400002
J	Gulland, A				Gulland, Anne			Sixty seconds on ... STPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Davenport A, 2016, NHS PROVIDERS    OCT; Edwards N, 2016, NUFFIELD TRUST   AUG; Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4449; Vize R., 2016, GUARDIAN	4	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2016	355								i5752	10.1136/bmj.i5752	http://dx.doi.org/10.1136/bmj.i5752			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LG	27784705				2022-12-28	WOS:000386661400014
J	Lund, H; Brunnhuber, K; Juhl, C; Robinson, K; Leenaars, M; Dorch, BF; Jamtvedt, G; Nortvedt, MW; Christensen, R; Chalmers, I				Lund, Hans; Brunnhuber, Klara; Juhl, Carsten; Robinson, Karen; Leenaars, Marlies; Dorch, Bertil F.; Jamtvedt, Gro; Nortvedt, Monica W.; Christensen, Robin; Chalmers, Iain			Towards evidence based research	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTEMATIC REVIEWS; CONTROLLED-TRIALS; INCREASING VALUE; CLINICAL-TRIALS; REDUCING WASTE; CITATION DISTORTIONS; RELEVANT EVIDENCE; BEGIN; AUTHORITY; SECTIONS		[Lund, Hans; Juhl, Carsten] Univ Southern Denmark, Dept Sports Sci & Clin Biomech, SEARCH Res Grp, DK-5230 Odense 55, Denmark; [Lund, Hans; Jamtvedt, Gro; Nortvedt, Monica W.] Bergen Univ Coll, Ctr Evidence Based Practice, Bergen, Norway; [Brunnhuber, Klara] BMJ, Evidence Ctr, London, England; [Juhl, Carsten] Copenhagen Univ Hosp, Dept Rehabil, Herlev, Denmark; [Juhl, Carsten] Copenhagen Univ Hosp, Dept Rehabil, Gentofte, Denmark; [Robinson, Karen] Johns Hopkins Univ, Baltimore, MD USA; [Leenaars, Marlies] Radboud Univ Nijmegen, Med Ctr, Cent Anim Lab, SYRCLE, Nijmegen, Netherlands; [Dorch, Bertil F.] Univ Southern Denmark, Univ Lib Southern Denmark, Odense, Denmark; [Jamtvedt, Gro] Norwegian Knowledge Ctr Hlth Serv, Dept Evidence Synth, Oslo, Norway; [Christensen, Robin] Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark; [Chalmers, Iain] James Lind Initiat, Oxford, England	University of Southern Denmark; Western Norway University of Applied Sciences; University of Copenhagen; University of Copenhagen; Johns Hopkins University; Radboud University Nijmegen; University of Southern Denmark; Norwegian Knowledge Centre for Health Services; University of Copenhagen; Bispebjerg Hospital	Lund, H (corresponding author), Univ Southern Denmark, Dept Sports Sci & Clin Biomech, SEARCH Res Grp, DK-5230 Odense 55, Denmark.	hlund@health.sdu.dk	Leenaars, P.P.A.M./L-4478-2015; Lund, Hans/E-4075-2013	Leenaars, P.P.A.M./0000-0002-9855-708X; Christensen, Robin/0000-0002-6600-0631; Dorch, Bertil/0000-0003-2594-6778; Nortvedt, Monica Wammen/0000-0002-1859-6071; Lund, Hans/0000-0001-6847-8324				Bastiaansen JA, 2015, BIOL PSYCHIAT, V78, pE35, DOI 10.1016/j.biopsych.2014.12.007; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Booth A, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-2; Chalmers I, 2005, LANCET, V365, P469; Chalmers I., 2007, TREATING INDIVIDUALS, P37; Chalmers I, 2016, LANCET, V387, P122, DOI 10.1016/S0140-6736(15)01353-7; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2014, LANCET, V383, P257, DOI 10.1016/S0140-6736(13)62296-5; Clarke M, 1998, JAMA-J AM MED ASSOC, V280, P280, DOI 10.1001/jama.280.3.280; Clarke M, 2002, JAMA-J AM MED ASSOC, V287, P2799, DOI 10.1001/jama.287.21.2799; Clarke M, 2007, J ROY SOC MED, V100, P187, DOI 10.1258/jrsm.100.4.187; Clarke M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102670; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Cooper NJ, 2005, CLIN TRIALS, V2, P260, DOI 10.1191/1740774505cn090oa; Dickersin K, 2003, JAMA-J AM MED ASSOC, V290, P516, DOI 10.1001/jama.290.4.516; Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603; Fergusson D, 2005, CLIN TRIALS, V2, P218, DOI 10.1191/1740774505cn085oa; Fiorentino F, 2011, BRIT J CANCER, V104, P1085, DOI 10.1038/sj.bjc.6606060; Garner P, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3507; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Greenberg Steven A, 2009, BMJ, V339, pb2680, DOI 10.1136/bmj.b2680; Habre C, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5219; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Jannot AS, 2013, J CLIN EPIDEMIOL, V66, P296, DOI 10.1016/j.jclinepi.2012.09.015; Jefferson T, 1999, PEER REV HLTH SCI, P224; Kleinert S, 2014, LANCET, V384, P2176, DOI 10.1016/S0140-6736(14)62047-X; Lund H, 2016, LANCET, V387, P123, DOI 10.1016/S0140-6736(15)01354-9; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Mahtani KR, 2016, J ROY SOC MED, V109, P264, DOI 10.1177/0141076816643954; National Institute for Health Research, 2016, GUID NOT APPL OUTL A; Perino AC, 2014, CIRC-CARDIOVASC QUAL, V7, P687, DOI 10.1161/CIRCOUTCOMES.114.000912; Robinson KA, 2009, USE PRIOR RES JUSTIF; Robinson KA, 2011, ANN INTERN MED, V154, P50, DOI 10.7326/0003-4819-154-1-201101040-00007; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Sawin VI, 2016, J CLIN EPIDEMIOL, V69, P174, DOI 10.1016/j.jclinepi.2015.03.026; Sheth U, 2011, J BONE JOINT SURG AM, V93A, P2079, DOI 10.2106/JBJS.J.01274; Siebert U, 2013, Z EVIDENZ FORTBILD Q, V107, P575, DOI 10.1016/j.zefq.2013.10.020; Starr M, 2009, INT J TECHNOL ASSESS, V25, P182, DOI 10.1017/S026646230909062X; Thornley C, 2015, INFORM RES, V20; Vandvik PO, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0596-4; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	42	58	61	0	28	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 21	2016	355								i5440	10.1136/bmj.i5440	http://dx.doi.org/10.1136/bmj.i5440			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8LC	27797786	Green Published			2022-12-28	WOS:000386120900001
J	Samarasekera, U; Horton, R				Samarasekera, Udani; Horton, Richard			Women's cancers: shining a light on a neglected health inequity	LANCET			English	Editorial Material									[Samarasekera, Udani; Horton, Richard] The Lancet, London EC2Y 5AS, England		Samarasekera, U (corresponding author), The Lancet, London EC2Y 5AS, England.							Bruni L, 2016, LANCET GLOB HEALTH, V4, pE453, DOI 10.1016/S2214-109X(16)30099-7; Denny L., 2016, LANCET; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gavi the Vaccine Alliance, 2015, VACC ALL PROGR REP 2; Ginsburg O., 2016, LANCET; UN, 2015, SUSTAINABLE DEV GOAL; United Nations Secretary-General, 2015, GLOB STRAT WOM CHILD	7	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					771	773		10.1016/S0140-6736(16)31798-6	http://dx.doi.org/10.1016/S0140-6736(16)31798-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	27814968				2022-12-28	WOS:000394966400008
J	de Bock, CE; Thorne, RE				de Bock, Charles E.; Thorne, Rick E.			CELL BIOLOGY A mitochondrial brake on vascular repair	NATURE			English	Editorial Material							FAT1 CADHERIN	Injured blood vessels are repaired by vascular smooth-muscle cells. It emerges that the protein Fat1 regulates the proliferation of these cells by inhibiting the function of mitochondria. See Letter p.575	[de Bock, Charles E.] VIB Ctr Biol f Dis, B-3000 Leuven, Belgium; [de Bock, Charles E.] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Thorne, Rick E.] Hunter Med Res Inst, New Lambton Hts, NSW 2305, Australia; [Thorne, Rick E.] Univ Newcastle, Callaghan, NSW 2308, Australia	Flanders Institute for Biotechnology (VIB); KU Leuven; Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Thorne, RE (corresponding author), Hunter Med Res Inst, New Lambton Hts, NSW 2305, Australia.; Thorne, RE (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	rick.thorne@newcastle.edu.au	de Bock, Charles/H-7699-2019	de Bock, Charles/0000-0001-5182-8535; Thorne, Rick/0000-0001-7882-7081				Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Cao LYL, 2016, NATURE, V539, P575, DOI 10.1038/nature20170; Chiong M, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00072; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; Gao YS, 2016, AM J RESP CELL MOL, V54, P451, DOI 10.1165/rcmb.2015-0323TR; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Kranz D, 2014, EMBO J, V33, P181, DOI 10.1002/embj.201385686; Madan E, 2016, INT J CANCER, V139, P2570, DOI 10.1002/ijc.30386; Magg T, 2005, EXP CELL RES, V307, P100, DOI 10.1016/j.yexcr.2005.03.006; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Sadeqzadeh E, 2014, MED RES REV, V34, P190, DOI 10.1002/med.21286; Sing A, 2014, CELL, V158, P1293, DOI 10.1016/j.cell.2014.07.036	13	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					503	505		10.1038/nature20476	http://dx.doi.org/10.1038/nature20476			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27828945				2022-12-28	WOS:000388520600031
J	Swinburn, B; Arroll, B				Swinburn, Boyd; Arroll, Bruce			Rethinking primary care systems for obesity	LANCET			English	Editorial Material									[Swinburn, Boyd] Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1142, New Zealand; [Arroll, Bruce] Univ Auckland, Sch Populat Hlth, Dept Gen Practice, Auckland 1142, New Zealand	University of Auckland; University of Auckland	Swinburn, B (corresponding author), Univ Auckland, Sch Populat Hlth, Epidemiol & Biostat Sect, Auckland 1142, New Zealand.	Boyd.swinburn@auckland.ac.nz						Aveyard P, 2016, LANCET; Elley CR, 2003, BRIT MED J, V326, P793, DOI 10.1136/bmj.326.7393.793; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Green Gary, 2015, Am Fam Physician, V92, p24A; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Klass P, 2010, HEALTH AFFAIR, V29, P554, DOI [10.1377/HLTHAFF.2009.0931, 10.1377/hlthaff.2009.0931]; Lillis J, 2014, J CONTEXTUAL BEHAV S, V3, P1, DOI 10.1010/j.jcbs.2013.11.005; Madigan CD, 2014, BRIT J GEN PRACT, V64, pE128, DOI 10.3399/bjgp14X677491; Queensland Clincal Senate, 2015, EV K IS NOT OK PUTT; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Swinburn B, 2004, BMJ-BRIT MED J, V329, P736, DOI 10.1136/bmj.329.7468.736	12	8	8	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2452	2454		10.1016/S0140-6736(16)31913-4	http://dx.doi.org/10.1016/S0140-6736(16)31913-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC5IA	27789060	hybrid, Green Published			2022-12-28	WOS:000388166300005
J	De Henau, O; Rausch, M; Winkler, D; Campesato, LF; Liu, CL; Hirschhorn-Cymerman, D; Budhu, S; Ghosh, A; Pink, M; Tchaicha, J; Douglas, M; Tibbitts, T; Sharma, S; Proctor, J; Kosmider, N; White, K; Stern, H; Soglia, J; Adams, J; Palombella, VJ; McGovern, K; Kutok, JL; Wolchok, JD; Merghoub, T				De Henau, Olivier; Rausch, Matthew; Winkler, David; Campesato, Luis Felipe; Liu, Cailian; Hirschhorn-Cymerman, Daniel; Budhu, Sadna; Ghosh, Arnab; Pink, Melissa; Tchaicha, Jeremy; Douglas, Mark; Tibbitts, Thomas; Sharma, Sujata; Proctor, Jennifer; Kosmider, Nicole; White, Kerry; Stern, Howard; Soglia, John; Adams, Julian; Palombella, Vito J.; McGovern, Karen; Kutok, Jeffery L.; Wolchok, Jedd D.; Merghoub, Taha			Overcoming resistance to checkpoint blockade therapy by targeting PI3K gamma in myeloid cells	NATURE			English	Article							SUPPRESSOR-CELLS; TUMOR; INFLAMMATION; MACROPHAGES	Recent clinical trials using immunotherapy have demonstrated its potential to control cancer by disinhibiting the immune system. Immune checkpoint blocking (ICB) antibodies against cytotoxic-T-lymphocyte-associated protein 4 or programmed cell death protein 1/programmed death-ligand 1 have displayed durable clinical responses in various cancers(1). Although these new immunotherapies have had a notable effect on cancer treatment, multiple mechanisms of immune resistance exist in tumours. Among the key mechanisms, myeloid cells have a major role in limiting effective tumour immunity(2-4). Growing evidence suggests that high infiltration of immune-suppressive myeloid cells correlates with poor prognosis and ICB resistance(5,6). These observations suggest a need for a precision medicine approach in which the design of the immunotherapeutic combination is modified on the basis of the tumour immune landscape to overcome such resistance mechanisms. Here we employ a pre-clinical mouse model system and show that resistance to ICB is directly mediated by the suppressive activity of infiltrating myeloid cells in various tumours. Furthermore, selective pharmacologic targeting of the gamma isoform of phosphoinositide 3-kinase (PI3K gamma), highly expressed in myeloid cells, restores sensitivity to ICB. We demonstrate that targeting PI3K gamma with a selective inhibitor, currently being evaluated in a phase 1 clinical trial (NCT02637531), can reshape the tumour immune microenvironment and promote cytotoxic-T-cell-mediated tumour regression without targeting cancer cells directly. Our results introduce opportunities for new combination strategies using a selective small molecule PI3K gamma inhibitor, such as IPI-549, to overcome-resistance to ICB in patients with high levels of suppressive myeloid cell infiltration in tumours.	[De Henau, Olivier; Campesato, Luis Felipe; Liu, Cailian; Hirschhorn-Cymerman, Daniel; Budhu, Sadna; Ghosh, Arnab; Wolchok, Jedd D.; Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10065 USA; [De Henau, Olivier; Campesato, Luis Felipe; Liu, Cailian; Hirschhorn-Cymerman, Daniel; Budhu, Sadna; Ghosh, Arnab; Wolchok, Jedd D.; Merghoub, Taha] Swim Across Amer, Ludwig Collaborat Lab, New York, NY 10065 USA; [Rausch, Matthew; Winkler, David; Pink, Melissa; Tchaicha, Jeremy; Douglas, Mark; Tibbitts, Thomas; Sharma, Sujata; Proctor, Jennifer; Kosmider, Nicole; White, Kerry; Stern, Howard; Soglia, John; Adams, Julian; Palombella, Vito J.; McGovern, Karen; Kutok, Jeffery L.] Infin Pharmaceut Inc, Cambridge, MA 02139 USA; [Wolchok, Jedd D.] Weill Cornell Med Sch, New York, NY 10065 USA; [Wolchok, Jedd D.] Weill Cornell Grad Sch, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Wolchok, JD; Merghoub, T (corresponding author), Mem Sloan Kettering Canc Ctr, Parker Inst Canc Immunotherapy, New York, NY 10065 USA.; Wolchok, JD; Merghoub, T (corresponding author), Swim Across Amer, Ludwig Collaborat Lab, New York, NY 10065 USA.; Wolchok, JD (corresponding author), Weill Cornell Med Sch, New York, NY 10065 USA.	wolchokj@mskcc.org; merghout@mskcc.org	Merghoub, Taha/ABD-8362-2021	Ghosh, Arnab/0000-0003-3355-5427	Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Center for Experimental Therapeutics at MSKCC (ETC); Breast Cancer Research Foundation; MSKCC [P30 CA008748]; J. Houtard foundation; Nuovo Soldati Foundation; Wallonie-Bruxelles International; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Swim Across America; Ludwig Institute for Cancer Research; Parker Institute for Cancer Immunotherapy; Center for Experimental Therapeutics at MSKCC (ETC); Breast Cancer Research Foundation; MSKCC; J. Houtard foundation; Nuovo Soldati Foundation; Wallonie-Bruxelles International; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank the Flow Cytometry and Integrated Genomics Operation Core Facilities at MSKCC. Swim Across America, Ludwig Institute for Cancer Research, Parker Institute for Cancer Immunotherapy, Center for Experimental Therapeutics at MSKCC (ETC), and the Breast Cancer Research Foundation supported this work. The work was also supported in part by the MSKCC Core Grant (P30 CA008748). O.D.H. was supported by J. Houtard foundation, Nuovo Soldati Foundation and Wallonie-Bruxelles International. We would also like to thank Y. Senbabaoglu for his help in bioinformatics data analysis, A. Bossert for his contribution as part of the GME program as well as J. Gladstone and K. Walsh for their contributions while working as co-op students in the laboratory.	Evans CA, 2016, ACS MED CHEM LETT, V7, P862, DOI 10.1021/acsmedchemlett.6b00238; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; KANEDA MM, 2016, NATURE; Laoui D, 2014, CANCER RES, V74, P24, DOI 10.1158/0008-5472.CAN-13-1196; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lesokhin AM, 2012, CANCER RES, V72, P876, DOI 10.1158/0008-5472.CAN-11-1792; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Movahedi K, 2010, CANCER RES, V70, P5728, DOI 10.1158/0008-5472.CAN-09-4672; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Ugel S, 2015, J CLIN INVEST, V125, P3365, DOI 10.1172/JCI80006	11	491	496	9	156	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					443	447		10.1038/nature20554	http://dx.doi.org/10.1038/nature20554			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27828943	Green Accepted			2022-12-28	WOS:000388161700057
J	Iacobucci, G				Iacobucci, Gareth			Health campaigners welcome government plan to phase out coal power	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Department for Business Energy and Industrial Strategy, 2016, COAL GEN GREAT BRIT; Iacobucci G, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5621; Rudd A., 2015, COMMUNICATION	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 10	2016	355								i6066	10.1136/bmj.i6066	http://dx.doi.org/10.1136/bmj.i6066			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CV	27834278				2022-12-28	WOS:000388003200013
J	Foukakis, T; von Minckwitz, G; Bengtsson, NO; Brandberg, Y; Wallberg, B; Fornander, T; Mlineritsch, B; Schmatloch, S; Singer, CF; Steger, G; Egle, D; Karlsson, E; Carlsson, L; Loibl, S; Untch, M; Hellstrom, M; Johansson, H; Anderson, H; Malmstrom, P; Gnant, M; Greil, R; Mobus, V; Bergh, J				Foukakis, Theodoros; von Minckwitz, Gunter; Bengtsson, Nils-Olof; Brandberg, Yvonne; Wallberg, Birgitta; Fornander, Tommy; Mlineritsch, Brigitte; Schmatloch, Sabine; Singer, Christian F.; Steger, Guenther; Egle, Daniel; Karlsson, Eva; Carlsson, Lena; Loibl, Sibylle; Untch, Michael; Hellstrom, Mats; Johansson, Hemming; Anderson, Harald; Malmstrom, Per; Gnant, Michael; Greil, Richard; Mobus, Volker; Bergh, Jonas		Swedish Breast Canc Grp; German Breast Grp; Austrian Breast Colorectal Canc	Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EUROPEAN-ORGANIZATION; FOLLOW-UP; THERAPY; CMF	IMPORTANCE Standard dosing of chemotherapy based on body surface area results in marked interpatient variation in pharmacokinetics, toxic effects, and efficacy. Whether tailored dosing can improve outcomes is unknown, as is the role of dose-dense adjuvant chemotherapy. OBJECTIVE To determine whether tailored dose-dense adjuvant chemotherapy improves the outcomes of early breast cancer compared with a standard 3-weekly chemotherapy schedule. DESIGN, SETTING, AND PARTICIPANTS A randomized, open-label, phase 3 trial of women aged 65 years and younger who had surgery for nonmetastatic node-positive or high-risk node-negative breast cancer at 86 sites in Sweden, Germany, and Austria between February 20, 2007, and September 14, 2011. INTERVENTIONS Patients were randomized 1:1 either to 4 cycles of leukocyte nadir-based tailored and dose-dense adjuvant epirubicin and cyclophosphamide every 2 weeks followed by 4 cycles of tailored dose-dense docetaxel every 2 weeks, or to standard-interval chemotherapy with 3 cycles of fluorouracil and epirubicin-cyclophosphamide every 3 weeks followed by 3 cycles of docetaxel every 3 weeks. MAIN OUTCOMES AND MEASURES The primary end point was breast cancer recurrence-free survival (BCRFS). Secondary end points included 5-year event-free survival (EFS), distant disease-free survival (DDFS), overall survival (OS), and rates of grade 3 or 4 toxic effects. RESULTS Among 2017 randomized patients (1006 in the tailored dose-dense group and 1011 in the control group; median [IQR] age, 51 [45-58] years; 80% with hormone receptor-positive tumors; 97% with node-positive disease), 2000 received study treatment (>= 1 cycle of chemotherapy; 1001 in the tailored dose-dense group and 999 in the control group). After a median follow-up of 5.3 years (IQR, 4.5-6.1 years), 269 BCRFS events were reported, 118 in the tailored dose-dense group and 151 in the control group (HR, 0.79; 95% CI, 0.61-1.01; log-rank P=.06; 5-year BCRFS, 88.7% vs 85.0%). The tailored dose-dense group had significantly better EFS than the control group (HR, 0.79; 95% CI, 0.63-0.99; P=.04; 5-year EFS, 86.7% vs 82.1%). The groups did not differ in OS (HR, 0.77; 95% CI, 0.57-1.05; P=.09; 5-year OS, 92.1% vs 90.2%) or DDFS (HR, 0.83; 95% CI, 0.64-1.08; P=.17; 5-year DDFS, 89.4% vs 86.7%). Grade 3 or 4 nonhematologic toxic effects occurred in 527 (52.6%) in the tailored dose-dense group and 366 (36.6%) in the control group. CONCLUSIONS AND RELEVANCE Among women with high-risk early breast cancer, the use of tailored dose-dense chemotherapy compared with standard adjuvant chemotherapy did not result in a statistically significant improvement in breast cancer recurrence-free survival. Nonhematologic toxic effects were more frequent in the tailored dose-dense group.	[Foukakis, Theodoros; Brandberg, Yvonne; Wallberg, Birgitta; Fornander, Tommy; Hellstrom, Mats; Johansson, Hemming; Bergh, Jonas] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden; [Foukakis, Theodoros; Brandberg, Yvonne; Wallberg, Birgitta; Fornander, Tommy; Hellstrom, Mats; Johansson, Hemming; Bergh, Jonas] Univ Hosp, S-17176 Stockholm, Sweden; [von Minckwitz, Gunter; Loibl, Sibylle] German Breast Grp, Neu Isenburg, Germany; [Bengtsson, Nils-Olof] Norrland Univ Hosp, Umea, Sweden; [Mlineritsch, Brigitte; Greil, Richard] Landeskrankenhaus & Paracelsus Med Univ, Salzburg, Austria; [Schmatloch, Sabine] Elisabeth Hosp, Kassel, Germany; [Singer, Christian F.] Med Univ, Dept Gynecol, Ctr Comprehens Canc, Vienna, Austria; [Steger, Guenther] Med Univ, Dept Internal Med, Ctr Comprehens Canc, Vienna, Austria; [Egle, Daniel] Med Univ Innsbruck, Dept Gynecol, Innsbruck, Austria; [Karlsson, Eva] Cent Hosp Karlstad, Karlstad, Sweden; [Carlsson, Lena] Cty Hosp, Sundsvall, Sweden; [Untch, Michael] HELIOS Klin, Berlin, Germany; [Anderson, Harald] Lund Univ, Dept Clin Sci, Canc Epidemiol, Lund, Sweden; [Malmstrom, Per] Skane Univ Hosp, Lund, Sweden; [Gnant, Michael] Med Univ, Dept Surg, Ctr Comprehens Canc, Vienna, Austria; [Mobus, Volker] Klinikum Frankfurt Hochst, Frankfurt, Germany	Karolinska Institutet; German Breast Group; Umea University; Medical University of Innsbruck; Helios Kliniken; Lund University; Lund University; Skane University Hospital	Bergh, J (corresponding author), Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, S-17176 Stockholm, Sweden.; Bergh, J (corresponding author), Univ Hosp, S-17176 Stockholm, Sweden.	jonas.bergh@ki.se	Gnant, Michael/AAN-7054-2020; Meyer, Anne S/AAN-2157-2020; Greil, Richard F/C-7673-2017	Gnant, Michael/0000-0003-1002-2118; Meyer, Anne S/0000-0001-8910-9931; Greil, Richard F/0000-0002-4462-3694; Foukakis, Theodoros/0000-0001-8952-9987	Swedish Cancer Society; Radiumhemmet; Amgen; Roche; Sanofi-Aventis; German Breast Group (GBG); Austrian Breast & Colorectal Cancer Study Group (ABCSG)	Swedish Cancer Society(Swedish Cancer Society); Radiumhemmet; Amgen(Amgen); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); German Breast Group (GBG); Austrian Breast & Colorectal Cancer Study Group (ABCSG)	This study was supported by grants from the Swedish Cancer Society to the Karolinska Institutet, from the research funds at Radiumhemmet, and from Amgen, Roche, and Sanofi-Aventis to the Swedish Breast Cancer Group (SweBCG) at Karolinska University Hospital, the German Breast Group (GBG), and the Austrian Breast & Colorectal Cancer Study Group (ABCSG).	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Baker SD, 2002, JNCI-J NATL CANCER I, V94, P1883, DOI 10.1093/jnci/94.24.1883; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Bonilla L, 2010, JNCI-J NATL CANCER I, V102, P1845, DOI 10.1093/jnci/djq409; Bonnefoi H, 2011, LANCET ONCOL, V12, P527, DOI 10.1016/S1470-2045(11)70094-8; Cameron DA, 2003, BRIT J CANCER, V89, P1837, DOI 10.1038/sj.bjc.6601366; Citron ML, 2003, J CLIN ONCOL, V21, P1431, DOI 10.1200/JCO.2003.09.081; Colleoni M, 1998, EUR J CANCER, V34, P1693, DOI 10.1016/S0959-8049(98)00209-3; Del Mastro L, 2015, LANCET, V385, P1863, DOI 10.1016/S0140-6736(14)62048-1; Fayers P, 2001, EORTC QLQ C30 SCORIN; Freedman L S, 1982, Stat Med, V1, P121, DOI 10.1002/sim.4780010204; Margolin S, 2011, ACTA ONCOL, V50, P35, DOI 10.3109/0284186X.2010.535847; Moebus V, 2010, J CLIN ONCOL, V28, P2874, DOI 10.1200/JCO.2009.24.7643; NORTON L, 1988, CANCER RES, V48, P7067; Perez EA, 2011, J CLIN ONCOL, V29, P4491, DOI 10.1200/JCO.2011.36.7045; Saarto T, 1997, BRIT J CANCER, V75, P301, DOI 10.1038/bjc.1997.49; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; Sprangers MAG, 1996, J CLIN ONCOL, V14, P2756, DOI 10.1200/JCO.1996.14.10.2756; Wilking N, 2007, ANN ONCOL, V18, P694, DOI 10.1093/annonc/mdl488	21	51	54	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1888	1896		10.1001/jama.2016.15865	http://dx.doi.org/10.1001/jama.2016.15865			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27825007				2022-12-28	WOS:000387116500017
J	Gershenwald, JE; Halpern, AC; Sondak, VK				Gershenwald, Jeffrey E.; Halpern, Allan C.; Sondak, Vernon K.			Melanoma Prevention-Avoiding Indoor Tanning and Minimizing Overexposure to the Sun	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE In the United States and Minnesota, melanoma incidence is rising more steeply among women than men younger than 50 years. To our knowledge, no study has examined age-and sex-specific associations between indoor tanning and melanoma to determine if these trends could be due to greater indoor tanning use among younger women. OBJECTIVE To examine associations between indoor tanning and melanoma among men and women younger than 50 years. DESIGN, SETTING, AND PARTICIPANTS Population-based case-control study conducted in Minnesota of 681 patients (465 [68.3%] women) diagnosed as having melanoma between 2004 and 2007, and 654 controls (446 [68.2%] women), ages 25 to 49 years. EXPOSURE Indoor tanning, defined as any use, first age of use, and total sessions. MAIN OUTCOMES AND MEASURES Crude and adjusted odds ratios (ORs) and 95% CIs were calculated for melanoma in relation to indoor tanning exposure for men and women by diagnosis or reference age (<30, 30-39, 40-49 years). Sex-specific associations for indoor tanning and melanoma by anatomic site were examined. RESULTS Compared with women aged 40 to 49 years, women younger than 40 years initiated indoor tanning at a younger age (16 vs 25 years, P<.001) and reported more frequent indoor tanning (median number of sessions, 100 vs 40, P<.001). Women younger than 30 years were 6 times more likely to be in the case than the control group if they tanned indoors (crude OR, 6.0; 95% CI, 1.3-28.5). Odds ratios were also significantly elevated among women, ages 30 to 49 years (adjusted OR, 3.5; 95% CI, 1.2-9.7 for women 30-39 years; adjusted OR, 2.3; 95% CI, 1.4-3.6 for women 40-49 years); a dose response was observed among women regardless of age. Among men, results by age were inconsistent. The strongest OR for indoor tanning by anatomic site was for melanomas arising on the trunk of women (adjusted OR, 3.7; 95% CI, 1.9-7.2). CONCLUSIONS AND RELEVANCE Indoor tanning is a likely factor for the steeper increase in melanoma rates in the United States among younger women compared with men, given the timing of when women initiated indoor tanning relative to diagnosis. The melanoma epidemic can be expected to continue unless indoor tanning is restricted and reduced.	[Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Melanoma & Skin Ctr, Melanoma Moon Shots Program, Houston, TX 77030 USA; [Gershenwald, Jeffrey E.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Melanoma & Skin Ctr, Melanoma Moon Shots Program, Houston, TX 77030 USA; [Halpern, Allan C.] Mem Sloan Kettering Canc Ctr, Dermatol Serv, Melanoma Dis Management Team, 1275 York Ave, New York, NY 10021 USA; [Sondak, Vernon K.] H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL USA; [Sondak, Vernon K.] Univ S Florida, Morsani Coll Med, Dept Oncol Sci, Tampa, FL USA; [Sondak, Vernon K.] Univ S Florida, Morsani Coll Med, Dept Surg, Tampa, FL USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Memorial Sloan Kettering Cancer Center; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Gershenwald, JE (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jgershen@mdanderson.org	Gershenwald, Jeff/AAX-4367-2020	Gershenwald, Jeff/0000-0003-4519-5369; halpern, allan/0000-0001-7320-1901	NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Cust AE, 2011, INT J CANCER, V128, P2425, DOI 10.1002/ijc.25576; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Guy GP, 2015, JAMA DERMATOL, V151, P448, DOI 10.1001/jamadermatol.2014.4677; Lazovich D, 2016, JAMA DERMATOL, V152, P268, DOI 10.1001/jamadermatol.2015.2938; Mays D, 2015, JAMA-J AM MED ASSOC, V313, P2423, DOI 10.1001/jama.2015.5975; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tripp MK, 2016, CA-CANCER J CLIN, V66, P461, DOI 10.3322/caac.21352	8	3	3	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1913	+		10.1001/jama.2016.16430	http://dx.doi.org/10.1001/jama.2016.16430			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27824997				2022-12-28	WOS:000387116500020
J	Navon, N; Gaunt, AL; Smith, RP; Hadzibabic, Z				Navon, Nir; Gaunt, Alexander L.; Smith, Robert P.; Hadzibabic, Zoran			Emergence of a turbulent cascade in a quantum gas	NATURE			English	Article							SUPERFLUID TURBULENCE; SURFACE	A central concept in the modern understanding of turbulence is the existence of cascades of excitations from large to small length scales, or vice versa. This concept was introduced in 1941 by Kolmogorov and Obukhov(1,2), and such cascades have since been observed in various systems, including interplanetary plasmas(3), supernovae(4), ocean waves(5) and financial markets(6). Despite much progress, a quantitative understanding of turbulence remains a challenge, owing to the interplay between many length scales that makes theoretical simulations of realistic experimental conditions difficult. Here we observe the emergence of a turbulent cascade in a weakly interacting homogeneous Bose gas-a quantum fluid that can be theoretically described on all relevant length scales. We prepare a Bose-Einstein condensate in an optical box(7), drive it out of equilibrium with an oscillating force that pumps energy into the system at the largest length scale, study its nonlinear response to the periodic drive, and observe a gradual development of a cascade characterized by an isotropic power-law distribution in momentum space. We numerically model our experiments using the Gross-Pitaevskii equation and find excellent agreement with the measurements. Our experiments establish the uniform Bose gas as a promising new medium for investigating many aspects of turbulence, including the interplay between vortex and wave turbulence, and the relative importance of quantum and classical effects.	[Navon, Nir; Gaunt, Alexander L.; Smith, Robert P.; Hadzibabic, Zoran] Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England	University of Cambridge	Navon, N (corresponding author), Univ Cambridge, Cavendish Lab, JJ Thomson Ave, Cambridge CB3 0HE, England.	nn270@cam.ac.uk	Smith, Robert P/A-1286-2014; Hadzibabic, Zoran/B-8102-2011	Smith, Robert P/0000-0002-6881-5690; Hadzibabic, Zoran/0000-0002-0118-9285; Navon, Nir/0000-0002-8917-3463	AFOSR; ARO; DARPA OLE; EPSRC [EP/N011759/1]; ERC (QBox); Trinity College, Cambridge; Royal Society; Engineering and Physical Sciences Research Council [EP/N011759/1, 1104880] Funding Source: researchfish	AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); ARO; DARPA OLE(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ERC (QBox); Trinity College, Cambridge; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank G. V. Shlyapnikov, B. Svistunov, S. Stringari, N. R. Cooper, J. Dalibard, M. J. Davis, R. J. Fletcher, M. W. Zwierlein, K. Fujimoto and M. Tsubota for discussions, and C. Eigen for experimental assistance. This work was supported by AFOSR, ARO, DARPA OLE, EPSRC (Grant No. EP/N011759/1) and ERC (QBox). The GeForce GTX TITAN X used for the numerical simulations was donated by the NVIDIA Corporation. N. N. and A. L. G. acknowledge support from Trinity College, Cambridge; R. P. S. acknowledges support from the Royal Society.	Abdurakhimov LV, 2012, JETP LETT+, V95, P670, DOI 10.1134/S0021364012120028; Berloff NG, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.013603; Bradley DI, 2011, NAT PHYS, V7, P473, DOI [10.1038/NPHYS1963, 10.1038/nphys1963]; Chesler PM, 2013, SCIENCE, V341, P368, DOI 10.1126/science.1233529; Ganshin AN, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.065303; Gaunt AL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.200406; Ghashghaie S, 1996, NATURE, V381, P767, DOI 10.1038/381767a0; Gotlibovych I, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.061604; Henn EAL, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.045301; Hwang PA, 2000, J PHYS OCEANOGR, V30, P2753, DOI 10.1175/1520-0485(2001)031<2753:AMOTWS>2.0.CO;2; Kagan Y, 1998, PHYS REV LETT, V80, P892, DOI 10.1103/PhysRevLett.80.892; Kobayashi M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.065302; Kolmakov GV, 2014, P NATL ACAD SCI USA, V111, P4727, DOI 10.1073/pnas.1312575110; Kolmogorov A.N., 1941, DOKL AKAD NAUK SSSR, V30, P299, DOI DOI 10.1098/RSPA.1991.0075; Kwon WJ, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.063627; Maurer J, 1998, EUROPHYS LETT, V43, P29, DOI 10.1209/epl/i1998-00314-9; Mosta P, 2015, NATURE, V528, P376, DOI 10.1038/nature15755; Neely TW, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.235301; Nore C, 1997, PHYS REV LETT, V78, P3896, DOI 10.1103/PhysRevLett.78.3896; Obukhov A., 1941, DOKL AKAD NAUK SSSR, V32, P22; Paoletti MS, 2011, ANNU REV CONDEN MA P, V2, P213, DOI 10.1146/annurev-conmatphys-062910-140533; Pitaevskii L. P., 2016, BOSE EINSTEIN CONDEN; Proment D, 2009, PHYS REV A, V80, DOI 10.1103/PhysRevA.80.051603; Reeves MT, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.104501; Schmidutz TF, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.040403; Sorriso-Valvo L, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.115001; Stenger J, 1999, PHYS REV LETT, V82, P4569, DOI 10.1103/PhysRevLett.82.4569; Tsatsos MC, 2016, PHYS REP, V622, P1, DOI 10.1016/j.physrep.2016.02.003; Walmsley PM, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.245301; Zakharov V., 1992, KOLMOGOROV SPECTRA T	30	121	121	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					72	+		10.1038/nature20114	http://dx.doi.org/10.1038/nature20114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808196	Green Submitted, Green Accepted			2022-12-28	WOS:000386670100031
J	McCarthy, M				McCarthy, Michael			Phenotype is king, researchers say, after 20 family members have condition misdiagnosed	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ackerman JP, 2016, MAYO CLIN PROC, V91, P1606, DOI 10.1016/j.mayocp.2016.08.008	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2016	355								i5884	10.1136/bmj.i5884	http://dx.doi.org/10.1136/bmj.i5884			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CU	27806950				2022-12-28	WOS:000387317900013
J	Voelker, R				Voelker, Rebecca			Lifesaving App for Opioid Users	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1756	1756		10.1001/jama.2016.15572	http://dx.doi.org/10.1001/jama.2016.15572			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802527				2022-12-28	WOS:000386569300007
J	Mayor, S				Mayor, Susan			Cranberry capsules do not reduce urinary tract infections in older women, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Juthani-Mehta M, 2016, JAMA-J AM MED ASSOC, V316, P1879, DOI 10.1001/jama.2016.16141; Nicolle LE, 2016, JAMA-J AM MED ASSOC, V316, P1873, DOI 10.1001/jama.2016.16140	2	0	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2016	355								i5835	10.1136/bmj.i5835	http://dx.doi.org/10.1136/bmj.i5835			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CM	27799145				2022-12-28	WOS:000387316800005
J	Zuber, MT; Smith, DE; Neumann, GA; Goossens, S; Andrews-Hanna, JC; Head, JW; Kiefer, WS; Asmar, SW; Konopliv, AS; Lemoine, FG; Matsuyama, I; Melosh, HJ; McGovern, PJ; Nimmo, F; Phillips, RJ; Solomon, SC; Taylor, GJ; Watkins, MM; Wieczorek, MA; Williams, JG; Jansen, JC; Johnson, BC; Keane, JT; Mazarico, E; Miljkovic, K; Park, RS; Soderblom, JM; Yuan, DN				Zuber, Maria T.; Smith, David E.; Neumann, Gregory A.; Goossens, Sander; Andrews-Hanna, Jeffrey C.; Head, James W.; Kiefer, Walter S.; Asmar, Sami W.; Konopliv, Alexander S.; Lemoine, Frank G.; Matsuyama, Isamu; Melosh, H. Jay; McGovern, Patrick J.; Nimmo, Francis; Phillips, Roger J.; Solomon, Sean C.; Taylor, G. Jeffrey; Watkins, Michael M.; Wieczorek, Mark A.; Williams, James G.; Jansen, Johanna C.; Johnson, Brandon C.; Keane, James T.; Mazarico, Erwan; Miljkovic, Katarina; Park, Ryan S.; Soderblom, Jason M.; Yuan, Dah-Ning			Gravity field of the Orientale basin from the Gravity Recovery and Interior Laboratory Mission	SCIENCE			English	Article							MULTIRING BASINS; LUNAR CRUST; MOON; GRAIL; ORIGIN; RINGS	The Orientale basin is the youngest and best-preserved major impact structure on the Moon. We used the Gravity Recovery and Interior Laboratory (GRAIL) spacecraft to investigate the gravitational field of Orientale at 3- to 5-kilometer (km) horizontal resolution. A volume of at least (3.4 +/- 0.2) x 10(6) km(3) of crustal material was removed and redistributed during basin formation. There is no preserved evidence of the transient crater that would reveal the basin's maximum volume, but its diameter may now be inferred to be between 320 and 460 km. The gravity field resolves distinctive structures of Orientale's three rings and suggests the presence of faults associated with the outer two that penetrate to the mantle. The crustal structure of Orientale provides constraints on the formation of multiring basins.	[Zuber, Maria T.; Smith, David E.; Johnson, Brandon C.; Miljkovic, Katarina; Soderblom, Jason M.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Neumann, Gregory A.; Lemoine, Frank G.; Mazarico, Erwan] NASA, Goddard Space Flight Ctr, Solar Syst Explorat Div, Greenbelt, MD 20771 USA; [Goossens, Sander] Univ Maryland Baltimore Cty, Ctr Res & Explorat Space Sci & Technol, Baltimore, MD 21250 USA; [Andrews-Hanna, Jeffrey C.; Jansen, Johanna C.] Colorado Sch Mines, Dept Geophys, Golden, CO 80401 USA; [Andrews-Hanna, Jeffrey C.; Jansen, Johanna C.] Colorado Sch Mines, Ctr Space Resources, Golden, CO 80401 USA; [Andrews-Hanna, Jeffrey C.; Phillips, Roger J.] Southwest Res Inst, Boulder, CO 80302 USA; [Head, James W.; Johnson, Brandon C.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Kiefer, Walter S.; McGovern, Patrick J.] Lunar & Planetary Inst, 3303 NASA Rd 1, Houston, TX 77058 USA; [Asmar, Sami W.; Konopliv, Alexander S.; Watkins, Michael M.; Williams, James G.; Park, Ryan S.; Yuan, Dah-Ning] Jet Prop Lab, Pasadena, CA 91109 USA; [Matsuyama, Isamu; Keane, James T.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Melosh, H. Jay] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Solomon, Sean C.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Solomon, Sean C.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Taylor, G. Jeffrey] Univ Hawaii, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Watkins, Michael M.] Univ Texas Austin, Ctr Space Res, Austin, TX 78712 USA; [Wieczorek, Mark A.] Univ Paris Diderot, Sorbonne Paris Cite, Inst Phys Globe Paris, F-75205 Paris 13, France; [Miljkovic, Katarina] Curtin Univ, Dept Appl Geol, Perth, WA 6845, Australia	Massachusetts Institute of Technology (MIT); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; Colorado School of Mines; Colorado School of Mines; Southwest Research Institute; Brown University; National Aeronautics & Space Administration (NASA); National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Arizona; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of California System; University of California Santa Cruz; Carnegie Institution for Science; Columbia University; University of Hawaii System; University of Texas System; University of Texas Austin; UDICE-French Research Universities; Universite Paris Cite; Curtin University	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	zuber@mit.edu	Lemoine, Frank/D-1215-2013; Wieczorek, Mark A/G-6427-2010; Goossens, Sander J/K-2526-2015; Kiefer, Walter/F-2759-2016; Mazarico, Erwan/N-6034-2014; Neumann, Gregory A/I-5591-2013; Keane, James/AAI-5137-2020; Miljkovic, Katarina/D-4844-2013	Wieczorek, Mark A/0000-0001-7007-4222; Goossens, Sander J/0000-0002-7707-1128; Kiefer, Walter/0000-0001-6741-5460; Mazarico, Erwan/0000-0003-3456-427X; Neumann, Gregory A/0000-0003-0644-9944; Soderblom, Jason/0000-0003-3715-6407; Miljkovic, Katarina/0000-0001-8644-8903; Matsuyama, Isamu/0000-0002-2917-8633; Lemoine, Frank G./0000-0002-3051-1456	NASA's Discovery Program	NASA's Discovery Program(National Aeronautics & Space Administration (NASA))	The GRAIL mission is supported by NASA's Discovery Program and is performed under contract to the Massachusetts Institute of Technology and the Jet Propulsion Laboratory. Topography was obtained from the Lunar Orbiter Laser Altimeter on the Lunar Reconnaissance Mission, managed by NASA's Goddard Space Flight Center. The NASA Pleiades and Center for Climate Simulation supercomputers were used to compute the gravity solutions. All data used in this study are archived in the Geosciences Node of the NASA Planetary Data System at http://geo.pds.nasa.gov/missions/grail/default.htm.	Andrews-Hanna JC, 2013, ICARUS, V222, P159, DOI 10.1016/j.icarus.2012.10.031; Besserer J, 2014, GEOPHYS RES LETT, V41, P5771, DOI 10.1002/2014GL060240; Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2011JE003951; Gulick SPS, 2013, REV GEOPHYS, V51, P31, DOI 10.1002/rog.20007; Head JW, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041790; Head J. W., 1974, Moon, V11, P327, DOI 10.1007/BF00589168; Head J.W., 1977, IMPACT EXPLOSION CRA, P563; HODGES CA, 1978, ICARUS, V34, P294, DOI 10.1016/0019-1035(78)90169-0; HOWARD KA, 1974, REV GEOPHYS, V12, P309, DOI 10.1029/RG012i003p00309; Ivanov BA, 2010, GEOL SOC AM SPEC PAP, V465, P29, DOI 10.1130/2010.2465(03); Johnson BC, 2016, SCIENCE, V354, P441, DOI 10.1126/science.aag0518; Kattoum YN, 2013, ICARUS, V226, P694, DOI 10.1016/j.icarus.2013.06.025; Kiefer WS, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051319; Konopliv AS, 1998, SCIENCE, V281, P1476, DOI 10.1126/science.281.5382.1476; Lemoine FG, 2014, GEOPHYS RES LETT, V41, P3382, DOI 10.1002/2014GL060027; MCCAULEY JF, 1977, PHYS EARTH PLANET IN, V15, P220, DOI 10.1016/0031-9201(77)90033-4; Melosh HJ, 2013, SCIENCE, V340, P1552, DOI [10.1126/science.1235768, 10.1126/science.1238663]; MULLER PM, 1968, SCIENCE, V161, P680, DOI 10.1126/science.161.3842.680; Nahm AL, 2013, J GEOPHYS RES-PLANET, V118, P190, DOI 10.1002/jgre.20045; Namiki N, 2009, SCIENCE, V323, P900, DOI 10.1126/science.1168029; Neumann GA, 1996, J GEOPHYS RES-PLANET, V101, P16841, DOI 10.1029/96JE01246; Neumann GA, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500852; Potter RWK, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052981; Potter R. W. K., 2013, J GEOPHYS RES, V118, P1; Rowlands DD, 2002, J GEODESY, V76, P307, DOI 10.1007/s00190-002-0255-8; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; Smith DE, 2017, ICARUS, V283, P70, DOI 10.1016/j.icarus.2016.06.006; Smith DE, 2010, SPACE SCI REV, V150, P209, DOI 10.1007/s11214-009-9512-y; Spudis P.D., 1993, GEOLOGY MULTIRING IM; Stoffler D, 2006, REV MINERAL GEOCHEM, V60, P519, DOI 10.2138/rmg.2006.60.05; Sweetser T. H., 2012, AIAA ASTR SPEC C MIN; Wieczorek MA, 1999, ICARUS, V139, P246, DOI 10.1006/icar.1999.6102; Wieczorek MA, 2006, REV MINERAL GEOCHEM, V60, P221, DOI 10.2138/rmg.2006.60.3; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Wilhelms D., 1987, GEOLOGIC HIST MOON, DOI [10.3133/pp1348, DOI 10.3133/PP1348]; Xie MG, 2016, EARTH PLANET SC LETT, V440, P71, DOI 10.1016/j.epsl.2016.02.012; Zuber MT, 2013, SPACE SCI REV, V178, P3, DOI 10.1007/s11214-012-9952-7; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839	39	21	21	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					438	441		10.1126/science.aag0519	http://dx.doi.org/10.1126/science.aag0519			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789835	Green Submitted, Green Accepted			2022-12-28	WOS:000387684400034
J	Albert, RK; Au, DH; Blackford, AL; Casaburi, R; Cooper, JA; Criner, GJ; Diaz, P; Fuhlbrigge, AL; Gay, SE; Kanner, RE; MacIntyre, N; Martinez, FJ; Panos, RJ; Piantadosi, S; Sciurba, F; Shade, D; Stibolt, T; Stoller, JK; Wise, R; Yusen, RD; Tonascia, J; Sternberg, AL; Bailey, W				Albert, Richard K.; Au, David H.; Blackford, Amanda L.; Casaburi, Richard; Cooper, J. Allen, Jr.; Criner, Gerard J.; Diaz, Philip; Fuhlbrigge, Anne L.; Gay, Steven E.; Kanner, Richard E.; MacIntyre, Neil; Martinez, Fernando J.; Panos, Ralph J.; Piantadosi, Steven; Sciurba, Frank; Shade, David; Stibolt, Thomas; Stoller, James K.; Wise, Robert; Yusen, Roger D.; Tonascia, James; Sternberg, Alice L.; Bailey, William		Long-Term Oxygen Treatment Trial	A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EXERCISE; THERAPY; SCALE; VALIDITY; QUALITY; DYSPNEA; INDEX	BACKGROUND Long-term treatment with supplemental oxygen has unknown efficacy in patients with stable chronic obstructive pulmonary disease (COPD) and resting or exercise-induced moderate desaturation. METHODS We originally designed the trial to test whether long-term treatment with supplemental oxygen would result in a longer time to death than no use of supplemental oxygen among patients who had stable COPD with moderate resting desaturation (oxyhemoglobin saturation as measured by pulse oximetry [Spo(2)], 89 to 93%). After 7 months and the randomization of 34 patients, the trial was redesigned to also include patients who had stable COPD with moderate exercise-induced desaturation (during the 6-minute walk test, Spo(2) >= 80% for >= 5 minutes and < 90% for >= 10 seconds) and to incorporate the time to the first hospitalization for any cause into the new composite primary outcome. Patients were randomly assigned, in a 1: 1 ratio, to receive long-term supplemental oxygen (supplemental-oxygen group) or no long-term supplemental oxygen (no-supplemental-oxygen group). In the supplemental-oxygen group, patients with resting desaturation were prescribed 24-hour oxygen, and those with desaturation only during exercise were prescribed oxygen during exercise and sleep. The trial-group assignment was not masked. RESULTS A total of 738 patients at 42 centers were followed for 1 to 6 years. In a time-to-event analysis, we found no significant difference between the supplemental-oxygen group and the no-supplemental-oxygen group in the time to death or first hospitalization (hazard ratio, 0.94; 95% confidence interval [CI], 0.79 to 1.12; P = 0.52), nor in the rates of all hospitalizations (rate ratio, 1.01; 95% CI, 0.91 to 1.13), COPD exacerbations (rate ratio, 1.08; 95% CI, 0.98 to 1.19), and COPD-related hospitalizations (rate ratio, 0.99; 95% CI, 0.83 to 1.17). We found no consistent between-group differences in measures of quality of life, lung function, and the distance walked in 6 minutes. CONCLUSIONS In patients with stable COPD and resting or exercise-induced moderate desaturation, the prescription of long-term supplemental oxygen did not result in a longer time to death or first hospitalization than no long-term supplemental oxygen, nor did it provide sustained benefit with regard to any of the other measured outcomes. (Funded by the National Heart, Lung, and Blood Institute and the Centers for Medicare and Medicaid Services; LOTT ClinicalTrials.gov number, NCT00692198.)	[Albert, Richard K.] Univ Colorado, Denver, CO 80202 USA; [Au, David H.] Vet Affairs VA Puget Sound Hlth Care Syst, Seattle, WA USA; [Au, David H.] Univ Washington, Seattle, WA 98195 USA; [Blackford, Amanda L.; Casaburi, Richard] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Shade, David; Tonascia, James; Sternberg, Alice L.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Casaburi, Richard] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA USA; [Piantadosi, Steven] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Cooper, J. Allen, Jr.] Birmingham VA Med Ctr, Birmingham, AL USA; [Cooper, J. Allen, Jr.; Bailey, William] Univ Alabama Birmingham, Birmingham, AL USA; [Criner, Gerard J.] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Sciurba, Frank] Univ Pittsburgh, Pittsburgh, PA USA; [Diaz, Philip] Ohio State Univ, Columbus, OH 43210 USA; [Panos, Ralph J.] Cincinnati VA Med Ctr, Cincinnati, OH USA; [Panos, Ralph J.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Stoller, James K.] Cleveland Clin, Cleveland, OH 44106 USA; [Fuhlbrigge, Anne L.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Fuhlbrigge, Anne L.] Harvard Med Sch, Boston, MA USA; [Gay, Steven E.] Univ Michigan, Ann Arbor, MI 48109 USA; [Kanner, Richard E.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [MacIntyre, Neil] Duke Univ, Med Ctr, Durham, NC USA; [Martinez, Fernando J.] Weill Cornell Med Ctr, New York, NY USA; [Stibolt, Thomas] Kaiser Permanente, Ctr Hlth Res, Portland, OR USA; [Yusen, Roger D.] Washington Univ, Sch Med, St Louis, MO 63130 USA	University of Colorado System; University of Colorado Denver; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Cedars Sinai Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; University of Cincinnati; Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Michigan System; University of Michigan; Utah System of Higher Education; University of Utah; Duke University; Cornell University; Kaiser Permanente; Washington University (WUSTL)	Wise, R (corresponding author), Johns Hopkins Asthma & Allergy Ctr, Div Pulm & Crit Care, 4B-72,5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	rwise@jhmi.edu	Sciurba, Frank/AAZ-9339-2021	Sriram, P.S/0000-0002-6103-3573; sciurba, frank/0000-0001-7468-2225; Wise, Robert/0000-0002-8353-2349; Aboussouan, Loutfi/0000-0003-2716-0904	National Heart, Lung, and Blood Institute; Centers for Medicare and Medicaid Services	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Centers for Medicare and Medicaid Services	Funded by the National Heart, Lung, and Blood Institute and the Centers for Medicare and Medicaid Services; LOTT ClinicalTrials.gov number, NCT00692198.	Ameer F, 2014, COCHRANE DB SYST REV, V6; [Anonymous], 1980, ANN INTERN MED, V93, P391; [Anonymous], 2013, 2013 CMS STAT CMS PU, V03504; Barr JT, 2000, CLIN THER, V22, P1121, DOI 10.1016/S0149-2918(00)80089-2; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Chaouat A, 1999, EUR RESPIR J, V14, P1002, DOI 10.1183/09031936.99.14510029; COX DR, 1972, J R STAT SOC B, V34, P187; Drummond MB, 2008, CHEST, V134, P497, DOI 10.1378/chest.08-0117; Emtner M, 2003, AM J RESP CRIT CARE, V168, P1034, DOI 10.1164/rccm.200212-1525OC; FLENLEY DC, 1981, LANCET, V1, P681; FLETCHER EC, 1987, CHEST, V92, P604, DOI 10.1378/chest.92.4.604; FLETCHER EC, 1989, AM REV RESPIR DIS, V140, P1237, DOI 10.1164/ajrccm/140.5.1237; Gorecka D, 1997, THORAX, V52, P674, DOI 10.1136/thx.52.8.674; Hsu J., 1996, MULTIPLE COMP THEORY; Jones Paul W, 2005, COPD, V2, P75; KAPLAN RM, 1984, J CHRON DIS, V37, P85, DOI 10.1016/0021-9681(84)90050-X; Kaplan Robert M, 2005, COPD, V2, P91; O'Donnell DE, 2001, AM J RESP CRIT CARE, V163, P892, DOI 10.1164/ajrccm.163.4.2007026; Puhan MA, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-46; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Ringbaek T, 2013, CHRON RESP DIS, V10, P77, DOI 10.1177/1479972312473135; Spira AP, 2012, J GERONTOL A-BIOL, V67, P433, DOI 10.1093/gerona/glr172; Stoller JK, 2010, CHEST, V138, P179, DOI 10.1378/chest.09-2555; TIMMS RM, 1985, AM REV RESPIR DIS, V131, P69; Uronis HE, 2015, THORAX, V70, P492, DOI 10.1136/thoraxjnl-2014-205720; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Williamson W, 2012, PULM MED, V2012, DOI 10.1155/2012/874020; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	238	245	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2016	375	17					1617	1627		10.1056/NEJMoa1604344	http://dx.doi.org/10.1056/NEJMoa1604344			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2DX	27783918	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000387168900008
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, KW; Epling, JW; Garcia, FAR; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Philips, WR; Phipps, MG; Pignone, MP				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Philips, William R.; Phipps, Maureen G.; Pignone, Michael P.		US Preventive Serv Task Force	Primary Care Interventions to Support Breastfeeding US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED-TRIAL	IMPORTANCE There is convincing evidence that breastfeeding provides substantial health benefits for children. However, nearly half of all US mothers who initially breastfeed stop doing so by 6 months, and there are significant disparities in breastfeeding rates among younger mothers and in disadvantaged communities. OBJECTIVE To update the 2008 US Preventive Services Task Force (USPSTF) recommendation on primary care interventions to promote breastfeeding. EVIDENCE REVIEW The USPSTF reviewed the evidence on the effectiveness of interventions to support breastfeeding on breastfeeding initiation, duration, and exclusivity. The USPSTF also briefly reviewed the literature on the effects of these interventions on child and maternal health outcomes. FINDINGS The USPSTF found adequate evidence that interventions to support breastfeeding, including professional support, peer support, and formal education, change behavior and that the harms of these interventions are no greater than small. The USPSTF concludes with moderate certainty that interventions to support breastfeeding have a moderate net benefit. CONCLUSIONS AND RECOMMENDATION The USPSTF recommends providing interventions during pregnancy and after birth to support breastfeeding. (B recommendation)	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Philips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ Texas Austin, Austin, TX 78712 USA	University of California System; University of California San Francisco; University of Iowa; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Brown University; University of Texas System; University of Texas Austin	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Epling, John W/J-1097-2019; Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X	NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Academy of Family Physicians, 2016, CLIN PREV SERV REC B; American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, 2016, Obstet Gynecol, V127, pe86, DOI 10.1097/AOG.0000000000001318; Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; [Anonymous], 2013, J PEDIATR HEALTH CAR, V27, pE13, DOI 10.1016/j.pedhc.2012.09.001; [Anonymous], 2011, SURG GEN CALL ACT SU; Bonuck KA, 2006, ARCH PEDIAT ADOL MED, V160, P953, DOI 10.1001/archpedi.160.9.953; Bunik M, 2010, ACAD PEDIATR, V10, P21, DOI 10.1016/j.acap.2009.09.014; Centers for Disease Control and Prevention, 2013, CDC GUID STRAT SUPP; Centers for Disease Control and Prevention, 2016, BREASTF PROM SUPP; Centers for Disease Control and Prevention, 2016, CDC NAT IMM SURV BRE; Chapman DJ, 2013, PEDIATRICS, V131, pE162, DOI 10.1542/peds.2012-0688; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Gagnon AJ, 2002, PEDIATRICS, V109, P1074, DOI 10.1542/peds.109.6.1074; Hopkinson J, 2009, J HUM LACT, V25, P287, DOI 10.1177/0890334409335482; Patnode CD, 2016, JAMA-J AM MED ASSOC, V316, P1694, DOI 10.1001/jama.2016.8882; Patnode CD, 2016, AHRQ PUBLICATION, V15; US Department of Health and Human Services, 2016, HLTH PEOPL 2020 MAT; WHO UNICEF, 1989, PROT PROM SUPP BREAS; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED	19	57	59	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1688	1693		10.1001/jama.2016.14697	http://dx.doi.org/10.1001/jama.2016.14697			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784102				2022-12-28	WOS:000386107800035
J	Slomski, A				Slomski, Anita			Eating Oily Fish May Protect Against Diabetic Retinopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1637	1637		10.1001/jama.2016.15436	http://dx.doi.org/10.1001/jama.2016.15436			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784095				2022-12-28	WOS:000386107800009
J	Jaffe, S				Jaffe, Susan			US global health leadership hangs on election result	LANCET			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1969	1970		10.1016/S0140-6736(16)31898-0	http://dx.doi.org/10.1016/S0140-6736(16)31898-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ6EQ	27789008				2022-12-28	WOS:000385954800011
J	Smith, TJ; Hegedus, L				Smith, Terry J.; Hegedus, Laszlo			Graves' Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							DRUG-INDUCED AGRANULOCYTOSIS; AUTOIMMUNE THYROID-DISEASE; FACTOR-I RECEPTOR; THYROTROPIN-RECEPTOR; ORBITAL RADIOTHERAPY; ABERRANT EXPRESSION; IGF-1 RECEPTOR; SINGLE-BLIND; EYE DISEASE; HLA-DR		[Smith, Terry J.] Univ Michigan, Sch Med, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [Smith, Terry J.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Hegedus, Laszlo] Univ Southern Denmark, Odense Univ Hosp, Dept Endocrinol, Odense, Denmark; [Hegedus, Laszlo] Univ Southern Denmark, Odense Univ Hosp, Dept Metab, Odense, Denmark; [Smith, Terry J.] Univ Southern Denmark, Odense Univ Hosp, Dept Ophthalmol, Odense, Denmark	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Smith, TJ (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Brehm Tower,1000 Wall St, Ann Arbor, MI 48105 USA.	terrysmi@med.umich.edu	Smith, Terry/ABG-1360-2020	Smith, Terry/0000-0002-6279-9685	NATIONAL EYE INSTITUTE [R01EY008976] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abraham P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003420.pub4; Andersen SL, 2016, J CLIN ENDOCR METAB, V101, P1606, DOI 10.1210/jc.2015-4274; Armengol MP, 2003, J IMMUNOL, V170, P6320, DOI 10.4049/jimmunol.170.12.6320; Azizi F, 2000, J CLIN ENDOCR METAB, V85, P3233, DOI 10.1210/jc.85.9.3233; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Bartalena L, 2016, CLIN ENDOCRINOL, V84, P115, DOI 10.1111/cen.12688; Bartalena L, 2012, J CLIN ENDOCR METAB, V97, P4454, DOI 10.1210/jc.2012-2389; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; Bartalena L, 2008, THYROID, V18, P333, DOI 10.1089/thy.2007.0315; Bartalena L, 2013, NAT REV ENDOCRINOL, V9, P724, DOI 10.1038/nrendo.2013.193; Bartalena L, 2009, NEW ENGL J MED, V360, P994, DOI 10.1056/NEJMcp0806317; Bartley GB, 1996, AM J OPHTHALMOL, V121, P284, DOI 10.1016/S0002-9394(14)70276-4; Boboridis KG, 2015, ADV THER, V32, P595, DOI 10.1007/s12325-015-0228-y; Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Bonnema SJ, 2012, ENDOCR REV, V33, P920, DOI 10.1210/er.2012-1030; Brandt F, 2015, EUR J ENDOCRINOL, V173, P595, DOI 10.1530/EJE-15-0306; Brandt F, 2014, EUR J ENDOCRINOL, V170, P341, DOI 10.1530/EJE-13-0708; Brandt F, 2012, J CLIN ENDOCR METAB, V97, P4123, DOI 10.1210/jc.2012-2268; Brix TH, 2001, J CLIN ENDOCR METAB, V86, P930, DOI 10.1210/jc.86.2.930; Burch HB, 2015, JAMA-J AM MED ASSOC, V314, P2544, DOI 10.1001/jama.2015.16535; Burch HB, 2012, J CLIN ENDOCR METAB, V97, P4549, DOI 10.1210/jc.2012-2802; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; Choe CH, 2011, OPHTHAL PLAST RECONS, V27, P4, DOI 10.1097/IOP.0b013e3181df6a87; Coles AJ, 1999, LANCET, V354, P1691, DOI 10.1016/S0140-6736(99)02429-0; Cooper DS, 2013, LANCET DIABETES ENDO, V1, P238, DOI 10.1016/S2213-8587(13)70086-X; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Di Maria C, 2014, J CLIN ENDOCR METAB, V99, P4600, DOI 10.1210/jc.2014-1957; Diana T, 2015, THYROID, V25, P169, DOI 10.1089/thy.2014.0346; Douglas RS, 2008, J IMMUNOL, V181, P5768, DOI 10.4049/jimmunol.181.8.5768; Douglas RS, 2007, J IMMUNOL, V178, P3281, DOI 10.4049/jimmunol.178.5.3281; Douglas RS, 2010, J CLIN ENDOCR METAB, V95, P430, DOI 10.1210/jc.2009-1614; Douglas RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1155, DOI 10.1001/archophthalmol.2009.232; Effraimidis G, 2014, EUR J ENDOCRINOL, V170, pR241, DOI 10.1530/EJE-14-0047; Erbil Y, 2007, J CLIN ENDOCR METAB, V92, P2182, DOI 10.1210/jc.2007-0229; Fatourechi V, 2012, BEST PRACT RES CL EN, V26, P551, DOI [10.1016/j.beem.2011.10.001, 10.1016/j.beem.2012.07.002]; Faure GC, 1997, CLIN IMMUNOL IMMUNOP, V84, P212, DOI 10.1006/clin.1997.4391; FELICIELLO A, 1993, LANCET, V342, P337, DOI 10.1016/0140-6736(93)91475-2; Fernando R, 2014, J CLIN ENDOCR METAB, V99, pE1236, DOI 10.1210/jc.2013-4271; Fernando R, 2012, P NATL ACAD SCI USA, V109, P7427, DOI 10.1073/pnas.1202064109; Feroci F, 2014, SURGERY, V155, P529, DOI 10.1016/j.surg.2013.10.017; Fukata S, 1999, THYROID, V9, P29, DOI 10.1089/thy.1999.9.29; HANAFUSA T, 1983, LANCET, V2, P1111; Hegedus L, 2012, BEST PRACT RES CL EN, V26, P313, DOI 10.1016/j.beem.2011.09.005; HEUFELDER AE, 1995, EUR J ENDOCRINOL, V132, P266, DOI 10.1530/eje.0.1320266; Jellema HM, 2015, ACTA OPHTHALMOL, V93, P601, DOI 10.1111/aos.12717; Kahaly GJ, 2005, CLIN ENDOCRINOL, V63, P395, DOI 10.1111/j.1365-2265.2005.02352.x; Kahaly GJ, 2000, J CLIN ENDOCR METAB, V85, P102, DOI 10.1210/jc.85.1.102; Krieger CC, 2015, J CLIN ENDOCR METAB, V100, P1071, DOI 10.1210/jc.2014-3566; Limbach M, 2016, J AUTOIMMUN, V67, P46, DOI 10.1016/j.jaut.2015.09.006; Liu ZW, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010576.pub2; Ljunggren JG, 1998, THYROID, V8, P653, DOI 10.1089/thy.1998.8.653; Marcocci C, 2001, J CLIN ENDOCR METAB, V86, P3562, DOI 10.1210/jc.86.8.3562; Marcocci C, 2011, NEW ENGL J MED, V364, P1920, DOI 10.1056/NEJMoa1012985; MARTIN A, 1989, J CLIN ENDOCR METAB, V69, P1104, DOI 10.1210/jcem-69-6-1104; Mitchell AL, 2013, CLIN ENDOCRINOL, V79, P437, DOI 10.1111/cen.12141; Momotani N, 2000, CLIN ENDOCRINOL, V53, P177, DOI 10.1046/j.1365-2265.2000.01078.x; Morshed SA, 2009, ENDOCRINOLOGY, V150, P519, DOI 10.1210/en.2008-0878; Nagata K, 2015, AUTOIMMUNITY, V48, P328, DOI 10.3109/08916934.2015.1022163; Nakamura H, 2013, J CLIN ENDOCR METAB, V98, P4776, DOI 10.1210/jc.2013-2569; Nakashima M, 1996, J CLIN ENDOCR METAB, V81, P3346, DOI 10.1210/jc.81.9.3346; NORDYKE RA, 1988, ARCH INTERN MED, V148, P626, DOI 10.1001/archinte.148.3.626; Pedersen IB, 2001, CLIN ENDOCRINOL, V55, P381, DOI 10.1046/j.1365-2265.2001.01347.x; Pritchard J, 2003, J IMMUNOL, V170, P6348, DOI 10.4049/jimmunol.170.12.6348; Rapoport B, 2015, J CLIN ENDOCR METAB, V100, pE871, DOI 10.1210/jc.2015-1528; Rapoport B, 2014, J CLIN ENDOCR METAB, V99, P4060, DOI 10.1210/jc.2014-3011; Ron E, 1998, JAMA-J AM MED ASSOC, V280, P347, DOI 10.1001/jama.280.4.347; RUNDLE FF, 1945, CLIN SCI, V5, P177; Salvi M, 2015, J CLIN ENDOCR METAB, V100, P422, DOI 10.1210/jc.2014-3014; Sisti E, 2015, EUR J ENDOCRINOL, V172, P269, DOI 10.1530/EJE-14-0712; Smith TJ, 1999, THYROID, V9, P749, DOI 10.1089/thy.1999.9.749; Stan MN, 2015, J CLIN ENDOCR METAB, V100, P432, DOI 10.1210/jc.2014-2572; Tanda ML, 2012, J CLIN ENDOCR METAB, V97, P3857, DOI 10.1210/jc.2012-2758; TELLEZ M, 1992, CLIN ENDOCRINOL, V36, P291, DOI 10.1111/j.1365-2265.1992.tb01445.x; Tomer Y, 2014, ANNU REV PATHOL-MECH, V9, P147, DOI 10.1146/annurev-pathol-012513-104713; Tozzoli R, 2012, AUTOIMMUN REV, V12, P107, DOI 10.1016/j.autrev.2012.07.003; Tsui S, 2008, J IMMUNOL, V181, P4397, DOI 10.4049/jimmunol.181.6.4397; VILLADOLID MC, 1995, J CLIN ENDOCR METAB, V80, P2830, DOI 10.1210/jc.80.9.2830; Walter MA, 2007, BRIT MED J, V334, P514, DOI 10.1136/bmj.39114.670150.BE; WEETMAN AP, 1990, J CLIN INVEST, V86, P723, DOI 10.1172/JCI114768; Wiersinga WM, 2013, CLIN ENDOCRINOL, V79, P145, DOI 10.1111/cen.12222; Zang S, 2011, J CLIN ENDOCR METAB, V96, P320, DOI 10.1210/jc.2010-1962; Zimmermann MB, 2015, LANCET DIABETES ENDO, V3, P286, DOI 10.1016/S2213-8587(14)70225-6	83	520	534	14	118	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1552	1565		10.1056/NEJMra1510030	http://dx.doi.org/10.1056/NEJMra1510030			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3HF	27797318	Green Published			2022-12-28	WOS:000393102500008
J	Ploumen, L; Schippers, E				Ploumen, Lilianne; Schippers, Edith			Better life through medicine-let's leave no one behind	LANCET			English	Editorial Material									[Ploumen, Lilianne] Minist Foreign Affairs, Bezuidenhoutseweg 67, NL-2594 AC The Hague, Netherlands; [Schippers, Edith] Minist Hlth Welf & Sport, Parnassuspl 5, NL-2511 VX The Hague, Netherlands	Ministry of Health, Welfare & Sport	Ploumen, L (corresponding author), Minist Foreign Affairs, Bezuidenhoutseweg 67, NL-2594 AC The Hague, Netherlands.	com@minbuza.nl						Andres F., 2016, SEUSWHT16870; Andres F., 2016, IEUSWHT16847; [Anonymous], 2016, FORTUNE; DNDi, 2014, INN APPR R D NEGL PA; Ministry of Agriculture, 2016, SUMM MED PLAN, P7; Roy V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3718; Silverman E., 2016, STAT; UN Secretary-General and Co-Chairs of the High-Level Panel, 2016, UN SECR GEN HIGH LEV; Vyas K, 2016, WALL STREET J; Wirtz VJ, 2016, LANCET	10	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					339	341		10.1016/S0140-6736(16)31905-5	http://dx.doi.org/10.1016/S0140-6736(16)31905-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27832876				2022-12-28	WOS:000392804700008
J	Abeliovich, A; Gitler, AD				Abeliovich, Asa; Gitler, Aaron D.			Defects in trafficking bridge Parkinson's disease pathology and genetics	NATURE			English	Review							SYNUCLEIN ACTIVATES MICROGLIA; GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; GAUCHER-DISEASE; NEUROTRANSMITTER RELEASE; INTELLECTUAL DISABILITY; LYSOSOMAL DYSFUNCTION; DAMAGED MITOCHONDRIA; MEDIATED AUTOPHAGY; DOPAMINE NEURONS	Parkinson's disease is a debilitating, age-associated movement disorder. A central aspect of the pathophysiology of Parkinson's disease is the progressive demise of midbrain dopamine neurons and their axonal projections, but the underlying causes of this loss are unclear. Advances in genetics and experimental model systems have illuminated an important role for defects in intracellular transport pathways to lysosomes. The accumulation of altered proteins and damaged mitochondria, particularly at axon terminals, ultimately might overwhelm the capacity of intracellular disposal mechanisms. Cell-extrinsic mechanisms, including inflammation and prion-like spreading, are proposed to have both protective and deleterious functions in Parkinson's disease.	[Abeliovich, Asa] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Abeliovich, Asa] Columbia Univ, Dept Neurol, New York, NY 10032 USA; [Abeliovich, Asa] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA; [Gitler, Aaron D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Columbia University; Columbia University; Columbia University; Stanford University	Abeliovich, A (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.; Abeliovich, A (corresponding author), Columbia Univ, Dept Neurol, New York, NY 10032 USA.; Abeliovich, A (corresponding author), Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA.; Gitler, AD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	aa900@columbia.edu; agitler@stanford.edu		Gitler, Aaron/0000-0001-8603-1526	Michael J. Fox Foundation; US National Institute of Neurological Disorders and Stroke	Michael J. Fox Foundation; US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Pfeffer for reading the manuscript. This work was funded by grants from the Michael J. Fox Foundation and the US National Institute of Neurological Disorders and Stroke.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Arranz AM, 2015, J CELL SCI, V128, P541, DOI 10.1242/jcs.158196; Ashrafi G, 2014, J CELL BIOL, V206, P655, DOI 10.1083/jcb.201401070; Bae EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5755; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Bento CF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11803; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Braak H, 2000, J NEUROL, V247, P3; Burre J, 2014, P NATL ACAD SCI USA, V111, pE4274, DOI 10.1073/pnas.1416598111; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen LA, 2015, J NEUROSCI, V35, P890, DOI 10.1523/JNEUROSCI.0089-14.2015; Chung CY, 2013, SCIENCE, V342, P983, DOI 10.1126/science.1245296; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Czirr E, 2012, J CLIN INVEST, V122, P1156, DOI 10.1172/JCI58656; Daher JPL, 2015, J BIOL CHEM, V290, P19433, DOI 10.1074/jbc.M115.660001; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Deng HX, 2016, NAT GENET, V48, P733, DOI 10.1038/ng.3589; Dettmer U, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8314; Dhungel N, 2015, NEURON, V85, P76, DOI 10.1016/j.neuron.2014.11.027; Dickson DW, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009258; Do CB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002141; Dodson MW, 2014, DIS MODEL MECH, V7, P1351, DOI 10.1242/dmm.017020; Dubos A, 2015, HUM MOL GENET, V24, P6736, DOI 10.1093/hmg/ddv380; Edvardson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036458; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fellner L, 2013, GLIA, V61, P349, DOI 10.1002/glia.22437; Fuji RN, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3634; Gitler AD, 2007, J NEUROSCI, V27, P2433, DOI 10.1523/JNEUROSCI.0094-07.2007; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Goedert M, 2013, NAT REV NEUROL, V9, P13, DOI 10.1038/nrneurol.2012.242; Goker-Alpan O, 2004, J MED GENET, V41, P937, DOI 10.1136/jmg.2004.024455; Harms AS, 2013, J NEUROSCI, V33, P9592, DOI 10.1523/JNEUROSCI.5610-12.2013; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; HORNYKIEWICZ O, 1962, DEUT MED WOCHENSCHR, V87, P1807, DOI 10.1055/s-0028-1114024; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Kett LR, 2015, J NEUROSCI, V35, P5724, DOI 10.1523/JNEUROSCI.0632-14.2015; Kim C, 2015, CELL REP, V13, P771, DOI 10.1016/j.celrep.2015.09.044; Kim C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2534; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kong SMY, 2014, HUM MOL GENET, V23, P2816, DOI 10.1093/hmg/ddu099; Korvatska O, 2013, HUM MOL GENET, V22, P3259, DOI 10.1093/hmg/ddt180; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.45; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Lesage S, 2016, AM J HUM GENET, V98, P500, DOI 10.1016/j.ajhg.2016.01.014; Lin MK, 2014, GENOME MED, V6, DOI 10.1186/gm566; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Luzio JP, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016840; Lynch-Day MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009357; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mazzulli JR, 2016, P NATL ACAD SCI USA, V113, P1931, DOI 10.1073/pnas.1520335113; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McGough IJ, 2014, CURR BIOL, V24, P1670, DOI 10.1016/j.cub.2014.06.024; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mecozzi VJ, 2014, NAT CHEM BIOL, V10, P443, DOI [10.1038/NCHEMBIO.1508, 10.1038/nchembio.1508]; Miura E, 2014, NEUROBIOL DIS, V71, P1, DOI 10.1016/j.nbd.2014.07.014; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Munsie LN, 2015, HUM MOL GENET, V24, P1691, DOI 10.1093/hmg/ddu582; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parks WT, 2001, J BIOL CHEM, V276, P19332, DOI 10.1074/jbc.M100606200; Pickrell AM, 2015, NEURON, V87, P371, DOI 10.1016/j.neuron.2015.06.034; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Polymeropoulos MH, 1996, SCIENCE, V274, P1197, DOI 10.1126/science.274.5290.1197; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Rannikko EH, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0192-0; Rhinn H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2032; Richter F, 2014, NEUROTHERAPEUTICS, V11, P840, DOI 10.1007/s13311-014-0294-x; Rothaug M, 2014, P NATL ACAD SCI USA, V111, P15573, DOI 10.1073/pnas.1405700111; Ryan SD, 2013, CELL, V155, P1351, DOI 10.1016/j.cell.2013.11.009; Sanders DW, 2016, NEURON, V89, P433, DOI 10.1016/j.neuron.2016.01.026; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Seaman Matthew Nj, 2014, Commun Integr Biol, V7, pe29483, DOI 10.4161/cib.29483; Sidransky E, 2005, MOL GENET METAB, V84, P302, DOI 10.1016/j.ymgme.2004.11.007; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Small SA, 2015, NAT REV NEUROSCI, V16, P126, DOI 10.1038/nrn3896; Soldner F, 2016, NATURE, V533, P95, DOI 10.1038/nature17939; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sudhof TC, 2014, ANGEW CHEM INT EDIT, V53, P12696, DOI 10.1002/anie.201406359; Tang FL, 2015, J NEUROSCI, V35, P10613, DOI 10.1523/JNEUROSCI.0042-15.2015; Theillet FX, 2016, NATURE, V530, P45, DOI 10.1038/nature16531; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Tran HT, 2014, CELL REP, V7, P2054, DOI 10.1016/j.celrep.2014.05.033; Tsika E, 2014, HUM MOL GENET, V23, P4621, DOI 10.1093/hmg/ddu178; Tsunemi T, 2014, J NEUROSCI, V34, P15281, DOI 10.1523/JNEUROSCI.1629-14.2014; Usenovic M, 2012, J NEUROSCI, V32, P4240, DOI 10.1523/JNEUROSCI.5575-11.2012; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Vilarino-Guell C, 2014, HUM MOL GENET, V23, P1794, DOI 10.1093/hmg/ddt570; Vilarino-Guell C, 2011, AM J HUM GENET, V89, P162, DOI 10.1016/j.ajhg.2011.06.001; Volpicelli-Daley LA, 2014, MOL BIOL CELL, V25, P4010, DOI 10.1091/mbc.E14-02-0741; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Wang SJ, 2015, P NATL ACAD SCI USA, V112, pE1926, DOI 10.1073/pnas.1417883112; Waschbusch D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111632; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wilson GR, 2014, AM J HUM GENET, V95, P729, DOI 10.1016/j.ajhg.2014.10.015; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Wong YC, 2014, P NATL ACAD SCI USA, V111, pE4439, DOI 10.1073/pnas.1405752111; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Zavodszky E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4828; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005; Zimprich A, 2011, AM J HUM GENET, V89, P168, DOI 10.1016/j.ajhg.2011.06.008; Zuckerman S, 2007, JAMA-J AM MED ASSOC, V298, P1281, DOI 10.1001/jama.298.11.1281	138	280	290	4	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					207	216		10.1038/nature20414	http://dx.doi.org/10.1038/nature20414			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830778				2022-12-28	WOS:000387318500031
J	Cocker, TL; Peller, D; Yu, P; Repp, J; Huber, R				Cocker, Tyler L.; Peller, Dominik; Yu, Ping; Repp, Jascha; Huber, Rupert			Tracking the ultrafast motion of a single molecule by femtosecond orbital imaging	NATURE			English	Article							SCANNING-TUNNELING-MICROSCOPY; ATTOSECOND CONTROL; REAL-SPACE; RESOLUTION; DYNAMICS; ELECTRONS; SPECTROSCOPY; MANIPULATION	Watching a single molecule move on its intrinsic timescale has been one of the central goals of modern nanoscience, and calls for measurements that combine ultrafast temporal resolution(1-8) with atomic spatial resolution(9-30). Steady-state experiments access the requisite spatial scales, as illustrated by direct imaging of individual molecular orbitals using scanning tunnelling microscopy(9-11) or the acquisition of tip-enhanced Raman and luminescence spectra with sub-molecular resolution(26-28). But tracking the intrinsic dynamics of a single molecule directly in the time domain faces the challenge that interactions with the molecule must be confined to a femtosecond time window. For individual nanoparticles, such ultrafast temporal confinement has been demonstrated(18) by combining scanning tunnelling microscopy with so-called lightwave electronics(1-8), which uses the oscillating carrier wave of tailored light pulses to directly manipulate electronic motion on timescales faster even than a single cycle of light. Here we build on ultrafast terahertz scanning tunnelling microscopy to access a state-selective tunnelling regime, where the peak of a terahertz electric-field waveform transiently opens an otherwise forbidden tunnelling channel through a single molecular state. It thereby removes a single electron from an individual pentacene molecule's highest occupied molecular orbital within a time window shorter than one oscillation cycle of the terahertz wave. We exploit this effect to record approximately 100-femtosecond snapshot images of the orbital structure with sub-angstrom spatial resolution, and to reveal, through pump/probe measurements, coherent molecular vibrations at terahertz frequencies directly in the time domain. We anticipate that the combination of lightwave electronics(1-8) and the atomic resolution of our approach will open the door to visualizing ultrafast photochemistry and the operation of molecular electronics on the single-orbital scale.	[Cocker, Tyler L.; Peller, Dominik; Yu, Ping; Repp, Jascha; Huber, Rupert] Univ Regensburg, Dept Phys, D-93040 Regensburg, Germany	University of Regensburg	Repp, J; Huber, R (corresponding author), Univ Regensburg, Dept Phys, D-93040 Regensburg, Germany.	jascha.repp@physik.uni-regensburg.de; rupert.huber@physik.uni-regensburg.de	Yu, Ping/AAU-5067-2021; Repp, Jascha/B-1843-2014; Huber, Rupert/N-4126-2018	Repp, Jascha/0000-0003-2883-7083; Huber, Rupert/0000-0001-6617-9283; Yu, Ping/0000-0001-6361-8439	Volkswagen Foundation (Lichtenberg program); European Research Council [305003]; Deutsche Forschungsgemeinschaft (DFG) [GRK 1570];  [HU1598/3];  [CO1492/1]	Volkswagen Foundation (Lichtenberg program); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); ; 	We thank A. Pollmann, F. Albrecht, R. Kronfeldner, M. Eisele and M. Furthmeier for assistance, and F. Evers, F. A. Hegmann, V. Jelic, P. C. M. Planken, M. Grifoni and K. Richter for discussions. We acknowledge financial support from the Volkswagen Foundation (Lichtenberg program), the European Research Council through grant number 305003 (QUANTUMsubCYCLE), and the Deutsche Forschungsgemeinschaft (DFG) through GRK 1570 and research grants HU1598/3 and CO1492/1. T.L.C. thanks the A. v. Humboldt Foundation.	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Chen C. J., 1993, INTRO SCANNING TUNNE; Cocker TL, 2013, NAT PHOTONICS, V7, P620, DOI [10.1038/nphoton.2013.151, 10.1038/NPHOTON.2013.151]; Eisele M, 2014, NAT PHOTONICS, V8, P841, DOI [10.1038/nphoton.2014.225, 10.1038/NPHOTON.2014.225]; Feist A, 2015, NATURE, V521, P200, DOI 10.1038/nature14463; Gao M, 2013, NATURE, V496, P343, DOI 10.1038/nature12044; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; HAMERS RJ, 1990, APPL PHYS LETT, V57, P2031, DOI 10.1063/1.103997; Hohenleutner M, 2015, NATURE, V523, P572, DOI 10.1038/nature14652; Itatani J, 2004, NATURE, V432, P867, DOI 10.1038/nature03183; Iwaszczuk K, 2015, OPTICA, V2, P116, DOI 10.1364/OPTICA.2.000116; Jahng J, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913853; Kemiktarak U, 2007, NATURE, V450, P85, DOI 10.1038/nature06238; Kruger M, 2011, NATURE, V475, P78, DOI 10.1038/nature10196; Lee J, 2014, ACS NANO, V8, P54, DOI 10.1021/nn405335h; Loth S, 2010, SCIENCE, V329, P1628, DOI [10.1126/science.1191688, 10.1126/science.191688]; Merino P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9461; Meyer G, 1996, REV SCI INSTRUM, V67, P2960, DOI 10.1063/1.1147080; Neppl S, 2015, NATURE, V517, P342, DOI 10.1038/nature14094; NUNES G, 1993, SCIENCE, V262, P1029, DOI 10.1126/science.262.5136.1029; Park H, 2000, NATURE, V407, P57, DOI 10.1038/35024031; Repp J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.026803; Steurer W, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4883219; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Stroscio JA, 2004, SCIENCE, V306, P242, DOI 10.1126/science.1102370; Terada Y, 2010, NAT PHOTONICS, V4, P869, DOI 10.1038/nphoton.2010.235; Wagner M, 2014, NANO LETT, V14, P894, DOI 10.1021/nl4042577; Wimmer L, 2014, NAT PHYS, V10, P432, DOI [10.1038/NPHYS2974, 10.1038/nphys2974]; WITTE G, 1995, J CHEM PHYS, V103, P5860, DOI 10.1063/1.470465; Witte G, 1998, PHYS REV LETT, V80, P121, DOI 10.1103/PhysRevLett.80.121; Wu SW, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.085444; Yoshida K, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.138302; Yoshida S, 2014, NAT NANOTECHNOL, V9, P588, DOI [10.1038/NNANO.2014.125, 10.1038/nnano.2014.125]; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135; Zhang R, 2013, NATURE, V498, P82, DOI 10.1038/nature12151; Zhang Y, 2016, NATURE, V531, P623, DOI 10.1038/nature17428	36	272	276	15	417	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					263	+		10.1038/nature19816	http://dx.doi.org/10.1038/nature19816			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830788	Green Accepted			2022-12-28	WOS:000387318500039
J	Horton, R				Horton, Richard			Offline: A barometer for trust in China	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2222	2222		10.1016/S0140-6736(16)32110-9	http://dx.doi.org/10.1016/S0140-6736(16)32110-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8MO	27825494				2022-12-28	WOS:000386889300011
J	van Leeuwen, J; Pons, C; Mellor, JC; Yamaguchi, TN; Friesen, H; Koschwanez, J; Usaj, MM; Pechlaner, M; Takar, M; Usaj, M; VanderSluis, B; Andrusiak, K; Bansal, P; Baryshnikova, A; Boone, CE; Cao, J; Cote, A; Gebbia, M; Horecka, G; Horecka, I; Kuzmin, E; Legro, N; Liang, W; van Lieshout, N; McNee, M; Luis, BJS; Shaeri, F; Shuteriqi, E; Sun, S; Yang, L; Youn, JY; Yuen, M; Costanzo, M; Gingras, AC; Aloy, P; Oostenbrink, C; Murray, A; Graham, TR; Myers, CL; Andrews, BJ; Roth, FP; Boone, C				van Leeuwen, Jolanda; Pons, Carles; Mellor, Joseph C.; Yamaguchi, Takafumi N.; Friesen, Helena; Koschwanez, John; Usaj, Mojca Mattiazzi; Pechlaner, Maria; Takar, Mehmet; Usaj, Matej; VanderSluis, Benjamin; Andrusiak, Kerry; Bansal, Pritpal; Baryshnikova, Anastasia; Boone, Claire E.; Cao, Jessica; Cote, Atina; Gebbia, Marinella; Horecka, Gene; Horecka, Ira; Kuzmin, Elena; Legro, Nicole; Liang, Wendy; van Lieshout, Natascha; McNee, Margaret; Luis, Bryan-Joseph San; Shaeri, Fatemeh; Shuteriqi, Ermira; Sun, Song; Yang, Lu; Youn, Ji-Young; Yuen, Michael; Costanzo, Michael; Gingras, Anne-Claude; Aloy, Patrick; Oostenbrink, Chris; Murray, Andrew; Graham, Todd R.; Myers, Chad L.; Andrews, Brenda J.; Roth, Frederick P.; Boone, Charles			Exploring genetic suppression interactions on a global scale	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; INTERACTION NETWORKS; INTERACTION DATASETS; DELETION MUTANTS; ORDERED ARRAYS; YEAST; PROTEIN; GENOME; CELL; FITNESS		[van Leeuwen, Jolanda; Mellor, Joseph C.; Yamaguchi, Takafumi N.; Friesen, Helena; Usaj, Mojca Mattiazzi; Usaj, Matej; Andrusiak, Kerry; Bansal, Pritpal; Boone, Claire E.; Cao, Jessica; Cote, Atina; Gebbia, Marinella; Horecka, Gene; Horecka, Ira; Kuzmin, Elena; Legro, Nicole; Liang, Wendy; van Lieshout, Natascha; McNee, Margaret; Luis, Bryan-Joseph San; Shaeri, Fatemeh; Shuteriqi, Ermira; Sun, Song; Yang, Lu; Yuen, Michael; Costanzo, Michael; Andrews, Brenda J.; Roth, Frederick P.; Boone, Charles] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Pons, Carles; VanderSluis, Benjamin; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, 200 Union St, Minneapolis, MN 55455 USA; [Pons, Carles; Aloy, Patrick] Barcelona Inst Sci & Technol, IRB Barcelona, Barcelona, Catalonia, Spain; [Mellor, Joseph C.; Yamaguchi, Takafumi N.; Bansal, Pritpal; Cote, Atina; Gebbia, Marinella; van Lieshout, Natascha; Shaeri, Fatemeh; Youn, Ji-Young; Gingras, Anne-Claude; Roth, Frederick P.] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada; [Yamaguchi, Takafumi N.; Andrusiak, Kerry; Kuzmin, Elena; van Lieshout, Natascha; Gingras, Anne-Claude; Andrews, Brenda J.; Roth, Frederick P.; Boone, Charles] Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada; [Koschwanez, John; Murray, Andrew] Harvard Univ, Dept Cellular & Mol Biol, 52 Oxford St, Cambridge, MA 02138 USA; [Pechlaner, Maria; Oostenbrink, Chris] Univ Nat Resources & Life Sci, Inst Mol Modeling & Simulat, Muthgasse 18, A-1190 Vienna, Austria; [Takar, Mehmet; Graham, Todd R.] Vanderbilt Univ, Dept Biol Sci, 1161 21st Ave South, Nashville, TN 37232 USA; [Baryshnikova, Anastasia] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA; [Aloy, Patrick] Inst Catalana Recerca & Estudis Avancats, Barcelona, Catalonia, Spain; [Roth, Frederick P.; Boone, Charles] Canadian Inst Adv Res, 180 Dundas St West, Toronto, ON M5G 1Z8, Canada; [Roth, Frederick P.] Univ Toronto, Dept Comp Sci, 160 Coll St, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Minnesota System; University of Minnesota Twin Cities; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Harvard University; University of Natural Resources & Life Sciences, Vienna; Vanderbilt University; Princeton University; ICREA; Canadian Institute for Advanced Research (CIFAR); University of Toronto	Andrews, BJ; Roth, FP; Boone, C (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, 160 Coll St, Toronto, ON M5S 3E1, Canada.; Myers, CL (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, 200 Union St, Minneapolis, MN 55455 USA.; Roth, FP (corresponding author), Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.; Andrews, BJ; Roth, FP; Boone, C (corresponding author), Univ Toronto, Dept Mol Genet, 160 Coll St, Toronto, ON M5S 3E1, Canada.; Roth, FP; Boone, C (corresponding author), Canadian Inst Adv Res, 180 Dundas St West, Toronto, ON M5G 1Z8, Canada.; Roth, FP (corresponding author), Univ Toronto, Dept Comp Sci, 160 Coll St, Toronto, ON M5S 3E1, Canada.	cmyers@cs.umn.edu; brenda.andrews@utoronto.ca; fritz.roth@utoronto.ca; charlie.boone@utoronto.ca	Aloy, Patrick/AAB-3538-2019; Gingras, Anne-Claude/ABA-8341-2020; Yang, Lu/Y-2586-2019; Pons, Carles/B-6841-2016; Oostenbrink, Chris/S-8002-2019; Roth, Frederick P/H-6308-2011; Gingras, Anne-Claude/E-9982-2010; Usaj, Matej/J-5454-2015	Gingras, Anne-Claude/0000-0002-6090-4437; Yang, Lu/0000-0002-2694-1189; Pons, Carles/0000-0002-9131-9089; Oostenbrink, Chris/0000-0002-4232-2556; Gingras, Anne-Claude/0000-0002-6090-4437; LEGRO, NICOLE/0000-0002-7455-3850; van Leeuwen, Jolanda/0000-0003-3991-518X; Mattiazzi Usaj, Mojca/0000-0002-7389-8478; Yamaguchi, Takafumi/0000-0003-1082-3871; van Lieshout, Natascha/0000-0001-8025-8412; Pechlaner, Maria/0000-0002-1615-5600; Usaj, Matej/0000-0003-0675-2847	NIH [R01HG005853, R01HG005084, P50HG004233, U01HG001715, R01GM107978]; Canadian Institutes of Health Research [FDN-143264, FDN-143265, FDN-143301]; Ontario Research Fund (Research Excellence Grant); Canada Excellence Research Chairs Program; Canadian Institutes of Health Research; Vienna Science and Technology Fund [LS08-QM03]; ICREA Funding Source: Custom	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Research Fund (Research Excellence Grant); Canada Excellence Research Chairs Program(Canada Research Chairs); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vienna Science and Technology Fund; ICREA(ICREA)	We thank G. Fairn, C. Dunn, N. Pascoe, and E. Styles for reagents and technical assistance. This work was primarily supported by grants from the NIH (R01HG005853, R01HG005084, P50HG004233, and U01HG001715) (C.B., B.J.A., C.L.M., and F.P.R.); the Canadian Institutes of Health Research (FDN-143264 and FDN-143265) (C.B. and B.J.A.); the Ontario Research Fund (Research Excellence Grant) (F.P.R.); the Canada Excellence Research Chairs Program (F.P.R.); and a postdoctoral fellowship from the Canadian Institutes of Health Research (J.v.L.). Additional support was provided by the Canadian Institutes of Health Research (FDN-143301) (A.-C.G.), the Vienna Science and Technology Fund (LS08-QM03) (C.O. and M.P.), and the NIH (R01GM107978) (T.R.G.). C.B., B.J.A., F.P.R., and C.L.M. are Senior Fellows in the Canadian Institute for Advanced Research Genetic Networks program. All whole-genome sequencing data are publicly available at NCBI's Sequencing Read Archive, under accession number SRP067030. All suppression interaction data are included in tables S1 and S2.	Barbosa S, 2010, TRAFFIC, V11, P1092, DOI 10.1111/j.1600-0854.2010.01079.x; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Botstein D., 2015, DECODING LANGUAGE GE; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Cameroni E, 2004, CELL CYCLE, V3, P462; Chen R, 2016, NAT BIOTECHNOL, V34, P531, DOI 10.1038/nbt.3514; Clark-Walker GD, 2003, MITOCHONDRION, V2, P257, DOI 10.1016/S1567-7249(02)00107-1; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/NMETH.1284, 10.1038/nmeth.1284]; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Dunn CD, 2003, GENETICS, V165, P35; Fairn GD, 2011, NAT CELL BIOL, V13, P1424, DOI 10.1038/ncb2351; Gillingham AK, 2006, J BIOL CHEM, V281, P2273, DOI 10.1074/jbc.M510176200; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; Jordan DM, 2015, NATURE, V524, P225, DOI 10.1038/nature14497; Jorgensen P, 2002, GENETICS, V162, P1091; Kaida D, 2002, GENES CELLS, V7, P543, DOI 10.1046/j.1365-2443.2002.00538.x; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Kvitek DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003972; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; Magtanong L, 2011, NAT BIOTECHNOL, V29, P505, DOI 10.1038/nbt.1855; Parsons AB, 2006, CELL, V126, P611, DOI 10.1016/j.cell.2006.06.040; Peiro-Chova L, 2007, GENETICS, V176, P125, DOI 10.1534/genetics.106.066829; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sunshine AB, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002155; Takar M, 2016, J BIOL CHEM, V291, P15727, DOI 10.1074/jbc.M115.686253; TANAKA K, 1990, CELL, V60, P803, DOI 10.1016/0092-8674(90)90094-U; Teng X, 2013, MOL CELL, V52, P485, DOI 10.1016/j.molcel.2013.09.026; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Valencia-Burton M, 2006, GENETICS, V174, P41, DOI 10.1534/genetics.106.058685; Wahl LM, 2015, GENETICS, V200, P309, DOI 10.1534/genetics.114.172890; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	46	99	99	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312							aag0839	10.1126/science.aag0839	http://dx.doi.org/10.1126/science.aag0839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811238	Green Accepted			2022-12-28	WOS:000386869800043
J	Goering, S; Yuste, R				Goering, Sara; Yuste, Rafael			On the Necessity of Ethical Guidelines for Novel Neurotechnologies	CELL			English	Editorial Material								Because novel neurotechnologies may alter human identity and society in profound ways, we advocate for the early integration of ethics into neurotechnology. We recommend developing and adopting a set of guidelines, like the Belmont Report on human subject research, as a framework for development and use of brain-related technologies.	[Goering, Sara] Univ Washington, Dept Philosophy, Seattle, WA 98195 USA; [Goering, Sara] Univ Washington, Ctr Sensorimotor Neural Engn, Seattle, WA 98195 USA; [Yuste, Rafael] Columbia Univ, Neurotechnol Ctr, Kavli Inst Brain Sci, Dept Biol Sci & Neurosci, New York, NY 10027 USA	University of Washington; University of Washington Seattle; National Science Foundation (NSF); NSF - Center for Neurotechnology (CNT); University of Washington; University of Washington Seattle; Columbia University	Goering, S (corresponding author), Univ Washington, Dept Philosophy, Seattle, WA 98195 USA.; Goering, S (corresponding author), Univ Washington, Ctr Sensorimotor Neural Engn, Seattle, WA 98195 USA.; Yuste, R (corresponding author), Columbia Univ, Neurotechnol Ctr, Kavli Inst Brain Sci, Dept Biol Sci & Neurosci, New York, NY 10027 USA.	sgoering@uw.edu; rmy5@columbia.edu		Goering, Sara/0000-0002-1882-3764				Aas S, 2016, J MED ETHICS, V42, P37, DOI 10.1136/medethics-2015-102807; [Anonymous], 2016, COGNITIVE ENHANCEMEN, DOI [DOI 10.1093/ACPROF:OSO/9780199396818.003.0005, 10.1093/acprof:oso/9780199396818.003.0005]; Baylis F, 2013, NEUROETHICS-NETH, V6, P513, DOI 10.1007/s12152-011-9137-1; Carrillo-Reid L, 2016, SCIENCE, V353, P691, DOI 10.1126/science.aaf7560; Farahany NA, 2012, STANFORD LAW REV, V64, P351; Haselager P, 2013, MIND MACH, V23, P405, DOI 10.1007/s11023-012-9298-7; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kitcher P., 2011, SCI DEMOCRATIC SOC; Pais-Vieira M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11869; Ramirez S, 2013, SCIENCE, V341, P387, DOI 10.1126/science.1239073; Stocco A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137303; Vlek RJ, 2012, J NEUROL PHYS THER, V36, P94, DOI 10.1097/NPT.0b013e31825064cc; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	14	22	22	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					882	885		10.1016/j.cell.2016.10.029	http://dx.doi.org/10.1016/j.cell.2016.10.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814514	Bronze			2022-12-28	WOS:000389469000004
J	Kerbrat, A; Ferre, JC; Fillatre, P; Ronziere, T; Vannier, S; Carsin-Nicol, B; Lavoue, S; Verin, M; Gauvrit, JY; Le Tulzo, Y; Edan, G				Kerbrat, Anne; Ferre, Jean-Christophe; Fillatre, Pierre; Ronziere, Thomas; Vannier, Stephane; Carsin-Nicol, Beatrice; Lavoue, Sylvain; Verin, Marc; Gauvrit, Jean-Yves; Le Tulzo, Yves; Edan, Gilles			Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAIN	BACKGROUND A decrease in fatty acid amide hydrolase (FAAH) activity increases the levels of endogenous analogues of cannabinoids, or endocannabinoids. FAAH inhibitors have shown analgesic and antiinflammatory activity in animal models, and some have been tested in phase 1 and 2 studies. In a phase 1 study, BIA 10-2474, an orally administered reversible FAAH inhibitor, was given to healthy volunteers to assess safety. METHODS Single doses (0.25 to 100 mg) and repeated oral doses (2.5 to 20 mg for 10 days) of BIA 10-2474 had been administered to 84 healthy volunteers in sequential cohorts; no severe adverse events had been reported. Another cohort of participants was then assigned to placebo (2 participants) or 50 mg of BIA 10-2474 per day (6 participants). This report focuses on neurologic adverse events in participants in this final cohort. A total of 4 of the 6 participants who received active treatment consented to have their clinical and radiologic data included in this report. RESULTS An acute and rapidly progressive neurologic syndrome developed in three of the four participants starting on the fifth day of drug administration. The main clinical features were headache, a cerebellar syndrome, memory impairment, and altered consciousness. Magnetic resonance imaging showed bilateral and symmetric cerebral lesions, including microhemorrhages and hyperintensities on fluid-attenuated inversion recovery and diffusion-weighted imaging sequences predominantly involving the pons and hippocampi. One patient became brain dead; the condition of two patients subsequently improved, but one patient had residual memory impairment, and the other patient had a residual cerebellar syndrome. One patient remained asymptomatic. CONCLUSIONS An unanticipated severe neurologic disorder occurred after ingestion of BIA 10-2474 at the highest dose level used in a phase 1 trial. The underlying mechanism of this toxic cerebral syndrome remains unknown.	[Kerbrat, Anne; Ronziere, Thomas; Vannier, Stephane; Verin, Marc; Edan, Gilles] Rennes Univ Hosp, Dept Neurol, Rennes, France; [Ferre, Jean-Christophe; Carsin-Nicol, Beatrice; Gauvrit, Jean-Yves] Rennes Univ Hosp, Dept Radiol, Rennes, France; [Fillatre, Pierre; Lavoue, Sylvain; Le Tulzo, Yves] Rennes Univ Hosp, Dept Infect Dis & Med Intens Care, Rennes, France; [Fillatre, Pierre; Le Tulzo, Yves; Edan, Gilles] Rennes Univ Hosp, INSERM 1414, Ctr Invest Clin Plurithemat, Rennes, France; [Verin, Marc] Rennes Univ Hosp, EA 4712, Comportement & Noyaux Gris Cent Lab, Rennes, France; [Kerbrat, Anne; Ferre, Jean-Christophe; Gauvrit, Jean-Yves] Inst Natl Rech Informat & Automat, Vis Act & Informat Management Syst Hlth Team, Rennes, France	CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Universite de Rennes; CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes	Edan, G (corresponding author), CHU Hop Pontchaillou, 2 Rue Henri Le Guilloux, F-35033 Rennes 9, France.	gilles.edan@chu-rennes.fr	Edan, Gilles/AAI-5944-2020; Verin, Marc/ABC-6924-2020	Ferre, Jean-Christophe/0000-0003-3911-1800				Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Hu SSJ, 2015, HANDB EXP PHARMACOL, V231, P59, DOI 10.1007/978-3-319-20825-1_3; Huggins JP, 2012, PAIN, V153, P1837, DOI 10.1016/j.pain.2012.04.020; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Sharma P, 2009, AM J ROENTGENOL, V193, P879, DOI 10.2214/AJR.08.2257	5	124	127	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1717	1725		10.1056/NEJMoa1604221	http://dx.doi.org/10.1056/NEJMoa1604221			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806235				2022-12-28	WOS:000387007300005
J	Marraffini, LA; Hay, A; Grinstein, S; Patel, DJ; Chen, L; Cisse, II				Marraffini, Luciano A.; Hay, Angela; Grinstein, Sergio; Patel, Dinshaw J.; Chen, Lu; Cisse, Ibrahim I.			Breaking Down Walls	CELL			English	Editorial Material									[Marraffini, Luciano A.] Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA; [Hay, Angela] Max Planck Inst, Frankfurt, Germany; [Grinstein, Sergio] Univ Toronto, Toronto, ON, Canada; [Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Chen, Lu] Stanford Univ, Stanford, CA 94305 USA; [Cisse, Ibrahim I.] MIT, Cambridge, MA 02139 USA	Rockefeller University; Max Planck Society; University of Toronto; Memorial Sloan Kettering Cancer Center; Stanford University; Massachusetts Institute of Technology (MIT)	Marraffini, LA (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.								0	0	0	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					880	881						2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814513	Bronze			2022-12-28	WOS:000389469000003
J	Hoffman, GS				Hoffman, Gary S.			Giant Cell Arteritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PLACEBO-CONTROLLED TRIAL; LARGE-VESSEL VASCULITIS; FRENCH STUDY-GROUP; POLYMYALGIA-RHEUMATICA; DOUBLE-BLIND; RISK-FACTORS; TEMPORAL ARTERITIS; TAKAYASU ARTERITIS; AORTIC-ANEURYSM; BIOPSY											ACHKAR AA, 1994, ANN INTERN MED, V120, P987, DOI 10.7326/0003-4819-120-12-199406150-00003; Amiri N, 2016, RHEUMATOLOGY, V55, P33, DOI 10.1093/rheumatology/kev262; [Anonymous], 2015, MKSAP 17 MED KNOWL S; [Anonymous], 2013, MKSAP 16 MEDICAL KNO; Bienvenu B, 2016, REV MED INTERNE, V37, P154, DOI 10.1016/j.revmed.2015.12.015; Borchers AT, 2012, AUTOIMMUN REV, V11, pA544, DOI 10.1016/j.autrev.2012.01.003; Brack A, 1999, ARTHRITIS RHEUM, V42, P311, DOI 10.1002/1529-0131(199902)42:2<311::AID-ANR14>3.0.CO;2-F; Breuer GS, 2009, J RHEUMATOL, V36, P794, DOI 10.3899/jrheum.080792; Dasgupta B, 2010, RHEUMATOLOGY, V49, P1594, DOI 10.1093/rheumatology/keq039a; Carmona FD, 2015, AM J HUM GENET, V96, P565, DOI 10.1016/j.ajhg.2015.02.009; Duhaut P, 1998, ARTHRITIS RHEUM-US, V41, P1960, DOI 10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X; Felicetti P, 2015, VACCINE; Garcia-Martinez A, 2014, ANN RHEUM DIS, V73, P1826, DOI 10.1136/annrheumdis-2013-203322; Gilden D, 2015, NEUROLOGY, V84, P1948, DOI 10.1212/WNL.0000000000001409; Gonzalez-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z; Gonzalez-Gay MA, 2004, MEDICINE, V83, P335, DOI 10.1097/01.md.0000145366.40805.f8; Grayson PC, 2012, ANN RHEUM DIS, V71, P1329, DOI 10.1136/annrheumdis-2011-200795; HALL S, 1983, LANCET, V2, P1217; Hoffman GS, 2016, REV MED INTERNE, V37, P151, DOI 10.1016/j.revmed.2015.12.016; Hoffman GS, 2007, ANN INTERN MED, V146, P621, DOI 10.7326/0003-4819-146-9-200705010-00004; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; Jover JA, 2001, ANN INTERN MED, V134, P106, DOI 10.7326/0003-4819-134-2-200101160-00010; Kermani TA, 2015, J RHEUMATOL, V42, P1213, DOI 10.3899/jrheum.141347; Kermani TA, 2013, ANN RHEUM DIS, V72, P1989, DOI 10.1136/annrheumdis-2012-202408; Kermani TA, 2012, SEMIN ARTHRITIS RHEU, V41, P866, DOI 10.1016/j.semarthrit.2011.10.005; Klink T, 2014, RADIOLOGY, V273, P844, DOI 10.1148/radiol.14140056; Larsson K, 2006, ANN RHEUM DIS, V65, P529, DOI 10.1136/ard.2005.039404; Lee MS, 2006, ARTHRITIS RHEUM, V54, P3306, DOI 10.1002/art.22141; Mackie SL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0692-4; Maksimowicz-McKinnon K, 2009, MEDICINE, V88, P221, DOI 10.1097/MD.0b013e3181af70c1; Mohammad AJ, 2015, ANN RHEUM DIS, V74, P993, DOI 10.1136/annrheumdis-2013-204652; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P318, DOI 10.1136/ard.2008.088351; Nagel MA, 2015, JAMA NEUROL, V72, P1281, DOI 10.1001/jamaneurol.2015.2101; Narvaez J, 2007, SEMIN ARTHRITIS RHEU, V37, P13, DOI 10.1016/j.semarthrit.2006.12.005; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Nuenninghoff DM, 2003, ARTHRITIS RHEUM-US, V48, P3522, DOI 10.1002/art.11353; Ostberg G, 1972, Acta Med Scand Suppl, V533, P135; Petri H, 2015, ARTHRIT CARE RES, V67, P390, DOI 10.1002/acr.22429; Prieto-Gonzalez S, 2015, CURR OPIN RHEUMATOL, V27, P53, DOI 10.1097/BOR.0000000000000130; Prieto-Gonzalez S, 2012, ANN RHEUM DIS, V71, P1170, DOI 10.1136/annrheumdis-2011-200865; Proven A, 2003, ARTHRIT RHEUM-ARTHR, V49, P703, DOI 10.1002/art.11388; RodriguezValverde V, 1997, AM J MED, V102, P331, DOI 10.1016/S0002-9343(97)00117-4; Salvarani C, 2002, ANN INTERN MED, V137, P232, DOI 10.7326/0003-4819-137-4-200208200-00006; Salvarani C, 2008, LANCET, V372, P234, DOI 10.1016/S0140-6736(08)61077-6; Seror R, 2014, ANN RHEUM DIS, V73, P2074, DOI 10.1136/annrheumdis-2013-203586; Smetana GW, 2002, JAMA-J AM MED ASSOC, V287, P92, DOI 10.1001/jama.287.1.92; Soriano A, 2012, LUPUS, V21, P153, DOI 10.1177/0961203311430222; Soussan M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000622; Spiera RF, 2001, CLIN EXP RHEUMATOL, V19, P495; Svensson LG, 2015, J THORAC CARDIOV SUR, V149, pS170, DOI 10.1016/j.jtcvs.2014.08.003; Taylor-Gjevre R, 2005, J RHEUMATOL, V32, P1279; Tomasson G, 2014, ANN INTERN MED, V160, P73, DOI 10.7326/M12-3046; Tso E, 2002, ARTHRITIS RHEUM-US, V46, P1634, DOI 10.1002/art.10251; Ungprasert P, 2015, SEMIN ARTHRITIS RHEU, V44, P586, DOI 10.1016/j.semarthrit.2014.10.010; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; Villiger PM, 2016, LANCET, V387, P1921, DOI 10.1016/S0140-6736(16)00560-2; Weyand CM, 2003, ANN INTERN MED, V139, P505, DOI 10.7326/0003-4819-139-6-200309160-00015; WEYAND CM, 1994, ANN INTERN MED, V121, P484, DOI 10.7326/0003-4819-121-7-199410010-00003; Weyand CM, 2000, ARTHRITIS RHEUM, V43, P1041, DOI 10.1002/1529-0131(200005)43:5<1041::AID-ANR12>3.0.CO;2-7	59	36	36	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					ITC65	ITC80		10.7326/AITC201611010	http://dx.doi.org/10.7326/AITC201611010			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802475				2022-12-28	WOS:000386908600001
J	Hu, LT				Hu, Linden T.			Lyme Disease RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Hu, Linden T.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Tufts University	Hu, LT (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.							Johnson BJB, 2014, J CLIN MICROBIOL, V52, P721, DOI 10.1128/JCM.01674-13; Nadelman RB, 2001, NEW ENGL J MED, V345, P79, DOI 10.1056/NEJM200107123450201	2	13	13	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					677	677		10.7326/L16-0409	http://dx.doi.org/10.7326/L16-0409			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802469				2022-12-28	WOS:000386908600021
J	Riva, MA				Riva, Michele A.			Judging the Past: How History Should Inform Bioethics	ANNALS OF INTERNAL MEDICINE			English	Letter									[Riva, Michele A.] Univ Milano Bicocca, Monza, Italy	University of Milano-Bicocca	Riva, MA (corresponding author), Univ Milano Bicocca, Monza, Italy.		Riva, Michele Augusto/R-7600-2017	Riva, Michele Augusto/0000-0001-7147-3460				Lerner BH, 2016, ANN INTERN MED, V164, P553, DOI 10.7326/M15-2642	1	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					675	675		10.7326/L16-0331	http://dx.doi.org/10.7326/L16-0331			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802465				2022-12-28	WOS:000386908600017
J	Siprashvili, Z; Nguyen, NT; Gorell, ES; Loutit, K; Khuu, P; Furukawa, LK; Lorenz, HP; Leung, TH; Keene, DR; Rieger, KE; Khavari, P; Lane, AT; Tang, JY; Marinkovich, MP				Siprashvili, Zurab; Nguyen, Ngon T.; Gorell, Emily S.; Loutit, Kylie; Khuu, Phuong; Furukawa, Louise K.; Lorenz, H. Peter; Leung, Thomas H.; Keene, Douglas R.; Rieger, Kerri E.; Khavari, Paul; Lane, Alfred T.; Tang, Jean Y.; Marinkovich, M. Peter			Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VII COLLAGEN; CELL THERAPY; SKIN; TRANSPLANTATION	IMPORTANCE Recessive dystrophic epidermolysis bullosa (RDEB) is a devastating, often fatal, inherited blistering disorder caused by mutations in the COL7A1 gene encoding type VII collagen. Support and palliation are the only current therapies. OBJECTIVE To evaluate the safety and wound outcomes following genetically corrected autologous epidermal grafts in patients with RDEB. DESIGN, SETTING, AND PARTICIPANTS Single-center phase 1 clinical trial conducted in the United States of 4 patients with severe RDEB with a measured area of wounds suitable for grafting of at least 100 cm(2). Patients with undetectable type VII collagen keratinocyte expression were excluded. INTERVENTIONS Autologous keratinocytes isolated from biopsy samples collected from 4 patients with RDEB were transduced with good manufacturing practice-grade retrovirus carrying full-length human COL7A1 and assembled into epidermal sheet grafts. Type VII collagen gene-corrected grafts (approximately 35 cm2) were transplanted onto 6 wounds in each of the patients (n = 24 grafts). MAIN OUTCOMES AND MEASURES The primary safety outcomes were recombination competent retrovirus, cancer, and autoimmune reaction. Molecular correction was assessed as type VII collagen expression measured by immunofluorescence and immunoelectron microscopy. Wound healing was assessed using serial photographs taken at 3, 6, and 12 months after grafting. RESULTS The 4 patients (mean age, 23 years [range, 18-32 years]) were all male with an estimated body surface area affected with RDEB of 4% to 30%. All 24 grafts were well tolerated without serious adverse events. Type VII collagen expression at the dermal-epidermal junction was demonstrated on the graft sites by immunofluorescence microscopy in 9 of 10 biopsy samples (90%) at 3 months, in 8 of 12 samples (66%) at 6 months, and in 5 of 12 samples (42%) at 12 months, including correct type VII collagen localization to anchoring fibrils. Wounds with recombinant type VII collagen graft sites displayed 75% or greater healing at 3 months (21 intact graft sites of 24 wound sites; 87%), 6 months (16/24; 67%), and 12 months (12/24; 50%) compared with baseline wound sites. CONCLUSIONS AND RELEVANCE In this preliminary study of 4 patients with RDEB, there was wound healing in some type VII collagen gene-corrected grafts, but the response was variable among patients and among grafted sites and generally declined over 1 year. Long-term follow-up is necessary for these patients, and controlled trials are needed with a broader range of patients to better understand the potential long-term efficacy of genetically corrected autologous epidermal grafts.	[Siprashvili, Zurab; Nguyen, Ngon T.; Gorell, Emily S.; Loutit, Kylie; Khuu, Phuong; Leung, Thomas H.; Rieger, Kerri E.; Khavari, Paul; Lane, Alfred T.; Tang, Jean Y.; Marinkovich, M. Peter] Stanford Univ, Dept Dermatol, Sch Med, 269 Campus Dr, Stanford, CA 94305 USA; [Furukawa, Louise K.; Lorenz, H. Peter] Stanford Univ, Lucile Packard Childrens Hosp, Stanford, CA 94305 USA; [Leung, Thomas H.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Keene, Douglas R.] Shriners Hosp Children, Portland, OR 97201 USA; [Khavari, Paul; Marinkovich, M. Peter] Vet Affairs Med Ctr, 3801 Miranda Ave, Palo Alto, CA 94304 USA	Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Tang, JY; Marinkovich, MP (corresponding author), Stanford Univ, Dept Dermatol, Sch Med, 269 Campus Dr, Stanford, CA 94305 USA.; Tang, JY; Marinkovich, MP (corresponding author), 450 Broadway St, Redwood City, CA 94063 USA.	tangy@stanford.edu; mpm@stanford.edu	Gorell, Emily/AAF-4966-2021	Gorell, Emily/0000-0002-2813-3089; Seeley, Kylie/0000-0002-0363-6069; Tang, Jean/0000-0002-5510-6502	National Institutes of Health [R01 AR055914]; Epidermolysis Bullosa Medical Research Foundation; Epidermolysis Bullosa Research Partnership; Office of Research and Development, Palo Alto VA Medical Center; Damon Runyon Clinical Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055914] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Epidermolysis Bullosa Medical Research Foundation; Epidermolysis Bullosa Research Partnership; Office of Research and Development, Palo Alto VA Medical Center; Damon Runyon Clinical Investigator Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant R01 AR055914 from the National Institutes of Health and by funding from the Epidermolysis Bullosa Medical Research Foundation and the Epidermolysis Bullosa Research Partnership. Drs Khavari and Marinkovich were supported by funding from the Office of Research and Development, Palo Alto VA Medical Center. Dr Tang was supported by a Damon Runyon Clinical Investigator Award.	Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Chen M, 2002, J BIOL CHEM, V277, P2118, DOI 10.1074/jbc.M108779200; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; De Rosa L, 2014, STEM CELL REP, V2, P1, DOI 10.1016/j.stemcr.2013.11.001; Falabella AF, 2000, ARCH DERMATOL, V136, P1225, DOI 10.1001/archderm.136.10.1225; Fine JD, 2014, J AM ACAD DERMATOL, V70, P1103, DOI 10.1016/j.jaad.2014.01.903; Gorell ES, 2015, BRIT J DERMATOL, V173, P821, DOI 10.1111/bjd.13737; Gorell ES, 2015, PEDIATR DERMATOL, V32, P220, DOI 10.1111/pde.12492; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hashmi S, 2011, CLIN DERMATOL, V29, P398, DOI 10.1016/j.clindermatol.2011.01.009; LAPIERE JC, 1993, J CLIN INVEST, V92, P1831, DOI 10.1172/JCI116774; Marinkovich MP, 2012, INHERITED EPIDERMOLY; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Natsuga K, 2010, ACTA DERM-VENEREOL, V90, P165, DOI 10.2340/00015555-0776; Petrof G, 2013, BRIT J DERMATOL, V169, P1025, DOI 10.1111/bjd.12599; Petrof G, 2015, J INVEST DERMATOL, V135, P2319, DOI 10.1038/jid.2015.158; Siprashvili Z, 2010, HUM GENE THER, V21, P1299, DOI 10.1089/hum.2010.023; Venugopal SS, 2013, J AM ACAD DERMATOL, V69, P898, DOI 10.1016/j.jaad.2013.08.014; Wagner JE, 2010, NEW ENGL J MED, V363, P1383; Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501	20	120	129	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1808	1817		10.1001/jama.2016.15588	http://dx.doi.org/10.1001/jama.2016.15588			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802546				2022-12-28	WOS:000386569300020
J	[Anonymous]				[Anonymous]			Current Comment (Reprinted from JAMA, vol 67, pg 1376, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1831	1831		10.1001/jama.2015.17108	http://dx.doi.org/10.1001/jama.2015.17108			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802532				2022-12-28	WOS:000386569300031
J	Briegel, HJ				Briegel, Hans J.			Versatile cluster entangled light	SCIENCE			English	Editorial Material									[Briegel, Hans J.] Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria	University of Innsbruck	Briegel, HJ (corresponding author), Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria.	hans.briegel@uibk.ac.at						Barz S, 2012, SCIENCE, V335, P303, DOI 10.1126/science.1214707; Lanyon BP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.210501; Lindner N. H., 2016, PHYS REV LETT, V103; Poem E, 2010, NAT PHYS, V6, P993, DOI [10.1038/nphys1812, 10.1038/NPHYS1812]; Reiserer A, 2014, NATURE, V508, P237, DOI 10.1038/nature13177; Walther P, 2005, NATURE, V434, P169, DOI 10.1038/nature03347; Zwerger M, 2016, APPL PHYS B-LASERS O, V122, DOI 10.1007/s00340-015-6285-8	13	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					416	417		10.1126/science.aai8675	http://dx.doi.org/10.1126/science.aai8675			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789828				2022-12-28	WOS:000387684400023
J	Butt, CA				Butt, Carrie A.			Art in My Veins A Medical Self-portrait	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Butt, Carrie A.] JAMA Network, Digital Content Operat, Chicago, IL 60654 USA		Butt, CA (corresponding author), JAMA Network, Digital Content Operat, Chicago, IL 60654 USA.	carri.butt@jamanetwork.org							0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1628	1629		10.1001/jama.2016.15507	http://dx.doi.org/10.1001/jama.2016.15507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784076				2022-12-28	WOS:000386107800001
J	Ezzedine, K; Whitton, M; Pinart, M				Ezzedine, Khaled; Whitton, Maxine; Pinart, Mariona			Interventions for Vitiligo	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINES		[Ezzedine, Khaled] Univ Paris Est Creteil Val de Marne, Henri Mondor Hosp, Dept Dermatol, F-94010 Creteil, France; [Ezzedine, Khaled] Univ Paris Est Creteil Val de Marne, EpiDermE, F-94010 Creteil, France; [Whitton, Maxine] Univ Nottingham, Ctr Evidence Based Dermatol, Cochrane Skin Grp, Nottingham, England; [Pinart, Mariona] ISGlobal, Ctr Res Environm Epidemiol, Barcelona, Spain	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Nottingham; ISGlobal	Ezzedine, K (corresponding author), Univ Paris Est Creteil Val de Marne, Henri Mondor Hosp, Dept Dermatol, F-94010 Creteil, France.; Ezzedine, K (corresponding author), Univ Paris Est Creteil Val de Marne, EpiDermE, F-94010 Creteil, France.	khaled.ezzedine@aphp.fr	Ezzedine, Khaled/F-2716-2017; Pinart Gilberga, Mariona/GLS-8842-2022	Ezzedine, Khaled/0000-0002-5468-4589; Pinart Gilberga, Mariona/0000-0002-8223-1325				Ezzedine K, 2015, LANCET, V386, P74, DOI 10.1016/S0140-6736(14)60763-7; Oiso N, 2013, J DERMATOL, V40, P344, DOI 10.1111/1346-8138.12099; Taieb A, 2013, BRIT J DERMATOL, V168, P5, DOI 10.1111/j.1365-2133.2012.11197.x; Whitton ME, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003263.pub5	4	31	32	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1708	1709		10.1001/jama.2016.12399	http://dx.doi.org/10.1001/jama.2016.12399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784078				2022-12-28	WOS:000386107800038
J	[Anonymous]				[Anonymous]			Five minutes with ... Ivan Oransky	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2016	354								i4134	10.1136/bmj.i4134	http://dx.doi.org/10.1136/bmj.i4134			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZH	27815250				2022-12-28	WOS:000380931600008
J	Burki, T				Burki, Talha			China faces challenges to fix its pharmaceutical system	LANCET			English	Editorial Material																			0	4	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					353	354		10.1016/S0140-6736(16)32138-9	http://dx.doi.org/10.1016/S0140-6736(16)32138-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27836191				2022-12-28	WOS:000392804700017
J	Dunne, EM; Gordon, H; Kurten, A; Almeida, J; Duplissy, J; Williamson, C; Ortega, IK; Pringle, KJ; Adamov, A; Baltensperger, U; Barmet, P; Benduhn, F; Bianchi, F; Breitenlechner, M; Clarke, A; Curtius, J; Dommen, J; Donahue, NM; Ehrhart, S; Flagan, RC; Franchin, A; Guida, R; Hakala, J; Hansel, A; Heinritzi, M; Jokinen, T; Kangasluoma, J; Kirkby, J; Kulmala, M; Kupc, A; Lawler, MJ; Lehtipalo, K; Makhmutov, V; Mann, G; Mathot, S; Merikanto, J; Miettinen, P; Nenes, A; Onnela, A; Rap, A; Reddington, CLS; Riccobono, F; Richards, NAD; Rissanen, MP; Rondo, L; Sarnela, N; Schobesberger, S; Sengupta, K; Simon, M; Sipilaa, M; Smith, JN; Stozkhov, Y; Tome, A; Trostl, J; Wagner, PE; Wimmer, D; Winkler, PM; Worsnop, DR; Carslaw, KS				Dunne, Eimear M.; Gordon, Hamish; Kuerten, Andreas; Almeida, Joao; Duplissy, Jonathan; Williamson, Christina; Ortega, Ismael K.; Pringle, Kirsty J.; Adamov, Alexey; Baltensperger, Urs; Barmet, Peter; Benduhn, Francois; Bianchi, Federico; Breitenlechner, Martin; Clarke, Antony; Curtius, Joachim; Dommen, Josef; Donahue, Neil M.; Ehrhart, Sebastian; Flagan, Richard C.; Franchin, Alessandro; Guida, Roberto; Hakala, Jani; Hansel, Armin; Heinritzi, Martin; Jokinen, Tuija; Kangasluoma, Juha; Kirkby, Jasper; Kulmala, Markku; Kupc, Agnieszka; Lawler, Michael J.; Lehtipalo, Katrianne; Makhmutov, Vladimir; Mann, Graham; Mathot, Serge; Merikanto, Joonas; Miettinen, Pasi; Nenes, Athanasios; Onnela, Antti; Rap, Alexandru; Reddington, Carly L. S.; Riccobono, Francesco; Richards, Nigel A. D.; Rissanen, Matti P.; Rondo, Linda; Sarnela, Nina; Schobesberger, Siegfried; Sengupta, Kamalika; Simon, Mario; Sipila, Mikko; Smith, James N.; Stozkhov, Yuri; Tome, Antonio; Trostl, Jasmin; Wagner, Paul E.; Wimmer, Daniela; Winkler, Paul M.; Worsnop, Douglas R.; Carslaw, Kenneth S.			Global atmospheric particle formation from CERN CLOUD measurements	SCIENCE			English	Article							SULFURIC ACID-AMINE; COSMIC-RAYS; NUMBER CONCENTRATIONS; NUCLEATION; AEROSOL; MODEL; TROPOSPHERE; CLIMATE; UNCERTAINTY; TRANSPORT	Fundamental questions remain about the origin of newly formed atmospheric aerosol particles because data from laboratory measurements have been insufficient to build global models. In contrast, gas-phase chemistry models have been based on laboratory kinetics measurements for decades. We built a global model of aerosol formation by using extensive laboratory measurements of rates of nucleation involving sulfuric acid, ammonia, ions, and organic compounds conducted in the CERN CLOUD (Cosmics Leaving Outdoor Droplets) chamber. The simulations and a comparison with atmospheric observations show that nearly all nucleation throughout the present-day atmosphere involves ammonia or biogenic organic compounds, in addition to sulfuric acid. A considerable fraction of nucleation involves ions, but the relatively weak dependence on ion concentrations indicates that for the processes studied, variations in cosmic ray intensity do not appreciably affect climate through nucleation in the present-day atmosphere.	[Dunne, Eimear M.; Pringle, Kirsty J.; Mann, Graham; Rap, Alexandru; Reddington, Carly L. S.; Richards, Nigel A. D.; Sengupta, Kamalika; Carslaw, Kenneth S.] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Gordon, Hamish; Almeida, Joao; Ehrhart, Sebastian; Guida, Roberto; Kirkby, Jasper; Mathot, Serge; Onnela, Antti] CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland; [Kuerten, Andreas; Almeida, Joao; Williamson, Christina; Curtius, Joachim; Ehrhart, Sebastian; Heinritzi, Martin; Kirkby, Jasper; Rondo, Linda; Simon, Mario; Wimmer, Daniela] Goethe Univ Frankfurt Main, Inst Atmospher & Environm Sci, Altenhoferallee 1, D-60438 Frankfurt, Germany; [Duplissy, Jonathan] Helsinki Inst Phys, FI-00014 Helsinki, Finland; [Ortega, Ismael K.] Univ Lille 1, UMR CNRS 8523, Lab Phys Lasers Atomes & Mol PhLAM, F-59655 Villeneuve Dascq, France; [Adamov, Alexey; Bianchi, Federico; Donahue, Neil M.; Franchin, Alessandro; Hakala, Jani; Jokinen, Tuija; Kangasluoma, Juha; Kulmala, Markku; Lehtipalo, Katrianne; Merikanto, Joonas; Rissanen, Matti P.; Sarnela, Nina; Schobesberger, Siegfried; Sipila, Mikko; Wimmer, Daniela; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, POB 64, FI-00014 Helsinki, Finland; [Baltensperger, Urs; Barmet, Peter; Bianchi, Federico; Dommen, Josef; Lehtipalo, Katrianne; Riccobono, Francesco; Trostl, Jasmin] Paul Scherrer Inst, Lab Atmospher Chem, CH-5232 Villigen, Switzerland; [Benduhn, Francois] Inst Adv Sustainabil Studies, Berliner Str 130, D-14467 Potsdam, Germany; [Breitenlechner, Martin] Leopold Franzens Univ, Inst Ion Phys & Appl Phys, Technikerstr 25, A-6020 Innsbruck, Austria; [Clarke, Antony] Univ Hawaii, Dept Oceanog, 1000 Pope Rd, Honolulu, HI 96822 USA; [Donahue, Neil M.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, 5000 Forbes Ave, Pittsburgh, PA 15213 USA; [Flagan, Richard C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Hansel, Armin] Ionicon, A-6020 Innsbruck, Austria; [Kupc, Agnieszka; Wagner, Paul E.; Winkler, Paul M.] Univ Vienna, Fac Phys, Boltzmanngasse 5, A-1090 Vienna, Austria; [Lawler, Michael J.; Miettinen, Pasi; Smith, James N.] Univ Eastern Finland, POB 1627, Kuopio 70211, Finland; [Makhmutov, Vladimir; Stozkhov, Yuri] Lebedev Phys Inst, Solar & Cosm Ray Res Lab, Moscow 119991, Russia; [Nenes, Athanasios] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Nenes, Athanasios] Fdn Res & Technol, Inst Chem Engn Sci ICE HT, Patras 26504, Greece; [Nenes, Athanasios] Natl Observ Athens, Inst Environm Res & Sustainable Dev, 1 Metaxa & Vas Pavlou, Palea Penteli 15236, Greece; [Tome, Antonio] Univ Lisbon, CENTRA SIM, P-1749016 Lisbon, Portugal; [Tome, Antonio] Univ Beira Interior, P-1749016 Lisbon, Portugal; [Worsnop, Douglas R.] Aerodyne Res, Billerica, MA 01821 USA; [Dunne, Eimear M.] Atmospher Res Ctr Eastern Finland, Finnish Meteorol Inst, PL 1627, Kuopio 70211, Finland; [Williamson, Christina; Kupc, Agnieszka] NOAA, Div Chem Sci, Earth Syst Res Lab, 325 Broadway, Boulder, CO 80305 USA; [Williamson, Christina; Kupc, Agnieszka] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Ortega, Ismael K.] Off Natl Etud & Rech Aerosp, F-91123 Palaiseau, France; [Breitenlechner, Martin] Harvard Univ, Sch Engn & Appl Sci, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Jokinen, Tuija; Lawler, Michael J.; Smith, James N.] Univ Calif Irvine, Dept Chem, 1102 Nat Sci 2, Irvine, CA 92697 USA; [Schobesberger, Siegfried] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Leeds; European Organization for Nuclear Research (CERN); Goethe University Frankfurt; Helsinki Institute of Physics; Universite de Lille - ISITE; Universite de Lille; University of Helsinki; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Innsbruck; University of Hawaii System; Carnegie Mellon University; California Institute of Technology; University of Vienna; University of Eastern Finland; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; University System of Georgia; Georgia Institute of Technology; Foundation for Research & Technology - Hellas (FORTH); Institute of Chemical Engineering Sciences (ICE-HT); National Observatory of Athens; Universidade de Lisboa; Universidade da Beira Interior; Aerodyne Research; Finnish Meteorological Institute; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; National Office for Aerospace Studies & Research (ONERA); UDICE-French Research Universities; Universite Paris Saclay; Harvard University; University of California System; University of California Irvine; University of Washington; University of Washington Seattle	Carslaw, KS (corresponding author), Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England.; Gordon, H (corresponding author), CERN, European Org Nucl Res, CH-1211 Geneva, Switzerland.	hamish.gordon@cern.ch; lecksc@ds.leeds.ac.uk	Carslaw, Ken S/C-8514-2009; Rap, Alexandru/G-7532-2016; Bianchi, Federico/G-8428-2012; Sarnela, Nina/AAE-1372-2020; Donahue, Neil M/A-2329-2008; Williamson, Christina J/D-1484-2016; Hansel, Armin/F-3915-2010; Simon, Mario/AGI-2749-2022; Kulmala, Markku T/I-7671-2016; Nenes, Athanasios/ABE-6478-2020; Sipilä, Mikko/G-3024-2010; Jokinen, Tuija/B-3365-2014; Kirkby, Jasper/A-4973-2012; Franchin, Alessandro/GVR-8219-2022; Schobesberger, Siegfried/L-4454-2014; Reddington, Carly LS/I-3390-2015; Worsnop, Douglas R/D-2817-2009; Dunne, Eimear M/H-1567-2014; Makhmutov, Vladimir/N-2086-2015; Breitenlechner, Martin/AAA-3402-2021; Adamov, Alexey/V-2477-2018; Kangasluoma, Juha/AAY-7941-2021; Tome, Antonio R/A-5681-2013; kangasluoma, juha/W-7450-2019; Duplissy, Jonathan/A-1723-2010; Kürten, Andreas/O-3851-2019; Franchin, Alessandro/AAH-3069-2019; Lawler, Michael/AAI-9557-2021; Smith, James/C-5614-2008; Curtius, Joachim/A-2681-2011; Merikanto, Joonas/B-1039-2008; Ortega Colomer, Ismael Kenneth/A-7930-2008; Mann, Graham/L-9529-2017	Carslaw, Ken S/0000-0002-6800-154X; Rap, Alexandru/0000-0002-2319-6769; Bianchi, Federico/0000-0003-2996-3604; Donahue, Neil M/0000-0003-3054-2364; Williamson, Christina J/0000-0002-5188-9378; Hansel, Armin/0000-0002-1062-2394; Kulmala, Markku T/0000-0003-3464-7825; Nenes, Athanasios/0000-0003-3873-9970; Sipilä, Mikko/0000-0002-8594-7003; Jokinen, Tuija/0000-0002-1280-1396; Kirkby, Jasper/0000-0003-2341-9069; Schobesberger, Siegfried/0000-0002-5777-4897; Reddington, Carly LS/0000-0002-5990-4966; Worsnop, Douglas R/0000-0002-8928-8017; Dunne, Eimear M/0000-0001-7085-8473; Makhmutov, Vladimir/0000-0002-2242-1055; Kangasluoma, Juha/0000-0002-1639-1187; Tome, Antonio R/0000-0001-9144-7120; Duplissy, Jonathan/0000-0001-8819-0264; Kürten, Andreas/0000-0002-8955-4450; Smith, James/0000-0003-4677-8224; Curtius, Joachim/0000-0003-3153-4630; Merikanto, Joonas/0000-0002-1145-2569; Gordon, Hamish/0000-0002-1822-3224; Ortega Colomer, Ismael Kenneth/0000-0002-9299-2013; Rissanen, Matti/0000-0003-0463-8098; Ehrhart, Sebastian/0000-0002-6517-5341; Mann, Graham/0000-0003-1746-2837; Simon, Mario/0000-0002-4900-7460; Winkler, Paul/0000-0001-6861-6029; Lehtipalo, Katrianne/0000-0002-1660-2706; Sarnela, Nina/0000-0003-1874-3235; Breitenlechner, Martin/0000-0002-2382-6660	CERN; N8 consortium; Engineering and Physical Sciences Research Council [EP/K000225/1]; European Commission Seventh Framework Programme [Marie Curie Initial Training Network CLOUD-ITN] [215072]; European Commission Seventh Framework Programme [Marie Curie Initial Training Network CLOUD-TRAIN] [316662]; European Research Council (ERC) [5736, 227463]; German Federal Ministry of Education and Research [01LK0902A, 01LK1222A]; Swiss National Science Foundation [200020 135307, 206620 141278]; Academy of Finland (Center of Excellence) [1118615, 135054, 133872, 251427, 139656, 139995, 137749, 141217, 141451, 138951]; Finnish Funding Agency for Technology and Innovation; V.is.l. Foundation; Nessling Foundation; Austrian Science Fund (FWF) [J3198-N21]; Portuguese Foundation for Science and Technology [CERN/FP/116387/2010]; Swedish Research Council; Vetenskapsradet [2011-5120]; Presidium of the Russian Academy of Sciences; Russian Foundation for Basic Research [08-02-91006-CERN, 12-02-91522-CERN]; U.S. National Science Foundation [AGS1136479, AGS1447056, AGC1439551, CHE1012293]; U.S. Department of Energy [DE-SC0014469]; PEGASOS (Pan-European Gas-Aerosol-Climate Interaction Study) project - European Commission under Framework Programme 7 [FP7-ENV-2010-265148]; Davidow Foundation; Natural Environment Research Council project GASSP (Global Aerosol Synthesis and Science Project) [NE/J024252/1]; Royal Society Wolfson Merit Award; Natural Environment Research Council [NE/J024252/1] Funding Source: researchfish; EPSRC [EP/K000225/1] Funding Source: UKRI; NERC [NE/J024252/1] Funding Source: UKRI; Directorate For Geosciences [1447056, 1439551] Funding Source: National Science Foundation	CERN; N8 consortium; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission Seventh Framework Programme [Marie Curie Initial Training Network CLOUD-ITN]; European Commission Seventh Framework Programme [Marie Curie Initial Training Network CLOUD-TRAIN]; European Research Council (ERC)(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Academy of Finland (Center of Excellence)(Academy of Finland); Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); V.is.l. Foundation; Nessling Foundation; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Swedish Research Council(Swedish Research CouncilEuropean Commission); Vetenskapsradet(Swedish Research Council); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); PEGASOS (Pan-European Gas-Aerosol-Climate Interaction Study) project - European Commission under Framework Programme 7; Davidow Foundation; Natural Environment Research Council project GASSP (Global Aerosol Synthesis and Science Project); Royal Society Wolfson Merit Award(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank CERN for supporting CLOUD with important technical and financial resources and for providing a particle beam from the CERN Proton Synchrotron. We also thank P. Carrie, L.-P. De Menezes, J. Dumollard, K. Ivanova, F. Josa, I. Krasin, R. Kristic, A. Laassiri, O. S. Maksumov, B. Marichy, H. Martinati, S. V. Mizin, R. Sitals, H. U. Walther, A. Wasem, and M. Wilhelmsson for their important contributions to the experiment. The computer modeling simulations were performed on ARC1 and ARC2, part of the high-performance computing facilities at the University of Leeds, UK. This work also made use of the POLARIS facility of the N8 High Performance Computing Centre of Excellence, provided and funded by the N8 consortium and the Engineering and Physical Sciences Research Council (grant no. EP/K000225/1). The Centre is coordinated by the Universities of Leeds and Manchester. This research has received funding from the European Commission Seventh Framework Programme [Marie Curie Initial Training Networks CLOUD-ITN (no. 215072) and CLOUD-TRAIN (no. 316662)]; European Research Council (ERC) Starting Grant no. 5736 [MOCAPAF (Role of Molecular Clusters in Atmospheric Particle Formation)] and ERC Advanced grant no. 227463 [ATMNUCLE (Atmospheric Nucleation: From Molecular to Global Scale)]; the German Federal Ministry of Education and Research (project nos. 01LK0902A and 01LK1222A); the Swiss National Science Foundation (project nos. 200020 135307 and 206620 141278); the Academy of Finland (Center of Excellence project no. 1118615 and other projects 135054, 133872, 251427, 139656, 139995, 137749, 141217, 141451, and 138951); the Finnish Funding Agency for Technology and Innovation; the V.is.l. Foundation; the Nessling Foundation; the Austrian Science Fund (FWF) (project no. J3198-N21); the Portuguese Foundation for Science and Technology (project no. CERN/FP/116387/2010); the Swedish Research Council; Vetenskapsradet (grant 2011-5120); the Presidium of the Russian Academy of Sciences and the Russian Foundation for Basic Research (grants 08-02-91006-CERN and 12-02-91522-CERN); the U.S. National Science Foundation (grants AGS1136479, AGS1447056, AGC1439551, and CHE1012293); the U.S. Department of Energy (grant DE-SC0014469); the PEGASOS (Pan-European Gas-Aerosol-Climate Interaction Study) project funded by the European Commission under Framework Programme 7 (FP7-ENV-2010-265148); the Davidow Foundation; and the Natural Environment Research Council project GASSP (Global Aerosol Synthesis and Science Project) under grant NE/J024252/1. We acknowledge financial support from the Royal Society Wolfson Merit Award. The nucleation rates used in our manuscript are available in the supplementary materials as a CSV file.	Adams PJ, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001010; Almeida J, 2013, NATURE, V502, P359, DOI 10.1038/nature12663; Atkinson R, 2004, ATMOS CHEM PHYS, V4, P1461, DOI 10.5194/acp-4-1461-2004; Ball SM, 1999, J GEOPHYS RES-ATMOS, V104, P23709, DOI 10.1029/1999JD900411; Benson DR, 2011, ATMOS CHEM PHYS, V11, P4755, DOI 10.5194/acp-11-4755-2011; Bergman T, 2015, J GEOPHYS RES-ATMOS, V120, P9606, DOI 10.1002/2015JD023181; Bond G, 2001, SCIENCE, V294, P2130, DOI 10.1126/science.1065680; Bouwman AF, 1997, GLOBAL BIOGEOCHEM CY, V11, P561, DOI 10.1029/97GB02266; BROCK CA, 1995, SCIENCE, V270, P1650, DOI 10.1126/science.270.5242.1650; Carslaw KS, 2013, NATURE, V503, P67, DOI 10.1038/nature12674; Carslaw KS, 2013, FARADAY DISCUSS, V165, P495, DOI 10.1039/c3fd00043e; Carslaw KS, 2002, SCIENCE, V298, P1732, DOI 10.1126/science.1076964; Chen M, 2012, P NATL ACAD SCI USA, V109, P18713, DOI 10.1073/pnas.1210285109; Clarke AD, 2002, J ATMOS SCI, V59, P363, DOI 10.1175/1520-0469(2002)059<0363:APASPI>2.0.CO;2; Clarke AD, 1999, J GEOPHYS RES-ATMOS, V104, P5735, DOI 10.1029/98JD02303; CLARKE AD, 1992, J ATMOS CHEM, V14, P479, DOI 10.1007/BF00115252; Clarke AD, 1998, J GEOPHYS RES-ATMOS, V103, P16397, DOI 10.1029/97JD02987; Crounse JD, 2013, J PHYS CHEM LETT, V4, P3513, DOI 10.1021/jz4019207; Cubasch U, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P119; D'Andrea SD, 2013, ATMOS CHEM PHYS, V13, P11519, DOI 10.5194/acp-13-11519-2013; Duplissy J, 2016, J GEOPHYS RES-ATMOS, V121, P1752, DOI 10.1002/2015JD023539; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Erupe ME, 2011, ATMOS CHEM PHYS, V11, P4767, DOI 10.5194/acp-11-4767-2011; Franchin A, 2015, ATMOS CHEM PHYS, V15, P7203, DOI 10.5194/acp-15-7203-2015; Ge XL, 2011, ATMOS ENVIRON, V45, P561, DOI 10.1016/j.atmosenv.2010.10.013; Jen CN, 2014, J GEOPHYS RES-ATMOS, V119, P7502, DOI 10.1002/2014JD021592; Jung JG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012313; Kazil J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050058; Kazil J, 2010, ATMOS CHEM PHYS, V10, P10733, DOI 10.5194/acp-10-10733-2010; Kirkby J, 2007, SURV GEOPHYS, V28, P333, DOI 10.1007/s10712-008-9030-6; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kurten A, 2016, J GEOPHYS RES-ATMOS, V121, P12377, DOI 10.1002/2015JD023908; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P2553, DOI 10.5194/acp-4-2553-2004; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Lee LA, 2013, ATMOS CHEM PHYS, V13, P8879, DOI 10.5194/acp-13-8879-2013; Lee SH, 2003, SCIENCE, V301, P1886, DOI 10.1126/science.1087236; Makkonen R, 2009, ATMOS CHEM PHYS, V9, P1747, DOI 10.5194/acp-9-1747-2009; Merikanto J, 2009, ATMOS CHEM PHYS, V9, P8601, DOI 10.5194/acp-9-8601-2009; Napari I, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002132; Neff U, 2001, NATURE, V411, P290, DOI 10.1038/35077048; Paasonen P, 2013, NAT GEOSCI, V6, P438, DOI [10.1038/NGEO1800, 10.1038/ngeo1800]; PETERS LK, 1979, ATMOS ENVIRON, V13, P1443, DOI 10.1016/0004-6981(79)90113-6; Pierce JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037946; Riccobono F, 2014, SCIENCE, V344, P717, DOI 10.1126/science.1243527; RODHE H, 1980, J GEOPHYS RES-OCEANS, V85, P7401, DOI 10.1029/JC085iC12p07401; Schobesberger S, 2015, ATMOS CHEM PHYS, V15, P55, DOI 10.5194/acp-15-55-2015; Schobesberger S, 2013, P NATL ACAD SCI USA, V110, P17223, DOI 10.1073/pnas.1306973110; Spracklen DV, 2010, ATMOS CHEM PHYS, V10, P4775, DOI 10.5194/acp-10-4775-2010; Spracklen DV, 2005, ATMOS CHEM PHYS, V5, P2227, DOI 10.5194/acp-5-2227-2005; Svensmark H, 1997, J ATMOS SOL-TERR PHY, V59, P1225, DOI 10.1016/S1364-6826(97)00001-1; Vehkamaki H, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002184; Wang M, 2009, ATMOS CHEM PHYS, V9, P239, DOI 10.5194/acp-9-239-2009; Yu F, 2012, ATMOS CHEM PHYS, V12, P2399, DOI 10.5194/acp-12-2399-2012; Yu F, 2009, ATMOS CHEM PHYS, V9, P7691, DOI 10.5194/acp-9-7691-2009; Zhang RY, 2004, SCIENCE, V304, P1487, DOI 10.1126/science.1095139; Zhao J, 2011, ATMOS CHEM PHYS, V11, P10823, DOI 10.5194/acp-11-10823-2011	56	208	209	9	287	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 2	2016	354	6316					1119	1124		10.1126/science.aaf2649	http://dx.doi.org/10.1126/science.aaf2649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED5TY	27789796	Green Accepted, Green Submitted			2022-12-28	WOS:000388916400035
J	Ali, ZA; Maehara, A; Genereux, P; Shlofmitz, RA; Fabbiocchi, F; Nazif, TM; Guagliumi, G; Meraj, PM; Alfonso, F; Samady, H; Akasaka, T; Carlson, EB; Leesar, MA; Matsumura, M; Ozan, MO; Mintz, GS; Ben-Yehuda, O; Stone, GW				Ali, Ziad A.; Maehara, Akiko; Genereux, Philippe; Shlofmitz, Richard A.; Fabbiocchi, Franco; Nazif, Tamim M.; Guagliumi, Giulio; Meraj, Perwaiz M.; Alfonso, Fernando; Samady, Habib; Akasaka, Takashi; Carlson, Eric B.; Leesar, Massoud A.; Matsumura, Mitsuaki; Ozan, Melek Ozgu; Mintz, Gary S.; Ben-Yehuda, Ori; Stone, Gregg W.		ILUMIEN III OPTIMIZE PCI Investiga	Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial	LANCET			English	Article							FRACTIONAL FLOW RESERVE; EXPERT CONSENSUS DOCUMENT; CARDIOVASCULAR ANGIOGRAPHY; ARTERY-DISEASE; ADAPT-DES; INTERVENTIONS; THROMBOSIS; METAANALYSIS; MECHANISMS; OUTCOMES	Background Percutaneous coronary intervention (PCI) is most commonly guided by angiography alone. Intravascular ultrasound (IVUS) guidance has been shown to reduce major adverse cardiovascular events (MACE) after PCI, principally by resulting in a larger postprocedure lumen than with angiographic guidance. Optical coherence tomography (OCT) provides higher resolution imaging than does IVUS, although findings from some studies suggest that it might lead to smaller luminal diameters after stent implantation. We sought to establish whether or not a novel OCT-based stent sizing strategy would result in a minimum stent area similar to or better than that achieved with IVUS guidance and better than that achieved with angiography guidance alone. Methods In this randomised controlled trial, we recruited patients aged 18 years or older undergoing PCI from 29 hospitals in eight countries. Eligible patients had one or more target lesions located in a native coronary artery with a visually estimated reference vessel diameter of 2.25-3.50 mm and a length of less than 40 mm. We excluded patients with left main or ostial right coronary artery stenoses, bypass graft stenoses, chronic total occlusions, planned two-stent bifurcations, and in-stent restenosis. Participants were randomly assigned (1: 1: 1; with use of an interactive web-based system in block sizes of three, stratified by site) to OCT guidance, IVUS guidance, or angiography-guided stent implantation. We did OCT-guided PCI using a specific protocol to establish stent length, diameter, and expansion according to reference segment external elastic lamina measurements. All patients underwent final OCT imaging (operators in the IVUS and angiography groups were masked to the OCT images). The primary efficacy endpoint was post-PCI minimum stent area, measured by OCT at a masked independent core laboratory at completion of enrolment, in all randomly allocated participants who had primary outcome data. The primary safety endpoint was procedural MACE. We tested non-inferiority of OCT guidance to IVUS guidance (with a non-inferiority margin of 1.0 mm(2)), superiority of OCT guidance to angiography guidance, and superiority of OCT guidance to IVUS guidance, in a hierarchical manner. This trial is registered with ClinicalTrials.gov, number NCT02471586. Findings Between May 13, 2015, and April 5, 2016, we randomly allocated 450 patients (158 [35%] to OCT, 146 [32%] to IVUS, and 146 [32%] to angiography), with 415 final OCT acquisitions analysed for the primary endpoint (140 [34%] in the OCT group, 135 [33%] in the IVUS group, and 140 [34%] in the angiography group). The final median minimum stent area was 5.79 mm(2) (IQR 4.54-7.34) with OCT guidance, 5.89 mm(2) (4.67-7.80) with IVUS guidance, and 5.49 mm(2) (4.39-6.59) with angiography guidance. OCT guidance was non-inferior to IVUS guidance (one-sided 97.5% lower CI -0.70 mm(2); p = 0.001), but not superior (p = 0.42). OCT guidance was also not superior to angiography guidance (p = 0.12). We noted procedural MACE in four (3%) of 158 patients in the OCT group, one (1%) of 146 in the IVUS group, and one (1%) of 146 in the angiography group (OCT vs IVUS p = 0.37; OCT vs angiography p = 0.37). Interpretation OCT-guided PCI using a specific reference segment external elastic lamina-based stent optimisation strategy was safe and resulted in similar minimum stent area to that of IVUS-guided PCI. These data warrant a large-scale randomised trial to establish whether or not OCT guidance results in superior clinical outcomes to angiography guidance.	[Ali, Ziad A.; Maehara, Akiko; Nazif, Tamim M.; Ben-Yehuda, Ori; Stone, Gregg W.] New York Presbyterian Hosp, New York, NY 10032 USA; [Ali, Ziad A.; Maehara, Akiko; Nazif, Tamim M.; Ben-Yehuda, Ori; Stone, Gregg W.] Columbia Univ, New York, NY 10032 USA; [Ali, Ziad A.; Maehara, Akiko; Genereux, Philippe; Ozan, Melek Ozgu; Mintz, Gary S.; Ben-Yehuda, Ori; Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Shlofmitz, Richard A.] St Francis Hosp, New York, NY USA; [Fabbiocchi, Franco] Ist Ricovero & Cura Carattere Sci, Ctr Cardiol Monzino, Milan, Italy; [Guagliumi, Giulio] Osped Papa Giovanni XXIII, Bergamo, Italy; [Meraj, Perwaiz M.] Northwell Hlth, New York, NY USA; [Alfonso, Fernando] Hosp Univ La Princesa, Madrid, Spain; [Samady, Habib] Emory Univ Hosp, 1364 Clifton Rd NE, Atlanta, GA 30322 USA; [Akasaka, Takashi] Wakayama Med Univ, Wakayama, Japan; [Carlson, Eric B.] Eastern Cardiol, Greenville, NC USA; [Leesar, Massoud A.] Univ Alabama Birmingham, Birmingham, AL USA	NewYork-Presbyterian Hospital; Columbia University; Cardiovascular Research Foundation (CRF); IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Centro Cardiologico Monzino; ASST Papa Giovanni XXIII; Northwell Health; Hospital de La Princesa; Emory University; Wakayama Medical University; University of Alabama System; University of Alabama Birmingham	Stone, GW (corresponding author), New York Presbyterian Hosp, New York, NY 10032 USA.; Stone, GW (corresponding author), Columbia Univ, New York, NY 10032 USA.	gs2184@columbia.edu	Guagliumi, Giulio/K-8006-2016	Nazif, Tamim/0000-0003-1239-2489	St Jude Medical	St Jude Medical(St. Jude Medical)	This study was funded by St Jude Medical.	Ahn JM, 2014, AM J CARDIOL, V113, P1338, DOI 10.1016/j.amjcard.2013.12.043; Bezerra HG, 2013, JACC-CARDIOVASC INTE, V6, P228, DOI 10.1016/j.jcin.2012.09.017; Cox CE., 2015, POSITIVE SIGNS OCT G; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Elgendy IY, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.116.003700; Guagliumi G, 2012, JACC-CARDIOVASC INTE, V5, P12, DOI 10.1016/j.jcin.2011.09.018; Habara M, 2012, CIRC-CARDIOVASC INTE, V5, P193, DOI 10.1161/CIRCINTERVENTIONS.111.965111; Hong SJ, 2015, JAMA-J AM MED ASSOC, V314, P2155, DOI 10.1001/jama.2015.15454; Jang JS, 2014, JACC-CARDIOVASC INTE, V7, pE27, DOI 10.1016/j.jcin.2013.09.013; Kobayashi N, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003553; Kubo T, 2016, J CARDIOL, V68, P455, DOI 10.1016/j.jjcc.2015.11.007; Kubo T, 2013, JACC-CARDIOVASC IMAG, V6, P1095, DOI 10.1016/j.jcmg.2013.04.014; Lotfi A, 2014, CATHETER CARDIO INTE, V83, P509, DOI 10.1002/ccd.25222; Maehara A, 2015, JACC-CARDIOVASC INTE, V8, P1704, DOI 10.1016/j.jcin.2015.07.024; Meneveau N, 2016, CIRCULATION, V134, P906, DOI 10.1161/CIRCULATIONAHA.116.024393; Mintz GS, 1996, CIRCULATION, V93, P924, DOI 10.1161/01.CIR.93.5.924; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Nakano M, 2014, J AM COLL CARDIOL, V63, P2510, DOI 10.1016/j.jacc.2014.02.607; Prail F, 2015, JACC-CARDIOVASC IMAG, V8, P1297, DOI 10.1016/j.jcmg.2015.08.013; Song HG, 2014, CATHETER CARDIO INTE, V83, P873, DOI 10.1002/ccd.24560; Souteyrand G, 2016, EUR HEART J, V37, P1208, DOI 10.1093/eurheartj/ehv711; Taniwaki M, 2016, CIRCULATION, V133, P650, DOI 10.1161/CIRCULATIONAHA.115.019071; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Wijns W, 2015, EUR HEART J, V36, P3346, DOI 10.1093/eurheartj/ehv367; Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942; Wolfrum M, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0355-7; Zhang YJ, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0144-8	28	314	328	6	46	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 26	2016	388	10060					2618	2628		10.1016/S0140-6736(16)31922-5	http://dx.doi.org/10.1016/S0140-6736(16)31922-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED0EW	27806900				2022-12-28	WOS:000388516800030
J	Aveyard, P; Lewis, A; Tearne, S; Hood, K; Christian-Brown, A; Adab, P; Begh, R; Jolly, K; Daley, A; Farley, A; Lycett, D; Nickless, A; Yu, LM; Retat, L; Webber, L; Pimpin, L; Jebb, SA				Aveyard, Paul; Lewis, Amanda; Tearne, Sarah; Hood, Kathryn; Christian-Brown, Anna; Adab, Peymane; Begh, Rachna; Jolly, Kate; Daley, Amanda; Farley, Amanda; Lycett, Deborah; Nickless, Alecia; Yu, Ly-Mee; Retat, Lise; Webber, Laura; Pimpin, Laura; Jebb, Susan A.			Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial	LANCET			English	Article							WEIGHT-LOSS; MANAGEMENT; PATIENT; PROGRAMS; CONSULTATIONS; OVERWEIGHT; PHYSICIANS; HEALTH	Background Obesity is a common cause of non-communicable disease. Guidelines recommend that physicians screen and off er brief advice to motivate weight loss through referral to behavioural weight loss programmes. However, physicians rarely intervene and no trials have been done on the subject. We did this trial to establish whether physician brief intervention is acceptable and effective for reducing bodyweight in patients with obesity. Methods In this parallel, two-arm, randomised trial, patients who consulted 137 primary care physicians in England were screened for obesity. Individuals could be enrolled if they were aged at least 18 years, had a body-mass index of at least 30 kg/m(2) (or at least 25 kg/m(2) if of Asian ethnicity), and had a raised body fat percentage. At the end of the consultation, the physician randomly assigned participants (1:1) to one of two 30 s interventions. Randomisation was done via preprepared randomisation cards labelled with a code representing the allocation, which were placed in opaque sealed envelopes and given to physicians to open at the time of treatment assignment. In the active intervention, the physician offered referral to a weight management group (12 sessions of 1 h each, once per week) and, if the referral was accepted, the physician ensured the patient made an appointment and off ered follow-up. In the control intervention, the physician advised the patient that their health would benefit from weight loss. The primary outcome was weight change at 12 months in the intention-to-treat population, which was assessed blinded to treatment allocation. We also assessed asked patients' about their feelings on discussing their weight when they have visited their general practitioner for other reasons. Given the nature of the intervention, we did not anticipate any adverse events in the usual sense, so safety outcomes were not assessed. This trial is registered with the ISRCTN Registry, number ISRCTN26563137. Findings Between June 4, 2013, and Dec 23, 2014, we screened 8403 patients, of whom 2728 (32%) were obese. Of these obese patients, 2256 (83%) agreed to participate and 1882 were eligible, enrolled, and included in the intention-to-treat analysis, with 940 individuals in the support group and 942 individuals in the advice group. 722 (77%) individuals assigned to the support intervention agreed to attend the weight management group and 379 (40%) of these individuals attended, compared with 82 (9%) participants who were allocated the advice intervention. In the entire study population, mean weight change at 12 months was 2.43 kg with the support intervention and 1.04 kg with the advice intervention, giving an adjusted difference of 1.43 kg (95% CI 0.89-1.97). The reactions of the patients to the general practitioners' brief interventions did not differ significantly between the study groups in terms of appropriateness (adjusted odds ratio 0.89, 95% CI 0.75-1.07, p=0.21) or helpfulness (1.05, 0.89-1.26, p=0.54); overall, four (< 1%) patients thought their intervention was inappropriate and unhelpful and 1530 (81%) patients thought it was appropriate and helpful. Interpretation A behaviourally-informed, very brief, physician-delivered opportunistic intervention is acceptable to patients and an effective way to reduce population mean weight. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Aveyard, Paul; Tearne, Sarah; Hood, Kathryn; Christian-Brown, Anna; Begh, Rachna; Nickless, Alecia; Yu, Ly-Mee; Jebb, Susan A.] Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Lewis, Amanda] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Adab, Peymane; Jolly, Kate; Daley, Amanda; Farley, Amanda] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Lycett, Deborah] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England; [Retat, Lise; Webber, Laura; Pimpin, Laura] UK Hlth Forum, London, England	University of Oxford; University of Bristol; University of Birmingham; Coventry University	Aveyard, P (corresponding author), Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	paul.aveyard@phc.ox.ac.uk	Adab, Peymane/ABC-9651-2021; Jolly, Kate/AAA-1341-2019	Adab, Peymane/0000-0001-9087-3945; Jolly, Kate/0000-0002-6224-2115; Pimpin, Laura/0000-0001-5021-0143; Jebb, Susan/0000-0001-9190-2920; Lycett, Deborah/0000-0002-4525-6419; Aveyard, Paul/0000-0002-1802-4217; Nickless, Alecia/0000-0001-8534-116X; Yu, Ly-Mee/0000-0003-0331-7364; Lewis, Amanda/0000-0003-0488-5347	NPRI of the UK; Alzheimer's Research UK; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; British Heart Foundation; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate, Department of Health; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Health and Social Care Research Division; Public Health Agency, Northern Ireland; MRC; Stroke Association; Wellcome Trust; Welsh Government; World Cancer Research Fund; UK Centre for Tobacco and Alcohol Studies (UKCTAS), a UK Clinical Research Collaboration (UKCRC), Public Health Research Centre of Excellence; NIHR; Collaboration for Leadership in Applied Health Research and Care (CLAHRC); Diabetes UK; MRC [MC_U105960389, MR/J000515/1] Funding Source: UKRI; Medical Research Council [MR/K023195/1, MR/J000515/1, MC_U105960389] Funding Source: researchfish; National Institute for Health Research [SPCR-001] Funding Source: researchfish	NPRI of the UK; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Alzheimer's Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office, Scottish Government Health Directorate, Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Health and Social Care Research Division; Public Health Agency, Northern Ireland; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Stroke Association; Wellcome Trust(Wellcome TrustEuropean Commission); Welsh Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); UK Centre for Tobacco and Alcohol Studies (UKCTAS), a UK Clinical Research Collaboration (UKCRC), Public Health Research Centre of Excellence; NIHR(National Institute for Health Research (NIHR)); Collaboration for Leadership in Applied Health Research and Care (CLAHRC); Diabetes UK(Diabetes UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The trial was funded by the NPRI of the UK, administered by the MRC. The funding partners are Alzheimer's Research UK, Alzheimer's Society, Biotechnology and Biological Sciences Research Council, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Scottish Government Health Directorate, Department of Health, Diabetes UK, Economic and Social Research Council, Engineering and Physical Sciences Research Council, Health and Social Care Research Division, Public Health Agency, Northern Ireland, MRC, Stroke Association, Wellcome Trust, Welsh Government, and World Cancer Research Fund. The weight loss programmes we used were provided by Slimming World and Rosemary Conley Health and Fitness Clubs. These are widely available through the English NHS at no cost to the patient and for which these organisations receive a fee. In this trial these 12-week programs were donated to the NHS by both these organisations and we are very grateful to them for this. Neither organisation had input into the protocol, the data analysis, or were involved in the decision to publish the findings. The investigators have no financial relationships with these companies. PAv is part-funded by The UK Centre for Tobacco and Alcohol Studies (UKCTAS), a UK Clinical Research Collaboration (UKCRC), Public Health Research Centre of Excellence. KJ is part-funded by the NIHR and Collaboration for Leadership in Applied Health Research and Care (CLAHRC). The views expressed are those of the authors and not necessarily those of the NIHR, the NHS, or the Department of Health.	Ahern AL, 2013, ANN FAM MED, V11, P251, DOI 10.1370/afm.1446; Ashman JJ, 2012, NCHS DATA BRIEF, V212, P1; Aveyard P, 2012, ADDICTION, V107, P1066, DOI 10.1111/j.1360-0443.2011.03770.x; Booth HP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006642; Elobeid MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006624; Fleming D M, 1993, Scand J Prim Health Care Suppl, V2, P37; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694; Hartmann-Boyce J, 2014, OBES REV, V15, P920, DOI 10.1111/obr.12220; Henderson E, 2015, BRIT J GEN PRACT, V65, pE240, DOI 10.3399/bjgp15X684397; HIDDINK GJ, 1995, EUR J CLIN NUTR, V49, P842; Hobbs FDR, 2016, LANCET, V387, P2323, DOI 10.1016/S0140-6736(16)00620-6; Jackson SE, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003693; Johns DJ, 2016, OBESITY, V24, P772, DOI 10.1002/oby.21255; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Lewis A, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-393; Madigan CD, 2014, BRIT J GEN PRACT, V64, pE128, DOI 10.3399/bjgp14X677491; Michie Susan, 2007, Psychol Health Med, V12, P521, DOI 10.1080/13548500701203441; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; National Center for Health Statistics, 2016, AMB CAR US PHYS OFF; National Institute for Health and Care Excellence, 2014, WEIGHT MAN LIF SERV; Noordman J, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-87; Post RE, 2011, ARCH INTERN MED, V171, P316, DOI 10.1001/archinternmed.2010.549; Potter MB, 2001, J FAM PRACTICE, V50, P513; Rose SA, 2013, INT J OBESITY, V37, P118, DOI 10.1038/ijo.2012.24; Shiffman S, 2009, PREV MED, V49, P482, DOI 10.1016/j.ypmed.2009.09.015; Stead LF, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub4; Tillin T, 2015, DIABETIC MED, V32, P226, DOI 10.1111/dme.12576; Vidrine JI, 2013, JAMA INTERN MED, V173, P458, DOI 10.1001/jamainternmed.2013.3751; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	33	169	170	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2492	2500		10.1016/S0140-6736(16)31893-1	http://dx.doi.org/10.1016/S0140-6736(16)31893-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC5IA	27789061	Green Published, hybrid			2022-12-28	WOS:000388166300027
J	Laburthe-Tolra, B				Laburthe-Tolra, Bruno			ATOMIC PHYSICS A strange kind of liquid	NATURE			English	Editorial Material									[Laburthe-Tolra, Bruno] Univ Paris 13, Lab Phys Lasers, F-93430 Villetaneuse, France	Universite Paris 13	Laburthe-Tolra, B (corresponding author), Univ Paris 13, Lab Phys Lasers, F-93430 Villetaneuse, France.	laburthe-tolra@univ-paris13.fr						[Anonymous], 2003, BOSE EINSTEIN CONDEN; DIEDRICH F, 1987, PHYS REV LETT, V59, P2931, DOI 10.1103/PhysRevLett.59.2931; Ferrier-Barbut I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.215301; Kadau H, 2016, NATURE, V530, P194, DOI 10.1038/nature16485; McDonald GD, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.013002; Petrov DS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.155302; Schmitt M, 2016, NATURE, V539, P259, DOI 10.1038/nature20126; Strecker KE, 2002, NATURE, V417, P150, DOI 10.1038/nature747	8	7	7	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					176	177		10.1038/539176a	http://dx.doi.org/10.1038/539176a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830805				2022-12-28	WOS:000387318500025
J	Mohan, D; Schell, J; Angus, DC				Mohan, Deepika; Schell, Jesse; Angus, Derek C.			Not Thinking Clearly? Play a Game, Seriously!	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mohan, Deepika; Angus, Derek C.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Schell, Jesse] Schell Games, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mohan, D (corresponding author), Univ Pittsburgh, Room 638 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mohand@upmc.edu	Angus, Derek C/E-9671-2012		NLM NIH HHS [DP2 LM012339] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [DP2LM012339] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; [Anonymous], 2015, IMPR DIAGN HLTH CAR; Gonzalez C, 2013, SOC SCI COMPUT REV, V31, P236, DOI 10.1177/0894439312453979; Kahneman D., 2011, THINKING FAST SLOW; Mohan D, 2010, ANN SURG, V251, P946, DOI 10.1097/SLA.0b013e3181d76cb5; Perez S., 2016, POKEMON GO PASSED 10; Primack BA, 2012, AM J PREV MED, V42, P630, DOI 10.1016/j.amepre.2012.02.023; Schactman N., 2007, LETS ALL PLAY TSA VI; US Government Accountability Office (GAO), 2016, GAO PUBL	9	9	9	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1867	1868		10.1001/jama.2016.14174	http://dx.doi.org/10.1001/jama.2016.14174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27825014	Green Accepted			2022-12-28	WOS:000387116500010
J	[Anonymous]				[Anonymous]			The Bacteriology of the Bubble Fountain (Reprinted from JAMA, vol 97, pg 1451, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		PETTIBONE DF, 1916, JAMA-J AM MED ASSOC, V67, P1451	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1926	1926		10.1001/jama.2015.17109	http://dx.doi.org/10.1001/jama.2015.17109			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27824999				2022-12-28	WOS:000387116500033
J	De Ambrogi, M				De Ambrogi, Marco			The long road to dignity	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2228	2228		10.1016/S0140-6736(16)32079-7	http://dx.doi.org/10.1016/S0140-6736(16)32079-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8MO	27831467				2022-12-28	WOS:000386889300016
J	Cohen, J				Cohen, Jon			AIDS EPIDEMIC Controversial HIV vaccine strategy gets a second chance	SCIENCE			English	News Item																			0	1	1	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					535	535		10.1126/science.354.6312.535	http://dx.doi.org/10.1126/science.354.6312.535			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811245				2022-12-28	WOS:000386869800013
J	Inagaki, T; Haribara, Y; Igarashi, K; Sonobe, T; Tamate, S; Honjo, T; Marandi, A; McMahon, PL; Umeki, T; Enbutsu, K; Tadanaga, O; Takenouchi, H; Aihara, K; Kawarabayashi, K; Inoue, K; Utsunomiya, S; Takesue, H				Inagaki, Takahiro; Haribara, Yoshitaka; Igarashi, Koji; Sonobe, Tomohiro; Tamate, Shuhei; Honjo, Toshimori; Marandi, Alireza; McMahon, Peter L.; Umeki, Takeshi; Enbutsu, Koji; Tadanaga, Osamu; Takenouchi, Hirokazu; Aihara, Kazuyuki; Kawarabayashi, Ken-ichi; Inoue, Kyo; Utsunomiya, Shoko; Takesue, Hiroki			A coherent Ising machine for 2000-node optimization problems	SCIENCE			English	Article							OPTICAL PARAMETRIC OSCILLATOR; QUANTUM-NOISE; INTERFEROMETER; NETWORK; MODELS; STATES; SPINS	The analysis and optimization of complex systems can be reduced to mathematical problems collectively known as combinatorial optimization. Many such problems can be mapped onto ground-state search problems of the Ising model, and various artificial spin systems are now emerging as promising approaches. However, physical Ising machines have suffered from limited numbers of spin-spin couplings because of implementations based on localized spins, resulting in severe scalability problems. We report a 2000-spin network with all-to-all spin-spin couplings. Using a measurement and feedback scheme, we coupled time-multiplexed degenerate optical parametric oscillators to implement maximum cut problems on arbitrary graph topologies with up to 2000 nodes. Our coherent Ising machine outperformed simulated annealing in terms of accuracy and computation time for a 2000-node complete graph.	[Inagaki, Takahiro; Honjo, Toshimori; Takesue, Hiroki] NTT Corp, Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan; [Haribara, Yoshitaka; Aihara, Kazuyuki] Univ Tokyo, Dept Math Informat, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan; [Haribara, Yoshitaka; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538505, Japan; [Haribara, Yoshitaka; Sonobe, Tomohiro; Tamate, Shuhei; Kawarabayashi, Ken-ichi; Utsunomiya, Shoko] Natl Inst Informat, Chiyoda Ku, Hitotsubashi 2-1-2, Tokyo 1018403, Japan; [Igarashi, Koji] Osaka Univ, Div Elect Elect & Informat Engn, Osaka 5650871, Japan; [Sonobe, Tomohiro; Kawarabayashi, Ken-ichi] Japan Sci & Technol Agcy, ERATO Kawarabayashi Large Graph Project, Chiyoda Ku, Hitotsubashi 2-1-2, Tokyo 1018403, Japan; [Marandi, Alireza; McMahon, Peter L.] Stanford Univ, EL Ginzton Lab, Stanford, CA 94305 USA; [Umeki, Takeshi; Enbutsu, Koji; Tadanaga, Osamu; Takenouchi, Hirokazu] NTT Corp, Device Technol Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan	Nippon Telegraph & Telephone Corporation; University of Tokyo; University of Tokyo; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Osaka University; Japan Science & Technology Agency (JST); Stanford University; Nippon Telegraph & Telephone Corporation	Inagaki, T; Takesue, H (corresponding author), NTT Corp, Basic Res Labs, 3-1 Morinosato Wakamiya, Atsugi, Kanagawa 2430198, Japan.	inagaki.takahiro@lab.ntt.co.jp; takesue.hiroki@lab.ntt.co.jp	McMahon, Peter/ABI-1817-2020; Takenouchi, Hirokazu/A-8882-2012; Takesue, Hiroki/J-4514-2012	McMahon, Peter/0000-0002-1177-9887; Takenouchi, Hirokazu/0000-0002-3804-4557; 	Impulsing Paradigm Change Through Disruptive Technologies (ImPACT) Program of the Council of Science, Technology and Innovation (Cabinet Office, Government of Japan)	Impulsing Paradigm Change Through Disruptive Technologies (ImPACT) Program of the Council of Science, Technology and Innovation (Cabinet Office, Government of Japan)	Supported by the Impulsing Paradigm Change Through Disruptive Technologies (ImPACT) Program of the Council of Science, Technology and Innovation (Cabinet Office, Government of Japan). We thank H. Nishimori for fruitful discussions, K. Inaba for fruitful discussions, and H. Tamura for various types of support during this research. S.U. and H. Takesue are inventors on patent application PCT/JP2015/059057 submitted by the National Institute of Informatics (NII) and Nippon Telegraph and Telephone (NTT) Corporation that covers the coherent Ising machine based on the measurement and feedback scheme. A.M. and S.U. are inventors on patent application PCT/US2014/046025 submitted by Stanford University and NII that covers the implementation of a coherent Ising machine using degenerate optical parametric oscillators. T.U., K.E., and H. Takenouchi are inventors on patent application PCT/JP1012/000360 submitted by NTT that covers the configurations of phase-sensitive amplifiers based on periodically poled lithium niobate waveguides.	BARAHONA F, 1982, J PHYS A-MATH GEN, V15, P3241, DOI 10.1088/0305-4470/15/10/028; Drummond PD, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.033806; Helmberg C, 2000, SIAM J OPTIMIZ, V10, P673, DOI 10.1137/S1052623497328987; Inagaki T, 2016, NAT PHOTONICS, V10, P415, DOI [10.1038/nphoton.2016.68, 10.1038/NPHOTON.2016.68]; Ising E, 1925, Z PHYS, V31, P253, DOI 10.1007/BF02980577; Johnson MW, 2011, NATURE, V473, P194, DOI 10.1038/nature10012; Karp R. M., 1972, P COMPL COMP COMP, P85; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KRIPPNER L, 1994, PHYS REV A, V50, P4330, DOI 10.1103/PhysRevA.50.4330; LI RD, 1994, J LIGHTWAVE TECHNOL, V12, P541, DOI 10.1109/50.285338; Marandi A, 2014, NAT PHOTONICS, V8, P937, DOI [10.1038/nphoton.2014.249, 10.1038/NPHOTON.2014.249]; Marandi A, 2012, OPT EXPRESS, V20, P7255, DOI 10.1364/OE.20.007255; MARHIC ME, 1991, ELECTRON LETT, V27, P210, DOI 10.1049/el:19910136; Maruo D, 2016, PHYS SCRIPTA, V91, DOI 10.1088/0031-8949/91/8/083010; NABORS CD, 1990, J OPT SOC AM B, V7, P815, DOI 10.1364/JOSAB.7.000815; Okawachi Y, 2015, OPT LETT, V40, P5267, DOI 10.1364/OL.40.005267; Serkland DK, 1998, OPT LETT, V23, P795, DOI 10.1364/OL.23.000795; Takata K, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.043821; Utsunomiya S, 2011, OPT EXPRESS, V19, P18091, DOI 10.1364/OE.19.018091; Wang Z, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063853; WOLINSKY M, 1988, PHYS REV LETT, V60, P1836, DOI 10.1103/PhysRevLett.60.1836; Yamaoka M, 2016, IEEE J SOLID-ST CIRC, V51, P303, DOI 10.1109/JSSC.2015.2498601	25	284	288	14	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					603	606		10.1126/science.aah4243	http://dx.doi.org/10.1126/science.aah4243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811271				2022-12-28	WOS:000386869800045
J	Mokalled, MH; Patra, C; Dickson, AL; Endo, T; Stainier, DYR; Poss, KD				Mokalled, Mayssa H.; Patra, Chinmoy; Dickson, Amy L.; Endo, Toyokazu; Stainier, Didier Y. R.; Poss, Kenneth D.			Injury-induced ctgfa directs glial bridging and spinal cord regeneration in zebrafish	SCIENCE			English	Article							TISSUE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; ADULT ZEBRAFISH; ASTROCYTES; CELLS; SCAR; RAT	Unlike mammals, zebrafish efficiently regenerate functional nervous system tissue after major spinal cord injury. Whereas glial scarring presents a roadblock for mammalian spinal cord repair, glial cells in zebrafish form a bridge across severed spinal cord tissue and facilitate regeneration. We performed a genome-wide profiling screen for secreted factors that are up-regulated during zebrafish spinal cord regeneration. We found that connective tissue growth factor a (ctgfa) is induced in and around glial cells that participate in initial bridging events. Mutations in ctgfa disrupted spinal cord repair, and transgenic ctgfa overexpression or local delivery of human CTGF recombinant protein accelerated bridging and functional regeneration. Our study reveals that CTGF is necessary and sufficient to stimulate glial bridging and natural spinal cord regeneration.	[Mokalled, Mayssa H.; Dickson, Amy L.; Endo, Toyokazu; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Patra, Chinmoy; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany; [Patra, Chinmoy] Agharkar Res Inst, Pune, Maharashtra, India	Duke University; Max Planck Society; Department of Science & Technology (India); Agharkar Research Institute (ARI)	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	kenneth.poss@duke.edu		Patra, Chinmoy/0000-0003-3849-5187; Stainier, Didier/0000-0002-0382-0026	NIH [T32HL007101, R01 HL081674]; Max Planck Society; Duke University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081674, T32HL007101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Society(Max Planck Society); Duke University School of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank A. Johnson, C. Eroglu, and M. Bagnat for discussions; N. Lee and K. Jones for technical and bioinformatics help; and the Duke University School of Medicine Zebrafish Shared Resource for animal care. Supported by NIH training grant T32HL007101 (M.H.M.), NIH grant R01 HL081674 (K.D.P.), the Max Planck Society (C.P. and D.Y.R.S.), and Duke University School of Medicine (K.D.P.). RNA sequencing data are archived at GEO (accession number GSE77025). The supplementary materials contain additional data. M.H.M. and K.D.P. are inventors on patent applications (62/159,413 and 62/398,781) submitted by Duke University that cover the use of Ctgf for spinal cord regeneration.	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Becker T, 1997, J COMP NEUROL, V377, P577, DOI 10.1002/(SICI)1096-9861(19970127)377:4<577::AID-CNE8>3.0.CO;2-#; Conrad S, 2005, J NEUROSURG-SPINE, V2, P319, DOI 10.3171/spi.2005.2.3.0319; Goldshmit Y, 2012, J NEUROSCI, V32, P7477, DOI 10.1523/JNEUROSCI.0758-12.2012; Grotendorst GR, 2005, FASEB J, V19, P729, DOI 10.1096/fj.04-3217com; Hertel M, 2000, EUR J NEUROSCI, V12, P376, DOI 10.1046/j.1460-9568.2000.00930.x; Hill SJ, 1996, J NEUROPATH EXP NEUR, V55, P1221, DOI 10.1097/00005072-199612000-00005; Hui SP, 2010, DEV DYNAM, V239, P2962, DOI 10.1002/dvdy.22438; Lin CY, 2012, J NEUROTRAUM, V29, P589, DOI 10.1089/neu.2011.2059; Liu YQ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-141; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Robinson PM, 2012, INVEST OPHTH VIS SCI, V53, P8093, DOI 10.1167/iovs.12-10419; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tom VJ, 2004, J NEUROSCI, V24, P9282, DOI 10.1523/JNEUROSCI.2120-04.2004; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Waselle L, 2009, MOL CELL NEUROSCI, V42, P315, DOI 10.1016/j.mcn.2009.08.004; White BD, 2010, STEM CELLS, V28, P297, DOI 10.1002/stem.268	19	129	133	6	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					630	634		10.1126/science.aaf2679	http://dx.doi.org/10.1126/science.aaf2679			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811277	Green Accepted			2022-12-28	WOS:000386869800052
J	Bedford, T; Malik, HS				Bedford, Trevor; Malik, Harmit S.			Did a Single Amino Acid Change Make Ebola Virus More Virulent?	CELL			English	Editorial Material							NIEMANN-PICK C1; INFECTION	A mutation in the Ebola virus glycoprotein arose early during the 2013-2016 epidemic and dominated the viral population. Two studies by Diehl et al. and Urbanowicz et al. now reveal that this mutation is associated with higher infectivity to human cells, representing the clearest example of Ebola's functional adaptation to human hosts.	[Bedford, Trevor] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Basic Sci Div, Seattle, WA 98109 USA; [Malik, Harmit S.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Bedford, T (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.	tbedford@fredhutch.org						Bornholdt ZA, 2016, MBIO, V7, DOI 10.1128/mBio.02154-15; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044	10	9	9	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					892	894		10.1016/j.cell.2016.10.032	http://dx.doi.org/10.1016/j.cell.2016.10.032			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814518	Bronze			2022-12-28	WOS:000389469000008
J	Koch, M				Koch, Marta			Firing Up in Anticipation	CELL			English	Editorial Material							NEURONS; SLEEP											Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Gizowski C, 2016, NATURE, V537, P685, DOI 10.1038/nature19756; Trudel E, 2010, NAT NEUROSCI, V13, P467, DOI 10.1038/nn.2503; Zimmerman CA, 2016, NATURE, V537, P680, DOI 10.1038/nature18950	4	0	0	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					871	873		10.1016/j.cell.2016.10.033	http://dx.doi.org/10.1016/j.cell.2016.10.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814511	Bronze			2022-12-28	WOS:000389469000001
J	Schirmer, M; Smeekens, SP; Vlamakis, H; Jaeger, M; Oosting, M; Franzosa, EA; ter Horst, R; Jansen, T; Jacobs, L; Bonder, MJ; Kurilshikov, A; Fu, JY; Joosten, LAB; Zhernakova, A; Huttenhower, C; Wijmenga, C; Netea, MG; Xavier, RJ				Schirmer, Melanie; Smeekens, Sanne P.; Vlamakis, Hera; Jaeger, Martin; Oosting, Marije; Franzosa, Eric A.; ter Horst, Rob; Jansen, Trees; Jacobs, Liesbeth; Bonder, Marc Jan; Kurilshikov, Alexander; Fu, Jingyuan; Joosten, Leo A. B.; Zhernakova, Alexandra; Huttenhower, Curtis; Wijmenga, Cisca; Netea, Mihai G.; Xavier, Ramnik J.			Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity	CELL			English	Article							CANDIDA-ALBICANS; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; IMMUNE-RESPONSE; FATTY-ACIDS; METABOLITES; TRYPTOPHAN; COLITIS; BLOOD; SUSCEPTIBILITY	Gut microbial dysbioses are linked to aberrant immune responses, which are often accompanied by abnormal production of inflammatory cytokines. As part of the Human Functional Genomics Project (HFGP), we investigate how differences in composition and function of gut microbial communities may contribute to inter-individual variation in cytokine responses to microbial stimulations in healthy humans. We observe microbiome-cytokine interaction patterns that are stimulus specific, cytokine specific, and cytokine and stimulus specific. Validation of two predicted host-microbial interactions reveal that TNF alpha and IFN gamma production are associated with specific microbial metabolic pathways: palmitoleic acid metabolism and tryptophan degradation to tryptophol. Besides providing a resource of predicted microbially derived mediators that influence immune phenotypes in response to common microorganisms, these data can help to define principles for understanding disease susceptibility. The three HFGP studies presented in this issue lay the groundwork for further studies aimed at understanding the interplay between microbial, genetic, and environmental factors in the regulation of the immune response in humans.	[Schirmer, Melanie; Vlamakis, Hera; Franzosa, Eric A.; Huttenhower, Curtis; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Schirmer, Melanie; Franzosa, Eric A.; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Smeekens, Sanne P.; Jaeger, Martin; Oosting, Marije; ter Horst, Rob; Jansen, Trees; Jacobs, Liesbeth; Joosten, Leo A. B.; Netea, Mihai G.] Radboudumc, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Smeekens, Sanne P.; Jaeger, Martin; Oosting, Marije; ter Horst, Rob; Jansen, Trees; Jacobs, Liesbeth; Joosten, Leo A. B.; Netea, Mihai G.] Radboudumc, Radboud Ctr Infect Dis RCI, NL-6525 GA Nijmegen, Netherlands; [Bonder, Marc Jan; Kurilshikov, Alexander; Fu, Jingyuan; Zhernakova, Alexandra; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 EX Groningen, Netherlands; [Kurilshikov, Alexander] RAS, SB, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia; [Kurilshikov, Alexander] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Fu, Jingyuan] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9713 EX Groningen, Netherlands; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Xavier, Ramnik J.] MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard T.H. Chan School of Public Health; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; University of Groningen; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Netea, MG (corresponding author), Radboudumc, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands.; Netea, MG (corresponding author), Radboudumc, Radboud Ctr Infect Dis RCI, NL-6525 GA Nijmegen, Netherlands.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), MIT, Ctr Microbiome Informat & Therapeut, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mihai.netea@radboudumc.nl; xavier@molbio.mgh.harvard.edu	Wijmenga, Cisca/AAE-7719-2019; Joosten, Leo AB/H-3138-2015; Fu, Jingyuan/E-8980-2012; Netea, Mihai/N-5155-2014; Smeekens, Sanne/AAZ-2061-2021; Smeekens, Sanne/G-8307-2011; Jaeger, Martin/H-3359-2015; Horst, Rob Ter/G-3536-2016; Kurilshikov, Alexander/GWC-1519-2022; Fu, Jingyuan/ABE-6868-2020; Fu, JY/GRR-6179-2022; Oosting, Marije/H-7437-2015; Schirmer, Melanie/HDN-5528-2022; Zhernakova, Alexandra/ABA-9372-2020	Wijmenga, Cisca/0000-0002-5635-1614; Joosten, Leo AB/0000-0001-6166-9830; Smeekens, Sanne/0000-0002-7835-914X; Smeekens, Sanne/0000-0002-7835-914X; Jaeger, Martin/0000-0001-6994-493X; Horst, Rob Ter/0000-0003-0576-5873; Kurilshikov, Alexander/0000-0003-2541-5627; Fu, Jingyuan/0000-0001-5578-1236; Bonder, Marc Jan/0000-0002-8431-3180; Schirmer, Melanie/0000-0001-6456-3679	ERC Consolidator Grant [3310372]; Spinoza Prize [NOW SPI 94-212, NWO SPI 92-266]; IN-CONTROL CVON grant [CVON 2012-03]; ERC Advanced Grant [FP/ERC grant] [2012-322698]; Dutch Digestive Diseases Foundation [MLDS WO11-30]; European Union's Seventh Framework Programme[EU FP7] TANDEM project [HEALTH-F3-2012-305279]; NIH [U54DK102557, R01DK092405]; Helmsley Charitable Trust [2014PG-IBD016]; JDRF [17-2011-529]; CCFA [20144126]; CVON grant [CVON 2012-03]; STW grant [STW13546]; Rosalind Franklin Fellowship (University of Groningen); Netherlands Organisation for Scientific Research [NWO-VIDI 864.13.013]; BBMRI-NL; Netherlands Organisation for Scientific Research (NWO) [184.021.007]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, U54DK102557, R01DK092405] Funding Source: NIH RePORTER	ERC Consolidator Grant; Spinoza Prize; IN-CONTROL CVON grant; ERC Advanced Grant [FP/ERC grant]; Dutch Digestive Diseases Foundation; European Union's Seventh Framework Programme[EU FP7] TANDEM project; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; JDRF(Juvenile Diabetes Research Foundation); CCFA; CVON grant; STW grant; Rosalind Franklin Fellowship (University of Groningen); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BBMRI-NL; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank all volunteers from the 500FG cohort for participating. The HFGP is supported by grants to M.G.N. (ERC Consolidator Grant [3310372], Spinoza Prize [NOW SPI 94-212], and IN-CONTROL CVON grant [CVON 2012-03]) and C.W. (ERC Advanced Grant [FP/2007-2013/ERC grant 2012-322698], Spinoza Prize [NWO SPI 92-266], the Dutch Digestive Diseases Foundation [MLDS WO11-30], and the European Union's Seventh Framework Programme[EU FP7] TANDEM project [HEALTH-F3-2012-305279]). R.J.X. was supported by grants from NIH (U54DK102557 and R01DK092405), Helmsley Charitable Trust (2014PG-IBD016), JDRF (17-2011-529), and CCFA (20144126). A.Z., J.F., and A.K. were supported by a CVON grant (CVON 2012-03). S.P.S. was financially supported by STW grant STW13546. A.Z. holds a Rosalind Franklin Fellowship (University of Groningen). J.F. is funded by the Netherlands Organisation for Scientific Research (NWO-VIDI 864.13.013). We thank Tiffany Poon for help in sequence production and sample management and Natalia Nedelsky (Massachusetts General Hospital) for editorial help and help with figure generation. We also thank Edith Adriaanse, Marije van der Geest, and Marieke Bijlsma for structuring the online database and the MOLGENIS open source team, Dennis Hendriksen, ErwinWinder, Bart Charbon, Fleur Kelpin, Jonathan Jetten, Mark de Haan, Tommy de Boer, David van Enckevort, Chao Pang, Joeri van der Velde, and Morris Swertz for designing and implementing the database software. The creation and hosting of the online database was supported by BBMRI-NL, a research infrastructure financed by the Netherlands Organisation for Scientific Research (NWO), grant number 184.021.007. We thank Maria Carmen Cenit, Astrid Maatman, Mathieu Plateel, and Jody Arends for technical support, and Daniel Graham for helpful advice and discussions. We also thank https://thenounproject.comfor providing the figure icons "Male Aging''/''Female Aging'' by Marie Van den Broeck.	Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Crost EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076341; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Eyerich S, 2011, EUR J IMMUNOL, V41, P1894, DOI 10.1002/eji.201041197; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kosiewicz MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00180; Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lee WJ, 2014, NAT CHEM BIOL, V10, P416, DOI 10.1038/nchembio.1535; LEHRER RI, 1969, J BACTERIOL, V98, P996, DOI 10.1128/JB.98.3.996-1004.1969; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Lopez P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024776; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Menard O, 2008, APPL ENVIRON MICROB, V74, P660, DOI 10.1128/AEM.01261-07; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Nowak EC, 2012, J EXP MED, V209, P2127, DOI 10.1084/jem.20120408; Opitz CA, 2007, CELL MOL LIFE SCI, V64, P2542, DOI 10.1007/s00018-007-7140-9; Paun A, 2016, J AUTOIMMUN, V71, P10, DOI 10.1016/j.jaut.2016.02.004; Qin OY, 2002, EUR CYTOKINE NETW, V13, P392; Regitz-Zagrosek V, 2006, CLIN RES CARDIOL, V95, P136, DOI 10.1007/s00392-006-0351-5; Regitz-Zagrosek V, 2006, NAT REV DRUG DISCOV, V5, P425, DOI 10.1038/nrd2032; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; RUSCHEN S, 1992, CLIN EXP IMMUNOL, V89, P32; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sridharan GV, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6492; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Tigchelaar EF, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006772; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007; Welters HJ, 2004, FEBS LETT, V560, P103, DOI 10.1016/S0014-5793(04)00079-1; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Zanvit P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9424; Zhang MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109146; Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	48	503	528	11	147	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					1125	+		10.1016/j.cell.2016.10.020	http://dx.doi.org/10.1016/j.cell.2016.10.020			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814509	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000389469000027
J	Urbanowicz, RA; McClure, CP; Sakuntabhai, A; Sall, AA; Kobinger, G; Muller, MA; Holmes, EC; Rey, FA; Simon-Loriere, E; Ball, JK				Urbanowicz, Richard A.; McClure, C. Patrick; Sakuntabhai, Anavaj; Sall, Amadou A.; Kobinger, Gary; Mueller, Marcel A.; Holmes, Edward C.; Rey, Felix A.; Simon-Loriere, Etienne; Ball, Jonathan K.			Human Adaptation of Ebola Virus during the West African Outbreak	CELL			English	Article							NIEMANN-PICK C1; FRUIT BATS; ZAIRE-EBOLAVIRUS; SIERRA-LEONE; GLYCOPROTEIN; SURVEILLANCE; EVOLUTION; ANTIBODY; INFECTIVITY; PREVALENCE	The 2013-2016 outbreak of Ebola virus (EBOV) in West Africa was the largest recorded. It began following the cross-species transmission of EBOV from an animal reservoir, most likely bats, into humans, with phylogenetic analysis revealing the co-circulation of several viral lineages. We hypothesized that this prolonged human circulation led to genomic changes that increased viral transmissibility in humans. We generated a synthetic glycoprotein (GP) construct based on the earliest reported isolate and introduced amino acid substitutions that defined viral lineages. Mutant GPs were used to generate a panel of pseudoviruses, which were used to infect different human and bat cell lines. These data revealed that specific amino acid substitutions in the EBOV GP have increased tropism for human cells, while reducing tropism for bat cells. Such increased infectivity may have enhanced the ability of EBOV to transmit among humans and contributed to the wide geographic distribution of some viral lineages.	[Urbanowicz, Richard A.; McClure, C. Patrick; Ball, Jonathan K.] Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England; [Urbanowicz, Richard A.; McClure, C. Patrick; Ball, Jonathan K.] Univ Nottingham, Nottingham Univ Hosp NHS Trust, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham NG7 2UH, England; [Sakuntabhai, Anavaj; Simon-Loriere, Etienne] Inst Pasteur, Funct Genet Infect Dis Unit, F-75724 Paris 15, France; [Sakuntabhai, Anavaj; Simon-Loriere, Etienne] CNRS, Unite Rech Associee 3012, F-75015 Paris, France; [Sall, Amadou A.] Inst Pasteur, Arbovirus & Viral Hemorrhag Fever Unit, BP 220, Dakar, Senegal; [Kobinger, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Ottawa, ON K1A 0K9, Canada; [Kobinger, Gary] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada; [Kobinger, Gary] Univ Manitoba, Fac Med, Dept Med Microbiol, Winnipeg, MB R32T 2N2, Canada; [Mueller, Marcel A.] Univ Bonn, Med Ctr, Inst Virol, D-53127 Bonn, Germany; [Holmes, Edward C.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Charles Perkins Ctr, Sch Life & Environm Sci, Sydney, NSW 2050, Australia; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2050, Australia; [Rey, Felix A.] Inst Pasteur, Dept Virol, Unite Virol Struct, F-75724 Paris 15, France; [Rey, Felix A.] CNRS, Unite Mixte Rech 3569, F-75724 Paris 15, France; [Kobinger, Gary] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 0A6, Canada; [Kobinger, Gary] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Public Health Agency of Canada; Public Health Agency of Canada; University of Manitoba; University of Bonn; University of Sydney; University of Sydney; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Laval University; University of Pennsylvania	Ball, JK (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham NG7 2RD, England.; Ball, JK (corresponding author), Univ Nottingham, Nottingham Univ Hosp NHS Trust, NIHR Nottingham Digest Dis Biomed Res Unit, Nottingham NG7 2UH, England.; Simon-Loriere, E (corresponding author), Inst Pasteur, Funct Genet Infect Dis Unit, F-75724 Paris 15, France.; Simon-Loriere, E (corresponding author), CNRS, Unite Rech Associee 3012, F-75015 Paris, France.	etienne.simon-loriere@pasteur.fr; jonathan.ball@nottingham.ac.uk	de Villers, Thierry/AAF-3646-2021; Müller, Marcel A./O-2425-2019; Holmes, Edward/GVR-9499-2022; McClure, Patrick/J-4619-2019; Urbanowicz, Richard Antoni/M-3354-2019; Ball, Jonathan/HGU-3130-2022; Holmes, Edward/Y-2789-2019	Müller, Marcel A./0000-0003-2242-5117; McClure, Patrick/0000-0002-1710-1049; Urbanowicz, Richard Antoni/0000-0002-2461-4993; Holmes, Edward/0000-0001-9596-3552; , Etienne/0000-0001-8420-7743; ball, jonathan/0000-0001-5773-8733; Rey, Felix/0000-0002-9953-7988	Medical Research Council [G0801169]; Biotechnology and Biological Sciences Research Council [BB/M018636/1]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' [ANR-10-LABX-62-IBEID]; Institut Pasteur Ebola Task Force; University of Nottingham Faculty of Medicine and Health Sciences International Research Collaboration Fund; NHMRC Australia fellowship [AF30]; Federal Ministry of Education and Research (BMBF); BBSRC [BB/M018636/1] Funding Source: UKRI; MRC [G0801169] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases''(French National Research Agency (ANR)); Institut Pasteur Ebola Task Force; University of Nottingham Faculty of Medicine and Health Sciences International Research Collaboration Fund; NHMRC Australia fellowship(National Health and Medical Research Council (NHMRC) of Australia); Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by funding from the Medical Research Council (G0801169), the Biotechnology and Biological Sciences Research Council (BB/M018636/1), the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases'' (grant no ANR-10-LABX-62-IBEID), the Institut Pasteur Ebola Task Force, and the University of Nottingham Faculty of Medicine and Health Sciences International Research Collaboration Fund. E.C.H. is supported by an NHMRC Australia fellowship (AF30). Bat cells were generated within the framework of EU-FP7 ANTIGONE (no. 278976) and the EBOKON project supported by the Federal Ministry of Education and Research (BMBF). The authors would like to thank Prof. Greg Towers of University College London for discussions about host lentiviral restriction factors and Andrew Rambaut of University of Edinburgh for the sequence alignment dataset	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Azarian T, 2015, SCI REP-UK, V5, DOI 10.1038/srep10170; Besnier C, 2003, J VIROL, V77, P13403, DOI 10.1128/JVI.77.24.13403-13406.2003; Capobianchi M.R., 2015, GENOME ANNOUNC; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014; Faye O, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001908; Fitzpatrick G, 2015, J INFECT DIS, V212, P1752, DOI 10.1093/infdis/jiv304; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Han BA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004815; Herrera C, 2005, VIROLOGY, V338, P154, DOI 10.1016/j.virol.2005.05.002; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Ladner JT, 2015, CELL HOST MICROBE, V18, P659, DOI 10.1016/j.chom.2015.11.008; Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082; Leendertz SAJ, 2016, ECOHEALTH, V13, P18, DOI 10.1007/s10393-015-1053-0; Lennemann NJ, 2014, MBIO, V5, DOI 10.1128/mBio.00862-13; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Liu SQ, 2015, INFECT GENET EVOL, V32, P51, DOI 10.1016/j.meegid.2015.02.024; Martinez O, 2013, J VIROL, V87, P3324, DOI 10.1128/JVI.01598-12; Marzi A, 2006, J VIROL, V80, P6305, DOI 10.1128/JVI.02545-05; Mohan GS, 2015, J VIROL, V89, P1205, DOI 10.1128/JVI.01810-14; Moncla LH, 2016, CELL HOST MICROBE, V19, P169, DOI 10.1016/j.chom.2016.01.011; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785; Ogawa H, 2015, J INFECT DIS, V212, pS101, DOI 10.1093/infdis/jiv063; Olabode AS, 2015, VIROLOGY, V482, P202, DOI 10.1016/j.virol.2015.03.029; Olal D, 2012, J VIROL, V86, P2809, DOI 10.1128/JVI.05549-11; Pepin KM, 2010, NAT REV MICROBIOL, V8, P802, DOI 10.1038/nrmicro2440; Pourrut X, 2007, J INFECT DIS, V196, pS176, DOI 10.1086/520541; Pourrut X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-159; Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996; Reddel R.R., 1989, U.S. Patent, Patent No. [4,885,238, 4885238]; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Schieffelin JS, 2014, NEW ENGL J MED, V371, P2092, DOI 10.1056/NEJMoa1411680; Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612; SMITH BT, 1977, AM REV RESPIR DIS, V115, P285; Swanepoel R, 1996, EMERG INFECT DIS, V2, P321, DOI 10.3201/eid0204.960407; Urbanowicz RA, 2016, J GEN VIROL, V97, P2265, DOI 10.1099/jgv.0.000537; Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044; World Health Organisation, 2016, EB SIT REP 30 MARCH; Yap MW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003968	44	119	123	0	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					1079	+		10.1016/j.cell.2016.10.013	http://dx.doi.org/10.1016/j.cell.2016.10.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814505	Green Published, hybrid			2022-12-28	WOS:000389469000023
J	Harris, AM; Hicks, LA; Qaseem, A				Harris, Aaron M.; Hicks, Lauri A.; Qaseem, Amir			Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Harris, Aaron M.; Hicks, Lauri A.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA USA	Centers for Disease Control & Prevention - USA; American College of Physicians	Harris, AM (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.							Bennett JE, 2015, MANDELL DOUGLAS BENN; Fleming-Dutra KE, 2016, JAMA-J AM MED ASSOC, V315, P1864, DOI 10.1001/jama.2016.4151; Shulman ST, 2012, CLIN INFECT DIS, V55, P1279, DOI 10.1093/cid/cis847; Spinks A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000023.pub4	4	14	14	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					674	674		10.7326/L16-0284	http://dx.doi.org/10.7326/L16-0284			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802463				2022-12-28	WOS:000386908600015
J	Kickbusch, I; Woods, N; Piot, P; Abbasi, K				Kickbusch, Ilona; Woods, Ngaire; Piot, Peter; Abbasi, Kamran			How to choose the world's top health diplomat	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kickbusch, Ilona] Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland; [Woods, Ngaire] Univ Oxford, Blavatnik Sch Govt, Oxford, England; [Woods, Ngaire] Univ Oxford, Global Econ Governance Programme, Oxford, England; [Piot, Peter] London Sch Hyg & Trop Med, London, England; [Abbasi, Kamran] BMJ, London, England	University of Oxford; University of Oxford; University of London; London School of Hygiene & Tropical Medicine	Kickbusch, I (corresponding author), Grad Inst Int & Dev Studies, Global Hlth Ctr, Geneva, Switzerland.	Ilona.Kickbusch@graduateinstitute.ch						[Anonymous], 2016, ECONOMIST; Branswell H, 2016, STAT; Checchi F, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i469; Davies SC, 2016, LANCET, V387, P321, DOI 10.1016/S0140-6736(16)00105-7; Decoster K, 2016, TWEET; Garrett L., 2016, SECRET VOTE WHO BODE; Kelland K, 2016, FIGHTER GLOBAL HLTH; Kupferschmidt K, 2016, SCIENCE; Mabey C, 2011, LEADERSHIP-LONDON, V7, P105, DOI 10.1177/1742715010394732; Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0; Myers DK, 2016, DESPERATELY SEEKING; Woods N, 2016, WHO SHOULD LEAD INT; World Health Organization, FAQS REG EL PROC WHO; World Health Organization, 2016, 69 WORLD HLTH ASS FR; World Health Organization, 2012, 65 WORLD HLTH ASS	15	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 28	2016	355								i5746	10.1136/bmj.i5746	http://dx.doi.org/10.1136/bmj.i5746			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LR	27793839				2022-12-28	WOS:000386662600003
J	Sanyaolu, LN; Javed, M; Wilson-Jones, N				Sanyaolu, Leigh N.; Javed, Muhammad; Wilson-Jones, Nick			CASE REVIEW A baby with a discharging umbilical lesion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SILVER-NITRATE		[Sanyaolu, Leigh N.; Javed, Muhammad; Wilson-Jones, Nick] Morriston Hosp, Welsh Ctr Burns & Plast Surg, Plast & Reconstruct Surg, Swansea, W Glam, Wales	Morriston Hospital	Sanyaolu, LN (corresponding author), Morriston Hosp, Welsh Ctr Burns & Plast Surg, Plast & Reconstruct Surg, Swansea, W Glam, Wales.	lnsanyaolu@doctors.org.uk	Javed, Muhammad Umair/AAI-7134-2021	Javed, Muhammad Umair/0000-0002-6337-4435; Sanyaolu, Leigh/0000-0002-6762-6986				Bedfordshire and Luton Joint Prescribing Committee, 2014, BEDF LUT JOINT PRESC; Daniels J, 2003, ARCH DIS CHILD-FETAL, V88, P257, DOI 10.1136/fn.88.3.F257; Daniels J, 2001, ARCH DIS CHILD, V85, P432; Giardino AP, 2004, HOSP PHYS, V40, P19; Hsu JW, 2011, PEDIATR DERMATOL, V28, P404, DOI 10.1111/j.1525-1470.2010.01295.x; Kesaree N, 1983, Indian Pediatr, V20, P690; Leicestershire Partnership NHS Trust, 2014, UMB GRAN BAB; Majjiga VS, 2005, ARCH DIS CHILD, V90, P674, DOI 10.1136/adc.2004.067918; O'Donnell KA, 1998, PEDIATR CLIN N AM, V45, P791, DOI 10.1016/S0031-3955(05)70045-6; Piparsaliya S, 2011, SURG SCI, V2, P134, DOI DOI 10.4236/SS.2011.23027; Pomeranz A, 2004, PEDIATR CLIN N AM, V51, P819, DOI 10.1016/j.pcl.2004.01.010; Royal United Hospital Bath NHS Trust, 2012, UMB GRAN BAB; Salah AS Al, 2016, INT J MED SCI PUBLIC, V5, P911; Snyder Charles L, 2007, Semin Pediatr Surg, V16, P41, DOI 10.1053/j.sempedsurg.2006.10.006; Zahid Hossain AKM, 2010, BANGLADESH J CHILD H, V34, P99, DOI DOI 10.3329/BJCH.V34I3.1036011	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2016	355								i5587	10.1136/bmj.i5587	http://dx.doi.org/10.1136/bmj.i5587			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LG	27784715				2022-12-28	WOS:000386661400003
J	Abbasi, J				Abbasi, Jennifer			Repurposing Drugs to Treat Zika	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1636	1636		10.1001/jama.2016.14757	http://dx.doi.org/10.1001/jama.2016.14757			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784079				2022-12-28	WOS:000386107800004
J	Slomski, A				Slomski, Anita			Tumor Gene Testing May Help Guide Breast Cancer Treatment Decisions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1637	1637		10.1001/jama.2016.14764	http://dx.doi.org/10.1001/jama.2016.14764			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784093				2022-12-28	WOS:000386107800007
J	McClurg, D; Norton, C				McClurg, Doreen; Norton, Christine			UNCERTAINTIES What is the best way to manage neurogenic bowel dysfunction?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPINAL-CORD-INJURY; CONSTIPATION; SYMPTOMS; PEOPLE; TRIAL		[McClurg, Doreen] Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow G4 0BA, Lanark, Scotland; [Norton, Christine] Kings Coll London, Sch Med Educ, Florence Nightingale Sch Nursing & Midwifery, London, England	Glasgow Caledonian University; University of London; King's College London	McClurg, D (corresponding author), Glasgow Caledonian Univ, Nursing Midwifery & Allied Hlth Profess Res Unit, Glasgow G4 0BA, Lanark, Scotland.	Doreen.mcclurg@gcu.ac.uk		McClurg, Doreen/0000-0002-2872-1702				Coggrave M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002115.pub5; Correa GI, 2000, SPINAL CORD, V38, P301, DOI 10.1038/sj.sc.3100851; Emmanuel A, 2010, SPINAL CORD, V48, P664, DOI 10.1038/sc.2010.5; Grijalva I, 2007, ARCH MED RES, V38, P392, DOI 10.1016/j.arcmed.2006.11.007; Harari D, 1997, SPINAL CORD, V35, P394, DOI 10.1038/sj.sc.3100417; ISRCTN Registry, 2014, ISRCTN 85007023 ABD; Khan U, 2014, COLORECTAL DIS, V16, P1001, DOI 10.1111/codi.12789; Krogh K, 2006, SPINAL CORD, V44, P625, DOI 10.1038/sj.sc.3101887; Kwok S, 2015, SPINAL CORD, V53, P36, DOI 10.1038/sc.2014.189; Lynch AC, 2000, SPINAL CORD, V38, P717, DOI 10.1038/sj.sc.3101058; McClurg D, 2013, NEUROUROL URODYNAM, V32, P685; McClurg D., 2012, J ASS CHARTERED PHYS, V111, P13; Multidisciplinary Association of Spinal Cord Injured Professionals, 2012, GUID MAN NEUR BOW DY; National Institute for Health and Care Excellence, 2007, FAEC INC MAN FAEC IN; Ondo WG, 2012, NEUROLOGY, V78, P1650, DOI 10.1212/WNL.0b013e3182574f28; Ren Zhen, 2013, Zhongguo Zhen Jiu, V33, P893; Worsoe J, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/563294; Xiao Lei, 2011, Zhongguo Zhen Jiu, V31, P400	18	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2016	354								i3931	10.1136/bmj.i3931	http://dx.doi.org/10.1136/bmj.i3931			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZH	27815246	Green Published			2022-12-28	WOS:000380931600004
J	Davidoff, F				Davidoff, Frank			Can Knowledge About Heterogeneity in Treatment Effects Help Us Choose Wisely?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Davidoff, Frank] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA	Dartmouth College	Davidoff, F (corresponding author), 1010 Waltham St,Apartment 311, Lexington, MA 02421 USA.	fdavidoff34@gmail.com						Bothwell LE, 2016, NEW ENGL J MED, V374, P2175, DOI 10.1056/NEJMms1604593; Casarett D, 2016, NEW ENGL J MED, V374, P1203, DOI 10.1056/NEJMp1516803; Dahabreh IJ, 2016, INT J EPIDE IN PRESS; Gagnier JJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-111; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kent DM, 2016, INT J EPIDEMIOL; Rothwell Peter M., 2007, TREATING INDIVIDUALS; Schmid CH, 1998, STAT MED, V17, P1923, DOI 10.1002/(SICI)1097-0258(19980915)17:17<1923::AID-SIM874>3.0.CO;2-6; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	10	9	9	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 17	2017	166	2					141	+		10.7326/M16-1721	http://dx.doi.org/10.7326/M16-1721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH5WB	27820948				2022-12-28	WOS:000391842600020
J	Qaseem, A; Harris, RP; Forciea, MA				Qaseem, Amir; Harris, Russell P.; Forciea, Mary Ann		Clinical Guidelines Comm Amer Coll	Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM URIC-ACID; CUTANEOUS ADVERSE-REACTIONS; DOUBLE-BLIND TRIAL; ADRENOCORTICOTROPIC HORMONE; TRIAMCINOLONE ACETONIDE; INITIATING ALLOPURINOL; DICLOFENAC SODIUM; ORAL PREDNISOLONE; CHINESE PATIENTS; KIDNEY-DISEASE	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of gout. Methods: Using the ACP grading system, the committee based these recommendations on a systematic review of randomized, controlled trials; systematic reviews; and large observational studies published between January 2010 and March 2016. Clinical outcomes evaluated included pain, joint swelling and tenderness, activities of daily living, patient global assessment, recurrence, intermediate outcomes of serum urate levels, and harms. Target Audience and Patient Population: The target audience for this guideline includes all clinicians, and the target patient population includes adults with acute or recurrent gout. Recommendation 1: ACP recommends that clinicians choose corticosteroids, nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine to treat patients with acute gout. (Grade: strong recommendation, high-quality evidence) Recommendation 2: ACP recommends that clinicians use low-dose colchicine when using colchicine to treat acute gout. (Grade: strong recommendation, moderate-quality evidence) Recommendation 3: ACP recommends against initiating long-term urate-lowering therapy in most patients after a first gout attack or in patients with infrequent attacks. (Grade: strong recommendation, moderate-quality evidence) Recommendation 4: ACP recommends that clinicians discuss benefits, harms, costs, and individual preferences with patients before initiating urate-lowering therapy, including concomitant prophylaxis, in patients with recurrent gout attacks. (Grade: strong recommendation, moderate-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Harris, Russell P.] Univ N Carolina, Sch Med, 725 Martin Luther King Blvd, Chapel Hill, NC 27599 USA; [Forciea, Mary Ann] Univ Penn Hlth Syst, 3615 Chestnut St, Philadelphia, PA 19104 USA	American College of Physicians; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Pennsylvania	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Agency for Healthcare Research and Quality, 2014, AHRQ PUBL, V10(14)-EHC063-EF; AHERN MJ, 1987, AUST NZ J MED, V17, P301, DOI 10.1111/j.1445-5994.1987.tb01232.x; ALLOWAY JA, 1993, J RHEUMATOL, V20, P111; ALTMAN RD, 1988, J RHEUMATOL, V15, P1422; Andres M, 2014, J RHEUMATOL, V41, P55, DOI 10.3899/jrheum.140463; Andres M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010156.pub2; AXELROD D, 1988, ARTHRITIS RHEUM-US, V31, P803, DOI 10.1002/art.1780310618; Becker MA, 2013, DIABETES OBES METAB, V15, P1049, DOI 10.1111/dom.12135; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2008, NUCLEOS NUCLEOT NUCL, V27, P585, DOI 10.1080/15257770802136032; Becker MA, 2011, NUCLEOS NUCLEOT NUCL, V30, P1011, DOI 10.1080/15257770.2011.603715; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Becker MA, 2009, J RHEUMATOL, V36, P1273, DOI 10.3899/jrheum.080814; Bongartz T, 2013, ANN RHEUM DIS, V72, P2013; Borstad GC, 2004, J RHEUMATOL, V31, P2429; BUTLER RC, 1985, BRIT J CLIN PHARMACO, V20, P511, DOI 10.1111/j.1365-2125.1985.tb05110.x; Cheng L, 2015, BRIT J DERMATOL, V173, P555, DOI 10.1111/bjd.13688; Cheng TT, 2004, CLIN THER, V26, P399, DOI 10.1016/S0149-2918(04)90035-5; Choi HK, 2005, ARCH INTERN MED, V165, P742, DOI 10.1001/archinte.165.7.742; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi TY, 2011, CLIN RHEUMATOL, V30, P937, DOI 10.1007/s10067-011-1706-5; Chung WH, 2015, ANN RHEUM DIS, V74, P2157, DOI 10.1136/annrheumdis-2014-205577; DOUGLAS G, 1970, Annals of Physical Medicine, V10, P275; EBERL R, 1983, ARZNEIMITTEL-FORSCH, V33-1, P641; Faruque LI, 2013, SEMIN ARTHRITIS RHEU, V43, P367, DOI 10.1016/j.semarthrit.2013.05.004; Garcia de la Torre I, 1987, INVEST MED INT, V14, P92; Halpern R, 2009, JCR-J CLIN RHEUMATOL, V15, P3, DOI 10.1097/RHU.0b013e3181945d2c; Hamburger MI, 2012, ARTHRITIS RHEUM-US, V64, pS808; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holland R, 2015, INTERN MED J, V45, P189, DOI 10.1111/imj.12661; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Juraschek SP, 2011, ARTHRIT CARE RES, V63, P1295, DOI 10.1002/acr.20519; Khanna D, 2013, ANN RHEUM DIS, V71, P2012; Khanna PP, 2013, ANN RHEUM DIS, V72, P2013; Khanna PP, 2014, SEMIN ARTHRITIS RHEU, V44, P31, DOI 10.1016/j.semarthrit.2014.02.003; Ko TM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4848; Krishnan E, 2013, ARTHRITIS RHEUM-US, V65, P3271, DOI 10.1002/art.38171; Krishnan E, 2013, J RHEUMATOL, V40, P1166, DOI 10.3899/jrheum.121061; LEDERMAN R, 1990, Advances in Therapy, V7, P344; Lee MH, 2012, INTERN MED J, V42, P411, DOI 10.1111/j.1445-5994.2011.02567.x; Lee WB, 2013, RHEUMATOLOGY, V52, P1225, DOI 10.1093/rheumatology/ket013; Li C, 2013, AM J PHARM BENEFIST, V5, pe46; Li T, 2013, CHINESE MED J-PEKING, V126, P1867, DOI 10.3760/cma.j.issn.0366-6999.20122892; Li XX, 2013, CLIN RHEUMATOL, V32, P943, DOI 10.1007/s10067-013-2274-7; [刘颖 Liu Ying], 2015, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V40, P652; LOEBL WY, 1974, ANN RHEUM DIS, V33, P304, DOI 10.1136/ard.33.4.304; LOMEN PL, 1986, AM J MED, V80, P134, DOI 10.1016/0002-9343(86)90131-2; MACCAGNO A, 1991, CURR MED RES OPIN, V12, P423, DOI 10.1185/03007999109111513; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; Moi JHY, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010519.pub2; PAULUS HE, 1974, ARTHRITIS RHEUM-US, V17, P609, DOI 10.1002/art.1780170517; Perez-Ruiz F, 2006, ARTHRIT RHEUM-ARTHR, V55, P786, DOI 10.1002/art.22232; Perez-Ruiz F, 2011, ARTHRITIS RHEUM-US, V63, P4002, DOI 10.1002/art.30649; Qaseem A, 2017, ANN INTERN MED, V166, P52, DOI 10.7326/M16-0569; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Rainer TH, 2016, ANN INTERN MED, V164, P464, DOI 10.7326/M14-2070; Ramasamy SN, 2013, DRUG SAFETY, V36, P953, DOI 10.1007/s40264-013-0084-0; Richette P, 2010, EXPERT OPIN PHARMACO, V11, P2933, DOI 10.1517/14656566.2010.529432; Rubin BR, 2004, ARTHRITIS RHEUM-US, V50, P598, DOI 10.1002/art.20007; RUOTSI A, 1978, SCAND J RHEUMATOL, P15; Sarawate CA, 2006, JCR-J CLIN RHEUMATOL, V12, P61, DOI 10.1097/01.rhu.0000209882.50228.9f; Schlesinger N, 2002, J RHEUMATOL, V29, P331; Schumacher HR, 2009, RHEUMATOLOGY, V48, P188, DOI 10.1093/rheumatology/ken457; Schumacher HR, 2012, J RHEUMATOL, V39, P1859, DOI 10.3899/jrheum.110916; Schumacher HR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1540, DOI 10.1002/art.24209; Schumacher HR, 2002, BMJ-BRIT MED J, V324, P1488, DOI 10.1136/bmj.324.7352.1488; Seth R, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006077.pub3; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shekelle PG, 2017, ANN INTERN MED, V166, P37, DOI 10.7326/M16-0461; Shekelle PG, 2016, AHRQ PUBLICATION; SHRESTHA M, 1995, ANN EMERG MED, V26, P682, DOI 10.1016/S0196-0644(95)70037-4; SIEGEL LB, 1994, J RHEUMATOL, V21, P1325; SIEGMETH W, 1976, WIEN KLIN WOCHENSCHR, V88, P535; Tassaneeyakul W, 2009, PHARMACOGENET GENOM, V19, P704, DOI 10.1097/FPC.0b013e328330a3b8; Tayar JH, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008653.pub2; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; Terkeltaub RA, 2009, SEMIN ARTHRITIS RHEU, V38, P411, DOI 10.1016/j.semarthrit.2008.08.006; van Echteld I, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006190.pub2; Wang DD, 2012, J NUTR, V142, P916, DOI 10.3945/jn.111.151951; Wechalekar MD, 2014, J RHEUMATOL, V41, P15, DOI 10.3899/jrheum.140458; Wechalekar MD, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009920.pub2; WEINER GI, 1979, ARTHRITIS RHEUM, V22, P425, DOI 10.1002/art.1780220420; Wells AF, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-15; Wu EQ, 2009, J RHEUMATOL, V36, P1032, DOI 10.3899/jrheum.080487; Yang CY, 2015, JAMA INTERN MED, V175, P1550, DOI 10.1001/jamainternmed.2015.3536; Ye P, 2013, CLIN THER, V35, P180, DOI 10.1016/j.clinthera.2012.12.011; Yu KH, 2016, SCAND J RHEUMATOL, V45, P304, DOI 10.3109/03009742.2015.1099729; Zeng Y, 2012, CHINESE J CLIN NUTR, V20, P210; Zhang SB, 2016, CLIN RHEUMATOL, V35, P151, DOI 10.1007/s10067-015-2991-1; Zhang YK, 2014, INT J CLIN PRACT, V68, P633, DOI 10.1111/ijcp.12359; Zhou L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085008; Zhu Y, 2010, VALUE HEALTH, V13, pA304, DOI 10.1016/S1098-3015(11)72163-5	94	177	187	7	62	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 3	2017	166	1					58	+		10.7326/M16-0570	http://dx.doi.org/10.7326/M16-0570			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH0QD	27802508	Green Published			2022-12-28	WOS:000391467900009
J	Beal, LM; Elipot, S				Beal, Lisa M.; Elipot, Shane			Broadening not strengthening of the Agulhas Current since the early 1990s	NATURE			English	Article							WESTERN BOUNDARY CURRENTS; WIND-DRIVEN CIRCULATION; EAST AUSTRALIAN CURRENT; CLIMATE-CHANGE; VARIABILITY; PACIFIC; SEA; INTENSIFICATION; TRANSPORT; PROJECT	Western boundary currents-such as the Agulhas Current in the Indian Ocean-carry heat poleward, moderating Earth's climate and fuelling the mid-latitude storm tracks(1,2). They could exacerbate or mitigate warming and extreme weather events in the future, depending on their response to anthropogenic climate change. Climate models show an ongoing poleward expansion and intensification of the global wind systems, most robustly in the Southern Hemisphere(3-5), and linear dynamical theory(6,7) suggests that western boundary currents will intensify and shift poleward as a result(3,8). Observational evidence of such changes comes from accelerated warming and air-sea heat flux rates within all western boundary currents, which are two or three times faster than global mean rates(5,9,10). Here we show that, despite these expectations, the Agulhas Current has not intensified since the early 1990s. Instead, we find that it has broadened as a result of more eddy activity. Recent analyses of other western boundary currents-the Kuroshio and East Australia currents-hint at similar trends(11-15). These results indicate that intensifying winds may be increasing the eddy kinetic energy of boundary currents, rather than their mean flow. This could act to decrease poleward heat transport and increase cross-frontal exchange of nutrients and pollutants between the coastal ocean and the deep ocean. Sustained in situ measurements are needed to properly understand the role of these current systems in a changing climate.	[Beal, Lisa M.; Elipot, Shane] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	University of Miami	Beal, LM (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	lbeal@rsmas.miami.edu		Elipot, Shane/0000-0001-6051-5426; Beal, Lisa/0000-0003-3678-5367	US National Science Foundation [OCE-0850891]; Cnes; Directorate For Geosciences [1459543] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Cnes(Centre National D'etudes Spatiales); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	L.M.B. and S.E. acknowledge support from the US National Science Foundation, grant OCE-0850891. The altimeter products distributed by Aviso were produced by Ssalto/ Duacs, with support from Cnes (http://www.aviso.altimetry.fr/duacs/).	Ablain M, 2015, OCEAN SCI, V11, P67, DOI 10.5194/os-11-67-2015; Backeberg BC, 2012, NAT CLIM CHANGE, V2, P608, DOI 10.1038/NCLIMATE1587; Beal LM, 2015, J PHYS OCEANOGR, V45, P1302, DOI 10.1175/JPO-D-14-0119.1; Bryden HL, 2005, J OCEANOGR, V61, P479, DOI 10.1007/s10872-005-0057-8; Cai W, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024911; Cetina-Heredia P, 2014, J GEOPHYS RES-OCEANS, V119, P4351, DOI 10.1002/2014JC010071; Cheng W, 2013, J CLIMATE, V26, P7187, DOI 10.1175/JCLI-D-12-00496.1; Compo GP, 2011, Q J ROY METEOR SOC, V137, P1, DOI 10.1002/qj.776; Ebisuzaki W, 1997, J CLIMATE, V10, P2147, DOI 10.1175/1520-0442(1997)010<2147:AMTETS>2.0.CO;2; Elipot S, 2015, J PHYS OCEANOGR, V45, P2294, DOI 10.1175/JPO-D-14-0254.1; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Ezer T, 2013, J GEOPHYS RES-OCEANS, V118, P685, DOI 10.1002/jgrc.20091; Farneti R, 2010, J PHYS OCEANOGR, V40, P1539, DOI 10.1175/2010JPO4353.1; GRIMM EC, 1993, SCIENCE, V261, P198, DOI 10.1126/science.261.5118.198; Hu DX, 2015, NATURE, V522, P299, DOI 10.1038/nature14504; Jianqing Fan, 1996, LOCAL POLYNOMIAL MOD, V66; Kent EC, 2013, INT J CLIMATOL, V33, P2520, DOI 10.1002/joc.3606; Ma XH, 2016, NATURE, V535, P533, DOI 10.1038/nature18640; McGregor S, 2012, J CLIMATE, V25, P8164, DOI 10.1175/JCLI-D-12-00105.1; MUNK WH, 1950, J METEOROL, V7, P79; Oliver ECJ, 2014, J GEOPHYS RES-OCEANS, V119, P2788, DOI 10.1002/2013JC009591; Palter JB, 2015, ANNU REV MAR SCI, V7, P113, DOI 10.1146/annurev-marine-010814-015656; Pedlosky J., 1987, GEOPHYS FLUID DYN, VVolume 710; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Rossby T, 2014, GEOPHYS RES LETT, V41, P114, DOI 10.1002/2013GL058636; Rouault M, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037987; Saenko OA, 2005, CLIM DYNAM, V25, P415, DOI 10.1007/s00382-005-0032-5; Sloyan BM, 2015, J GEOPHYS RES-OCEANS, V120, P3193, DOI 10.1002/2014JC010550; Sprintall J, 2014, J GEOPHYS RES-OCEANS, V119, P1161, DOI 10.1002/2013JC009533; Stommel H., 1948, EOS T AM GEOPHYS UN, V29, P202, DOI DOI 10.1029/TR029I002P00202; SVERDRUP HU, 1947, P NATL ACAD SCI USA, V33, P318, DOI 10.1073/pnas.33.11.318; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Tsugawa M, 2010, J PHYS OCEANOGR, V40, P1597, DOI 10.1175/2010JPO4347.1; Uchida H, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2008JC004796; Wu LX, 2012, NAT CLIM CHANGE, V2, P161, DOI 10.1038/NCLIMATE1353; Yan XM, 2015, SCI CHINA EARTH SCI, V58, P697, DOI 10.1007/s11430-014-5024-z; Yang H, 2016, J GEOPHYS RES-OCEANS, V121, P4928, DOI 10.1002/2015JC011513	37	78	82	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 22	2016	540	7634					570	+		10.1038/nature19853	http://dx.doi.org/10.1038/nature19853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG6XV	27828944				2022-12-28	WOS:000391190500049
J	Endres, M; Bernien, H; Keesling, A; Levine, H; Anschuetz, ER; Krajenbrink, A; Senko, C; Vuletic, V; Greiner, M; Lukin, MD				Endres, Manuel; Bernien, Hannes; Keesling, Alexander; Levine, Harry; Anschuetz, Eric R.; Krajenbrink, Alexandre; Senko, Crystal; Vuletic, Vladan; Greiner, Markus; Lukin, Mikhail D.			Atom-by-atom assembly of defect-free one-dimensional cold atom arrays	SCIENCE			English	Article							SINGLE-ATOM; OPTICAL TWEEZERS; MOTT INSULATOR; QUANTUM INFORMATION; NEUTRAL ATOMS; QUBIT; GATES; TRAP	The realization of large-scale fully controllable quantum systems is an exciting frontier in modern physical science. We use atom-by-atom assembly to implement a platform for the deterministic preparation of regular one-dimensional arrays of individually controlled cold atoms. In our approach, a measurement and feedback procedure eliminates the entropy associated with probabilistic trap occupation and results in defect-free arrays of more than 50 atoms in less than 400 milliseconds. The technique is based on fast, real-time control of 100 optical tweezers, which we use to arrange atoms in desired geometric patterns and to maintain these configurations by replacing lost atoms with surplus atoms from a reservoir. This bottom-up approach may enable controlled engineering of scalable many-body systems for quantum information processing, quantum simulations, and precision measurements.	[Endres, Manuel; Bernien, Hannes; Keesling, Alexander; Levine, Harry; Anschuetz, Eric R.; Krajenbrink, Alexandre; Senko, Crystal; Greiner, Markus; Lukin, Mikhail D.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Endres, Manuel] CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA; [Vuletic, Vladan] MIT, Dept Phys, Cambridge, MA 02139 USA; [Vuletic, Vladan] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Krajenbrink, Alexandre] Ecole Normale Super, Lab Phys Theor, CNRS, 24 Rue Homond, F-75231 Paris, France	Harvard University; California Institute of Technology; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Endres, M (corresponding author), Harvard Univ, Dept Phys, Cambridge, MA 02138 USA.; Endres, M (corresponding author), CALTECH, Div Phys Math & Astron, Pasadena, CA 91125 USA.	mendres@caltech.edu	Krajenbrink, Alexandre/ABG-5168-2020; Vuletic, Vladan/M-8736-2019; Bernien, Hannes/AAM-5598-2020	Krajenbrink, Alexandre/0000-0002-8551-0178; Bernien, Hannes/0000-0002-1950-7368; Levine, Harry/0000-0001-8270-3233; Keesling, Alexander/0000-0003-3931-0949; Anschuetz, Eric/0000-0002-9825-3692	NSF; Center for Ultracold Atoms; National Security Science and Engineering Faculty Fellowship; Harvard Quantum Optics Center; Rubicon Grant of the Netherlands Organization for Scientific Research (NWO); Direct For Mathematical & Physical Scien [1506284] Funding Source: National Science Foundation; Division Of Physics [1505862] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Ultracold Atoms; National Security Science and Engineering Faculty Fellowship; Harvard Quantum Optics Center; Rubicon Grant of the Netherlands Organization for Scientific Research (NWO); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank K.-K. Ni, N. Hutzler, A. Mazurenko, and A. Kaufman for insightful discussion. This work was supported by NSF, Center for Ultracold Atoms, National Security Science and Engineering Faculty Fellowship, and Harvard Quantum Optics Center. H.B. acknowledges support by a Rubicon Grant of the Netherlands Organization for Scientific Research (NWO). During the completion of this work, we became aware of a related approach (39).	Bakr WS, 2010, SCIENCE, V329, P547, DOI 10.1126/science.1192368; Barredo D, 2016, SCIENCE, V354, P1021, DOI 10.1126/science.aah3778; Barry JF, 2014, NATURE, V512, P286, DOI 10.1038/nature13634; Beugnon J, 2007, NAT PHYS, V3, P696, DOI 10.1038/nphys698; Browaeys A, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/15/152001; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Fung YH, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/7/073011; Goban A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4808; Grunzweig T, 2010, NAT PHYS, V6, P951, DOI 10.1038/NPHYS1778; Haroche S, 2013, ANN PHYS-BERLIN, V525, P753, DOI 10.1002/andp.201300737; Jaksch D, 2000, PHYS REV LETT, V85, P2208, DOI 10.1103/PhysRevLett.85.2208; Kaufman AM, 2015, NATURE, V527, P208, DOI 10.1038/nature16073; Kaufman AM, 2014, SCIENCE, V345, P306, DOI 10.1126/science.1250057; Kaufman AM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041014; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13317; Komar P, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.060506; Lester BJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073003; Miroshnychenko Y, 2006, NATURE, V442, P151, DOI 10.1038/442151a; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Murmann S, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.215301; Nelson KD, 2007, NAT PHYS, V3, P556, DOI 10.1038/nphys645; Nogrette F, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021034; Piotrowicz MJ, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.013420; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Schlosser M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123034; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Sherson JF, 2010, NATURE, V467, P68, DOI 10.1038/nature09378; Thompson JD, 2013, SCIENCE, V340, P1202, DOI 10.1126/science.1237125; Thompson JD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.133001; Vala J, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032324; Wang Y, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.043003; Weber M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.043406; Weimer H, 2010, NAT PHYS, V6, P382, DOI 10.1038/NPHYS1614; Weiss DS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.040302; Weitenberg C, 2011, NATURE, V471, P319, DOI 10.1038/nature09827; Wineland DJ, 2013, REV MOD PHYS, V85, P1103, DOI 10.1103/RevModPhys.85.1103; Xia T, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.100503	37	389	391	7	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2016	354	6315			SI		1024	1027		10.1126/science.aah3752	http://dx.doi.org/10.1126/science.aah3752			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0KQ	27811284	Green Accepted, Green Submitted			2022-12-28	WOS:000388531800042
J	Mallarino, R; Henegar, C; Mirasierra, M; Manceau, M; Schradin, C; Vallejo, M; Beronja, S; Barsh, GS; Hoekstra, HE				Mallarino, Ricardo; Henegar, Corneliu; Mirasierra, Mercedes; Manceau, Marie; Schradin, Carsten; Vallejo, Mario; Beronja, Slobodan; Barsh, Gregory S.; Hoekstra, Hopi E.			Developmental mechanisms of stripe patterns in rodents	NATURE			English	Article							COLOR PATTERN; GENOMIC DNA; MOUSE COAT; EXPRESSION; PIGMENTATION; EVOLUTION; ALX3; GENE; BINDING; CELLS	Mammalian colour patterns are among the most recognizable characteristics found in nature and can have a profound impact on fitness. However, little is known about the mechanisms underlying the formation and subsequent evolution of these patterns. Here we show that, in the African striped mouse (Rhabdomys pumilio), periodic dorsal stripes result from underlying differences in melanocyte maturation, which give rise to spatial variation in hair colour. We identify the transcription factor ALX3 as a regulator of this process. In embryonic dorsal skin, patterned expression of Alx3 precedes pigment stripes and acts to directly repress Mitf, a master regulator of melanocyte differentiation, thereby giving rise to light-coloured hair. Moreover, Alx3 is upregulated in the light stripes of chipmunks, which have independently evolved a similar dorsal pattern. Our results show a previously undescribed mechanism for modulating spatial variation in hair colour and provide insights into how phenotypic novelty evolves.	[Mallarino, Ricardo; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Howard Hughes Med Inst, Dept Cellular Biol, Cambridge, MA 02138 USA; [Mallarino, Ricardo; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Howard Hughes Med Inst, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Henegar, Corneliu; Barsh, Gregory S.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Henegar, Corneliu; Barsh, Gregory S.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Mirasierra, Mercedes; Vallejo, Mario] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain; [Mirasierra, Mercedes; Vallejo, Mario] Ciber Diabet & Enfermedades Metabol Asociadas Cib, Madrid 28029, Spain; [Manceau, Marie] Coll France, Ctr Interdisciplinary Res Biol, F-75005 Paris, France; [Schradin, Carsten] Univ Strasbourg, CNRS, IPHC, UMR 7178, F-67000 Strasbourg, France; [Schradin, Carsten] Univ Witwatersrand, Sch Anim Plant & Environm Sci, ZA-2000 Johannesburg, South Africa; [Beronja, Slobodan] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; HudsonAlpha Institute for Biotechnology; Stanford University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Witwatersrand; Fred Hutchinson Cancer Center	Hoekstra, HE (corresponding author), Harvard Univ, Museum Comparat Zool, Howard Hughes Med Inst, Dept Cellular Biol, Cambridge, MA 02138 USA.; Hoekstra, HE (corresponding author), Harvard Univ, Museum Comparat Zool, Howard Hughes Med Inst, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hoekstra@oeb.harvard.edu	Vallejo, Mario/ABG-4610-2020; Mirasierra, Mercedes/ABG-6999-2020; Henegar, Corneliu R/K-9166-2013; Hoekstra, Hopi/I-6690-2012	Vallejo, Mario/0000-0002-6422-0323; Mirasierra, Mercedes/0000-0002-0023-8903; Henegar, Corneliu R/0000-0002-8486-5591; Beronja, Slobodan/0000-0002-6769-9261; Hoekstra, Hopi/0000-0003-1431-1769	Spanish Ministry of Economy and Competitiveness (MINECO) [BFU2011-24245, BFU2014-52149-R]; Instituto de Salud Carlos III; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R00AR061469, R01AR067925] Funding Source: NIH RePORTER	Spanish Ministry of Economy and Competitiveness (MINECO); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Mishkind, M. Omura, J. Chupasko, P. Walsh, T. Capellini, T. Linden, K. Turner and N. Hughes for providing technical and logistical support, and C. Perdomo, A. Bendesky, C. K. Hu, D. M. Kingsley and J. M. Lassance for discussions. M.Mi. and M.V. are supported by the Spanish Ministry of Economy and Competitiveness (MINECO grants BFU2011-24245 and BFU2014-52149-R) and Instituto de Salud Carlos III. CIBERDEM is an initiative of the Instituto de Salud Carlos III. H.E.H. is an Investigator of the Howard Hughes Medical Institute.	Barsh GS, 1996, TRENDS GENET, V12, P299, DOI 10.1016/0168-9525(96)10031-7; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Beverdam A, 2001, DEVELOPMENT, V128, P3975; BRODIE ED, 1992, EVOLUTION, V46, P1284, DOI 10.1111/j.1558-5646.1992.tb01124.x; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Cloudsley-Thompson JL, 1999, NATURWISSENSCHAFTEN, V86, P123, DOI 10.1007/s001140050584; de la Serna IL, 2006, J BIOL CHEM, V281, P20233, DOI 10.1074/jbc.M512052200; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; Garcia-Sanz P, 2013, BIOCHEM J, V450, P199, DOI 10.1042/BJ20120962; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; JACKSON IJ, 1994, ANNU REV GENET, V28, P189, DOI 10.1146/annurev.ge.28.120194.001201; JACKSON IJ, 1994, PIGM CELL RES, V7, P73, DOI 10.1111/j.1600-0749.1994.tb00024.x; Kaelin CB, 2012, SCIENCE, V337, P1536, DOI 10.1126/science.1220893; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KING RB, 1987, EVOLUTION, V41, P241, DOI 10.1111/j.1558-5646.1987.tb05794.x; Lakhwani S, 2010, DEV BIOL, V344, P869, DOI 10.1016/j.ydbio.2010.06.002; Lee M, 2000, J BIOL CHEM, V275, P37978, DOI 10.1074/jbc.M003816200; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallarino R, 2011, P NATL ACAD SCI USA, V108, P4057, DOI 10.1073/pnas.1011480108; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Mills MG, 2009, SEMIN CELL DEV BIOL, V20, P72, DOI 10.1016/j.semcdb.2008.11.012; Mirasierra M, 2016, DIABETOLOGIA, V59, P766, DOI 10.1007/s00125-015-3849-4; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Morris Animal Foundation, 2022, ANIMAL WATCHING FIEL; Parichy DM, 2003, CURR BIOL, V13, pR947, DOI 10.1016/j.cub.2003.11.038; Perez-Villamil B, 2004, J BIOL CHEM, V279, P38062, DOI 10.1074/jbc.M400800200; Peters EMJ, 2002, J HISTOCHEM CYTOCHEM, V50, P751, DOI 10.1177/002215540205000602; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; Rawls JF, 2001, DEV BIOL, V240, P301, DOI 10.1006/dbio.2001.0418; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schradin C, 2012, MOL ECOL, V21, P541, DOI 10.1111/j.1365-294X.2011.05256.x; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Singh AP, 2015, CURR BIOL, V25, pR81, DOI 10.1016/j.cub.2014.11.013; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; ten Berge D, 1998, DEV BIOL, V199, P11, DOI 10.1006/dbio.1998.8921; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; VRIELING H, 1994, P NATL ACAD SCI USA, V91, P5667, DOI 10.1073/pnas.91.12.5667	47	68	69	5	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					518	+		10.1038/nature20109	http://dx.doi.org/10.1038/nature20109			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27806375	Green Accepted, Green Submitted			2022-12-28	WOS:000388520600035
J	Hamm, G; Mitchell, P; Arnold, LJ; Prideaux, GJ; Questiaux, D; Spooner, NA; Levchenko, VA; Foley, EC; Worthy, TH; Stephenson, B; Coulthard, V; Coulthard, C; Wilton, S; Johnston, D				Hamm, Giles; Mitchell, Peter; Arnold, Lee J.; Prideaux, Gavin J.; Questiaux, Daniele; Spooner, Nigel A.; Levchenko, Vladimir A.; Foley, Elizabeth C.; Worthy, Trevor H.; Stephenson, Birgitta; Coulthard, Vincent; Coulthard, Clifford; Wilton, Sophia; Johnston, Duncan			Cultural innovation and megafauna interaction in the early settlement of arid Australia	NATURE			English	Article							LATE PLEISTOCENE; SINGLE GRAINS; LUMINESCENCE; QUARTZ; EXTINCTION; LOESS; HOLOCENE; SOUTH; OSL; DISTRIBUTIONS	Elucidating the material culture of early people in arid Australia and the nature of their environmental interactions is essential for understanding the adaptability of populations and the potential causes of megafaunal extinctions 50-40 thousand years ago (ka). Humans colonized the continent by 50 ka(1,2), but an apparent lack of cultural innovations compared to people in Europe and Africa(3,4) has been deemed a barrier to early settlement in the extensive arid zone(2,3). Here we present evidence from Warratyi rock shelter in the southern interior that shows that humans occupied arid Australia by around 49 ka, 10 thousand years (kyr) earlier than previously reported(2). The site preserves the only reliably dated, stratified evidence of extinct Australian megafauna(5,6), including the giant marsupial Diprotodon optatum, alongside artefacts more than 46 kyr old. We also report on the earliest-known use of ochre in Australia and Southeast Asia (at or before 49-46 ka), gypsum pigment (40-33 ka), bone tools (40-38 ka), hafted tools (38-35 ka), and backed artefacts (30-24 ka), each up to 10 kyr older than any other known occurrence(7,8). Thus, our evidence shows that people not only settled in the arid interior within a few millennia of entering the continent(9), but also developed key technologies much earlier than previously recorded for Australia and Southeast Asia(8).	[Hamm, Giles; Foley, Elizabeth C.] La Trobe Univ, Dept Archaeol & Hist, Melbourne, Vic 3083, Australia; [Mitchell, Peter] Geomorph Consultant Gladesville, Sydney, NSW 2111, Australia; [Arnold, Lee J.] Univ Adelaide, Inst Environm, Sch Phys Sci, Adelaide, SA 5005, Australia; [Arnold, Lee J.] Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA 5005, Australia; [Prideaux, Gavin J.; Worthy, Trevor H.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Questiaux, Daniele; Spooner, Nigel A.] Univ Adelaide, Sch Phys Sci, Inst Photon & Adv Sensing, Adelaide, SA 5005, Australia; [Spooner, Nigel A.] Def Sci & Technol Grp, Adelaide, SA 5111, Australia; [Levchenko, Vladimir A.] Australian Nucl Sci & Technol Org, Sydney, NSW 2234, Australia; [Stephenson, Birgitta] Groove Anal Pty Ltd, Brisbane, Qld 4068, Australia; [Stephenson, Birgitta] Univ Queensland, Sch Social Sci, Brisbane, Qld 4072, Australia; [Coulthard, Vincent; Coulthard, Clifford; Wilton, Sophia; Johnston, Duncan] Adnyamathanha Tradit Lands Assoc, Port Augusta, SA 5700, Australia	La Trobe University; University of Adelaide; University of Adelaide; Flinders University South Australia; University of Adelaide; Australian Nuclear Science & Technology Organisation; University of Queensland	Hamm, G (corresponding author), La Trobe Univ, Dept Archaeol & Hist, Melbourne, Vic 3083, Australia.	A.R.A.S@bigpond.com	Arnold, Lee J/J-4356-2018; Worthy, Trevor/B-3781-2012	Arnold, Lee J/0000-0001-9603-3824; Worthy, Trevor/0000-0001-7047-4680; Prideaux, Gavin/0000-0002-9958-0265	Australian Research Council [FT130100195, FT130101728]; Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS)	Australian Research Council(Australian Research Council); Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science)	The fieldwork was undertaken with the approval of Adnyamathanha Traditional Lands Association (ATLA) and the South Australian Department of Aboriginal Affairs and Reconciliation. We thank for their contributions: A Coulthard who participated in the fieldwork; R. Frank for his support both in the field and with drawing site maps; field assistants L. Foley and S. Adams; R. Cosgrove provided faunal advice; G. Robertson assisted with residue laboratory work; C. Brown assisted with graphic design, N. Bonney provided botanical advice; M. Raven and J. Webb carried out analyses of ochres; G. Medlin provided faunal advice; B. Barker provided botanical advice; P. Toms provided access to single grain OSL dating assessment; F. Williams for assistance in fieldwork and sample collection for optical dating; A. Couzens, W. Handley and G. Gully for their assistance with micro-CT imaging and photography of megafaunal specimens; and P Veth, Hiscock, B. Cundy, W. Shawcross, S. Webb, J. Magee and D. Witter for critical feedback on the manuscript This research was supported by Alinta Energy who provided financial support for fieldwork carried out in May 2013. LA and G.P. were supported by Australian Research Council Future Fellowship Grants FT130100195 and FT130101728, respectively. V.L. and Centre for Accelerator Science at ANSTO, acknowledge the support of the Australian Government through the National Collaborative Research Infrastructure Strategy (NCRIS). FWS is who - they did the drawing of the lithics and ought to be here.	Aitken M.J., 1998, INTRO OPTICAL DATING; Allen J, 2014, AUST ARCHAEOL, P86; Arnold LJ, 2007, QUAT GEOCHRONOL, V2, P162, DOI 10.1016/j.quageo.2006.05.003; Arnold LJ, 2012, RADIAT MEAS, V47, P652, DOI 10.1016/j.radmeas.2012.02.005; Arnold LJ, 2014, J HUM EVOL, V67, P85, DOI 10.1016/j.jhevol.2013.12.001; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Attenbrow V, 2009, J ARCHAEOL SCI, V36, P2765, DOI 10.1016/j.jas.2009.08.018; Aubert M, 2014, NATURE, V514, P223, DOI 10.1038/nature13422; Balme J, 2009, QUATERN INT, V202, P59, DOI 10.1016/j.quaint.2008.10.002; Barnosky AD, 2004, SCIENCE, V306, P70, DOI 10.1126/science.1101476; Barton H, 2009, J ARCHAEOL SCI, V36, P1708, DOI 10.1016/j.jas.2009.03.027; Boivin N, 2013, QUATERN INT, V300, P32, DOI 10.1016/j.quaint.2013.01.008; Botter-Jensen L, 2000, RADIAT MEAS, V32, P523, DOI 10.1016/S1350-4487(00)00039-1; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brennan BJ, 2003, RADIAT MEAS, V37, P299, DOI 10.1016/S1350-4487(03)00011-8; Brook BW, 2013, P NATL ACAD SCI USA, V110, pE3368, DOI 10.1073/pnas.1309226110; Cohen TJ, 2015, GEOLOGY, V43, P195, DOI 10.1130/G36346.1; Cosgrove R, 1999, J WORLD PREHIST, V13, P357, DOI 10.1023/A:1022310029016; Demuro M, 2008, QUAT GEOCHRONOL, V3, P346, DOI 10.1016/j.quageo.2007.12.003; Demuro M, 2015, QUATERN INT, V389, P191, DOI 10.1016/j.quaint.2014.08.035; Demuro M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110169; Demuro M, 2013, QUAT GEOCHRONOL, V15, P67, DOI 10.1016/j.quageo.2012.11.003; Dortch C. E., 1996, AUST ARCHAEOL, V43, P28; Dortch C. E., 1984, DEVILS LAIR STUDY PR; Duller G.A.T., 2007, ANCIENT TL, V25, P15; Field J, 2013, QUATERN INT, V285, P76, DOI 10.1016/j.quaint.2011.04.013; Galbraith RF, 2002, ANCIENT TL, V20, P49; Grellet-Tinner G, 2016, QUATERNARY SCI REV, V133, P147, DOI 10.1016/j.quascirev.2015.12.011; Grun R, 2010, QUATERNARY SCI REV, V29, P596, DOI 10.1016/j.quascirev.2009.11.004; Guerin G., 2011, ANCIENT TL, V29, P5; Habgood PJ, 2008, J HUM EVOL, V55, P187, DOI 10.1016/j.jhevol.2007.11.006; Hiscock P., 2005, DESERT PEOPLES ARCHA, P34, DOI DOI 10.1002/9780470774632.CH3; Hogg AG, 2013, RADIOCARBON, V55, P1889, DOI 10.2458/azu_js_rc.55.16783; Jacobs Z, 2006, RADIAT MEAS, V41, P264, DOI 10.1016/j.radmeas.2005.07.027; Larson M.L., 1997, LITHIC TECHNOL, V22, P4, DOI [DOI 10.1080/01977261.1997.11754530, 10.1080/01977261.1997.11754530]; Laughlin JP, 2010, J ARCHAEOL SCI, V37, P427, DOI 10.1016/j.jas.2009.10.007; Macken AC, 2013, QUAT GEOCHRONOL, V17, P26, DOI 10.1016/j.quageo.2013.03.001; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Mejdahl V., 1987, ANCIENT TL, V5, P10; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Mulvaney D. J., 1999, PREHISTORY AUSTR; Murray AS, 1997, EARTH PLANET SC LETT, V152, P163, DOI 10.1016/S0012-821X(97)00150-7; O'Connell JF, 2015, J ARCHAEOL SCI, V56, P73, DOI 10.1016/j.jas.2015.02.020; O'Connor S, 2014, J HUM EVOL, V67, P108, DOI 10.1016/j.jhevol.2013.12.002; O'Connor S, 2001, HIST OLD AGES ESSAYS, P287; Olley JM, 2004, GEOMORPHOLOGY, V60, P337, DOI 10.1016/j.geomorph.2003.09.020; Pawley SM, 2008, QUATERNARY SCI REV, V27, P1363, DOI 10.1016/j.quascirev.2008.02.013; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; QUESTIAUX DG, 1991, NUCL TRACKS RAD MEAS, V18, P133; Rabett R.J., 2005, ASIAN PERSPECT, P154, DOI DOI 10.1353/ASI.2005.0013; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Rees-Jones J, 1995, ANCIENT TL, V13, P9; ReesJones J, 1997, ARCHAEOMETRY, V39, P177, DOI 10.1111/j.1475-4754.1997.tb00797.x; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Slack Michael J., 2004, Archaeology in Oceania, V39, P131; Smith M., 2013, ARCHAEOLOGY AUSTR DE, P185; Stephenson B, 2015, J ARCHAEOL SCI, V61, P235, DOI 10.1016/j.jas.2015.06.007; Stevens T, 2009, RADIAT MEAS, V44, P639, DOI 10.1016/j.radmeas.2009.02.015; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Tsukamoto S, 2008, RADIAT MEAS, V43, P1204, DOI 10.1016/j.radmeas.2008.02.018; Veth P., 2013, CAMBRIDGE HIST AUSTR, P1; VILLA P, 1982, AM ANTIQUITY, V47, P276, DOI 10.2307/279901; Wang XL, 2006, RADIAT MEAS, V41, P649, DOI 10.1016/j.radmeas.2006.01.001; WEBB C, 1990, Archaeology in Oceania, V25, P75; Wroe S, 2013, P NATL ACAD SCI USA, V110, P8777, DOI 10.1073/pnas.1302698110	67	81	84	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					280	+		10.1038/nature20125	http://dx.doi.org/10.1038/nature20125			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EB4CZ	27806378				2022-12-28	WOS:000387318500043
J	Wei, XC; Song, HW; Yin, L; Rizzo, MG; Sidhu, R; Covey, DF; Ory, DS; Semenkovich, CF				Wei, Xiaochao; Song, Haowei; Yin, Li; Rizzo, Michael G., Jr.; Sidhu, Rohini; Covey, Douglas F.; Ory, Daniel S.; Semenkovich, Clay F.			Fatty acid synthesis configures the plasma membrane for inflammation in diabetes	NATURE			English	Article							LIPID RAFTS; QUANTITATIVE PROTEOMICS; INSULIN SENSITIVITY; ACTIVATION; SYNTHASE; CHOLESTEROL; MACROPHAGES; VESICLES; OBESITY; PALMITOYLATION	Dietary fat promotes pathological insulin resistance through chronic inflammation(1-3). The inactivation of inflammatory proteins produced by macrophages improves diet-induced diabetes(4), but how nutrient-dense diets induce diabetes is unknown(5). Membrane lipids affect the innate immune response(6), which requires domains(7) that influence high-fat-diet-induced chronic inflammation(8,9) and alter cell function based on phospholipid composition(10). Endogenous fatty acid synthesis, mediated by fatty acid synthase (FAS)(11), affects membrane composition. Here we show that macrophage FAS is indispensable for diet-induced inflammation. Deleting Fasn in macrophages prevents diet-induced insulin resistance, recruitment of macrophages to adipose tissue and chronic inflammation in mice. We found that FAS deficiency alters membrane order and composition, impairing the retention of plasma membrane cholesterol and disrupting Rho GTPase trafficking-a process required for cell adhesion, migration and activation. Expression of a constitutively active Rho GTPase, however, restored inflammatory signalling. Exogenous palmitate was partitioned to different pools from endogenous lipids and did not rescue inflammatory signalling. However, exogenous cholesterol, as well as other planar sterols, did rescue signalling, with cholesterol restoring FAS-induced perturbations in membrane order. Our results show that the production of endogenous fat in macrophages is necessary for the development of exogenous-fatinduced insulin resistance through the creation of a receptive environment at the plasma membrane for the assembly of cholesterol-dependent signalling networks.	[Wei, Xiaochao; Song, Haowei; Yin, Li; Rizzo, Michael G., Jr.; Semenkovich, Clay F.] Washington Univ, Div Endocrinol Metab & Lipid Res, Sch Med, St Louis, MO 63110 USA; [Sidhu, Rohini; Ory, Daniel S.] Washington Univ, Diabet Cardiovasc Dis Ctr, Sch Med, St Louis, MO 63110 USA; [Covey, Douglas F.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Semenkovich, Clay F.] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Semenkovich, CF (corresponding author), Washington Univ, Div Endocrinol Metab & Lipid Res, Sch Med, St Louis, MO 63110 USA.; Semenkovich, CF (corresponding author), Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA.	csemenko@wustl.edu	Sidhu, Rohini/G-3547-2012	Sidhu, Rohini/0000-0003-1703-2167; Semenkovich, Clay/0000-0003-1163-1871	NIH [DK101392, DK076729, DK088083, DK20579, DK56341, RR00954, HL067773]; Taylor Family Institute for Innovative Psychiatric Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579, T32DK007120, P60DK020579, R01DK101392, R01DK088083, R01DK076729] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taylor Family Institute for Innovative Psychiatric Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK101392, DK076729, DK088083, DK20579, DK56341, RR00954, HL067773 and the Taylor Family Institute for Innovative Psychiatric Research. S. Teitelbaum provided the constitutively active Rac construct, T. Pryse performed confocal microscopy, L. Yang and M. Miller assisted with imaging and L. Mydock-McGrane prepared the cholesterol alkyne.	Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Carvalheira JBC, 2013, BLOOD, V122, P3263, DOI 10.1182/blood-2013-04-459446; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Ciepla P, 2014, CHEM SCI, V5, P4249, DOI 10.1039/c4sc01600a; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Ferrante AW, 2013, J CLIN INVEST, V123, P4992, DOI 10.1172/JCI73658; Fessler MB, 2004, J BIOL CHEM, V279, P39989, DOI 10.1074/jbc.M401080200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Funai K, 2013, J CLIN INVEST, V123, P1229, DOI 10.1172/JCI65726; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Holzer RG, 2011, CELL, V147, P173, DOI 10.1016/j.cell.2011.08.034; Jiang XT, 2011, J LIPID RES, V52, P1435, DOI 10.1194/jlr.D015735; Koberlin MS, 2015, CELL, V162, P170, DOI 10.1016/j.cell.2015.05.051; Lange Y, 2004, P NATL ACAD SCI USA, V101, P11664, DOI 10.1073/pnas.0404766101; Lange Y, 2009, J LIPID RES, V50, P1881, DOI 10.1194/jlr.M900116-JLR200; Levental I, 2011, P NATL ACAD SCI USA, V108, P11411, DOI 10.1073/pnas.1105996108; Levental I, 2009, BIOCHEM J, V424, P163, DOI 10.1042/BJ20091283; Levental KR, 2015, METHODS MOL BIOL, V1232, P65, DOI 10.1007/978-1-4939-1752-5_6; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Maier T, 2008, SCIENCE, V321, P1315, DOI 10.1126/science.1161269; Monetti M, 2011, NAT METHODS, V8, P655, DOI [10.1038/nmeth.1647, 10.1038/NMETH.1647]; Moon JS, 2015, J CLIN INVEST, V125, P665, DOI 10.1172/JCI78253; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Schneider JG, 2010, J BIOL CHEM, V285, P23396, DOI 10.1074/jbc.M110.100321; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Wei XC, 2012, CELL HOST MICROBE, V11, P140, DOI 10.1016/j.chom.2011.12.006; Wei XC, 2011, J BIOL CHEM, V286, P2933, DOI 10.1074/jbc.M110.193037; Westover EJ, 2004, J MEMBRANE BIOL, V202, P61, DOI 10.1007/s00232-004-0714-7; Wu M, 2011, P NATL ACAD SCI USA, V108, P5378, DOI 10.1073/pnas.1002588108; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619	41	152	156	3	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					294	+		10.1038/nature20117	http://dx.doi.org/10.1038/nature20117			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27806377	Green Accepted			2022-12-28	WOS:000387318500046
J	Abbasi, J				Abbasi, Jennifer			Tig Notaro A Comedian Makes "Sick" Humor the Main Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												jennifer.abbasi@jamanetwork.org							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1850	1851		10.1001/jama.2016.16652	http://dx.doi.org/10.1001/jama.2016.16652			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27824988	Bronze			2022-12-28	WOS:000387116500001
J	Best, JA				Best, Jennifer A.			The Things We Have Lost	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ROUNDS		[Best, Jennifer A.] Univ Washington, Sch Med, Off Grad Med Educ, Seattle, WA 98105 USA	University of Washington; University of Washington Seattle	Best, JA (corresponding author), Univ Washington, Sch Med, Off Grad Med Educ, Seattle, WA 98105 USA.	jabest@uw.edu						Campo R, 2005, JAMA-J AM MED ASSOC, V294, P1009, DOI 10.1001/jama.294.9.1009; Lown BA, 2010, ACAD MED, V85, P1073, DOI 10.1097/ACM.0b013e3181dbf741; Smith L, 2011, J PALLIAT MED, V14, P55, DOI 10.1089/jpm.2010.0190	3	1	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1871	1872		10.1001/jama.2016.9954	http://dx.doi.org/10.1001/jama.2016.9954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27825012				2022-12-28	WOS:000387116500012
J	Rubin, R				Rubin, Rita			US CDC celebrates 70 years	LANCET			English	Editorial Material													Rubin, Rita/AAD-1259-2020						0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2224	2225		10.1016/S0140-6736(16)32117-1	http://dx.doi.org/10.1016/S0140-6736(16)32117-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8MO	27825496				2022-12-28	WOS:000386889300013
J	Hampton, T				Hampton, Tracy			DNA Vaccine Protects Monkeys Against Zika Virus Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1755	1755		10.1001/jama.2016.15862	http://dx.doi.org/10.1001/jama.2016.15862			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802535				2022-12-28	WOS:000386569300005
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Long live generics!	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Adams S., 2012, DAILY TELEGRAPH; [Anonymous], 2016, GUARDIAN; Bradshaw J., 2016, TELEGRAPH; Hire Carly, 2013, Inform Prim Care, V21, P1, DOI 10.14236/jhi.v21i1.6; KIRKNESS CM, 1995, EYE, V9, pR7, DOI 10.1038/eye.1995.97; NHS Greater Glasgow and Clyde, 2010, CAS STUD SCRIPTSWITC	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 31	2016	355								i5808	10.1136/bmj.i5808	http://dx.doi.org/10.1136/bmj.i5808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CM	27799144	Bronze, Green Published			2022-12-28	WOS:000387316800003
J	Torjesen, I				Torjesen, Ingrid			Updated Gin Lane exemplifies modern day public health challenges	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	2016	355								i5758	10.1136/bmj.i5758	http://dx.doi.org/10.1136/bmj.i5758			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LG	27784665				2022-12-28	WOS:000386661400015
J	Canaud, B; Hegbrant, J; Nissenson, AR; Barth, C; Maddux, F; Etter, M; Krishnan, M				Canaud, Bernard; Hegbrant, Jorgen; Nissenson, Allen R.; Barth, Claudia; Maddux, Franklin; Etter, Michael; Krishnan, Mahesh			Improving outcomes of dialysis patients by population health management-the Global Chief Medical Officer Initiative	LANCET			English	Editorial Material							STAGE KIDNEY-DISEASE; RENAL REGISTRIES; CARE; QUALITY; ACCESS		[Canaud, Bernard] Fresenius Med Care Europe Middle East Afr, D-61352 Bad Homburg, Germany; [Hegbrant, Jorgen] Diaverum Renal Serv Grp, Lund, Sweden; [Nissenson, Allen R.; Krishnan, Mahesh] DaVita HealthCare Partners Inc, Denver, CO USA; [Barth, Claudia] BBraun Avitum AG, Melsungen, Germany; [Maddux, Franklin] Fresenius Med Care North Amer, Waltham, MA USA; [Etter, Michael] Fresenius Med Care Asia Pacific, Hong Kong, Hong Kong, Peoples R China	Diaverum; DaVita	Canaud, B (corresponding author), Fresenius Med Care Europe Middle East Afr, D-61352 Bad Homburg, Germany.	bernard.canaud@fmc-ag.com		Maddux, Franklin/0000-0003-1395-2011				Breckenridge K, 2015, NEPHROL DIAL TRANSPL, V30, P1605, DOI 10.1093/ndt/gfv209; Claudia B., 2010, DIALYSIS TRANSPLANT, V39, P404; Hodach R., 2012, POPULATION HLTH MANA; Krishnan M, 2014, CLIN J AM SOC NEPHRO, V9, P1124, DOI 10.2215/CJN.11061013; Krishnan M, 2012, CLIN J AM SOC NEPHRO, V7, P1891, DOI 10.2215/CJN.03220312; Liu FX, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0028-2; Liyanage T, 2015, LANCET, V385, P1975, DOI 10.1016/S0140-6736(14)61601-9; National Institute for Health and Care Excellence, 2011, QS5 NICE; Parker T, 2011, CLIN J AM SOC NEPHRO, V6, P457, DOI 10.2215/CJN.08450910; Porter ME, 2016, JAMA-J AM MED ASSOC, V316, P1047, DOI 10.1001/jama.2016.11698; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Robinson BM, 2016, LANCET, V388, P294, DOI 10.1016/S0140-6736(16)30448-2; US Food and Drug Administration. National Environmental Policy Act; Environmental Assessments for Tobacco Products; Categorical Exclusions, 2015, FED REG; van der Veer SN, 2014, NEPHROL DIAL TRANSPL, V29, P1460, DOI 10.1093/ndt/gft473; van der Veer SN, 2011, KIDNEY INT, V80, P1021, DOI 10.1038/ki.2011.222; Wetmore JB, 2016, CLIN J AM SOC NEPHRO, V11, P1297, DOI 10.2215/CJN.12981215	16	6	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1966	1967		10.1016/S0140-6736(16)31894-3	http://dx.doi.org/10.1016/S0140-6736(16)31894-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ6EQ	27789006				2022-12-28	WOS:000385954800009
J	Hicks, BM; Yin, H; Yu, OHY; Pollak, MN; Platt, RW; Azoulay, L				Hicks, Blanaid M.; Yin, Hui; Yu, Oriana H. Y.; Pollak, Michael N.; Platt, Robert W.; Azoulay, Laurent			Glucagon-like peptide-1 analogues and risk of breast cancer in women with type 2 diabetes: population based cohort study using the UK Clinical Practice Research Datalink	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MARGINAL STRUCTURAL MODELS; CARDIOVASCULAR OUTCOMES; GROWTH-FACTOR; SCORES; LIRAGLUTIDE; PERFORMANCE; REGRESSION; THERAPIES; WEIGHT; BIAS	OBJECTIVE To determine whether the use of glucagon-like peptide-1 (GLP-1) analogues, compared with the use of dipeptidylpeptidase-4 (DPP-4) inhibitors, is associated with an increased risk of incident breast cancer in patients with type 2 diabetes. DESIGN Population based cohort study. SETTING Clinical Practice Research Datalink, UK. PARTICIPANTS 44 984 women aged at least 40 years, who were newly treated with glucose lowering drugs between 1 January 2007 and 31 March 2015, with follow-up until 31 March 2016. MAIN OUTCOMES AND MEASURES Time varying use of GLP-1 analogues compared with use of DPP-4 inhibitors, with exposures lagged by one year for latency purposes. Time dependent Cox proportional hazards models were used to estimate adjusted hazard ratios with 95% confidence intervals of incident breast cancer associated with use of GLP-1 analogues overall, by cumulative duration of use, and time since initiation. RESULTS The cohort was followed for a mean of 3.5 years (standard deviation 2.2), with 549 incident events of breast cancer recorded (crude incidence 3.5 (95% confidence interval 3.3 to 3.8) per 1000 person years). Overall, compared with use of DPP-4 inhibitors, use of GLP-1 analogues was not associated with an increased risk of breast cancer (incidence 4.4 v 3.4 per 1000 person years; hazard ratio 1.40 (95% confidence interval 0.91 to 2.16)). Hazard ratios gradually increased with longer durations of use, with a peak between two to three years of GLP-1 use (2.66 (95% confidence interval 1.32 to 5.38)), and returned closer to the null after more than three years of use (0.98 (0.24 to 4.03)). A similar pattern was observed with time since initiation of GLP-1 analogues. CONCLUSIONS In this population based cohort study, use of GLP-1 analogues was not associated with an overall increased risk of breast cancer. Although it is not possible to rule out a tumour promoter effect, the observed duration-response associations are likely the result of a transient increase in detection of breast cancers in GLP-1 analogue users.	[Hicks, Blanaid M.; Yin, Hui; Yu, Oriana H. Y.; Platt, Robert W.; Azoulay, Laurent] Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine,H-425-1, Montreal, PQ H3T 1E2, Canada; [Hicks, Blanaid M.; Platt, Robert W.; Azoulay, Laurent] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Yu, Oriana H. Y.] Jewish Gen Hosp, Div Endocrinol, Montreal, PQ, Canada; [Pollak, Michael N.; Azoulay, Laurent] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada; [Platt, Robert W.] Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Dept Pediat, Montreal, PQ, Canada; [Platt, Robert W.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; McGill University; McGill University	Azoulay, L (corresponding author), Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine,H-425-1, Montreal, PQ H3T 1E2, Canada.; Azoulay, L (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Azoulay, L (corresponding author), McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada.	laurent.azoulay@mcgill.ca	Azoulay, Laurent/Z-4421-2019	Pollak, Michael/0000-0003-3047-0604; Azoulay, Laurent/0000-0001-5162-3556	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a foundation grant from the Canadian Institutes of Health Research. The sponsor had no influence on design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Arbogast PG, 2011, AM J EPIDEMIOL, V174, P613, DOI 10.1093/aje/kwr143; Arbogast PG, 2009, STAT METHODS MED RES, V18, P67, DOI 10.1177/0962280208092347; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Cook NR, 2009, AM J EPIDEMIOL, V170, P1422, DOI 10.1093/aje/kwp304; Cui F, 2016, BREAST CANCER RES TR, V155, P313, DOI 10.1007/s10549-015-3670-2; Elmore JG, 2004, ARCH INTERN MED, V164, P1140, DOI 10.1001/archinte.164.10.1140; European Medical Agency Committee for Medicinal Products for Human Use, 2015, ASS REP SAX INT NONP; FDA, 2016, AN CANC INC OBS CLIN; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gale EAM, 2012, DIABETES, V61, P986, DOI 10.2337/db11-1838; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Haut ER, 2011, JAMA-J AM MED ASSOC, V305, P2462, DOI 10.1001/jama.2011.822; Heinzl H, 1996, STAT MED, V15, P2589, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2589::AID-SIM373>3.0.CO;2-O; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Joffe MM, 1998, STAT MED, V17, P2233, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2233::AID-SIM922>3.0.CO;2-0; Koehler JA, 2015, CELL METAB, V21, P379, DOI 10.1016/j.cmet.2015.02.005; Korner M, 2007, J NUCL MED, V48, P736, DOI 10.2967/jnumed.106.038679; Labuzek K, 2013, EUR J INTERN MED, V24, P207, DOI 10.1016/j.ejim.2013.01.009; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Leiter LA, 2016, DIABETES OBES METAB, V18, P186, DOI 10.1111/dom.12582; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Njor SH, 2016, EUR J CANCER, V60, P93, DOI 10.1016/j.ejca.2016.02.028; Palmieri C, 2003, J ENDOCRINOL, V177, P65, DOI 10.1677/joe.0.1770065; Pi-Sunyer X, 2015, NEW ENGL J MED, V373, P11, DOI 10.1056/NEJMoa1411892; Public Health England, NHS BREAST SCREEN PR; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rubin DB, 1987, MULTIPLE IMPUTATION; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Sschafer JL., 1997, ANAL INCOMPLETE MULT, P1006; Tannheimer SL, 2000, BREAST CANCER RES, V2, P311, DOI 10.1186/bcr73; The National Institute of Heath and Care Excellence, 2015, TYP 2 DIAB AD MAN RE; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	38	22	23	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 20	2016	355								i5340	10.1136/bmj.i5340	http://dx.doi.org/10.1136/bmj.i5340			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8KX	27797785	Green Published, hybrid			2022-12-28	WOS:000386120400001
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Essential medicines for universal health coverage	LANCET			English	Editorial Material									[Das, Pamela; Horton, Richard] The Lancet, London EC2Y 5AS, England		Das, P (corresponding author), The Lancet, London EC2Y 5AS, England.				Bill & Melinda Gates Foundation; WHO; University Medical Centre Groningen; Boston University	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); WHO(World Health Organization); University Medical Centre Groningen; Boston University	We thank Veronika Wirtz, Hans Hogerzeil, and Andy Gray for their leadership of the Lancet Commission on Essential Medicines Policies, and commissioners for their contributions to this report. We also thank the Bill & Melinda Gates Foundation, WHO, University Medical Centre Groningen, and Boston University for their financial support, together with the academic and other institutions that have generously allowed colleagues to devote time to the work of the Commission.	[Anonymous], 2015, LANCET, V386, P220; Rubin R, 2016, LANCET, V388, P1266, DOI 10.1016/S0140-6736(16)31708-1; UN, 2015, SUSTAINABLE DEV GOAL; UN Secretary-General and Co-Chairs of the High-Level Panel, 2016, UN SECR GEN HIGH LEV; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Wirtz VJ, 2016, LANCET; Witty A, 2016, LANCET	7	2	2	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 28	2017	389	10067					337	339		10.1016/S0140-6736(16)31907-9	http://dx.doi.org/10.1016/S0140-6736(16)31907-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9CK	27832878				2022-12-28	WOS:000392804700007
J	Kamakura, M				Kamakura, M.			Kamakura replies (vol 537, pg E13, 2016)	NATURE			English	Correction																		Kamakura M, 2016, NATURE, V537, pE13, DOI 10.1038/nature19350	1	0	0	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 15	2016	540	7633								10.1038/nature20163	http://dx.doi.org/10.1038/nature20163			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE6JR	27828946	Bronze			2022-12-28	WOS:000389716800052
J	Barredo, D; de Leseleuc, S; Lienhard, V; Lahaye, T; Browaeys, A				Barredo, Daniel; de Leseleuc, Sylvain; Lienhard, Vincent; Lahaye, Thierry; Browaeys, Antoine			An atom-by-atom assembler of defect-free arbitrary two-dimensional atomic arrays	SCIENCE			English	Article							OPTICAL TWEEZERS; SINGLE ATOMS; QUANTUM	Large arrays of individually controlled atoms trapped in optical tweezers are a very promising platform for quantum engineering applications. However, deterministic loading of the traps is experimentally challenging. We demonstrate the preparation of fully loaded two-dimensional arrays of up to similar to 50 microtraps, each containing a single atom and arranged in arbitrary geometries. Starting from initially larger, half-filled matrices of randomly loaded traps, we obtain user-defined target arrays at unit filling. This is achieved with a real-time control system and a moving optical tweezers, which together enable a sequence of rapid atom moves depending on the initial distribution of the atoms in the arrays. These results open exciting prospects for quantum engineering with neutral atoms in tunable two-dimensional geometries.	[Barredo, Daniel; de Leseleuc, Sylvain; Lienhard, Vincent; Lahaye, Thierry; Browaeys, Antoine] Univ Paris Saclay, CNRS, Inst Opt Grad Sch, Lab Charles Fabry, F-91127 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lahaye, T (corresponding author), Univ Paris Saclay, CNRS, Inst Opt Grad Sch, Lab Charles Fabry, F-91127 Palaiseau, France.	thierry.lahaye@institutoptique.fr	Barredo, Daniel/D-3561-2015; Lahaye, Thierry/E-1551-2017; Browaeys, Antoine/E-1547-2017	Barredo, Daniel/0000-0001-5307-1927; Lahaye, Thierry/0000-0002-2260-9859; Browaeys, Antoine/0000-0001-9941-8869; de Leseleuc, Sylvain/0000-0002-4761-5753	European Union FET-Open Xtrack Project HAIRS; H2020 FET-PROACT Project RySQ; "PALM" Labex (project QUANTICA); Region Ile-de-France in the framework of DIM Nano-K	European Union FET-Open Xtrack Project HAIRS; H2020 FET-PROACT Project RySQ; "PALM" Labex (project QUANTICA); Region Ile-de-France in the framework of DIM Nano-K(Region Ile-de-France)	We thank V. Josse for lending us AODs and H. Labuhn for contributions in the early stage of the experiment. Supported by European Union FET-Open Xtrack Project HAIRS and H2020 FET-PROACT Project RySQ, the "PALM" Labex (project QUANTICA), and the Region Ile-de-France in the framework of DIM Nano-K.	Bakr WS, 2009, NATURE, V462, P74, DOI 10.1038/nature08482; Beguin L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263201; Beugnon J, 2007, NAT PHYS, V3, P696, DOI 10.1038/nphys698; Browaeys A, 2016, J PHYS B-AT MOL OPT, V49, DOI 10.1088/0953-4075/49/15/152001; Ebert M, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.043602; Endres M, 2016, SCIENCE, V354, P1024, DOI 10.1126/science.aah3752; Fung YH, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/7/073011; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Giovannetti V, 2011, NAT PHOTONICS, V5, P222, DOI [10.1038/NPHOTON.2011.35, 10.1038/nphoton.2011.35]; Grunzweig T, 2010, NAT PHYS, V6, P951, DOI 10.1038/NPHYS1778; Haroche S, 2013, REV MOD PHYS, V85, P1083, DOI 10.1103/RevModPhys.85.1083; Isenhower L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010503; Islam R, 2013, SCIENCE, V340, P583, DOI 10.1126/science.1232296; Kaufman AM, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.041014; Kim H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13317; Labuhn H, 2016, NATURE, V534, P667, DOI 10.1038/nature18274; Lee W, 2016, OPT EXPRESS, V24, P9816, DOI 10.1364/OE.24.009816; Lester BJ, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073003; Miroshnychenko Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243003; Miroshnychenko Y, 2006, NATURE, V442, P151, DOI 10.1038/442151a; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Nogrette F, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021034; Piotrowicz MJ, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.013420; Schlosser M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/12/123034; Thompson JD, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.133001; Weiss DS, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.040302; Wineland DJ, 2013, REV MOD PHYS, V85, P1103, DOI 10.1103/RevModPhys.85.1103; Zeiher J, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.031015	30	388	392	8	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 25	2016	354	6315			SI		1021	1023		10.1126/science.aah3778	http://dx.doi.org/10.1126/science.aah3778			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0KQ	27811285	Green Submitted			2022-12-28	WOS:000388531800041
J	Zayed, A				Zayed, Amro			EVOLUTION Insect invasions and natural selection	NATURE			English	Editorial Material							COMPLEMENTARY SEX DETERMINATION; CONSEQUENCES	Observations of a real-time invasion of Australia by Asian honeybees demonstrate how natural selection can allow a small founding population to overcome the genetic odds stacked against success.	[Zayed, Amro] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	York University - Canada	Zayed, A (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada.	zayed@yorku.ca	Zayed, Amro/G-6405-2011	Zayed, Amro/0000-0003-3233-4585				Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Gloag R, 2016, NATURE ECOL EVOL; Harpur BA, 2013, ENTOMOL EXP APPL, V146, P156, DOI 10.1111/j.1570-7458.2012.01306.x; Hasselmann M, 2004, P NATL ACAD SCI USA, V101, P4888, DOI 10.1073/pnas.0307147101; Holway DA, 1998, SCIENCE, V282, P949, DOI 10.1126/science.282.5390.949; Holway DA, 2002, ANNU REV ECOL SYST, V33, P181, DOI 10.1146/annurev.ecolsys.33.010802.150444; Liebert AE, 2005, BIOL LETT-UK, V1, P200, DOI 10.1098/rsbl.2004.0284; PLOWRIGHT RC, 1979, CAN ENTOMOL, V111, P289, DOI 10.4039/Ent111289-3; ROSS KG, 1993, GENETICS, V135, P843; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; WOYKE J, 1979, J APICULT RES, V18, P122, DOI 10.1080/00218839.1979.11099955; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zayed A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000868	14	3	4	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					500	502		10.1038/nature20472	http://dx.doi.org/10.1038/nature20472			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27820944				2022-12-28	WOS:000388520600029
J	Juthani-Mehta, M; Van Ness, PH; Bianco, L; Rink, A; Rubeck, S; Ginter, S; Argraves, S; Charpentier, P; Acampora, D; Trentalange, M; Quagliarello, V; Peduzzi, P				Juthani-Mehta, Manisha; Van Ness, Peter H.; Bianco, Luann; Rink, Andrea; Rubeck, Sabina; Ginter, Sandra; Argraves, Stephanie; Charpentier, Peter; Acampora, Denise; Trentalange, Mark; Quagliarello, Vincent; Peduzzi, Peter			Effect of Cranberry Capsules on Bacteriuria Plus Pyuria Among Older Women in Nursing Homes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							URINARY-TRACT-INFECTIONS; ASYMPTOMATIC BACTERIURIA; ESCHERICHIA-COLI; DOUBLE-BLIND; PREVENTION; REDUCTION; INGESTION; DIAGNOSIS; PRODUCTS; JUICE	IMPORTANCE Bacteriuria plus pyuria is highly prevalent among older women living in nursing homes. Cranberry capsules are an understudied, nonantimicrobial prevention strategy used in this population. OBJECTIVE To test the effect of 2 oral cranberry capsules once a day on presence of bacteriuria plus pyuria among women residing in nursing homes. DESIGN, SETTING, AND PARTICIPANTS Double-blind, randomized, placebo-controlled efficacy trial with stratification by nursing home and involving 185 English-speaking women aged 65 years or older, with or without bacteriuria plus pyuria at baseline, residing in 21 nursing homes located within 50 miles (80 km) of New Haven, Connecticut (August 24, 2012-October 26, 2015). INTERVENTIONS Two oral cranberry capsules, each capsule containing 36 mg of the active ingredient proanthocyanidin (ie, 72 mg total, equivalent to 20 ounces of cranberry juice) vs placebo administered once a day in 92 treatment and 93 control group participants. MAIN OUTCOMES AND MEASURES Presence of bacteriuria (ie, at least 105 colony-forming units [CFUs] per milliliter of 1 or 2 microorganisms in urine culture) plus pyuria (ie, any number of white blood cells on urinalysis) assessed every 2 months over the 1-year study surveillance; any positive finding was considered to meet the primary outcome. Secondary outcomes were symptomatic urinary tract infection (UTI), all-cause death, all-cause hospitalization, all multidrug antibiotic-resistant organisms, antibiotics administered for suspected UTI, and total antimicrobial administration. RESULTS Of the 185 randomized study participants (mean age, 86.4 years [SD, 8.2], 90.3% white, 31.4% with bacteriuria plus pyuria at baseline), 147 completed the study. Overall adherence was 80.1%. Unadjusted results showed the presence of bacteriuria plus pyuria in 25.5%(95% CI, 18.6%-33.9%) of the treatment group and in 29.5%(95% CI, 22.2%-37.9%) of the control group. The adjusted generalized estimating equations model that accounted for missing data and covariates showed no significant difference in the presence of bacteriuria plus pyuria between the treatment group vs the control group (29.1% vs 29.0%; OR, 1.01; 95% CI, 0.61-1.66; P=.98). There were no significant differences in number of symptomatic UTIs (10 episodes in the treatment group vs 12 in the control group), rates of death (17 vs 16 deaths; 20.4 vs 19.1 deaths/100 person-years; rate ratio [RR], 1.07; 95% CI, 0.54-2.12), hospitalization (33 vs 50 admissions; 39.7 vs 59.6 hospitalizations/100 person-years; RR, 0.67; 95% CI, 0.32-1.40), bacteriuria associated with multidrug-resistant gram-negative bacilli (9 vs 24 episodes; 10.8 vs 28.6 episodes/100 person-years; RR, 0.38; 95% CI, 0.10-1.46), antibiotics administered for suspected UTIs (692 vs 909 antibiotic days; 8.3 vs 10.8 antibiotic days/person-year; RR, 0.77; 95% CI, 0.44-1.33), or total antimicrobial utilization (1415 vs 1883 antimicrobial days; 17.0 vs 22.4 antimicrobial days/person-year; RR, 0.76; 95% CI, 0.46-1.25). CONCLUSIONS AND RELEVANCE Among older women residing in nursing homes, administration of cranberry capsules vs placebo resulted in no significant difference in presence of bacteriuria plus pyuria over 1 year.	[Juthani-Mehta, Manisha; Quagliarello, Vincent] Yale Sch Med, Infect Dis Sect, Dept Internal Med, New Haven, CT USA; [Van Ness, Peter H.; Bianco, Luann; Rink, Andrea; Rubeck, Sabina; Ginter, Sandra; Argraves, Stephanie; Charpentier, Peter; Acampora, Denise; Trentalange, Mark] Yale Sch Med, Sect Geriatr, Dept Internal Med, New Haven, CT USA; [Peduzzi, Peter] Yale Sch Publ Hlth, Yale Ctr Analyt Sci, Dept Biostat, New Haven, CT USA	Yale University; Yale University; Yale University	Juthani-Mehta, M (corresponding author), Yale Univ, Infect Dis Sect, Dept Internal Med, Sch Med, POB 208022, New Haven, CT 06520 USA.	manisha.juthani@yale.edu			Claude D. Pepper Older Americans Independence Center [P30 AG021342]; National Institute on Aging, National Institutes of Health [R01 AG041153, K07 AG030093]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021342, K07AG030093, R01AG041153] Funding Source: NIH RePORTER	Claude D. Pepper Older Americans Independence Center; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants P30 AG021342 Claude D. Pepper Older Americans Independence Center, R01 AG041153, and K07 AG030093 all from the National Institute on Aging, National Institutes of Health. Cranberry and placebo capsules used in this study were manufactured and donated by Pharmatoka.	ABRUTYN E, 1994, ANN INTERN MED, V120, P827, DOI 10.7326/0003-4819-120-10-199405150-00003; AVORN J, 1994, JAMA-J AM MED ASSOC, V271, P751, DOI 10.1001/jama.271.10.751; Bianco L, 2012, J AM GERIATR SOC, V60, P1180, DOI 10.1111/j.1532-5415.2012.03976.x; Caljouw MAA, 2014, J AM GERIATR SOC, V62, P103, DOI 10.1111/jgs.12593; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Foxman B, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.04.003; HAVERKORN MJ, 1994, JAMA-J AM MED ASSOC, V272, P590; HOPKINS WJ, 1994, JAMA-J AM MED ASSOC, V272, P588, DOI 10.1001/jama.1994.03520080030023; Howell AB, 1998, NEW ENGL J MED, V339, P1085, DOI 10.1056/NEJM199810083391516; Jepson R, 2013, JAMA-J AM MED ASSOC, V310, P1395, DOI 10.1001/jama.2013.277509; Jepson RG, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001321.pub5; Juthani-Mehta M, 2015, CLIN INFECT DIS, V60, P849, DOI 10.1093/cid/ciu935; Juthani-Mehta M, 2014, JAMA-J AM MED ASSOC, V312, P1687, DOI 10.1001/jama.2014.13554; Juthani-Mehta M, 2010, J AM GERIATR SOC, V58, P2028, DOI 10.1111/j.1532-5415.2010.03080.x; Juthani-Mehta M, 2009, J AM GERIATR SOC, V57, P963, DOI 10.1111/j.1532-5415.2009.02227.x; Lavigne JP, 2008, CLIN MICROBIOL INFEC, V14, P350, DOI 10.1111/j.1469-0691.2007.01917.x; McMurdo MET, 2005, AGE AGEING, V34, P256, DOI 10.1093/ageing/afi101; Mody L, 2014, JAMA-J AM MED ASSOC, V311, P844, DOI 10.1001/jama.2014.303; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; NICOLLE LE, 1987, AM J MED, V83, P27, DOI 10.1016/0002-9343(87)90493-1; Pop-Vicas A, 2009, INFECT CONT HOSP EP, V30, P325, DOI 10.1086/596608; Prior RL, 2010, J SCI FOOD AGR, V90, P1473, DOI 10.1002/jsfa.3966; Rowe TA, 2014, INFECT DIS CLIN N AM, V28, P75, DOI 10.1016/j.idc.2013.10.004; SAS, 2015, SAS QUAL TOOLS US GU; Stone ND, 2012, INFECT CONT HOSP EP, V33, P965, DOI 10.1086/667743; Terris MK, 2001, UROLOGY, V57, P26, DOI 10.1016/S0090-4295(00)00884-0; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; van den Hout WB, 2014, J AM GERIATR SOC, V62, P111, DOI 10.1111/jgs.12595; Wang CH, 2012, ARCH INTERN MED, V172, P988, DOI 10.1001/archinternmed.2012.3004; Wing DA, 2008, J UROLOGY, V180, P1367, DOI 10.1016/j.juro.2008.06.016; Wotton K, 2008, CONTEMP NURSE, V31, P44, DOI 10.5172/conu.673.31.1.44	31	48	48	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 8	2016	316	18					1879	1887		10.1001/jama.2016.16141	http://dx.doi.org/10.1001/jama.2016.16141			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB1MN	27787564	Green Accepted, Bronze			2022-12-28	WOS:000387116500016
J	Harris, M				Harris, Mark			FUNDING Ambitious web fundraising startup fails to meet big goals	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					534	534		10.1126/science.354.6312.534	http://dx.doi.org/10.1126/science.354.6312.534			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811244				2022-12-28	WOS:000386869800012
J	Gorelick, DA				Gorelick, David A.			Judging the Past: How History Should Inform Bioethics	ANNALS OF INTERNAL MEDICINE			English	Letter									[Gorelick, David A.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Gorelick, DA (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.		Gorelick, David/ABF-4941-2021					Lerner BH, 2016, ANN INTERN MED, V164, P553, DOI 10.7326/M15-2642	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					674	675		10.7326/L16-0332	http://dx.doi.org/10.7326/L16-0332			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802466				2022-12-28	WOS:000386908600016
J	Herzer, KR				Herzer, Kurt R.			Moving From Disability to Possibility	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; TIME; ACT		[Herzer, Kurt R.] Johns Hopkins Univ, Sch Med, Training Program, Baltimore, MD 21218 USA	Johns Hopkins University	Herzer, KR (corresponding author), Johns Hopkins Univ, Sch Med, Training Program, Baltimore, MD 21218 USA.	kherzer@jhmi.edu			NIA NIH HHS [R36 AG051727] Funding Source: Medline; NIGMS NIH HHS [T32 GM007309] Funding Source: Medline; T32GM007309-41 Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R36AG051727] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); T32GM007309-41; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		CASSEL EJ, 1982, NEW ENGL J MED, V306, P639, DOI 10.1056/NEJM198203183061104; Gostin LO, 2015, JAMA-J AM MED ASSOC, V313, P2231, DOI 10.1001/jama.2015.6405; Meeks LM, 2015, JAMA-J AM MED ASSOC, V314, P1517, DOI 10.1001/jama.2015.10741; Meeks LM., 2015, GUIDE ASSISTING STUD; Searcy CA, 2015, JAMA-J AM MED ASSOC, V313, P2253, DOI 10.1001/jama.2015.5511; University of California San Francisco, 2015, COAL DIS ACC HLTH SC; Zazove P, 2016, ACAD MED, V91, P979, DOI 10.1097/ACM.0000000000001087	7	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1767	1768		10.1001/jama.2016.9956	http://dx.doi.org/10.1001/jama.2016.9956			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802549	Green Accepted			2022-12-28	WOS:000386569300013
J	Voosen, P				Voosen, Paul			Climate scientists open up their black boxes to scrutiny	SCIENCE			English	News Item																			0	6	6	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					401	402		10.1126/science.354.6311.401	http://dx.doi.org/10.1126/science.354.6311.401			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789819				2022-12-28	WOS:000387684400014
J	Minetti, C; Chalmers, RM; Beeching, NJ; Probert, C; Lamden, K				Minetti, Corrado; Chalmers, Rachel M.; Beeching, Nick J.; Probert, Chris; Lamden, Kenneth			CLINICAL UPDATES Giardiasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; INTESTINAL PARASITIC INFECTIONS; RISK-FACTORS; REFRACTORY GIARDIASIS; WATERBORNE TRANSMISSION; PROTOZOAN PARASITES; SPORADIC GIARDIASIS; LAMBLIA INFECTION; DUODENALIS; OUTBREAKS		[Minetti, Corrado] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Grp, Liverpool, Merseyside, England; [Chalmers, Rachel M.] Singleton Hosp, Publ Hlth Wales Microbiol ABM, Cryptosporidium Reference Unit, Swansea, W Glam, Wales; [Beeching, Nick J.] Univ Liverpool Liverpool Sch Trop Med, Clin Sci Grp, Infect Dis, Liverpool, Merseyside, England; [Probert, Chris] Univ Liverpool, Inst Translat Med, Gastroenterol, Liverpool, Merseyside, England; [Lamden, Kenneth] Wingate Med Ctr, Kirkby L33 6YJ, England	Liverpool School of Tropical Medicine; Singleton Hospital; Liverpool School of Tropical Medicine; University of Liverpool	Lamden, K (corresponding author), Wingate Med Ctr, Kirkby L33 6YJ, England.	kenneth.lamden@gmail.com	Minetti, Corrado/AAR-9931-2021; Beeching, Nicholas J/L-5363-2017	Minetti, Corrado/0000-0001-7862-4874; Beeching, Nicholas/0000-0002-7019-8791; Probert, Christopher/0000-0003-4550-0239				Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; Agarwal S, 2013, CLIN GASTROENTEROL H, V11, P1050, DOI 10.1016/j.cgh.2013.02.024; [Anonymous], 2015, BMJ, DOI DOI 10.1136/BMJ.H1622; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Barrett J, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1937; Breathnach AS, 2010, EPIDEMIOL INFECT, V138, P1459, DOI 10.1017/S0950268810000208; Buret AG, 2008, PARASITE, V15, P261, DOI 10.1051/parasite/2008153261; Chew TS, 2008, SCAND J GASTROENTERO, V43, P1219, DOI 10.1080/00365520802101853; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; Department of Health, 2010, HLTH PROT LEG ENGL G; DEREGNIER DP, 1989, APPL ENVIRON MICROB, V55, P1223, DOI 10.1128/AEM.55.5.1223-1229.1989; Ellam H, 2008, Euro Surveill, V13; Escobedo AA, 2016, ACTA TROP, V162, P196, DOI 10.1016/j.actatropica.2016.06.026; Escobedo AA, 2016, ACTA TROP, V153, P120, DOI 10.1016/j.actatropica.2015.09.023; Escobedo AA, 2014, EXPERT REV ANTI-INFE, V12, P1143, DOI 10.1586/14787210.2014.942283; Escobedo AA, 2014, ACTA TROP, V132, P106, DOI 10.1016/j.actatropica.2013.12.025; Espelage W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-41; Farthing MJG, 1996, GASTROENTEROL CLIN N, V25, P493, DOI 10.1016/S0889-8553(05)70260-0; Fletcher SM, 2012, CLIN MICROBIOL REV, V25, P420, DOI 10.1128/CMR.05038-11; Gagnon F, 2006, INT J ENVIRON HEAL R, V16, P349, DOI 10.1080/09603120600869265; Gardner TB, 2001, CLIN MICROBIOL REV, V14, P114, DOI 10.1128/CMR.14.1.114-128.2001; Gotfred-Rasmussen H, 2016, DIAGN MICR INFEC DIS, V84, P187, DOI 10.1016/j.diagmicrobio.2015.11.005; Granados CE, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007787.pub2; GRAY SF, 1994, EPIDEMIOL INFECT, V113, P95, DOI 10.1017/S0950268800051505; Grazioli B, 2006, WORLD J GASTROENTERO, V12, P1941, DOI 10.3748/wjg.v12.i12.1941; Grit GH, 2012, VET PARASITOL, V184, P330, DOI 10.1016/j.vetpar.2011.08.021; Gutierrez JM, 2013, TRAVEL MED INFECT DI, V11, P126, DOI 10.1016/j.tmaid.2012.10.004; Hanevik K, 2014, CLIN INFECT DIS, V59, P1394, DOI 10.1093/cid/ciu629; HERMASZEWSKI RA, 1993, Q J MED, V86, P31; Heyworth MF, 2014, T ROY SOC TROP MED H, V108, P123, DOI 10.1093/trstmh/tru005; Hill DR, 2001, PRINCIPLES PRACTICE, P219, DOI [DOI 10.1002/0470842504.CH10, 10.1002/0470842504.ch10]; Hoque M. Ekramul, 2002, International Journal of Infectious Diseases, V6, P191, DOI 10.1016/S1201-9712(02)90110-4; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Joint Formulary Committee, 2019, BRIT NATL FORMULARY; Karanis P, 2007, J WATER HEALTH, V5, P1, DOI 10.2166/wh.2006.002; Leitsch David, 2015, Curr Trop Med Rep, V2, P128; Llewellyn S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004380; McGregor AC, 2012, T ROY SOC TROP MED H, V106, P549, DOI 10.1016/j.trstmh.2012.04.008; McHardy IH, 2014, J CLIN MICROBIOL, V52, P712, DOI 10.1128/JCM.02877-13; Meltzer E, 2014, EMERG INFECT DIS, V20, P1742, DOI 10.3201/eid2010.140073; Minetti C, 2015, J CLIN MICROBIOL, V53, P3133, DOI 10.1128/JCM.00715-15; Morch K, 2008, J INFECTION, V56, P268, DOI 10.1016/j.jinf.2008.01.013; Nabarro LEB, 2015, CLIN MICROBIOL INFEC, V21, P791, DOI 10.1016/j.cmi.2015.04.019; NAIMAN HL, 1980, CAN MED ASSOC J, V122, P185; Nash TE, 2001, CLIN INFECT DIS, V33, P22, DOI 10.1086/320886; National Institute for Health and Care Excellence, 2015, CLIN GUID; Nygard K, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-141; Olson ME, 1999, J ENVIRON QUAL, V28, P1991, DOI 10.2134/jeq1999.00472425002800060040x; Painter JE, 2015, MMWR SURVEILL SUMM, V64, P15; Pasupuleti V, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002733; PHLS Advisory Committee on Gastrointestinal Infections, 2004, Commun Dis Public Health, V7, P362; Public Health England, 2013, PHE NAT PAR REF LAB; Public Health England, 2014, PUBL HLTH ENGL; Public Health England, 2014, GIARDIA GUIDANCE AND; RAUCH AM, 1990, PEDIATR INFECT DIS J, V9, P186, DOI 10.1097/00006454-199003000-00008; Roberts L, 2013, CLIN PARASITOLOGY PR, P14; Robertson LJ, 2010, TRENDS PARASITOL, V26, P75, DOI 10.1016/j.pt.2009.11.010; ROSENTHAL P, 1980, J PEDIATR-US, V96, P278, DOI 10.1016/S0022-3476(80)80826-2; Ross AGP, 2013, NEW ENGL J MED, V368, P1817, DOI 10.1056/NEJMra1207777; Ryan U, 2013, INT J PARASITOL, V43, P943, DOI 10.1016/j.ijpara.2013.06.001; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; Smith A, 2006, EPIDEMIOL INFECT, V134, P1141, DOI 10.1017/S0950268806006406; Soares R, 2016, J MICROBIOL METH, V129, P98, DOI 10.1016/j.mimet.2016.08.017; Solaymani-Mohammadi S, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000682; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stuart JM, 2003, EMERG INFECT DIS, V9, P229; Swaminathan A, 2009, J INFECTION, V59, P19, DOI 10.1016/j.jinf.2009.05.008; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; ten Hove RJ, 2009, EUR J CLIN MICROBIOL, V28, P1045, DOI 10.1007/s10096-009-0745-1; van den Bijllaardt W, 2014, CLIN MICROBIOL INFEC, V20, pO972, DOI 10.1111/1469-0691.12626; Verweij JJ, 2011, PARASITOLOGY, V138, P1492, DOI 10.1017/S0031182011001211; Waldram A, 2015, 5 NAT HLTH PROT C; World Health Organization (WHO), 2006, GUID SAF RECR WAT EN, V2	73	31	33	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	2016	355								i5369	10.1136/bmj.i5369	http://dx.doi.org/10.1136/bmj.i5369			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA5LM	27789441	Green Accepted			2022-12-28	WOS:000386662000001
J	Patnode, CD; Henninger, ML; Senger, CA; Perdue, LA; Whitlock, EP				Patnode, Carrie D.; Henninger, Michelle L.; Senger, Caitlyn A.; Perdue, Leslie A.; Whitlock, Evelyn P.			Primary Care Interventions to Support Breastfeeding Updated Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							RANDOMIZED-CONTROLLED-TRIAL; LACTATION CONSULTANT INTERVENTION; PEER SUPPORT; SELF-EFFICACY; ANTENATAL EDUCATION; CLINICAL-TRIALS; BLOOD-PRESSURE; PACIFIER USE; OBESE WOMEN; HOME VISITS	IMPORTANCE Although 80% of infants in the United States start breastfeeding, only 22% are exclusively breastfed up to around 6 months as recommended by a number of professional organizations. OBJECTIVE To systematically review the evidence on the benefits and harms of breastfeeding interventions to support the US Preventive Services Task Force in updating its 2008 recommendation. DATA SOURCES MEDLINE, PubMed, Cumulative Index for Nursing and Allied Health Literature, Cochrane Central Register of Controlled Trials, and PsycINFO for studies published in the English language between January 1, 2008, and September 25, 2015. Studies included in the previous review were re-evaluated for inclusion. Surveillance for new evidence in targeted publications was conducted through January 26, 2016. STUDY SELECTION Review of randomized clinical trials and before-and-after studies with concurrent controls conducted in a developed country that evaluated a primary care-relevant breastfeeding intervention among mothers of full-or near-term infants. Of 211 full-text articles reviewed, 52 studiesmet inclusion criteria. Thirty-one studies were newly identified, and 21 studies were carried forward from the previous review. DATA EXTRACTION AND SYNTHESIS Independent critical appraisal of all provisionally included studies. Data were independently abstracted by one reviewer and confirmed by another. MAIN OUTCOMES AND MEASURES Child and maternal health outcomes, rates and duration of breastfeeding, and harms related to interventions as prespecified before data collection. RESULTS Fifty-two studies (n = 66 757) in 57 publications were included. Six trials (n = 2219) reported inconsistent effects of the interventions on infant health outcomes; no studies reported maternal healthoutcomes. Pooled estimates based on random-effects meta-analyses using the DerSimonian and Laird method indicated beneficial associations between individual-level breastfeeding interventions and any breastfeeding for less than 3 months (risk ratio [RR], 1.07 [95% CI, 1.03-1.11]; 26 studies [n = 11 588]), at 3 to less than 6 months (RR, 1.11 [95% CI, 1.04-1.18]; 23 studies [n = 8942]), and for exclusive breastfeeding for less than 3 months (RR, 1.21 [95% CI, 1.11-1.33]; 22 studies [n = 8246]), 3 to less than 6 months (RR, 1.20 [95% CI, 1.05-1.38]; 18 studies [n = 7027]), and at 6 months (RR, 1.16 [95% CI, 1.02-1.32]; 17 studies [n = 7690]). Absolute differences in the rates of any breastfeeding ranged from 14.1% in favor of the control group to 18.4% in favor of the intervention group. There was no significant association between interventions and breastfeeding initiation (RR, 1.00 [95% CI, 0.99-1.02]; 14 studies [n = 9428]). There was limited mixed evidence of an association between system-level interventions and rates of breastfeeding from well-controlled studies as well as for harms related to breast feeding interventions, including maternal anxiety scores, decreased confidence, and concerns about confidentiality. CONCLUSIONS AND RELEVANCE The updated evidence confirms that breastfeeding support interventions are associated with an increase in the rates of any and exclusive breastfeeding. There are limited well-controlled studies examining the effectiveness of system-level policies and practices on rates of breastfeeding or child health and none for maternal health.	[Patnode, Carrie D.; Henninger, Michelle L.; Senger, Caitlyn A.; Perdue, Leslie A.; Whitlock, Evelyn P.] Kaiser Permanente, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, Portland, OR USA; [Whitlock, Evelyn P.] Patient Ctr Outcomes Res Inst, Washington, DC USA	Kaiser Permanente	Patnode, CD (corresponding author), Kaiser Permanente Northwest, Kaiser Permanente Res Affiliates Evidence Based P, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	carrie.d.patnode@kpchr.org						Abbass-Dick J, 2015, PEDIATRICS, V135, P102, DOI 10.1542/peds.2014-1416; American Academy of Family Physicians, 2012, BREASTFEEDING; Amitay EL, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.1025; Anderson AK, 2005, ARCH PEDIAT ADOL MED, V159, P836, DOI 10.1001/archpedi.159.9.836; Aune D, 2014, NUTR METAB CARDIOVAS, V24, P107, DOI 10.1016/j.numecd.2013.10.028; Bonuck KA, 2005, PEDIATRICS, V116, P1413, DOI 10.1542/peds.2005-0435; Bonuck K, 2014, AM J PUBLIC HEALTH, V104, pS119, DOI 10.2105/AJPH.2013.301360; Bonuck KA, 2006, ARCH PEDIAT ADOL MED, V160, P953, DOI 10.1001/archpedi.160.9.953; Bowatte G, 2015, ACTA PAEDIATR, V104, P85, DOI 10.1111/apa.13151; Bunik M, 2010, ACAD PEDIATR, V10, P21, DOI 10.1016/j.acap.2009.09.014; Calonge N, 2008, ANN INTERN MED, V149, P560, DOI 10.7326/0003-4819-149-8-200810210-00008; Cardwell CR, 2012, DIABETES CARE, V35, P2215, DOI 10.2337/dc12-0438; Carfoot S, 2005, MIDWIFERY, V21, P71, DOI 10.1016/j.midw.2004.09.002; Carlsen EM, 2013, AM J CLIN NUTR, V98, P1226, DOI 10.3945/ajcn.113.059600; Centers for Disease Control (CDC), 2015, BREASTF US CHILDR BO; Chapman DJ, 2013, PEDIATRICS, V131, pE162, DOI 10.1542/peds.2012-0688; Chowdhury R, 2015, ACTA PAEDIATR, V104, P96, DOI 10.1111/apa.13102; Chung M, 2008, INTERVENTIONS PRIMAR; Chung M, 2008, ANN INTERN MED, V149, P565, DOI 10.7326/0003-4819-149-8-200810210-00009; Committee on Health Care for Underserved Women American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V109, P479; Corriveau SK, 2013, PEDIATRICS, V131, P942, DOI 10.1542/peds.2012-1310; Dennis CL, 2002, CAN MED ASSOC J, V166, P21; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Di Meglio G, 2010, BREASTFEED MED, V5, P41, DOI 10.1089/bfm.2009.0016; Di Napoli A, 2004, ACTA PAEDIATR, V93, P1108, DOI [10.1111/j.1651-2227.2004.tb02725.x, 10.1080/08035250410028525]; Edwards RC, 2013, PEDIATRICS, V132, pS160, DOI 10.1542/peds.2013-1021P; Eidelman AI, 2012, PEDIATRICS, V129, pE827, DOI 10.1542/peds.2011-3552; Elliott-Rudder M, 2014, ACTA PAEDIATR, V103, pE11, DOI 10.1111/apa.12434; Forster D, 2004, BIRTH-ISS PERINAT C, V31, P176, DOI 10.1111/j.0730-7659.2004.00302.x; Fu ICY, 2014, BJOG-INT J OBSTET GY, V121, P1673, DOI 10.1111/1471-0528.12884; Gagnon AJ, 2002, PEDIATRICS, V109, P1074, DOI 10.1542/peds.109.6.1074; Gijsbers Barbara, 2006, Pediatric Asthma Allergy & Immunology, V19, P214, DOI 10.1089/pai.2006.19.214; Gouchon S, 2010, NURS RES, V59, P78, DOI 10.1097/NNR.0b013e3181d1a8bc; Graffy J, 2004, BRIT MED J, V328, P26, DOI 10.1136/bmj.328.7430.26; Hartung J, 2001, STAT MED, V20, P3875, DOI 10.1002/sim.1009; Hawkins SS, 2015, PUBLIC HEALTH NUTR, V18, P189, DOI 10.1017/S1368980014000238; Hawkins SS, 2014, ARCH DIS CHILD-FETAL, V99, pF138, DOI 10.1136/archdischild-2013-304842; Henderson A, 2001, BIRTH-ISS PERINAT C, V28, P236, DOI 10.1046/j.1523-536X.2001.00236.x; Hoddinott P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3026; Hopkinson J, 2009, J HUM LACT, V25, P287, DOI 10.1177/0890334409335482; Horta BL, 2015, ACTA PAEDIATR, V104, P30, DOI 10.1111/apa.13133; Howard CR, 2003, PEDIATRICS, V111, P511, DOI 10.1542/peds.111.3.511; Howell EA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.028; Howell EA, 2012, OBSTET GYNECOL, V119, P942, DOI 10.1097/AOG.0b013e318250ba48; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Jenik AG, 2009, J PEDIATR-US, V155, P350, DOI 10.1016/j.jpeds.2009.03.038; Jolly K, 2012, MIDWIFERY, V28, P740, DOI 10.1016/j.midw.2011.08.005; Kellams AL, 2016, J HUM LACT, V32, P152, DOI 10.1177/0890334415599402; Kools EJ, 2005, PREV MED, V40, P60, DOI 10.1016/j.ypmed.2004.05.013; Kramer MS, 2007, CARIES RES, V41, P484, DOI 10.1159/000108596; Kramer MS, 2008, PEDIATRICS, V121, pE435, DOI 10.1542/peds.2007-1248; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kramer MS, 2007, BMJ-BRIT MED J, V335, P815, DOI 10.1136/bmj.39304.464016.AE; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003517.pub2; Kramer MS, 2001, JAMA-J AM MED ASSOC, V286, P322, DOI 10.1001/jama.286.3.322; Kramer MS, 2001, JAMA-J AM MED ASSOC, V285, P413, DOI 10.1001/jama.285.4.413; Kronborg H, 2012, MIDWIFERY, V28, P784, DOI 10.1016/j.midw.2011.08.016; Labarere J, 2005, PEDIATRICS, V115, pE139, DOI 10.1542/peds.2004-1362; Labarere J, 2003, BJOG-INT J OBSTET GY, V110, P847, DOI 10.1111/j.1471-0528.2003.02539.x; LABBOK M, 1990, STUD FAMILY PLANN, V21, P226, DOI 10.2307/1966617; Labbok MH, 2012, BREASTFEED MED, V7, P397, DOI 10.1089/bfm.2012.9975; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lavender T, 2005, BJOG-INT J OBSTET GY, V112, P1047, DOI 10.1111/j.1471-0528.2005.00644.x; Lodge CJ, 2015, ACTA PAEDIATR, V104, P38, DOI 10.1111/apa.13132; MacArthur C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b131; Mattar CN, 2007, OBSTET GYNECOL, V109, P73, DOI 10.1097/01.AOG.0000249613.15466.26; McDonald SJ, 2010, MIDWIFERY, V26, P88, DOI 10.1016/j.midw.2008.03.001; McQueen KA, 2011, JOGNN-J OBST GYN NEO, V40, P35, DOI 10.1111/j.1552-6909.2010.01210.x; Mesters I, 2013, BREASTFEED MED, V8, P23, DOI 10.1089/bfm.2012.0011; Muirhead PE, 2006, BRIT J GEN PRACT, V56, P191; Noel-Weiss J, 2006, JOGNN-J OBST GYN NEO, V35, P349, DOI 10.1111/J.1552-6909.2006.00053.x; Noel-Weiss J, 2006, JOGNN-J OBST GYN NEO, V35, P616, DOI 10.1111/J.1552-6909.2006.00077.x; Nolan A, 2009, JOGNN-J OBST GYN NEO, V38, P430, DOI 10.1111/j.1552-6909.2009.01039.x; Paul IM, 2012, ARCH PEDIAT ADOL MED, V166, P263, DOI 10.1001/archpediatrics.2011.198; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Philipp BL, 2001, PEDIATRICS, V108, P677, DOI 10.1542/peds.108.3.677; Pollard DL, 2011, MATERN CHILD HLTH J, V15, P395, DOI 10.1007/s10995-010-0583-x; Quinlivan JA, 2003, LANCET, V361, P893, DOI 10.1016/S0140-6736(03)12770-5; Reeder JA, 2014, PEDIATRICS, V134, pE700, DOI 10.1542/peds.2013-4146; Sankar MJ, 2015, ACTA PAEDIATR, V104, P3, DOI 10.1111/apa.13147; Stockdale J, 2008, EVIDENCE BASED MIDWI, V6, P76; Su LL, 2007, BMJ-BRIT MED J, V335, P596, DOI 10.1136/bmj.39279.656343.55; U. S. Preventive Services Task Force, 2011, PROC MAN; United Nations Development Programme, 2014, HUM DEV REP 2014 SUS; US Department of Health and Human Services, 2014, HLTH PEOPL 2020 OBJ; US Preventive Services Task Force, 2008, AHRQ PUBLICATION, V08-05124-EF-3; Wallace LM, 2006, MIDWIFERY, V22, P262, DOI 10.1016/j.midw.2005.06.004; Wambach KA, 2011, WESTERN J NURS RES, V33, P486, DOI 10.1177/0193945910380408; Wen LM, 2011, ARCH PEDIAT ADOL MED, V165, P701, DOI 10.1001/archpediatrics.2011.115; Wen LM, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-76; Wong KL, 2014, OBSTET GYNECOL, V124, P961, DOI 10.1097/AOG.0000000000000481; World Health Organization, 2003, UNICEF GLOB STRAT IN; World Health Organization, 2008, IND ASS INF YOUNG CH	93	81	87	2	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1694	1705		10.1001/jama.2016.8882	http://dx.doi.org/10.1001/jama.2016.8882			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ8GB	27784101	Bronze			2022-12-28	WOS:000386107800036
J	Rotter, N; Brenner, RE				Rotter, Nicole; Brenner, Rolf E.			Cartilage rep air across germ layer origins	LANCET			English	Editorial Material							ENGINEERED CARTILAGE; NASAL CHONDROCYTES		[Rotter, Nicole] Univ Ulm, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-89075 Ulm, Germany; [Brenner, Rolf E.] Univ Ulm, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89081 Ulm, Germany	Ulm University; Ulm University	Rotter, N (corresponding author), Univ Ulm, Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, D-89075 Ulm, Germany.	nicole.rotter@uniklinik-ulm.de		Rotter, Nicole/0000-0003-1537-8340				Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; Khan IM, 2008, EUR CELLS MATER, V16, P26, DOI 10.22203/eCM.v016a04; Lee CR, 2000, J ORTHOP RES, V18, P790, DOI 10.1002/jor.1100180517; Lyman S, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.15.00573; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17; Mumme M, 2016, LANCET, V388, P1985, DOI 10.1016/S0140-6736(16)31658-0; Pelttari K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009688; Rotter N, 2002, BIOMATERIALS, V23, P3087, DOI 10.1016/S0142-9612(02)00031-5; Scheithauer MO, 2006, FACIAL PLASTIC RECON, P247; Scotti C, 2012, TISSUE ENG PT A, V18, P362, DOI [10.1089/ten.tea.2011.0234, 10.1089/ten.TEA.2011.0234]; Vinatier C, 2009, J BIOMED MATER RES A, V89A, P176, DOI 10.1002/jbm.a.31988	12	3	3	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1957	1958		10.1016/S0140-6736(16)31892-X	http://dx.doi.org/10.1016/S0140-6736(16)31892-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27789004				2022-12-28	WOS:000385954800004
J	Prandoni, P; Lensing, AWA; Prins, MH; Ciammaichella, M; Perlati, M; Mumoli, N; Bucherini, E; Visona, A; Bova, C; Imberti, D; Campostrini, S; Barbar, S				Prandoni, Paolo; Lensing, Anthonie W. A.; Prins, Martin H.; Ciammaichella, Maurizio; Perlati, Marica; Mumoli, Nicola; Bucherini, Eugenio; Visona, Adriana; Bova, Carlo; Imberti, Davide; Campostrini, Stefano; Barbar, Sofia		PESIT Investigators	Prevalence of Pulmonary Embolism among Patients Hospitalized for Syncope	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							D-DIMER; CLINICAL PROBABILITY; MANAGEMENT; THROMBOEMBOLISM; COMBINATION; CARDIOLOGY; DIAGNOSIS; SOCIETY; RULE; CARE	BACKGROUND The prevalence of pulmonary embolism among patients hospitalized for syncope is not well documented, and current guidelines pay little attention to a diagnostic workup for pulmonary embolism in these patients. METHODS We performed a systematic workup for pulmonary embolism in patients admitted to 11 hospitals in Italy for a first episode of syncope, regardless of whether there were alternative explanations for the syncope. The diagnosis of pulmonary embolism was ruled out in patients who had a low pretest clinical probability, which was defined according to the Wells score, in combination with a negative D-dimer assay. In all other patients, computed tomographic pulmonary angiography or ventilation-perfusion lung scanning was performed. RESULTS A total of 560 patients (mean age, 76 years) were included in the study. A diagnosis of pulmonary embolism was ruled out in 330 of the 560 patients (58.9%) on the basis of the combination of a low pretest clinical probability of pulmonary embolism and negative D- dimer assay. Among the remaining 230 patients, pulmonary embolism was identified in 97 (42.2%). In the entire cohort, the prevalence of pulmonary embolism was 17.3% (95% confidence interval, 14.2 to 20.5). Evidence of an embolus in a main pulmonary or lobar artery or evidence of perfusion defects larger than 25% of the total area of both lungs was found in 61 patients. Pulmonary embolism was identified in 45 of the 355 patients (12.7%) who had an alternative explanation for syncope and in 52 of the 205 patients (25.4%) who did not. CONCLUSIONS Pulmonary embolism was identified in nearly one of every six patients hospitalized for a first episode of syncope.	[Prandoni, Paolo; Lensing, Anthonie W. A.] Univ Padua, Vasc Med Unit, Dept Cardiovasc Sci, Via Giustiniani 2, I-35128 Padua, Italy; [Ciammaichella, Maurizio] San Giovanni Addolorata Hosp, Dept Internal & Emergency Med, Rome, Italy; [Perlati, Marica; Barbar, Sofia] Civic Hosp Camposampiero, Dept Internal & Emergency Med, Camposampiero, Italy; [Mumoli, Nicola] Civic Hosp Livorno, Dept Internal Med, Livorno, Italy; [Bucherini, Eugenio] Civic Hosp Ravenna, Angiol Unit, Ravenna, Italy; [Visona, Adriana] Hosp Castelfranco Veneto, Angiol Unit, Castelfranco Veneto, Italy; [Bova, Carlo] Civic Hosp Cosenza, Dept Internal Med, Cosenza, Italy; [Imberti, Davide] Civic Hosp Piacenza, Dept Internal Med, Piacenza, Italy; [Campostrini, Stefano] Ca Foscari Univ Venice, Dept Econ, Venice, Italy; [Prins, Martin H.] Maastricht Univ, Dept Clin Epidemiol & Technol Assessment, Maastricht, Netherlands	University of Padua; Azienda Ospedaliera San Giovanni Addolorata; ULSS 6 Euganea; Ospedale di Camposampiero; ULSS 2 Marca TV; Ospedale Castelfranco Veneto; Universita Ca Foscari Venezia; Maastricht University	Prandoni, P (corresponding author), Univ Padua, Vasc Med Unit, Dept Cardiovasc Sci, Via Giustiniani 2, I-35128 Padua, Italy.	paoloprandoni@tin.it	Benedetti, Raffaella/ABE-1226-2020; Imberti, Davide/AGB-5049-2022; Mumoli, Nicola/J-4652-2019; Bova, Carlo/AAO-7422-2021	Benedetti, Raffaella/0000-0001-8127-8765; Imberti, Davide/0000-0002-9284-6227; Mumoli, Nicola/0000-0001-7166-5630; Campostrini, Stefano/0000-0002-7113-4458	University of Padua	University of Padua	Supported by institutional research funding from the University of Padua.	Blanc JJ, 2002, EUR HEART J, V23, P815, DOI 10.1053/euhj.2001.2975; Buller HR, 2007, NEW ENGL J MED, V357, P1094; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Castelli R, 2003, VASC MED, V8, P257, DOI 10.1191/1358863x03vm510oa; Del Rosso A, 2008, HEART, V94, P1620, DOI 10.1136/hrt.2008.143123; Jenab Y, 2015, CLIN APPL THROMB-HEM, V21, P772, DOI 10.1177/1076029614540037; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kearon C, 2006, ANN INTERN MED, V144, P812, DOI 10.7326/0003-4819-144-11-200606060-00007; Keller K, 2016, AM J EMERG MED, V34, P1251, DOI 10.1016/j.ajem.2016.03.061; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Koutkia P, 1999, HEART LUNG, V28, P342, DOI 10.1053/hl.1999.v28.a99733; Kruip MJHA, 2002, ARCH INTERN MED, V162, P1631, DOI 10.1001/archinte.162.14.1631; Leclercq MGL, 2003, THROMB HAEMOSTASIS, V89, P97; MEYER G, 1990, EUR J NUCL MED, V17, P315, DOI 10.1007/BF01268022; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Puppala VK, 2014, J CARDIOL, V63, P171, DOI 10.1016/j.jjcc.2013.03.019; Sarasin FP, 2001, AM J MED, V111, P177, DOI 10.1016/S0002-9343(01)00797-5; Saravi M, 2015, CASP J INTERN MED, V6, P233; SIMPSON RJ, 1983, JAMA-J AM MED ASSOC, V249, P390, DOI 10.1001/jama.249.3.390; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Stein PD, 2006, AM J MED, V119, P1048, DOI 10.1016/j.amjmed.2006.05.060; Strickberger SA, 2006, CIRCULATION, V113, P316, DOI 10.1161/CIRCULATIONAHA.105.170274; Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; THAMES MD, 1977, JAMA-J AM MED ASSOC, V238, P2509, DOI 10.1001/jama.238.23.2509; Theilade J, 2010, J THROMB HAEMOST, V8, P1723, DOI 10.1111/j.1538-7836.2010.03922.x; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; Vanbrabant P, 2011, ACTA CLIN BELG, V66, P110, DOI 10.2143/ACB.66.2.2062528; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416	28	125	133	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1524	1531		10.1056/NEJMoa1602172	http://dx.doi.org/10.1056/NEJMoa1602172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ3HF	27797317	Green Published, Bronze			2022-12-28	WOS:000393102500005
J	Ginsburg, O; Badwe, R; Boyle, P; Derricks, G; Dare, A; Evans, T; Eniu, A; Jimenez, J; Kutluk, T; Lopes, G; Mohammed, SI; Qiao, YL; Rashid, SF; Summers, D; Sarfati, D; Temmerman, M; Trimble, EL; Padela, AI; Aggarwal, A; Sullivan, R				Ginsburg, Ophira; Badwe, Rajan; Boyle, Peter; Derricks, Gemma; Dare, Anna; Evans, Tim; Eniu, Alexandru; Jimenez, Jorge; Kutluk, Tezer; Lopes, Gilberto; Mohammed, Sulma I.; Qiao, You-Lin; Rashid, Sabina Faiz; Summers, Diane; Sarfati, Diana; Temmerman, Marleen; Trimble, Edward L.; Padela, Aasim I.; Aggarwal, Ajay; Sullivan, Richard			Changing global policy to deliver safe, equitable, and affordable care for women's cancers	LANCET			English	Article							UNIVERSAL HEALTH COVERAGE; HIGH-INCOME COUNTRIES; BREAST-CANCER; SCREENING PRACTICES; AMERICAN MUSLIMS; DISEASE BURDEN; MORTALITY; MIDDLE; INDIA; AFRICA	Breast and cervical cancer are major threats to the health of women globally, particularly in low-income and middle-income countries. Radical progress to close the global cancer divide for women requires not only evidence-based policy making, but also broad multisectoral collaboration that capitalises on recent progress in the associated domains of women's health and innovative public health approaches to cancer care and control. Such multisectoral collaboration can serve to build health systems for cancer, and more broadly for primary care, surgery, and pathology. This Series paper explores the global health and public policy landscapes that intersect with women's health and global cancer control, with new approaches to bringing policy to action. Cancer is a major global social and political priority, and women's cancers are not only a tractable socioeconomic policy target in themselves, but also an important Trojan horse to drive improved cancer control and care.	[Ginsburg, Ophira] Univ Toronto, Dalla Lana Sch Publ Hlth, Fac Med, Womens Coll Res Inst, Toronto, ON, Canada; [Ginsburg, Ophira; Temmerman, Marleen] WHO, Geneva, Switzerland; [Badwe, Rajan] Tata Mem Hosp, Bombay, Maharashtra, India; [Boyle, Peter] Int Prevent Res Inst, Lyon, France; [Boyle, Peter] Univ Strathclyde, Inst Global Publ Hlth iPRI, Glasgow, Lanark, Scotland; [Derricks, Gemma] Brunel Univ, London, England; [Dare, Anna] Univ Toronto, Ctr Global Hlth Res, Toronto, ON, Canada; [Dare, Anna] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Evans, Tim] World Bank Grp, Hlth Nutr & Populat Global Practice, Washington, DC USA; [Eniu, Alexandru] Canc Inst Ion Chiricuta, Cluj Napoca, Romania; [Jimenez, Jorge] Pontificia Univ Catolica Chile, Santiago, Chile; [Kutluk, Tezer] Hacettepe Univ, Dept Pediat Oncol, Ankara, Turkey; [Lopes, Gilberto] Oncoclin Grp, Sao Paulo, Brazil; [Lopes, Gilberto] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA; [Mohammed, Sulma I.] Purdue Univ, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Mohammed, Sulma I.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Qiao, You-Lin] Chinese Acad Med Sci, Natl Canc Ctr, Dept Canc Epidemiol, Beijing, Peoples R China; [Qiao, You-Lin] Peking Union Med Coll, Beijing, Peoples R China; [Rashid, Sabina Faiz] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Summers, Diane] UNICEF, South Asia Reg Off, Kathmandu, Nepal; [Sarfati, Diana] Univ Otago, Dept Publ Hlth, Wellington, New Zealand; [Temmerman, Marleen] Univ Ghent, Ghent, Belgium; [Temmerman, Marleen] Aga Khan Univ, Nairobi, Kenya; [Trimble, Edward L.] NCI, Ctr Global Hlth, Bethesda, MD 20892 USA; [Padela, Aasim I.] Univ Chicago, Initiat Islam & Med, Chicago, IL 60637 USA; [Padela, Aasim I.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Aggarwal, Ajay] London Sch Hyg & Trop, London, England; [Aggarwal, Ajay; Sullivan, Richard] Kings Hlth Partners, Kings Ctr Global Hlth, Kings Hlth Partners Comprehens Canc Ctr, Inst Canc Policy, London, England; [Aggarwal, Ajay; Sullivan, Richard] Kings Coll London, London, England; Univ Toronto, Womens Coll Hosp, Toronto, ON M5S 1B2, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; World Health Organization; Tata Memorial Centre (TMC); Tata Memorial Hospital; University of Strathclyde; Brunel University; University of Toronto; University of Toronto; The World Bank; Oncology Institute Prof. Dr. Ion Chiricuta; Pontificia Universidad Catolica de Chile; Hacettepe University; University of Miami; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University Bloomington; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of Otago; Ghent University; Aga Khan University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Chicago; University of Chicago; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London; University of Toronto; University Toronto Affiliates; Womens College Hospital	Ginsburg, O (corresponding author), Univ Toronto, Womens Coll Hosp, 75 Grenville St, Toronto, ON M5S 1B2, Canada.	ophira.ginsburg@wchospital.ca	Qiao, You-Lin/B-4139-2012; Eniu, Alexandru/ABD-1687-2020; Trimble, Edward/J-9647-2019; Derrick, Gemma/D-8970-2018; Boyle, Peter/A-4380-2014	Qiao, You-Lin/0000-0001-6380-0871; Eniu, Alexandru/0000-0001-6666-5599; Trimble, Edward/0000-0001-5028-0598; Derrick, Gemma/0000-0001-5386-8653; Rashid, Sabina Faiz/0000-0003-0916-2631; Mohammed, Sulma I/0000-0002-6031-3442; Sullivan, Richard/0000-0002-6435-1825; Aggarwal, Ajay/0000-0001-9645-6659; Ginsburg, Ophira/0000-0002-1384-2675; Boyle, Peter/0000-0001-6251-0610	Canadian Institutes for Health Research; Dalla Lana School of Public Health, University of Toronto; EU Commission [602536]; American Cancer Society [MRSG-14-032-01-CPPB]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Dalla Lana School of Public Health, University of Toronto; EU Commission(European CommissionEuropean Commission Joint Research Centre); American Cancer Society(American Cancer Society)	This work was part funded by Canadian Institutes for Health Research and the Dalla Lana School of Public Health, University of Toronto, and the EU Commission Grant Mapping NCD (no: 602536). OG thanks Ms Sabiha Merchant (Women's College Research Institute, Toronto, ON, Canada) for administrative support. RS thanks the NCI Centre for Global Health for their core support and Dr G Lewison and Miss M Begum for research analysis (Institue of Cancer Policy, King's College London, London, UK). AIP was supported by a Mentored Research Scholar Grant in Applied and Clinical Research (MRSG-14-032-01-CPPB), from the American Cancer Society. The opinions expressed here are those of the authors and do not necessarily represent an official position of the organisations with which they are affiliated.	AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8; Alkire BC, 2015, LANCET GLOB HEALTH, V3, pS21, DOI 10.1016/S2214-109X(15)70088-4; Anderson BO, 2011, LANCET ONCOL, V12, P387, DOI 10.1016/S1470-2045(11)70031-6; [Anonymous], 2012, NAT BIOTECHNOL, V30, P1, DOI 10.1038/nbt.2096; [Anonymous], GEN EQ WOM EMP; Arce-Salinas C, 2012, REV INVEST CLIN, V64, P9; Atun R, 2015, LANCET ONCOL, V16, P1153, DOI 10.1016/S1470-2045(15)00222-3; Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Balabanova D, 2013, LANCET, V381, P2118, DOI 10.1016/S0140-6736(12)62000-5; Balarajan Y, 2011, LANCET, V377, P505, DOI 10.1016/S0140-6736(10)61894-6; Beaglehole R, 2011, LANCET, V378, P449, DOI 10.1016/S0140-6736(11)60879-9; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Canfell K, 2012, VACCINE, V30, pF157, DOI 10.1016/j.vaccine.2012.06.091; Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; Chang MH, 2009, JNCI-J NATL CANCER I, V101, P1348, DOI 10.1093/jnci/djp288; Denny L., 2016, LANCET; Dieleman JL, 2014, HEALTH AFFAIR, V33, P878, DOI 10.1377/hlthaff.2013.1432; Dikshit R, 2012, LANCET, V379, P1807, DOI 10.1016/S0140-6736(12)60358-4; Feldman PH, 2001, GERONTOLOGIST, V41, P312, DOI 10.1093/geront/41.3.312; Frenk J, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-42; Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2; Ginsburg O., 2016, LANCET; Glassman A, PRIORITY SETTING HLT; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Hasnain M, 2014, J WOMENS HEALTH, V23, P602, DOI 10.1089/jwh.2013.4569; Haynes AS, 2011, MILBANK Q, V89, P564, DOI 10.1111/j.1468-0009.2011.00643.x; Riquelme CAH, 2015, REV PANAM SALUD PUBL, V37, P44; Jamison DT, 2013, LANCET, V382, P1898, DOI 10.1016/S0140-6736(13)62105-4; Kidd AD, 2015, CLIN J ONCOL NURS, V19, pE52, DOI 10.1188/15.CJON.E52-E58; Kim JY, 2013, LANCET, V382, P1060, DOI 10.1016/S0140-6736(13)61047-8; Kimman M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0433-1; Kingdon JohnW., 2003, AGENDAS ALTERNATIVES; Lagomarsino G, 2012, LANCET, V380, P933, DOI 10.1016/S0140-6736(12)61147-7; Langer A, 2015, LANCET, V386, P1165, DOI 10.1016/S0140-6736(15)60497-4; Mallath MK, 2014, LANCET ONCOL, V15, pE205, DOI 10.1016/S1470-2045(14)70115-9; Knaul FM, 2012, LANCET, V380, P1259, DOI 10.1016/S0140-6736(12)61068-X; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Mohar A, 2009, SALUD PUBLICA MEXICO, V51, pS263; Padela AI, 2015, J IMMIGR MINOR HEALT, V17, P660, DOI 10.1007/s10903-014-0014-y; Padela AI, 2013, J RELIG HEALTH, V52, P1333, DOI 10.1007/s10943-012-9620-y; Percy-Smith J., 2002, PROMOTING CHANGE RES; Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7; Pramesh CS, 2014, LANCET ONCOL, V15, pE223, DOI 10.1016/S1470-2045(14)70117-2; Puri L., 2015, TRANSFORMATIVE FINAN; Quick Jonathan, 2014, PLoS Med, V11, pe1001580, DOI 10.1371/journal.pmed.1001580; Raffle AE, 2007, BMJ-BRIT MED J, V335, P375, DOI 10.1136/bmj.39273.458322.BE; Research Exercise Framework, 2014, PAN CRIT WORK METH; Roberts I, 2013, LANCET, V381, P2219, DOI 10.1016/S0140-6736(13)60602-9; Rottingen JA, 2013, LANCET, V382, P1286, DOI 10.1016/S0140-6736(13)61046-6; Sachs JD, 2012, LANCET, V380, P944, DOI 10.1016/S0140-6736(12)61149-0; Sancho-Garnier H, 2013, VACCINE, V31, pG51, DOI 10.1016/j.vaccine.2012.06.046; Shaheen M, 2005, ANN EPIDEMIOL, V15, P649; Stenberg K, 2014, LANCET, V383, P1333, DOI 10.1016/S0140-6736(13)62231-X; Strother RM, 2013, J Cancer Policy, V1, pE42, DOI 10.1016/j.jcpo.2013.06.002; Stulac S, 2015, LANCET ONCOL, V16, pE405, DOI 10.1016/S1470-2045(15)00161-8; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Sullivan R, 2011, LANCET ONCOL, V12, P933, DOI 10.1016/S1470-2045(11)70141-3; UN, 2010, EVERY WOMEN EVERY CH; US Health in International Perspective, 2013, SHORT LIV POOR LIV; USAID, 2015, US EV DES HLTH BEN T; Venkatapuram S, 2013, BIOETHICS, V27, P271, DOI 10.1111/j.1467-8519.2011.01953.x; Venkatapuram S, 2009, BIOETHICS, V23, P79, DOI 10.1111/j.1467-8519.2008.00714.x; WEISS CH, 1979, PUBLIC ADMIN REV, V39, P426, DOI 10.2307/3109916; WHO, 2014, COMPR CERV CANC CONT; Wigle J, 2013, VACCINE, V31, P3811, DOI 10.1016/j.vaccine.2013.06.016; Wollum A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0438-9; World Health Organization, 2014, WHO POS PAP MAMM SCR; Youngkong S, 2012, VALUE HEALTH, V15, P961, DOI 10.1016/j.jval.2012.06.006	71	51	53	0	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					871	880		10.1016/S0140-6736(16)31393-9	http://dx.doi.org/10.1016/S0140-6736(16)31393-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	27814964				2022-12-28	WOS:000394966400039
J	Visser, LG; Roukens, AHE				Visser, Leo G.; Roukens, Anna H. E.			Modelling a way out of yellow fever	LANCET			English	Editorial Material							DOSE-RESPONSE; VACCINE; TRIAL		[Visser, Leo G.; Roukens, Anna H. E.] Leiden Univ, Med Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Visser, LG (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands.	l.g.visser@lumc.nl	Visser, Leo/AAH-5755-2021					[Anonymous], 2007, WKLY EPIDEMIOL REC; CIDRAP, WHO LAUNCH YELL FEV; FREESTONE DS, 1977, J BIOL STAND, V5, P181, DOI 10.1016/S0092-1157(77)80003-6; Martins RM, 2013, HUM VACC IMMUNOTHER, V9, P879, DOI 10.4161/hv.22982; Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993; WHO, 2016, YELLOW FEVER; WHO, 2015, YELL FEV IN EL YELL; WHO, 2016, YELL FEV SIT REP; WHO, 2004, INCR RISK URB YELL F; World Health Organization, 2016, FRACT DOS YELL FEV V; Wu JT, 2016, LANCET	11	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2847	2848		10.1016/S0140-6736(16)31330-7	http://dx.doi.org/10.1016/S0140-6736(16)31330-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	27837922				2022-12-28	WOS:000389631700011
J	Makikallio, T; Holm, NR; Lindsay, M; Spence, MS; Erglis, A; Menown, IBA; Trovik, T; Eskola, M; Romppanen, H; Kellerth, T; Ravkilde, J; Jensen, LO; Kalinauskas, G; Linder, RBA; Pentikainen, M; Hervold, A; Banning, A; Zaman, A; Cotton, J; Eriksen, E; Margus, S; Sorensen, HT; Nielsen, PH; Niemela, M; Kervinen, K; Lassen, JF; Maeng, M; Oldroyd, K; Berg, G; Walsh, SJ; Hanratty, CG; Kumsars, I; Stradins, P; Steigen, TK; Frobert, O; Graham, ANJ; Endresen, PC; Corbascio, M; Kajander, O; Trivedi, U; Hartikainen, J; Anttila, V; Hildick-Smith, D; Thuesen, L; Christiansen, EH				Makikallio, Timo; Holm, Niels R.; Lindsay, Mitchell; Spence, Mark S.; Erglis, Andrejs; Menown, Ian B. A.; Trovik, Thor; Eskola, Markku; Romppanen, Hannu; Kellerth, Thomas; Ravkilde, Jan; Jensen, Lisette O.; Kalinauskas, Gintaras; Linder, Rikard B. A.; Pentikainen, Markku; Hervold, Anders; Banning, Adrian; Zaman, Azfar; Cotton, Jamen; Eriksen, Erlend; Margus, Sulev; Sorensen, Henrik T.; Nielsen, Per H.; Niemela, Matti; Kervinen, Kari; Lassen, Jens F.; Maeng, Michael; Oldroyd, Keith; Berg, Geoff; Walsh, Simon J.; Hanratty, Colm G.; Kumsars, Indulis; Stradins, Peteris; Steigen, Terje K.; Frobert, Ole; Graham, Alastair N. J.; Endresen, Petter C.; Corbascio, Matthias; Kajander, Olli; Trivedi, Uday; Hartikainen, Juha; Anttila, Vesa; Hildick-Smith, David; Thuesen, Leif; Christiansen, Evald H.		NOBLE Study Investigators	Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial	LANCET			English	Article							SIROLIMUS-ELUTING STENT; INTRAVASCULAR ULTRASOUND GUIDANCE; CLINICAL-OUTCOMES; 5-YEAR OUTCOMES; SAPHENOUS-VEIN; DES PLATFORMS; FOLLOW-UP; INTERVENTION; DISEASE; SURGERY	Background Coronary artery bypass grafting (CABG) is the standard treatment for revascularisation in patients with left main coronary artery disease, but use of percutaneous coronary intervention (PCI) for this indication is increasing. We aimed to compare PCI and CABG for treatment of left main coronary artery disease. Methods In this prospective, randomised, open-label, non-inferiority trial, patients with left main coronary artery disease were enrolled in 36 centres in northern Europe and randomised 1: 1 to treatment with PCI or CABG. Eligible patients had stable angina pectoris, unstable angina pectoris, or non-ST-elevation myocardial infarction. Exclusion criteria were ST-elevation myocardial infarction within 24 h, being considered too high risk for CABG or PCI, or expected survival of less than 1 year. The primary endpoint was major adverse cardiac or cerebrovascular events (MACCE), a composite of all-cause mortality, non-procedural myocardial infarction, any repeat coronary revascularisation, and stroke. Non-inferiority of PCI to CABG required the lower end of the 95% CI not to exceed a hazard ratio (HR) of 1 . 35 after up to 5 years of follow-up. The intention-to-treat principle was used in the analysis if not specified otherwise. This trial is registered with ClinicalTrials.gov identifier, number NCT01496651. Findings Between Dec 9, 2008, and Jan 21, 2015, 1201 patients were randomly assigned, 598 to PCI and 603 to CABG, and 592 in each group entered analysis by intention to treat. Kaplan-Meier 5 year estimates of MACCE were 29% for PCI (121 events) and 19% for CABG (81 events), HR 1 . 48 (95% CI 1 . 11-1 . 96), exceeding the limit for non-inferiority, and CABG was significantly better than PCI (p=0 . 0066). As-treated estimates were 28% versus 19% (1 . 55, 1 . 18-2 . 04, p= 0 . 0015). Comparing PCI with CABG, 5 year estimates were 12% versus 9% (1 . 07, 0 . 67-1 . 72, p= 0 . 77) for all-cause mortality, 7% versus 2% (2 . 88, 1 . 40-5 . 90, p= 0 . 0040) for non-procedural myocardial infarction, 16% versus 10% (1 . 50, 1 . 04-2 . 17, p= 0 . 032) for any revascularisation, and 5% versus 2% (2 . 25, 0 . 93-5 . 48, p= 0 . 073) for stroke. Interpretation The findings of this study suggest that CABG might be better than PCI for treatment of left main stem coronary artery disease.	[Makikallio, Timo; Niemela, Matti; Kervinen, Kari] Oulu Univ Hosp, Dept Cardiol, Oulu, Finland; [Holm, Niels R.; Lassen, Jens F.; Maeng, Michael; Christiansen, Evald H.] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Lindsay, Mitchell; Oldroyd, Keith; Berg, Geoff] Golden Jubilee Natl Hosp, Dept Cardiol, Clydebank, Scotland; [Spence, Mark S.; Walsh, Simon J.; Hanratty, Colm G.; Graham, Alastair N. J.] Belfast Trust, Belfast Heart Ctr, Belfast, Antrim, North Ireland; [Erglis, Andrejs; Kumsars, Indulis; Stradins, Peteris] Paul Stradins Clin Hosp, Latvia Ctr Cardiol, Riga, Latvia; [Menown, Ian B. A.] Craigavon Cardiac Ctr, Craigavon, North Ireland; [Trovik, Thor; Steigen, Terje K.] Univ Northern Norway, Dept Cardiol, Tromso, Norway; [Endresen, Petter C.] Univ Northern Norway, Dept Cardiovasc Surg, Tromso, Norway; [Eskola, Markku; Kajander, Olli] Tampere Univ Hosp, Heart Hosp, Tampere, Finland; [Romppanen, Hannu; Hartikainen, Juha] Kuopio Univ Hosp, Ctr Heart, Kuopio, Finland; [Kellerth, Thomas; Frobert, Ole] Orebro Univ Hosp, Dept Cardiol, Orebro, Sweden; [Ravkilde, Jan; Thuesen, Leif] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Jensen, Lisette O.] Odense Univ Hosp, Dept Cardiol, Odense, Denmark; [Kalinauskas, Gintaras] Vilnius Univ Hosp, Dept Cardiol, Vilnius, Lithuania; [Linder, Rikard B. A.] Danderyd Hosp, Dept Cardiol, Stockholm, Sweden; [Pentikainen, Markku] Helsinki Univ Hosp, Heart & Lung Ctr, Helsinki, Finland; [Hervold, Anders] Oslo Univ Hosp, Rikshosp, Dept Cardiol, Oslo, Norway; [Banning, Adrian] Oxford Heart Ctr, Oxford, England; [Zaman, Azfar] Freeman Rd Hosp, Dept Cardiol, Newcastle, England; [Zaman, Azfar] Inst Cellular Med, Newcastle, England; [Cotton, Jamen] New Cross Hosp, Heart & Lung Ctr, Wolverhampton, England; [Eriksen, Erlend] Haukeland Hosp, Dept Cardiol, Bergen, Norway; [Margus, Sulev] East Tallinn Hosp, Dept Cardiol, Tallinn, Estonia; [Sorensen, Henrik T.] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Sorensen, Henrik T.] Stanford Univ, Dept Hlth Res & Policy Epidemiol, Stanford, CA USA; [Nielsen, Per H.] Aarhus Univ Hosp, Dept Cardiac Surg, DK-8200 Aarhus N, Denmark; [Corbascio, Matthias] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Anttila, Vesa] Oulu Univ Hosp, Dept Cardiac Surg, Oulu, Finland; [Trivedi, Uday; Hildick-Smith, David] Brighton & Sussex Univ Hosp, Sussex Cardiac Ctr, Brighton, E Sussex, England	University of Oulu; Aarhus University; Golden Jubilee Hospital; Pauls Stradins Clinical University Hospital; Tampere University; Tampere University Hospital; Kuopio University Hospital; University of Eastern Finland; Orebro University; Aalborg University; Aalborg University Hospital; University of Southern Denmark; Odense University Hospital; Vilnius University Hospital Santariskiu Klinikos; Danderyds Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oslo; National Hospital Norway; Newcastle Freeman Hospital; New Cross Hospital; University of Bergen; Haukeland University Hospital; Aarhus University; Stanford University; Aarhus University; Karolinska Institutet; Karolinska University Hospital; University of Oulu; Brighton and Sussex University Hospitals NHS Trust	Christiansen, EH (corresponding author), Aarhus Univ Hosp, Dept Cardiac Surg, DK-8200 Aarhus N, Denmark.		Sorensen, Henrik Toft/Z-6181-2019; Lassen, Jens Flensted/AAY-2127-2021; Stradins, Peteris/AAE-9588-2020; banning, adrian p/AAF-7229-2021; Menown, Ian/AAL-8439-2021; Maeng, Michael/AAY-2135-2021	Sorensen, Henrik Toft/0000-0003-4299-7040; Lassen, Jens Flensted/0000-0001-7972-9192; Stradins, Peteris/0000-0002-7419-6136; Menown, Ian/0000-0001-9971-4350; Maeng, Michael/0000-0002-4310-6433; Holm, Niels/0000-0002-2316-3107; Banning, Adrian/0000-0002-2842-7861; Kumsars, Indulis/0000-0002-7734-8174	Biosensors, Aarhus University Hospital, and participating sites	Biosensors, Aarhus University Hospital, and participating sites	Biosensors, Aarhus University Hospital, and participating sites.	Ahn JM, 2015, J AM COLL CARDIOL, V65, P2198, DOI 10.1016/j.jacc.2015.03.033; Boudriot E, 2011, J AM COLL CARDIOL, V57, P538, DOI 10.1016/j.jacc.2010.09.038; Buszman PE, 2008, J AM COLL CARDIOL, V51, P538, DOI 10.1016/j.jacc.2007.09.054; CAMPEAU L, 1984, NEW ENGL J MED, V311, P1329, DOI 10.1056/NEJM198411223112101; Campos Carlos M, 2015, EuroIntervention, V11 Suppl V, pV115, DOI 10.4244/EIJV11SVA26; Cavalcante R, 2016, J AM COLL CARDIOL, V68, P999, DOI 10.1016/j.jacc.2016.06.024; Chen SL, 2015, JACC-CARDIOVASC INTE, V8, P1335, DOI 10.1016/j.jcin.2015.05.017; Chieffo A, 2005, CIRCULATION, V111, P791, DOI 10.1161/01.CIR.0000155256.88940.F8; Foin N, 2013, EUROINTERVENTION, V8, P1315, DOI 10.4244/EIJV8I11A200; Goldman S, 2004, J AM COLL CARDIOL, V44, P2149, DOI 10.1016/j.jacc.2004.08.064; Jang JS, 2012, AM J CARDIOL, V110, P1411, DOI 10.1016/j.amjcard.2012.06.051; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P562, DOI 10.1161/CIRCINTERVENTIONS.111.964643; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Morice MC, 2014, CIRCULATION, V129, P2388, DOI 10.1161/CIRCULATIONAHA.113.006689; Morice MC, 2010, CIRCULATION, V121, P2645, DOI 10.1161/CIRCULATIONAHA.109.899211; Nakamura S, 1997, J AM COLL CARDIOL, V29, P21, DOI 10.1016/S0735-1097(96)00431-7; Park SJ, 2009, CIRC-CARDIOVASC INTE, V2, P167, DOI 10.1161/CIRCINTERVENTIONS.108.799494; Park SJ, 2005, J AM COLL CARDIOL, V45, P351, DOI 10.1016/j.jacc.2004.10.039; Pyxaras SA, 2016, EUROINTERVENTION, V12, pE623, DOI 10.4244/EIJV12I5A102; Raungaard B, 2015, LANCET, V385, P1527, DOI 10.1016/S0140-6736(14)61794-3; Serruys PW, 2013, JACC-CARDIOVASC INTE, V6, P777, DOI 10.1016/j.jcin.2013.04.011; Serruys PW, 2010, J AM COLL CARDIOL, V55, P1093, DOI 10.1016/j.jacc.2009.11.049; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shand JA, 2014, CATHETER CARDIO INTE, V84, P351, DOI 10.1002/ccd.25265; Shiomi H, 2015, CIRC J, V79, P1282, DOI 10.1253/circj.CJ-15-0034; Sianos Georgios, 2005, EuroIntervention, V1, P219; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Valgimigli M, 2005, CIRCULATION, V111, P1383, DOI 10.1161/01.CIR.0000158486.20865.8B	30	152	155	0	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2743	2752		10.1016/S0140-6736(16)32052-9	http://dx.doi.org/10.1016/S0140-6736(16)32052-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FB	27810312	Green Published, Green Submitted			2022-12-28	WOS:000389629800026
J	Cao, LYL; Riascos-Bernal, DF; Chinnasamy, P; Dunaway, CM; Hou, R; Pujato, MA; O'Rourke, BP; Miskolci, V; Gou, L; Hodgson, L; Fiser, A; Sibinga, NES				Cao, Longyue L.; Riascos-Bernal, Dario F.; Chinnasamy, Prameladevi; Dunaway, Charlene M.; Hou, Rong; Pujato, Mario A.; O'Rourke, Brian P.; Miskolci, Veronika; Gou, Liang; Hodgson, Louis; Fiser, Andras; Sibinga, Nicholas E. S.			Control of mitochondrial function and cell growth by the atypical cadherin Fat1	NATURE			English	Article							STOMATIN-LIKE PROTEIN-2; COMPLEX I; HUMAN INTERACTOME; LIVING CELLS; CANCER-CELLS; GENE; IDENTIFICATION; BIOGENESIS; EXPRESSION; MATRIX	Mitochondrial products such as ATP, reactive oxygen species, and aspartate are key regulators of cellular metabolism and growth. Abnormal mitochondrial function compromises integrated growth-related processes such as development and tissue repair(1,2), as well as homeostatic mechanisms that counteract ageing and neurodegeneration(3), cardiovascular disease(4,5), and cancer(6,7). Physiologic mechanisms that control mitochondrial activity in such settings remain incompletely understood. Here we show that the atypical Fat1 cadherin acts as a molecular 'brake' on mitochondrial respiration that regulates vascular smooth muscle cell (SMC) proliferation after arterial injury. Fragments of Fat1 accumulate in SMC mitochondria, and the Fat1 intracellular domain interacts with multiple mitochondrial proteins, including critical factors associated with the inner mitochondrial membrane. SMCs lacking Fat1 (Fat1(KO)) grow faster, consume more oxygen for ATP production, and contain more aspartate. Notably, expression in Fat1(KO) cells of a modified Fat1 intracellular domain that localizes exclusively to mitochondria largely normalizes oxygen consumption, and the growth advantage of these cells can be suppressed by inhibition of mitochondrial respiration, which suggest that a Fat1-mediated growth control mechanism is intrinsic to mitochondria. Consistent with this idea, Fat1 species associate with multiple respiratory complexes, and Fat1 deletion both increases the activity of complexes I and II and promotes the formation of complex-I-containing supercomplexes. In vivo, Fat1 is expressed in injured human and mouse arteries, and inactivation of SMC Fat1 in mice potentiates the response to vascular damage, with markedly increased medial hyperplasia and neointimal growth, and evidence of higher SMC mitochondrial respiration. These studies suggest that Fat1 controls mitochondrial activity to restrain cell growth during the reparative, proliferative state induced by vascular injury. Given recent reports linking Fat1 to cancer, abnormal kidney and muscle development, and neuropsychiatric disease(8-13), this Fat1 function may have importance in other settings of altered cell growth and metabolism.	[Cao, Longyue L.; Riascos-Bernal, Dario F.; Chinnasamy, Prameladevi; Dunaway, Charlene M.; Hou, Rong; Sibinga, Nicholas E. S.] Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med Cardiol, Bronx, NY 10461 USA; [Cao, Longyue L.; Riascos-Bernal, Dario F.; Chinnasamy, Prameladevi; Dunaway, Charlene M.; Hou, Rong; Sibinga, Nicholas E. S.] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Pujato, Mario A.; Fiser, Andras] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [O'Rourke, Brian P.] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; [Miskolci, Veronika; Hodgson, Louis] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Gou, Liang] CVPath Inst, Gaithersburg, MD 20878 USA; [Hodgson, Louis] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Pujato, Mario A.] St Louis Univ Hosp, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63104 USA; [Pujato, Mario A.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, 3333 Burnet Ave, Cincinnati, OH 45229 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; CVPath Institute; Yeshiva University; Albert Einstein College of Medicine; Saint Louis University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Sibinga, NES (corresponding author), Albert Einstein Coll Med, Wilf Family Cardiovasc Res Inst, Dept Med Cardiol, Bronx, NY 10461 USA.; Sibinga, NES (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA.	nicholas.sibinga@einstein.yu.edu	Sibinga, Nicholas/GOJ-8544-2022	Hodgson, Louis/0000-0001-9188-7580; Guo, Liang/0000-0003-1633-1544; Sibinga, Nicholas/0000-0003-4838-910X; Riascos Bernal, Dario/0000-0002-8790-4699	Diabetes Training and Research Center of Albert Einstein College of Medicine (NIH) [P60DK20541]; Medical Scientist Training Program (NIH) [T32-GM007288]; Cellular, Molecular Biology, and, Genetics Training Grant (NIH) [T32-GM007491]; American Medical Association Seed Grant; American Heart Association [11PRE5450002, 13GRNT16950064]; NIH [CA205262, HL088104, HL104518]; NATIONAL CANCER INSTITUTE [R21CA205262, P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088104, R01HL104518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P60DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491, T32GM007288] Funding Source: NIH RePORTER	Diabetes Training and Research Center of Albert Einstein College of Medicine (NIH); Medical Scientist Training Program (NIH); Cellular, Molecular Biology, and, Genetics Training Grant (NIH); American Medical Association Seed Grant; American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R.N. Kitsis for helpful discussions; A. Jenny for critical reading of the manuscript; X.L. Du for technical help with the Seahorse experiments and for scientific advice; G. Perumal at the Einstein Analytical Imaging Facility for help with electron microscopy imaging; and M.A. Gawinowicz at the Columbia Proteomics laboratory for performing the mass spectrometry analysis. This work was supported by funds from the Diabetes Training and Research Center of Albert Einstein College of Medicine (NIH P60DK20541); funds from the Medical Scientist Training Program (NIH T32-GM007288), Cellular, Molecular Biology, and, Genetics Training Grant (NIH T32-GM007491), and an American Medical Association Seed Grant (all to L.L.C.); from the American Heart Association to D.F.R-B. (pre-doctoral award 11PRE5450002) and to N.E.S.S. (Grant-in-Aid 13GRNT16950064); and from the NIH to L.H. (CA205262) and to N.E.S.S. (HL088104 and HL104518).	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Ahmad T, 2014, EMBO J, V33, P994, DOI 10.1002/embj.201386030; Bereiter-Hahn J, 2014, PROG MOL BIOL TRANSL, V127, P93, DOI 10.1016/B978-0-12-394625-6.00004-0; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Castillejo-Lopez C, 2004, J BIOL CHEM, V279, P24034, DOI 10.1074/jbc.M313878200; Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726; Chen ZF, 1998, J PHARMACOL EXP THER, V285, P608; Christie DA, 2011, MOL CELL BIOL, V31, P3845, DOI 10.1128/MCB.05393-11; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; Cukier HN, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-1; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; Dieteren CEJ, 2008, J BIOL CHEM, V283, P34753, DOI 10.1074/jbc.M807323200; Dikshit B, 2013, ONCOGENE, V32, P3798, DOI 10.1038/onc.2012.393; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Favre C, 2010, ONCOGENE, V29, P3964, DOI 10.1038/onc.2010.146; Fiermonte G, 2002, J BIOL CHEM, V277, P19289, DOI 10.1074/jbc.M201572200; Gee HY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10822; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Gilquin B, 2010, MOL CELL BIOL, V30, P1984, DOI 10.1128/MCB.00007-10; Gnoni GV, 2009, IUBMB LIFE, V61, P987, DOI 10.1002/iub.249; Guarani V, 2014, MOL CELL BIOL, V34, P847, DOI 10.1128/MCB.01551-13; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Ikeda Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/210934; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Karblane K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116702; Kaul SC, 2002, EXP GERONTOL, V37, P1157, DOI 10.1016/S0531-5565(02)00135-3; Krimmer T, 2000, MOL CELL BIOL, V20, P5879, DOI 10.1128/MCB.20.16.5879-5887.2000; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Lepore JJ, 2005, GENESIS, V41, P179, DOI 10.1002/gene.20112; Liu QL, 2001, J BIOL CHEM, V276, P6112, DOI 10.1074/jbc.M009519200; Martinez-Outschoorn U, 2014, SEMIN ONCOL, V41, P195, DOI 10.1053/j.seminoncol.2014.03.002; Matsuzaki H, 2013, BIOCHEM BIOPH RES CO, V433, P322, DOI 10.1016/j.bbrc.2013.02.099; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Merle N, 2012, MITOCHONDRION, V12, P441, DOI 10.1016/j.mito.2012.05.005; Mitsopoulos P, 2015, MOL CELL BIOL, V35, P1838, DOI 10.1128/MCB.00047-15; Miwa S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4837; Morris LGT, 2013, NAT GENET, V45, P253, DOI 10.1038/ng.2538; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Palmieri L, 2001, EMBO J, V20, P5060, DOI 10.1093/emboj/20.18.5060; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Procaccio V, 2000, MAMM GENOME, V11, P808, DOI 10.1007/s003350010160; Puppo F, 2015, HUM MUTAT, V36, P443, DOI 10.1002/humu.22760; Riascos-Bernal DF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12389; Sadeqzadeh E, 2011, J BIOL CHEM, V286, P28181, DOI 10.1074/jbc.M111.234419; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/NMETH.2212, 10.1038/nmeth.2212]; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Sing A, 2014, CELL, V158, P1293, DOI 10.1016/j.cell.2014.07.036; Spiering D, 2013, METHOD CELL BIOL, V114, P593, DOI 10.1016/B978-0-12-407761-4.00025-7; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Waypa GB, 2010, CIRC RES, V106, P526, DOI 10.1161/CIRCRESAHA.109.206334; Yu EPK, 2014, TRENDS ENDOCRIN MET, V25, P481, DOI 10.1016/j.tem.2014.06.008	66	33	33	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 24	2016	539	7630					575	+		10.1038/nature20170	http://dx.doi.org/10.1038/nature20170			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED0GI	27828948	Green Accepted			2022-12-28	WOS:000388520600046
J	Pickles, A; Le Couteur, A; Leadbitter, K; Salomone, E; Cole-Fletcher, R; Tobin, H; Gammer, I; Lowry, J; Vamvakas, G; Byford, S; Aldred, C; Slonims, V; McConachie, H; Howlin, P; Parr, JR; Charman, T; Green, J				Pickles, Andrew; Le Couteur, Ann; Leadbitter, Kathy; Salomone, Erica; Cole-Fletcher, Rachel; Tobin, Hannah; Gammer, Isobel; Lowry, Jessica; Vamvakas, George; Byford, Sarah; Aldred, Catherine; Slonims, Vicky; McConachie, Helen; Howlin, Patricia; Parr, Jeremy R.; Charman, Tony; Green, Jonathan			Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomised controlled trial	LANCET			English	Article							SPECTRUM; QUESTIONNAIRE; INTERVENTIONS; DISORDERS; SEVERITY	Background It is not known whether early intervention can improve long-term autism symptom outcomes. We aimed to follow-up the Preschool Autism Communication Trial (PACT), to investigate whether the PACT intervention had a long-term effect on autism symptoms and continued effects on parent and child social interaction. Methods PACT was a randomised controlled trial of a parent-mediated social communication intervention for children aged 2-4 years with core autism. Follow-up ascertainment was done at three specialised clinical services centres in the UK (London, Manchester, and Newcastle) at a median of 5.75 years (IQR 5.42-5.92) from the original trial endpoint. The main blinded outcomes were the comparative severity score (CSS) from the Autism Diagnostic Observation Schedule (ADOS), the Dyadic Communication Assessment Measure (DCMA) of the proportion of child initiatiations when interacting with the parent, and an expressive-receptive language composite. All analyses followed the intention-to-treat principle. PACT is registered with the ISRCTN registry, number ISRCTN58133827. Findings 121 (80%) of the 152 trial participants (59 [77%] of 77 assigned to PACT intervention vs 62 [83%] of 75 assigned to treatment as usual) were traced and consented to be assessed between July, 2013, and September, 2014. Mean age at follow-up was 10.5 years (SD 0.8). Group difference in favour of the PACT intervention based on ADOS CSS of log-odds effect size (ES) was 0.64 (95% CI 0.07 to 1.20) at treatment endpoint and ES 0.70 (95% CI -0.05 to 1.47) at follow-up, giving an overall reduction in symptom severity over the course of the whole trial and follow-up period (ES 0.55, 95% CI 0.14 to 0.91, p = 0.004). Group difference in DCMA child initiations at follow-up showed a Cohen's d ES of 0.29 (95% CI -0.02 to 0.57) and was significant over the course of the study (ES 0.33, 95% CI 0.11 to 0.57, p = 0.004). There were no group differences in the language composite at follow-up (ES 0.15, 95% CI -0.23 to 0.53). Interpretation The results are the first to show long-term symptom reduction after a randomised controlled trial of early intervention in autism spectrum disorder. They support the clinical value of the PACT intervention and have implications for developmental theory. Copyright (C) The Author(s). Published by Elsevier Ltd.	[Pickles, Andrew; Salomone, Erica; Gammer, Isobel; Vamvakas, George; Byford, Sarah; Howlin, Patricia; Charman, Tony] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Le Couteur, Ann; Cole-Fletcher, Rachel; Lowry, Jessica; McConachie, Helen; Parr, Jeremy R.] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Le Couteur, Ann] Northumberland Tyne & Wear NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Leadbitter, Kathy; Tobin, Hannah; Aldred, Catherine; Green, Jonathan] Univ Manchester, 3-311 Jean MacFarlane Bldg, Manchester M13 9PL, Lancs, England; [Slonims, Vicky] Guys & St Thomas Univ NHS Trust, Evelina London Childrens Hosp, London, England; [Green, Jonathan] Royal Manchester Childrens Hosp, Manchester, Lancs, England; [Green, Jonathan] Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of London; King's College London; Newcastle University - UK; University of Manchester; Royal Manchester Children's Hospital; University of Manchester	Green, J (corresponding author), Univ Manchester, 3-311 Jean MacFarlane Bldg, Manchester M13 9PL, Lancs, England.	jonathan.green@manchester.ac.uk	Charman, Tony/A-2085-2014; Howlin, Patricia/A-7622-2011; Byford, Sarah/D-1699-2010; Pickles, Andrew/A-9625-2011; Salomone, Erica/M-3309-2017	Charman, Tony/0000-0003-1993-6549; Byford, Sarah/0000-0001-7084-1495; Pickles, Andrew/0000-0003-1283-0346; Salomone, Erica/0000-0002-8083-5942; Green, Jonathan/0000-0002-0143-181X; Collum, Rachel/0000-0002-1760-149X; Vamvakas, George/0000-0002-2817-3320; Leadbitter, Kathy/0000-0002-0744-2800; Howlin, Patricia/0000-0002-1804-6053	University of Manchester; Medical Research Council [MR/K005863/1]; UK Department of Health; National Institute for Health Research (NIHR) Biomedical Research Centre at South London; Maudsley NHS Foundation Trust; King's College London; MRC [MR/K005863/1, G0401546] Funding Source: UKRI; Medical Research Council [G0401546] Funding Source: researchfish; National Institute for Health Research [13/119/18] Funding Source: researchfish	University of Manchester; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health; National Institute for Health Research (NIHR) Biomedical Research Centre at South London(National Institute for Health Research (NIHR)); Maudsley NHS Foundation Trust; King's College London(General Electric); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was sponsored by the University of Manchester. The study was principally funded by the Medical Research Council (MR/K005863/1) with additional funding from the UK Department of Health and the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. We gratefully thank all families who participated in the study and the referring professionals.	Aldred C, 2004, J CHILD PSYCHOL PSYC, V45, P1420, DOI 10.1111/j.1469-7610.2004.00338.x; Aldred C, 2012, J AUTISM DEV DISORD, V42, P447, DOI 10.1007/s10803-011-1248-3; Anderson DK, 2013, J CHILD PSYCHOL PSYC, P485; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Brownell R, 2010, RECEPTIVE EXPRESSIVE; Buescher AVS, 2014, JAMA PEDIATR, V168, P721, DOI 10.1001/jamapediatrics.2014.210; Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Estes A, 2015, J AM ACAD CHILD PSY, V54, P580, DOI 10.1016/j.jaac.2015.04.005; Goodman A, 2011, SOC PSYCH PSYCH EPID, V46, P521, DOI 10.1007/s00127-010-0219-x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gotham K, 2012, PEDIATRICS, V130, pE1278, DOI 10.1542/peds.2011-3668; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Green J, 2010, LANCET, V375, P2152, DOI 10.1016/S0140-6736(10)60587-9; Honey E, 2012, RES AUTISM SPECT DIS, V6, P355, DOI 10.1016/j.rasd.2011.06.009; Howlin P, 2009, AJIDD-AM J INTELLECT, V114, P23, DOI [10.1352/2009.114:23-41, 10.1352/2009.114:23;nd41]; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Kaale A, 2014, J AM ACAD CHILD PSY, V53, P188, DOI 10.1016/j.jaac.2013.09.019; Kasari C, 2012, J AM ACAD CHILD PSY, V51, P487, DOI 10.1016/j.jaac.2012.02.019; Lidstone J, 2014, RES AUTISM SPECT DIS, V8, P82, DOI 10.1016/j.rasd.2013.10.001; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2012, LOS ANGELES W PSYCHO; MCEACHIN JJ, 1993, AM J MENT RETARD, V97, P359; National Institute for Health Care Excellence, 2013, AUTISM SPECTRUM DISO; Oono IP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009774.pub2; Pickles A, 2015, J CHILD PSYCHOL PSYC, V56, P162, DOI 10.1111/jcpp.12291; Rutter M., 2003, SOCIAL COMMUNICATION; Sallows GO, 2005, AM J MENT RETARD, V110, P417, DOI 10.1352/0895-8017(2005)110[417:IBTFCW]2.0.CO;2; Semel E., 2006, CLIN EVALUATION LANG, V4th UK ed.; Sparrow SS., 2005, VINELAND ADAPTIVE BE, V2nd ed, DOI [10.1037/t15164-000, DOI 10.1037/T15164-000]; Wolfe R, 1998, STATA TECH B, V42, P24	32	244	249	4	100	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2501	2509		10.1016/S0140-6736(16)31229-6	http://dx.doi.org/10.1016/S0140-6736(16)31229-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC5IA	27793431	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000388166300028
J	Sigafoos, J; Waddington, H				Sigafoos, Jeff; Waddington, Hannah			6 year follow-up supports early autism intervention	LANCET			English	Editorial Material							SPECTRUM; CHILDREN		[Sigafoos, Jeff; Waddington, Hannah] Victoria Univ Wellington, Sch Educ, Wellington 6140, New Zealand	Victoria University Wellington	Sigafoos, J (corresponding author), Victoria Univ Wellington, Sch Educ, Wellington 6140, New Zealand.	jeff.sigafoos@vuw.ac.nz						Dawson G, 2012, J AM ACAD CHILD PSY, V51, P1150, DOI 10.1016/j.jaac.2012.08.018; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Estes A, 2015, J AM ACAD CHILD PSY, V54, P580, DOI 10.1016/j.jaac.2015.04.005; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Green J, 2010, LANCET, V375, P2152, DOI 10.1016/S0140-6736(10)60587-9; Kasari C, 2010, J AUTISM DEV DISORD, V40, P1045, DOI 10.1007/s10803-010-0955-5; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; Pickles A, 2016, LANCET; Spence SJ, 2010, LANCET, V375, P2124, DOI 10.1016/S0140-6736(10)60757-X	9	5	7	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2454	2455		10.1016/S0140-6736(16)31656-7	http://dx.doi.org/10.1016/S0140-6736(16)31656-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EC5IA	27793429	hybrid			2022-12-28	WOS:000388166300006
J	Dijk, DJ; Winsky-Sommerer, R				Dijk, Derk-Jan; Winsky-Sommerer, Raphaelle			Sleepy and dreamless mutant mice	NATURE			English	Editorial Material							CLOCK; REM	Sleep in mammals consists of non-rapid-eye-movement and rapid-eye movement sleep. A large genetic screen reveals that these two sleep states are altered in mice by mutations dubbed Sleepy and Dreamless. SEE ARTICLE p.378	[Dijk, Derk-Jan; Winsky-Sommerer, Raphaelle] Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 7XP, Surrey, England	University of Surrey	Dijk, DJ (corresponding author), Univ Surrey, Surrey Sleep Res Ctr, Guildford GU2 7XP, Surrey, England.	d.j.dijk@surrey.ac.uk; r.winsky-sommerer@surrey.ac.uk						Baylor GW, 2001, SLEEP, V24, P165; Billiard M, 2016, SLEEP MED REV, V29, P23, DOI 10.1016/j.smrv.2015.08.007; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Franken P, 1999, SLEEP, V22, P155; Funato H, 2016, NATURE, V539, P378, DOI 10.1038/nature20142; Krueger JM, 2016, SLEEP MED REV, V28, P46, DOI 10.1016/j.smrv.2015.08.005; Scullin MK, 2015, SLEEP, V38, P335, DOI 10.5665/sleep.4482; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325	10	0	0	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					364	365		10.1038/nature20471	http://dx.doi.org/10.1038/nature20471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27806380				2022-12-28	WOS:000388161700040
J	Wyss-Coray, T				Wyss-Coray, Tony			Ageing, neurodegeneration and brain rejuvenation	NATURE			English	Review							MILD COGNITIVE IMPAIRMENT; ANTIINFLAMMATORY DRUG-USE; ALZHEIMERS-DISEASE; DNA METHYLATION; COMMON VARIANTS; GROWTH-HORMONE; OLDER-ADULTS; AGE; YOUNG; BETA	Although systemic diseases take the biggest toll on human health and well-being, increasingly, a failing brain is the arbiter of a death preceded by a gradual loss of the essence of being. Ageing, which is fundamental to neurodegeneration and dementia, affects every organ in the body and seems to be encoded partly in a blood-based signature. Indeed, factors in the circulation have been shown to modulate ageing and to rejuvenate numerous organs, including the brain. The discovery of such factors, the identification of their origins and a deeper understanding of their functions is ushering in a new era in ageing and dementia research.	[Wyss-Coray, Tony] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; [Wyss-Coray, Tony] VA Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Wyss-Coray, T (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA.; Wyss-Coray, T (corresponding author), VA Palo Alto Hlth Care Syst, Ctr Tissue Regenerat Repair & Restorat, Palo Alto, CA 94304 USA.	twc@stanford.edu	Wyss-Coray, Tony/AAF-3380-2019	Wyss-Coray, Tony/0000-0001-5893-0831	US Department of Veterans Affairs; US National Institute on Aging [AG045034]; NATIONAL INSTITUTE ON AGING [R01AG045034, P50AG047366] Funding Source: NIH RePORTER	US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	I would like to thank T. Montine at Stanford University for his critical reading of the manuscript. This work was supported by the US Department of Veterans Affairs and the US National Institute on Aging (AG045034).	Ash PEA, 2014, BRAIN RES, V1584, P52, DOI 10.1016/j.brainres.2014.05.052; Baht GS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8131; Baird GS, 2012, AM J PATHOL, V180, P446, DOI 10.1016/j.ajpath.2011.10.024; Baker LD, 2012, ARCH NEUROL-CHICAGO, V69, P1420, DOI 10.1001/archneurol.2012.1970; Baruch K, 2013, P NATL ACAD SCI USA, V110, P2264, DOI 10.1073/pnas.1211270110; Britschgi M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.008862; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Caccamo A, 2013, AGING CELL, V12, P370, DOI 10.1111/acel.12057; Castellano JM, 2015, JAMA NEUROL, V72, P1191, DOI 10.1001/jamaneurol.2015.1616; Choi KM, 2007, EUR J ENDOCRINOL, V157, P437, DOI 10.1530/EJE-07-0127; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy MJ, 2013, AGING CELL, V12, P525, DOI 10.1111/acel.12065; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Cote S, 2012, ALZHEIMERS DEMENT, V8, P219, DOI 10.1016/j.jalz.2011.03.012; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Dubois B, 2016, ALZHEIMERS DEMENT, V12, P292, DOI 10.1016/j.jalz.2016.02.002; Elobeid A, 2016, J NEUROPATH EXP NEUR, V75, P316, DOI 10.1093/jnen/nlw002; Erikson GA, 2016, CELL, V165, P1002, DOI 10.1016/j.cell.2016.03.022; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Friedlander AL, 2001, J CLIN ENDOCR METAB, V86, P1496, DOI 10.1210/jc.86.4.1496; Gjoneska E, 2015, NATURE, V518, P365, DOI 10.1038/nature14252; Grabert K, 2016, NAT NEUROSCI, V19, P504, DOI 10.1038/nn.4222; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holmes C, 2011, NEUROLOGY, V77, P212, DOI 10.1212/WNL.0b013e318225ae07; Holmes C, 2009, NEUROLOGY, V73, P768, DOI 10.1212/WNL.0b013e3181b6bb95; Horvath S, 2015, AGING-US, V7, P1130, DOI 10.18632/aging.100859; Horvath S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0649-6; Hu WT, 2012, NEUROLOGY, V79, P897, DOI 10.1212/WNL.0b013e318266fa70; Hye A, 2014, ALZHEIMERS DEMENT, V10, P799, DOI 10.1016/j.jalz.2014.05.1749; Jack CR, 2016, NAT REV NEUROL, V12, P117, DOI 10.1038/nrneurol.2015.251; Jaeger PA, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0095-2; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Kawas CH, 2015, NEUROLOGY, V85, P535, DOI 10.1212/WNL.0000000000001831; Kiddle SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044260; Kim MJ, 2015, J IMMUNOL, V194, P4784, DOI 10.4049/jimmunol.1403158; Lalli MA, 2015, MOL PSYCHIATR, V20, P1294, DOI 10.1038/mp.2015.131; Lambert J. C., NATURE GENET, V45, P1452; Landau SM, 2016, NEUROLOGY, V86, P1377, DOI 10.1212/WNL.0000000000002576; Linnartz B, 2013, GLIA, V61, P37, DOI 10.1002/glia.22359; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lord J, 2014, NAT NEUROSCI, V17, P1138, DOI 10.1038/nn.3792; Lucin KM, 2009, NEURON, V64, P110, DOI 10.1016/j.neuron.2009.08.039; Lunnon K, 2014, NAT NEUROSCI, V17, P1164, DOI 10.1038/nn.3782; Manthripragada AD, 2011, NEUROEPIDEMIOLOGY, V36, P155, DOI 10.1159/000325653; Matteini AM, 2016, AGING CELL, V15, P792, DOI 10.1111/acel.12468; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Middeldorp J., 2016, JAMA NEUROL; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Mrak RE, 1997, J NEUROPATH EXP NEUR, V56, P1269, DOI 10.1097/00005072-199712000-00001; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Newman AB, 2013, EPIDEMIOL REV, V35, P181, DOI 10.1093/epirev/mxs013; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pilling LC, 2016, AGING-US, V8, P547, DOI 10.18632/aging.100930; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Putin E, 2016, AGING-US, V8, P1021, DOI 10.18632/aging.100968; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Salpeter SJ, 2013, DIABETES, V62, P2843, DOI 10.2337/db13-0160; Satoh J, 2014, GENE REGUL SYST BIO, V8, P127, DOI 10.4137/GRSB.S19711; Sattlecker M, 2014, ALZHEIMERS DEMENT, V10, P724, DOI 10.1016/j.jalz.2013.09.016; Schafer MJ, 2016, CELL METAB, V23, P1207, DOI 10.1016/j.cmet.2016.05.023; Sebastiani P, 2013, AGING-US, V5, P653, DOI 10.18632/aging.100594; Shadyab AH, 2015, AGEING RES REV, V19, P1, DOI 10.1016/j.arr.2014.10.005; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Small SA, 2011, NAT REV NEUROSCI, V12, P585, DOI 10.1038/nrn3085; Smith LK, 2015, NAT MED, V21, P932, DOI 10.1038/nm.3898; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Sonntag WE, 2005, AGEING RES REV, V4, P195, DOI 10.1016/j.arr.2005.02.001; Spencer B, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00114; Stern SA, 2014, NEUROPSYCHOPHARMACOL, V39, P2179, DOI 10.1038/npp.2014.69; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; United Nations Department of Economic and Social Affairs Population Division, 2015, STESASERA390 POP DIV; Vanderweyde T, 2012, J NEUROSCI, V32, P8270, DOI 10.1523/JNEUROSCI.1592-12.2012; Vasudevan AR, 2006, J CLIN ENDOCR METAB, V91, P256, DOI 10.1210/jc.2005-1280; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Vlad SC, 2008, NEUROLOGY, V70, P1672, DOI 10.1212/01.wnl.0000311269.57716.63; Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391; Zeng Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21243; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143	97	492	513	13	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					180	186		10.1038/nature20411	http://dx.doi.org/10.1038/nature20411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830812	Green Accepted			2022-12-28	WOS:000387318500028
J	Altschuler, S				Altschuler, Sari			The art of medicine The medical imagination	LANCET			English	Editorial Material									[Altschuler, Sari] Emory Univ, Dept English, Atlanta, GA 30322 USA	Emory University	Altschuler, S (corresponding author), Emory Univ, Dept English, Atlanta, GA 30322 USA.	sari.b.altschuler@emory.edu						Altschuler S., 1894, LANCET, V144, P837; [Anonymous], 1901, LANCET, p[79, 631]; [Anonymous], 1912, LANCET, V179, P179; Foster M, 1878, Br Med J, V1, P559; Foster M., 1899, C BERNARD; Herter CA, 1910, J AMER MED ASSOC, V54, P423; Marcy HO, 1892, JAMA-J AM MED ASSOC, V17, P725; Osler W., 1908, ALABAMA STUDENT OTHE; Rush B., 1812, MED INQUIRIES OBSERV; Rush B, 1981, B RUSHS LECT MIND; Stedman TL, 1911, MED RECORDER, V80, P1030; Wakley T, 1823, LANCET, V1, P1	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2230	2231		10.1016/S0140-6736(16)32080-3	http://dx.doi.org/10.1016/S0140-6736(16)32080-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	EA8MO	27831469				2022-12-28	WOS:000386889300017
J	Beyeler, A				Beyeler, Anna			Parsing reward from aversion	SCIENCE			English	Editorial Material							AMYGDALA; INFORMATION; CIRCUITS; BRAIN		[Beyeler, Anna] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Beyeler, A (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	annabey@gmail.com	Beyeler, Anna/V-9934-2019	/0000-0003-2371-5706				Beyeler A, 2016, NEURON, V90, P348, DOI 10.1016/j.neuron.2016.03.004; Ciocchi S, 2015, SCIENCE, V348, P560, DOI 10.1126/science.aaa3245; Felix-Ortiz AC, 2013, NEURON, V79, P658, DOI 10.1016/j.neuron.2013.06.016; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Luthi A, 2014, NAT NEUROSCI, V17, P1635, DOI 10.1038/nn.3849; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Shabel SJ, 2009, P NATL ACAD SCI USA, V106, P15031, DOI 10.1073/pnas.0905580106; Tye KM, 2012, NAT REV NEUROSCI, V13, P251, DOI 10.1038/nrn3171	11	5	5	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312								10.1126/science.aak9762	http://dx.doi.org/10.1126/science.aak9762			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811259	Bronze			2022-12-28	WOS:000386869800026
J	Gleick, PH				Gleick, Peter H.			WATER Water strategies for the next administration	SCIENCE			English	Editorial Material							CLIMATE-CHANGE		[Gleick, Peter H.] Pacific Inst, Oakland, CA 94612 USA		Gleick, PH (corresponding author), Pacific Inst, Oakland, CA 94612 USA.	pgleick@pipeline.com	Gleick, Peter H/E-5528-2015	Gleick, Peter H/0000-0001-7232-9284				Christian-Smith J., 2011, 21 CENTURY US WATER; Defense Intelligence Agency, 2012, GLOB WAT SEC INT COM; Gleick P., 2013, CLIMATE SCI SERVING, P151; Gleick PH, 2014, WEATHER CLIM SOC, V6, P331, DOI 10.1175/WCAS-D-13-00059.1; Gleick PH, 2010, CLIMATIC CHANGE, V100, P125, DOI 10.1007/s10584-010-9831-8; Hay JE, 2016, WEATHER CLIM EXTREME, V11, P103, DOI 10.1016/j.wace.2015.11.002; Hsiang SM, 2013, SCIENCE, V341, P1212, DOI 10.1126/science.1235367; King CW, 2013, NAT RESOUR J, V53, P117; Maupin MA., 2014, 1405 USGS, DOI [10.3133/cir1405, DOI 10.3133/CIR1405]; McCaffrey S., 2016, INTR UN CONV LAW NON; Melillo J.M., 2014, 3 NATL COMMUNICATION; Moore E., 2013, SUSTAINABLE WATER JO; Murray KE, 2010, ENVIRON POLLUT, V158, P3462, DOI 10.1016/j.envpol.2010.08.009; Stott P, 2016, SCIENCE, V352, P1517, DOI 10.1126/science.aaf7271; U.S. National Water Commission, 1973, NEW DIR US WAT POL S; UNICEF, 2015, PROGR SAN DRINK WAT	16	28	31	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					555	556		10.1126/science.aaj2221	http://dx.doi.org/10.1126/science.aaj2221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA8FD	27811257				2022-12-28	WOS:000386869800024
J	Mayor, S				Mayor, Susan			Over a third of children aged 10-11 in England are overweight or obese	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS Digital, 2016, NAT CHILD MEAS PROGR	1	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2016	355								i5948	10.1136/bmj.i5948	http://dx.doi.org/10.1136/bmj.i5948			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4DC	27815251				2022-12-28	WOS:000387318900007
J	McCarthy, M				McCarthy, Michael			Soda tax brings sharp fall in sugary drink consumption in Californian city	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							EXCISE TAX											Colchero MA, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6704; Ecorys, 2014, FOOD TAX THEIR IMP C; Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362	3	6	6	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 4	2016	355								i5940	10.1136/bmj.i5940	http://dx.doi.org/10.1136/bmj.i5940			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB4DC	27815249				2022-12-28	WOS:000387318900006
J	Cembrowski, MS; Spruston, N				Cembrowski, Mark S.; Spruston, Nelson			Illuminating the Neuronal Architecture Underlying Context in Fear Memory	CELL			English	Editorial Material							BRAIN	Context plays a foundational role in determining how to interpret potentially fear-producing stimuli, yet the precise neurobiological substrates of context are poorly understood. In this issue of Cell, Xu et al. elegantly show that parallel neuronal circuits are necessary for two distinct roles of context in fear conditioning.	[Cembrowski, Mark S.; Spruston, Nelson] Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA	Howard Hughes Medical Institute	Cembrowski, MS (corresponding author), Howard Hughes Med Inst, Janelia Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	cembrowskim@janelia.hhmi.org	Cembrowski, Mark/V-7083-2019	Spruston, Nelson/0000-0003-3118-1636				Ciocchi S, 2015, SCIENCE, V348, P560, DOI 10.1126/science.aaa3245; Gross CT, 2012, NAT REV NEUROSCI, V13, P651, DOI 10.1038/nrn3301; Hardy J., 1895, THE DENHAM TRACTS; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Okuyama T, 2016, SCIENCE, V353, P1536, DOI 10.1126/science.aaf7003; Pitkanen A, 2000, ANN NY ACAD SCI, V911, P369; Urcelay GP, 2014, BEHAV PROCESS, V104, P2, DOI 10.1016/j.beproc.2014.02.008; Xu C, 2016, CELL, V167, P961, DOI 10.1016/j.cell.2016.09.051	10	2	2	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					888	889		10.1016/j.cell.2016.10.035	http://dx.doi.org/10.1016/j.cell.2016.10.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814516	Bronze			2022-12-28	WOS:000389469000006
J	Pappalardo, JL; Hafler, DA				Pappalardo, Jenna L.; Hafler, David A.			The Human Functional Genomics Project: Understanding Generation of Diversity	CELL			English	Editorial Material							CYTOKINE PRODUCTION; MICROBIOME	Generation of biologic diversity is a cornerstone of immunity, yet the tools to investigate the causal influence of genetic and environmental factors have been greatly limited. Studies from the Human Functional Genomics Project, presented in Cell and other Cell Press journals, integrate environmental and genetic factors with the direction and magnitude of immune responses to decipher inflammatory disease pathogenesis.	[Pappalardo, Jenna L.; Hafler, David A.] Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Pappalardo, Jenna L.; Hafler, David A.] Yale Sch Med, Dept Neurol, New Haven, CT 06520 USA	Yale University; Yale University	Hafler, DA (corresponding author), Yale Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Hafler, DA (corresponding author), Yale Sch Med, Dept Neurol, New Haven, CT 06520 USA.	david.hafler@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007019] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aguirre-Gamboa R., 2016, CELL REPORTS; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Housley WJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9223; Krintel SB, 2012, PHARMACOGENET GENOM, V22, P577, DOI 10.1097/FPC.0b013e3283544043; Li Y, 2016, CELL, V167, P1099, DOI 10.1016/j.cell.2016.10.017; Oosting M, 2016, CELL HOST MICROBE; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; ter Horst R, 2016, CELL, V167, P1111, DOI 10.1016/j.cell.2016.10.018; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Vatanen T, 2016, CELL, V165, P842, DOI 10.1016/j.cell.2016.04.007	11	9	9	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					894	896		10.1016/j.cell.2016.10.040	http://dx.doi.org/10.1016/j.cell.2016.10.040			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814519	Bronze			2022-12-28	WOS:000389469000009
J	Scully, EP; Earp, BE; Miller, AL; Loscalzo, J				Scully, Eileen P.; Earp, Brandon E.; Miller, Amy L.; Loscalzo, Joseph			Just a Cut	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VIBRIO-VULNIFICUS; IN-VITRO; INFECTIONS; MANAGEMENT		[Scully, Eileen P.; Miller, Amy L.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Earp, Brandon E.] Brigham & Womens Hosp, Dept Orthoped, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Miller, AL (corresponding author), 75 Francis St, Boston, MA 02115 USA.	almiller@partners.org	Earp, Brandon/AAF-6760-2019; Loscalzo, Joseph/ABD-8980-2021	Earp, Brandon/0000-0002-7983-3325; 				[Anonymous], 2011, NAT ENT DIS SURV COV; Bishop GB, 2013, J HAND SURG-AM, V38A, P2208, DOI 10.1016/j.jhsa.2013.08.094; Chiang Shyh-Ren, 2003, Journal of Microbiology Immunology and Infection, V36, P81; Daniels NA, 2011, CLIN INFECT DIS, V52, P788, DOI 10.1093/cid/ciq251; Hlady WG, 1996, J INFECT DIS, V173, P1176, DOI 10.1093/infdis/173.5.1176; Huang KC, 2008, J INFECTION, V57, P290, DOI 10.1016/j.jinf.2008.07.009; Oliver JD, 2005, EPIDEMIOL INFECT, V133, P383, DOI 10.1017/S0950268805003894; Ramiro S, 2014, ANN RHEUM DIS, V73, P529, DOI 10.1136/annrheumdis-2013-204575; ROLAND FP, 1970, NEW ENGL J MED, V282, P1306, DOI 10.1056/NEJM197006042822306; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; TACKET CO, 1984, J INFECT DIS, V149, P558, DOI 10.1093/infdis/149.4.558; Tang HJ, 2002, ANTIMICROB AGENTS CH, V46, P3580, DOI 10.1128/AAC.46.11.3580-3584.2002; Tang HJ, 2010, JPN J INFECT DIS, V63, P16	13	2	5	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1780	1786		10.1056/NEJMcps1512793	http://dx.doi.org/10.1056/NEJMcps1512793			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB0BB	27806242				2022-12-28	WOS:000387007300013
J	Heath, I				Heath, Iona			How medicine has exploited rationality at the expense of humanity: an essay by Iona Heath	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH											Auden WH, 1938, THE POETS TONGUE; Cassell EJ, 1991, NATURE SUFFERING GOA; Eliot G., 1982, DANIEL DERONDA; Eliot TS., 1950, WHAT IS CLASSIC ADDR; FEINSTEIN AR, 1994, ANN INTERN MED, V120, P799, DOI 10.7326/0003-4819-120-9-199405010-00012; Greenhalgh T, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i563; Heaney S., 1995, REDRESS POETRY OXFOR, P146; Kleinman A, 1988, ILLNESS NARRATIVES S; Mike V, 1999, EVAL HEALTH PROF, V22, P3, DOI 10.1177/01632789922034149; Mol Annemarie, 2008, LOGIC CARE HLTH PROB, DOI DOI 10.4324/9780203927076; Sackett DL, 2002, CAN MED ASSOC J, V167, P363; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Shapin S, 2000, BRIT MED J, V321, P1580, DOI 10.1136/bmj.321.7276.1580; Winters Y., 1937, PRIMITIVISM DECADENC	14	16	16	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2016	355								i5705	10.1136/bmj.i5705	http://dx.doi.org/10.1136/bmj.i5705			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CP	27802938				2022-12-28	WOS:000387317200002
J	Wise, J				Wise, Jacqui			Daylight saving is linked to depression, Danish study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hansen BT, 2017, EPIDEMIOLOGY, V28, P346, DOI 10.1097/EDE.0000000000000580	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 1	2016	355								i5857	10.1136/bmj.i5857	http://dx.doi.org/10.1136/bmj.i5857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CP	27803014				2022-12-28	WOS:000387317200007
J	Poole, R				Poole, Rochelle			Bullied out of research	SCIENCE			English	Editorial Material												SciCareerEditor@aaas.org							0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					514	514		10.1126/science.354.6311.514	http://dx.doi.org/10.1126/science.354.6311.514			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789844				2022-12-28	WOS:000387684400046
J	Powers, SW; Coffey, CS; Chamberlin, LA; Ecklund, DJ; Klingner, EA; Yankey, JW; Korbee, LL; Porter, LL; Hershey, AD				Powers, Scott W.; Coffey, Christopher S.; Chamberlin, Leigh A.; Ecklund, Dixie J.; Klingner, Elizabeth A.; Yankey, Jon W.; Korbee, Leslie L.; Porter, Linda L.; Hershey, Andrew D.		CHAMP Investigators	Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHARMACOLOGICAL-TREATMENT; ADOLESCENT MIGRAINE; PREVENTION CHAMP; CHILDHOOD; HEADACHE; PREVALENCE; DISABILITY; EFFICACY; CHILDREN; AGE	BACKGROUND Which, medication, if any, to use to prevent the headache of pediatric migraine has not been established. METHODS We conducted a randomized, double-blind, placebo-controlled trial of amitriptyline (1 mg per kilogram of body weight per day), topiramate (2 mg per kilogram per day), and placebo in children and adolescents 8 to 17 years of age with migraine. Patients were randomly assigned in a 2: 2: 1 ratio to receive one of the medications or placebo. The primary outcome was a relative reduction of 50% or more in the number of headache days in the comparison of the 28-day baseline period with the last 28 days of a 24-week trial. Secondary outcomes were headache-related disability, headache days, number of trial completers, and serious adverse events that emerged during treatment. RESULTS A total of 361 patients underwent randomization, and 328 were included in the primary efficacy analysis (132 in the amitriptyline group, 130 in the topiramate group, and 66 in the placebo group). The trial was concluded early for futility after a planned interim analysis. There were no significant between-group differences in the primary outcome, which occurred in 52% of the patients in the amitriptyline group, 55% of those in the topiramate group, and 61% of those in the placebo group (amitriptyline vs. placebo, P = 0.26; topiramate vs. placebo, P = 0.48; amitriptyline vs. topiramate, P = 0.49). There were also no significant between-group differences in headache-related disability, headache days, or the percentage of patients who completed the 24-week treatment period. Patients who received amitriptyline or topiramate had higher rates of several adverse events than those receiving placebo, including fatigue (30% vs. 14%) and dry mouth (25% vs. 12%) in the amitriptyline group and paresthesia (31% vs. 8%) and weight loss (8% vs. 0%) in the topiramate group. Three patients in the amitriptyline group had serious adverse events of altered mood, and one patient in the topiramate group had a suicide attempt. CONCLUSIONS There were no significant differences in reduction in headache frequency or headache-related disability in childhood and adolescent migraine with amitriptyline, topiramate, or placebo over a period of 24 weeks. The active drugs were associated with higher rates of adverse events. (Funded by the National Institutes of Health; CHAMP ClinicalTrials.gov number, NCT01581281).	[Powers, Scott W.; Hershey, Andrew D.] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH 45221 USA; [Powers, Scott W.; Chamberlin, Leigh A.] Cincinnati Childrens Hosp Med Ctr, Div Behav Med & Clin Psychol, Cincinnati, OH 45229 USA; [Korbee, Leslie L.] Cincinnati Childrens Hosp Med Ctr, Off Clin & Translat Res, Cincinnati, OH 45229 USA; [Hershey, Andrew D.] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Coffey, Christopher S.; Ecklund, Dixie J.; Klingner, Elizabeth A.; Yankey, Jon W.] Univ Iowa, Dept Biostat, Clin Trials Stat & Data Management Ctr, Iowa City, IA USA; [Porter, Linda L.] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Powers, SW (corresponding author), Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave,MLC 7039, Cincinnati, OH 45229 USA.	scott.powers@cchmc.org	Hershey, Andrew D./K-1245-2019	Hershey, Andrew D./0000-0002-1598-7536; Powers, Scott/0000-0002-5348-9650	National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK059973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS076788, U01NS077108] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institutes of Health; CHAMP ClinicalTrials.gov number, NCT01581281).	ABUAREFEH I, 1994, BRIT MED J, V309, P765, DOI 10.1136/bmj.309.6957.765; [Anonymous], 2015, NINDS COMMON DATA EL; Arruda MA, 2013, JAMA PEDIATR, V167, P300, DOI 10.1001/jamapediatrics.2013.1105; Bille B, 1997, CEPHALALGIA, V17, P488, DOI 10.1046/j.1468-2982.1997.1704488.x; Cormier S, 2016, PAIN, V157, P329, DOI 10.1097/j.pain.0000000000000379; El-Chammas K, 2013, JAMA PEDIATR, V167, P250, DOI 10.1001/jamapediatrics.2013.508; Evers S, 2009, CEPHALALGIA, V29, P436, DOI 10.1111/j.1468-2982.2008.01752.x; Faria V, 2014, J PEDIATR-US, V165, P659, DOI 10.1016/j.jpeds.2014.06.040; Gioia GA, 2000, CHILD NEUROPSYCHOL, V6, P235, DOI 10.1076/chin.6.3.235.3152; Hershey AD, 2001, NEUROLOGY, V57, P2034, DOI 10.1212/WNL.57.11.2034; Hershey AD, 2013, HEADACHE, V53, P799, DOI 10.1111/head.12105; Hershey AD, 2010, LANCET NEUROL, V9, P190, DOI 10.1016/S1474-4422(09)70303-5; KOVACS M, 1981, ACTA PAEDOPSYCHIATR, V46, P305; Lewis D, 2004, NEUROLOGY, V63, P2215, DOI 10.1212/01.WNL.0000147332.41993.90; Lewis DW, 2005, HEADACHE, V45, P786, DOI 10.1111/j.1526-4610.2005.05050.x; Powers SW, 2016, HEADACHE, V56, P859, DOI 10.1111/head.12810; Powers SW, 2003, PEDIATRICS, V112, pE1, DOI 10.1542/peds.112.1.e1; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Rizzoli P, 2014, HEADACHE, V54, P364, DOI 10.1111/head.12273; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; STEWART WF, 1992, JAMA-J AM MED ASSOC, V267, P64, DOI 10.1001/jama.267.1.64; STEWART WF, 1991, AM J EPIDEMIOL, V134, P1111, DOI 10.1093/oxfordjournals.aje.a116014; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	25	188	188	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 12	2017	376	2					115	124		10.1056/NEJMoa1610384	http://dx.doi.org/10.1056/NEJMoa1610384			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EI0XI	27788026	Green Accepted			2022-12-28	WOS:000392198400006
J	Rodriguez, F; Harrington, RA				Rodriguez, Fatima; Harrington, Robert A.			Cholesterol, Cardiovascular Risk, Statins, PCSK9 Inhibitors, and the Future of LDL-C Lowering	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPY		[Rodriguez, Fatima; Harrington, Robert A.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Harrington, Robert A.] Stanford Univ, Dept Med, 300 Pasteur Dr,S-102,MC 5110, Stanford, CA 94305 USA	Stanford University; Stanford University	Harrington, RA (corresponding author), Stanford Univ, Dept Med, 300 Pasteur Dr,S-102,MC 5110, Stanford, CA 94305 USA.	robert.harrington@stanford.edu						Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Buyse M, 1998, BIOMETRICS, V54, P1014, DOI 10.2307/2533853; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Lloyd-Jones DM, 2016, J AM COLL CARDIOL, V68, P92, DOI 10.1016/j.jacc.2016.03.519; Rodriguez F, 2015, AM J CARDIOL, V115, P190, DOI 10.1016/j.amjcard.2014.10.021; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002	9	14	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 15	2016	316	19					1967	1968		10.1001/jama.2016.16575	http://dx.doi.org/10.1001/jama.2016.16575			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB8XC	27838727				2022-12-28	WOS:000387673800008
J	Hochkirch, A				Hochkirch, Axel			The insect crisis we can't ignore	NATURE			English	Editorial Material									[Hochkirch, Axel] IUCN SSC Invertebrate Conservat Subcomm, Gland, Switzerland; [Hochkirch, Axel] IUCN SSC Grasshopper Specialist Grp, Gland, Switzerland; [Hochkirch, Axel] Univ Trier, D-54286 Trier, Germany	Universitat Trier	Hochkirch, A (corresponding author), IUCN SSC Invertebrate Conservat Subcomm, Gland, Switzerland.; Hochkirch, A (corresponding author), IUCN SSC Grasshopper Specialist Grp, Gland, Switzerland.; Hochkirch, A (corresponding author), Univ Trier, D-54286 Trier, Germany.	hochkirch@uni-trier.de	Hochkirch, Axel/A-4092-2008	Hochkirch, Axel/0000-0002-4475-0394					0	41	45	1	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					141	141		10.1038/539141a	http://dx.doi.org/10.1038/539141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB4CZ	27830820				2022-12-28	WOS:000387318500004
J	Jaffe, S				Jaffe, Susan			Clinton versus Trump on health care	LANCET			English	Editorial Material																			0	0	0	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2223	2223		10.1016/S0140-6736(16)32116-X	http://dx.doi.org/10.1016/S0140-6736(16)32116-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EA8MO	27825495				2022-12-28	WOS:000386889300012
J	Gage, R				Gage, Rusty			How Old Brains Got New Neurons	CELL			English	Editorial Material																			0	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					875	879		10.1016/j.cell.2016.10.041	http://dx.doi.org/10.1016/j.cell.2016.10.041			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814512	Bronze			2022-12-28	WOS:000389469000002
J	Okamoto, H				Okamoto, Hitoshi			For Motor Adjustments, Serotonin Steps In	CELL			English	Editorial Material								To adapt to their environment, animals subconsciously calculate how motor commands can be efficiently translated into the actual movements. Kawashima et al. discovered that serotonergic neurons in the dorsal raphe nucleus regulate the transient memory of such efficacy; thus, successive behaviors do not require repeated cumbersome readjustment of efficacy.	[Okamoto, Hitoshi] RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3511098, Japan	RIKEN	Okamoto, H (corresponding author), RIKEN, Brain Sci Inst, 2-1 Hirosawa, Wako, Saitama 3511098, Japan.	hitoshi@brain.riken.jp	Okamoto, Hitoshi/P-9767-2015	Okamoto, Hitoshi/0000-0002-7512-8549				Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; Dayan P, 2015, ELIFE, V4, DOI 10.7554/eLife.07390; Kawashima T, 2016, CELL, V167, P933, DOI 10.1016/j.cell.2016.09.055; Pezzulo G, 2015, PROG NEUROBIOL, V134, P17, DOI 10.1016/j.pneurobio.2015.09.001; Portugues R, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00072; Sumbre G, 2008, NATURE, V456, P102, DOI 10.1038/nature07351	6	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					886	887		10.1016/j.cell.2016.10.037	http://dx.doi.org/10.1016/j.cell.2016.10.037			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814515	Bronze			2022-12-28	WOS:000389469000005
J	Zhao, LD; Lo, SH; Zhang, YS; Sun, H; Tan, GJ; Uher, C; Wolverton, C; Dravid, VP; Kanatzidis, MG				Zhao, Li-Dong; Lo, Shih-Han; Zhang, Yongsheng; Sun, Hui; Tan, Gangjian; Uher, Ctirad; Wolverton, C.; Dravid, Vinayak P.; Kanatzidis, Mercouri G.			The intrinsic thermal conductivity of SnSe Reply	NATURE			English	Letter							ENHANCED THERMOELECTRIC PERFORMANCE; POLYCRYSTALLINE SNSE; TRANSPORT-PROPERTIES; ELECTRICAL-TRANSPORT; COMPOSITES; OXIDATION; IMPACT		[Zhao, Li-Dong; Tan, Gangjian; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Lo, Shih-Han; Zhang, Yongsheng; Wolverton, C.; Dravid, Vinayak P.; Kanatzidis, Mercouri G.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Sun, Hui] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA; [Uher, Ctirad] Univ Michigan, Dept Phys, Ann Arbor, MI 48109 USA	Northwestern University; Northwestern University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kanatzidis, MG (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.; Kanatzidis, MG (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.	m-kanatzidis@northwestern.edu	Tan, Gangjian/AAG-5433-2019; Zhao, Li-Dong/B-1045-2019; Wolverton, Chris/AAZ-3899-2020; Wolverton, Christopher/B-7542-2009; Dravid, Vinayak/B-6688-2009	Tan, Gangjian/0000-0002-9087-4048; Zhao, Li-Dong/0000-0003-1247-4345; 				Bera T., 2016, PREPRINT; Chen CL, 2014, J MATER CHEM A, V2, P11171, DOI 10.1039/c4ta01643b; Chen YX, 2016, ADV FUNCT MATER, V26, P6836, DOI 10.1002/adfm.201602652; Chere EK, 2016, J MATER CHEM A, V4, P1848, DOI 10.1039/c5ta08847j; de Kergommeaux A, 2012, J AM CHEM SOC, V134, P11659, DOI 10.1021/ja3033313; Fu YJ, 2016, J MATER CHEM C, V4, P1201, DOI 10.1039/c5tc03652f; Ge ZH, 2015, J SOLID STATE CHEM, V225, P354, DOI 10.1016/j.jssc.2015.01.004; Gharsallah M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26774; Guan XH, 2015, J ALLOY COMPD, V643, P116, DOI 10.1016/j.jallcom.2015.04.073; Guo HF, 2016, J ALLOY COMPD, V689, P87, DOI 10.1016/j.jallcom.2016.07.291; Han YM, 2015, J MATER CHEM A, V3, P4555, DOI 10.1039/c4ta06955b; Ju H, 2016, CERAM INT, V42, P9550, DOI 10.1016/j.ceramint.2016.03.035; Kim JH, 2016, J ALLOY COMPD, V682, P785, DOI 10.1016/j.jallcom.2016.04.308; Kucek V, 2016, J ELECTRON MATER, V45, P2943, DOI 10.1007/s11664-016-4415-7; Leng HQ, 2016, RSC ADV, V6, P9112, DOI 10.1039/c5ra19469e; Leng HQ, 2016, J ELECTRON MATER, V45, P527, DOI 10.1007/s11664-015-4143-4; Li Y, 2016, J ALLOY COMPD, V669, P224, DOI 10.1016/j.jallcom.2016.01.258; Li YW, 2016, J MATER CHEM C, V4, P2047, DOI 10.1039/c5tc04202j; Li YL, 2015, ENERGIES, V8, P6275, DOI 10.3390/en8076275; Morales Ferreiro J., APPL THERM IN PRESS; Peng KL, 2016, ENERG ENVIRON SCI, V9, P454, DOI 10.1039/c5ee03366g; Popuri SR, 2016, J MATER CHEM C, V4, P1685, DOI 10.1039/c6tc00204h; Sassi S, 2015, MATER TODAY-PROC, V2, P690, DOI 10.1016/j.matpr.2015.05.093; Sassi S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4880817; Serrano-Sanchez F, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4913260; Singh NK, 2016, J ALLOY COMPD, V668, P152, DOI 10.1016/j.jallcom.2016.01.190; Sist M, 2016, ACTA CRYSTALLOGR B, V72, P310, DOI 10.1107/S2052520616003334; Tyagi K, 2016, RSC ADV, V6, P11562, DOI 10.1039/c5ra23742d; Wang X, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4942890; Wei P.-C., 2016, NATURE, V539; Wei TR, 2016, J AM CHEM SOC, V138, P8875, DOI 10.1021/jacs.6b04181; Wei TR, 2015, PHYS CHEM CHEM PHYS, V17, P30102, DOI 10.1039/c5cp05510e; Zhang Q, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500360; Zhao LD, 2016, ENERG ENVIRON SCI, V9, P3044, DOI 10.1039/c6ee01755j; Zhao LD, 2016, SCIENCE, V351, P141, DOI 10.1126/science.aad3749; Zhao LD, 2014, NATURE, V508, P373, DOI 10.1038/nature13184	36	8	8	4	211	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					E2	E3		10.1038/nature19833	http://dx.doi.org/10.1038/nature19833			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OJ	27808182				2022-12-28	WOS:000386670100002
J	Choo, EK; Feldstein, SW; Lovejoy, TI				Choo, Esther K.; Feldstein, Sarah W.; Lovejoy, Travis I.			Opioids Out, Cannabis In Negotiating the Unknowns in Patient Care for Chronic Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Choo, Esther K.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, 3181 SW Sam Jackson Pk Rd,HRC 11D47, Portland, OR 97239 USA; [Feldstein, Sarah W.; Lovejoy, Travis I.] Oregon Hlth & Sci Univ, Dept Psychiat, Portland, OR 97201 USA; [Lovejoy, Travis I.] VA Portland Hlth Care Syst, Ctr Improve Vet Involvement Care, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Portland Health Care System	Choo, EK (corresponding author), Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, 3181 SW Sam Jackson Pk Rd,HRC 11D47, Portland, OR 97239 USA.	chooe@ohsu.edu		Choo, Esther/0000-0001-8847-5745	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA023658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA031881] Funding Source: NIH RePORTER; Veterans Affairs [IK2HX001516] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA023658] Funding Source: Medline; NIDA NIH HHS [K23 DA031881] Funding Source: Medline; HSRD VA [IK2 HX001516] Funding Source: Medline; 3R01AA023658-02S1 Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); HSRD VA; 3R01AA023658-02S1		[Anonymous], 2016, COMMUNICATION; Department of Health and Human Services, 2016, OP EP NUMB; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Hayes MJ, 2014, JAMA INTERN MED, V174, P1673, DOI 10.1001/jamainternmed.2014.2716; Powell D, 2015, DO MED MARIJUANA LAW; Rahn B, QUALIFYING CONDITION; Whiting PF, 2015, JAMA-J AM MED ASSOC, V313, P2456, DOI 10.1001/jama.2015.6358; Ziemianski D, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0335-0	8	35	35	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 1	2016	316	17					1763	1764		10.1001/jama.2016.13677	http://dx.doi.org/10.1001/jama.2016.13677			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA4GP	27802551	Green Accepted			2022-12-28	WOS:000386569300011
J	Matthys, J				Matthys, Jan			Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults	ANNALS OF INTERNAL MEDICINE			English	Letter							PHARYNGITIS		[Matthys, Jan] Univ Ghent, Ghent, Belgium	Ghent University	Matthys, J (corresponding author), Univ Ghent, Ghent, Belgium.							Harris AM, 2016, ANN INTERN MED, V164, P425, DOI 10.7326/M15-1840; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; Matthys J, 2015, ANN INTERN MED, V162, P876, DOI 10.7326/L15-5099; Scottish Intercollegiate Guidelines Network, 2010, SORE THROAT OTHER PO; Spurling GKP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004417.pub4	5	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					673	674		10.7326/L16-0283	http://dx.doi.org/10.7326/L16-0283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802462				2022-12-28	WOS:000386908600014
J	Childs, BG; Baker, DJ; Wijshake, T; Conover, CA; Campisi, J; van Deursen, JM				Childs, Bennett G.; Baker, Darren J.; Wijshake, Tobias; Conover, Cheryl A.; Campisi, Judith; van Deursen, Jan M.			Senescent intimal foam cells are deleterious at all stages of atherosclerosis	SCIENCE			English	Article							SMOOTH-MUSCLE-CELLS; KNOCKOUT MICE; PLAQUE VULNERABILITY; CELLULAR SENESCENCE; APOPTOSIS; PATHOGENESIS; MECHANISMS; MACROPHAGE; CLEARANCE; FEATURES	Advanced atherosclerotic lesions contain senescent cells, but the role of these cells in atherogenesis remains unclear. Using transgenic and pharmacological approaches to eliminate senescent cells in atherosclerosis-prone low-density lipoprotein receptor-deficient (Ldlr(-/-)) mice, we show that these cells are detrimental throughout disease pathogenesis. We find that foamy macrophages with senescence markers accumulate in the subendothelial space at the onset of atherosclerosis, where they drive pathology by increasing expression of key atherogenic and inflammatory cytokines and chemokines. In advanced lesions, senescent cells promote features of plaque instability, including elastic fiber degradation and fibrous cap thinning, by heightening metalloprotease production. Together, these results demonstrate that senescent cells are key drivers of atheroma formation and maturation and suggest that selective clearance of these cells by senolytic agents holds promise for the treatment of atherosclerosis.	[Childs, Bennett G.; van Deursen, Jan M.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Baker, Darren J.; Wijshake, Tobias; van Deursen, Jan M.] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Wijshake, Tobias] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, NL-9713 AV Groningen, Netherlands; [Conover, Cheryl A.] Mayo Clin, Div Endocrinol Metab & Nutr, Rochester, MN 55905 USA; [Campisi, Judith] Buck Inst Res Aging, Novato, CA 94945 USA; [Campisi, Judith] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Mayo Clinic; Mayo Clinic; University of Groningen; Mayo Clinic; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	van Deursen, JM (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.; van Deursen, JM (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA.	vandeursen.jan@mayo.edu		Baker, Darren/0000-0001-9006-1939; Wijshake, Tobias/0000-0003-1784-2100	Paul F. Glenn Foundation; NIH [R01CA96985, CA168709]; NATIONAL CANCER INSTITUTE [R01CA168709, R01CA166347, R01CA096985] Funding Source: NIH RePORTER	Paul F. Glenn Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R.-M. Laberge and M. Demaria for sharing data on the senolytic properties of ABT263, as well as N. David, Y. Poon, M. Hofker, B. van de Sluis, and the van Deursen lab for helpful discussions. This work was supported by a grant from the Paul F. Glenn Foundation (to J.M.v.D. and D.J.B.) and NIH grants R01CA96985 and CA168709 (to J.M.v.D.). J.M.v.D. and J.C. are cofounders of Unity Biotechnology, a company developing senolytic medicines including small molecules that selectively eliminate senescent cells. J.M.v.D., D.J.B., B.G.C., and J.C. are co-inventors on patent applications licensed to or filed by Unity Biotechnology. The p16-3MR mice are available from J.C. under a material transfer agreement. INK-ATTAC and INK-NTR mice are available from J.M.v.D. under a material transfer agreement.	Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Clarke MCH, 2006, NAT MED, V12, P1075, DOI 10.1038/nm1459; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Ghaderian SMH, 2010, CORONARY ARTERY DIS, V21, P330, DOI 10.1097/MCA.0b013e32833ce065; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; Khanna AK, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-66; Kuo CL, 2011, ARTERIOSCL THROM VAS, V31, P2483, DOI 10.1161/ATVBAHA.111.234492; Maldonado N, 2012, AM J PHYSIOL-HEART C, V303, pH619, DOI 10.1152/ajpheart.00036.2012; Mercer J, 2005, CIRC RES, V96, P667, DOI 10.1161/01.RES.0000161069.15577.ca; Minamino T, 2002, CIRCULATION, V105, P1541, DOI 10.1161/01.CIR.0000013836.85741.17; Munoz-Espin D, 2014, NAT REV MOL CELL BIO, V15, P482, DOI 10.1038/nrm3823; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Sakakura K, 2013, HEART LUNG CIRC, V22, P399, DOI 10.1016/j.hlc.2013.03.001; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Silvestre-Roig C, 2014, CIRC RES, V114, P214, DOI 10.1161/CIRCRESAHA.114.302355; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Wang JL, 2015, CIRCULATION, V132, P1909, DOI 10.1161/CIRCULATIONAHA.115.016457; Wang JC, 2012, CIRC RES, V111, P245, DOI 10.1161/CIRCRESAHA.111.261388; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Wouters K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032440	27	579	609	17	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					472	477		10.1126/science.aaf6659	http://dx.doi.org/10.1126/science.aaf6659			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789842	Green Submitted, Green Accepted			2022-12-28	WOS:000387684400043
J	Guiot, J; Cramer, W				Guiot, Joel; Cramer, Wolfgang			Climate change: The 2015 Paris Agreement thresholds and Mediterranean basin ecosystems	SCIENCE			English	Article							DROUGHT; NICHE; VARIABILITY; FUTURE	The United Nations Framework Convention on Climate Change Paris Agreement of December 2015 aims to maintain the global average warming well below 2 degrees C above the preindustrial level. In the Mediterranean basin, recent pollen-based reconstructions of climate and ecosystem variability over the past 10,000 years provide insights regarding the implications of warming thresholds for biodiversity and land-use potential. We compare scenarios of climate-driven future change in land ecosystems with reconstructed ecosystem dynamics during the past 10,000 years. Only a 1.5 degrees C warming scenario permits ecosystems to remain within the Holocene variability. At or above 2 degrees C of warming, climatic change will generate Mediterranean land ecosystem changes that are unmatched in the Holocene, a period characterized by recurring precipitation deficits rather than temperature anomalies.	[Guiot, Joel] Aix Marseille Univ, Coll France, Ecosyst Continentaux & Risques Environm ECCOREV, CNRS,IRD,CEREGE, Aix En Provence, France; [Cramer, Wolfgang] Aix Marseille Univ, Avignon Univ, CNRS, IMBE,IRD, F-13545 Aix En Provence, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; PSL Research University Paris; College de France; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Guiot, J (corresponding author), Aix Marseille Univ, Coll France, Ecosyst Continentaux & Risques Environm ECCOREV, CNRS,IRD,CEREGE, Aix En Provence, France.	guiot@cerege.fr	Cramer, Wolfgang/B-8221-2008; Guiot, Joel/G-7818-2011	Cramer, Wolfgang/0000-0002-9205-5812; Guiot, Joel/0000-0001-7345-4466	Labex OT-Med [ANR-11-LABEX-0061]; "Investissements d'Avenir" French government project of the French National Research Agency (ANR); AMidex [11-IDEX-0001-02]; European Union FP7-ENVIRONMENT project OPERAs [308393]	Labex OT-Med; "Investissements d'Avenir" French government project of the French National Research Agency (ANR)(French National Research Agency (ANR)); AMidex(French National Research Agency (ANR)); European Union FP7-ENVIRONMENT project OPERAs	The authors are members of the Observatoire des Sciences de l'Univers Pytheas Institute and the ECCOREV network. This research has been funded by Labex OT-Med (project ANR-11-LABEX-0061), the "Investissements d'Avenir" French government project of the French National Research Agency (ANR), AMidex (project 11-IDEX-0001-02), and the European Union FP7-ENVIRONMENT project OPERAs (grant 308393). We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups (table S2) for producing and making their model outputs available. For CMIP, the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led the development of software infrastructure, in partnership with the Global Organization for Earth System Science Portals. R. Suarez and S. Shi have extracted and preprocessed the model simulations. Holocene climate reconstructions are available at http://database.otmed.fr/geonetworkotmed/srv/eng/search - |54b9bf34-57ae-45ea-b455-9f90351e538f. Future climate projections are available at http://cmip-pcmdi.llnl.gov/cmip5/.	Cook BI, 2016, J GEOPHYS RES-ATMOS, V121, P2060, DOI 10.1002/2015JD023929; Cramer W, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P979; Guiot J, 2015, FRONT EARTH SC-SWITZ, V3, DOI 10.3389/feart.2015.00028; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Kaniewski D, 2012, P NATL ACAD SCI USA, V109, P3862, DOI 10.1073/pnas.1116304109; Keenan T, 2011, GLOBAL CHANGE BIOL, V17, P565, DOI 10.1111/j.1365-2486.2010.02254.x; Kelley CP, 2015, P NATL ACAD SCI USA, V112, P3241, DOI 10.1073/pnas.1421533112; Knapp AB, 2016, AM J ARCHAEOL, V120, P99, DOI 10.3764/aja.120.1.0099; Maiorano L, 2011, PHILOS T R SOC B, V366, P2681, DOI 10.1098/rstb.2011.0121; MEDAIL F, 2004, HOTSPOTS REVISITED E, P144, DOI DOI 10.1111/J.1365-2699.2008.02051.X; Middleton G, 2012, J ARCHAEOL RES, V20, P257, DOI 10.1007/s10814-011-9054-1; Roberts N, 2011, HOLOCENE, V21, P3, DOI 10.1177/0959683610388058; Roumieux C., 2010, Ecologia Mediterranea, V36, P17; Schleussner C. F., 2015, EARTH SYST DYN DISCU, V6, P2447, DOI DOI 10.5194/ESDD-6-2447-2015; Seneviratne SI, 2016, NATURE, V529, P477, DOI 10.1038/nature16542; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Weninger B., DOC PRAEHIST, V36, P7; Xoplaki E, 2004, CLIM DYNAM, V23, P63, DOI 10.1007/s00382-004-0422-0; Yackulic CB, 2015, ECOLOGY, V96, P16, DOI 10.1890/14-1361.1	19	158	161	4	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					465	468		10.1126/science.aah5015	http://dx.doi.org/10.1126/science.aah5015			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789841	Green Published			2022-12-28	WOS:000387684400041
J	Moisseiev, E; Yiu, G				Moisseiev, Elad; Yiu, Glenn			Retinal detachment in severe myopia	LANCET			English	Editorial Material									[Moisseiev, Elad; Yiu, Glenn] Univ Calif Davis, Dept Ophthalmol & Vis Sci, Sacramento, CA 95817 USA	University of California System; University of California Davis	Yiu, G (corresponding author), Univ Calif Davis, Dept Ophthalmol & Vis Sci, Sacramento, CA 95817 USA.	gyiu@ucdavis.edu	Yiu, Glenn/AAF-2858-2020	Yiu, Glenn/0000-0003-3061-3310					0	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1133	1133		10.1016/S0140-6736(16)31407-6	http://dx.doi.org/10.1016/S0140-6736(16)31407-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	27817867				2022-12-28	WOS:000396408700029
J	Schillinger, D; Tran, J; Mangurian, C; Kearns, C				Schillinger, Dean; Tran, Jessica; Mangurian, Christina; Kearns, Cristin			Do Sugar-Sweetened Beverages Cause Obesity and Diabetes? Industry and the Manufacture of Scientific Controversy	ANNALS OF INTERNAL MEDICINE			English	Letter							SCIENCE		[Schillinger, Dean; Tran, Jessica; Mangurian, Christina; Kearns, Cristin] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Schillinger, Dean; Tran, Jessica; Mangurian, Christina] Zuckerberg San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94110 USA; [Kearns, Cristin] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA; [Kearns, Cristin] Univ Calif San Francisco, Sch Dent, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Schillinger, D (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.; Schillinger, D (corresponding author), Zuckerberg San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94110 USA.				NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE007306] Funding Source: NIH RePORTER; NIDCR NIH HHS [T32 DE007306] Funding Source: Medline; NIDDK NIH HHS [P30 DK098722, P30 DK092924, T32 DK007418] Funding Source: Medline; NIMH NIH HHS [K23 MH093689] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Lesser LI, 2007, PLOS MED, V4, P41, DOI 10.1371/journal.pmed.0040005; Mandrioli D, 2016, PLOS ONE, V11, DOI [10.1371/Journal.none.0162198, DOI 10.1371/JOURNAL.NONE.0162198]; Nestle M, 2016, JAMA INTERN MED, V176, P13, DOI 10.1001/jamainternmed.2015.6667; Schillinger D, 2016, JAMA-J AM MED ASSOC, V316, P1545, DOI 10.1001/jama.2016.10516; Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990	5	38	38	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 20	2016	165	12					895	897		10.7326/L16-0534	http://dx.doi.org/10.7326/L16-0534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG7OJ	27802504	Green Accepted			2022-12-28	WOS:000391236900035
J	Schmitt, M; Wenzel, M; Bottcher, F; Ferrier-Barbut, I; Pfau, T				Schmitt, Matthias; Wenzel, Matthias; Boettcher, Fabian; Ferrier-Barbut, Igor; Pfau, Tilman			Self-bound droplets of a dilute magnetic quantum liquid	NATURE			English	Article							HELIUM NANODROPLETS	Self-bound many-body systems are formed through a balance of attractive and repulsive forces and occur in many physical scenarios. Liquid droplets are an example of a self-bound system, formed by a balance of the mutual attractive and repulsive forces that derive from different components of the inter-particle potential. It has been suggested(1,2) that self-bound ensembles of ultracold atoms should exist for atom number densities that are 10(8) times lower than in a helium droplet, which is formed from a dense quantum liquid. However, such ensembles have been elusive up to now because they require forces other than the usual zero-range contact interaction, which is either attractive or repulsive but never both. On the basis of the recent finding that an unstable bosonic dipolar gas can be stabilized by a repulsive many-body term(3), it was predicted that three-dimensional self-bound quantum droplets of magnetic atoms should exist(4,5). Here we report the observation of such droplets in a trap-free levitation field. We find that this dilute magnetic quantum liquid requires a minimum, critical number of atoms, below which the liquid evaporates into an expanding gas as a result of the quantum pressure of the individual constituents. Consequently, around this critical atom number we observe an interaction-driven phase transition between a gas and a self-bound liquid in the quantum degenerate regime with ultracold atoms. These droplets are the dilute counterpart of strongly correlated self-bound systems such as atomic nuclei(6) and helium droplets(7).	[Schmitt, Matthias; Wenzel, Matthias; Boettcher, Fabian; Ferrier-Barbut, Igor; Pfau, Tilman] Univ Stuttgart, Phys Inst 5, Pfaffenwaldring 57, D-70550 Stuttgart, Germany; [Schmitt, Matthias; Wenzel, Matthias; Boettcher, Fabian; Ferrier-Barbut, Igor; Pfau, Tilman] Univ Stuttgart, Ctr Integrated Quantum Sci & Technol, Pfaffenwaldring 57, D-70550 Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Schmitt, M; Pfau, T (corresponding author), Univ Stuttgart, Phys Inst 5, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.; Schmitt, M; Pfau, T (corresponding author), Univ Stuttgart, Ctr Integrated Quantum Sci & Technol, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.	m.schmitt@physik.uni-stuttgart.de; t.pfau@physik.uni-stuttgart.de	Pfau, Tilman/G-1774-2011; Ferrier-Barbut, Igor/J-8759-2016	Pfau, Tilman/0000-0003-3272-3468; Ferrier-Barbut, Igor/0000-0002-4707-0474	German Research Foundation (DFG) [SFB/TRR21]; FOR [2247]; EU within Horizon2020 Marie Sklodowska Curie IF [703419]	German Research Foundation (DFG)(German Research Foundation (DFG)); FOR; EU within Horizon2020 Marie Sklodowska Curie IF	We thank H. P. Buchler, L. Santos, F. Ferlaino, W. Ketterle, H. Sadeghpour, M. Zwierlein and V. Vuletic for discussions. This work is supported by the German Research Foundation (DFG) within SFB/TRR21 as well as FOR 2247. I.F.-B. acknowledges support from the EU within Horizon2020 Marie Sklodowska Curie IF (703419 DipInQuantum).	Baillie D, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.021602; Bender M, 2003, REV MOD PHYS, V75, P121, DOI 10.1103/RevModPhys.75.121; Bisset RN, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.033619; Bulgac A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.050402; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Chomaz L., 2016, PREPRINT; Dalfovo F, 2001, J CHEM PHYS, V115, P10078, DOI 10.1063/1.1424926; Ferrier-Barbut I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.215301; Gomez LF, 2014, SCIENCE, V345, P906, DOI 10.1126/science.1252395; Kadau H, 2016, NATURE, V530, P194, DOI 10.1038/nature16485; Lahaye T, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/12/126401; Lima ARP, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.063609; Lima ARP, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.041604; Lu MW, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.190401; Maier T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041029; Petrov DS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.155302; Saito H, 2016, J PHYS SOC JPN, V85, DOI 10.7566/JPSJ.85.053001; Tang YJ, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.022703; Toennies JP, 2004, ANGEW CHEM INT EDIT, V43, P2622, DOI 10.1002/anie.200300611; Volovik G E, 2009, UNIVERSE HELIUM DROP, P27; Wachtler F, 2016, PHYS REV A, V94, DOI 10.1103/PhysRevA.94.043618; Wachtler F, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.061603	22	283	285	7	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					259	+		10.1038/nature20126	http://dx.doi.org/10.1038/nature20126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830811	Green Submitted			2022-12-28	WOS:000387318500038
J	Chokshi, DA; Chang, JE; Wilson, RM				Chokshi, Dave A.; Chang, Ji E.; Wilson, Ross M.			Health Reform and the Changing Safety Net in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							READMISSIONS REDUCTION PROGRAM; HOSPITALS; MEDICAID; PENALTIES; PROVIDERS; ACA		[Chokshi, Dave A.; Chang, Ji E.; Wilson, Ross M.] New York City Hlth & Hosp, New York, NY 10003 USA; [Chokshi, Dave A.] NYU, Sch Med, New York, NY USA; [Chang, Ji E.] NYU, Coll Global Publ Hlth, New York, NY USA	New York University; New York University	Chokshi, DA (corresponding author), New York City Hlth & Hosp, New York, NY 10003 USA.			Chokshi, Dave/0000-0001-7467-4591				Adulius DP, 2015, SAFETY NET HOSP SYST; Andrulis DP, 2011, HEALTH AFFAIR, V30, P1830, DOI 10.1377/hlthaff.2011.0661; [Anonymous], 2016, TRENDW CHARTB 2016 S; [Anonymous], 2016, DES MED ACO PROGR IN; [Anonymous], 2015, UPD EST INS COV PROV; [Anonymous], 2016, C MED DISPR SHAR HOS; [Anonymous], 2016, 2014 ESS DAT OUR HOS; [Anonymous], 2015, MEDIC DSH FACTSH; Bauchner H, 2015, JAMA-J AM MED ASSOC, V314, P353, DOI 10.1001/jama.2015.8587; Boozary AS, 2015, JAMA-J AM MED ASSOC, V314, P347, DOI 10.1001/jama.2015.6507; Cerise FP, 2015, HARVARD BUSINESS REV; Chase D., 2010, MONTEFIORE MED CTR I; Cole ES, 2014, HEALTH AFFAIR, V33, P2025, DOI 10.1377/hlthaff.2014.0109; Coughlin T. A., 2015, EVOLVING PICTURE 9 S; Cunningham P., 2016, UNDERSTANDING MEDICA; Food and Drug Administration, 2016, FED REG; Gates A., 2014, OVERVIEW DELIVERY SY; Gilman M, 2015, HEALTH AFFAIR, V34, P398, DOI 10.1377/hlthaff.2014.1059; Gilman M, 2014, HEALTH AFFAIR, V33, P1314, DOI 10.1377/hlthaff.2014.0138; Gusmano MK, 2015, HEALTH AFFAIR, V34, P1162, DOI 10.1377/hlthaff.2015.0165; Herman B, 2015, MODERN HEALTHCARE; Joynt KE, 2013, JAMA-J AM MED ASSOC, V309, P342, DOI 10.1001/jama.2012.94856; Lewin ME, 2000, AM HLTH CARE SAFETY; Mahadevan R., 2015, SUPPORTING SOCIAL SE; McConnell KJ, 2016, JAMA-J AM MED ASSOC, V315, P869, DOI 10.1001/jama.2016.0206; McDonald Ruth, 2015, IMPACT INSURANCE EXP; Muhlestein DR, 2016, HLTH AFFAIRS BLOG; Murphy J, 2015, J HEALTH POLIT POLIC, V40, P403, DOI 10.1215/03616878-2882267; Nath JB, 2016, JAMA INTERN MED, V176, P712, DOI 10.1001/jamainternmed.2016.0705; National Academies of Sciences Engineering and Medicine, 2016, SYST PRACT CAR SOC A; National Association of Public Hospitals and Health Systems, WHAT IS SAF NET HOSP; National Center for Health Statistics, 2016, HLTH INSURANCE COVER; Neuhausen K, 2014, HEALTH AFFAIR, V33, P988, DOI 10.1377/hlthaff.2013.1222; Neuhausen K, 2013, NEW ENGL J MED, V369, P1675, DOI 10.1056/NEJMp1310572; Pearson CF, 2015, UPCOMING MANAGED CAR; Rosenbaum S., 2015, COMMONWEALTH FD 0701; Rosenbaum Sara, 2015, HEALTH AFFAIR, DOI [10.1377/forefront.20150123.044073, DOI 10.1377/FOREFRONT.20150123.044073]; Saloner B, 2014, NEW ENGL J MED, V370, P1177, DOI 10.1056/NEJMp1316370; Sandberg SF, 2014, HEALTH AFFAIR, V33, P1975, DOI 10.1377/hlthaff.2014.0648; Shah NR, 2013, JAMA-J AM MED ASSOC, V310, P1561, DOI 10.1001/jama.2013.280015; Sheingold SH, 2016, HEALTH AFFAIR, V35, P124, DOI 10.1377/hlthaff.2015.0534; Shin P, 2015, HLTH CTR PATIENT TRE; Siegel B., 2015, COMMUNICATION; Wang CJ, 2009, NEW ENGL J MED, V361, P1821, DOI 10.1056/NEJMp0907656	44	30	30	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	NOV 3	2016	375	18					1790	1796		10.1056/NEJMhpr1608578	http://dx.doi.org/10.1056/NEJMhpr1608578			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EB0BB	27806232				2022-12-28	WOS:000387007300015
J	Nowogrodzki, A				Nowogrodzki, Anna			MINING THE SECRETS OF COLLEGE SYLLABUSES	NATURE			English	Editorial Material																			0	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 3	2016	539	7627					125	126		10.1038/539125a	http://dx.doi.org/10.1038/539125a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5OJ	27808216	Bronze			2022-12-28	WOS:000386670100045
J	Hoelzel, AR				Hoelzel, A. Rus			The road to speciation runs both ways	SCIENCE			English	Editorial Material							ENVIRONMENTAL-CHANGE; CHIMPANZEE		[Hoelzel, A. Rus] Univ Durham, Dept Biosci, South Rd, Durham DH1 3LE, England	Durham University	Hoelzel, AR (corresponding author), Univ Durham, Dept Biosci, South Rd, Durham DH1 3LE, England.	a.r.hoelzel@durham.ac.uk						Arnold M.L., 2015, DIVERGENCE GENETIC E; Becquet C, 2007, GENOME RES, V17, P1505, DOI 10.1101/gr.6409707; Coolidge HJ, 1933, AM J PHYS ANTHROPOL, V18, P1, DOI 10.1002/ajpa.1330180113; Darwin C., 1959, ORIGIN SPECIES MEANS; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; Dupont LM, 2001, GEOLOGY, V29, P195, DOI 10.1130/0091-7613(2001)029<0195:MPECIT>2.0.CO;2; Fennessy J, 2016, CURR BIOL, V26, P2543, DOI 10.1016/j.cub.2016.07.036; Moura AE, 2013, SYST BIOL, V62, P865, DOI 10.1093/sysbio/syt051; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; VERVAECKE H, 1992, MAMMALIA, V56, P667	11	4	4	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					414	415		10.1126/science.aaj2007	http://dx.doi.org/10.1126/science.aaj2007			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789826				2022-12-28	WOS:000387684400021
J	Nixon-Abell, J; Obara, CJ; Weigel, AV; Li, D; Legant, WR; Xu, CS; Pasolli, HA; Harvey, K; Hess, HF; Betzig, E; Blackstone, C; Lippincott-Schwartz, J				Nixon-Abell, Jonathon; Obara, Christopher J.; Weigel, Aubrey V.; Li, Dong; Legant, Wesley R.; Xu, C. Shan; Pasolli, H. Amalia; Harvey, Kirsten; Hess, Harald F.; Betzig, Eric; Blackstone, Craig; Lippincott-Schwartz, Jennifer			Increased spatiotemporal resolution reveals highly dynamic dense tubular matrices in the peripheral ER	SCIENCE			English	Article							ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; PLASMA-MEMBRANE; LIVING CELLS; LIVE CELLS; GENERATION; MICROSCOPY; TRANSFORMATION; MORPHOLOGY; TRACKING	The endoplasmic reticulum (ER) is an expansive, membrane-enclosed organelle that plays crucial roles in numerous cellular functions. We used emerging superresolution imaging technologies to clarify the morphology and dynamics of the peripheral ER, which contacts and modulates most other intracellular organelles. Peripheral components of the ER have classically been described as comprising both tubules and flat sheets. We show that this system consists almost exclusively of tubules at varying densities, including structures that we term ER matrices. Conventional optical imaging technologies had led to misidentification of these structures as sheets because of the dense clustering of tubular junctions and a previously uncharacterized rapid form of ER motion. The existence of ER matrices explains previous confounding evidence that had indicated the occurrence of ER "sheet" proliferation after overexpression of tubular junction-forming proteins.	[Nixon-Abell, Jonathon; Blackstone, Craig] NINDS, Cell Biol Sect, Neurogenet Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Nixon-Abell, Jonathon; Harvey, Kirsten] UCL, UCL Sch Pharm, Dept Pharmacol, London, England; [Obara, Christopher J.; Weigel, Aubrey V.; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA; [Obara, Christopher J.; Weigel, Aubrey V.; Li, Dong; Legant, Wesley R.; Xu, C. Shan; Pasolli, H. Amalia; Hess, Harald F.; Betzig, Eric; Lippincott-Schwartz, Jennifer] HHMI, Janelia Res Campus, Ashburn, VA 20147 USA; [Li, Dong] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of London; University College London; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; Chinese Academy of Sciences; Institute of Biophysics, CAS	Blackstone, C (corresponding author), NINDS, Cell Biol Sect, Neurogenet Branch, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Lippincott-Schwartz, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA.; Lippincott-Schwartz, J (corresponding author), HHMI, Janelia Res Campus, Ashburn, VA 20147 USA.	blackstc@ninds.nih.gov; lippincottschwartzj@janelia.hhmi.org	Nixon-Abell, Jonathon/AAN-3897-2021	Pasolli, Hilda Amalia/0000-0003-3899-3530; Xu, C. Shan/0000-0002-8564-7836; Nixon-Abell, Jonathon/0000-0003-4169-0012; Weigel, Aubrey/0000-0003-1694-4420	NIGMS Postdoctoral Research Associate Program fellowship; AIDS research fellowship from the NIH Office of AIDS Research; NIH Intramural AIDS Targeted Antiviral Program; National Key Research Program of China [2016YFA0500200]; HHMI; Intramural Research Program of NINDS; Intramural Research Program of NICHD; UCL School of Pharmacy PhD studentship; MRC [MR/M00676X/1] Funding Source: UKRI	NIGMS Postdoctoral Research Associate Program fellowship; AIDS research fellowship from the NIH Office of AIDS Research; NIH Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key Research Program of China; HHMI(Howard Hughes Medical Institute); Intramural Research Program of NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Intramural Research Program of NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UCL School of Pharmacy PhD studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a NIGMS Postdoctoral Research Associate Program fellowship (A.V.W.), an intramural AIDS research fellowship from the NIH Office of AIDS Research (C.J.O.), a grant from the NIH Intramural AIDS Targeted Antiviral Program (J.L.-S. and C.J.O.), National Key Research Program of China grant 2016YFA0500200 (D.L.), and HHMI and the Intramural Research Programs of NINDS and NICHD. J.N.-A. is supported by a UCL School of Pharmacy PhD studentship (to K.H.). We thank H. White for assistance with cell culture, L. Shao for assistance with imaging and data processing, P.-P. Zhu for advice on immunocytochemistry, R. Yan for a generous gift of an RTN4A/B antibody, and E. Snapp for provision of an MDCK ER-RFP stable cell line and critical reading of the manuscript. The authors declare that there are no conflicts of interest. All data to support the conclusions are provided either in the manuscript or in the supplementary materials.	Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Chen S, 2015, P NATL ACAD SCI USA, V112, P418, DOI 10.1073/pnas.1423026112; Cole N. B., 1998, CURR PROTOC CELL BIO, V26; Deerinck T. J., 2010, MICROSCOPY-JPN, V1, P6; DONALDSON JG, 1991, SCIENCE, V254, P1197, DOI 10.1126/science.1957170; English AR, 2013, NAT CELL BIOL, V15, P169, DOI 10.1038/ncb2647; Fernandez-Busnadiego R, 2015, P NATL ACAD SCI USA, V112, pE2004, DOI 10.1073/pnas.1503191112; Goyal U, 2013, BBA-MOL CELL RES, V1833, P2492, DOI 10.1016/j.bbamcr.2013.04.009; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; Hetzer MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000539; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Kner P, 2009, NAT METHODS, V6, P339, DOI [10.1038/NMETH.1324, 10.1038/nmeth.1324]; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Lai CW, 2010, MOL BIOL CELL, V21, P1909, DOI 10.1091/mbc.E09-12-1066; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; Legant WR, 2016, NAT METHODS, V13, P359, DOI [10.1038/nmeth.3797, 10.1038/NMETH.3797]; Li D, 2015, SCIENCE, V349, DOI 10.1126/science.aab3500; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112; Puhka M, 2012, MOL BIOL CELL, V23, P2424, DOI 10.1091/mbc.E10-12-0950; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Shemesh T, 2014, P NATL ACAD SCI USA, V111, pE5243, DOI 10.1073/pnas.1419997111; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Stefano G, 2014, J CELL SCI, V127, P947, DOI 10.1242/jcs.139907; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Terasaki M, 2013, CELL, V154, P285, DOI 10.1016/j.cell.2013.06.031; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Weigel AV, 2013, P NATL ACAD SCI USA, V110, pE4591, DOI 10.1073/pnas.1315202110; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	39	242	243	8	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311							aaf3928	10.1126/science.aaf3928	http://dx.doi.org/10.1126/science.aaf3928			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789813	Green Accepted, Green Submitted			2022-12-28	WOS:000387684400032
J	Powell, K				Powell, Kendall			YOUNG, TALENTED AND FED-UP	NATURE			English	Editorial Material																		Hermans F, 2013, PROCEEDINGS OF THE 35TH INTERNATIONAL CONFERENCE ON SOFTWARE ENGINEERING (ICSE 2013), P292, DOI 10.1109/ICSE.2013.6606575; Mondragon-Solorzano G, 2016, J INCL PHENOM MACRO, V85, P169, DOI 10.1007/s10847-016-0617-0; Tierney JE, 2014, GEOCHIM COSMOCHIM AC, V127, P83, DOI 10.1016/j.gca.2013.11.026; Tingley MP, 2013, NATURE, V496, P201, DOI 10.1038/nature11969	4	28	28	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 27	2016	538	7626					446	449		10.1038/538446a	http://dx.doi.org/10.1038/538446a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EA5IY	27786221	Bronze			2022-12-28	WOS:000386654400031
J	Mayor, S				Mayor, Susan			NICE proposes faster process to appraise cheaper drugs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		National Institute for Health and Care Excellence NHS England, 2016, PROP CHANG ARR EV FU	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2016	355								i5592	10.1136/bmj.i5592	http://dx.doi.org/10.1136/bmj.i5592			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8KN	27797748				2022-12-28	WOS:000386119400009
J	Halbertal, D; Cuppens, J; Ben Shalom, M; Embon, L; Shadmi, N; Anahory, Y; Naren, HR; Sarkar, J; Uri, A; Ronen, Y; Myasoedov, Y; Levitov, LS; Joselevich, E; Geim, AK; Zeldov, E				Halbertal, D.; Cuppens, J.; Ben Shalom, M.; Embon, L.; Shadmi, N.; Anahory, Y.; Naren, H. R.; Sarkar, J.; Uri, A.; Ronen, Y.; Myasoedov, Y.; Levitov, L. S.; Joselevich, E.; Geim, A. K.; Zeldov, E.			Nanoscale thermal imaging of dissipation in quantum systems	NATURE			English	Article							THERMOMETRY; TEMPERATURE	Energy dissipation is a fundamental process governing the dynamics of physical, chemical and biological systems. It is also one of the main characteristics that distinguish quantum from classical phenomena. In particular, in condensed matter physics, scattering mechanisms, loss of quantum information or breakdown of topological protection are deeply rooted in the intricate details of how and where the dissipation occurs. Yet the microscopic behaviour of a system is usually not formulated in terms of dissipation because energy dissipation is not a readily measurable quantity on the micrometre scale. Although nanoscale thermometry has gained much recent interest(1-15), existing thermal imaging methods are not sensitive enough for the study of quantum systems and are also unsuitable for the low-temperature operation that is required. Here we report a nano-thermometer based on a superconducting quantum interference device with a diameter of less than 50 nanometres that resides at the apex of a sharp pipette: it provides scanning cryogenic thermal sensing that is four orders of magnitude more sensitive than previous devices-below 1 mu K Hz(-1/2). This non contact, non-invasive thermometry allows thermal imaging of very low intensity, nanoscale energy dissipation down to the fundamental Landauer limit(16-18) of 40 femtowatts for continuous readout of a single qubit at one gigahertz at 4.2 kelvin. These advances enable the observation of changes in dissipation due to single-electron charging of individual quantum dots in carbon nanotubes. They also reveal a dissipation mechanism attributable to resonant localized states in graphene encapsulated within hexagonal boron nitride, opening the door to direct thermal imaging of nanoscale dissipation processes in quantum matter.	[Halbertal, D.; Cuppens, J.; Embon, L.; Anahory, Y.; Naren, H. R.; Sarkar, J.; Uri, A.; Ronen, Y.; Myasoedov, Y.; Zeldov, E.] Weizmann Inst Sci, Dept Condensed Matter Phys, IL-7610001 Rehovot, Israel; [Cuppens, J.] CSIC, ICN2, Campus UAB, Barcelona 08193, Spain; [Cuppens, J.] Barcelona Inst Sci & Technol, Campus UAB, Barcelona 08193, Spain; [Ben Shalom, M.; Geim, A. K.] Univ Manchester, Natl Graphene Inst, Booth St East, Manchester M13 9PL, Lancs, England; [Ben Shalom, M.; Geim, A. K.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Shadmi, N.; Joselevich, E.] Weizmann Inst Sci, Dept Mat & Interfaces, IL-7610001 Rehovot, Israel; [Levitov, L. S.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Embon, L.] Columbia Univ, Dept Phys, 538 W 120th St, New York, NY 10027 USA	Weizmann Institute of Science; Autonomous University of Barcelona; Barcelona Institute of Science & Technology; Catalan Institute of Nanoscience & Nanotechnology (ICN2); Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Barcelona Institute of Science & Technology; University of Manchester; University of Manchester; Weizmann Institute of Science; Massachusetts Institute of Technology (MIT); Columbia University	Halbertal, D; Zeldov, E (corresponding author), Weizmann Inst Sci, Dept Condensed Matter Phys, IL-7610001 Rehovot, Israel.	dorri.halbertal@weizmann.ac.il; eli.zeldov@weizmann.ac.il	Ronen, Yuval/AAA-6722-2022; Ben Shalom, Moshe/ABC-3999-2021; Geim, Andre K/J-7888-2012; Zeldov, Eli/K-1546-2012	Ronen, Yuval/0000-0002-2427-2591; Geim, Andre K/0000-0003-2861-8331; Zeldov, Eli/0000-0002-8200-4974; Levitov, Leonid/0000-0002-4268-731X; Ben Shalom, Moshe/0000-0001-5781-0037; Joselevich, Ernesto/0000-0002-9919-0734; Anahory, Yonathan/0000-0002-9368-1129; Halbertal, Dorri/0000-0002-1665-0724	European Research Council (ERC) under the European Union [655416]; Minerva Foundation; Federal German Ministry of Education and Research; Rosa and Emilio Segre Research Award; MISTI MIT-Israel Seed Fund; Engineering and Physical Sciences Research Council [EP/N010345/1, EP/K005014/1] Funding Source: researchfish; EPSRC [EP/K005014/1, EP/N010345/1] Funding Source: UKRI	European Research Council (ERC) under the European Union(European Research Council (ERC)); Minerva Foundation; Federal German Ministry of Education and Research; Rosa and Emilio Segre Research Award; MISTI MIT-Israel Seed Fund; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. F. Young for discussions, M. V. Costache and S. O. Valenzuela for facilitation of fabrication of permalloy (Py)/copper (Cu) samples that were used in Supplementary Information section S9, D. Shahar, I. Tamir, T. Levinson and S. Mitra for assistance in fabrication of a:In<INF>2</INF>O<INF>3</INF> integrated devices that were used in Supplementary Information section S2, M. E. Huber for SOT readout setup, and M. L. Rappaport for technical assistance. This work was supported by the European Research Council (ERC) under the European Union's Horizon 2020 programme (grant no. 655416), by the Minerva Foundation with funding from the Federal German Ministry of Education and Research, and by a Rosa and Emilio Segre Research Award. L.S.L. and E.Z. acknowledge the support of the MISTI MIT-Israel Seed Fund.	Bandurin DA, 2016, SCIENCE, V351, P1055, DOI 10.1126/science.aad0201; Berut A, 2012, NATURE, V483, P187, DOI 10.1038/nature10872; Bistritzer R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.206410; Brites CDS, 2012, NANOSCALE, V4, P4799, DOI 10.1039/c2nr30663h; Faivre T, 2014, J APPL PHYS, V116, DOI 10.1063/1.4894516; Finkler A, 2010, NANO LETT, V10, P1046, DOI 10.1021/nl100009r; Giazotto F, 2006, REV MOD PHYS, V78, P217, DOI 10.1103/RevModPhys.78.217; Gonzalez-Herrero H, 2016, SCIENCE, V352, P437, DOI 10.1126/science.aad8038; Grabert H., 2013, SINGLE CHARGE TUNNEL, V294; Grosse KL, 2011, NAT NANOTECHNOL, V6, P287, DOI [10.1038/NNANO.2011.39, 10.1038/nnano.2011.39]; Herr QP, 2011, J APPL PHYS, V109, DOI 10.1063/1.3585849; Jin CY, 2011, NANO LETT, V11, P4818, DOI 10.1021/nl2026585; Kim K, 2012, ACS NANO, V6, P4248, DOI 10.1021/nn300774n; Kucsko G, 2013, NATURE, V500, P54, DOI 10.1038/nature12373; Kuhn K. J., 2012, IEEE INT EL DEV M; Lachman EO, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500740; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; Majumdar A, 1999, ANNU REV MATER SCI, V29, P505, DOI 10.1146/annurev.matsci.29.1.505; Mecklenburg M, 2015, SCIENCE, V347, P629, DOI 10.1126/science.aaa2433; Menges F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10874; Neumann P, 2013, NANO LETT, V13, P2738, DOI 10.1021/nl401216y; Pekola JP, 2015, NAT PHYS, V11, P118, DOI [10.1038/nphys3169, 10.1038/NPHYS3169]; Pereira VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036801; Reparaz JS, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4867166; Sadat S, 2010, NANO LETT, V10, P2613, DOI 10.1021/nl101354e; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; Shadmi N, 2014, J PHYS CHEM C, V118, P14044, DOI 10.1021/jp5042603; Song JCW, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106602; Teyssieux D, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2714040; Toyli DM, 2013, P NATL ACAD SCI USA, V110, P8417, DOI 10.1073/pnas.1306825110; Vasyukov D, 2013, NAT NANOTECHNOL, V8, P639, DOI [10.1038/nnano.2013.169, 10.1038/NNANO.2013.169]; Woodside MT, 2002, SCIENCE, V296, P1098, DOI 10.1126/science.1069923; Yue YA, 2012, NANO REV EXP, V3, DOI 10.3402/nano.v3i0.11586	33	114	114	3	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 17	2016	539	7629					407	410		10.1038/nature19843	http://dx.doi.org/10.1038/nature19843			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC5GP	27786173	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000388161700049
J	Collinge, J				Collinge, John			Mammalian prions and their wider relevance in neurodegenerative diseases	NATURE			English	Review							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBRAL BETA-AMYLOIDOSIS; ALPHA-SYNUCLEIN STRAINS; MICE EXPRESSING HUMAN; ALZHEIMERS-DISEASE; SCRAPIE PRION; TRANSGENIC MICE; MONOCLONAL-ANTIBODIES; IN-VITRO	Prions are notorious protein-only infectious agents that cause invariably fatal brain diseases following silent incubation periods that can span a lifetime. These diseases can arise spontaneously, through infection or be inherited. Remarkably, prions are composed of self-propagating assemblies of a misfolded cellular protein that encode information, generate neurotoxicity and evolve and adapt in vivo. Although parallels have been drawn with Alzheimer's disease and other neurodegenerative conditions involving the deposition of assemblies of misfolded proteins in the brain, insights are now being provided into the usefulness and limitations of prion analogies and their aetiological and therapeutic relevance.	[Collinge, John] UCL, Inst Neurol, Med Res Council, Prion Unit, London WC1N 3BG, England; [Collinge, John] UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of London; University College London	Collinge, J (corresponding author), UCL, Inst Neurol, Med Res Council, Prion Unit, London WC1N 3BG, England.; Collinge, J (corresponding author), UCL, Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.	jc@prion.ucl.ac.uk			Medical Research Council [MC_U123192748] Funding Source: Medline; MRC [MC_U123192748] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALPER T, 1967, NATURE, V214, P764, DOI 10.1038/214764a0; Antonyuk SV, 2009, P NATL ACAD SCI USA, V106, P2554, DOI 10.1073/pnas.0809170106; Asante EA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004953; BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brandner S, 2008, PHILOS T R SOC B, V363, P3755, DOI 10.1098/rstb.2008.0091; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BRUCE M, 1994, PHILOS T R SOC B, V343, P405, DOI 10.1098/rstb.1994.0036; Bruce M. E., 1992, PRION DIS HUMANS ANI; BRUCE ME, 1993, BRIT MED BULL, V49, P822, DOI 10.1093/oxfordjournals.bmb.a072649; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Clavaguera F, 2014, ACTA NEUROPATHOL, V127, P299, DOI 10.1007/s00401-013-1231-5; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; Cohen ML, 2015, BRAIN, V138, P1009, DOI 10.1093/brain/awv006; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; COLLINGE J, 1995, LANCET, V346, P569, DOI 10.1016/S0140-6736(95)91405-6; COLLINGE J, 1995, NATURE, V378, P779, DOI 10.1038/378779a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collinge J, 2010, SCIENCE, V328, P1111, DOI 10.1126/science.1190815; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; COME JH, 1993, P NATL ACAD SCI USA, V90, P5959, DOI 10.1073/pnas.90.13.5959; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Daude N, 1997, J BIOL CHEM, V272, P11604, DOI 10.1074/jbc.272.17.11604; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Diaz-Espinoza R, 2012, NAT STRUCT MOL BIOL, V19, P370, DOI 10.1038/nsmb.2266; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; FRASER H, 1985, BRAIN RES, V346, P32, DOI 10.1016/0006-8993(85)91091-1; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Frontzek K, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14287; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Gandy S, 2012, NEW ENGL J MED, V367, P864, DOI 10.1056/NEJMe1207995; GIBBS CJ, 1968, SCIENCE, V161, P388, DOI 10.1126/science.161.3839.388; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Goedert M, 2015, SCIENCE, V349, DOI 10.1126/science.1255555; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; Haley NJ, 2015, ANNU REV ANIM BIOSCI, V3, P305, DOI 10.1146/annurev-animal-022114-111001; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Herva ME, 2014, J BIOL CHEM, V289, P11897, DOI 10.1074/jbc.M113.542340; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Hill AF, 2003, TRENDS MICROBIOL, V11, P578, DOI 10.1016/j.tim.2003.10.007; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; House of Commons Science and Technology Committee, 2014, STORM UK BLOOD SAF R; Irwin DJ, 2013, JAMA NEUROL, V70, P462, DOI 10.1001/jamaneurol.2013.1933; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Khalili-Shirazi A, 2005, J GEN VIROL, V86, P2635, DOI 10.1099/vir.0.80375-0; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Klyubin I, 2014, J NEUROSCI, V34, P6140, DOI 10.1523/JNEUROSCI.3526-13.2014; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P911, DOI 10.1007/s00401-016-1565-x; Kraus A, 2013, ANNU REV MICROBIOL, V67, P543, DOI 10.1146/annurev-micro-092412-155735; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Mahillo-Fernandez I, 2008, NEUROEPIDEMIOLOGY, V31, P229, DOI 10.1159/000163097; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, NEURODEGENERATION, V3, P331; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Mead S, 2016, JAMA NEUROL, V73, P447, DOI 10.1001/jamaneurol.2015.4885; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Morillas M, 2001, BIOCHEMISTRY-US, V40, P6982, DOI 10.1021/bi010232q; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Ohsawa N, 2013, MICROBIOL IMMUNOL, V57, P288, DOI 10.1111/1348-0421.12037; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Prusiner SB, 2015, P NATL ACAD SCI USA, V112, pE5308, DOI 10.1073/pnas.1514475112; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Requena JR, 2014, PRION, V8, P60, DOI 10.4161/pri.28368; Ridley RM, 2006, J NEURAL TRANSM, V113, P1243, DOI 10.1007/s00702-005-0385-2; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, J VIROL, V79, P10796, DOI 10.1128/JVI.79.16.10796-10806.2005; Salvadores N, 2014, CELL REP, V7, P261, DOI 10.1016/j.celrep.2014.02.031; Sandberg MK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5347; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Sawyer EB, 2015, SCI REP-UK, V5, DOI 10.1038/srep17742; Scheltens P, 2016, LANCET, V388, P505, DOI 10.1016/S0140-6736(15)01124-1; Schmidt C, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150165; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Sonati T, 2013, NATURE, V501, P102, DOI 10.1038/nature12402; Song CH, 2008, J GEN VIROL, V89, P1533, DOI 10.1099/vir.0.83578-0; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; Taylor DM, 1998, VET MICROBIOL, V64, P33, DOI 10.1016/S0378-1135(98)00257-0; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Terry C, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160035; Thackray AM, 2003, J VIROL, V77, P7991, DOI 10.1128/JVI.77.14.7991-7998.2003; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Tjernberg LO, 2016, J INTERN MED, V280, P153, DOI 10.1111/joim.12499; Torrent J, 2004, BIOCHEMISTRY-US, V43, P7162, DOI 10.1021/bi049939d; Urwin PJM, 2016, VOX SANG, V110, P310, DOI 10.1111/vox.12371; Vickery CM, 2013, INT J EXP PATHOL, V94, P320, DOI 10.1111/iep.12036; Wadsworth JDF, 2010, NEUROPATH APPL NEURO, V36, P576, DOI 10.1111/j.1365-2990.2010.01129.x; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Walsh DM, 2016, NAT REV NEUROSCI, V17, P251, DOI 10.1038/nrn.2016.13; Walsh DM, 2012, PROG MOL BIOL TRANSL, V107, P101, DOI 10.1016/B978-0-12-385883-2.00012-6; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Ward HJT, 2002, NEUROLOGY, V59, P543, DOI 10.1212/WNL.59.4.543; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Wenborn A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10062; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wickner RB, 2011, SEMIN CELL DEV BIOL, V22, P469, DOI 10.1016/j.semcdb.2011.02.021; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766	144	136	136	0	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					217	226		10.1038/nature20415	http://dx.doi.org/10.1038/nature20415			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27830781				2022-12-28	WOS:000387318500032
J	Greene, JS; Brown, M; Dobosiewicz, M; Ishida, IG; Macosko, EZ; Zhang, XX; Butcher, RA; Cline, DJ; McGrath, PT; Bargmann, CI				Greene, Joshua S.; Brown, Maximillian; Dobosiewicz, May; Ishida, Itzel G.; Macosko, Evan Z.; Zhang, Xinxing; Butcher, Rebecca A.; Cline, Devin J.; McGrath, Patrick T.; Bargmann, Cornelia I. .			Balancing selection shapes density-dependent foraging behaviour	NATURE			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; PROTEIN-KINASE; PHEROMONE; GENE; EVOLUTION; CGMP; POLYMORPHISM; DROSOPHILA; DIVERSITY	The optimal foraging strategy in a given environment depends on the number of competing individuals and their behavioural strategies. Little is known about the genes and neural circuits that integrate social information into foraging decisions. Here we show that ascaroside pheromones, small glycolipids that signal population density, suppress exploratory foraging in Caenorhabditis elegans, and that heritable variation in this behaviour generates alternative foraging strategies. We find that natural C. elegans isolates differ in their sensitivity to the potent ascaroside icas#9 (IC-asc-C5). A quantitative trait locus (QTL) regulating icas#9 sensitivity includes srx-43, a G-protein-coupled icas#9 receptor that acts in the ASI class of sensory neurons to suppress exploration. Two ancient haplotypes associated with this QTL confer competitive growth advantages that depend on ascaroside secretion, its detection by srx-43 and the distribution of food. These results suggest that balancing selection at the srx-43 locus generates alternative density-dependent behaviours, fulfilling a prediction of foraging game theory.	[Greene, Joshua S.; Brown, Maximillian; Dobosiewicz, May; Ishida, Itzel G.; Macosko, Evan Z.; Bargmann, Cornelia I. .] Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA; [Zhang, Xinxing; Butcher, Rebecca A.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Cline, Devin J.; McGrath, Patrick T.] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA	Howard Hughes Medical Institute; Rockefeller University; State University System of Florida; University of Florida; University System of Georgia; Georgia Institute of Technology	Bargmann, CI (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lulu & Anthony Wang Lab Neural Circuits & Behav, New York, NY 10065 USA.	cori@rockefeller.edu	Macosko, Evan/X-4664-2019	Dobosiewicz, May/0000-0001-5922-5309	Research Corporation for Science Advancement [22844]; NIH [R01GM114170, F30 MH101931-03]; Ellison Medical Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH101931] Funding Source: NIH RePORTER	Research Corporation for Science Advancement(Research Corporation for Science Advancement); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank E. Andersen for sharing the unpublished CeNDR database; the Caenorhabditis Genetics Center (NIH P40 OD010440) and the Million Mutation Project for strains; S. Flavell and A. Lopez for advice and insight; and P. Sengupta, M. O'Donnell, X. Jin and A. Sordillo for comments on the manuscript. R.A.B. and X.Z. were supported by the Research Corporation for Science Advancement (Cottrell Scholar Award, 22844). P.T.M. was supported by NIH grant R01GM114170 and the Ellison Medical Foundation. J.S.G. was supported by the NIH grant F30 MH101931-03. C.I.B. is an investigator of the HHMI. This work was supported by the Ellison Medical Foundation.	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Arribere JA, 2014, GENETICS, V198, P837, DOI 10.1534/genetics.114.169730; Artyukhin AB, 2013, J BIOL CHEM, V288, P18778, DOI 10.1074/jbc.C113.477000; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere A, 2005, WORMBOOK, DOI 10.1895/wormbook.1.43.1; Ben Arous J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007584; Bendesky A, 2011, NAT REV GENET, V12, P809, DOI 10.1038/nrg3065; BRENNER S, 1974, GENETICS, V77, P71; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Flavell SW, 2013, CELL, V154, P1023, DOI 10.1016/j.cell.2013.08.001; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Ghosh R, 2012, SCIENCE, V335, P574, DOI 10.1126/science.1214318; Giraldeau L.A., 1998, GAME THEORY ANIMAL B; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Larsch J, 2013, P NATL ACAD SCI USA, V110, pE4266, DOI 10.1073/pnas.1318325110; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; McGrath PT, 2011, NATURE, V477, P321, DOI 10.1038/nature10378; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; Sokolowski MB, 1997, P NATL ACAD SCI USA, V94, P7373, DOI 10.1073/pnas.94.14.7373; SORENSEN PW, 1989, HORM BEHAV, V23, P317, DOI 10.1016/0018-506X(89)90046-9; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Thompson O, 2013, GENOME RES, V23, P1749, DOI 10.1101/gr.157651.113; Thompson OA, 2015, GENETICS, V200, P975, DOI 10.1534/genetics.115.175950; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zhang XX, 2015, P NATL ACAD SCI USA, V112, P3955, DOI 10.1073/pnas.1423951112	38	75	76	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 10	2016	539	7628					254	+		10.1038/nature19848	http://dx.doi.org/10.1038/nature19848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB4CZ	27799655	Green Accepted			2022-12-28	WOS:000387318500037
J	Auerbach, PS				Auerbach, Paul S.			The last gasp	LANCET			English	Editorial Material									[Auerbach, Paul S.] Stanford Univ, Sch Med, Dept Emergency Med, Alway Bldg M121,300 Pasteur Dr, Stanford, CA 94305 USA	Stanford University	Auerbach, PS (corresponding author), Stanford Univ, Sch Med, Dept Emergency Med, Alway Bldg M121,300 Pasteur Dr, Stanford, CA 94305 USA.	paul.auerbach@gmail.com						Al Ghofaily L., 2012, J ANESTH CLIN RES, V3, P252, DOI [10.4172/2155-6148.1000252, DOI 10.4172/2155-6148.1000252]; Bhaskar B, 2011, SAUDI J ANAESTH, V5, P308, DOI 10.4103/1658-354X.84108; Glisenti P, 2016, LANCET, V388, P2321, DOI 10.1016/S0140-6736(16)31010-8; McIntosh SE, 2007, WILD ENVIRON MED, V18, P293, DOI 10.1580/07-WEME-OR-092R1.1	4	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 5	2016	388	10057					2322	2322		10.1016/S0140-6736(16)31722-6	http://dx.doi.org/10.1016/S0140-6736(16)31722-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8MO	27825510				2022-12-28	WOS:000386889300038
J	Gramling, C				Gramling, Carolyn			PALEONTOLOGY 'Four-legged snake' may be ancient lizard instead	SCIENCE			English	News Item																			0	4	4	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 4	2016	354	6312					536	537		10.1126/science.354.6312.536	http://dx.doi.org/10.1126/science.354.6312.536			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA8FD	27811246				2022-12-28	WOS:000386869800014
J	Sharon, G; Sampson, TR; Geschwind, DH; Mazmanian, SK				Sharon, Gil; Sampson, Timothy R.; Geschwind, Daniel H.; Mazmanian, Sarkis K.			The Central Nervous System and the Gut Microbiome	CELL			English	Review							MATERNAL IMMUNE ACTIVATION; EARLY-LIFE; GASTROINTESTINAL SYMPTOMS; INTESTINAL MICROBIOTA; BRAIN-DEVELOPMENT; PSYCHOLOGICAL STRESS; TEMPORAL STABILITY; VAGINAL MICROBIOTA; PREGNANT-WOMEN; ANTIBIOTIC USE	Neurodevelopment is a complex process governed by both intrinsic and extrinsic signals. While historically studied by researching the brain, inputs from the periphery impact many neurological conditions. Indeed, emerging data suggest communication between the gut and the brain in anxiety, depression, cognition, and autism spectrum disorder (ASD). The development of a healthy, functional brain depends on key pre-and post-natal events that integrate environmental cues, such as molecular signals from the gut. These cues largely originate from the microbiome, the consortium of symbiotic bacteria that reside within all animals. Research over the past few years reveals that the gut microbiomeplays a role in basic neurogenerative processes such as the formation of the blood-brain barrier, myelination, neurogenesis, and microglia maturation and also modulates many aspects of animal behavior. Herein, we discuss the biological intersection of neurodevelopment and the microbiome and explore the hypothesis that gut bacteria are integral contributors to development and function of the nervous system and to the balance between mental health and disease.	[Sharon, Gil; Sampson, Timothy R.; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurobehav Genet, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Autism Treatment & Res, Semel Inst, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Sharon, G; Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	gsharon@caltech.edu; sarkis@caltech.edu		Sampson, Timothy/0000-0002-2486-8766; Sharon, Gil/0000-0002-4605-9943	Meixner Postdoctoral Fellowship in Translational Research; Larry L. Hillblom Foundation Postdoctoral Fellowship; NIH [MH100556, DK078938, GM099535, NS085910]; Department of Defense; Simons Foundation; NIMH [HD055784, MH100027, MH110927, MH1064382]; Heritage Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078938, R56DK078938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH106482, R01MH100027, R01MH110927, R01MH100556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910] Funding Source: NIH RePORTER	Meixner Postdoctoral Fellowship in Translational Research; Larry L. Hillblom Foundation Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Simons Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Heritage Medical Research Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors apologize to colleagues whose work could not be included in this Review. We thank Drs. Hiutung Chu and Wei-li Wu, as well as Carly Stewart for critical reading of this manuscript. The authors are supported by the Meixner Postdoctoral Fellowship in Translational Research (to G.S.) and the Larry L. Hillblom Foundation Postdoctoral Fellowship (to T.R.S.). Related research in the Mazmanian laboratory is funded by grants from the NIH (MH100556, DK078938, GM099535, and NS085910), the Department of Defense, the Heritage Medical Research Institute, and the Simons Foundation. Related research in the Geschwind lab is supported by NIMH grants (HD055784, MH100027, MH110927, and MH1064382), and the Simons Foundation.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Ait-Belgnaoui A, 2014, NEUROGASTROENT MOTIL, V26, P510, DOI 10.1111/nmo.12295; Ait-Belgnaoui A, 2012, PSYCHONEUROENDOCRINO, V37, P1885, DOI 10.1016/j.psyneuen.2012.03.024; AlAmeel T, 2012, CAN J GASTROENTEROL, V26, P881, DOI 10.1155/2012/324602; Alenina N, 2015, BEHAV BRAIN RES, V277, P49, DOI 10.1016/j.bbr.2014.07.038; Allen JM, 2015, J APPL PHYSIOL, V118, P1059, DOI 10.1152/japplphysiol.01077.2014; Amaral FA, 2008, P NATL ACAD SCI USA, V105, P2193, DOI 10.1073/pnas.0711891105; Arentsen Tim, 2015, Microbial Ecology in Health and Disease, V26, P29719, DOI 10.3402/mehd.v26.29719; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.05.012, 10.1016/j.chom.2015.04.004]; Bahrini I, 2015, SCI REP-UK, V5, DOI 10.1038/srep07989; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Bercik P, 2011, NEUROGASTROENT MOTIL, V23, P1132, DOI 10.1111/j.1365-2982.2011.01796.x; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Biagi E, 2016, CURR BIOL, V26, P1480, DOI 10.1016/j.cub.2016.04.016; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Biagi E, 2012, AGE, V34, P247, DOI 10.1007/s11357-011-9217-5; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Britton E, 2013, P NUTR SOC, V72, P173, DOI 10.1017/S0029665112002807; Buffington SA, 2016, CELL, V165, P1762, DOI 10.1016/j.cell.2016.06.001; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Castro-Nallar E, 2015, PEERJ, V3, DOI 10.7717/peerj.1140; Ceni Claire, 2014, Handb Exp Pharmacol, V220, P193, DOI 10.1007/978-3-642-45106-5_8; Chang Chia-Yu, 2009, Acta Neurol Taiwan, V18, P231; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DAVISON AN, 1966, BRIT MED BULL, V22, P40, DOI 10.1093/oxfordjournals.bmb.a070434; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; de la Torre-Ubieta L, 2016, NAT MED, V22, P345, DOI 10.1038/nm.4071; De Palma G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8735; de Theije CGM, 2014, PEDIAT ALLERG IMM-UK, V25, P218, DOI 10.1111/pai.12149; Desbonnet L, 2014, MOL PSYCHIATR, V19, P146, DOI 10.1038/mp.2013.65; Desbonnet L, 2010, NEUROSCIENCE, V170, P1179, DOI 10.1016/j.neuroscience.2010.08.005; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dotterud CK, 2015, J PEDIATR GASTR NUTR, V61, P200, DOI 10.1097/MPG.0000000000000781; Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Mello BSF, 2013, J PSYCHIATR RES, V47, P1521, DOI 10.1016/j.jpsychires.2013.06.008; Finegold SM, 2002, CLIN INFECT DIS, V35, pS6, DOI 10.1086/341914; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Foley KA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087072, 10.1371/journal.pone.0108413]; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Friedland RP, 2015, J ALZHEIMERS DIS, V45, P349, DOI 10.3233/JAD-142841; Gacias M, 2016, ELIFE, V5, DOI 10.7554/eLife.13442; Gardener H, 2011, PEDIATRICS, V128, P344, DOI 10.1542/peds.2010-1036; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goodrich JK, 2016, SCIENCE, V352, P532, DOI 10.1126/science.aad9379; Harach T, 2015, ARXIV150902273; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hill JM, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00009; Hoban AE, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.42; Hong S, 2016, DEV CELL, V38, P126, DOI 10.1016/j.devcel.2016.07.006; Horai R, 2015, IMMUNITY, V43, P343, DOI 10.1016/j.immuni.2015.07.014; Hourigan SK, 2016, PEDIATR RES, V80, P2, DOI 10.1038/pr.2016.48; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Humann J, 2016, CELL HOST MICROBE, V19, P388, DOI [10.1016/j.chom.2016.02.009, 10.1016/j.chom.2016.05.017]; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jasarevic E, 2015, ENDOCRINOLOGY, V156, P3265, DOI 10.1210/en.2015-1177; Jasarevic E, 2015, NEUROBIOL STRESS, V1, P81, DOI 10.1016/j.ynstr.2014.10.005; Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322; Kelly JR, 2016, J PSYCHIATR RES, V82, P109, DOI 10.1016/j.jpsychires.2016.07.019; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Khandaker GM, 2013, PSYCHOL MED, V43, P239, DOI 10.1017/S0033291712000736; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koprich JB, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-8; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Krajmalnik-Brown Rosa, 2015, Microbial Ecology in Health and Disease, V26, P26914, DOI 10.3402/mehd.v26.26914; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kuperman AA, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0636-0; Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Liu JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/412946; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Luczynski P, 2016, EUR J NEUROSCI, V44, P2654, DOI 10.1111/ejn.13291; Luczynski P, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw020; MacIntyre DA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08988; Mangul S., 2016, BIORXIV; Mannion A, 2013, RES AUTISM SPECT DIS, V7, P35, DOI 10.1016/j.rasd.2012.05.002; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McElhanon BO, 2014, PEDIATRICS, V133, P872, DOI 10.1542/peds.2013-3995; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Miyaoka T, 2012, PROG NEURO-PSYCHOPH, V37, P222, DOI 10.1016/j.pnpbp.2012.02.002; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Molina-Hernandez M, 2008, PROG NEURO-PSYCHOPH, V32, P380, DOI 10.1016/j.pnpbp.2007.09.004; MOLLGARD K, 1986, NEUROPATH APPL NEURO, V12, P337, DOI 10.1111/j.1365-2990.1986.tb00146.x; Moussaoui N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088382; Moya A, 2016, TRENDS MICROBIOL, V24, P402, DOI 10.1016/j.tim.2016.02.002; Mussell M, 2008, J PSYCHOSOM RES, V64, P605, DOI 10.1016/j.jpsychores.2008.02.019; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Nuriel-Ohayon M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01031; O'Mahoney D, 2002, DRUG AGING, V19, P515, DOI 10.2165/00002512-200219070-00005; O'Mahony SM, 2015, BEHAV BRAIN RES, V277, P32, DOI 10.1016/j.bbr.2014.07.027; O'Mahony SM, 2014, NEUROSCIENCE, V277, P885, DOI 10.1016/j.neuroscience.2014.07.054; O'Toole PW, 2010, INT DAIRY J, V20, P281, DOI 10.1016/j.idairyj.2009.11.010; Ogbonnaya ES, 2015, BIOL PSYCHIAT, V78, pE7, DOI 10.1016/j.biopsych.2014.12.023; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Pal GD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00306; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parikshak NN, 2015, NAT REV GENET, V16, P441, DOI 10.1038/nrg3934; Park AJ, 2013, NEUROGASTROENT MOTIL, V25, P733, DOI 10.1111/nmo.12153; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Pressler R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00036; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Rosenberg E, 2016, MBIO, V7, DOI 10.1128/mBio.01395-15; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Salazar N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00406; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Severance EG, 2016, SCHIZOPHR RES, V176, P23, DOI 10.1016/j.schres.2014.06.027; Severance EG, 2013, SCHIZOPHR RES, V148, P130, DOI 10.1016/j.schres.2013.05.018; Slykerman R.F., 2016, ACTA PAEDIATR; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137725; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Stilling RM, 2015, BRAIN BEHAV IMMUN, V50, P209, DOI 10.1016/j.bbi.2015.07.009; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sun J, 2016, BRAIN RES, V1642, P180, DOI 10.1016/j.brainres.2016.03.042; Tillisch K, 2013, GASTROENTEROLOGY, V144, P1394, DOI 10.1053/j.gastro.2013.02.043; Tochitani S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138293; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; van Tongeren SP, 2005, APPL ENVIRON MICROB, V71, P6438, DOI 10.1128/AEM.71.10.6438-6442.2005; Varvel NH, 2012, P NATL ACAD SCI USA, V109, P18150, DOI 10.1073/pnas.1210150109; Williams BL, 2012, MBIO, V3, DOI 10.1128/mBio.00261-11; Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585; Yassour M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0917; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Yolken RH, 2015, SCHIZOPHRENIA BULL, V41, P1153, DOI 10.1093/schbul/sbu197; Zeisel SH, 2004, J AM COLL NUTR, V23, p621S, DOI 10.1080/07315724.2004.10719433; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641; Zheng J, 2015, NUTRIENTS, V7, P6924, DOI 10.3390/nu7085315; Zheng LS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00005; Zheng P, 2016, MOL PSYCHIATR, V21, P786, DOI 10.1038/mp.2016.44; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	179	651	704	25	398	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 3	2016	167	4					915	932		10.1016/j.cell.2016.10.027	http://dx.doi.org/10.1016/j.cell.2016.10.027			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	EE3EB	27814521	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000389469000011
J	Sinnott, JD; Howlett, DC				Sinnott, Joseph Dalby; Howlett, David C.			SPOT DIAGNOSIS A swollen painful foot	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sinnott, Joseph Dalby] East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, England; [Howlett, David C.] East Sussex Hosp NHS Trust, Dept Radiol, Eastbourne, England		Sinnott, JD (corresponding author), East Sussex Hosp NHS Trust, Dept Surg, Eastbourne, England.	j.d.sinnott@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 2	2016	355								i5418	10.1136/bmj.i5418	http://dx.doi.org/10.1136/bmj.i5418			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB4CU	27806963				2022-12-28	WOS:000387317900001
J	Mahon, SM				Mahon, Suzanne M.			The Deceptive Appeal of Direct-to-Consumer Genetics	ANNALS OF INTERNAL MEDICINE			English	Letter									[Mahon, Suzanne M.] St Louis Univ, St Louis, MO 63103 USA	Saint Louis University	Mahon, SM (corresponding author), St Louis Univ, St Louis, MO 63103 USA.							Burke W, 2016, ANN INTERN MED, V164, P564, DOI 10.7326/M16-0257; Dean M, 2016, HEALTH COMMUN, V31, P752, DOI 10.1080/10410236.2014.995866; Singleton A, 2012, J GENET COUNS, V21, P433, DOI 10.1007/s10897-011-9474-6; Skirton H, 2012, CLIN GENET, V82, P210, DOI 10.1111/j.1399-0004.2012.01863.x; van der Wouden CH, 2016, ANN INTERN MED, V164, P513, DOI 10.7326/M15-0995	5	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					675	676		10.7326/L16-0333	http://dx.doi.org/10.7326/L16-0333			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27802467				2022-12-28	WOS:000386908600019
J	Birks, HJB; Birks, HH; Ammann, B				Birks, H. John B.; Birks, Hilary H.; Ammann, Brigitta			The fourth dimension of vegetation	SCIENCE			English	Editorial Material									[Birks, H. John B.; Birks, Hilary H.] Univ Bergen, Dept Biol, POB 7803, N-5020 Bergen, Norway; [Birks, H. John B.] UCL, Environm Change Res Ctr, London WC1E 6BT, England; [Ammann, Brigitta] Univ Bern, Oeschger Ctr Climate Change Res, CH-3013 Bern, Switzerland; [Ammann, Brigitta] Univ Bern, Inst Plant Sci, CH-3013 Bern, Switzerland	University of Bergen; University of London; University College London; University of Bern; University of Bern	Birks, HJB (corresponding author), Univ Bergen, Dept Biol, POB 7803, N-5020 Bergen, Norway.; Birks, HJB (corresponding author), UCL, Environm Change Res Ctr, London WC1E 6BT, England.	john.birks@uib.no; hilary.birks@uib.no; brigitta.ammann@ips.unibe.ch						Ammann B, 2013, PALAEOGEOGR PALAEOCL, V391, P40, DOI 10.1016/j.palaeo.2012.07.010; [Anonymous], 2016, CENTENARY 1916 2016; Birks HJB, 2005, GRANA, V44, P1, DOI 10.1080/00173130510010477; Birks HJB, 2008, NATURAL CLIMATE VARI, P7, DOI DOI 10.1002/9781444300932.CH2; Brewer S, 2017, J MAPS, V13, P921, DOI 10.1080/17445647.2016.1197613; DEEVEY ES, 1969, BIOSCIENCE, V19, P40, DOI 10.2307/1294629; Faegri K., 1950, TXB MODERN POLLEN AN; National Research Council, 2005, GEOL REC EC DYN UND; RITCHIE JC, 1995, NEW PHYTOL, V130, P469, DOI 10.1111/j.1469-8137.1995.tb04325.x; Seddon AWR, 2014, J ECOL, V102, P256, DOI 10.1111/1365-2745.12195; von Post L., 1918, FORH 16 SKAND NATURF, V1916, P433; von Post L., 1950, GEOL FOREN STOCKH FO, V72, P363; Von Post L, 1916, GEOLOGISKA FORENINGE, V38, P384; VON POST LENNART, 1967, POLLEN SPORES, V9, P375	14	23	25	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					412	413		10.1126/science.aai8737	http://dx.doi.org/10.1126/science.aai8737			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9AT	27789825				2022-12-28	WOS:000387684400020
J	Bjork, BJ; Bui, TQ; Heckl, OH; Changala, PB; Spaun, B; Heu, P; Follman, D; Deutsch, C; Cole, GD; Aspelmeyer, M; Okumura, M; Ye, J				Bjork, B. J.; Bui, T. Q.; Heckl, O. H.; Changala, P. B.; Spaun, B.; Heu, P.; Follman, D.; Deutsch, C.; Cole, G. D.; Aspelmeyer, M.; Okumura, M.; Ye, J.			Direct frequency comb measurement of OD plus CO -> DOCO kinetics	SCIENCE			English	Article							PRESSURE-DEPENDENCE; RATE-CONSTANT; VIBRATIONAL-EXCITATION; REACTION OH; SPECTROSCOPY; RADICALS; COMPLEX; TEMPERATURE; ABSORPTION; RESOLUTION	The kinetics of the hydroxyl radical (OH) + carbon monoxide (CO) reaction, which is fundamental to both atmospheric and combustion chemistry, are complex because of the formation of the hydrocarboxyl radical (HOCO) intermediate. Despite extensive studies of this reaction, HOCO has not been observed under thermal reaction conditions. Exploiting the sensitive, broadband, and high-resolution capabilities of time-resolved cavity-enhanced direct frequency comb spectroscopy, we observed deuteroxyl radical (OD) + CO reaction kinetics and detected stabilized trans-DOCO, the deuterated analog of trans-HOCO. By simultaneously measuring the time-dependent concentrations of the trans-DOCO and OD species, we observed unambiguous low-pressure termolecular dependence of the reaction rate coefficients for N-2 and CO bath gases. These results confirm the HOCO formation mechanism and quantify its yield.	[Bjork, B. J.; Bui, T. Q.; Heckl, O. H.; Changala, P. B.; Spaun, B.; Ye, J.] NIST, JILA, Boulder, CO 80309 USA; [Bjork, B. J.; Bui, T. Q.; Heckl, O. H.; Changala, P. B.; Spaun, B.; Ye, J.] Univ Colorado, Boulder, CO 80309 USA; [Bjork, B. J.; Bui, T. Q.; Heckl, O. H.; Changala, P. B.; Spaun, B.; Ye, J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Heu, P.; Follman, D.; Cole, G. D.] Crystalline Mirror Solut, 114 East Haley St,Suite G, Santa Barbara, CA 93101 USA; [Deutsch, C.; Cole, G. D.] Crystalline Mirror Solut, Parkring 10, A-1010 Vienna, Austria; [Aspelmeyer, M.] Univ Vienna, Vienna Ctr Quantum Sci & Technol, Fac Phys, A-1090 Vienna, Austria; [Okumura, M.] CALTECH, Div Chem & Chem Engn, Arthur Amos Noyes Lab Chem Phys, 1200 East Calif Blvd, Pasadena, CA 91125 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Vienna; California Institute of Technology	Bjork, BJ; Ye, J (corresponding author), NIST, JILA, Boulder, CO 80309 USA.; Bjork, BJ; Ye, J (corresponding author), Univ Colorado, Boulder, CO 80309 USA.; Bjork, BJ; Ye, J (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.	bryce.bjork@colorado.edu; ye@jila.colorado.edu	Cole, Garrett D/B-9383-2011; Heckl, Oliver/M-5348-2017; Aspelmeyer, Markus/C-4098-2017; Ye, Jun/C-3312-2011; Okumura, Mitchio/I-3326-2013	Cole, Garrett D/0000-0001-7149-3218; Heckl, Oliver/0000-0003-2879-1564; Aspelmeyer, Markus/0000-0003-4499-7335; Ye, Jun/0000-0003-0076-2112; Okumura, Mitchio/0000-0001-6874-1137; Bui, Thinh Q./0000-0001-6090-0930	Air Force Office of Scientific Research; Defense Advanced Research Projects Agency (DARPA) Spectral Combs from UV; National Institute of Standards and Technology; NSF; DARPA [FAA-9550-14-C-0030, W31P4Q-16-C-0001]; NSF [CHE-1413712]; National Research Council Research Associate Fellowship; NSF Graduate Research Fellowship Program; Humboldt Fellowship; Direct For Mathematical & Physical Scien [1413712] Funding Source: National Science Foundation	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Defense Advanced Research Projects Agency (DARPA) Spectral Combs from UV; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NSF(National Science Foundation (NSF)); National Research Council Research Associate Fellowship; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Humboldt Fellowship(Alexander von Humboldt Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Additional data supporting the conclusions are available in supplementary materials. We thank K. Sung of the NASA Jet Propulsion Laboratory (JPL) for providing a list of D<INF>2</INF>O mid-IR line positions and intensities measured by R. A. Toth of JPL. We acknowledge financial support from the Air Force Office of Scientific Research, the Defense Advanced Research Projects Agency (DARPA) Spectral Combs from UV to THz (SCOUT) program, the National Institute of Standards and Technology, NSF, and DARPA (grants FAA-9550-14-C-0030 and W31P4Q-16-C-0001). M.O. is supported by NSF grant CHE-1413712. T.Q.B. and B.S. are supported by the National Research Council Research Associate Fellowship, P.B.C. is supported by the NSF Graduate Research Fellowship Program, and O.H.H. is partially supported through a Humboldt Fellowship. P.H., D.F., and C.D. are employees of a startup company (Crystalline Mirror Solutions), cofounded by G.D.C. and M.A., and coinventors on a submitted patent focusing on the crystalline mirror technology applied in this Report.	ABRAMS MC, 1994, J MOL SPECTROSC, V165, P57, DOI 10.1006/jmsp.1994.1110; Adler F, 2009, OPT LETT, V34, P1330, DOI 10.1364/OL.34.001330; Boxe CS, 2014, ICARUS, V242, P97, DOI 10.1016/j.icarus.2014.07.023; BROCK JC, 1980, CHEM PHYS LETT, V71, P371, DOI 10.1016/0009-2614(80)80185-0; Brouard M, 2000, J CHEM PHYS, V112, P4557, DOI 10.1063/1.481081; BRUNNING J, 1988, J CHEM SOC FARAD T 2, V84, P105, DOI 10.1039/f29888400105; BUTLER JE, 1983, CHEM PHYS LETT, V95, P183, DOI 10.1016/0009-2614(83)87228-5; Chang CH, 2013, J PHYS CHEM A, V117, P13255, DOI 10.1021/jp403386d; Chen WC, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2031208; CLARY DC, 1993, J CHEM PHYS, V99, P4578, DOI 10.1063/1.466057; Cole GD, 2016, OPTICA, V3, P647, DOI 10.1364/OPTICA.3.000647; Fleisher AJ, 2014, J PHYS CHEM LETT, V5, P2241, DOI 10.1021/jz5008559; Francisco JS, 2010, ACCOUNTS CHEM RES, V43, P1519, DOI 10.1021/ar100087v; FROST MJ, 1993, J PHYS CHEM-US, V97, P12254, DOI 10.1021/j100149a027; FROST MJ, 1991, FARADAY DISCUSS, V91, P305, DOI 10.1039/dc9919100305; Fulle D, 1996, J CHEM PHYS, V105, P983, DOI 10.1063/1.471991; Golden DM, 1998, J PHYS CHEM A, V102, P8598, DOI 10.1021/jp982110m; HERNANDEZ MI, 1994, J CHEM PHYS, V101, P2779, DOI 10.1063/1.467593; IONOV SI, 1993, J CHEM PHYS, V99, P6553, DOI 10.1063/1.465847; Jasper AW, 2014, SCIENCE, V346, P1212, DOI 10.1126/science.1260856; Johnson CJ, 2014, PHYS CHEM CHEM PHYS, V16, P19091, DOI 10.1039/c4cp02593h; Kohno N, 2011, J PHYS CHEM A, V115, P4867, DOI 10.1021/jp200220f; LARSON CW, 1988, INT J CHEM KINET, V20, P27, DOI 10.1002/kin.550200105; Lelieveld J, 2008, NATURE, V452, P737, DOI 10.1038/nature06870; Liu YD, 2015, J PHYS CHEM A, V119, P10060, DOI 10.1021/acs.jpca.5b07220; Mauldin RL, 2012, NATURE, V488, P193, DOI 10.1038/nature11278; McCabe DC, 2001, GEOPHYS RES LETT, V28, P3135, DOI 10.1029/2000GL012719; McCarthy MC, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4944070; Oyama T, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3578179; PARASKEVOPOULOS G, 1982, CHEM PHYS LETT, V93, P138, DOI 10.1016/0009-2614(82)83680-4; PARASKEVOPOULOS G, 1984, J CHEM PHYS, V80, P259, DOI 10.1063/1.446488; PETTY JT, 1993, J CHEM PHYS, V99, P47, DOI 10.1063/1.465773; SCHERER NF, 1987, J CHEM PHYS, V87, P1451, DOI 10.1063/1.453280; SMITH IWM, 1973, J CHEM SOC FARAD T 2, V69, P1617, DOI 10.1039/f29736901617; Nguyen TL, 2012, J PHYS CHEM LETT, V3, P1549, DOI 10.1021/jz300443a; Toth RA, 1999, J MOL SPECTROSC, V195, P98, DOI 10.1006/jmsp.1999.7815; TROE J, 1981, J CHEM PHYS, V75, P226, DOI 10.1063/1.441829; WESTENBERG AA, 1966, J CHEM PHYS, V45, P338, DOI 10.1063/1.1727330; Western CM, 2017, J QUANT SPECTROSC RA, V186, P221, DOI 10.1016/j.jqsrt.2016.04.010; Weston RE, 2013, J PHYS CHEM A, V117, P821, DOI 10.1021/jp311928w	40	62	63	3	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					444	448		10.1126/science.aag1862	http://dx.doi.org/10.1126/science.aag1862			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789837	Green Submitted			2022-12-28	WOS:000387684400036
J	Kaiser, J				Kaiser, Jocelyn			Baby genome screening needs more time to gestate	SCIENCE			English	News Item																			0	6	6	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					398	399		10.1126/science.354.6311.398	http://dx.doi.org/10.1126/science.354.6311.398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27789817				2022-12-28	WOS:000387684400012
J	Blendon, RJ; Benson, JM; Casey, LS				Blendon, Robert J.; Benson, John M.; Casey, Logan S.			Health Care in the 2016 Election - A View through Voters' Polarized Lenses	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Blendon, Robert J.; Benson, John M.; Casey, Logan S.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Blendon, Robert J.] John F Kennedy Sch Govt, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health	Blendon, RJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave,4th Fl, Boston, MA 02115 USA.	rblendon@hsph.harvard.edu	Casey, Logan S./J-8263-2019	Casey, Logan S./0000-0002-8232-7925				[Anonymous], 2016, CBS NEWS NEW YO 0915; [Anonymous], 2016, CBS NEWS NEW YO 0321; Blendon RJ, 2012, NEW ENGL J MED, V367, P2443, DOI 10.1056/NEJMsr1213905; Edison Research-National Election Pool, 2012, EL DAY EXIT POLL; Gallup, 2016, MOR AM NEG POS ACA; Gallup, 2015, AM OWN HEALTHC RAT L; Hetherington Marc J., 2015, WHY WASHINGTON WONT; Kaiser Family Foundation, 2016, KAISER HLTH TRACKING; Levendusky Matthew., 2009, PARTISAN SORT LIBERA; National Public Radio Robert Wood Johnson Foundation Harvard T. H. Chan School of Public Health, 2016, PAT PERSP HLTH CAR U; National Public Radio Robert Wood Johnson Foundation Harvard T. H. Chan School of Public Health poll, 2015, IPOLL DAT; Pew Research Center, 2012, PART POL SURG BUSH O; Pew Research Center, 2014, POLITICAL POLARIZATI; Pew Research Center, 2015, PUBL TRUST GOV 1958; Pew Research Center, 2016, MOR AM DIS APPR HLTH; Pew Research Center Poll, 2016, 3 VIEWS EC GOV SERV; Politico Harvard T. H. Chan School of Public Health, 2016, AM VIEWS CURRENT TRA; Politico Harvard T. H. Chan School of Public Health Poll, 2016, VOT HLTH CAR 2016 EL	18	13	13	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 27	2016	375	17							e37	10.1056/NEJMsr1606159	http://dx.doi.org/10.1056/NEJMsr1606159			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB2DX	27783924				2022-12-28	WOS:000387168900003
J	[Anonymous]				[Anonymous]			A Pound of Prevention (Reprinted from JAMA, vol 198, pg 480, 1966)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		BOUCOT KR, 1961, ANN INTERN MED, V54, P363, DOI 10.7326/0003-4819-54-3-363; Early Diagnosis of Diabetes, 1966, BRIT MED J, V1, P497; ELSOM KA, 1966, ARCH ENVIRON HEALTH, V13, P274, DOI 10.1080/00039896.1966.10664555; SIEGEL GC, 2016, JAMA-J AM MED ASSOC, V316, P1719; SIEGEL GS, 1966, ARCH ENVIRON HEALTH, V13, P292, DOI 10.1080/00039896.1966.10664561; 1966, JAMA, V198, P480	6	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 25	2016	316	16					1719	1719		10.1001/jama.2015.17107	http://dx.doi.org/10.1001/jama.2015.17107			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ8GB	27784084				2022-12-28	WOS:000386107800048
J	Mumme, M; Barbero, A; Miot, S; Wixmerten, A; Feliciano, S; Wolf, F; Asnaghi, AM; Baumhoer, D; Bieri, O; Kretzschmar, M; Pagenstert, G; Haug, M; Schaefer, DJ; Martin, I; Jakob, M				Mumme, Marcus; Barbero, Andrea; Miot, Sylvie; Wixmerten, Anke; Feliciano, Sandra; Wolf, Francine; Asnaghi, Adelaide M.; Baumhoer, Daniel; Bieri, Oliver; Kretzschmar, Martin; Pagenstert, Geert; Haug, Martin; Schaefer, Dirk J.; Martin, Ivan; Jakob, Marcel			Nasal chondrocyte-based engineered autologous cartilage tissue for repair of articular cartilage defects: an observational first-in-human trial	LANCET			English	Article							GADOLINIUM-ENHANCED MRI; HYALINE CARTILAGE; IMPLANTATION; TRANSPLANTATION; MATURATION	Background Articular cartilage injuries have poor repair capacity, leading to progressive joint damage, and cannot be restored predictably by either conventional treatments or advanced therapies based on implantation of articular chondrocytes. Compared with articular chondrocytes, chondrocytes derived from the nasal septum have superior and more reproducible capacity to generate hyaline-like cartilage tissues, with the plasticity to adapt to a joint environment. We aimed to assess whether engineered autologous nasal chondrocyte-based cartilage grafts allow safe and functional restoration of knee cartilage defects. Methods In a first-in-human trial, ten patients with symptomatic, post-traumatic, full-thickness cartilage lesions (2-6 cm(2)) on the femoral condyle or trochlea were treated at University Hospital Basel in Switzerland. Chondrocytes isolated from a 6 mm nasal septum biopsy specimen were expanded and cultured onto collagen membranes to engineer cartilage grafts (30 x 40 x 2 mm). The engineered tissues were implanted into the femoral defects via mini-arthrotomy and assessed up to 24 months after surgery. Primary outcomes were feasibility and safety of the procedure. Secondary outcomes included self-assessed clinical scores and MRI-based estimation of morphological and compositional quality of the repair tissue. This study is registered with ClinicalTrials.gov, number NCT01605201. The study is ongoing, with an approved extension to 25 patients. Findings For every patient, it was feasible to manufacture cartilaginous grafts with nasal chondrocytes embedded in an extracellular matrix rich in glycosaminoglycan and type II collagen. Engineered tissues were stable through handling with forceps and could be secured in the injured joints. No adverse reactions were recorded and self-assessed clinical scores for pain, knee function, and quality of life were improved significantly from before surgery to 24 months after surgery. Radiological assessments indicated variable degrees of defect filling and development of repair tissue approaching the composition of native cartilage. Interpretation Hyaline-like cartilage tissues, engineered from autologous nasal chondrocytes, can be used clinically for repair of articular cartilage defects in the knee. Future studies are warranted to assess efficacy in large controlled trials and to investigate an extension of indications to early degenerative states or to other joints.	[Mumme, Marcus; Barbero, Andrea; Miot, Sylvie; Wixmerten, Anke; Feliciano, Sandra; Wolf, Francine; Asnaghi, Adelaide M.; Pagenstert, Geert; Haug, Martin; Schaefer, Dirk J.; Martin, Ivan; Jakob, Marcel] Univ Basel, Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland; [Mumme, Marcus; Barbero, Andrea; Miot, Sylvie; Wixmerten, Anke; Feliciano, Sandra; Wolf, Francine; Asnaghi, Adelaide M.; Pagenstert, Geert; Haug, Martin; Schaefer, Dirk J.; Martin, Ivan; Jakob, Marcel] Univ Basel, Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Baumhoer, Daniel] Univ Basel, Univ Basel Hosp, Inst Pathol, Basel, Switzerland; [Bieri, Oliver; Kretzschmar, Martin] Univ Basel, Univ Basel Hosp, Dept Radiol, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Martin, I (corresponding author), Univ Basel, Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.; Martin, I (corresponding author), Univ Basel, Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.	ivan.martin@usb.ch	Jakob, Marcel/AAI-6122-2021; Barbero, Andrea/A-6469-2008; Martin, Ivan/K-9286-2016	Jakob, Marcel/0000-0002-9021-0890; Martin, Ivan/0000-0001-6493-0432; Asnaghi, Maria Adelaide/0000-0002-4261-3767; Barbero, Andrea/0000-0001-5252-789X	Deutsche Arthrose-Hilfe [P245-A546-Martin-EP1-mumm1-knie-op-III-2011-15]; Deutsche Arthrose-Hilfe	Deutsche Arthrose-Hilfe; Deutsche Arthrose-Hilfe	Deutsche Arthrose-Hilfe.	Albrecht C, 2011, OSTEOARTHR CARTILAGE, V19, P1219, DOI 10.1016/j.joca.2011.07.004; Bornes TD, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0432-1; Buckwalter JA, 2006, ADV DRUG DELIVER REV, V58, P150, DOI 10.1016/j.addr.2006.01.006; Candrian C, 2008, ARTHRITIS RHEUM-US, V58, P197, DOI 10.1002/art.23155; Dewan AK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/272481; Endo J, 2015, OSTEOARTHR CARTILAGE, V23, P280, DOI 10.1016/j.joca.2014.10.012; European Medicines Agency, ICH TOP E 2 A NOT GU; Farhadi J, 2006, ANN SURG, V244, P978, DOI 10.1097/01.sla.0000247057.16710.be; Fulco I, 2014, LANCET, V384, P337, DOI 10.1016/S0140-6736(14)60544-4; Hambly K., 2009, SPORTEX MED, V39, P17; Heule R, 2014, MAGN RESON MED, V71, P1137, DOI 10.1002/mrm.24748; Jin CZ, 2011, TISSUE ENG PT A, V17, P3057, DOI [10.1089/ten.tea.2010.0605, 10.1089/ten.TEA.2010.0605]; Johnstone B, 2013, EUR CELLS MATER, V25, P248, DOI 10.22203/eCM.v025a18; Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178; Makris EA, 2015, NAT REV RHEUMATOL, V11, P21, DOI 10.1038/nrrheum.2014.157; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; Marlovits S, 2006, EUR J RADIOL, V57, P16, DOI 10.1016/j.ejrad.2005.08.007; Martin I, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008558; Minas T, 2012, J BONE JOINT SURG BR, V94B, P141, DOI 10.1302/0301-620X.94B11.30679; Miot S, 2012, EUR CELLS MATER, V23, P222, DOI 10.22203/eCM.v023a17; Mumme M, 2016, TISSUE ENG PT A, V22, P1286, DOI 10.1089/ten.tea.2016.0159; Niethammer TR, 2014, AM J SPORT MED, V42, P2199, DOI 10.1177/0363546514538756; Pelttari K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009688; Rotter N, 2002, BIOMATERIALS, V23, P3087, DOI 10.1016/S0142-9612(02)00031-5; Saris DBF, 2008, AM J SPORT MED, V36, P235, DOI 10.1177/0363546507311095; Scotti C, 2012, TISSUE ENG PT A, V18, P362, DOI [10.1089/ten.tea.2011.0234, 10.1089/ten.TEA.2011.0234]; Shafiee A, 2011, STEM CELLS DEV, V20, P2077, DOI 10.1089/scd.2010.0420; Trattnig S, 2008, EUR RADIOL, V18, P1251, DOI 10.1007/s00330-008-0859-3; Vinatier C, 2009, J BIOMED MATER RES A, V89A, P176, DOI 10.1002/jbm.a.31988; Watanabe A, 2006, RADIOLOGY, V239, P201, DOI 10.1148/radiol.2383050173; Wiewiorski M, 2013, CLIN RADIOL, V68, P1031, DOI 10.1016/j.crad.2013.04.016; Wolf F, 2008, EUR CELLS MATER, V15, P1; Zscharnack M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0517-x	33	145	150	7	51	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 22	2016	388	10055					1985	1994		10.1016/S0140-6736(16)31658-0	http://dx.doi.org/10.1016/S0140-6736(16)31658-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6EQ	27789021				2022-12-28	WOS:000385954800028
J	Bachelet, M				Bachelet, Michelle			Women, power, and the cancer divide	LANCET			English	Editorial Material									[Bachelet, Michelle] Palacio de La Moneda S-N, Santiago, Region Metropol, Chile		Bachelet, M (corresponding author), Palacio de La Moneda S-N, Santiago, Region Metropol, Chile.	auriarte@presidencia.cl						Bastias G, 2008, CAN MED ASSOC J, V179, P1289, DOI 10.1503/cmaj.071843; Denny L., 2016, LANCET; Ferlay, 2016, CANC TODAY; Ginsburg O., 2016, LANCET; Ginsburg OM, 2011, BREAST J, V17, P289, DOI 10.1111/j.1524-4741.2011.01067.x; Knaul F, 2012, CLOSING CANC DIVIDE; Mistral G, 1998, TIERRA TIENE ACTITUD; UN, 2015, 2030 AG SUST DEV; WHO, 2010, WORLD HLTH REP HLTH; Wild CP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju353	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 25	2017	389	10071					773	774		10.1016/S0140-6736(17)30071-5	http://dx.doi.org/10.1016/S0140-6736(17)30071-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EL9UU	27814967				2022-12-28	WOS:000394966400009
